data_1uen_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1uen _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.3 169.15 12.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.522 1.482 . . . . 0.0 113.261 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mtm -132.91 -40.53 0.94 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.986 0.914 . . . . 0.0 113.413 -165.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.32 168.66 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.01 166.1 12.56 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 126.754 2.021 . . . . 0.0 109.374 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.456 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 32.5 Cg_endo -70.98 141.6 40.66 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.332 1.355 . . . . 0.0 114.44 -166.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.63 178.56 23.86 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.506 1.526 . . . . 0.0 111.726 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 23.65 66.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.877 3.271 . . . . 0.0 114.477 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 t -76.27 132.53 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.46 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -148.23 166.48 27.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.442 1.497 . . . . 0.0 109.44 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.51 141.61 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 120.78 -1.2 . . . . 0.0 108.62 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.0 119.25 29.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.224 2.61 . . . . 0.0 109.225 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.72 130.21 35.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 119.196 0.907 . . . . 0.0 108.851 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.32 -64.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 126.139 1.776 . . . . 0.0 107.993 -171.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -115.88 179.16 4.06 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.589 1.156 . . . . 0.0 108.065 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -18.3 61.52 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.224 -0.922 . . . . 0.0 112.768 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -126.35 0.27 7.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.323 1.849 . . . . 0.0 112.687 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -139.16 128.1 23.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.695 1.598 . . . . 0.0 108.207 -170.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.94 172.57 8.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.65 117.29 13.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 152.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -132.47 148.81 52.41 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.549 1.54 . . . . 0.0 109.138 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -160.28 164.89 32.27 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.662 1.585 . . . . 0.0 109.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -87.83 145.24 36.31 Favored Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 120.942 -1.099 . . . . 0.0 112.034 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.31 102.58 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.854 3.036 . . . . 0.0 111.095 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.456 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 4.6 m -64.26 158.88 62.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.77 144.86 39.93 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.317 3.345 . . . . 0.0 110.229 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.08 -30.72 62.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.243 0.474 . . . . 0.0 111.143 169.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -56.75 -28.49 61.27 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.6 p -89.58 -29.81 18.62 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 111.459 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 81.9 mt -67.83 -38.44 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.331 1.053 . . . . 0.0 109.071 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 50.01 80.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.639 1.575 . . . . 0.0 110.606 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.61 -102.76 0.83 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -138.22 103.58 4.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.6 -166.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.0 tp -54.88 119.62 5.65 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 127.006 2.123 . . . . 0.0 109.393 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -86.72 -48.7 8.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.078 0.951 . . . . 0.0 108.941 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.26 173.0 45.98 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -99.93 136.13 40.31 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 161.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -105.7 152.09 23.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.9 mt -126.4 126.2 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.45 141.28 28.7 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -153.02 159.95 42.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.543 1.137 . . . . 0.0 110.962 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -148.46 158.27 44.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.357 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -68.94 127.32 32.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.641 1.576 . . . . 0.0 106.87 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttt . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.25 149.38 28.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.94 144.7 50.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 128.665 2.786 . . . . 0.0 107.533 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.5 m -130.52 117.14 19.16 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -128.67 85.74 2.37 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.278 1.031 . . . . 0.0 109.011 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -67.54 147.09 53.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.053 0.541 . . . . 0.0 110.245 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.61 167.55 26.24 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 122.705 1.17 . . . . 0.0 111.409 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -87.55 44.37 1.18 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -151.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 167.02 3.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.396 0.617 . . . . 0.0 111.304 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 p -124.53 -1.97 7.99 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.701 1.6 . . . . 0.0 111.355 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -148.61 160.7 42.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.172 1.389 . . . . 0.0 107.39 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.02 134.24 3.26 Favored Glycine 0 N--CA 1.454 -0.162 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.6 mtp -81.67 153.47 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.038 0.419 . . . . 0.0 111.338 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -106.92 91.08 5.9 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 167.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.87 154.92 2.27 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.953 3.102 . . . . 0.0 111.92 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.19 37.08 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.02 -166.41 1.23 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.402 3.081 . . . . 0.0 107.329 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -121.97 146.79 47.19 Favored Pre-proline 0 N--CA 1.45 -0.466 0 O-C-N 120.918 -1.114 . . . . 0.0 111.323 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 167.63 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.265 3.31 . . . . 0.0 111.963 163.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.262 0.3 OUTLIER 40.12 42.1 1.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.841 2.456 . . . . 0.0 111.525 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -133.62 153.12 51.91 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.557 -1.34 . . . . 0.0 108.44 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -94.14 146.53 23.92 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.11 153.99 51.82 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.8 m -126.64 143.71 51.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.08 163.12 39.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.354 1.861 . . . . 0.0 109.714 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -152.76 151.72 30.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 110.216 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.59 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.913 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -137.37 138.5 39.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.096 1.359 . . . . 0.0 108.326 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.12 152.41 3.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 64.0 t -137.36 134.94 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -128.3 -174.95 3.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.433 1.093 . . . . 0.0 109.713 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.72 -7.33 41.05 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.339 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.93 -38.93 5.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.95 1.7 . . . . 0.0 110.541 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.04 -173.27 45.13 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 110.638 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 166.78 22.81 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.34 -0.506 . . . . 0.0 110.814 164.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 -158.42 10.38 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 160.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.75 158.06 44.29 Favored 'Trans proline' 0 C--O 1.237 0.428 0 CA-C-N 119.886 1.843 . . . . 0.0 112.586 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.4 143.35 26.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.639 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.23 175.18 2.96 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 126.064 1.746 . . . . 0.0 111.185 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.35 137.48 65.61 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.731 1.621 . . . . 0.0 109.353 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.73 153.92 27.0 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.271 1.034 . . . . 0.0 110.729 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.4 mmt-85 -134.5 170.54 15.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 107.687 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.6 m -135.27 157.01 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.786 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -153.72 143.03 21.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -112.4 137.69 50.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 170.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -92.16 151.21 41.49 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.16 -73.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.846 3.031 . . . . 0.0 113.265 -159.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -154.0 -41.31 0.09 Allowed 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.562 0 CA-C-O 119.287 -0.729 . . . . 0.0 111.701 -167.874 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 119.131 -0.462 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.9 -175.78 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.295 2.663 . . . . 0.0 112.807 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 42.5 mtm -126.51 -59.37 1.3 Allowed 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 110.467 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.21 148.93 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.605 0.717 . . . . 0.0 111.635 -168.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.75 168.4 18.47 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.003 2.121 . . . . 0.0 109.912 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 2.0 Cg_endo -61.01 155.82 48.04 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.345 1.363 . . . . 0.0 113.308 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.34 -175.49 30.24 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.115 1.34 . . . . 0.0 111.088 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -36.09 103.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 127.476 2.311 . . . . 0.0 113.757 -163.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.56 139.73 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.27 156.44 45.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.46 118.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 119.214 0.915 . . . . 0.0 109.285 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -96.7 121.41 38.52 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.465 1.106 . . . . 0.0 109.202 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.0 t -86.5 108.62 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.1 -56.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.765 0.826 . . . . 0.0 108.885 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.19 -174.3 3.29 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.13 0.972 . . . . 0.0 109.674 -163.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -27.84 67.76 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.623 -0.673 . . . . 0.0 112.136 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.4 p -129.39 7.55 5.38 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.46 1.104 . . . . 0.0 111.795 -166.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -138.54 139.45 38.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.17 1.788 . . . . 0.0 108.352 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.03 173.42 11.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.938 167.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 151.22 51.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.635 1.974 . . . . 0.0 108.877 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 t -126.97 134.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -119.47 128.98 54.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -142.99 -179.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.529 1.132 . . . . 0.0 110.279 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.1 144.58 29.69 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.899 0.879 . . . . 0.0 111.704 -172.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.53 96.47 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.409 2.739 . . . . 0.0 111.192 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 32.4 m -64.03 157.04 71.62 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.052 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.31 146.01 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.308 2.672 . . . . 0.0 109.358 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.06 -30.75 71.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.759 -0.588 . . . . 0.0 111.798 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -59.3 -34.55 72.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.402 -0.808 . . . . 0.0 111.614 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.6 p -64.39 -42.99 95.84 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.494 1.043 . . . . 0.0 110.062 172.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.7 mt -64.25 -31.52 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.086 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 54.72 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.643 2.377 . . . . 0.0 115.232 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.13 -155.57 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.315 1.912 . . . . 0.0 109.591 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -103.94 109.73 21.6 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.82 1.248 . . . . 0.0 110.874 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -46.29 110.45 0.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 127.092 2.157 . . . . 0.0 109.678 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -86.01 -12.91 49.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.627 0.727 . . . . 0.0 111.544 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.15 28.43 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -101.47 155.76 17.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 164.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -122.1 144.6 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.48 120.17 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.86 150.85 20.84 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 163.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -158.67 160.23 36.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.695 1.598 . . . . 0.0 109.726 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -149.37 157.44 43.32 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.687 0.795 . . . . 0.0 109.789 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -68.12 125.45 26.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.098 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.8 tttp . . . . . 0 N--CA 1.441 -0.893 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.72 143.15 37.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.93 153.44 48.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 107.176 167.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -133.28 127.9 34.64 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -138.11 88.93 2.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.77 0.828 . . . . 0.0 109.386 -172.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -71.36 151.37 44.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.273 1.029 . . . . 0.0 110.286 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.62 164.0 29.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.133 1.349 . . . . 0.0 112.199 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -79.74 58.15 2.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.748 1.619 . . . . 0.0 110.428 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.04 171.08 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.556 1.143 . . . . 0.0 109.924 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 7.23 2.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.973 1.709 . . . . 0.0 111.932 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -144.4 159.57 42.5 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.574 0.75 . . . . 0.0 109.362 167.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.45 148.46 12.06 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.352 1.453 . . . . 0.0 111.266 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.4 mtp -77.96 169.51 18.17 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -169.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.78 96.32 32.68 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 126.835 2.054 . . . . 0.0 105.851 163.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -99.49 161.53 0.57 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.267 2.644 . . . . 0.0 111.702 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.36 35.5 56.33 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.331 -0.856 . . . . 0.0 111.784 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.45 161.65 18.52 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.59 130.03 24.12 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.12 166.5 18.65 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.381 2.721 . . . . 0.0 112.232 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.9 t80 42.95 52.76 5.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.206 . . . . 0.0 113.346 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -152.08 -178.84 7.02 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.55 1.14 . . . . 0.0 110.879 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 162.59 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.394 1.478 . . . . 0.0 108.651 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -136.03 165.58 25.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.669 1.188 . . . . 0.0 108.721 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 m -125.6 146.46 49.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 157.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.72 164.09 30.87 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.466 1.906 . . . . 0.0 108.848 167.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -148.54 144.94 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.824 -0.547 . . . . 0.0 109.903 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.01 152.4 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -149.64 143.21 25.38 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.6 146.58 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.1 t -135.29 142.7 39.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 126.156 1.783 . . . . 0.0 107.215 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -144.65 -174.29 4.29 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.525 1.13 . . . . 0.0 111.156 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.08 -10.05 31.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.057 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -117.27 -22.95 8.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.929 1.365 . . . . 0.0 112.322 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.0 -153.23 23.87 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -127.13 159.8 33.13 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.745 0.783 . . . . 0.0 110.35 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.84 -165.85 27.08 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.139 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.57 166.37 24.19 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.303 1.335 . . . . 0.0 109.92 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.01 150.07 23.28 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.088 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -75.15 165.36 54.46 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -55.58 123.65 14.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.918 2.412 . . . . 0.0 110.809 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.32 143.21 53.47 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.156 1.782 . . . . 0.0 107.896 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -122.23 163.61 19.31 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.31 166.58 22.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -158.67 159.49 35.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -117.53 143.45 46.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.77 1.228 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.2 p -98.75 143.4 26.28 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -66.09 167.17 18.71 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.846 2.364 . . . . 0.0 108.969 172.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -61.87 -23.69 66.45 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -172.107 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 CA--C 1.553 1.067 0 N-CA-C 119.999 3.333 . . . . 0.0 119.999 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.94 161.17 40.71 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.171 2.58 . . . . 0.0 111.878 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 mtm -125.76 -26.59 3.47 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -169.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.3 m -140.6 169.22 15.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.494 1.117 . . . . 0.0 110.862 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.29 163.0 17.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.34 2.256 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.58 156.58 60.11 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.828 1.685 . . . . 0.0 113.393 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 166.86 54.92 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -21.3 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 129.073 2.949 . . . . 0.0 115.356 -162.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.67 130.35 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -118.82 161.14 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.68 138.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -123.79 125.29 44.44 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.421 0.689 . . . . 0.0 110.369 169.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.39 101.28 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 166.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.0 -56.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.878 2.071 . . . . 0.0 109.759 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -132.34 172.35 12.56 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.187 1.395 . . . . 0.0 107.392 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.16 0.93 0.81 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.6 p -133.62 -1.25 3.12 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.301 1.84 . . . . 0.0 112.371 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -149.07 119.81 7.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.396 1.078 . . . . 0.0 109.594 -159.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.31 130.72 48.24 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.577 0.626 . . . . 0.0 109.893 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.24 146.03 39.3 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.69 139.91 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 164.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -120.68 151.79 39.06 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.58 1.552 . . . . 0.0 108.035 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -153.0 155.79 37.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.849 0.46 . . . . 0.0 110.819 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.35 136.72 45.88 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.07 129.59 15.39 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.342 2.695 . . . . 0.0 110.388 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.21 151.86 95.8 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.659 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -85.31 159.82 11.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.938 3.092 . . . . 0.0 110.809 -173.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -60.03 -34.37 73.29 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.031 0.532 . . . . 0.0 111.663 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -66.93 -23.01 65.93 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.1 p -76.46 -41.08 48.6 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 120.077 1.308 . . . . 0.0 109.49 170.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.22 -32.7 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.237 1.415 . . . . 0.0 110.146 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 50.22 60.82 3.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.471 1.508 . . . . 0.0 110.142 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.09 -147.87 19.41 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.91 122.83 46.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.381 1.472 . . . . 0.0 110.711 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.38 111.44 0.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.75 2.02 . . . . 0.0 109.802 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.5 -13.95 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.694 0.797 . . . . 0.0 112.053 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.16 -164.47 27.94 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.12 148.98 31.51 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 107.91 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -125.9 140.98 52.2 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.2 mt -128.85 122.12 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -91.45 148.16 22.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -158.33 164.54 36.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 111.124 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -149.26 162.23 40.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -68.61 136.09 52.48 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.934 2.093 . . . . 0.0 108.38 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m . . . . . 0 C--N 1.322 -0.6 0 C-N-CA 125.788 1.635 . . . . 0.0 106.881 -175.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 mttm . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.9 mm -122.84 159.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -130.8 141.29 50.34 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 127.16 2.184 . . . . 0.0 107.233 165.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.7 m -112.9 122.21 46.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.781 1.232 . . . . 0.0 107.809 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -128.64 80.22 1.95 Allowed 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.108 0.963 . . . . 0.0 109.168 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.28 155.68 27.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.86 157.7 33.89 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.583 1.563 . . . . 0.0 111.585 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -79.5 34.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.841 1.257 . . . . 0.0 113.937 -169.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 160.81 14.92 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.538 -1.351 . . . . 0.0 111.865 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.3 p -119.82 7.01 10.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.831 2.053 . . . . 0.0 111.089 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.9 170.67 18.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.009 1.323 . . . . 0.0 109.379 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.16 158.63 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 mtp -97.34 157.9 15.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.897 1.348 . . . . 0.0 112.282 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.06 80.93 1.14 Allowed Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 129.853 3.261 . . . . 0.0 106.236 169.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -86.22 153.09 9.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.648 2.899 . . . . 0.0 110.417 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 23.38 56.74 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.741 1.162 . . . . 0.0 112.316 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.5 166.44 12.05 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 172.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 150.7 55.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.553 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -70.29 -178.77 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.911 2.407 . . . . 0.0 111.87 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 53.41 36.87 24.17 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.636 1.175 . . . . 0.0 111.333 164.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 m -146.07 155.68 42.94 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.58 1.552 . . . . 0.0 109.477 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -100.63 153.81 19.11 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -143.2 156.24 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.839 0.856 . . . . 0.0 109.426 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.9 m -125.94 139.01 53.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.07 160.59 39.91 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 110.283 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.21 145.29 24.56 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.497 -0.752 . . . . 0.0 110.816 165.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.87 151.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.931 2.092 . . . . 0.0 107.873 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.28 139.69 18.63 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.39 134.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.366 1.067 . . . . 0.0 110.12 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.45 146.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -133.29 -178.86 5.17 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.287 1.435 . . . . 0.0 109.514 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.43 53.0 2.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.198 0.904 . . . . 0.0 111.267 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -162.78 -31.79 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.383 1.873 . . . . 0.0 109.983 172.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.95 -167.68 35.45 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.158 0.866 . . . . 0.0 113.468 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.28 169.09 12.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.044 2.937 . . . . 0.0 110.213 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.45 -155.26 6.57 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 128.32 2.867 . . . . 0.0 110.047 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 137.33 39.64 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.132 2.555 . . . . 0.0 111.991 -175.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.97 158.55 35.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.535 0.734 . . . . 0.0 110.195 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.6 p -63.21 174.22 0.96 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.939 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -50.72 140.44 37.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 153.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -61.18 106.0 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 161.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -85.96 166.2 16.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.76 157.72 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -152.04 136.78 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -86.7 159.69 19.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 161.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.9 p -111.2 162.44 20.83 Favored Pre-proline 0 C--O 1.243 0.727 0 C-N-CA 123.975 0.91 . . . . 0.0 108.862 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.44 166.22 30.43 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.193 1.928 . . . . 0.0 109.044 168.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.33 -21.26 66.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.069 0.948 . . . . 0.0 112.46 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.509 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 176.152 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 C--O 1.234 0.257 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.94 166.77 28.84 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 120.991 1.127 . . . . 0.0 110.158 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.3 mtm -117.86 -44.93 2.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.269 -169.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.252 33.5 m -129.96 -175.3 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.749 1.158 . . . . 0.0 111.726 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.67 152.6 69.4 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 128.268 2.627 . . . . 0.0 108.862 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.53 137.75 23.3 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.917 1.745 . . . . 0.0 109.253 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.94 -170.81 28.68 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.1 t30 30.43 56.25 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.464 1.905 . . . . 0.0 112.557 -170.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.44 121.68 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -133.36 155.06 50.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.26 -1.336 . . . . 0.0 107.87 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.46 146.0 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.81 129.92 51.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.42 150.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.213 161.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 t -117.03 -78.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -103.08 -179.83 4.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.408 1.083 . . . . 0.0 108.706 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -17.71 63.14 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.457 -1.402 . . . . 0.0 113.47 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.8 p -133.83 10.15 3.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.889 1.276 . . . . 0.0 112.598 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -130.95 132.35 45.01 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.943 1.697 . . . . 0.0 107.548 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.73 169.2 14.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.651 0.781 . . . . 0.0 109.012 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -126.3 135.75 51.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.493 1.517 . . . . 0.0 107.334 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.22 148.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.57 154.65 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.623 1.969 . . . . 0.0 108.664 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -158.09 171.35 20.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.281 0.632 . . . . 0.0 111.386 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.59 137.52 38.74 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.818 1.647 . . . . 0.0 111.317 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.17 112.78 3.63 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.727 2.951 . . . . 0.0 111.077 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.43 158.66 64.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 122.077 -0.389 . . . . 0.0 110.568 170.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.64 160.63 14.45 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.557 2.838 . . . . 0.0 112.288 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -25.39 67.78 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.404 -0.81 . . . . 0.0 112.871 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -60.69 -49.49 77.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.568 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.4 p -66.67 -23.66 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.818 1.19 . . . . 0.0 111.503 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.5 mt -67.57 -32.88 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.539 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 47.09 30.06 1.25 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.412 1.485 . . . . 0.0 113.624 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.6 -148.82 12.35 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.569 -1.332 . . . . 0.0 113.648 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -100.52 112.1 24.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.673 1.589 . . . . 0.0 107.84 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.65 121.74 15.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.466 1.906 . . . . 0.0 109.068 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -80.88 -38.44 28.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.81 -178.21 41.23 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 121.379 -0.826 . . . . 0.0 111.945 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -99.44 124.51 44.65 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -76.79 155.63 32.95 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 160.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.16 124.71 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 156.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -91.22 147.52 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 163.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 33.8 p90 -157.37 163.0 39.07 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.467 1.507 . . . . 0.0 110.265 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -149.08 157.16 43.17 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.762 0.791 . . . . 0.0 111.76 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -67.95 125.66 27.02 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.624 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.4 mm -132.25 155.02 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.448 0.699 . . . . 0.0 109.685 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.51 157.5 46.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.957 2.503 . . . . 0.0 108.816 170.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -131.02 116.37 17.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.773 1.229 . . . . 0.0 109.633 -170.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.16 97.6 5.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.922 1.289 . . . . 0.0 107.807 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.92 172.03 12.48 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.236 0.541 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.24 15.1 70.06 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.58 26.19 15.88 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 171.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.5 167.52 0.49 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.049 1.74 . . . . 0.0 112.701 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.6 p -102.92 5.12 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 112.399 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.79 168.07 21.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.225 0.61 . . . . 0.0 110.792 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.13 33.24 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.759 2.123 . . . . 0.0 108.626 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.4 mtp -131.85 167.91 18.77 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.891 1.345 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.11 76.42 51.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.914 1.686 . . . . 0.0 107.27 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -82.38 151.86 15.58 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.92 2.413 . . . . 0.0 110.88 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.89 18.64 46.57 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.428 0.537 . . . . 0.0 112.043 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.84 -169.55 2.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.972 1.309 . . . . 0.0 110.387 -171.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.52 149.33 64.5 Favored Pre-proline 0 CA--C 1.54 0.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.347 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -77.69 173.97 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.423 2.749 . . . . 0.0 112.851 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.1 t80 44.26 53.23 6.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.194 1.798 . . . . 0.0 111.868 172.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m -155.85 146.64 22.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 120.963 -1.086 . . . . 0.0 110.686 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -78.77 151.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.13 0.972 . . . . 0.0 108.876 171.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -143.7 154.93 43.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.632 1.573 . . . . 0.0 108.113 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.5 m -117.13 147.83 42.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 171.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -150.6 158.75 44.52 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.66 1.984 . . . . 0.0 110.141 171.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.75 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.3 155.83 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 107.622 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -152.4 142.12 21.92 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 119.832 -1.793 . . . . 0.0 108.686 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 m -81.51 148.21 5.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.4 t -136.44 136.57 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -136.24 -171.12 2.81 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.378 0.671 . . . . 0.0 110.22 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.67 -15.98 14.64 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.213 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -111.58 -46.99 3.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.117 1.958 . . . . 0.0 111.191 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.04 -170.17 34.12 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.363 0.983 . . . . 0.0 112.406 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -108.16 145.56 33.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 109.467 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.92 -165.23 31.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.906 1.241 . . . . 0.0 114.014 -168.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.71 133.58 49.03 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.252 1.968 . . . . 0.0 108.879 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.29 157.46 16.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.722 0.773 . . . . 0.0 109.977 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 p -67.79 165.46 31.1 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 156.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -63.47 152.91 77.86 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.356 1.37 . . . . 0.0 109.642 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.48 96.91 4.83 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.294 2.238 . . . . 0.0 105.94 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -76.69 168.46 20.04 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.1 1.36 . . . . 0.0 109.562 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.27 164.8 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.201 0.6 . . . . 0.0 111.306 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -160.14 156.47 26.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.942 2.097 . . . . 0.0 108.085 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -122.13 141.37 51.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.324 1.05 . . . . 0.0 109.758 165.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.2 154.25 88.34 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 123.619 0.574 . . . . 0.0 110.792 173.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.41 -73.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.802 3.001 . . . . 0.0 111.403 -168.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.68 -39.77 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.264 0 CA-C-N 118.817 0.735 . . . . 0.0 111.456 -166.929 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 mt . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -66.93 157.31 62.17 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.484 2.123 . . . . 0.0 112.152 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 mtm -112.0 -28.16 8.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -168.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.49 175.98 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.746 1.618 . . . . 0.0 108.052 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.06 167.45 12.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.204 2.202 . . . . 0.0 108.776 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 18.7 Cg_endo -68.27 113.85 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.436 2.091 . . . . 0.0 111.882 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.14 157.07 12.83 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 41.46 62.01 1.65 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.622 1.569 . . . . 0.0 110.326 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -55.46 146.58 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 157.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -140.85 161.32 38.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.3 146.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 O-C-N 119.725 -1.859 . . . . 0.0 109.057 169.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -123.98 151.28 43.84 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.099 2.56 . . . . 0.0 107.732 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.71 145.02 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.5 t -111.73 -57.78 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.45 -173.35 2.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.031 1.333 . . . . 0.0 107.593 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -31.89 71.9 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.863 -1.148 . . . . 0.0 112.377 175.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.8 p -122.5 13.13 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 111.008 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.4 ' CD1' ' HE3' ' A' ' 83' ' ' MET . 2.0 tm? -134.66 139.27 45.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.516 1.926 . . . . 0.0 107.804 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.05 170.14 16.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.34 117.36 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.67 145.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.77 159.2 27.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 108.054 173.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -161.51 162.07 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.493 1.042 . . . . 0.0 110.635 169.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -85.3 135.13 39.35 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.63 116.76 4.55 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.069 3.179 . . . . 0.0 111.559 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.437 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 34.7 m -72.78 158.02 87.89 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.957 -0.465 . . . . 0.0 112.218 -175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.44 149.81 13.15 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.951 3.101 . . . . 0.0 111.384 -176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mp -59.09 -26.63 64.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.873 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -60.33 -52.11 66.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 111.189 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.5 p -73.91 -23.25 59.53 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.05 -26.71 38.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 118.276 -0.868 . . . . 0.0 109.938 167.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? 72.77 -49.74 0.7 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.335 2.654 . . . . 0.0 113.956 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.19 -99.36 1.31 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.639 1.114 . . . . 0.0 112.007 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -137.84 105.34 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.384 1.874 . . . . 0.0 109.227 -169.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.27 131.46 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -95.65 -24.01 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.101 1.36 . . . . 0.0 110.847 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.71 -153.99 25.56 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -127.83 123.45 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.855 1.662 . . . . 0.0 106.564 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.61 106.0 17.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mt -78.73 118.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -92.49 143.2 26.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -154.79 170.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.864 1.211 . . . . 0.0 111.849 172.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -149.66 164.59 34.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.589 1.155 . . . . 0.0 110.44 165.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -68.61 137.62 54.39 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.09 1.356 . . . . 0.0 108.024 164.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 83.0 m . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 172.413 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 122.056 0.931 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -132.91 150.36 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.405 2.282 . . . . 0.0 106.895 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.18 100.64 3.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.535 1.934 . . . . 0.0 107.864 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 m -71.62 109.29 5.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -108.69 94.42 5.04 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.73 164.88 11.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.829 168.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.56 153.55 28.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -83.39 37.59 0.57 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.128 1.371 . . . . 0.0 111.154 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 170.76 3.53 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.887 2.075 . . . . 0.0 112.19 171.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -133.96 2.45 3.38 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 126.045 1.738 . . . . 0.0 110.614 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -158.32 142.08 15.44 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.111 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.92 138.85 8.03 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -172.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.4 ' HE3' ' CD1' ' A' ' 30' ' ' LEU . 39.8 mtp -77.23 163.03 26.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.002 0.921 . . . . 0.0 110.887 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -126.5 82.82 65.79 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.133 1.373 . . . . 0.0 107.546 168.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -90.75 154.06 4.14 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.823 2.349 . . . . 0.0 111.795 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.41 51.44 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.457 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.82 -177.7 4.61 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.351 1.46 . . . . 0.0 108.478 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.51 139.68 36.23 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.823 0.849 . . . . 0.0 108.974 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.62 178.4 7.16 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.966 3.111 . . . . 0.0 112.886 -172.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.7 t80 50.89 23.17 1.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.868 2.867 . . . . 0.0 113.514 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.9 m -123.06 157.06 33.62 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.49 1.516 . . . . 0.0 110.351 -172.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -96.83 151.78 19.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -142.07 156.37 45.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.325 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.9 m -126.03 136.12 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.69 166.68 22.69 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.743 1.617 . . . . 0.0 109.895 170.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.67 153.08 34.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.838 2.055 . . . . 0.0 106.578 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -121.07 137.54 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.807 1.243 . . . . 0.0 108.465 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.1 ttm105 -135.17 131.36 36.67 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.44 1.496 . . . . 0.0 108.421 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . 0.25 0.8 OUTLIER -70.99 140.19 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 127.933 2.493 . . . . 0.0 108.013 176.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.07 138.58 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -136.99 -175.6 4.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.758 0.823 . . . . 0.0 111.001 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.71 69.77 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.804 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -82.53 -40.25 21.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.973 1.309 . . . . 0.0 110.835 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.36 -165.96 34.05 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 121.943 0.746 . . . . 0.0 111.983 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.44 157.29 20.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.062 0.945 . . . . 0.0 112.534 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.91 -157.99 10.29 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.113 1.339 . . . . 0.0 111.039 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.86 166.57 22.12 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.013 1.809 . . . . 0.0 111.684 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.29 154.05 19.11 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.246 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -70.19 -174.85 0.26 Allowed Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.733 1.613 . . . . 0.0 110.871 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.35 161.4 44.93 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 CA-C-N 122.307 1.86 . . . . 0.0 109.532 167.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.69 162.09 24.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.258 1.027 . . . . 0.0 109.066 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -132.39 162.36 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.739 1.216 . . . . 0.0 108.271 166.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 159.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.87 147.07 29.36 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.71 144.48 42.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.11 160.73 29.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 110.317 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.76 168.66 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 N-CA-C 108.879 -1.239 . . . . 0.0 108.879 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -61.62 -29.43 70.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.679 0.791 . . . . 0.0 112.116 -174.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 125.709 1.624 . . . . 0.0 115.511 163.169 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.42 -174.33 1.95 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.773 1.649 . . . . 0.0 111.386 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.5 mtm -133.62 -47.03 0.81 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.337 1.455 . . . . 0.0 113.218 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.94 -178.42 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 118.858 0.754 . . . . 0.0 110.196 -169.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.45 164.17 19.25 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 126.487 1.915 . . . . 0.0 109.597 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 3.6 Cg_endo -66.21 144.6 75.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.459 1.44 . . . . 0.0 112.482 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.61 170.28 4.93 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.997 1.284 . . . . 0.0 111.468 166.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -49.23 142.44 7.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -147.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.79 121.11 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.157 1.783 . . . . 0.0 106.976 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -122.71 88.29 2.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.715 1.606 . . . . 0.0 111.312 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.417 HG11 ' HE ' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -87.45 143.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 157.16 35.47 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.78 2.032 . . . . 0.0 110.089 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.39 103.49 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.65 -54.08 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.656 1.182 . . . . 0.0 109.312 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -138.33 -179.88 6.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.699 1.2 . . . . 0.0 107.864 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -23.46 56.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.269 1.028 . . . . 0.0 111.25 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -122.17 -2.06 9.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.105 2.162 . . . . 0.0 112.694 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 tp -144.01 130.0 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.308 1.443 . . . . 0.0 109.619 -170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.28 117.45 8.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.172 0.896 . . . . 0.0 111.041 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.17 154.7 41.62 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.549 1.14 . . . . 0.0 110.305 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.95 103.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.809 2.043 . . . . 0.0 106.121 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -92.08 154.2 18.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.108 0.413 . . . . 0.0 110.082 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -151.02 177.63 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 110.124 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.86 142.27 25.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.71 122.93 10.4 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.284 2.656 . . . . 0.0 109.65 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 15.6 m -71.1 164.57 55.75 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 118.887 0.767 . . . . 0.0 110.45 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -64.61 138.93 61.45 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.221 1.947 . . . . 0.0 109.15 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -31.1 41.01 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.822 0.283 . . . . 0.0 111.228 166.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -50.27 -46.99 55.51 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.182 1.393 . . . . 0.0 110.881 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 61.6 p -71.49 -29.48 64.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.46 -20.21 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.672 0.789 . . . . 0.0 109.486 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 45.33 57.06 5.1 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.038 2.135 . . . . 0.0 110.419 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.16 -102.55 0.33 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.444 -1.198 . . . . 0.0 111.427 173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -138.18 119.66 14.9 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.316 1.047 . . . . 0.0 110.217 -164.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.46 124.71 23.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.451 1.5 . . . . 0.0 109.119 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -92.74 -14.38 28.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.888 0.475 . . . . 0.0 112.098 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 176.37 22.87 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 126.604 2.049 . . . . 0.0 108.25 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.75 151.64 21.01 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -127.9 109.19 11.35 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.904 -1.123 . . . . 0.0 108.939 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.05 133.6 30.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -104.5 147.77 27.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 152.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.81 158.93 40.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.694 1.198 . . . . 0.0 111.268 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.1 p90 -148.71 161.91 40.8 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.947 0.899 . . . . 0.0 110.253 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -68.38 136.26 53.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.2 m . . . . . 0 C--N 1.323 -0.57 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.523 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.4 tttt . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.15 155.7 41.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mt -133.12 165.93 23.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.206 1.402 . . . . 0.0 108.864 170.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.5 m -138.54 105.29 5.36 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.593 -0.692 . . . . 0.0 109.679 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -116.77 93.0 4.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -72.86 166.86 22.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.549 0.69 . . . . 0.0 109.76 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.89 173.25 47.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 p -73.8 11.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.003 2.121 . . . . 0.0 114.769 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -64.43 156.12 30.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.438 1.095 . . . . 0.0 109.856 -167.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.6 p -118.08 8.99 12.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.208 1.403 . . . . 0.0 111.307 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -150.12 158.87 44.61 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.627 0.771 . . . . 0.0 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.72 143.6 6.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.953 0.787 . . . . 0.0 111.409 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.8 mtp -97.46 153.11 18.33 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.892 -0.769 . . . . 0.0 112.551 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.32 87.13 0.72 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.52 2.328 . . . . 0.0 109.143 171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.42 162.42 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.252 2.634 . . . . 0.0 111.163 171.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.58 21.04 79.32 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.716 -0.615 . . . . 0.0 112.603 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.97 172.64 9.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.829 1.252 . . . . 0.0 107.803 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.53 161.26 49.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 124.769 1.228 . . . . 0.0 108.848 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -89.77 160.84 5.14 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 125.091 3.861 . . . . 0.0 115.086 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 65.1 44.82 3.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.496 3.518 . . . . 0.0 117.613 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.58 -169.39 2.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.992 2.117 . . . . 0.0 109.97 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -110.45 163.83 13.3 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 158.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.44 152.89 46.03 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.516 -0.74 . . . . 0.0 109.883 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.8 m -126.0 139.43 53.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 162.88 36.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.995 2.118 . . . . 0.0 107.18 172.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -137.35 -176.26 4.34 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.126 0.971 . . . . 0.0 108.937 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.25 160.15 41.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -154.31 154.21 32.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 106.193 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.48 145.39 8.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.0 t -129.22 139.42 51.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -133.33 -177.97 4.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.833 0.853 . . . . 0.0 109.787 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.54 7.49 3.75 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.098 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -122.05 -57.17 1.8 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.861 1.331 . . . . 0.0 110.327 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.73 -156.79 8.52 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -170.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 163.02 29.56 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.313 1.045 . . . . 0.0 110.917 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.32 -158.11 10.76 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.453 1.025 . . . . 0.0 111.978 -166.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.23 158.66 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.569 2.179 . . . . 0.0 111.807 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.58 156.51 25.14 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.941 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.9 p -64.82 -178.17 0.25 Allowed Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.183 166.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -48.33 132.69 24.42 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.591 -1.349 . . . . 0.0 108.591 145.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.22 157.6 19.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 155.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.417 ' HE ' HG11 ' A' ' 23' ' ' VAL . 3.2 mmm180 -126.21 168.55 13.92 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 123.824 0.85 . . . . 0.0 108.961 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -115.57 155.43 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.505 171.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -144.19 142.78 30.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 160.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -114.77 148.28 38.6 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.269 1.427 . . . . 0.0 107.437 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -111.79 162.61 20.42 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 110.421 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.62 170.54 18.35 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.248 1.966 . . . . 0.0 110.177 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.62 -31.32 67.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.902 1.281 . . . . 0.0 111.389 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.662 0 C-N-CA 126.225 1.869 . . . . 0.0 112.128 176.946 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.72 161.7 44.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.724 2.283 . . . . 0.0 111.329 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.7 mtm -108.45 -41.39 4.86 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.539 1.136 . . . . 0.0 112.797 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.25 152.56 36.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.535 0.683 . . . . 0.0 109.432 -165.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.96 168.43 21.9 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 108.339 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 1.6 Cg_endo -60.68 155.63 47.32 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 119.362 0.808 . . . . 0.0 110.635 165.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.25 -155.78 0.76 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.761 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -45.71 128.77 8.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.52 1.128 . . . . 0.0 111.28 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.4 t -105.08 145.43 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -120.96 150.73 40.66 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.48 119.5 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 174.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.28 130.05 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.2 t -76.8 118.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -85.63 -52.57 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.501 1.52 . . . . 0.0 107.606 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -136.33 177.73 7.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.337 1.455 . . . . 0.0 109.611 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -38.21 54.4 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.072 1.349 . . . . 0.0 112.608 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -113.61 5.95 16.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.402 1.081 . . . . 0.0 111.692 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 tp -137.39 125.2 22.52 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.712 -168.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.91 157.48 27.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 160.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -98.73 150.81 21.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 163.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.5 139.72 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.542 1.537 . . . . 0.0 107.54 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.81 135.4 49.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.348 2.259 . . . . 0.0 105.234 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -140.85 -170.87 3.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.13 0.972 . . . . 0.0 108.967 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -119.77 135.32 24.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.523 1.129 . . . . 0.0 110.321 -167.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.38 96.41 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.509 2.806 . . . . 0.0 110.606 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 19.7 m -63.78 156.08 74.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.392 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.03 149.74 32.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.558 2.172 . . . . 0.0 109.961 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.53 -39.05 72.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.39 1.076 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -58.64 -30.28 67.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.1 p -71.68 -37.89 70.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.806 0.73 . . . . 0.0 110.315 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.0 mt -63.34 -27.53 43.24 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.638 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 56.1 13.91 1.32 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.754 1.622 . . . . 0.0 113.393 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.75 -177.85 48.57 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -162.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 111.54 19.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.768 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 tp -44.89 132.01 6.9 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.038 2.135 . . . . 0.0 110.383 168.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -117.48 -12.08 10.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.027 1.331 . . . . 0.0 112.54 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.58 -171.05 30.45 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.529 1.538 . . . . 0.0 110.482 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -114.8 159.65 20.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.984 0.514 . . . . 0.0 109.808 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -127.31 147.42 50.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.842 1.257 . . . . 0.0 108.072 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.0 mt -120.17 124.53 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 162.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -97.22 145.78 25.73 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 160.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -155.91 161.25 40.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 109.556 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.41 ' CE2' ' HB ' ' A' ' 94' ' ' THR . 46.3 p90 -149.1 157.32 43.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.399 0.68 . . . . 0.0 109.893 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -68.8 140.21 55.27 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -175.342 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.4 tttt . . . . . 0 N--CA 1.438 -1.054 0 CA-C-O 119.89 -0.1 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.62 158.33 43.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 122.563 1.173 . . . . 0.0 110.374 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.83 130.99 23.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.319 2.248 . . . . 0.0 108.017 166.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -86.7 145.58 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.309 1.444 . . . . 0.0 108.181 171.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -139.95 161.15 38.28 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.285 1.034 . . . . 0.0 110.344 167.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -77.57 171.27 15.18 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.668 1.223 . . . . 0.0 112.148 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 151.66 36.18 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.812 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 t 62.91 -6.38 0.17 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.167 2.187 . . . . 0.0 115.736 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -67.25 146.35 54.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 120.527 -1.358 . . . . 0.0 107.444 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 p -110.23 7.77 23.34 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.249 1.419 . . . . 0.0 112.255 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.12 167.33 25.3 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.403 0.547 . . . . 0.0 112.037 168.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.61 -172.16 33.57 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 128.652 3.025 . . . . 0.0 107.396 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.9 mtp -129.84 169.29 15.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.968 1.384 . . . . 0.0 111.689 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.01 84.54 26.75 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -88.8 157.62 6.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.832 3.021 . . . . 0.0 111.326 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.67 14.33 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.284 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.8 -179.35 3.61 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.573 1.549 . . . . 0.0 108.95 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.16 147.91 37.95 Favored Pre-proline 0 C--O 1.237 0.405 0 CA-C-N 118.528 0.604 . . . . 0.0 111.624 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -70.17 173.28 11.58 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.312 2.674 . . . . 0.0 113.022 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.6 t80 48.55 36.97 8.27 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.025 2.13 . . . . 0.0 113.35 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -137.42 142.4 41.66 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 120.661 -1.274 . . . . 0.0 111.807 -169.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -79.47 146.65 32.62 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 161.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -139.0 148.58 43.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 167.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.41 ' HB ' ' CE2' ' A' ' 55' ' ' TRP . 5.1 m -115.07 154.14 29.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.68 163.8 38.33 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.96 1.704 . . . . 0.0 109.519 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -140.66 157.64 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.286 1.034 . . . . 0.0 108.936 164.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.72 143.76 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.66 147.33 42.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.31 148.68 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.7 137.92 51.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.463 1.505 . . . . 0.0 107.154 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -141.77 178.18 7.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.282 1.033 . . . . 0.0 109.292 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.22 -1.93 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.296 0.95 . . . . 0.0 114.667 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -123.18 -26.01 4.4 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.299 1.44 . . . . 0.0 110.997 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.46 -159.27 31.87 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-O 121.691 0.606 . . . . 0.0 111.853 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -132.72 124.89 29.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -160.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.39 -160.93 13.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 -165.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.04 171.37 11.39 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 118.997 1.398 . . . . 0.0 109.312 163.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.31 165.45 12.68 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.9 p -67.86 -178.04 0.36 Allowed Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 125.525 1.53 . . . . 0.0 111.034 -164.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -50.94 134.11 41.59 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 N-CA-C 108.485 -1.39 . . . . 0.0 108.485 149.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.44 141.32 56.56 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.05 169.18 9.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -135.25 150.23 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -156.93 141.04 16.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.156 0.982 . . . . 0.0 108.529 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -120.37 128.4 53.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.536 1.534 . . . . 0.0 109.043 175.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -82.43 158.86 65.6 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 123.946 0.898 . . . . 0.0 110.039 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.68 -89.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.938 3.092 . . . . 0.0 112.383 -167.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -151.0 -31.14 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.217 1.371 . . . . 0.0 112.631 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 C-N-CA 125.279 1.419 . . . . 0.0 112.649 -179.555 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -61.37 140.75 89.71 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.752 2.301 . . . . 0.0 113.638 -171.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.5 mtm -79.78 -43.54 22.31 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 125.128 1.371 . . . . 0.0 112.57 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.5 m -138.08 165.93 24.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.23 0.538 . . . . 0.0 111.279 -170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.22 172.19 5.68 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 109.84 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -65.25 169.52 12.16 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.468 2.112 . . . . 0.0 113.223 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.31 172.47 55.22 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.922 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -51.04 107.59 0.19 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 113.501 -157.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.21 152.08 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.862 2.065 . . . . 0.0 109.259 -172.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -141.86 156.53 45.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.139 1.776 . . . . 0.0 107.16 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 143.42 20.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 120.893 -1.129 . . . . 0.0 110.373 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -123.69 128.57 49.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.514 2.326 . . . . 0.0 108.835 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -82.26 122.31 36.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.53 -50.52 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -153.29 -172.48 4.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.302 0.572 . . . . 0.0 110.182 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -35.55 66.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.785 0.834 . . . . 0.0 112.191 -171.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.5 p -127.74 18.59 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.706 1.202 . . . . 0.0 111.204 -168.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -145.81 140.22 26.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.623 1.569 . . . . 0.0 110.94 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.19 167.62 21.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.948 1.299 . . . . 0.0 108.237 169.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 145.68 50.92 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.003 1.721 . . . . 0.0 109.993 174.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.56 133.35 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -166.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -122.24 149.36 43.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -147.98 154.29 40.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.84 142.13 28.8 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 123.76 11.38 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.283 2.655 . . . . 0.0 110.551 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -51.22 163.31 0.55 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 124.309 1.043 . . . . 0.0 110.73 160.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.76 -134.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 1 C-N-CA 126.738 4.959 . . . . 0.0 107.627 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.67 -31.64 1.76 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 117.476 -1.25 . . . . 0.0 111.446 161.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -49.9 -45.16 50.58 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.166 1.348 . . . . 0.0 112.399 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.5 p -75.3 -27.45 59.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.394 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.5 mt -64.04 -29.09 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.015 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 68.29 -26.13 0.13 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.431 2.692 . . . . 0.0 114.291 170.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.79 -164.76 11.7 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 128.473 2.94 . . . . 0.0 107.916 166.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -76.7 149.88 36.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.18 129.89 38.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.165 1.386 . . . . 0.0 107.891 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -98.4 -28.89 13.43 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.584 0.353 . . . . 0.0 111.015 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.52 179.75 38.81 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 121.402 -0.811 . . . . 0.0 111.278 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -122.34 149.92 43.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -122.63 125.83 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.7 mt -94.58 123.52 46.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -92.32 146.23 23.86 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 164.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.98 168.37 27.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.203 1.001 . . . . 0.0 112.356 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -148.91 156.98 43.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.166 1.386 . . . . 0.0 109.911 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -73.64 137.69 44.33 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.467 1.507 . . . . 0.0 108.351 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 124.202 1.001 . . . . 0.0 109.347 -171.497 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 122.349 1.071 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.48 149.85 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 106.223 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.22 137.08 35.66 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.258 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.0 m -98.76 132.36 44.19 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.767 0.827 . . . . 0.0 109.77 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -143.87 68.13 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.805 2.042 . . . . 0.0 108.036 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -66.08 133.91 51.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.954 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.76 176.47 25.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.665 1.602 . . . . 0.0 112.599 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.9 p -74.88 0.43 15.64 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 81' ' ' HIS . 2.2 mmmp? -45.9 146.72 1.14 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.035 1.289 . . . . 0.0 112.159 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 p -99.6 -2.95 34.34 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.425 1.89 . . . . 0.0 111.136 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.417 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 15.1 p80 -149.9 166.88 28.26 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.741 -0.599 . . . . 0.0 110.885 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.29 158.72 24.44 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.453 1.025 . . . . 0.0 112.228 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.2 mtp -88.18 160.32 17.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.911 0.884 . . . . 0.0 112.187 -170.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.35 89.33 31.13 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.641 1.576 . . . . 0.0 107.534 166.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -93.18 156.59 2.6 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.063 3.175 . . . . 0.0 111.421 168.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.73 29.15 19.45 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.887 0.756 . . . . 0.0 111.611 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.4 175.82 5.45 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.375 1.87 . . . . 0.0 107.932 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -133.22 150.36 75.12 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 124.851 1.26 . . . . 0.0 110.19 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -71.08 166.3 29.61 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.944 2.43 . . . . 0.0 112.277 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.1 t80 51.48 34.1 11.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.616 2.366 . . . . 0.0 113.461 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.4 m -132.53 148.45 52.38 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.491 1.117 . . . . 0.0 110.578 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.65 151.97 23.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -137.29 149.32 47.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.115 1.366 . . . . 0.0 108.289 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 m -126.03 134.78 51.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 163.25 37.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.823 2.049 . . . . 0.0 108.486 -171.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.94 169.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.05 1.34 . . . . 0.0 108.762 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.42 149.55 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.747 1.219 . . . . 0.0 108.113 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -140.13 147.31 40.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.481 1.512 . . . . 0.0 108.0 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -87.87 154.06 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.096 0.862 . . . . 0.0 109.363 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.4 t -132.12 139.1 51.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -138.63 -170.94 2.95 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.15 0.58 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.2 -8.25 17.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.535 1.065 . . . . 0.0 115.433 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -113.11 -57.41 2.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.15 1.475 . . . . 0.0 109.397 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.37 -163.61 25.64 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.302 0.956 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -87.28 160.65 18.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.74 -157.27 10.09 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 165.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -62.52 156.95 49.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 CA-C-N 119.607 1.703 . . . . 0.0 111.342 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.41 155.23 17.49 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.963 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -66.04 166.89 13.78 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.402 1.481 . . . . 0.0 108.603 168.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.18 162.7 28.77 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.73 1.62 . . . . 0.0 109.671 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -61.53 138.15 58.27 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 122.185 0.993 . . . . 0.0 110.064 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 173.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 159.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.86 156.56 42.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.7 145.36 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 158.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -123.64 146.81 47.92 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 p -90.64 157.43 44.1 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 124.232 1.013 . . . . 0.0 109.598 -167.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.07 164.98 31.75 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.417 2.078 . . . . 0.0 109.003 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.6 -27.57 62.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.556 1.142 . . . . 0.0 112.466 -173.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.41 0 C-N-CA 125.572 1.558 . . . . 0.0 112.012 155.637 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.8 172.81 15.09 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.627 2.218 . . . . 0.0 111.137 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.3 mtm -121.34 -30.79 4.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.286 1.435 . . . . 0.0 113.551 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.97 163.12 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 111.371 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.01 169.17 18.6 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.856 2.062 . . . . 0.0 109.029 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 7.6 Cg_endo -70.19 160.36 49.87 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.255 1.304 . . . . 0.0 110.474 165.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.47 -154.15 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.429 1.49 . . . . 0.0 114.46 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -47.41 131.59 13.55 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.528 1.131 . . . . 0.0 110.303 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.73 147.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -131.86 158.42 41.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.15 150.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.82 128.96 50.28 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.16 143.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 159.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -111.03 -53.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -132.27 -171.11 2.56 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.992 1.317 . . . . 0.0 108.687 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -37.14 86.44 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.056 -1.027 . . . . 0.0 112.517 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.0 p -123.34 11.63 9.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.947 1.299 . . . . 0.0 110.078 -166.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -134.69 137.77 43.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.58 1.952 . . . . 0.0 109.0 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.73 165.51 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.33 118.71 18.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.97 147.88 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 107.313 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -131.0 133.35 45.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -118.39 -158.81 0.73 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.961 2.104 . . . . 0.0 108.247 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.08 137.56 30.97 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 126.492 1.917 . . . . 0.0 109.909 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.68 101.16 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.505 2.804 . . . . 0.0 109.405 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 28.8 m -67.1 158.48 81.18 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.63 147.86 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.765 2.31 . . . . 0.0 109.128 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.18 -22.74 12.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.257 0.623 . . . . 0.0 110.736 171.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -61.68 -47.35 85.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.046 1.738 . . . . 0.0 114.557 174.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.9 p -71.37 -31.8 67.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.72 1.6 . . . . 0.0 109.732 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.1 mt -68.54 -26.02 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.846 0.859 . . . . 0.0 109.736 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 66.13 3.7 2.79 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.168 2.587 . . . . 0.0 113.823 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.67 -161.41 31.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -172.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -70.98 114.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.537 0.669 . . . . 0.0 109.735 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 49' ' ' GLY . 2.3 tm? -55.13 120.35 6.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 163.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -85.38 -31.4 22.95 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.419 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 165.85 168.55 28.2 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -99.6 112.5 24.71 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -81.0 142.87 32.97 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.1 mt -112.06 143.45 21.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.447 ' CE2' ' CD1' ' A' ' 72' ' ' ILE . 43.3 m-85 -112.45 140.56 47.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 166.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -153.63 162.15 41.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.122 1.328 . . . . 0.0 110.232 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -148.57 157.78 43.69 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.539 -0.725 . . . . 0.0 109.233 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -69.09 140.59 54.82 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.599 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.6 mttt . . . . . 0 N--CA 1.442 -0.849 0 CA-C-O 123.001 1.382 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 53' ' ' TYR . 3.4 mm -138.92 152.42 24.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.354 -2.203 . . . . 0.0 105.091 -162.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.498 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -148.69 160.47 43.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.259 169.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.1 m -133.58 97.35 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -161.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 73' ' ' LEU . 58.3 m-85 -105.53 112.1 25.06 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.29 166.92 16.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.903 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.51 172.91 4.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.7 m -85.5 41.61 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.469 -1.018 . . . . 0.0 111.387 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HE3' ' CE1' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -63.26 155.93 27.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.698 -1.251 . . . . 0.0 110.183 162.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -109.13 -3.78 17.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.605 1.962 . . . . 0.0 112.288 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.48 ' CE1' ' HE3' ' A' ' 79' ' ' LYS . 14.7 p80 -146.22 164.53 32.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.03 158.86 30.62 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 39.4 mtp -90.96 162.61 14.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.871 0.843 . . . . 0.0 111.117 -168.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -120.82 89.98 46.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 160.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.1 148.95 1.26 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.394 3.396 . . . . 0.0 112.037 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.43 51.11 8.73 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.47 179.71 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.606 2.362 . . . . 0.0 107.773 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.0 142.37 26.12 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 124.466 1.107 . . . . 0.0 110.485 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.29 166.4 25.43 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.425 2.083 . . . . 0.0 110.84 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 37.25 46.26 0.57 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 129.894 3.278 . . . . 0.0 113.869 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.1 m -119.72 -176.12 3.1 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.332 1.453 . . . . 0.0 109.122 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.07 157.21 19.57 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 148.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -137.61 154.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.1 m -124.24 141.8 51.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 155.23 44.26 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 127.235 2.214 . . . . 0.0 108.813 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.36 169.28 17.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.069 1.348 . . . . 0.0 107.734 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.25 152.71 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -146.53 131.17 17.86 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.9 1.28 . . . . 0.0 107.77 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.85 150.95 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.7 t -146.74 135.82 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.369 1.468 . . . . 0.0 107.069 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.65 178.85 6.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 107.716 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.8 57.28 3.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.345 0.974 . . . . 0.0 112.014 -172.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -160.71 -41.86 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.481 1.913 . . . . 0.0 109.327 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.74 -168.9 42.03 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.69 166.28 11.19 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 110.075 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.84 -174.48 21.48 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 124.367 0.984 . . . . 0.0 113.284 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.33 153.45 74.31 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.748 1.632 . . . . 0.0 110.444 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.44 165.39 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.688 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.0 p -110.78 -171.69 0.22 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.106 0.962 . . . . 0.0 112.112 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -64.84 139.46 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.01 89.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.57 159.94 23.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 O-C-N 121.952 -0.467 . . . . 0.0 110.425 173.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 t -128.8 167.22 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.47 156.96 36.19 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.85 2.06 . . . . 0.0 108.156 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.75 147.99 44.58 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 125.218 1.407 . . . . 0.0 110.009 170.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -105.21 166.25 11.74 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.377 1.071 . . . . 0.0 111.478 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.92 167.42 16.35 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.856 3.704 . . . . 0.0 111.791 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.49 -33.08 65.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.028 1.331 . . . . 0.0 111.327 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.921 0 C-N-CA 126.326 1.917 . . . . 0.0 109.341 160.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.56 152.02 53.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.649 2.899 . . . . 0.0 111.652 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 68.8 mtm -109.04 -38.98 5.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 117.652 -1.166 . . . . 0.0 113.854 -164.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.87 147.84 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.459 1.481 . . . . 0.0 113.102 -170.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.63 157.25 67.46 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 127.167 2.187 . . . . 0.0 109.991 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 29.7 Cg_endo -68.49 162.96 38.58 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.348 2.032 . . . . 0.0 112.196 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.87 -149.04 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.26 2.362 . . . . 0.0 115.053 -175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -66.94 78.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.339 1.455 . . . . 0.0 113.033 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.1 t -53.67 139.98 10.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.73 158.28 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.562 1.545 . . . . 0.0 107.082 171.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.36 123.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.027 0.831 . . . . 0.0 108.942 168.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.83 102.33 7.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 127.998 2.519 . . . . 0.0 109.39 -169.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.28 0.8 OUTLIER -73.87 116.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-O 121.558 0.694 . . . . 0.0 110.313 -171.991 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.8 t -69.66 -49.59 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -139.33 -163.85 1.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 108.971 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -29.94 56.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.654 -1.279 . . . . 0.0 113.151 177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 p -124.96 11.79 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.954 1.301 . . . . 0.0 110.764 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.56 136.31 27.41 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.222 1.409 . . . . 0.0 107.862 -171.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -140.08 165.87 26.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.42 121.62 26.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.27 141.75 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -126.96 150.7 49.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.975 0.51 . . . . 0.0 110.3 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -151.26 178.9 8.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.84 142.66 25.05 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.48 -0.762 . . . . 0.0 109.003 172.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.46 111.53 3.13 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 123.039 2.493 . . . . 0.0 107.636 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.41 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 20.4 m -66.59 156.34 86.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -78.51 143.88 19.6 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 122.348 2.032 . . . . 0.0 108.449 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.23 -27.62 65.93 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.655 0.382 . . . . 0.0 110.814 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -60.01 -38.55 82.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.2 p -67.4 -41.81 84.31 Favored 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 119.027 0.83 . . . . 0.0 110.344 172.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.74 -23.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.644 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 56.17 11.31 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.383 1.873 . . . . 0.0 114.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.52 179.01 41.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.436 1.969 . . . . 0.0 108.256 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -73.94 122.9 23.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.4 tp -57.45 112.55 1.45 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 108.525 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.17 -43.74 77.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.057 0.943 . . . . 0.0 109.472 168.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -177.2 45.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.87 112.51 25.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.453 1.901 . . . . 0.0 105.989 169.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -83.51 153.24 24.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.41 117.26 50.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -91.57 116.55 28.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -135.58 164.01 28.81 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.187 0.903 . . . . 0.0 110.912 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.71 163.51 37.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.202 1.001 . . . . 0.0 110.5 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.32 135.48 50.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.958 1.303 . . . . 0.0 108.177 168.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 122.343 1.068 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 mp -133.16 139.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 126.828 2.051 . . . . 0.0 105.864 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.86 153.04 37.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.651 2.38 . . . . 0.0 107.692 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.1 m -134.26 97.92 3.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 110.062 -168.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -110.13 92.35 4.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 123.945 0.898 . . . . 0.0 108.933 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.2 163.25 27.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.5 177.19 12.86 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.261 0.923 . . . . 0.0 113.023 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 p -76.53 25.3 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.04 2.536 . . . . 0.0 114.241 -169.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -58.2 160.36 5.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.049 1.34 . . . . 0.0 111.322 176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.5 p -128.91 -2.02 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.105 0.962 . . . . 0.0 111.987 -172.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -146.51 163.72 34.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.99 151.86 23.03 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 38.7 mtp -76.9 163.82 26.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.58 93.13 47.09 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 157.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -93.29 161.02 2.5 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.745 2.296 . . . . 0.0 111.137 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.75 31.82 59.93 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.69 171.72 12.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.693 1.997 . . . . 0.0 106.923 166.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.64 153.25 45.9 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 123.788 0.835 . . . . 0.0 110.067 163.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.66 169.51 17.28 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.683 2.255 . . . . 0.0 112.63 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.9 t80 47.49 51.04 14.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.146 1.778 . . . . 0.0 111.191 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -153.8 -178.74 7.25 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.812 -1.18 . . . . 0.0 109.683 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -110.0 158.99 17.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -145.5 151.43 38.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.5 m -123.33 142.76 50.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 170.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 162.67 34.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.333 1.853 . . . . 0.0 109.568 174.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.57 144.23 31.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.647 1.579 . . . . 0.0 106.826 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.99 132.56 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -129.93 134.14 47.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.046 1.294 . . . . 0.0 110.824 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.31 152.29 5.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.3 142.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -132.92 -162.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.59 1.156 . . . . 0.0 109.813 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.93 65.74 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -50.62 69.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.861 0.865 . . . . 0.0 110.763 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.42 -168.84 41.88 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 120.003 1.274 . . . . 0.0 112.945 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.56 154.36 27.52 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.746 1.218 . . . . 0.0 110.983 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.28 -172.91 21.65 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 0.0 112.074 166.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.44 156.32 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.139 1.893 . . . . 0.0 110.493 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.82 152.72 21.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.112 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -63.8 -171.79 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.812 1.645 . . . . 0.0 111.459 170.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.95 154.58 16.99 Favored 'Trans proline' 0 C--N 1.352 0.729 0 CA-C-N 120.663 1.272 . . . . 0.0 110.242 163.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.74 85.3 7.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 166.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -67.09 155.93 37.43 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.73 154.22 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -151.79 152.25 32.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -102.29 160.37 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 169.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p -107.94 146.28 33.15 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.88 -89.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.791 2.994 . . . . 0.0 113.257 -162.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -142.4 -34.97 0.44 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.381 0.991 . . . . 0.0 112.392 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 C-N-CA 125.787 1.66 . . . . 0.0 110.819 -168.099 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.06 160.39 47.59 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.61 2.207 . . . . 0.0 112.805 -171.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.3 mtm -114.7 -39.02 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -170.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.8 m -140.8 155.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.247 0.931 . . . . 0.0 109.521 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 172.02 10.98 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 127.081 2.152 . . . . 0.0 111.108 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 5.7 Cg_exo -56.6 161.49 9.77 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 120.651 0.9 . . . . 0.0 111.119 167.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.62 -170.51 5.04 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 165.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 151.83 17.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.28 1.038 . . . . 0.0 112.078 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.39 151.69 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.805 1.242 . . . . 0.0 108.009 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.47 158.44 38.34 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.56 1.944 . . . . 0.0 106.575 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.32 115.6 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 170.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -98.8 129.33 45.2 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.079 0.862 . . . . 0.0 109.019 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -79.58 109.99 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.8 m -78.88 -59.66 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 127.047 2.139 . . . . 0.0 109.0 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -124.58 -176.02 3.42 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.254 1.422 . . . . 0.0 109.914 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -58.4 8.72 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.108 -0.995 . . . . 0.0 110.065 161.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 p -89.72 2.08 55.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.91 1.684 . . . . 0.0 113.841 -165.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 tp -135.55 140.96 45.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.009 1.724 . . . . 0.0 107.66 -175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.43 153.83 45.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -95.25 139.07 32.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.78 139.85 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 169.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.9 146.99 50.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.0 p90 -139.4 166.87 23.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.151 1.38 . . . . 0.0 108.437 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.06 147.59 88.38 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.78 141.36 84.72 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.374 1.382 . . . . 0.0 108.615 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 35.3 m -85.64 159.47 55.3 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.218 159.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.88 148.02 81.58 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.702 2.935 . . . . 0.0 109.444 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -51.17 -27.93 9.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 168.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -63.87 -32.97 74.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 117.109 -1.424 . . . . 0.0 112.486 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.9 p -74.72 -36.69 62.69 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.373 1.442 . . . . 0.0 109.956 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 108.514 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 80.27 -61.4 0.27 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 129.273 3.029 . . . . 0.0 110.556 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.77 -160.44 17.14 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 126.129 1.823 . . . . 0.0 111.082 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -72.79 121.99 20.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.399 1.08 . . . . 0.0 109.248 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -59.94 119.5 7.87 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.743 0.817 . . . . 0.0 109.77 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -78.6 -36.57 44.07 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.09 -175.26 33.15 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -114.09 166.51 11.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -130.27 150.82 51.34 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.411 1.484 . . . . 0.0 107.531 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.2 mt -124.91 124.38 67.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -91.56 138.61 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 165.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.9 p90 -146.78 167.35 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 120.981 1.718 . . . . 0.0 111.366 168.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -149.04 158.03 43.86 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.87 0.868 . . . . 0.0 110.891 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.29 138.15 41.65 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.466 1.106 . . . . 0.0 108.772 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.417 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 11.1 mmtt . . . . . 0 CA--C 1.519 -0.227 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 mm -127.31 159.22 37.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.423 1.489 . . . . 0.0 107.368 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mt -136.19 159.17 42.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.174 1.789 . . . . 0.0 108.204 167.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -123.77 141.55 51.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.251 1.82 . . . . 0.0 107.155 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -145.67 104.84 3.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -77.43 175.44 9.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.777 -1.202 . . . . 0.0 109.867 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.28 160.62 5.02 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.651 1.139 . . . . 0.0 113.173 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.5 m -77.32 21.25 0.26 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.196 1.398 . . . . 0.0 113.458 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -48.49 154.59 0.62 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.277 1.031 . . . . 0.0 110.895 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 p -119.43 9.29 11.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.171 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 167.13 24.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.072 0.949 . . . . 0.0 109.062 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.17 -171.1 26.71 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 127.455 2.455 . . . . 0.0 107.505 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -138.28 159.72 41.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 117.963 0.882 . . . . 0.0 110.844 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.85 81.6 4.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 127.019 2.127 . . . . 0.0 107.394 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -84.4 155.94 12.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.836 2.357 . . . . 0.0 111.059 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.87 16.47 67.72 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.404 -0.665 . . . . 0.0 112.961 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.7 173.68 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.858 1.263 . . . . 0.0 110.527 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.42 144.69 32.84 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.472 -175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.93 176.38 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.976 2.451 . . . . 0.0 113.191 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 38.75 46.49 1.04 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 130.939 3.696 . . . . 0.0 113.933 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 64.1 m -135.09 174.13 10.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.101 1.76 . . . . 0.0 110.67 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -120.84 152.23 38.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.631 1.972 . . . . 0.0 107.106 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.33 161.43 38.99 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.056 1.342 . . . . 0.0 111.019 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.4 m -124.15 141.48 52.02 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 161.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.81 153.2 42.99 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.025 1.73 . . . . 0.0 110.137 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.18 129.79 20.23 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -170.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.5 t -89.43 147.32 5.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -145.74 124.08 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.331 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.5 152.55 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.414 1.007 . . . . 0.0 109.676 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.13 151.92 25.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.727 1.611 . . . . 0.0 108.352 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -144.68 -171.14 3.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.972 1.309 . . . . 0.0 109.015 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.01 -15.26 78.52 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.996 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -23.77 14.56 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.581 1.552 . . . . 0.0 111.919 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.47 -154.41 25.5 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.858 0.754 . . . . 0.0 111.305 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 173.93 10.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.392 1.477 . . . . 0.0 110.008 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.79 -155.44 6.87 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.693 1.139 . . . . 0.0 112.761 -166.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.57 160.79 41.41 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.689 2.259 . . . . 0.0 110.595 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.99 162.21 13.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.194 1.798 . . . . 0.0 111.462 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.1 p -67.58 -176.72 0.28 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.6 0.76 . . . . 0.0 110.335 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.28 129.84 36.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 N-CA-C 108.968 -1.204 . . . . 0.0 108.968 153.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.93 132.49 53.18 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 163.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -115.75 163.46 15.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.443 1.097 . . . . 0.0 109.239 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.49 158.77 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -150.47 151.97 33.52 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.31 141.74 44.45 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.365 1.466 . . . . 0.0 108.008 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.3 p -92.46 157.36 40.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.101 -0.375 . . . . 0.0 111.342 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -75.11 171.0 19.17 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.133 2.555 . . . . 0.0 108.178 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.97 -35.41 78.4 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 114.863 -162.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.33 0 C-N-CA 125.277 1.418 . . . . 0.0 110.293 174.747 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 101' ' ' ASN . 29.7 mt . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.15 177.29 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.179 1.253 . . . . 0.0 110.0 166.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.1 mtm -134.05 -27.37 1.44 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.59 178.52 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 120.193 1.361 . . . . 0.0 110.101 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.89 162.67 19.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 128.41 2.684 . . . . 0.0 107.626 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.35 151.07 81.87 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 120.863 1.042 . . . . 0.0 109.686 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.31 -94.62 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 125.137 1.351 . . . . 0.0 112.535 -163.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 162.03 13.41 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.5 t -128.97 148.76 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -142.99 152.7 42.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.828 2.051 . . . . 0.0 106.252 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.45 139.13 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 119.975 1.261 . . . . 0.0 110.387 171.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -116.5 145.69 43.13 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 127.398 2.279 . . . . 0.0 107.944 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.62 110.25 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.24 -59.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.642 0.777 . . . . 0.0 108.928 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.277 20.1 p30 -121.12 -105.52 0.38 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.627 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.37 -51.95 1.96 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.695 1.998 . . . . 0.0 109.696 174.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.9 p -101.12 4.32 42.03 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.192 1.397 . . . . 0.0 111.519 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -124.65 122.97 39.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.042 1.737 . . . . 0.0 109.02 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.41 163.38 17.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 109.552 165.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -125.54 115.57 20.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 129.123 2.969 . . . . 0.0 105.994 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.1 t -92.73 145.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.14 146.39 49.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -148.1 155.56 41.59 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -74.0 140.03 76.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.92 155.49 54.73 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.884 2.389 . . . . 0.0 109.374 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.2 m -102.31 157.54 33.5 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 166.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -76.16 153.35 36.35 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 122.753 2.302 . . . . 0.0 109.443 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.8 -27.4 68.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.064 0.945 . . . . 0.0 111.174 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -44.83 -58.78 2.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.574 1.15 . . . . 0.0 110.906 163.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.1 p -61.85 -26.31 68.06 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -171.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.6 mt -87.76 -17.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.159 1.384 . . . . 0.0 109.996 -174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 55.45 1.95 0.06 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.38 2.272 . . . . 0.0 115.33 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.87 -155.3 21.6 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 127.817 2.627 . . . . 0.0 107.261 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -74.09 132.81 42.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.267 1.533 . . . . 0.0 111.998 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 tt -69.32 125.28 26.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -81.07 -60.35 2.32 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.03 -178.79 39.12 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-O 121.955 0.753 . . . . 0.0 113.663 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -107.83 117.89 35.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.878 . . . . 0.0 106.589 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 92.09 4.92 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.74 123.02 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -92.19 145.62 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 164.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.43 163.71 39.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.777 1.231 . . . . 0.0 110.906 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -148.98 159.68 43.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.989 0.916 . . . . 0.0 110.538 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -68.83 132.22 46.42 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 166.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.8 m . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.638 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 tttp . . . . . 0 C--O 1.237 0.402 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -140.96 111.13 3.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.04 166.78 22.85 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.328 1.451 . . . . 0.0 110.165 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.4 m -126.06 125.75 43.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -135.91 116.45 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -79.24 164.44 24.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.323 0.965 . . . . 0.0 109.008 165.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.12 172.43 3.4 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.533 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -87.48 39.68 0.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.799 -0.701 . . . . 0.0 112.279 -153.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -59.88 167.22 2.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.314 1.446 . . . . 0.0 111.567 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -130.04 8.75 5.22 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.899 1.679 . . . . 0.0 110.626 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -156.35 160.47 39.71 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.418 1.887 . . . . 0.0 106.882 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.71 40.4 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 32.1 mtp -132.53 156.25 47.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 118.728 1.264 . . . . 0.0 110.953 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.57 82.4 4.79 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 126.363 1.865 . . . . 0.0 106.349 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -85.23 154.38 10.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.29 1.993 . . . . 0.0 110.848 165.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 16.8 46.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.344 0.973 . . . . 0.0 112.252 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.59 -171.56 3.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.097 0.949 . . . . 0.0 109.895 -173.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.46 141.57 41.9 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 128.279 2.632 . . . . 0.0 105.92 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -73.54 -173.91 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.004 3.136 . . . . 0.0 112.097 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 50.69 43.36 27.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.686 2.395 . . . . 0.0 113.032 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.8 m -157.54 163.48 38.34 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.97 0.908 . . . . 0.0 112.107 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -88.5 155.09 19.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.177 1.391 . . . . 0.0 107.678 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -144.68 146.95 32.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.826 1.65 . . . . 0.0 108.766 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 19.7 m -126.75 122.69 35.56 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.618 0.767 . . . . 0.0 109.025 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 158.07 39.22 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.209 1.804 . . . . 0.0 109.453 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.57 164.01 33.0 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.885 1.274 . . . . 0.0 109.555 171.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 t -125.71 142.89 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.807 1.643 . . . . 0.0 106.873 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -149.7 132.32 15.84 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 m -82.2 144.64 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.5 t -135.25 139.87 46.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.245 1.818 . . . . 0.0 106.315 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.43 HD22 ' C ' ' A' ' 13' ' ' LEU . 36.4 p-10 -149.21 -172.47 4.13 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.887 0.875 . . . . 0.0 112.246 -168.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.46 12.19 0.14 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.893 2.187 . . . . 0.0 116.86 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -141.94 -35.59 0.44 Allowed 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.061 1.93 . . . . 0.0 112.102 168.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.31 -154.66 9.61 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 119.165 0.893 . . . . 0.0 112.126 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.92 165.54 17.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.362 1.465 . . . . 0.0 109.976 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.29 -173.43 15.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 125.203 1.383 . . . . 0.0 112.71 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.49 135.86 51.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.363 2.709 . . . . 0.0 109.21 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.75 151.35 34.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.918 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -58.9 172.59 0.52 Allowed Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 124.683 1.193 . . . . 0.0 109.451 169.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -56.1 139.44 85.37 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 152.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.74 160.18 23.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.099 170.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -129.99 168.9 15.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.21 162.87 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.331 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -144.32 143.6 31.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -86.19 166.74 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 p -123.73 159.9 53.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 124.071 0.948 . . . . 0.0 109.737 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.49 161.37 43.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -58.65 -23.11 58.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.609 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 CA-C-O 118.281 -1.288 . . . . 0.0 114.537 163.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.83 172.61 12.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.887 2.392 . . . . 0.0 111.815 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.6 mtm -124.78 -19.03 5.42 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.7 m -144.02 179.37 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 120.392 1.451 . . . . 0.0 111.275 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.56 158.79 39.21 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 129.045 2.938 . . . . 0.0 108.708 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -69.06 144.67 58.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.252 1.968 . . . . 0.0 111.094 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.42 -179.14 52.27 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.414 1.959 . . . . 0.0 113.169 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 t30 2.05 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.539 3.536 . . . . 0.0 114.671 -171.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.95 132.02 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -126.17 153.96 43.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.506 1.923 . . . . 0.0 107.971 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.55 129.68 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.266 1.027 . . . . 0.0 108.743 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -125.21 135.66 52.79 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 125.337 1.455 . . . . 0.0 112.302 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.367 1.0 OUTLIER -84.73 128.85 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 123.113 1.435 . . . . 0.0 111.753 174.486 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.73 -40.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 128.18 2.592 . . . . 0.0 109.529 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -138.24 -179.91 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.714 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.46 88.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.668 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.8 p -114.63 4.77 15.2 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.137 1.375 . . . . 0.0 112.759 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.27 137.31 47.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.293 1.837 . . . . 0.0 108.328 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -131.51 170.34 14.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.921 1.288 . . . . 0.0 109.372 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -128.88 139.88 51.94 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.6 t -114.54 143.57 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -129.17 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.769 1.628 . . . . 0.0 107.265 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -150.14 151.65 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.786 1.234 . . . . 0.0 108.363 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -69.39 146.18 96.23 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.674 -0.641 . . . . 0.0 110.485 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.76 131.08 29.86 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 108.449 162.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 m -76.11 160.03 79.11 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.57 144.66 67.46 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.526 2.151 . . . . 0.0 109.275 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -26.2 68.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.529 -0.732 . . . . 0.0 111.027 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -55.93 -32.6 63.94 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 118.297 -0.858 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.4 p -72.32 -32.29 66.42 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 119.273 0.942 . . . . 0.0 111.642 -175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mt -75.77 -30.63 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.206 1.002 . . . . 0.0 109.994 -164.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 45.84 34.79 2.0 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.027 2.131 . . . . 0.0 112.81 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.77 -133.25 1.82 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -171.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.91 121.06 22.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.8 tp -52.01 118.08 3.21 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -79.88 -51.83 8.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.57 -170.22 40.34 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -106.09 157.6 17.42 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 163.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -123.91 144.5 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 169.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.5 mt -118.46 126.57 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -92.07 144.94 24.92 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 160.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 35.7 p90 -155.44 159.3 39.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.0 0.92 . . . . 0.0 110.987 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.77 155.51 40.25 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -68.52 130.53 43.12 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.711 1.604 . . . . 0.0 107.636 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.0 m . . . . . 0 C--N 1.325 -0.484 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.219 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt . . . . . 0 CA--C 1.51 -0.563 0 CA-C-O 121.562 0.696 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.24 149.43 33.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -138.55 145.52 40.77 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.593 1.957 . . . . 0.0 107.668 -173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 m -129.87 119.04 22.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.206 1.002 . . . . 0.0 108.694 -163.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -128.87 88.22 2.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.891 1.277 . . . . 0.0 108.401 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -69.3 173.51 5.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.852 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 -178.01 18.66 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.891 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -85.79 11.33 11.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -161.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -56.77 149.35 18.32 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 125.033 1.333 . . . . 0.0 112.307 -166.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -112.66 9.51 19.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.669 1.187 . . . . 0.0 111.312 175.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.92 160.61 43.46 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.059 1.343 . . . . 0.0 109.356 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.67 143.13 8.97 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.7 mtp -86.26 146.98 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.258 0.529 . . . . 0.0 109.818 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.8 94.53 10.6 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 126.687 1.995 . . . . 0.0 105.963 174.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -92.12 167.21 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.7 2.933 . . . . 0.0 112.175 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.96 19.96 74.12 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.681 -0.637 . . . . 0.0 112.79 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.23 168.67 14.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.651 0.781 . . . . 0.0 109.069 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.87 131.64 22.03 Favored Pre-proline 0 N--CA 1.432 -1.327 0 C-N-CA 126.092 1.757 . . . . 0.0 107.348 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -74.52 162.92 37.16 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.963 1.775 . . . . 0.0 111.529 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.6 t80 50.63 40.5 24.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.127 1.371 . . . . 0.0 112.134 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -136.14 158.82 43.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.269 1.427 . . . . 0.0 110.686 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -94.45 153.73 17.79 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -148.21 154.21 39.79 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.922 1.289 . . . . 0.0 110.017 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.9 m -126.21 149.78 48.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.867 1.667 . . . . 0.0 107.521 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.0 158.48 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.596 2.358 . . . . 0.0 110.488 171.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.05 145.13 29.57 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.683 1.193 . . . . 0.0 110.648 168.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.61 151.06 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.249 1.82 . . . . 0.0 108.496 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -144.76 133.5 22.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -73.94 151.41 7.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.91 136.37 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -134.69 -173.51 3.31 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.729 2.012 . . . . 0.0 107.031 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.85 13.44 13.4 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.033 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -123.07 -54.69 1.81 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.67 1.588 . . . . 0.0 110.037 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.09 48.94 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.039 0.836 . . . . 0.0 111.942 -173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -83.66 154.76 23.52 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.593 0.711 . . . . 0.0 110.702 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -100.82 -171.08 28.86 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.877 1.227 . . . . 0.0 112.349 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.18 137.99 54.33 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.945 1.764 . . . . 0.0 108.751 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.63 161.19 29.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.3 p -62.97 178.53 0.35 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.487 1.115 . . . . 0.0 108.943 172.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -61.49 155.52 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 107.346 -1.828 . . . . 0.0 107.346 157.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.27 151.79 46.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.688 1.232 . . . . 0.0 108.926 162.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -124.74 161.82 25.58 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.2 150.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.474 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.79 165.26 30.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -135.66 144.03 45.8 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.013 2.125 . . . . 0.0 107.289 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.8 p -110.59 153.32 43.62 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.085 0.554 . . . . 0.0 110.548 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.4 -68.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.757 2.304 . . . . 0.0 113.131 -152.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -163.41 -41.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.32 1.448 . . . . 0.0 109.848 168.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.728 0 C-N-CA 126.073 1.797 . . . . 0.0 113.673 175.26 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 118.342 -0.837 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.81 158.75 23.29 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.641 2.227 . . . . 0.0 112.632 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtm -121.5 -31.59 4.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.321 1.049 . . . . 0.0 113.545 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -140.96 158.05 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.825 0.739 . . . . 0.0 111.666 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.8 159.99 31.19 Favored Pre-proline 0 N--CA 1.444 -0.754 0 C-N-CA 130.021 3.329 . . . . 0.0 111.928 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.35 141.59 35.66 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.34 2.026 . . . . 0.0 111.403 -175.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.05 166.73 51.98 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.546 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.0 t30 49.35 54.55 10.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.619 1.567 . . . . 0.0 112.737 154.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.67 128.8 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.784 1.234 . . . . 0.0 109.296 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 116.13 9.04 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.235 1.814 . . . . 0.0 110.476 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.99 138.05 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.163 0.985 . . . . 0.0 108.937 -175.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -124.12 124.93 43.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.126 2.171 . . . . 0.0 110.36 -175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.59 102.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -72.65 -48.98 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -138.25 -179.03 5.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 122.271 1.034 . . . . 0.0 109.03 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -35.49 80.62 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.258 -0.901 . . . . 0.0 111.686 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -119.34 17.56 13.02 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.309 1.044 . . . . 0.0 111.363 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -139.32 137.99 36.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.501 1.92 . . . . 0.0 108.628 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.02 150.62 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -108.4 143.72 36.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.788 2.035 . . . . 0.0 107.046 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.04 119.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -108.34 152.96 23.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -154.12 163.52 39.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.942 0.897 . . . . 0.0 109.594 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -80.3 140.93 52.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.12 140.89 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.712 2.275 . . . . 0.0 108.49 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.11 156.59 79.25 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 164.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.29 147.01 17.98 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.611 2.874 . . . . 0.0 109.841 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.64 -29.06 64.27 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -50.58 -50.31 54.13 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.343 0.519 . . . . 0.0 110.939 168.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.8 p -59.74 -37.98 80.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.417 0.553 . . . . 0.0 112.259 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' GLY . 15.4 mt -70.42 -23.41 24.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.799 -169.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.54 -14.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.572 2.349 . . . . 0.0 115.82 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . -155.03 -163.74 12.34 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.72 3.057 . . . . 0.0 108.55 172.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -77.96 117.6 19.45 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.803 0.841 . . . . 0.0 111.695 -174.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.3 133.48 55.15 Favored 'General case' 0 CA--C 1.523 -0.07 0 C-N-CA 125.698 1.599 . . . . 0.0 109.987 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -103.72 -23.41 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.201 1.4 . . . . 0.0 110.455 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.82 -164.75 30.45 Favored Glycine 0 C--O 1.239 0.437 0 O-C-N 120.95 -1.094 . . . . 0.0 112.013 167.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.39 141.14 46.47 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.557 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -121.83 97.09 5.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.4 mt -77.95 120.63 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -91.67 141.55 28.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 164.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.477 ' CD2' HD11 ' A' ' 84' ' ' LEU . 41.4 p90 -151.25 166.08 32.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.751 0.82 . . . . 0.0 110.566 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -149.46 159.14 44.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -68.95 136.6 52.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 m . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.131 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt . . . . . 0 C--O 1.24 0.566 0 CA-C-O 120.435 0.159 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.74 149.67 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 128.275 2.63 . . . . 0.0 104.622 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.407 ' CD2' HD21 ' A' ' 84' ' ' LEU . 15.1 tp -133.02 161.09 35.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.122 1.769 . . . . 0.0 109.123 -174.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -131.18 121.77 25.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.798 1.181 . . . . 0.0 111.85 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -136.99 115.26 11.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 163.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -80.98 162.51 23.82 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.325 0.583 . . . . 0.0 110.227 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.65 -173.32 21.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.152 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.06 13.98 0.47 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.552 1.941 . . . . 0.0 115.106 -168.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -51.73 147.85 6.2 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.673 1.189 . . . . 0.0 112.036 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.9 p -109.4 5.37 23.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 111.983 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.13 159.43 43.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.883 0.873 . . . . 0.0 109.966 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.15 170.07 30.83 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 126.697 2.094 . . . . 0.0 108.139 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 59.9 mtp -138.37 143.94 40.06 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.282 1.041 . . . . 0.0 110.892 -166.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.477 HD11 ' CD2' ' A' ' 54' ' ' TYR . 4.0 mm? -110.33 84.95 4.12 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 127.507 2.323 . . . . 0.0 108.665 -173.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.63 156.75 3.54 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.413 2.742 . . . . 0.0 112.741 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.94 40.76 98.6 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.929 0.776 . . . . 0.0 111.406 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 ' CE2' ' A' ' 93' ' ' TYR . 4.0 mm? -96.1 165.88 12.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.754 1.621 . . . . 0.0 108.536 173.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.77 144.6 30.58 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.56 172.27 12.74 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.305 2.67 . . . . 0.0 111.962 165.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.25 0.3 OUTLIER 45.41 34.75 1.65 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.371 2.668 . . . . 0.0 114.063 172.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.19 -175.81 2.93 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.245 2.218 . . . . 0.0 109.554 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -124.64 154.28 40.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.43 ' CE2' HD11 ' A' ' 87' ' ' LEU . 81.8 m-85 -145.65 158.71 43.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.854 0.461 . . . . 0.0 109.945 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.3 m -126.45 140.84 52.16 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.47 154.27 47.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.934 2.094 . . . . 0.0 108.991 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.22 166.28 25.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.572 1.549 . . . . 0.0 107.933 166.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.2 147.39 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -139.07 121.31 15.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 111.527 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.43 136.54 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.176 1.39 . . . . 0.0 107.263 172.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.83 143.99 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -131.89 -173.78 3.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.805 2.042 . . . . 0.0 107.601 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.11 92.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.575 0.625 . . . . 0.0 112.052 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -36.13 80.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.89 0.845 . . . . 0.0 111.663 176.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.37 -143.24 10.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 119.358 0.981 . . . . 0.0 111.074 -174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -120.59 173.79 6.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.391 1.076 . . . . 0.0 112.354 -165.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.74 -162.36 9.09 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.293 1.425 . . . . 0.0 111.422 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.97 145.18 84.95 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.832 3.021 . . . . 0.0 111.668 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.99 157.64 34.63 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.387 1.075 . . . . 0.0 110.566 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.3 p -61.06 174.96 0.49 Allowed Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.127 162.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -51.35 148.4 19.4 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.498 0.798 . . . . 0.0 110.812 154.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.59 144.64 52.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 164.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -130.07 171.21 13.06 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.215 1.806 . . . . 0.0 108.514 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.49 164.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.982 1.313 . . . . 0.0 108.816 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -153.47 148.25 26.41 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.336 1.854 . . . . 0.0 107.219 159.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -86.77 168.12 13.8 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 158.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.0 p -117.53 162.36 28.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 163.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.2 -83.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.272 1.982 . . . . 0.0 113.576 -155.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -142.54 -53.46 0.41 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.304 1.042 . . . . 0.0 109.649 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.357 0 C-N-CA 123.412 0.53 . . . . 0.0 112.372 -179.813 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 118.772 -0.632 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -67.32 170.63 13.03 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.746 2.298 . . . . 0.0 114.272 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.5 mtm -122.35 -39.93 2.53 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 127.06 2.144 . . . . 0.0 111.041 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -136.51 150.42 27.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 119.133 0.879 . . . . 0.0 111.755 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.96 168.53 22.3 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 128.426 2.69 . . . . 0.0 110.248 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 3.4 Cg_exo -64.47 166.64 16.89 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 121.691 1.594 . . . . 0.0 114.048 173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.49 -163.04 1.4 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.625 2.059 . . . . 0.0 112.788 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -58.08 106.33 0.36 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.628 1.171 . . . . 0.0 109.198 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.81 141.6 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.209 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -124.12 152.06 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.94 132.75 14.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -124.05 128.91 50.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 125.016 1.326 . . . . 0.0 110.022 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.297 0.7 OUTLIER -88.46 115.89 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.093 0.949 . . . . 0.0 110.473 -175.874 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.27 -35.21 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.392 -169.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -156.35 -173.25 4.41 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 109.413 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -17.96 64.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -171.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.9 p -128.71 6.21 5.59 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.435 1.494 . . . . 0.0 111.122 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -142.7 142.27 31.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.421 1.088 . . . . 0.0 110.097 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -137.78 162.32 34.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -117.31 121.0 39.94 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -97.98 144.17 11.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -133.33 144.97 49.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.925 1.69 . . . . 0.0 107.592 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -148.31 173.07 13.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.029 1.332 . . . . 0.0 108.385 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -90.03 144.42 31.32 Favored Pre-proline 0 C--O 1.234 0.289 0 O-C-N 121.761 -0.587 . . . . 0.0 109.845 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.93 112.14 3.03 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.402 2.735 . . . . 0.0 109.104 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 23.5 m -83.22 159.17 62.75 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 150.65 18.93 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.536 2.824 . . . . 0.0 112.077 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -35.77 72.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.909 1.284 . . . . 0.0 109.763 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -60.02 -25.85 65.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 117.171 -1.395 . . . . 0.0 114.234 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 76.0 p -93.11 -20.77 20.18 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 120.743 1.61 . . . . 0.0 111.673 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.8 mt -63.23 -40.2 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 166.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 56.61 -3.24 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.616 2.767 . . . . 0.0 115.188 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 -166.56 12.73 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 125.466 1.507 . . . . 0.0 109.394 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -87.68 107.86 18.83 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.391 -0.476 . . . . 0.0 109.919 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -48.81 130.48 17.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.016 1.327 . . . . 0.0 107.956 172.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -84.73 -62.16 1.61 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.19 -165.15 30.34 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.34 160.57 14.19 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -134.95 99.44 4.29 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.601 -0.687 . . . . 0.0 109.2 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.7 mt -77.89 119.01 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.573 1.549 . . . . 0.0 107.019 170.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -91.74 149.64 21.51 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 39.8 p90 -154.24 164.82 37.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.521 1.51 . . . . 0.0 111.546 170.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -148.65 159.19 44.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.854 1.262 . . . . 0.0 111.197 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.64 138.32 54.92 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.816 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 2.3 mttp . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.0 mm -141.79 161.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.46 1.904 . . . . 0.0 107.199 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.94 108.88 2.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.736 1.214 . . . . 0.0 110.024 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -81.92 135.43 35.4 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.273 1.429 . . . . 0.0 111.257 -163.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -137.11 97.54 3.52 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 173.19 11.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.777 0.831 . . . . 0.0 110.865 175.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.81 175.43 46.33 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 121.964 0.758 . . . . 0.0 111.685 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.5 p -83.52 27.02 0.63 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.796 1.638 . . . . 0.0 112.748 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 164.95 3.93 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.932 1.349 . . . . 0.0 112.295 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.6 p -127.55 -0.94 6.19 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.762 2.025 . . . . 0.0 110.768 -174.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -152.14 163.45 39.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.06 1.344 . . . . 0.0 108.465 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.66 172.8 34.99 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 127.568 2.509 . . . . 0.0 107.92 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 77.5 mtp -115.09 159.01 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.583 1.191 . . . . 0.0 109.972 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.44 77.27 35.36 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 108.877 168.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -86.07 149.06 9.38 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.503 2.802 . . . . 0.0 110.892 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.46 26.74 9.05 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.737 0.684 . . . . 0.0 112.043 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -109.59 171.08 7.66 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 126.258 1.823 . . . . 0.0 108.02 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -115.25 144.77 32.87 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.896 0.878 . . . . 0.0 110.311 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -70.39 169.21 20.25 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.719 2.946 . . . . 0.0 113.059 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 35.88 51.12 0.71 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.819 2.448 . . . . 0.0 111.048 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 m -129.91 -179.69 5.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 108.528 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -130.14 143.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -136.35 168.2 19.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -126.12 142.6 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 153.85 49.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.452 1.501 . . . . 0.0 109.977 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.25 129.92 21.52 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.625 1.17 . . . . 0.0 109.281 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.49 162.17 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -152.55 161.3 42.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -106.57 146.91 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.09 139.68 41.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -134.1 178.87 6.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.324 0.65 . . . . 0.0 110.295 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.28 -40.14 52.36 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.015 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -73.11 -50.92 20.05 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.95 0.875 . . . . 0.0 111.865 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.4 -167.36 40.03 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -163.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -94.79 170.29 9.55 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 111.078 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.44 -154.29 6.96 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 167.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.0 152.67 79.89 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.505 2.137 . . . . 0.0 112.714 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.49 155.68 24.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.597 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.7 p -67.9 175.77 1.59 Allowed Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.371 1.068 . . . . 0.0 109.679 169.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -53.57 143.34 56.94 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 120.643 0.896 . . . . 0.0 109.857 155.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.66 155.56 37.63 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.3 mmt-85 -136.46 165.39 25.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 120.981 -1.075 . . . . 0.0 108.839 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.42 151.74 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.68 126.12 6.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.832 1.653 . . . . 0.0 107.491 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -88.94 146.95 24.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 p -87.65 156.36 53.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 123.392 0.433 . . . . 0.0 110.215 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.7 -80.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.698 2.932 . . . . 0.0 112.576 -166.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -156.29 -28.09 0.1 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.217 0 C-N-CA 124.491 1.043 . . . . 0.0 111.573 -176.48 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.0 mt . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 119.036 -0.506 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.76 139.59 25.14 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.32 2.013 . . . . 0.0 111.634 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.9 mtm -92.0 -38.13 12.42 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.993 1.317 . . . . 0.0 113.152 -172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.4 m -133.83 174.83 12.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 118.624 0.647 . . . . 0.0 110.382 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -118.26 162.86 27.89 Favored Pre-proline 0 N--CA 1.441 -0.889 0 C-N-CA 128.449 2.7 . . . . 0.0 108.612 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 46.1 Cg_endo -66.18 161.48 40.08 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.837 2.358 . . . . 0.0 111.368 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.64 -147.45 0.41 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.617 2.532 . . . . 0.0 114.3 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.9 91.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.922 1.689 . . . . 0.0 108.79 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.38 155.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.131 1.372 . . . . 0.0 108.725 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -132.43 163.57 28.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.973 1.709 . . . . 0.0 106.939 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.6 144.91 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -123.8 136.16 54.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.511 2.724 . . . . 0.0 108.204 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -92.94 102.03 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 m -71.45 -58.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.801 1.64 . . . . 0.0 109.507 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -131.76 -173.85 3.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.8 1.24 . . . . 0.0 110.907 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.32 95.14 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.012 -1.055 . . . . 0.0 113.635 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 p -129.23 12.41 6.04 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.614 0.766 . . . . 0.0 111.243 -169.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 tp -121.12 132.73 55.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 169.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.49 165.65 18.08 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 168.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -135.42 139.54 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 142.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -136.33 122.62 20.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.555 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -124.83 -178.47 4.17 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.05 1.74 . . . . 0.0 109.796 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.76 135.44 19.54 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.818 1.247 . . . . 0.0 109.332 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 100.48 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.469 2.78 . . . . 0.0 110.134 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 18.6 m -65.49 162.36 42.92 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.982 -176.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.06 150.02 86.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.126 2.551 . . . . 0.0 110.928 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.77 -25.32 68.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 167.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -57.2 -51.22 70.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.313 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.2 p -66.55 -34.09 77.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.092 0.86 . . . . 0.0 110.384 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.0 mt -66.46 -23.79 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.039 0.936 . . . . 0.0 110.413 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.26 19.1 mtp180 60.12 -13.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 129.324 3.05 . . . . 0.0 116.44 -173.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.53 -94.24 0.1 Allowed Glycine 0 CA--C 1.518 0.222 0 CA-C-N 120.351 1.432 . . . . 0.0 110.902 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -125.41 133.79 52.37 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.517 1.527 . . . . 0.0 109.824 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.1 tp -70.83 118.73 13.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -70.69 -50.89 31.71 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.01 -173.38 42.89 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -112.81 127.27 56.12 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.932 0.893 . . . . 0.0 109.032 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -103.44 118.86 37.72 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mt -92.94 127.48 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -92.06 154.88 18.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 159.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -159.63 164.03 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.147 1.379 . . . . 0.0 111.498 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -148.6 160.34 43.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.265 -0.897 . . . . 0.0 111.312 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -69.19 138.5 54.14 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 107.93 171.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.8 m . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 177.937 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tttt . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.24 153.73 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mt -135.04 152.51 51.77 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.663 2.385 . . . . 0.0 108.699 166.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.8 m -126.66 104.02 7.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.049 1.34 . . . . 0.0 109.048 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -104.17 98.29 8.12 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -74.17 169.43 17.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.17 -179.33 53.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 124.386 0.993 . . . . 0.0 111.205 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -81.31 -1.71 46.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -170.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.415 ' HE3' ' CE1' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -57.2 149.06 20.63 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.499 0.666 . . . . 0.0 112.427 -168.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -108.45 2.31 22.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 111.914 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.415 ' CE1' ' HE3' ' A' ' 79' ' ' LYS . 7.1 p80 -140.19 164.38 30.23 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.5 -0.75 . . . . 0.0 109.758 167.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.16 161.41 33.94 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -173.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 43.3 mtp -117.94 152.61 35.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.703 1.251 . . . . 0.0 111.732 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.97 84.98 3.8 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 127.63 2.372 . . . . 0.0 106.961 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -84.58 160.79 12.56 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.41 2.74 . . . . 0.0 110.754 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.86 8.94 81.84 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.469 -0.628 . . . . 0.0 112.844 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.03 -179.0 6.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.652 1.581 . . . . 0.0 108.996 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -123.03 150.82 60.28 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 122.999 0.52 . . . . 0.0 110.383 171.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.55 172.24 9.51 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.827 2.351 . . . . 0.0 111.683 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.3 t80 45.58 36.4 2.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.821 2.848 . . . . 0.0 113.258 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.9 m -133.34 164.51 26.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.029 1.732 . . . . 0.0 110.108 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -100.4 152.38 20.42 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -139.37 152.17 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.7 m -127.14 134.65 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 153.5 38.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.082 1.753 . . . . 0.0 110.761 -170.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 124.25 6.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.549 1.14 . . . . 0.0 110.435 -162.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.52 131.41 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 108.518 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -125.13 131.72 53.21 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.611 -1.306 . . . . 0.0 109.812 171.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.57 153.7 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.97 147.04 28.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -133.87 -174.91 3.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.692 1.197 . . . . 0.0 109.181 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.05 -3.56 6.42 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.667 -1.629 . . . . 0.0 115.114 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -117.33 -30.99 5.42 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 120.315 2.057 . . . . 0.0 111.553 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.73 -173.53 44.52 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 119.409 1.004 . . . . 0.0 113.971 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -86.64 144.22 27.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.373 1.069 . . . . 0.0 109.796 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -89.2 -168.77 43.95 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.141 0.877 . . . . 0.0 111.96 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.86 152.4 80.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.057 2.505 . . . . 0.0 111.064 169.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.23 139.45 42.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.602 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . 8.6 t -63.41 171.04 2.37 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.114 1.366 . . . . 0.0 108.644 158.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.39 155.7 36.69 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.151 2.567 . . . . 0.0 110.193 -169.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.12 110.04 9.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.6 171.05 14.48 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 170.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.82 161.8 26.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.56 0.744 . . . . 0.0 110.549 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.82 161.17 42.9 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.88 1.672 . . . . 0.0 109.081 167.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -128.55 128.77 44.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.759 2.023 . . . . 0.0 107.523 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.5 p -87.22 160.5 48.59 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.111 0.564 . . . . 0.0 110.503 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.13 172.04 15.39 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.991 3.127 . . . . 0.0 109.039 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.08 -31.49 67.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -167.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.26 0 C-N-CA 124.272 0.939 . . . . 0.0 111.371 178.562 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.39 155.35 55.62 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.211 1.94 . . . . 0.0 111.595 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.7 mtp -111.9 -33.96 6.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -160.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.47 178.57 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.003 0.82 . . . . 0.0 110.587 -165.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.04 145.93 41.03 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 127.663 2.385 . . . . 0.0 109.838 -173.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -72.2 125.88 11.23 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.187 1.925 . . . . 0.0 109.149 174.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.11 -172.09 43.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 123.972 0.796 . . . . 0.0 111.667 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.9 t30 40.31 58.49 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.563 2.345 . . . . 0.0 110.681 172.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.69 142.98 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.35 100.42 2.88 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.563 -0.711 . . . . 0.0 109.924 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.25 134.87 47.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -171.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -124.28 135.26 53.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.833 1.653 . . . . 0.0 109.89 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.2 102.34 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 118.837 0.744 . . . . 0.0 109.764 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.56 -56.76 11.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.768 2.027 . . . . 0.0 111.121 -177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -126.32 173.78 9.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.447 1.499 . . . . 0.0 107.531 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -30.14 69.51 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.066 -1.021 . . . . 0.0 112.635 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -120.7 10.42 11.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.531 1.132 . . . . 0.0 113.078 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -133.36 117.23 17.04 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.863 1.665 . . . . 0.0 109.597 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.57 166.06 11.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.35 148.04 36.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.754 2.422 . . . . 0.0 107.956 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.76 114.94 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -92.78 157.59 16.34 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.394 1.059 . . . . 0.0 109.249 166.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -149.76 177.43 9.8 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.168 2.187 . . . . 0.0 109.601 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -104.5 133.86 19.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.388 0.675 . . . . 0.0 110.785 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 107.96 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 125.185 3.923 . . . . 0.0 110.664 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 m -57.51 155.47 19.99 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 119.259 -0.401 . . . . 0.0 110.396 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -59.35 131.55 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.917 2.411 . . . . 0.0 108.245 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.09 -32.88 62.34 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.124 0.875 . . . . 0.0 112.138 -173.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -49.59 -41.8 42.86 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.69 1.196 . . . . 0.0 111.911 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.9 p -66.22 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.861 0.865 . . . . 0.0 112.777 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.74 -34.0 65.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.125 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 42.57 57.89 3.31 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 111.706 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.08 -168.64 28.86 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -77.36 128.23 33.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.427 ' CD1' ' H ' ' A' ' 78' ' ' SER . 2.6 tt -60.98 108.49 0.88 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.995 1.318 . . . . 0.0 107.491 172.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 48' ' ' GLN . 2.7 mm-40 -85.2 -21.25 29.22 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.522 -0.736 . . . . 0.0 112.04 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.32 -168.89 30.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.679 1.133 . . . . 0.0 110.945 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -124.16 118.27 26.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -96.05 130.92 42.94 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.35 119.76 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -91.16 145.36 24.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -156.67 166.0 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 120.202 1.364 . . . . 0.0 110.692 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -148.41 153.48 38.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.774 0.829 . . . . 0.0 111.217 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -68.73 128.35 36.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 C--N 1.326 -0.418 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.23 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 C--O 1.233 0.223 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.4 mm -135.13 163.08 37.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.67 155.46 46.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.752 1.621 . . . . 0.0 108.355 167.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -116.55 120.74 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.108 1.363 . . . . 0.0 107.613 -165.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -130.32 150.1 51.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -76.38 -175.49 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.908 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.7 53.83 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 122.628 1.127 . . . . 0.0 112.125 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.427 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 94.6 p 59.57 -23.42 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.768 3.627 . . . . 0.0 118.786 173.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 150.23 12.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.844 0.83 . . . . 0.0 109.237 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 p -110.9 14.25 22.1 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.139 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.47 162.21 40.79 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.949 0.9 . . . . 0.0 112.385 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.56 -174.67 26.6 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 128.246 2.831 . . . . 0.0 108.169 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 mtp -131.98 166.55 21.43 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.512 1.156 . . . . 0.0 110.017 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -122.5 85.36 48.26 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 125.272 1.429 . . . . 0.0 107.29 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.39 146.16 6.12 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.283 3.322 . . . . 0.0 111.46 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.51 18.71 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.628 0.632 . . . . 0.0 113.148 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.44 177.63 6.07 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.869 0.868 . . . . 0.0 109.081 -165.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.52 147.94 43.05 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 125.08 1.352 . . . . 0.0 108.32 171.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -74.06 164.48 34.3 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.501 2.134 . . . . 0.0 112.292 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.4 t80 61.2 22.81 13.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.678 1.991 . . . . 0.0 112.794 170.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -120.22 162.5 19.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.084 1.354 . . . . 0.0 111.414 167.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.08 150.7 23.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.182 2.193 . . . . 0.0 107.145 168.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -137.24 156.26 48.51 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.24 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.3 m -125.89 135.46 51.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.36 154.37 47.84 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.918 1.687 . . . . 0.0 109.358 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -138.62 157.26 46.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.89 152.82 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -147.95 145.27 28.52 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.01 147.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.07 146.84 26.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -132.95 -178.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.729 0.812 . . . . 0.0 110.886 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.51 50.4 2.1 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.792 1.187 . . . . 0.0 111.919 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -157.98 -52.79 0.07 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.146 2.178 . . . . 0.0 107.629 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.13 -172.05 36.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.538 0.608 . . . . 0.0 113.294 -171.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -97.44 161.59 13.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.249 1.02 . . . . 0.0 112.767 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.39 -170.58 14.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.855 1.216 . . . . 0.0 113.493 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.55 141.31 45.73 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 124.159 3.239 . . . . 0.0 111.365 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.85 41.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.387 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.4 p -60.54 169.99 1.57 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 164.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -54.32 145.81 53.99 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 108.646 -1.328 . . . . 0.0 108.646 156.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.33 104.55 10.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -80.93 168.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.247 1.819 . . . . 0.0 108.889 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.18 161.24 28.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 122.1 -0.375 . . . . 0.0 110.307 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -159.02 129.36 5.86 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 110.975 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -86.06 139.43 31.15 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 p -94.26 145.28 29.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 -77.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.269 2.646 . . . . 0.0 112.489 -159.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -159.7 -28.98 0.06 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.666 -0.646 . . . . 0.0 111.195 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.324 0 C-N-CA 125.435 1.493 . . . . 0.0 109.481 -178.71 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt . . . . . 0 C--O 1.237 0.421 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.45 170.09 16.35 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.939 3.093 . . . . 0.0 112.594 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.8 mtm -132.78 -31.38 1.33 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -161.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -139.48 147.17 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 121.145 1.793 . . . . 0.0 109.818 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.04 169.12 15.48 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.921 1.289 . . . . 0.0 109.91 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.79 162.32 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.095 1.863 . . . . 0.0 111.81 -168.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.25 166.81 52.9 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -31.41 104.51 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.517 2.327 . . . . 0.0 114.273 -160.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.81 142.98 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -122.3 160.14 25.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.681 1.992 . . . . 0.0 106.985 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.03 145.73 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -123.43 128.32 49.66 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.217 1.807 . . . . 0.0 108.444 172.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.5 103.1 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 170.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.32 -48.3 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.409 0.683 . . . . 0.0 109.734 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -143.12 -178.24 5.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.176 1.39 . . . . 0.0 108.013 -174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -38.87 92.37 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.893 -1.129 . . . . 0.0 111.959 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 p -112.8 6.06 17.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.262 1.425 . . . . 0.0 112.098 -171.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.48 137.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.959 1.703 . . . . 0.0 108.691 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.91 161.29 36.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -119.88 128.59 53.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.39 2.276 . . . . 0.0 106.396 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.28 141.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -147.6 159.68 43.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.029 1.286 . . . . 0.0 109.473 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.55 142.66 89.2 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.3 113.08 2.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.242 2.628 . . . . 0.0 109.049 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 4.9 p -71.94 149.19 92.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.036 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.482 ' HD2' ' CG2' ' A' ' 38' ' ' VAL . 37.2 Cg_endo -70.7 137.66 33.19 Favored 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.567 4.178 . . . . 0.0 108.841 -170.164 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.17 -28.7 59.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.688 0.677 . . . . 0.0 112.043 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -57.72 -42.42 83.76 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.522 173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.2 p -68.39 -28.65 67.28 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.01 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.9 -40.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 C-N-CA 124.247 1.019 . . . . 0.0 108.455 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 65.12 -70.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.499 1.92 . . . . 0.0 112.294 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.61 -169.82 1.5 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.705 2.098 . . . . 0.0 111.802 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -80.82 138.72 36.24 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.735 0.814 . . . . 0.0 109.847 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.05 127.58 32.23 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.319 1.048 . . . . 0.0 108.764 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -98.75 -23.52 15.39 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.727 0.811 . . . . 0.0 111.985 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.8 -155.73 21.75 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -128.53 156.28 43.53 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.621 1.168 . . . . 0.0 107.99 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.59 109.72 12.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mt -85.42 141.78 14.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -118.41 117.68 29.69 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.96 1.704 . . . . 0.0 108.932 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.48 ' CD2' HD12 ' A' ' 84' ' ' LEU . 26.5 p90 -133.43 160.63 36.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.429 1.013 . . . . 0.0 112.444 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -149.38 161.0 42.95 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.398 1.479 . . . . 0.0 110.7 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -68.79 137.19 53.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.296 1.838 . . . . 0.0 108.755 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.9 tttt . . . . . 0 N--CA 1.444 -0.728 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.26 141.02 43.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 124.85 1.26 . . . . 0.0 107.849 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.435 ' CD2' HD23 ' A' ' 84' ' ' LEU . 11.9 tp -130.58 150.02 51.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.74 2.416 . . . . 0.0 106.879 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.64 137.46 45.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.107 0.963 . . . . 0.0 108.957 -170.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -142.43 93.07 2.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.374 1.07 . . . . 0.0 109.814 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -77.55 171.1 15.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.255 0.55 . . . . 0.0 110.329 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.43 70.38 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.863 -0.523 . . . . 0.0 113.366 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.7 t 58.95 20.47 8.2 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 113.332 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HZ3' ' CE1' ' A' ' 81' ' ' HIS . 1.1 mmmt -56.53 134.05 53.89 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -89.66 -1.98 58.17 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.853 1.346 . . . . 0.0 112.069 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.43 ' CE1' ' HZ3' ' A' ' 79' ' ' LYS . 3.4 p80 -147.53 144.17 28.33 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.54 162.05 32.63 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -171.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 27.0 mtp -117.44 148.66 41.59 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.45 -0.441 . . . . 0.0 111.346 -162.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.48 HD12 ' CD2' ' A' ' 54' ' ' TYR . 3.6 mm? -105.38 90.62 4.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 128.122 2.569 . . . . 0.0 107.417 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -93.2 162.37 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.712 2.275 . . . . 0.0 112.734 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.28 33.34 86.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.98 163.08 16.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.296 1.038 . . . . 0.0 108.314 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -103.49 134.1 19.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -76.98 169.39 21.73 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.445 2.096 . . . . 0.0 111.652 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.7 t80 54.7 43.15 30.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.173 2.189 . . . . 0.0 111.937 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -149.51 162.61 39.8 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 120.727 -1.233 . . . . 0.0 111.112 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -93.6 156.14 16.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -143.87 159.7 42.08 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.0 m -120.64 130.09 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.6 163.73 22.8 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.125 1.37 . . . . 0.0 109.971 168.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.5 169.08 20.31 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.937 1.295 . . . . 0.0 109.043 165.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.9 t -114.59 132.18 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 m -87.36 153.56 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.99 142.49 31.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.549 1.539 . . . . 0.0 106.868 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -144.53 -175.44 4.65 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.326 0.584 . . . . 0.0 111.125 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.43 -1.06 2.98 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.872 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -124.09 -36.26 2.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 120.56 2.18 . . . . 0.0 111.323 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.57 -150.55 10.98 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 121.697 0.609 . . . . 0.0 112.208 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.74 159.01 22.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.726 1.61 . . . . 0.0 107.91 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -102.94 -162.24 25.74 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.874 0.75 . . . . 0.0 113.574 171.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.76 162.38 25.32 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 159.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.56 166.02 11.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.482 172.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.8 p -65.99 179.36 0.47 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.419 1.088 . . . . 0.0 109.544 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.75 168.71 6.6 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.356 1.163 . . . . 0.0 109.561 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 137.72 58.23 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.087 -1.008 . . . . 0.0 108.858 160.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -115.3 158.24 22.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 161.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.54 161.27 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 166.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -91.86 128.85 37.85 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.07 0.948 . . . . 0.0 108.748 171.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -78.21 163.78 60.3 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.979 -0.534 . . . . 0.0 109.6 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.67 -114.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.686 2.924 . . . . 0.0 110.192 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.79 -31.9 3.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.387 1.449 . . . . 0.0 112.975 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.489 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -164.218 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.45 167.41 16.9 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.348 2.699 . . . . 0.0 111.361 171.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.9 mtm -123.2 -35.24 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.44 1.496 . . . . 0.0 113.507 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.3 m -137.69 -176.88 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.342 0.973 . . . . 0.0 110.368 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.41 171.41 7.63 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 127.503 2.321 . . . . 0.0 109.685 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -63.97 141.54 77.82 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.97 1.113 . . . . 0.0 110.475 164.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.73 -177.49 31.91 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -23.9 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 129.942 3.297 . . . . 0.0 114.038 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.58 145.36 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -120.62 157.91 28.51 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 126.213 1.805 . . . . 0.0 106.859 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 141.84 21.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 173.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -124.29 136.75 54.35 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.383 1.473 . . . . 0.0 108.579 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 80.8 t -95.8 105.13 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.277 1.037 . . . . 0.0 108.726 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -80.11 -48.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.491 -173.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -130.91 -178.14 4.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.8 -29.78 64.81 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.626 -1.296 . . . . 0.0 112.922 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.6 p -123.88 14.24 9.25 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 111.096 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -124.89 137.04 54.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 106.628 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.5 155.55 48.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.01 150.36 38.74 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.088 1.355 . . . . 0.0 107.771 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.6 t -129.27 135.11 62.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.18 123.59 32.47 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -129.63 157.93 40.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 110.63 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.86 139.28 95.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.185 0.994 . . . . 0.0 111.369 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.38 109.07 2.84 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.549 2.833 . . . . 0.0 111.084 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.464 ' CG1' ' HD2' ' A' ' 39' ' ' PRO 0.32 48.9 t -79.61 159.17 72.41 Favored Pre-proline 0 N--CA 1.409 -2.492 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -169.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' ' CG1' ' A' ' 38' ' ' VAL . 4.7 Cg_exo -59.6 147.2 92.81 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.232 3.955 . . . . 0.0 111.124 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.83 -35.41 79.98 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.618 -0.676 . . . . 0.0 109.267 160.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -49.47 -36.69 23.52 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.201 0.6 . . . . 0.0 111.687 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.3 p -91.0 -13.67 32.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.12 -38.52 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 120.44 1.473 . . . . 0.0 108.634 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 47.7 56.4 7.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 110.659 -173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.36 -179.21 32.4 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -73.05 144.45 47.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.24 122.69 25.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 170.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -75.41 -24.27 57.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.978 1.711 . . . . 0.0 111.009 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.95 -177.74 32.04 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 125.836 1.684 . . . . 0.0 109.338 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -99.76 129.18 45.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -113.2 102.5 10.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.499 1.519 . . . . 0.0 107.837 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.6 mt -78.0 121.53 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.69 151.05 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 162.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -157.32 164.78 37.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.205 1.402 . . . . 0.0 111.043 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -149.22 158.65 44.35 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.255 1.022 . . . . 0.0 111.667 168.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -68.71 134.1 49.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.2 m . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.009 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 tttt . . . . . 0 N--CA 1.444 -0.735 0 CA-C-O 120.495 0.188 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.52 153.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.037 1.735 . . . . 0.0 106.575 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 tp -131.14 163.16 28.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.277 2.631 . . . . 0.0 107.196 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.4 m -138.25 120.58 15.9 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -132.08 102.67 5.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 107.603 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -84.63 163.75 19.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.483 1.113 . . . . 0.0 108.943 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.26 171.35 25.31 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.5 p -78.6 27.41 0.21 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.85 1.26 . . . . 0.0 113.875 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -52.16 145.32 10.78 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.598 1.159 . . . . 0.0 110.73 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -112.75 10.85 19.3 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.135 1.374 . . . . 0.0 111.956 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -148.67 156.53 42.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.31 1.044 . . . . 0.0 109.787 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.19 117.89 0.61 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.592 0.615 . . . . 0.0 112.033 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 9.7 mtp -76.02 153.0 36.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.886 0.875 . . . . 0.0 112.833 -171.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.71 88.22 1.75 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 128.119 2.568 . . . . 0.0 108.163 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.75 158.99 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.11 2.54 . . . . 0.0 112.073 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.21 18.18 79.48 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.509 -0.744 . . . . 0.0 113.366 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.5 -176.83 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.407 1.883 . . . . 0.0 110.224 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -102.54 147.56 34.2 Favored Pre-proline 0 C--O 1.242 0.689 0 CA-C-N 118.746 0.703 . . . . 0.0 111.229 168.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -73.51 176.8 8.8 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.807 3.005 . . . . 0.0 113.139 171.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 31.2 t80 48.52 29.32 2.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.977 2.511 . . . . 0.0 115.225 170.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.1 m -128.75 -175.44 3.54 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.151 1.38 . . . . 0.0 111.183 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -122.46 152.37 40.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.964 1.306 . . . . 0.0 107.772 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -144.55 158.2 43.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.53 1.132 . . . . 0.0 108.964 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 m -122.75 141.56 51.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.89 149.23 33.86 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.75 2.02 . . . . 0.0 110.181 173.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -137.22 128.17 27.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.038 1.735 . . . . 0.0 108.949 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -89.34 144.21 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -151.96 154.06 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.913 -1.742 . . . . 0.0 108.699 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.59 146.78 5.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.1 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -135.47 -178.31 5.06 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.252 1.021 . . . . 0.0 109.446 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.96 -36.27 89.72 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 121.91 -0.494 . . . . 0.0 112.94 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -75.2 -46.39 34.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.737 0.768 . . . . 0.0 110.427 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.99 -134.44 2.52 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.668 0.667 . . . . 0.0 111.86 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -136.14 165.43 25.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.343 2.257 . . . . 0.0 108.869 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -153.98 8.32 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.37 0.985 . . . . 0.0 112.004 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.29 137.14 50.27 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.865 1.71 . . . . 0.0 109.318 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 162.8 28.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.782 0.801 . . . . 0.0 109.384 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 99.1 p -71.3 171.84 7.95 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.261 -0.9 . . . . 0.0 110.179 168.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.18 136.92 54.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.716 1.611 . . . . 0.0 110.379 168.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.5 106.09 0.88 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.226 1.811 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.42 167.25 22.05 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.986 1.314 . . . . 0.0 110.417 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.92 166.36 29.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.114 1.365 . . . . 0.0 108.899 173.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.32 158.76 38.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.784 0.834 . . . . 0.0 109.64 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -112.52 152.98 28.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 126.003 1.721 . . . . 0.0 108.195 171.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 153.68 39.21 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 119.257 0.935 . . . . 0.0 110.887 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.57 -75.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.588 2.859 . . . . 0.0 113.126 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -158.2 -35.23 0.07 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.208 1.403 . . . . 0.0 112.828 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 O-C-N 121.149 -0.969 . . . . 0.0 110.903 -177.069 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.06 164.69 24.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.585 1.524 . . . . 0.0 110.354 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.1 mtm -107.77 -35.07 6.78 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.093 0.957 . . . . 0.0 112.023 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.06 160.71 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.318 0.963 . . . . 0.0 111.484 -163.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.57 68.69 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 126.488 1.915 . . . . 0.0 107.807 161.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.61 164.42 11.38 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 109.556 -0.979 . . . . 0.0 109.556 161.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.55 -165.36 2.74 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.445 1.498 . . . . 0.0 113.731 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -54.48 115.94 2.39 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.28 154.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.25 154.5 40.1 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.901 2.08 . . . . 0.0 106.411 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.71 138.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.486 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -124.09 118.9 27.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.312 2.245 . . . . 0.0 105.457 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.7 t -64.8 134.76 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.89 -52.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -141.52 -175.6 4.43 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.241 1.416 . . . . 0.0 109.12 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -33.09 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.366 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.6 p -133.59 36.8 3.33 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.369 1.068 . . . . 0.0 109.519 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -151.81 137.08 17.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.125 0.97 . . . . 0.0 109.701 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.39 138.37 24.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.46 125.24 50.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -99.12 145.35 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.486 ' CD2' HD22 ' A' ' 24' ' ' ASN . 39.3 m-70 -127.8 147.76 50.43 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.278 0.631 . . . . 0.0 109.506 170.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -135.73 -175.08 3.84 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.433 1.493 . . . . 0.0 108.369 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -114.08 136.85 22.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.44 112.44 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.347 2.698 . . . . 0.0 111.704 -172.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -70.52 143.02 89.67 Favored Pre-proline 0 N--CA 1.41 -2.432 0 C-N-CA 124.756 1.222 . . . . 0.0 110.205 -171.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 38' ' ' VAL . 2.5 Cg_endo -62.19 133.44 43.78 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 125.812 4.341 . . . . 0.0 111.864 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.42 -36.3 73.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -52.19 -36.57 52.25 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -94.99 -13.97 24.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.41 -34.67 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.477 1.035 . . . . 0.0 109.703 164.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 60.36 6.87 1.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.839 1.656 . . . . 0.0 115.083 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.15 -166.73 23.53 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.398 0.999 . . . . 0.0 110.625 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.27 118.97 13.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.41 HD21 ' H ' ' A' ' 49' ' ' GLY . 2.0 tm? -59.83 122.8 15.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.833 1.253 . . . . 0.0 107.79 167.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.32 -32.88 22.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.756 0.822 . . . . 0.0 111.198 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.41 ' H ' HD21 ' A' ' 47' ' ' LEU . . . 156.32 -178.56 32.75 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -116.56 112.6 21.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.68 109.44 19.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.16 122.74 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -91.97 153.02 19.74 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.462 ' CE1' HD13 ' A' ' 73' ' ' LEU . 33.8 p90 -160.61 159.71 30.81 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.28 1.832 . . . . 0.0 109.482 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -148.99 153.21 37.6 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.695 0.798 . . . . 0.0 110.735 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -68.58 118.6 11.81 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.643 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 121.644 0.735 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.63 148.25 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 106.69 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD13 ' CE1' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -130.3 147.47 52.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.717 2.007 . . . . 0.0 107.722 172.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.4 m -120.29 91.51 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 108.757 -164.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.09 76.85 4.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.03 144.74 55.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.319 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.93 167.33 40.15 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.349 0.976 . . . . 0.0 112.528 -175.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -79.57 16.92 0.96 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.324 2.25 . . . . 0.0 115.276 -167.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.07 163.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.794 1.637 . . . . 0.0 113.178 174.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -125.29 9.49 7.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.71 163.8 36.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.412 1.085 . . . . 0.0 108.954 173.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.63 165.66 36.34 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 46.1 mtp -111.91 150.56 30.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.134 0.974 . . . . 0.0 109.457 -168.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.46 79.85 7.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -86.75 162.37 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 110.247 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.18 74.4 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.935 0.779 . . . . 0.0 113.341 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -93.7 171.22 9.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.667 1.587 . . . . 0.0 108.723 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.2 156.74 35.5 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 124.359 1.064 . . . . 0.0 110.12 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -82.7 177.25 7.04 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 124.481 3.454 . . . . 0.0 112.957 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.9 t80 38.24 57.32 1.66 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.724 2.81 . . . . 0.0 111.85 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.5 m -149.98 157.79 43.51 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.378 1.871 . . . . 0.0 109.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -90.62 150.72 21.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -134.93 154.83 51.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.886 1.274 . . . . 0.0 108.162 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.2 m -125.93 138.88 53.8 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 172.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.47 162.85 35.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.388 2.275 . . . . 0.0 109.697 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -134.45 -176.08 4.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.74 139.52 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.561 1.944 . . . . 0.0 106.394 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -140.89 128.82 21.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.683 1.193 . . . . 0.0 107.798 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 m -74.65 153.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.6 t -138.03 150.03 24.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 171.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -138.95 -168.9 2.52 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 109.123 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.88 4.5 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.456 -1.191 . . . . 0.0 116.036 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.02 -47.89 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.182 1.991 . . . . 0.0 111.358 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.3 -166.66 34.46 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 120.689 1.586 . . . . 0.0 113.427 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -95.58 167.85 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.884 1.273 . . . . 0.0 110.259 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -128.6 -157.32 9.26 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.617 1.579 . . . . 0.0 112.582 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.06 150.48 82.51 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.917 2.411 . . . . 0.0 110.222 177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.43 164.6 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.089 0.947 . . . . 0.0 112.131 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 p -69.19 177.22 1.25 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.247 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.98 146.87 15.91 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.73 1.62 . . . . 0.0 110.087 158.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.78 100.5 6.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 168.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.9 mmt-85 -76.57 162.98 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.872 -0.518 . . . . 0.0 110.267 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.78 157.37 38.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.333 0.653 . . . . 0.0 110.046 174.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -150.49 146.74 26.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.382 1.073 . . . . 0.0 109.245 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -109.75 145.11 37.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.355 1.062 . . . . 0.0 108.4 169.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.72 169.2 19.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.775 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -68.23 -75.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.451 2.101 . . . . 0.0 109.266 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -172.45 -39.14 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.212 1.405 . . . . 0.0 110.592 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 C-N-CA 125.718 1.628 . . . . 0.0 112.258 -177.533 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.653 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 t -153.65 -71.48 0.14 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.154 0.982 . . . . 0.0 109.003 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 p 48.37 96.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.622 1.969 . . . . 0.0 111.492 -157.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.2 -154.99 8.09 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.6 m 60.42 176.68 0.1 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.437 1.495 . . . . 0.0 111.765 -166.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 t 62.14 137.18 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.359 1.864 . . . . 0.0 109.482 -155.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.96 -173.79 13.21 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.56 168.71 26.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.32 1.06 . . . . 0.0 109.234 167.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -150.45 151.15 32.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 166.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.44 -161.08 53.5 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -150.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . 0.253 5.6 mt-10 73.96 77.82 0.12 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 129.028 2.931 . . . . 0.0 112.284 173.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -60.14 -52.72 64.13 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.834 2.853 . . . . 0.0 112.201 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 mt 38.19 144.65 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.102 1 C-N-CA 134.986 5.314 . . . . 0.0 119.497 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.3 169.15 12.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.522 1.482 . . . . 0.0 113.261 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mtm -132.91 -40.53 0.94 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.986 0.914 . . . . 0.0 113.413 -165.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.32 168.66 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.01 166.1 12.56 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 126.754 2.021 . . . . 0.0 109.374 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.456 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 32.5 Cg_endo -70.98 141.6 40.66 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.332 1.355 . . . . 0.0 114.44 -166.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.63 178.56 23.86 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.506 1.526 . . . . 0.0 111.726 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 23.65 66.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.877 3.271 . . . . 0.0 114.477 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.3 t -76.27 132.53 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.46 175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -148.23 166.48 27.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.442 1.497 . . . . 0.0 109.44 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.51 141.61 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 120.78 -1.2 . . . . 0.0 108.62 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.0 119.25 29.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.224 2.61 . . . . 0.0 109.225 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.72 130.21 35.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 119.196 0.907 . . . . 0.0 108.851 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.32 -64.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 126.139 1.776 . . . . 0.0 107.993 -171.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -115.88 179.16 4.06 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.589 1.156 . . . . 0.0 108.065 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -18.3 61.52 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.224 -0.922 . . . . 0.0 112.768 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -126.35 0.27 7.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.323 1.849 . . . . 0.0 112.687 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -139.16 128.1 23.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.695 1.598 . . . . 0.0 108.207 -170.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.94 172.57 8.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.65 117.29 13.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 152.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -132.47 148.81 52.41 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.549 1.54 . . . . 0.0 109.138 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -160.28 164.89 32.27 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.662 1.585 . . . . 0.0 109.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -87.83 145.24 36.31 Favored Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 120.942 -1.099 . . . . 0.0 112.034 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.31 102.58 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.854 3.036 . . . . 0.0 111.095 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.456 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 4.6 m -64.26 158.88 62.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.77 144.86 39.93 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.317 3.345 . . . . 0.0 110.229 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.08 -30.72 62.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.243 0.474 . . . . 0.0 111.143 169.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -56.75 -28.49 61.27 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.6 p -89.58 -29.81 18.62 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 111.459 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 81.9 mt -67.83 -38.44 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.331 1.053 . . . . 0.0 109.071 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 50.01 80.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.639 1.575 . . . . 0.0 110.606 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.61 -102.76 0.83 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -138.22 103.58 4.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.6 -166.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.0 tp -54.88 119.62 5.65 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 127.006 2.123 . . . . 0.0 109.393 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -86.72 -48.7 8.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.078 0.951 . . . . 0.0 108.941 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.26 173.0 45.98 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -99.93 136.13 40.31 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 161.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -105.7 152.09 23.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.9 mt -126.4 126.2 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.45 141.28 28.7 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -153.02 159.95 42.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.543 1.137 . . . . 0.0 110.962 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -148.46 158.27 44.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.357 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -68.94 127.32 32.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.641 1.576 . . . . 0.0 106.87 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.2 m -110.26 165.73 11.53 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 60.5 15.63 5.75 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 t -102.44 -49.06 3.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.598 1.544 . . . . 0.0 109.416 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 t 53.05 78.94 0.13 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.661 1.984 . . . . 0.0 112.16 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.0 t -18.33 -60.48 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 130.193 3.397 . . . . 0.0 116.222 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.6 tttp 67.83 125.26 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.385 1.874 . . . . 0.0 113.556 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.69 -89.26 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.264 1.825 . . . . 0.0 113.096 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -62.6 107.71 1.0 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.23 1.412 . . . . 0.0 110.865 -166.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 46.32 45.37 13.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.685 1.594 . . . . 0.0 112.372 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -49.58 106.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.712 1.205 . . . . 0.0 111.274 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -153.05 -176.83 5.94 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.679 1.192 . . . . 0.0 108.759 164.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.1 mt -116.37 132.04 67.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.92 109.67 13.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -108.2 96.07 6.11 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -88.05 164.39 15.78 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.252 2.221 . . . . 0.0 109.854 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.25 149.38 28.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.94 144.7 50.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 128.665 2.786 . . . . 0.0 107.533 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.5 m -130.52 117.14 19.16 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -128.67 85.74 2.37 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.278 1.031 . . . . 0.0 109.011 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -67.54 147.09 53.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.053 0.541 . . . . 0.0 110.245 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.61 167.55 26.24 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 122.705 1.17 . . . . 0.0 111.409 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -87.55 44.37 1.18 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -151.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 167.02 3.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.396 0.617 . . . . 0.0 111.304 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 p -124.53 -1.97 7.99 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.701 1.6 . . . . 0.0 111.355 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -148.61 160.7 42.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.172 1.389 . . . . 0.0 107.39 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.02 134.24 3.26 Favored Glycine 0 N--CA 1.454 -0.162 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.6 mtp -81.67 153.47 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.038 0.419 . . . . 0.0 111.338 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -106.92 91.08 5.9 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 167.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.87 154.92 2.27 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.953 3.102 . . . . 0.0 111.92 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.19 37.08 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.02 -166.41 1.23 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.402 3.081 . . . . 0.0 107.329 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -121.97 146.79 47.19 Favored Pre-proline 0 N--CA 1.45 -0.466 0 O-C-N 120.918 -1.114 . . . . 0.0 111.323 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 167.63 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.265 3.31 . . . . 0.0 111.963 163.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.262 0.3 OUTLIER 40.12 42.1 1.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.841 2.456 . . . . 0.0 111.525 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -133.62 153.12 51.91 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.557 -1.34 . . . . 0.0 108.44 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -94.14 146.53 23.92 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.11 153.99 51.82 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.8 m -126.64 143.71 51.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.08 163.12 39.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.354 1.861 . . . . 0.0 109.714 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -152.76 151.72 30.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 110.216 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.59 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.913 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -137.37 138.5 39.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.096 1.359 . . . . 0.0 108.326 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.12 152.41 3.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 64.0 t -137.36 134.94 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -128.3 -174.95 3.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.433 1.093 . . . . 0.0 109.713 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.72 -7.33 41.05 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.339 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.93 -38.93 5.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.95 1.7 . . . . 0.0 110.541 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.04 -173.27 45.13 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 110.638 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 166.78 22.81 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.34 -0.506 . . . . 0.0 110.814 164.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 -158.42 10.38 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 160.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.75 158.06 44.29 Favored 'Trans proline' 0 C--O 1.237 0.428 0 CA-C-N 119.886 1.843 . . . . 0.0 112.586 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.4 143.35 26.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.639 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.23 175.18 2.96 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 126.064 1.746 . . . . 0.0 111.185 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.35 137.48 65.61 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.731 1.621 . . . . 0.0 109.353 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.73 153.92 27.0 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.271 1.034 . . . . 0.0 110.729 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 74.4 mmt-85 -134.5 170.54 15.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 107.687 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.6 m -135.27 157.01 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.786 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -153.72 143.03 21.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -112.4 137.69 50.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 170.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -92.16 151.21 41.49 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.16 -73.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.846 3.031 . . . . 0.0 113.265 -159.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -154.0 -41.31 0.09 Allowed 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 151.84 -175.87 30.43 Favored Glycine 0 N--CA 1.464 0.562 0 CA-C-O 119.287 -0.729 . . . . 0.0 111.701 -167.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.1 p 172.71 135.28 0.03 OUTLIER 'General case' 0 C--O 1.236 0.351 0 C-N-CA 128.599 2.76 . . . . 0.0 107.636 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.08 176.58 14.45 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.49 46.29 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.872 3.714 . . . . 0.0 111.506 -175.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.99 156.01 22.28 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.04 -1.037 . . . . 0.0 109.479 169.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.8 m -151.94 -50.26 0.11 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.319 -0.863 . . . . 0.0 110.753 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.307 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 178.369 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.679 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.7 m -149.79 162.7 39.76 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.929 2.092 . . . . 0.0 106.913 170.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -155.24 97.72 1.93 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.45 162.25 19.56 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -172.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 t -143.81 -40.4 0.29 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.549 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.2 m 59.21 -177.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.302 1.441 . . . . 0.0 111.505 -171.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.84 113.83 1.93 Allowed Glycine 0 C--N 1.339 0.737 0 O-C-N 121.138 -0.976 . . . . 0.0 112.481 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -133.04 135.43 45.38 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.767 1.227 . . . . 0.0 108.956 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t 62.6 171.86 0.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.019 1.728 . . . . 0.0 111.068 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.31 99.19 1.62 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -83.45 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 161.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.98 4.0 34.07 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 121.446 -0.784 . . . . 0.0 112.342 -165.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.1 153.59 80.65 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 124.959 1.304 . . . . 0.0 110.779 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.9 -175.78 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.295 2.663 . . . . 0.0 112.807 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 42.5 mtm -126.51 -59.37 1.3 Allowed 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 110.467 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.1 m -122.21 148.93 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.605 0.717 . . . . 0.0 111.635 -168.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.75 168.4 18.47 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.003 2.121 . . . . 0.0 109.912 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 2.0 Cg_endo -61.01 155.82 48.04 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.345 1.363 . . . . 0.0 113.308 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.34 -175.49 30.24 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.115 1.34 . . . . 0.0 111.088 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -36.09 103.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 127.476 2.311 . . . . 0.0 113.757 -163.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.56 139.73 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.27 156.44 45.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.46 118.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 119.214 0.915 . . . . 0.0 109.285 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -96.7 121.41 38.52 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.465 1.106 . . . . 0.0 109.202 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.0 t -86.5 108.62 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.1 -56.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.765 0.826 . . . . 0.0 108.885 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.19 -174.3 3.29 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.13 0.972 . . . . 0.0 109.674 -163.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -27.84 67.76 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.623 -0.673 . . . . 0.0 112.136 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.4 p -129.39 7.55 5.38 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.46 1.104 . . . . 0.0 111.795 -166.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -138.54 139.45 38.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.17 1.788 . . . . 0.0 108.352 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.03 173.42 11.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.938 167.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 151.22 51.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.635 1.974 . . . . 0.0 108.877 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 t -126.97 134.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -119.47 128.98 54.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -142.99 -179.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.529 1.132 . . . . 0.0 110.279 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.1 144.58 29.69 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.899 0.879 . . . . 0.0 111.704 -172.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.53 96.47 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.409 2.739 . . . . 0.0 111.192 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 32.4 m -64.03 157.04 71.62 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.052 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -77.31 146.01 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.308 2.672 . . . . 0.0 109.358 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.06 -30.75 71.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.759 -0.588 . . . . 0.0 111.798 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -59.3 -34.55 72.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.402 -0.808 . . . . 0.0 111.614 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.6 p -64.39 -42.99 95.84 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.494 1.043 . . . . 0.0 110.062 172.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.7 mt -64.25 -31.52 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.086 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 54.72 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.643 2.377 . . . . 0.0 115.232 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.13 -155.57 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.315 1.912 . . . . 0.0 109.591 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -103.94 109.73 21.6 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.82 1.248 . . . . 0.0 110.874 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -46.29 110.45 0.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 127.092 2.157 . . . . 0.0 109.678 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -86.01 -12.91 49.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.627 0.727 . . . . 0.0 111.544 169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.15 28.43 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -101.47 155.76 17.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 164.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -122.1 144.6 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.48 120.17 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.86 150.85 20.84 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 163.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -158.67 160.23 36.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.695 1.598 . . . . 0.0 109.726 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -149.37 157.44 43.32 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.687 0.795 . . . . 0.0 109.789 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -68.12 125.45 26.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.8 m -103.26 125.47 49.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -157.81 120.27 3.8 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -169.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.4 m -68.47 108.88 3.45 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.187 0.995 . . . . 0.0 110.175 -168.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 p -91.92 117.96 30.3 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.011 1.324 . . . . 0.0 110.257 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 t -63.4 153.71 34.35 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.057 -1.027 . . . . 0.0 108.47 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -48.97 97.79 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 128.894 2.878 . . . . 0.0 112.595 -168.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 -134.44 120.13 19.4 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.75 1.22 . . . . 0.0 108.627 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -65.13 159.17 24.01 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 57.67 74.0 0.44 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 126.552 1.941 . . . . 0.0 111.826 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.39 132.78 23.38 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.391 1.876 . . . . 0.0 106.471 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -125.34 111.0 14.67 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.979 1.263 . . . . 0.0 107.634 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.18 133.11 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.681 1.192 . . . . 0.0 108.068 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -88.72 91.3 8.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -69.5 135.58 50.31 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.981 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -117.68 158.02 25.42 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 126.513 1.925 . . . . 0.0 109.626 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.72 143.15 37.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.93 153.44 48.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 107.176 167.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -133.28 127.9 34.64 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -138.11 88.93 2.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.77 0.828 . . . . 0.0 109.386 -172.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -71.36 151.37 44.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.273 1.029 . . . . 0.0 110.286 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.62 164.0 29.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.133 1.349 . . . . 0.0 112.199 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -79.74 58.15 2.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.748 1.619 . . . . 0.0 110.428 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.04 171.08 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.556 1.143 . . . . 0.0 109.924 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 7.23 2.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.973 1.709 . . . . 0.0 111.932 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -144.4 159.57 42.5 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.574 0.75 . . . . 0.0 109.362 167.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.45 148.46 12.06 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.352 1.453 . . . . 0.0 111.266 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.4 mtp -77.96 169.51 18.17 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -169.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.78 96.32 32.68 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 126.835 2.054 . . . . 0.0 105.851 163.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -99.49 161.53 0.57 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.267 2.644 . . . . 0.0 111.702 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.36 35.5 56.33 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.331 -0.856 . . . . 0.0 111.784 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.45 161.65 18.52 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.59 130.03 24.12 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.12 166.5 18.65 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.381 2.721 . . . . 0.0 112.232 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.9 t80 42.95 52.76 5.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.206 . . . . 0.0 113.346 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -152.08 -178.84 7.02 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.55 1.14 . . . . 0.0 110.879 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 162.59 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.394 1.478 . . . . 0.0 108.651 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -136.03 165.58 25.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.669 1.188 . . . . 0.0 108.721 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 m -125.6 146.46 49.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 157.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.72 164.09 30.87 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.466 1.906 . . . . 0.0 108.848 167.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -148.54 144.94 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.824 -0.547 . . . . 0.0 109.903 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.01 152.4 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -149.64 143.21 25.38 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.6 146.58 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.1 t -135.29 142.7 39.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 126.156 1.783 . . . . 0.0 107.215 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -144.65 -174.29 4.29 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.525 1.13 . . . . 0.0 111.156 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.08 -10.05 31.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.057 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -117.27 -22.95 8.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.929 1.365 . . . . 0.0 112.322 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.0 -153.23 23.87 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -127.13 159.8 33.13 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.745 0.783 . . . . 0.0 110.35 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.84 -165.85 27.08 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.139 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.57 166.37 24.19 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.303 1.335 . . . . 0.0 109.92 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.01 150.07 23.28 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.088 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -75.15 165.36 54.46 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -55.58 123.65 14.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.918 2.412 . . . . 0.0 110.809 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.32 143.21 53.47 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.156 1.782 . . . . 0.0 107.896 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -122.23 163.61 19.31 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.31 166.58 22.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -158.67 159.49 35.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -117.53 143.45 46.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.77 1.228 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.2 p -98.75 143.4 26.28 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -66.09 167.17 18.71 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.846 2.364 . . . . 0.0 108.969 172.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -61.87 -23.69 66.45 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.81 66.91 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 m -61.36 107.15 0.72 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -176.74 21.89 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 123.575 0.607 . . . . 0.0 111.879 -156.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -63.97 -44.66 12.24 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.223 1.949 . . . . 0.0 110.432 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.8 m 50.58 60.05 4.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.687 1.995 . . . . 0.0 112.338 164.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.8 m 125.63 47.2 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 131.538 3.935 . . . . 0.0 111.609 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.524 0 C-N-CA 124.713 1.149 . . . . 0.0 111.186 173.421 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 CA-C-O 118.977 -0.902 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -117.01 173.3 6.73 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.899 1.279 . . . . 0.0 109.425 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 t -164.27 -175.03 3.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.127 1.371 . . . . 0.0 107.882 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.53 179.65 51.44 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.157 1.361 . . . . 0.0 112.78 171.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 m 127.16 157.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 1 C-N-CA 134.323 5.049 . . . . 0.0 108.621 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.4 t -165.6 170.36 14.32 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.792 1.637 . . . . 0.0 109.784 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.51 116.76 0.38 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.584 1.564 . . . . 0.0 110.647 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -156.32 157.39 35.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.976 1.711 . . . . 0.0 107.759 158.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.1 t -168.94 -40.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.925 2.09 . . . . 0.0 109.008 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.07 -92.91 0.1 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 51.03 67.25 0.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.994 1.718 . . . . 0.0 111.478 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.9 -40.18 72.65 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 113.163 -1.835 . . . . 0.0 112.915 -164.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt 33.9 141.18 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.067 1 C-N-CA 133.55 4.74 . . . . 0.0 119.999 168.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.94 161.17 40.71 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.171 2.58 . . . . 0.0 111.878 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 mtm -125.76 -26.59 3.47 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -169.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.3 m -140.6 169.22 15.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.494 1.117 . . . . 0.0 110.862 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.29 163.0 17.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.34 2.256 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.58 156.58 60.11 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.828 1.685 . . . . 0.0 113.393 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 166.86 54.92 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -21.3 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 129.073 2.949 . . . . 0.0 115.356 -162.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.67 130.35 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -118.82 161.14 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.68 138.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -123.79 125.29 44.44 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.421 0.689 . . . . 0.0 110.369 169.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.39 101.28 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 166.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.0 -56.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.878 2.071 . . . . 0.0 109.759 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -132.34 172.35 12.56 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.187 1.395 . . . . 0.0 107.392 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.16 0.93 0.81 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.6 p -133.62 -1.25 3.12 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.301 1.84 . . . . 0.0 112.371 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -149.07 119.81 7.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.396 1.078 . . . . 0.0 109.594 -159.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.31 130.72 48.24 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.577 0.626 . . . . 0.0 109.893 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.24 146.03 39.3 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.69 139.91 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 164.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -120.68 151.79 39.06 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.58 1.552 . . . . 0.0 108.035 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -153.0 155.79 37.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.849 0.46 . . . . 0.0 110.819 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.35 136.72 45.88 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.07 129.59 15.39 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.342 2.695 . . . . 0.0 110.388 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.21 151.86 95.8 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.659 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -85.31 159.82 11.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.938 3.092 . . . . 0.0 110.809 -173.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -60.03 -34.37 73.29 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.031 0.532 . . . . 0.0 111.663 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -66.93 -23.01 65.93 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 41.1 p -76.46 -41.08 48.6 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 120.077 1.308 . . . . 0.0 109.49 170.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.22 -32.7 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.237 1.415 . . . . 0.0 110.146 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 50.22 60.82 3.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.471 1.508 . . . . 0.0 110.142 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.09 -147.87 19.41 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.91 122.83 46.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.381 1.472 . . . . 0.0 110.711 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.38 111.44 0.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.75 2.02 . . . . 0.0 109.802 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.5 -13.95 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.694 0.797 . . . . 0.0 112.053 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.16 -164.47 27.94 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.12 148.98 31.51 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 107.91 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -125.9 140.98 52.2 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.2 mt -128.85 122.12 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -91.45 148.16 22.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -158.33 164.54 36.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 111.124 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -149.26 162.23 40.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -68.61 136.09 52.48 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.934 2.093 . . . . 0.0 108.38 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m -126.95 144.12 51.09 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.788 1.635 . . . . 0.0 106.881 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 51.92 76.76 0.16 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.067 1.747 . . . . 0.0 112.573 -171.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.8 t -133.96 -75.41 0.48 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.682 1.193 . . . . 0.0 109.516 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.6 t -51.93 148.24 6.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.868 1.667 . . . . 0.0 112.646 -171.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 t -52.82 146.15 11.14 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.692 1.597 . . . . 0.0 111.176 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -45.89 114.71 0.82 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.647 1.579 . . . . 0.0 109.972 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 38.4 67.64 0.39 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.629 1.572 . . . . 0.0 113.635 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.14 80.32 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.611 -0.681 . . . . 0.0 112.502 -175.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.0 mtt85 67.61 177.76 0.24 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 127.045 2.138 . . . . 0.0 110.433 -167.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -151.01 57.38 0.91 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.303 -0.873 . . . . 0.0 110.889 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -81.76 123.47 28.79 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.256 1.023 . . . . 0.0 108.615 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.2 mt -135.0 123.95 41.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -77.27 157.96 30.5 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 163.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -128.1 93.55 3.7 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 165.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -67.99 153.12 44.4 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.9 mm -122.84 159.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -130.8 141.29 50.34 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 127.16 2.184 . . . . 0.0 107.233 165.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.7 m -112.9 122.21 46.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.781 1.232 . . . . 0.0 107.809 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -128.64 80.22 1.95 Allowed 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.108 0.963 . . . . 0.0 109.168 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.28 155.68 27.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.86 157.7 33.89 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.583 1.563 . . . . 0.0 111.585 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -79.5 34.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.841 1.257 . . . . 0.0 113.937 -169.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 160.81 14.92 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.538 -1.351 . . . . 0.0 111.865 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.3 p -119.82 7.01 10.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.831 2.053 . . . . 0.0 111.089 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.9 170.67 18.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.009 1.323 . . . . 0.0 109.379 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.16 158.63 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 mtp -97.34 157.9 15.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.897 1.348 . . . . 0.0 112.282 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.06 80.93 1.14 Allowed Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 129.853 3.261 . . . . 0.0 106.236 169.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -86.22 153.09 9.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.648 2.899 . . . . 0.0 110.417 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 23.38 56.74 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.741 1.162 . . . . 0.0 112.316 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.5 166.44 12.05 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 172.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 150.7 55.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.553 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -70.29 -178.77 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.911 2.407 . . . . 0.0 111.87 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 53.41 36.87 24.17 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.636 1.175 . . . . 0.0 111.333 164.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 m -146.07 155.68 42.94 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.58 1.552 . . . . 0.0 109.477 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -100.63 153.81 19.11 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -143.2 156.24 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.839 0.856 . . . . 0.0 109.426 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.9 m -125.94 139.01 53.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.07 160.59 39.91 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 110.283 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.21 145.29 24.56 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.497 -0.752 . . . . 0.0 110.816 165.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.87 151.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.931 2.092 . . . . 0.0 107.873 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.28 139.69 18.63 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.39 134.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.366 1.067 . . . . 0.0 110.12 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.45 146.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -133.29 -178.86 5.17 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.287 1.435 . . . . 0.0 109.514 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.43 53.0 2.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.198 0.904 . . . . 0.0 111.267 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -162.78 -31.79 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.383 1.873 . . . . 0.0 109.983 172.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.95 -167.68 35.45 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.158 0.866 . . . . 0.0 113.468 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.28 169.09 12.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.044 2.937 . . . . 0.0 110.213 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.45 -155.26 6.57 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 128.32 2.867 . . . . 0.0 110.047 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 137.33 39.64 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.132 2.555 . . . . 0.0 111.991 -175.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.97 158.55 35.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.535 0.734 . . . . 0.0 110.195 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.6 p -63.21 174.22 0.96 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.939 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -50.72 140.44 37.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 153.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -61.18 106.0 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 161.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -85.96 166.2 16.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.76 157.72 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -152.04 136.78 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -86.7 159.69 19.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 161.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.9 p -111.2 162.44 20.83 Favored Pre-proline 0 C--O 1.243 0.727 0 C-N-CA 123.975 0.91 . . . . 0.0 108.862 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.44 166.22 30.43 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.193 1.928 . . . . 0.0 109.044 168.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.33 -21.26 66.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.069 0.948 . . . . 0.0 112.46 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.99 -126.57 7.87 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.7 m -118.04 152.27 35.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.432 1.093 . . . . 0.0 108.995 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -172.57 172.01 44.68 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.86 151.8 46.09 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.519 2.146 . . . . 0.0 111.333 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.6 t -150.75 169.44 21.63 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.788 2.035 . . . . 0.0 106.086 162.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.1 t -89.93 175.64 7.12 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 154.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.263 1.92 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 143.345 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.554 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 m -66.05 122.87 18.37 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 166.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 p -82.76 76.5 9.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.924 0.89 . . . . 0.0 108.704 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.11 161.54 32.63 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -148.51 45.19 1.04 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.959 1.304 . . . . 0.0 109.997 -169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -139.45 108.06 5.9 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 45.71 -140.04 5.7 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.838 1.208 . . . . 0.0 111.532 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.401 ' CD2' ' H ' ' A' ' 9' ' ' SER . 13.9 p-80 -133.1 -70.53 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.766 1.626 . . . . 0.0 107.384 166.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.401 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 29.4 t -163.45 -176.79 4.91 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 127.595 2.358 . . . . 0.0 106.579 -172.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.98 113.13 3.59 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 168.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -110.43 -47.47 3.27 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.572 1.149 . . . . 0.0 108.899 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -135.31 -11.28 2.17 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.613 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.99 153.14 94.83 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-N 120.748 1.613 . . . . 0.0 110.127 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.94 166.77 28.84 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 120.991 1.127 . . . . 0.0 110.158 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.3 mtm -117.86 -44.93 2.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.269 -169.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.252 33.5 m -129.96 -175.3 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.749 1.158 . . . . 0.0 111.726 -174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.67 152.6 69.4 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 128.268 2.627 . . . . 0.0 108.862 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.53 137.75 23.3 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.917 1.745 . . . . 0.0 109.253 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.94 -170.81 28.68 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.1 t30 30.43 56.25 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.464 1.905 . . . . 0.0 112.557 -170.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.44 121.68 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -133.36 155.06 50.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.26 -1.336 . . . . 0.0 107.87 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.46 146.0 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.81 129.92 51.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.42 150.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.213 161.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 t -117.03 -78.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -103.08 -179.83 4.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.408 1.083 . . . . 0.0 108.706 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -17.71 63.14 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.457 -1.402 . . . . 0.0 113.47 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.8 p -133.83 10.15 3.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.889 1.276 . . . . 0.0 112.598 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -130.95 132.35 45.01 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.943 1.697 . . . . 0.0 107.548 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.73 169.2 14.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.651 0.781 . . . . 0.0 109.012 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -126.3 135.75 51.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.493 1.517 . . . . 0.0 107.334 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.22 148.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.57 154.65 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.623 1.969 . . . . 0.0 108.664 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -158.09 171.35 20.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.281 0.632 . . . . 0.0 111.386 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.59 137.52 38.74 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.818 1.647 . . . . 0.0 111.317 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.17 112.78 3.63 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.727 2.951 . . . . 0.0 111.077 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.43 158.66 64.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 122.077 -0.389 . . . . 0.0 110.568 170.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.64 160.63 14.45 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.557 2.838 . . . . 0.0 112.288 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -25.39 67.78 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.404 -0.81 . . . . 0.0 112.871 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -60.69 -49.49 77.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.568 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.4 p -66.67 -23.66 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.818 1.19 . . . . 0.0 111.503 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.5 mt -67.57 -32.88 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.539 172.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 47.09 30.06 1.25 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.412 1.485 . . . . 0.0 113.624 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.6 -148.82 12.35 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.569 -1.332 . . . . 0.0 113.648 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -100.52 112.1 24.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.673 1.589 . . . . 0.0 107.84 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.65 121.74 15.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.466 1.906 . . . . 0.0 109.068 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -80.88 -38.44 28.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.81 -178.21 41.23 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 121.379 -0.826 . . . . 0.0 111.945 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -99.44 124.51 44.65 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -76.79 155.63 32.95 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 160.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.16 124.71 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 156.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -91.22 147.52 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 163.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 33.8 p90 -157.37 163.0 39.07 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.467 1.507 . . . . 0.0 110.265 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -149.08 157.16 43.17 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.762 0.791 . . . . 0.0 111.76 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -67.95 125.66 27.02 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m -107.06 165.75 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -141.37 172.69 12.34 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 170.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 m -65.18 115.03 5.1 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.122 -0.986 . . . . 0.0 108.605 169.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t 53.0 53.12 12.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.725 1.21 . . . . 0.0 114.056 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t -63.39 110.73 2.02 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 pmtp? -96.79 -170.24 2.02 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.746 1.618 . . . . 0.0 109.745 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ptt-85 -121.15 82.31 1.91 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.012 1.325 . . . . 0.0 111.215 -158.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -156.5 94.36 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.039 1.736 . . . . 0.0 107.74 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.86 175.16 0.28 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 127.338 2.255 . . . . 0.0 111.463 -176.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 53.13 -179.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.094 2.157 . . . . 0.0 111.876 -162.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -146.68 142.49 27.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.143 1.777 . . . . 0.0 106.291 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.51 116.56 17.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -71.08 105.34 3.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.609 2.364 . . . . 0.0 107.418 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -84.88 86.58 7.35 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -72.26 162.43 29.47 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.589 1.955 . . . . 0.0 109.257 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.4 mm -132.25 155.02 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.448 0.699 . . . . 0.0 109.685 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.51 157.5 46.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.957 2.503 . . . . 0.0 108.816 170.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -131.02 116.37 17.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.773 1.229 . . . . 0.0 109.633 -170.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.16 97.6 5.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.922 1.289 . . . . 0.0 107.807 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.92 172.03 12.48 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.236 0.541 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.24 15.1 70.06 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.58 26.19 15.88 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 171.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.5 167.52 0.49 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.049 1.74 . . . . 0.0 112.701 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.6 p -102.92 5.12 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 112.399 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.79 168.07 21.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.225 0.61 . . . . 0.0 110.792 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.13 33.24 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.759 2.123 . . . . 0.0 108.626 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.4 mtp -131.85 167.91 18.77 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.891 1.345 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.11 76.42 51.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.914 1.686 . . . . 0.0 107.27 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -82.38 151.86 15.58 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.92 2.413 . . . . 0.0 110.88 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.89 18.64 46.57 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.428 0.537 . . . . 0.0 112.043 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.84 -169.55 2.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.972 1.309 . . . . 0.0 110.387 -171.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.52 149.33 64.5 Favored Pre-proline 0 CA--C 1.54 0.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.347 178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -77.69 173.97 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.423 2.749 . . . . 0.0 112.851 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.1 t80 44.26 53.23 6.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.194 1.798 . . . . 0.0 111.868 172.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m -155.85 146.64 22.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 120.963 -1.086 . . . . 0.0 110.686 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -78.77 151.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.13 0.972 . . . . 0.0 108.876 171.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -143.7 154.93 43.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.632 1.573 . . . . 0.0 108.113 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.5 m -117.13 147.83 42.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 171.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -150.6 158.75 44.52 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.66 1.984 . . . . 0.0 110.141 171.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.75 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.3 155.83 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 107.622 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -152.4 142.12 21.92 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 119.832 -1.793 . . . . 0.0 108.686 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 m -81.51 148.21 5.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.4 t -136.44 136.57 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -136.24 -171.12 2.81 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.378 0.671 . . . . 0.0 110.22 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.67 -15.98 14.64 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.213 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -111.58 -46.99 3.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.117 1.958 . . . . 0.0 111.191 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.04 -170.17 34.12 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.363 0.983 . . . . 0.0 112.406 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -108.16 145.56 33.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 109.467 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.92 -165.23 31.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.906 1.241 . . . . 0.0 114.014 -168.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.71 133.58 49.03 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.252 1.968 . . . . 0.0 108.879 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.29 157.46 16.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.722 0.773 . . . . 0.0 109.977 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 p -67.79 165.46 31.1 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 156.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -63.47 152.91 77.86 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.356 1.37 . . . . 0.0 109.642 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.48 96.91 4.83 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.294 2.238 . . . . 0.0 105.94 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -76.69 168.46 20.04 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.1 1.36 . . . . 0.0 109.562 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.27 164.8 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.201 0.6 . . . . 0.0 111.306 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -160.14 156.47 26.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.942 2.097 . . . . 0.0 108.085 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -122.13 141.37 51.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.324 1.05 . . . . 0.0 109.758 165.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.2 154.25 88.34 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 123.619 0.574 . . . . 0.0 110.792 173.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.41 -73.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.802 3.001 . . . . 0.0 111.403 -168.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.68 -39.77 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.86 -156.52 26.96 Favored Glycine 0 N--CA 1.46 0.264 0 CA-C-N 118.817 0.735 . . . . 0.0 111.456 -166.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.0 m -134.55 92.28 2.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -115.28 167.34 12.33 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.312 0.958 . . . . 0.0 111.543 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.76 133.59 18.81 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.737 2.291 . . . . 0.0 108.704 168.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.6 t -63.15 -21.17 66.02 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 122.069 -0.395 . . . . 0.0 110.508 168.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.5 t 71.51 -2.91 2.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.38 2.272 . . . . 0.0 114.69 168.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.433 0 N-CA-C 105.778 -2.929 . . . . 0.0 105.778 146.168 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 CA-C-O 119.172 -0.793 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 p -169.53 46.55 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.522 1.529 . . . . 0.0 110.099 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -142.9 169.49 17.47 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 121.369 -0.832 . . . . 0.0 110.525 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.1 55.68 0.09 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.423 1.487 . . . . 0.0 111.006 -175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.4 m -109.81 151.57 26.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 169.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 p -81.53 -69.35 0.62 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.91 172.32 43.81 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.449 1.024 . . . . 0.0 111.274 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.99 -62.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.378 1.071 . . . . 0.0 109.749 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 t -162.99 -177.9 5.75 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.261 1.424 . . . . 0.0 108.298 -162.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.9 98.11 0.72 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -63.84 -55.84 19.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.525 0.73 . . . . 0.0 110.198 167.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -14.85 2.65 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.445 -0.788 . . . . 0.0 111.909 -171.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 mt -69.49 150.82 96.89 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 119.601 1.092 . . . . 0.0 110.857 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -66.93 157.31 62.17 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.484 2.123 . . . . 0.0 112.152 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 mtm -112.0 -28.16 8.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -168.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.49 175.98 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.746 1.618 . . . . 0.0 108.052 -174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.06 167.45 12.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.204 2.202 . . . . 0.0 108.776 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 18.7 Cg_endo -68.27 113.85 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.436 2.091 . . . . 0.0 111.882 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.14 157.07 12.83 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 41.46 62.01 1.65 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.622 1.569 . . . . 0.0 110.326 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -55.46 146.58 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 157.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -140.85 161.32 38.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.3 146.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 O-C-N 119.725 -1.859 . . . . 0.0 109.057 169.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -123.98 151.28 43.84 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.099 2.56 . . . . 0.0 107.732 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.71 145.02 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.5 t -111.73 -57.78 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.45 -173.35 2.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.031 1.333 . . . . 0.0 107.593 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -31.89 71.9 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.863 -1.148 . . . . 0.0 112.377 175.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.8 p -122.5 13.13 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 111.008 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.4 ' CD1' ' HE3' ' A' ' 83' ' ' MET . 2.0 tm? -134.66 139.27 45.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.516 1.926 . . . . 0.0 107.804 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.05 170.14 16.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.34 117.36 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.67 145.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.77 159.2 27.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 108.054 173.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -161.51 162.07 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.493 1.042 . . . . 0.0 110.635 169.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -85.3 135.13 39.35 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.63 116.76 4.55 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.069 3.179 . . . . 0.0 111.559 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.437 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 34.7 m -72.78 158.02 87.89 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.957 -0.465 . . . . 0.0 112.218 -175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.44 149.81 13.15 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.951 3.101 . . . . 0.0 111.384 -176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.6 mp -59.09 -26.63 64.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.873 -178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -60.33 -52.11 66.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 111.189 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.5 p -73.91 -23.25 59.53 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.7 mt -66.05 -26.71 38.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 118.276 -0.868 . . . . 0.0 109.938 167.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? 72.77 -49.74 0.7 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.335 2.654 . . . . 0.0 113.956 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.19 -99.36 1.31 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.639 1.114 . . . . 0.0 112.007 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -137.84 105.34 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.384 1.874 . . . . 0.0 109.227 -169.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.27 131.46 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -95.65 -24.01 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.101 1.36 . . . . 0.0 110.847 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.71 -153.99 25.56 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -127.83 123.45 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.855 1.662 . . . . 0.0 106.564 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.61 106.0 17.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mt -78.73 118.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -92.49 143.2 26.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -154.79 170.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.864 1.211 . . . . 0.0 111.849 172.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -149.66 164.59 34.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.589 1.155 . . . . 0.0 110.44 165.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -68.61 137.62 54.39 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.09 1.356 . . . . 0.0 108.024 164.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 83.0 m -114.02 140.52 48.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 52.59 73.91 0.32 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.329 1.452 . . . . 0.0 112.458 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t -57.71 136.92 56.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.949 1.3 . . . . 0.0 110.008 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t -82.09 -14.31 55.99 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -163.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -114.04 145.13 42.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.231 1.378 . . . . 0.0 109.945 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -58.64 -48.05 82.33 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 125.911 1.684 . . . . 0.0 110.544 -167.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -66.77 96.52 0.41 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 157.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -83.34 175.02 10.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 146.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -84.16 173.9 10.67 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.877 -1.14 . . . . 0.0 108.409 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -77.94 -71.83 0.4 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.699 -1.25 . . . . 0.0 108.821 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.61 133.72 56.38 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.8 mt -71.43 147.05 11.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.08 54.19 0.39 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.981 2.513 . . . . 0.0 111.83 169.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -51.68 135.77 28.33 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.299 1.44 . . . . 0.0 109.12 161.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -139.84 169.31 17.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.332 1.053 . . . . 0.0 111.329 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -132.91 150.36 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.405 2.282 . . . . 0.0 106.895 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.18 100.64 3.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.535 1.934 . . . . 0.0 107.864 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 m -71.62 109.29 5.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -108.69 94.42 5.04 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.73 164.88 11.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.829 168.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.56 153.55 28.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -83.39 37.59 0.57 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.128 1.371 . . . . 0.0 111.154 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 170.76 3.53 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.887 2.075 . . . . 0.0 112.19 171.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -133.96 2.45 3.38 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 126.045 1.738 . . . . 0.0 110.614 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -158.32 142.08 15.44 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.111 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.92 138.85 8.03 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -172.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.4 ' HE3' ' CD1' ' A' ' 30' ' ' LEU . 39.8 mtp -77.23 163.03 26.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.002 0.921 . . . . 0.0 110.887 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -126.5 82.82 65.79 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.133 1.373 . . . . 0.0 107.546 168.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -90.75 154.06 4.14 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.823 2.349 . . . . 0.0 111.795 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.41 51.44 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.457 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.82 -177.7 4.61 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.351 1.46 . . . . 0.0 108.478 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.51 139.68 36.23 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.823 0.849 . . . . 0.0 108.974 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.62 178.4 7.16 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.966 3.111 . . . . 0.0 112.886 -172.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.7 t80 50.89 23.17 1.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.868 2.867 . . . . 0.0 113.514 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.9 m -123.06 157.06 33.62 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.49 1.516 . . . . 0.0 110.351 -172.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -96.83 151.78 19.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -142.07 156.37 45.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.325 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.9 m -126.03 136.12 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.69 166.68 22.69 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.743 1.617 . . . . 0.0 109.895 170.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.67 153.08 34.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.838 2.055 . . . . 0.0 106.578 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -121.07 137.54 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.807 1.243 . . . . 0.0 108.465 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.1 ttm105 -135.17 131.36 36.67 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.44 1.496 . . . . 0.0 108.421 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . 0.25 0.8 OUTLIER -70.99 140.19 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 127.933 2.493 . . . . 0.0 108.013 176.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.07 138.58 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -136.99 -175.6 4.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.758 0.823 . . . . 0.0 111.001 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.71 69.77 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.804 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -82.53 -40.25 21.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.973 1.309 . . . . 0.0 110.835 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.36 -165.96 34.05 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 121.943 0.746 . . . . 0.0 111.983 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.44 157.29 20.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.062 0.945 . . . . 0.0 112.534 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.91 -157.99 10.29 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.113 1.339 . . . . 0.0 111.039 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.86 166.57 22.12 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.013 1.809 . . . . 0.0 111.684 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.29 154.05 19.11 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.246 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -70.19 -174.85 0.26 Allowed Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.733 1.613 . . . . 0.0 110.871 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.35 161.4 44.93 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 CA-C-N 122.307 1.86 . . . . 0.0 109.532 167.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.69 162.09 24.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.258 1.027 . . . . 0.0 109.066 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -132.39 162.36 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.739 1.216 . . . . 0.0 108.271 166.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 159.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.87 147.07 29.36 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.71 144.48 42.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.11 160.73 29.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 110.317 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.76 168.66 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 N-CA-C 108.879 -1.239 . . . . 0.0 108.879 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -61.62 -29.43 70.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.679 0.791 . . . . 0.0 112.116 -174.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.68 37.71 7.88 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 125.709 1.624 . . . . 0.0 115.511 163.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -58.02 148.96 24.43 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 117.783 0.791 . . . . 0.0 109.94 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.53 110.06 3.61 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 169.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.01 121.19 8.34 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.547 2.174 . . . . 0.0 110.412 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -102.62 146.3 28.37 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.877 1.271 . . . . 0.0 107.712 165.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.1 m -74.22 169.02 18.44 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 161.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.596 0 N-CA-C 106.229 -2.749 . . . . 0.0 106.229 151.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.0 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p -166.6 -178.95 4.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -170.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 t -139.11 177.18 8.08 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 161.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.69 110.81 2.33 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -165.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 t -155.69 -57.12 0.09 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.99 -164.9 0.25 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.788 0.835 . . . . 0.0 109.376 -168.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.33 160.93 16.75 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -168.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -147.61 121.89 9.6 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -71.7 175.74 5.43 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.687 1.232 . . . . 0.0 109.039 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.7 159.82 15.23 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.999 -2.441 . . . . 0.0 106.999 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -65.88 -62.94 1.22 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.029 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.0 -52.18 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.989 0.806 . . . . 0.0 111.11 162.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.3 mt 49.93 161.35 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 130.168 3.387 . . . . 0.0 115.74 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.42 -174.33 1.95 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.773 1.649 . . . . 0.0 111.386 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.5 mtm -133.62 -47.03 0.81 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.337 1.455 . . . . 0.0 113.218 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.94 -178.42 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 118.858 0.754 . . . . 0.0 110.196 -169.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.45 164.17 19.25 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 126.487 1.915 . . . . 0.0 109.597 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 3.6 Cg_endo -66.21 144.6 75.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.459 1.44 . . . . 0.0 112.482 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.61 170.28 4.93 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.997 1.284 . . . . 0.0 111.468 166.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -49.23 142.44 7.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -147.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.79 121.11 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.157 1.783 . . . . 0.0 106.976 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -122.71 88.29 2.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.715 1.606 . . . . 0.0 111.312 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.417 HG11 ' HE ' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -87.45 143.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 157.16 35.47 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.78 2.032 . . . . 0.0 110.089 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.39 103.49 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.65 -54.08 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.656 1.182 . . . . 0.0 109.312 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -138.33 -179.88 6.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.699 1.2 . . . . 0.0 107.864 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -23.46 56.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.269 1.028 . . . . 0.0 111.25 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -122.17 -2.06 9.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.105 2.162 . . . . 0.0 112.694 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 tp -144.01 130.0 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.308 1.443 . . . . 0.0 109.619 -170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.28 117.45 8.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.172 0.896 . . . . 0.0 111.041 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.17 154.7 41.62 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.549 1.14 . . . . 0.0 110.305 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.95 103.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.809 2.043 . . . . 0.0 106.121 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -92.08 154.2 18.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.108 0.413 . . . . 0.0 110.082 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -151.02 177.63 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 110.124 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.86 142.27 25.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.71 122.93 10.4 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.284 2.656 . . . . 0.0 109.65 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 15.6 m -71.1 164.57 55.75 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 118.887 0.767 . . . . 0.0 110.45 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -64.61 138.93 61.45 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.221 1.947 . . . . 0.0 109.15 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -31.1 41.01 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.822 0.283 . . . . 0.0 111.228 166.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -50.27 -46.99 55.51 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.182 1.393 . . . . 0.0 110.881 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 61.6 p -71.49 -29.48 64.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.46 -20.21 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.672 0.789 . . . . 0.0 109.486 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 45.33 57.06 5.1 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.038 2.135 . . . . 0.0 110.419 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.16 -102.55 0.33 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.444 -1.198 . . . . 0.0 111.427 173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -138.18 119.66 14.9 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.316 1.047 . . . . 0.0 110.217 -164.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.46 124.71 23.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.451 1.5 . . . . 0.0 109.119 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -92.74 -14.38 28.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.888 0.475 . . . . 0.0 112.098 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 176.37 22.87 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 126.604 2.049 . . . . 0.0 108.25 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.75 151.64 21.01 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -127.9 109.19 11.35 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.904 -1.123 . . . . 0.0 108.939 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.05 133.6 30.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -104.5 147.77 27.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 152.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.81 158.93 40.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.694 1.198 . . . . 0.0 111.268 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.1 p90 -148.71 161.91 40.8 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.947 0.899 . . . . 0.0 110.253 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -68.38 136.26 53.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.2 m -117.39 155.63 29.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 59.38 173.76 0.08 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.474 1.109 . . . . 0.0 112.002 -164.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.1 m -165.78 97.47 0.65 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.898 1.279 . . . . 0.0 109.913 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.2 m -67.57 84.32 0.18 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.234 1.014 . . . . 0.0 111.266 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 t 65.72 141.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.364 2.666 . . . . 0.0 111.608 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 75.46 1.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.223 -0.923 . . . . 0.0 112.517 -159.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -68.81 106.09 2.56 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.51 -0.744 . . . . 0.0 110.475 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 41.86 76.88 0.07 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 129.044 2.938 . . . . 0.0 114.504 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -79.0 152.04 31.19 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 121.437 -0.789 . . . . 0.0 111.805 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -85.92 -100.49 0.07 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.96 0.904 . . . . 0.0 109.181 164.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -122.47 170.07 10.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.969 1.708 . . . . 0.0 108.001 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.5 mt -78.4 130.91 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -69.09 126.95 31.41 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 167.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -105.49 102.98 12.42 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -78.53 161.02 27.33 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.889 2.076 . . . . 0.0 109.389 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.15 155.7 41.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.8 mt -133.12 165.93 23.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.206 1.402 . . . . 0.0 108.864 170.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.5 m -138.54 105.29 5.36 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.593 -0.692 . . . . 0.0 109.679 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -116.77 93.0 4.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -72.86 166.86 22.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.549 0.69 . . . . 0.0 109.76 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.89 173.25 47.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 p -73.8 11.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.003 2.121 . . . . 0.0 114.769 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -64.43 156.12 30.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.438 1.095 . . . . 0.0 109.856 -167.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.6 p -118.08 8.99 12.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.208 1.403 . . . . 0.0 111.307 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -150.12 158.87 44.61 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.627 0.771 . . . . 0.0 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.72 143.6 6.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.953 0.787 . . . . 0.0 111.409 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.8 mtp -97.46 153.11 18.33 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.892 -0.769 . . . . 0.0 112.551 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -100.32 87.13 0.72 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.52 2.328 . . . . 0.0 109.143 171.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.42 162.42 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.252 2.634 . . . . 0.0 111.163 171.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.58 21.04 79.32 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.716 -0.615 . . . . 0.0 112.603 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.97 172.64 9.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.829 1.252 . . . . 0.0 107.803 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.53 161.26 49.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 124.769 1.228 . . . . 0.0 108.848 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -89.77 160.84 5.14 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 125.091 3.861 . . . . 0.0 115.086 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 65.1 44.82 3.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.496 3.518 . . . . 0.0 117.613 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.58 -169.39 2.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.992 2.117 . . . . 0.0 109.97 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -110.45 163.83 13.3 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 158.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.44 152.89 46.03 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.516 -0.74 . . . . 0.0 109.883 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.8 m -126.0 139.43 53.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.3 162.88 36.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.995 2.118 . . . . 0.0 107.18 172.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -137.35 -176.26 4.34 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.126 0.971 . . . . 0.0 108.937 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.25 160.15 41.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -154.31 154.21 32.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 106.193 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.48 145.39 8.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.0 t -129.22 139.42 51.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -133.33 -177.97 4.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.833 0.853 . . . . 0.0 109.787 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.54 7.49 3.75 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.098 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -122.05 -57.17 1.8 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.861 1.331 . . . . 0.0 110.327 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.73 -156.79 8.52 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -170.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 163.02 29.56 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.313 1.045 . . . . 0.0 110.917 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.32 -158.11 10.76 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.453 1.025 . . . . 0.0 111.978 -166.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.23 158.66 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.569 2.179 . . . . 0.0 111.807 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.58 156.51 25.14 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.941 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.9 p -64.82 -178.17 0.25 Allowed Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.183 166.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -48.33 132.69 24.42 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.591 -1.349 . . . . 0.0 108.591 145.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.22 157.6 19.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 155.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.417 ' HE ' HG11 ' A' ' 23' ' ' VAL . 3.2 mmm180 -126.21 168.55 13.92 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 123.824 0.85 . . . . 0.0 108.961 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -115.57 155.43 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.505 171.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -144.19 142.78 30.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 160.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -114.77 148.28 38.6 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.269 1.427 . . . . 0.0 107.437 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -111.79 162.61 20.42 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 110.421 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.62 170.54 18.35 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.248 1.966 . . . . 0.0 110.177 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.62 -31.32 67.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.902 1.281 . . . . 0.0 111.389 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 65.63 97.38 0.02 OUTLIER Glycine 0 C--N 1.338 0.662 0 C-N-CA 126.225 1.869 . . . . 0.0 112.128 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.3 m 55.13 39.08 31.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 117.754 0.777 . . . . 0.0 111.596 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.29 125.32 38.72 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.047 -1.418 . . . . 0.0 109.759 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.99 168.12 24.08 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 CA-C-N 119.848 1.824 . . . . 0.0 109.308 169.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -154.53 -173.14 4.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.1 m -149.91 170.68 18.25 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.988 1.315 . . . . 0.0 108.548 171.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.821 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 -177.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.586 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 77.41 145.55 0.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.341 2.257 . . . . 0.0 109.951 -169.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.0 p -165.64 -172.96 2.57 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.161 1.384 . . . . 0.0 109.096 167.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.19 -81.77 1.51 Allowed Glycine 0 CA--C 1.522 0.499 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.887 160.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t -154.17 -101.81 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 t -60.82 136.48 58.09 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.66 1.118 . . . . 0.0 110.945 -174.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.0 33.99 1.03 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.38 1.466 . . . . 0.0 110.584 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -158.71 76.72 0.74 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -165.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.7 p -144.83 90.78 2.09 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.847 -0.533 . . . . 0.0 110.258 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.77 7.85 0.02 OUTLIER Glycine 0 CA--C 1.523 0.556 0 CA-C-O 117.149 -1.917 . . . . 0.0 117.229 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -34.91 -57.03 0.56 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.438 1.895 . . . . 0.0 114.391 -159.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.31 -0.08 13.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.447 1.099 . . . . 0.0 111.59 -173.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 mt -63.85 140.99 97.95 Favored Pre-proline 0 N--CA 1.472 0.634 0 O-C-N 120.668 -1.27 . . . . 0.0 112.937 -166.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.72 161.7 44.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.724 2.283 . . . . 0.0 111.329 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.7 mtm -108.45 -41.39 4.86 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.539 1.136 . . . . 0.0 112.797 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.25 152.56 36.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.535 0.683 . . . . 0.0 109.432 -165.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.96 168.43 21.9 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 108.339 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 1.6 Cg_endo -60.68 155.63 47.32 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 119.362 0.808 . . . . 0.0 110.635 165.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.25 -155.78 0.76 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.761 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -45.71 128.77 8.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.52 1.128 . . . . 0.0 111.28 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.4 t -105.08 145.43 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -120.96 150.73 40.66 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.48 119.5 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 174.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.28 130.05 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.2 t -76.8 118.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -85.63 -52.57 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.501 1.52 . . . . 0.0 107.606 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -136.33 177.73 7.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.337 1.455 . . . . 0.0 109.611 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -38.21 54.4 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.072 1.349 . . . . 0.0 112.608 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -113.61 5.95 16.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.402 1.081 . . . . 0.0 111.692 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 tp -137.39 125.2 22.52 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.712 -168.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.91 157.48 27.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 160.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -98.73 150.81 21.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 163.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.5 t -130.5 139.72 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.542 1.537 . . . . 0.0 107.54 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.81 135.4 49.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.348 2.259 . . . . 0.0 105.234 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -140.85 -170.87 3.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.13 0.972 . . . . 0.0 108.967 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -119.77 135.32 24.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.523 1.129 . . . . 0.0 110.321 -167.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.38 96.41 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.509 2.806 . . . . 0.0 110.606 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 19.7 m -63.78 156.08 74.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.392 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.03 149.74 32.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.558 2.172 . . . . 0.0 109.961 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.53 -39.05 72.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.39 1.076 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -58.64 -30.28 67.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.1 p -71.68 -37.89 70.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.806 0.73 . . . . 0.0 110.315 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.0 mt -63.34 -27.53 43.24 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.638 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 56.1 13.91 1.32 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.754 1.622 . . . . 0.0 113.393 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.75 -177.85 48.57 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -162.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 111.54 19.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.768 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 tp -44.89 132.01 6.9 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.038 2.135 . . . . 0.0 110.383 168.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -117.48 -12.08 10.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.027 1.331 . . . . 0.0 112.54 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.58 -171.05 30.45 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.529 1.538 . . . . 0.0 110.482 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -114.8 159.65 20.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.984 0.514 . . . . 0.0 109.808 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -127.31 147.42 50.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.842 1.257 . . . . 0.0 108.072 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.0 mt -120.17 124.53 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 162.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -97.22 145.78 25.73 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 160.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -155.91 161.25 40.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 109.556 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.41 ' CE2' ' HB ' ' A' ' 94' ' ' THR . 46.3 p90 -149.1 157.32 43.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.399 0.68 . . . . 0.0 109.893 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 tptm -68.8 140.21 55.27 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.8 m -130.85 131.31 44.51 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -166.06 -10.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.2 m 60.84 -60.1 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.161 1.785 . . . . 0.0 113.517 -160.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.87 47.66 6.94 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 127.787 2.435 . . . . 0.0 112.844 -175.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -55.48 131.17 45.39 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -167.57 166.57 14.05 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.696 1.998 . . . . 0.0 106.242 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -61.08 -28.08 68.82 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.571 1.532 . . . . 0.0 113.512 -171.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -134.34 162.36 32.4 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.329 0.968 . . . . 0.0 110.217 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.7 ttt85 98.35 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 130.435 3.494 . . . . 0.0 108.641 164.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -134.49 86.58 2.28 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.736 1.615 . . . . 0.0 107.931 -173.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -150.58 120.57 7.16 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.62 1.568 . . . . 0.0 107.704 171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.0 mt -98.79 124.76 52.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 171.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -81.7 116.24 21.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.389 1.076 . . . . 0.0 108.911 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -98.55 142.65 29.88 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.177 0.991 . . . . 0.0 109.154 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -137.44 165.95 25.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 127.705 2.402 . . . . 0.0 110.94 -164.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.62 158.33 43.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 122.563 1.173 . . . . 0.0 110.374 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.83 130.99 23.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.319 2.248 . . . . 0.0 108.017 166.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -86.7 145.58 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.309 1.444 . . . . 0.0 108.181 171.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -139.95 161.15 38.28 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.285 1.034 . . . . 0.0 110.344 167.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -77.57 171.27 15.18 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.668 1.223 . . . . 0.0 112.148 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 151.66 36.18 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.812 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 t 62.91 -6.38 0.17 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.167 2.187 . . . . 0.0 115.736 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -67.25 146.35 54.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 120.527 -1.358 . . . . 0.0 107.444 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 p -110.23 7.77 23.34 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.249 1.419 . . . . 0.0 112.255 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.12 167.33 25.3 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.403 0.547 . . . . 0.0 112.037 168.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.61 -172.16 33.57 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 128.652 3.025 . . . . 0.0 107.396 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.9 mtp -129.84 169.29 15.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.968 1.384 . . . . 0.0 111.689 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.01 84.54 26.75 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -88.8 157.62 6.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.832 3.021 . . . . 0.0 111.326 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.67 14.33 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.284 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.8 -179.35 3.61 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.573 1.549 . . . . 0.0 108.95 174.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.16 147.91 37.95 Favored Pre-proline 0 C--O 1.237 0.405 0 CA-C-N 118.528 0.604 . . . . 0.0 111.624 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -70.17 173.28 11.58 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.312 2.674 . . . . 0.0 113.022 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.6 t80 48.55 36.97 8.27 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.025 2.13 . . . . 0.0 113.35 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -137.42 142.4 41.66 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 120.661 -1.274 . . . . 0.0 111.807 -169.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -79.47 146.65 32.62 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 161.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -139.0 148.58 43.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 167.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.41 ' HB ' ' CE2' ' A' ' 55' ' ' TRP . 5.1 m -115.07 154.14 29.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.68 163.8 38.33 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.96 1.704 . . . . 0.0 109.519 -177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -140.66 157.64 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.286 1.034 . . . . 0.0 108.936 164.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.72 143.76 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.66 147.33 42.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.31 148.68 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.7 137.92 51.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.463 1.505 . . . . 0.0 107.154 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -141.77 178.18 7.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.282 1.033 . . . . 0.0 109.292 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.22 -1.93 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.296 0.95 . . . . 0.0 114.667 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -123.18 -26.01 4.4 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.299 1.44 . . . . 0.0 110.997 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.46 -159.27 31.87 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-O 121.691 0.606 . . . . 0.0 111.853 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -132.72 124.89 29.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -160.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.39 -160.93 13.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 -165.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.04 171.37 11.39 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 118.997 1.398 . . . . 0.0 109.312 163.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.31 165.45 12.68 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.9 p -67.86 -178.04 0.36 Allowed Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 125.525 1.53 . . . . 0.0 111.034 -164.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -50.94 134.11 41.59 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 N-CA-C 108.485 -1.39 . . . . 0.0 108.485 149.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.44 141.32 56.56 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.05 169.18 9.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -135.25 150.23 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -156.93 141.04 16.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.156 0.982 . . . . 0.0 108.529 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -120.37 128.4 53.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.536 1.534 . . . . 0.0 109.043 175.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -82.43 158.86 65.6 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 123.946 0.898 . . . . 0.0 110.039 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -67.68 -89.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.938 3.092 . . . . 0.0 112.383 -167.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -151.0 -31.14 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.217 1.371 . . . . 0.0 112.631 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.91 -161.18 25.55 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.279 1.419 . . . . 0.0 112.649 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.08 73.79 0.37 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.396 2.278 . . . . 0.0 112.051 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -167.68 158.44 31.29 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 161.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.41 -43.56 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.428 2.752 . . . . 0.0 111.745 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.8 t -144.56 -98.43 0.1 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -174.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 t -65.6 -39.0 91.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.46 1.027 . . . . 0.0 109.367 165.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 103.117 -3.993 . . . . 0.0 103.117 -139.235 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.173 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -73.99 90.86 1.99 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 163.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -162.88 162.03 26.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.217 1.007 . . . . 0.0 109.057 -167.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.43 158.2 28.51 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 165.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -174.67 -62.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.2 m -68.43 172.06 6.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.028 1.331 . . . . 0.0 109.96 164.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.69 -42.98 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.55 162.24 29.2 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.596 0.698 . . . . 0.0 109.208 165.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 t -146.77 158.01 43.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.458 1.503 . . . . 0.0 107.381 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.81 -67.49 0.55 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 126.107 1.813 . . . . 0.0 108.772 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 50.11 61.23 3.3 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 126.251 1.82 . . . . 0.0 112.852 170.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.15 -23.18 67.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.274 -167.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.28 134.34 89.18 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 121.246 1.839 . . . . 0.0 110.263 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -61.37 140.75 89.71 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.752 2.301 . . . . 0.0 113.638 -171.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.5 mtm -79.78 -43.54 22.31 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 125.128 1.371 . . . . 0.0 112.57 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.5 m -138.08 165.93 24.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.23 0.538 . . . . 0.0 111.279 -170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.22 172.19 5.68 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 109.84 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -65.25 169.52 12.16 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.468 2.112 . . . . 0.0 113.223 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.31 172.47 55.22 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.922 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -51.04 107.59 0.19 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 113.501 -157.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.21 152.08 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.862 2.065 . . . . 0.0 109.259 -172.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -141.86 156.53 45.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.139 1.776 . . . . 0.0 107.16 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 143.42 20.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 120.893 -1.129 . . . . 0.0 110.373 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -123.69 128.57 49.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.514 2.326 . . . . 0.0 108.835 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -82.26 122.31 36.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.53 -50.52 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -153.29 -172.48 4.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.302 0.572 . . . . 0.0 110.182 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -35.55 66.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.785 0.834 . . . . 0.0 112.191 -171.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.5 p -127.74 18.59 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.706 1.202 . . . . 0.0 111.204 -168.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -145.81 140.22 26.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.623 1.569 . . . . 0.0 110.94 176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.19 167.62 21.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.948 1.299 . . . . 0.0 108.237 169.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 145.68 50.92 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.003 1.721 . . . . 0.0 109.993 174.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.56 133.35 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -166.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -122.24 149.36 43.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.3 p90 -147.98 154.29 40.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.84 142.13 28.8 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 123.76 11.38 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.283 2.655 . . . . 0.0 110.551 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -51.22 163.31 0.55 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 124.309 1.043 . . . . 0.0 110.73 160.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.76 -134.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 1 C-N-CA 126.738 4.959 . . . . 0.0 107.627 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.67 -31.64 1.76 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 117.476 -1.25 . . . . 0.0 111.446 161.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -49.9 -45.16 50.58 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.166 1.348 . . . . 0.0 112.399 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.5 p -75.3 -27.45 59.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.394 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.5 mt -64.04 -29.09 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.015 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 68.29 -26.13 0.13 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.431 2.692 . . . . 0.0 114.291 170.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.79 -164.76 11.7 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 128.473 2.94 . . . . 0.0 107.916 166.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -76.7 149.88 36.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.18 129.89 38.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.165 1.386 . . . . 0.0 107.891 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -98.4 -28.89 13.43 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.584 0.353 . . . . 0.0 111.015 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.52 179.75 38.81 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 121.402 -0.811 . . . . 0.0 111.278 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -122.34 149.92 43.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -122.63 125.83 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.7 mt -94.58 123.52 46.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -92.32 146.23 23.86 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 164.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.98 168.37 27.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.203 1.001 . . . . 0.0 112.356 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -148.91 156.98 43.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.166 1.386 . . . . 0.0 109.911 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -73.64 137.69 44.33 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.467 1.507 . . . . 0.0 108.351 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.1 m -130.61 148.17 52.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.202 1.001 . . . . 0.0 109.347 -171.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -146.37 -28.52 0.41 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 31.22 69.6 0.1 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.874 2.47 . . . . 0.0 114.028 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 m -119.55 -179.05 3.76 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 159.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.0 m -114.45 90.04 3.24 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.153 0.581 . . . . 0.0 109.56 -168.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -63.04 157.85 21.0 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.843 -0.536 . . . . 0.0 110.329 172.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ttt-85 -86.51 -37.97 17.7 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -148.09 92.68 2.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.606 1.162 . . . . 0.0 108.486 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -160.03 136.31 8.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.181 0.9 . . . . 0.0 109.815 165.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.37 81.63 1.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.395 1.078 . . . . 0.0 108.272 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -157.96 101.7 1.79 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.678 0.791 . . . . 0.0 109.332 171.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.16 122.2 41.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 166.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -78.91 139.3 38.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 165.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -120.31 125.35 47.85 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -97.67 163.71 12.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.714 1.605 . . . . 0.0 108.733 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.48 149.85 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 106.223 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.22 137.08 35.66 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.258 -170.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.0 m -98.76 132.36 44.19 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.767 0.827 . . . . 0.0 109.77 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -143.87 68.13 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.805 2.042 . . . . 0.0 108.036 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -66.08 133.91 51.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.954 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.76 176.47 25.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.665 1.602 . . . . 0.0 112.599 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.9 p -74.88 0.43 15.64 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HE2' ' CE1' ' A' ' 81' ' ' HIS . 2.2 mmmp? -45.9 146.72 1.14 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.035 1.289 . . . . 0.0 112.159 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 p -99.6 -2.95 34.34 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.425 1.89 . . . . 0.0 111.136 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.417 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 15.1 p80 -149.9 166.88 28.26 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.741 -0.599 . . . . 0.0 110.885 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.29 158.72 24.44 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.453 1.025 . . . . 0.0 112.228 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 55.2 mtp -88.18 160.32 17.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.911 0.884 . . . . 0.0 112.187 -170.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.35 89.33 31.13 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.641 1.576 . . . . 0.0 107.534 166.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -93.18 156.59 2.6 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.063 3.175 . . . . 0.0 111.421 168.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.73 29.15 19.45 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.887 0.756 . . . . 0.0 111.611 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.4 175.82 5.45 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.375 1.87 . . . . 0.0 107.932 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -133.22 150.36 75.12 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 124.851 1.26 . . . . 0.0 110.19 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -71.08 166.3 29.61 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.944 2.43 . . . . 0.0 112.277 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.1 t80 51.48 34.1 11.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.616 2.366 . . . . 0.0 113.461 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.4 m -132.53 148.45 52.38 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.491 1.117 . . . . 0.0 110.578 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.65 151.97 23.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -137.29 149.32 47.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.115 1.366 . . . . 0.0 108.289 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 m -126.03 134.78 51.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 163.25 37.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.823 2.049 . . . . 0.0 108.486 -171.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.94 169.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.05 1.34 . . . . 0.0 108.762 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.42 149.55 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.747 1.219 . . . . 0.0 108.113 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -140.13 147.31 40.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.481 1.512 . . . . 0.0 108.0 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -87.87 154.06 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.096 0.862 . . . . 0.0 109.363 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.4 t -132.12 139.1 51.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -138.63 -170.94 2.95 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.15 0.58 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.2 -8.25 17.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.535 1.065 . . . . 0.0 115.433 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -113.11 -57.41 2.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.15 1.475 . . . . 0.0 109.397 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.37 -163.61 25.64 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.302 0.956 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -87.28 160.65 18.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.74 -157.27 10.09 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 165.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -62.52 156.95 49.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 CA-C-N 119.607 1.703 . . . . 0.0 111.342 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.41 155.23 17.49 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.963 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -66.04 166.89 13.78 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.402 1.481 . . . . 0.0 108.603 168.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.18 162.7 28.77 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.73 1.62 . . . . 0.0 109.671 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -61.53 138.15 58.27 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 122.185 0.993 . . . . 0.0 110.064 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 173.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 159.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.86 156.56 42.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.7 145.36 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 158.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -123.64 146.81 47.92 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 p -90.64 157.43 44.1 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 124.232 1.013 . . . . 0.0 109.598 -167.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.07 164.98 31.75 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.417 2.078 . . . . 0.0 109.003 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.6 -27.57 62.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.556 1.142 . . . . 0.0 112.466 -173.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.63 -96.52 0.59 Allowed Glycine 0 C--O 1.239 0.41 0 C-N-CA 125.572 1.558 . . . . 0.0 112.012 155.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 t -152.01 165.96 33.05 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 175.64 -113.53 0.45 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 105.317 -3.113 . . . . 0.0 105.317 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.65 142.54 77.64 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.14 1.893 . . . . 0.0 110.726 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 p -141.61 148.49 39.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 161.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.4 m -72.61 173.51 8.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 167.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 C-N-CA 128.175 2.798 . . . . 0.0 106.461 168.757 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.546 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.22 123.55 42.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.021 1.328 . . . . 0.0 109.925 -164.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 m -136.61 73.64 1.46 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.19 1.396 . . . . 0.0 110.008 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.0 -178.49 27.66 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.293 1.425 . . . . 0.0 110.076 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m -114.11 161.91 17.16 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.596 1.158 . . . . 0.0 109.573 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 m -120.28 174.55 6.45 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.66 136.15 2.83 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -148.72 148.44 30.02 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -167.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -139.64 151.39 45.93 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.942 1.297 . . . . 0.0 109.215 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.18 175.38 50.97 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.059 1.314 . . . . 0.0 112.268 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -125.8 -53.09 1.55 Allowed 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 125.187 1.395 . . . . 0.0 109.09 172.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -76.97 -5.09 47.26 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.218 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 mt -71.68 151.69 93.52 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 126.09 1.756 . . . . 0.0 110.782 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.8 172.81 15.09 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.627 2.218 . . . . 0.0 111.137 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.3 mtm -121.34 -30.79 4.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.286 1.435 . . . . 0.0 113.551 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.97 163.12 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 111.371 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.01 169.17 18.6 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.856 2.062 . . . . 0.0 109.029 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 7.6 Cg_endo -70.19 160.36 49.87 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.255 1.304 . . . . 0.0 110.474 165.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.47 -154.15 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.429 1.49 . . . . 0.0 114.46 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -47.41 131.59 13.55 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.528 1.131 . . . . 0.0 110.303 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.73 147.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -131.86 158.42 41.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.15 150.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.82 128.96 50.28 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.16 143.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 159.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.9 t -111.03 -53.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -132.27 -171.11 2.56 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.992 1.317 . . . . 0.0 108.687 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -37.14 86.44 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.056 -1.027 . . . . 0.0 112.517 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.0 p -123.34 11.63 9.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.947 1.299 . . . . 0.0 110.078 -166.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -134.69 137.77 43.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.58 1.952 . . . . 0.0 109.0 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.73 165.51 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.33 118.71 18.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.97 147.88 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 107.313 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -131.0 133.35 45.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -118.39 -158.81 0.73 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.961 2.104 . . . . 0.0 108.247 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.08 137.56 30.97 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 126.492 1.917 . . . . 0.0 109.909 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.68 101.16 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.505 2.804 . . . . 0.0 109.405 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 28.8 m -67.1 158.48 81.18 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.63 147.86 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.765 2.31 . . . . 0.0 109.128 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.18 -22.74 12.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.257 0.623 . . . . 0.0 110.736 171.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -61.68 -47.35 85.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.046 1.738 . . . . 0.0 114.557 174.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.9 p -71.37 -31.8 67.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.72 1.6 . . . . 0.0 109.732 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.1 mt -68.54 -26.02 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.846 0.859 . . . . 0.0 109.736 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 66.13 3.7 2.79 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.168 2.587 . . . . 0.0 113.823 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.67 -161.41 31.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -172.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -70.98 114.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.537 0.669 . . . . 0.0 109.735 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 49' ' ' GLY . 2.3 tm? -55.13 120.35 6.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 163.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -85.38 -31.4 22.95 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.419 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 165.85 168.55 28.2 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -99.6 112.5 24.71 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -81.0 142.87 32.97 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.1 mt -112.06 143.45 21.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.447 ' CE2' ' CD1' ' A' ' 72' ' ' ILE . 43.3 m-85 -112.45 140.56 47.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 166.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -153.63 162.15 41.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.122 1.328 . . . . 0.0 110.232 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -148.57 157.78 43.69 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.539 -0.725 . . . . 0.0 109.233 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -69.09 140.59 54.82 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.01 150.58 29.08 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 171.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -91.91 158.76 16.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 166.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.4 p -98.15 -88.67 0.31 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -84.42 -52.91 5.81 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.201 0.6 . . . . 0.0 112.411 -170.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -69.57 116.23 9.73 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -89.7 118.18 29.11 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.499 1.119 . . . . 0.0 108.778 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 160.61 19.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 165.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -141.44 156.37 45.78 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 164.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 30.58 68.02 0.11 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.986 2.514 . . . . 0.0 113.825 -173.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -132.52 150.87 52.08 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 159.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -70.19 177.16 3.41 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 159.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.5 mt -124.54 129.25 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.55 124.17 23.58 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -119.75 92.46 3.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -69.81 167.37 17.37 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 127.134 2.174 . . . . 0.0 110.101 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 53' ' ' TYR . 3.4 mm -138.92 152.42 24.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.354 -2.203 . . . . 0.0 105.091 -162.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.498 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -148.69 160.47 43.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.259 169.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.1 m -133.58 97.35 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -161.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 73' ' ' LEU . 58.3 m-85 -105.53 112.1 25.06 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.29 166.92 16.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.903 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.51 172.91 4.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.7 m -85.5 41.61 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.469 -1.018 . . . . 0.0 111.387 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HE3' ' CE1' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -63.26 155.93 27.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.698 -1.251 . . . . 0.0 110.183 162.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -109.13 -3.78 17.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.605 1.962 . . . . 0.0 112.288 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.48 ' CE1' ' HE3' ' A' ' 79' ' ' LYS . 14.7 p80 -146.22 164.53 32.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.03 158.86 30.62 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 39.4 mtp -90.96 162.61 14.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.871 0.843 . . . . 0.0 111.117 -168.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -120.82 89.98 46.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 160.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.1 148.95 1.26 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.394 3.396 . . . . 0.0 112.037 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.43 51.11 8.73 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.47 179.71 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.606 2.362 . . . . 0.0 107.773 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.0 142.37 26.12 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 124.466 1.107 . . . . 0.0 110.485 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.29 166.4 25.43 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.425 2.083 . . . . 0.0 110.84 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 37.25 46.26 0.57 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 129.894 3.278 . . . . 0.0 113.869 176.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.1 m -119.72 -176.12 3.1 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.332 1.453 . . . . 0.0 109.122 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.07 157.21 19.57 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 148.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -137.61 154.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.1 m -124.24 141.8 51.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 155.23 44.26 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 127.235 2.214 . . . . 0.0 108.813 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.36 169.28 17.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.069 1.348 . . . . 0.0 107.734 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.25 152.71 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -146.53 131.17 17.86 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.9 1.28 . . . . 0.0 107.77 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.85 150.95 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.7 t -146.74 135.82 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.369 1.468 . . . . 0.0 107.069 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.65 178.85 6.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 107.716 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.8 57.28 3.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.345 0.974 . . . . 0.0 112.014 -172.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -160.71 -41.86 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.481 1.913 . . . . 0.0 109.327 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.74 -168.9 42.03 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.69 166.28 11.19 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 110.075 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.84 -174.48 21.48 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 124.367 0.984 . . . . 0.0 113.284 170.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.33 153.45 74.31 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.748 1.632 . . . . 0.0 110.444 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.44 165.39 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.688 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.0 p -110.78 -171.69 0.22 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.106 0.962 . . . . 0.0 112.112 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -64.84 139.46 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.01 89.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.57 159.94 23.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 O-C-N 121.952 -0.467 . . . . 0.0 110.425 173.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 t -128.8 167.22 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.47 156.96 36.19 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.85 2.06 . . . . 0.0 108.156 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.75 147.99 44.58 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 125.218 1.407 . . . . 0.0 110.009 170.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -105.21 166.25 11.74 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.377 1.071 . . . . 0.0 111.478 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.92 167.42 16.35 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.856 3.704 . . . . 0.0 111.791 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.49 -33.08 65.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.028 1.331 . . . . 0.0 111.327 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.66 -75.66 0.41 Allowed Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 126.326 1.917 . . . . 0.0 109.341 160.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.8 m -152.56 135.09 15.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.025 2.13 . . . . 0.0 105.481 166.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.87 116.84 8.3 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 117.535 -1.703 . . . . 0.0 109.119 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -72.93 169.82 21.23 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.575 2.183 . . . . 0.0 111.149 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 p -66.59 166.47 12.7 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.571 0.7 . . . . 0.0 109.849 162.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.9 m -154.36 173.73 15.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.035 1.734 . . . . 0.0 107.159 171.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.394 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 -179.792 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.801 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m 36.13 84.97 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 129.474 3.11 . . . . 0.0 113.943 162.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m -70.37 158.38 36.07 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.389 0.614 . . . . 0.0 110.998 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.56 147.72 6.35 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 106.558 -2.617 . . . . 0.0 106.558 -170.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.2 m -78.47 159.1 28.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 163.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.87 167.47 21.68 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.618 1.167 . . . . 0.0 108.81 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.9 -161.79 29.75 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.8 m170 66.77 67.72 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.559 2.344 . . . . 0.0 111.312 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -130.77 128.6 41.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.825 0.85 . . . . 0.0 111.958 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.2 -167.11 11.22 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 127.826 2.631 . . . . 0.0 109.548 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -87.78 -69.79 0.67 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.065 0.946 . . . . 0.0 112.043 -173.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -97.72 -19.08 18.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.828 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.0 mt -66.78 143.81 98.26 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 119.915 1.234 . . . . 0.0 112.002 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.56 152.02 53.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.649 2.899 . . . . 0.0 111.652 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 68.8 mtm -109.04 -38.98 5.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 117.652 -1.166 . . . . 0.0 113.854 -164.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.87 147.84 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.459 1.481 . . . . 0.0 113.102 -170.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.63 157.25 67.46 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 127.167 2.187 . . . . 0.0 109.991 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 29.7 Cg_endo -68.49 162.96 38.58 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.348 2.032 . . . . 0.0 112.196 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.87 -149.04 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.26 2.362 . . . . 0.0 115.053 -175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -66.94 78.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.339 1.455 . . . . 0.0 113.033 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.1 t -53.67 139.98 10.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.73 158.28 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.562 1.545 . . . . 0.0 107.082 171.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.36 123.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.027 0.831 . . . . 0.0 108.942 168.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.83 102.33 7.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 127.998 2.519 . . . . 0.0 109.39 -169.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.28 0.8 OUTLIER -73.87 116.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-O 121.558 0.694 . . . . 0.0 110.313 -171.991 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.8 t -69.66 -49.59 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -139.33 -163.85 1.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 108.971 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -29.94 56.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.654 -1.279 . . . . 0.0 113.151 177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 p -124.96 11.79 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.954 1.301 . . . . 0.0 110.764 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.56 136.31 27.41 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.222 1.409 . . . . 0.0 107.862 -171.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -140.08 165.87 26.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.42 121.62 26.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.27 141.75 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -126.96 150.7 49.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.975 0.51 . . . . 0.0 110.3 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -151.26 178.9 8.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.84 142.66 25.05 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.48 -0.762 . . . . 0.0 109.003 172.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.46 111.53 3.13 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 123.039 2.493 . . . . 0.0 107.636 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.41 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 20.4 m -66.59 156.34 86.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -78.51 143.88 19.6 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 122.348 2.032 . . . . 0.0 108.449 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.23 -27.62 65.93 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.655 0.382 . . . . 0.0 110.814 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -60.01 -38.55 82.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.2 p -67.4 -41.81 84.31 Favored 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 119.027 0.83 . . . . 0.0 110.344 172.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.3 mt -67.74 -23.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.644 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 56.17 11.31 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.383 1.873 . . . . 0.0 114.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.52 179.01 41.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.436 1.969 . . . . 0.0 108.256 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -73.94 122.9 23.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.4 tp -57.45 112.55 1.45 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 108.525 175.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.17 -43.74 77.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.057 0.943 . . . . 0.0 109.472 168.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -177.2 45.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -105.87 112.51 25.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.453 1.901 . . . . 0.0 105.989 169.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -83.51 153.24 24.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.41 117.26 50.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -91.57 116.55 28.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -135.58 164.01 28.81 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.187 0.903 . . . . 0.0 110.912 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.71 163.51 37.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.202 1.001 . . . . 0.0 110.5 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.32 135.48 50.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.958 1.303 . . . . 0.0 108.177 168.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 m -126.34 140.05 52.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -166.22 168.44 15.23 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.351 1.06 . . . . 0.0 108.792 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.1 t -135.89 106.64 6.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -145.26 37.56 1.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.274 1.43 . . . . 0.0 110.322 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 p -62.69 63.73 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 130.017 3.327 . . . . 0.0 113.919 -172.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.03 13.59 0.6 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.174 1.79 . . . . 0.0 111.001 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.45 175.54 8.14 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.786 1.235 . . . . 0.0 108.939 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -61.22 162.01 8.11 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -46.88 130.84 12.08 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.593 1.157 . . . . 0.0 111.064 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -105.72 -177.03 3.25 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.448 1.499 . . . . 0.0 107.506 162.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -112.62 157.39 21.28 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 152.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.6 mt -88.91 123.01 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.99 126.13 28.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 167.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -116.21 160.0 21.03 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.409 1.084 . . . . 0.0 110.031 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -142.51 166.4 24.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 122.343 1.068 . . . . 0.0 112.313 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 mp -133.16 139.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 126.828 2.051 . . . . 0.0 105.864 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.86 153.04 37.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.651 2.38 . . . . 0.0 107.692 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.1 m -134.26 97.92 3.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 110.062 -168.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -110.13 92.35 4.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 123.945 0.898 . . . . 0.0 108.933 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.2 163.25 27.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.5 177.19 12.86 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.261 0.923 . . . . 0.0 113.023 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 p -76.53 25.3 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.04 2.536 . . . . 0.0 114.241 -169.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -58.2 160.36 5.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.049 1.34 . . . . 0.0 111.322 176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.5 p -128.91 -2.02 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.105 0.962 . . . . 0.0 111.987 -172.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -146.51 163.72 34.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.99 151.86 23.03 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 38.7 mtp -76.9 163.82 26.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.58 93.13 47.09 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 157.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -93.29 161.02 2.5 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.745 2.296 . . . . 0.0 111.137 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.75 31.82 59.93 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.69 171.72 12.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.693 1.997 . . . . 0.0 106.923 166.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.64 153.25 45.9 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 123.788 0.835 . . . . 0.0 110.067 163.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.66 169.51 17.28 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.683 2.255 . . . . 0.0 112.63 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.9 t80 47.49 51.04 14.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.146 1.778 . . . . 0.0 111.191 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -153.8 -178.74 7.25 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.812 -1.18 . . . . 0.0 109.683 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -110.0 158.99 17.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -145.5 151.43 38.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.5 m -123.33 142.76 50.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 170.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 162.67 34.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.333 1.853 . . . . 0.0 109.568 174.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.57 144.23 31.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.647 1.579 . . . . 0.0 106.826 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.99 132.56 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -129.93 134.14 47.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.046 1.294 . . . . 0.0 110.824 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.31 152.29 5.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.3 142.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -132.92 -162.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.59 1.156 . . . . 0.0 109.813 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.93 65.74 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -50.62 69.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.861 0.865 . . . . 0.0 110.763 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.42 -168.84 41.88 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 120.003 1.274 . . . . 0.0 112.945 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.56 154.36 27.52 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.746 1.218 . . . . 0.0 110.983 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.28 -172.91 21.65 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 0.0 112.074 166.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.44 156.32 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.139 1.893 . . . . 0.0 110.493 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.82 152.72 21.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.112 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -63.8 -171.79 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.812 1.645 . . . . 0.0 111.459 170.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.95 154.58 16.99 Favored 'Trans proline' 0 C--N 1.352 0.729 0 CA-C-N 120.663 1.272 . . . . 0.0 110.242 163.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.74 85.3 7.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 166.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -67.09 155.93 37.43 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.73 154.22 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -151.79 152.25 32.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -102.29 160.37 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 169.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p -107.94 146.28 33.15 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.88 -89.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.791 2.994 . . . . 0.0 113.257 -162.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -142.4 -34.97 0.44 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.381 0.991 . . . . 0.0 112.392 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 66.6 144.51 0.06 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.787 1.66 . . . . 0.0 110.819 -168.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.34 -163.27 0.1 Allowed 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.214 -1.168 . . . . 0.0 110.251 -162.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 94.91 160.03 33.75 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -157.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.39 114.71 4.11 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.413 2.075 . . . . 0.0 110.763 -166.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 m -62.29 -43.45 98.79 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 166.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.9 m -138.89 161.02 38.32 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.466 1.506 . . . . 0.0 107.485 166.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.617 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 171.062 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.71 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 133.63 169.09 0.0 OUTLIER 'General case' 0 C--O 1.233 0.222 1 C-N-CA 131.975 4.11 . . . . 0.0 108.201 167.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m 45.52 -153.8 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.3 1.04 . . . . 0.0 110.461 -168.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.76 88.85 0.07 OUTLIER Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.907 1.231 . . . . 0.0 111.814 170.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 p -73.46 151.16 41.18 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.474 1.137 . . . . 0.0 111.805 176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.81 137.27 52.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.302 1.841 . . . . 0.0 109.928 -167.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.89 170.0 31.92 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.678 0.656 . . . . 0.0 111.53 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.15 133.85 3.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.167 0.987 . . . . 0.0 110.255 177.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 p -151.54 159.78 43.97 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.614 -0.679 . . . . 0.0 110.146 163.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.37 121.82 0.58 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.06 -66.8 0.48 Allowed 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 168.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -122.45 -8.31 8.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.723 0.809 . . . . 0.0 112.361 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.3 mt -69.71 143.71 92.81 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 123.951 0.901 . . . . 0.0 110.299 167.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.06 160.39 47.59 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.61 2.207 . . . . 0.0 112.805 -171.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.3 mtm -114.7 -39.02 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -170.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.8 m -140.8 155.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.247 0.931 . . . . 0.0 109.521 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 172.02 10.98 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 127.081 2.152 . . . . 0.0 111.108 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 5.7 Cg_exo -56.6 161.49 9.77 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 120.651 0.9 . . . . 0.0 111.119 167.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.62 -170.51 5.04 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 165.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 151.83 17.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.28 1.038 . . . . 0.0 112.078 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.39 151.69 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.805 1.242 . . . . 0.0 108.009 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.47 158.44 38.34 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.56 1.944 . . . . 0.0 106.575 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.32 115.6 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 170.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -98.8 129.33 45.2 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.079 0.862 . . . . 0.0 109.019 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -79.58 109.99 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.8 m -78.88 -59.66 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 127.047 2.139 . . . . 0.0 109.0 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -124.58 -176.02 3.42 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.254 1.422 . . . . 0.0 109.914 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -58.4 8.72 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.108 -0.995 . . . . 0.0 110.065 161.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 p -89.72 2.08 55.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.91 1.684 . . . . 0.0 113.841 -165.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.9 tp -135.55 140.96 45.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.009 1.724 . . . . 0.0 107.66 -175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.43 153.83 45.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -95.25 139.07 32.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.78 139.85 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 169.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.9 146.99 50.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.0 p90 -139.4 166.87 23.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.151 1.38 . . . . 0.0 108.437 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.06 147.59 88.38 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.78 141.36 84.72 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.374 1.382 . . . . 0.0 108.615 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 35.3 m -85.64 159.47 55.3 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.218 159.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.88 148.02 81.58 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.702 2.935 . . . . 0.0 109.444 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -51.17 -27.93 9.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 168.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -63.87 -32.97 74.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 117.109 -1.424 . . . . 0.0 112.486 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.9 p -74.72 -36.69 62.69 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.373 1.442 . . . . 0.0 109.956 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.2 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 108.514 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 80.27 -61.4 0.27 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 129.273 3.029 . . . . 0.0 110.556 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.77 -160.44 17.14 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 126.129 1.823 . . . . 0.0 111.082 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -72.79 121.99 20.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.399 1.08 . . . . 0.0 109.248 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -59.94 119.5 7.87 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.743 0.817 . . . . 0.0 109.77 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -78.6 -36.57 44.07 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.09 -175.26 33.15 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -114.09 166.51 11.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -130.27 150.82 51.34 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.411 1.484 . . . . 0.0 107.531 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.2 mt -124.91 124.38 67.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -91.56 138.61 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 165.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.9 p90 -146.78 167.35 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 120.981 1.718 . . . . 0.0 111.366 168.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -149.04 158.03 43.86 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.87 0.868 . . . . 0.0 110.891 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.29 138.15 41.65 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.466 1.106 . . . . 0.0 108.772 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -108.14 167.86 9.71 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -126.31 96.58 4.75 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.062 1.745 . . . . 0.0 106.781 175.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.0 t -55.49 -58.17 8.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.464 0.706 . . . . 0.0 110.169 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 t -132.05 103.58 6.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.384 0.993 . . . . 0.0 108.535 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 t -142.17 109.18 5.48 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 125.464 1.506 . . . . 0.0 107.707 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -62.14 -25.2 67.61 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.351 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -79.45 136.41 36.92 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -63.37 153.93 33.54 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -76.62 122.0 24.02 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -172.38 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 158.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -45.2 124.27 4.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.696 0.68 . . . . 0.0 111.108 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.6 mt -69.53 126.48 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -169.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -72.8 87.87 1.3 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.704 2.002 . . . . 0.0 107.783 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -90.13 126.1 35.67 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.517 1.527 . . . . 0.0 107.761 174.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 11.1 mmtt -114.27 168.1 10.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 118.833 0.742 . . . . 0.0 109.456 171.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 mm -127.31 159.22 37.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.423 1.489 . . . . 0.0 107.368 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mt -136.19 159.17 42.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.174 1.789 . . . . 0.0 108.204 167.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -123.77 141.55 51.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.251 1.82 . . . . 0.0 107.155 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -145.67 104.84 3.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -77.43 175.44 9.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.777 -1.202 . . . . 0.0 109.867 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.28 160.62 5.02 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.651 1.139 . . . . 0.0 113.173 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.5 m -77.32 21.25 0.26 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.196 1.398 . . . . 0.0 113.458 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -48.49 154.59 0.62 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.277 1.031 . . . . 0.0 110.895 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 p -119.43 9.29 11.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.171 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 167.13 24.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.072 0.949 . . . . 0.0 109.062 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.17 -171.1 26.71 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 127.455 2.455 . . . . 0.0 107.505 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -138.28 159.72 41.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 117.963 0.882 . . . . 0.0 110.844 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -112.85 81.6 4.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 127.019 2.127 . . . . 0.0 107.394 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -84.4 155.94 12.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.836 2.357 . . . . 0.0 111.059 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.87 16.47 67.72 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.404 -0.665 . . . . 0.0 112.961 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.7 173.68 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.858 1.263 . . . . 0.0 110.527 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.42 144.69 32.84 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.472 -175.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.93 176.38 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.976 2.451 . . . . 0.0 113.191 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 38.75 46.49 1.04 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 130.939 3.696 . . . . 0.0 113.933 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 64.1 m -135.09 174.13 10.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.101 1.76 . . . . 0.0 110.67 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -120.84 152.23 38.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.631 1.972 . . . . 0.0 107.106 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.33 161.43 38.99 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.056 1.342 . . . . 0.0 111.019 -174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.4 m -124.15 141.48 52.02 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 161.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.81 153.2 42.99 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.025 1.73 . . . . 0.0 110.137 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.18 129.79 20.23 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -170.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.5 t -89.43 147.32 5.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -145.74 124.08 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.331 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.5 152.55 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.414 1.007 . . . . 0.0 109.676 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.13 151.92 25.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.727 1.611 . . . . 0.0 108.352 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -144.68 -171.14 3.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.972 1.309 . . . . 0.0 109.015 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.01 -15.26 78.52 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.996 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -23.77 14.56 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.581 1.552 . . . . 0.0 111.919 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.47 -154.41 25.5 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.858 0.754 . . . . 0.0 111.305 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 173.93 10.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.392 1.477 . . . . 0.0 110.008 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.79 -155.44 6.87 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.693 1.139 . . . . 0.0 112.761 -166.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.57 160.79 41.41 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.689 2.259 . . . . 0.0 110.595 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.99 162.21 13.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.194 1.798 . . . . 0.0 111.462 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.1 p -67.58 -176.72 0.28 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.6 0.76 . . . . 0.0 110.335 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -54.28 129.84 36.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 N-CA-C 108.968 -1.204 . . . . 0.0 108.968 153.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.93 132.49 53.18 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 163.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -115.75 163.46 15.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.443 1.097 . . . . 0.0 109.239 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.49 158.77 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -150.47 151.97 33.52 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.31 141.74 44.45 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.365 1.466 . . . . 0.0 108.008 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.3 p -92.46 157.36 40.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.101 -0.375 . . . . 0.0 111.342 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -75.11 171.0 19.17 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.133 2.555 . . . . 0.0 108.178 173.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.97 -35.41 78.4 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 114.863 -162.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 122.91 -109.84 1.44 Allowed Glycine 0 N--CA 1.461 0.33 0 C-N-CA 125.277 1.418 . . . . 0.0 110.293 174.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 t -138.71 138.4 37.67 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 164.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.55 176.32 52.46 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.13 97.53 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.383 2.722 . . . . 0.0 110.515 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.8 m -142.41 165.11 28.31 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.741 2.016 . . . . 0.0 107.241 165.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 t -142.51 167.46 22.03 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 160.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.757 0 N-CA-C 104.3 -3.52 . . . . 0.0 104.3 -140.414 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.89 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 m -132.8 176.93 8.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.275 1.03 . . . . 0.0 108.579 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 t -150.97 -178.42 6.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.662 1.985 . . . . 0.0 107.289 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.81 174.85 29.18 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.079 1.323 . . . . 0.0 110.247 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.0 m -156.39 170.61 21.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.719 1.608 . . . . 0.0 108.55 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -160.83 -163.48 1.06 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.367 1.867 . . . . 0.0 107.859 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.76 174.91 30.13 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.598 1.571 . . . . 0.0 109.302 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.567 ' CG ' ' H ' ' A' ' 9' ' ' SER . 14.5 t-80 -146.92 -166.9 2.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.657 0.783 . . . . 0.0 109.452 171.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.567 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 11.8 p -112.69 103.06 11.09 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.107 1.363 . . . . 0.0 110.991 -165.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.09 -104.89 0.47 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 32.66 60.54 0.39 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 127.887 2.475 . . . . 0.0 112.073 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -55.87 -50.8 69.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.898 -169.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.43 ' C ' HD22 ' A' ' 101' ' ' ASN . 29.7 mt 50.1 173.89 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 128.72 2.808 . . . . 0.0 113.12 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.15 177.29 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.179 1.253 . . . . 0.0 110.0 166.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.1 mtm -134.05 -27.37 1.44 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.59 178.52 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 120.193 1.361 . . . . 0.0 110.101 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.89 162.67 19.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 128.41 2.684 . . . . 0.0 107.626 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.35 151.07 81.87 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 120.863 1.042 . . . . 0.0 109.686 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.31 -94.62 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 125.137 1.351 . . . . 0.0 112.535 -163.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 162.03 13.41 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.5 t -128.97 148.76 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -142.99 152.7 42.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.828 2.051 . . . . 0.0 106.252 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.45 139.13 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 119.975 1.261 . . . . 0.0 110.387 171.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -116.5 145.69 43.13 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 127.398 2.279 . . . . 0.0 107.944 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.62 110.25 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.24 -59.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.642 0.777 . . . . 0.0 108.928 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.277 20.1 p30 -121.12 -105.52 0.38 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.627 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.37 -51.95 1.96 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.695 1.998 . . . . 0.0 109.696 174.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.9 p -101.12 4.32 42.03 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.192 1.397 . . . . 0.0 111.519 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -124.65 122.97 39.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.042 1.737 . . . . 0.0 109.02 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.41 163.38 17.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 109.552 165.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -125.54 115.57 20.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 129.123 2.969 . . . . 0.0 105.994 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.1 t -92.73 145.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.14 146.39 49.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -148.1 155.56 41.59 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -74.0 140.03 76.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.92 155.49 54.73 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.884 2.389 . . . . 0.0 109.374 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.2 m -102.31 157.54 33.5 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 166.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -76.16 153.35 36.35 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 122.753 2.302 . . . . 0.0 109.443 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 mp -61.8 -27.4 68.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.064 0.945 . . . . 0.0 111.174 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -44.83 -58.78 2.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.574 1.15 . . . . 0.0 110.906 163.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 81.1 p -61.85 -26.31 68.06 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -171.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.6 mt -87.76 -17.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.159 1.384 . . . . 0.0 109.996 -174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 55.45 1.95 0.06 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.38 2.272 . . . . 0.0 115.33 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.87 -155.3 21.6 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 127.817 2.627 . . . . 0.0 107.261 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -74.09 132.81 42.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.267 1.533 . . . . 0.0 111.998 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.6 tt -69.32 125.28 26.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -81.07 -60.35 2.32 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.03 -178.79 39.12 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-O 121.955 0.753 . . . . 0.0 113.663 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -107.83 117.89 35.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.878 . . . . 0.0 106.589 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 92.09 4.92 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.74 123.02 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -92.19 145.62 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 164.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.43 163.71 39.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.777 1.231 . . . . 0.0 110.906 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -148.98 159.68 43.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.989 0.916 . . . . 0.0 110.538 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -68.83 132.22 46.42 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 166.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.8 m -107.47 159.32 16.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 43.68 71.62 0.23 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.051 1.741 . . . . 0.0 112.516 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.0 103.45 4.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.39 145.73 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.712 2.005 . . . . 0.0 112.633 -174.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.7 m -93.67 78.63 4.27 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.002 1.321 . . . . 0.0 109.279 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -139.79 148.21 41.87 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -145.25 129.1 17.33 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -172.8 -169.3 0.56 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.79 2.036 . . . . 0.0 107.046 168.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -61.98 165.79 5.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.122 0.874 . . . . 0.0 110.275 166.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? 45.55 60.58 3.02 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.254 1.422 . . . . 0.0 110.147 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -127.1 148.05 50.16 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.028 1.331 . . . . 0.0 109.086 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.4 mt 62.19 145.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 128.4 2.68 . . . . 0.0 109.702 -168.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -105.69 130.73 53.65 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -118.44 93.77 4.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.971 0.908 . . . . 0.0 109.017 -164.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -84.27 157.88 21.41 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.104 1.761 . . . . 0.0 110.103 -169.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -140.96 111.13 3.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.04 166.78 22.85 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.328 1.451 . . . . 0.0 110.165 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.4 m -126.06 125.75 43.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -135.91 116.45 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -79.24 164.44 24.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.323 0.965 . . . . 0.0 109.008 165.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.12 172.43 3.4 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.533 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -87.48 39.68 0.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.799 -0.701 . . . . 0.0 112.279 -153.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -59.88 167.22 2.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.314 1.446 . . . . 0.0 111.567 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -130.04 8.75 5.22 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.899 1.679 . . . . 0.0 110.626 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -156.35 160.47 39.71 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.418 1.887 . . . . 0.0 106.882 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.71 40.4 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 32.1 mtp -132.53 156.25 47.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 118.728 1.264 . . . . 0.0 110.953 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.57 82.4 4.79 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 126.363 1.865 . . . . 0.0 106.349 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -85.23 154.38 10.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.29 1.993 . . . . 0.0 110.848 165.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 16.8 46.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.344 0.973 . . . . 0.0 112.252 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.59 -171.56 3.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.097 0.949 . . . . 0.0 109.895 -173.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.46 141.57 41.9 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 128.279 2.632 . . . . 0.0 105.92 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -73.54 -173.91 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.004 3.136 . . . . 0.0 112.097 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 50.69 43.36 27.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.686 2.395 . . . . 0.0 113.032 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.8 m -157.54 163.48 38.34 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.97 0.908 . . . . 0.0 112.107 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -88.5 155.09 19.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.177 1.391 . . . . 0.0 107.678 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -144.68 146.95 32.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.826 1.65 . . . . 0.0 108.766 -176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 19.7 m -126.75 122.69 35.56 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.618 0.767 . . . . 0.0 109.025 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 158.07 39.22 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.209 1.804 . . . . 0.0 109.453 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.57 164.01 33.0 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.885 1.274 . . . . 0.0 109.555 171.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 t -125.71 142.89 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.807 1.643 . . . . 0.0 106.873 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -149.7 132.32 15.84 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 m -82.2 144.64 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.5 t -135.25 139.87 46.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.245 1.818 . . . . 0.0 106.315 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.43 HD22 ' C ' ' A' ' 13' ' ' LEU . 36.4 p-10 -149.21 -172.47 4.13 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.887 0.875 . . . . 0.0 112.246 -168.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.46 12.19 0.14 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.893 2.187 . . . . 0.0 116.86 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -141.94 -35.59 0.44 Allowed 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.061 1.93 . . . . 0.0 112.102 168.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.31 -154.66 9.61 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 119.165 0.893 . . . . 0.0 112.126 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.92 165.54 17.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.362 1.465 . . . . 0.0 109.976 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.29 -173.43 15.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 125.203 1.383 . . . . 0.0 112.71 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.49 135.86 51.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.363 2.709 . . . . 0.0 109.21 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.75 151.35 34.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.918 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -58.9 172.59 0.52 Allowed Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 124.683 1.193 . . . . 0.0 109.451 169.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -56.1 139.44 85.37 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 152.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.74 160.18 23.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.099 170.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -129.99 168.9 15.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.21 162.87 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.331 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -144.32 143.6 31.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -86.19 166.74 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 p -123.73 159.9 53.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 124.071 0.948 . . . . 0.0 109.737 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.49 161.37 43.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -58.65 -23.11 58.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.609 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.23 6.36 89.4 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.281 -1.288 . . . . 0.0 114.537 163.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.04 158.95 33.77 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.108 1.454 . . . . 0.0 110.778 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.71 155.41 48.27 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.08 87.06 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.876 2.384 . . . . 0.0 106.98 167.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.3 m -147.73 30.79 0.89 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.266 -0.896 . . . . 0.0 110.988 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.8 m -148.04 148.29 30.53 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 165.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.803 0 N-CA-C 106.531 -2.628 . . . . 0.0 106.531 -166.268 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.68 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t -141.65 150.23 41.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 166.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 m -146.36 164.54 32.09 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.453 1.501 . . . . 0.0 107.976 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.62 147.35 17.1 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 m -160.97 152.46 19.25 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.846 2.059 . . . . 0.0 107.489 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -157.16 -176.17 5.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.56 -152.63 24.0 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -173.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -64.17 162.91 13.57 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -59.66 -64.1 1.07 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.48 148.46 0.3 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -170.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -147.82 92.35 2.05 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 121.212 -1.169 . . . . 0.0 107.85 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -148.14 -34.59 0.22 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.436 1.094 . . . . 0.0 109.945 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.9 152.48 68.9 Favored Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.546 1.938 . . . . 0.0 112.29 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.83 172.61 12.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.887 2.392 . . . . 0.0 111.815 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.6 mtm -124.78 -19.03 5.42 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.7 m -144.02 179.37 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 120.392 1.451 . . . . 0.0 111.275 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.56 158.79 39.21 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 129.045 2.938 . . . . 0.0 108.708 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -69.06 144.67 58.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.252 1.968 . . . . 0.0 111.094 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.42 -179.14 52.27 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.414 1.959 . . . . 0.0 113.169 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 t30 2.05 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.539 3.536 . . . . 0.0 114.671 -171.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.95 132.02 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -126.17 153.96 43.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.506 1.923 . . . . 0.0 107.971 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.55 129.68 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.266 1.027 . . . . 0.0 108.743 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -125.21 135.66 52.79 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 125.337 1.455 . . . . 0.0 112.302 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.367 1.0 OUTLIER -84.73 128.85 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 123.113 1.435 . . . . 0.0 111.753 174.486 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.73 -40.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 128.18 2.592 . . . . 0.0 109.529 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -138.24 -179.91 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.714 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.46 88.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.668 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.8 p -114.63 4.77 15.2 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.137 1.375 . . . . 0.0 112.759 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.27 137.31 47.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.293 1.837 . . . . 0.0 108.328 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -131.51 170.34 14.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.921 1.288 . . . . 0.0 109.372 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -128.88 139.88 51.94 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.6 t -114.54 143.57 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -129.17 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.769 1.628 . . . . 0.0 107.265 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -150.14 151.65 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.786 1.234 . . . . 0.0 108.363 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -69.39 146.18 96.23 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.674 -0.641 . . . . 0.0 110.485 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.76 131.08 29.86 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 108.449 162.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 m -76.11 160.03 79.11 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.57 144.66 67.46 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.526 2.151 . . . . 0.0 109.275 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -26.2 68.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.529 -0.732 . . . . 0.0 111.027 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -55.93 -32.6 63.94 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 118.297 -0.858 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.4 p -72.32 -32.29 66.42 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 119.273 0.942 . . . . 0.0 111.642 -175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mt -75.77 -30.63 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.206 1.002 . . . . 0.0 109.994 -164.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 45.84 34.79 2.0 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.027 2.131 . . . . 0.0 112.81 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.77 -133.25 1.82 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -171.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.91 121.06 22.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.8 tp -52.01 118.08 3.21 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -79.88 -51.83 8.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.57 -170.22 40.34 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -106.09 157.6 17.42 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 163.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -123.91 144.5 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 169.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.5 mt -118.46 126.57 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -92.07 144.94 24.92 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 160.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 35.7 p90 -155.44 159.3 39.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.0 0.92 . . . . 0.0 110.987 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.77 155.51 40.25 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -68.52 130.53 43.12 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.711 1.604 . . . . 0.0 107.636 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.0 m -115.52 120.8 40.67 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -134.97 -33.19 0.93 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -170.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.6 m 54.44 -168.46 0.07 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.039 0.936 . . . . 0.0 110.844 -168.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.3 t -160.1 152.15 20.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 163.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -76.01 39.73 0.19 Allowed 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.936 165.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.2 tttm 37.27 62.89 0.79 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.115 1.766 . . . . 0.0 109.329 -161.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -11.92 8.09 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.94 0.896 . . . . 0.0 112.217 -168.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 146.52 88.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 1 C-N-CA 131.872 4.069 . . . . 0.0 108.286 162.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.3 138.13 20.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 168.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -134.89 169.68 17.02 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.156 1.783 . . . . 0.0 106.682 149.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.3 m80 67.66 138.6 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.765 2.826 . . . . 0.0 114.279 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 76.0 mt -133.3 126.99 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -76.84 118.81 19.81 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -112.71 140.44 47.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.694 1.198 . . . . 0.0 109.273 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -136.23 166.08 24.26 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 125.684 1.594 . . . . 0.0 109.807 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.24 149.43 33.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -138.55 145.52 40.77 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.593 1.957 . . . . 0.0 107.668 -173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 m -129.87 119.04 22.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.206 1.002 . . . . 0.0 108.694 -163.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -128.87 88.22 2.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.891 1.277 . . . . 0.0 108.401 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -69.3 173.51 5.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.852 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 -178.01 18.66 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.891 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -85.79 11.33 11.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -161.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -56.77 149.35 18.32 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 125.033 1.333 . . . . 0.0 112.307 -166.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -112.66 9.51 19.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.669 1.187 . . . . 0.0 111.312 175.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.92 160.61 43.46 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.059 1.343 . . . . 0.0 109.356 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.67 143.13 8.97 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.7 mtp -86.26 146.98 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.258 0.529 . . . . 0.0 109.818 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.8 94.53 10.6 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 126.687 1.995 . . . . 0.0 105.963 174.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -92.12 167.21 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.7 2.933 . . . . 0.0 112.175 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.96 19.96 74.12 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.681 -0.637 . . . . 0.0 112.79 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.23 168.67 14.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.651 0.781 . . . . 0.0 109.069 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.87 131.64 22.03 Favored Pre-proline 0 N--CA 1.432 -1.327 0 C-N-CA 126.092 1.757 . . . . 0.0 107.348 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -74.52 162.92 37.16 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.963 1.775 . . . . 0.0 111.529 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.6 t80 50.63 40.5 24.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.127 1.371 . . . . 0.0 112.134 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -136.14 158.82 43.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.269 1.427 . . . . 0.0 110.686 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -94.45 153.73 17.79 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -148.21 154.21 39.79 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.922 1.289 . . . . 0.0 110.017 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.9 m -126.21 149.78 48.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.867 1.667 . . . . 0.0 107.521 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.0 158.48 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.596 2.358 . . . . 0.0 110.488 171.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.05 145.13 29.57 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.683 1.193 . . . . 0.0 110.648 168.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.61 151.06 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.249 1.82 . . . . 0.0 108.496 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -144.76 133.5 22.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -73.94 151.41 7.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.91 136.37 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -134.69 -173.51 3.31 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.729 2.012 . . . . 0.0 107.031 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.85 13.44 13.4 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.033 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -123.07 -54.69 1.81 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.67 1.588 . . . . 0.0 110.037 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.09 48.94 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.039 0.836 . . . . 0.0 111.942 -173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -83.66 154.76 23.52 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.593 0.711 . . . . 0.0 110.702 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -100.82 -171.08 28.86 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.877 1.227 . . . . 0.0 112.349 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.18 137.99 54.33 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.945 1.764 . . . . 0.0 108.751 170.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.63 161.19 29.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.3 p -62.97 178.53 0.35 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.487 1.115 . . . . 0.0 108.943 172.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -61.49 155.52 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 107.346 -1.828 . . . . 0.0 107.346 157.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.27 151.79 46.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.688 1.232 . . . . 0.0 108.926 162.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -124.74 161.82 25.58 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.2 150.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.474 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.79 165.26 30.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -135.66 144.03 45.8 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.013 2.125 . . . . 0.0 107.289 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.8 p -110.59 153.32 43.62 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.085 0.554 . . . . 0.0 110.548 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.4 -68.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.757 2.304 . . . . 0.0 113.131 -152.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -163.41 -41.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.32 1.448 . . . . 0.0 109.848 168.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.31 59.19 3.4 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 126.073 1.797 . . . . 0.0 113.673 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -3.92 34.89 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.559 1.18 . . . . 0.0 113.921 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.89 -169.39 52.72 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.6 165.57 7.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.156 1.904 . . . . 0.0 111.91 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -141.73 -153.98 0.49 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.7 t -52.31 -45.21 65.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.012 0.925 . . . . 0.0 111.921 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.653 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 177.177 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.468 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -168.27 66.28 0.07 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.573 1.186 . . . . 0.0 108.277 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -157.54 70.01 0.58 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.69 28.05 1.18 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-O 118.447 -1.196 . . . . 0.0 113.135 -169.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.3 m -140.93 156.58 46.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.037 1.419 . . . . 0.0 111.374 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -151.68 -46.29 0.11 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.831 1.652 . . . . 0.0 108.125 166.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.44 170.78 15.33 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 -165.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.42 106.63 1.73 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 167.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t -158.87 165.23 34.66 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.602 1.161 . . . . 0.0 109.756 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.64 132.04 7.54 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 125.693 1.616 . . . . 0.0 112.967 164.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -93.99 -31.81 14.1 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.856 1.262 . . . . 0.0 110.607 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.77 -24.39 1.33 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.317 -167.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.8 mt -66.08 149.5 97.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.315 1.416 . . . . 0.0 112.108 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.81 158.75 23.29 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.641 2.227 . . . . 0.0 112.632 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtm -121.5 -31.59 4.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.321 1.049 . . . . 0.0 113.545 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -140.96 158.05 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.825 0.739 . . . . 0.0 111.666 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.8 159.99 31.19 Favored Pre-proline 0 N--CA 1.444 -0.754 0 C-N-CA 130.021 3.329 . . . . 0.0 111.928 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.35 141.59 35.66 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.34 2.026 . . . . 0.0 111.403 -175.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.05 166.73 51.98 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.546 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.0 t30 49.35 54.55 10.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.619 1.567 . . . . 0.0 112.737 154.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.67 128.8 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.784 1.234 . . . . 0.0 109.296 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 116.13 9.04 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.235 1.814 . . . . 0.0 110.476 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.99 138.05 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.163 0.985 . . . . 0.0 108.937 -175.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -124.12 124.93 43.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.126 2.171 . . . . 0.0 110.36 -175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.59 102.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -72.65 -48.98 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -138.25 -179.03 5.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 122.271 1.034 . . . . 0.0 109.03 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -35.49 80.62 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.258 -0.901 . . . . 0.0 111.686 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -119.34 17.56 13.02 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.309 1.044 . . . . 0.0 111.363 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -139.32 137.99 36.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.501 1.92 . . . . 0.0 108.628 176.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.02 150.62 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -108.4 143.72 36.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.788 2.035 . . . . 0.0 107.046 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.04 119.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -108.34 152.96 23.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -154.12 163.52 39.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.942 0.897 . . . . 0.0 109.594 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -80.3 140.93 52.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.12 140.89 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.712 2.275 . . . . 0.0 108.49 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.11 156.59 79.25 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 164.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.29 147.01 17.98 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.611 2.874 . . . . 0.0 109.841 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.64 -29.06 64.27 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -50.58 -50.31 54.13 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.343 0.519 . . . . 0.0 110.939 168.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.8 p -59.74 -37.98 80.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.417 0.553 . . . . 0.0 112.259 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 45' ' ' GLY . 15.4 mt -70.42 -23.41 24.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.799 -169.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.54 -14.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.572 2.349 . . . . 0.0 115.82 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 43' ' ' ILE . . . -155.03 -163.74 12.34 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.72 3.057 . . . . 0.0 108.55 172.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -77.96 117.6 19.45 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.803 0.841 . . . . 0.0 111.695 -174.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.3 133.48 55.15 Favored 'General case' 0 CA--C 1.523 -0.07 0 C-N-CA 125.698 1.599 . . . . 0.0 109.987 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -103.72 -23.41 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.201 1.4 . . . . 0.0 110.455 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.82 -164.75 30.45 Favored Glycine 0 C--O 1.239 0.437 0 O-C-N 120.95 -1.094 . . . . 0.0 112.013 167.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.39 141.14 46.47 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.557 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -121.83 97.09 5.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.4 mt -77.95 120.63 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -91.67 141.55 28.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 164.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.477 ' CD2' HD11 ' A' ' 84' ' ' LEU . 41.4 p90 -151.25 166.08 32.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.751 0.82 . . . . 0.0 110.566 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -149.46 159.14 44.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -68.95 136.6 52.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 m -124.06 141.99 51.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -146.48 6.35 0.96 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.814 0.846 . . . . 0.0 111.019 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.8 m -146.14 152.48 39.33 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.242 1.817 . . . . 0.0 108.315 166.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -138.45 4.45 2.4 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.358 1.063 . . . . 0.0 110.882 164.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.49 93.94 3.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.467 1.507 . . . . 0.0 108.088 -174.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.5 mttt 93.64 121.79 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 131.252 3.821 . . . . 0.0 111.213 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -75.62 80.38 2.61 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.626 1.571 . . . . 0.0 109.354 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -74.47 178.02 5.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -73.1 147.08 45.27 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 157.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.89 164.71 11.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.941 0.896 . . . . 0.0 110.119 150.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -68.7 146.63 52.8 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 160.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.5 mt -133.81 124.98 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -76.43 103.01 6.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 166.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -95.69 162.08 13.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.227 1.411 . . . . 0.0 110.91 174.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -148.72 171.94 15.4 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.508 1.523 . . . . 0.0 110.792 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.74 149.67 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 128.275 2.63 . . . . 0.0 104.622 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.407 ' CD2' HD21 ' A' ' 84' ' ' LEU . 15.1 tp -133.02 161.09 35.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.122 1.769 . . . . 0.0 109.123 -174.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -131.18 121.77 25.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.798 1.181 . . . . 0.0 111.85 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -136.99 115.26 11.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 163.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -80.98 162.51 23.82 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.325 0.583 . . . . 0.0 110.227 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.65 -173.32 21.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.152 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.06 13.98 0.47 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.552 1.941 . . . . 0.0 115.106 -168.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -51.73 147.85 6.2 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.673 1.189 . . . . 0.0 112.036 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.9 p -109.4 5.37 23.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 111.983 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.13 159.43 43.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.883 0.873 . . . . 0.0 109.966 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.15 170.07 30.83 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 126.697 2.094 . . . . 0.0 108.139 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 59.9 mtp -138.37 143.94 40.06 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.282 1.041 . . . . 0.0 110.892 -166.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.477 HD11 ' CD2' ' A' ' 54' ' ' TYR . 4.0 mm? -110.33 84.95 4.12 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 127.507 2.323 . . . . 0.0 108.665 -173.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.63 156.75 3.54 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.413 2.742 . . . . 0.0 112.741 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.94 40.76 98.6 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.929 0.776 . . . . 0.0 111.406 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 HD11 ' CE2' ' A' ' 93' ' ' TYR . 4.0 mm? -96.1 165.88 12.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.754 1.621 . . . . 0.0 108.536 173.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.77 144.6 30.58 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.56 172.27 12.74 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.305 2.67 . . . . 0.0 111.962 165.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.25 0.3 OUTLIER 45.41 34.75 1.65 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.371 2.668 . . . . 0.0 114.063 172.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.19 -175.81 2.93 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.245 2.218 . . . . 0.0 109.554 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -124.64 154.28 40.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.43 ' CE2' HD11 ' A' ' 87' ' ' LEU . 81.8 m-85 -145.65 158.71 43.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.854 0.461 . . . . 0.0 109.945 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.3 m -126.45 140.84 52.16 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.47 154.27 47.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.934 2.094 . . . . 0.0 108.991 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.22 166.28 25.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.572 1.549 . . . . 0.0 107.933 166.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.2 147.39 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -139.07 121.31 15.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 111.527 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.43 136.54 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.176 1.39 . . . . 0.0 107.263 172.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.83 143.99 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -131.89 -173.78 3.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.805 2.042 . . . . 0.0 107.601 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.11 92.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.575 0.625 . . . . 0.0 112.052 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -36.13 80.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.89 0.845 . . . . 0.0 111.663 176.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.37 -143.24 10.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 119.358 0.981 . . . . 0.0 111.074 -174.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -120.59 173.79 6.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.391 1.076 . . . . 0.0 112.354 -165.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.74 -162.36 9.09 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.293 1.425 . . . . 0.0 111.422 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.97 145.18 84.95 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.832 3.021 . . . . 0.0 111.668 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.99 157.64 34.63 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.387 1.075 . . . . 0.0 110.566 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.3 p -61.06 174.96 0.49 Allowed Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.127 162.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -51.35 148.4 19.4 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.498 0.798 . . . . 0.0 110.812 154.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.59 144.64 52.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 164.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -130.07 171.21 13.06 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.215 1.806 . . . . 0.0 108.514 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.49 164.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.982 1.313 . . . . 0.0 108.816 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -153.47 148.25 26.41 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.336 1.854 . . . . 0.0 107.219 159.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -86.77 168.12 13.8 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 158.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.0 p -117.53 162.36 28.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 163.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.2 -83.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.272 1.982 . . . . 0.0 113.576 -155.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -142.54 -53.46 0.41 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.304 1.042 . . . . 0.0 109.649 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 144.69 -157.47 27.27 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 123.412 0.53 . . . . 0.0 112.372 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 m -150.33 178.21 9.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.655 2.782 . . . . 0.0 105.804 166.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 150.62 -108.49 0.39 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-O 117.84 -1.534 . . . . 0.0 110.243 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 87.61 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.355 2.703 . . . . 0.0 110.601 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.1 t -157.69 -175.17 5.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.129 1.772 . . . . 0.0 108.084 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.0 m -149.37 171.06 17.16 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 126.176 1.79 . . . . 0.0 108.582 163.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 CA-C-O 116.459 -2.3 . . . . 0.0 108.231 163.721 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.496 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.5 p -82.73 -168.74 2.16 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.838 2.055 . . . . 0.0 109.28 165.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p -150.07 173.41 13.9 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.051 -1.031 . . . . 0.0 109.035 147.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.09 98.37 0.3 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -71.19 10.78 0.52 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.386 1.474 . . . . 0.0 113.363 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -56.06 -73.86 0.05 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.272 1.429 . . . . 0.0 108.676 166.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.91 140.12 6.06 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -167.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -129.93 -173.51 3.05 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.199 1.4 . . . . 0.0 107.297 166.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.9 p -139.54 -173.92 3.74 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 166.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.01 122.04 0.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -138.35 -17.2 1.17 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.976 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.36 -17.31 0.2 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.279 0.945 . . . . 0.0 111.833 168.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt -76.95 150.02 80.73 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 119.304 0.956 . . . . 0.0 110.587 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -67.32 170.63 13.03 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.746 2.298 . . . . 0.0 114.272 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.5 mtm -122.35 -39.93 2.53 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 127.06 2.144 . . . . 0.0 111.041 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -136.51 150.42 27.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 119.133 0.879 . . . . 0.0 111.755 -175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.96 168.53 22.3 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 128.426 2.69 . . . . 0.0 110.248 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.419 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 3.4 Cg_exo -64.47 166.64 16.89 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 121.691 1.594 . . . . 0.0 114.048 173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.49 -163.04 1.4 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.625 2.059 . . . . 0.0 112.788 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -58.08 106.33 0.36 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.628 1.171 . . . . 0.0 109.198 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.81 141.6 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.209 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -124.12 152.06 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.94 132.75 14.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -124.05 128.91 50.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 125.016 1.326 . . . . 0.0 110.022 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.297 0.7 OUTLIER -88.46 115.89 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.093 0.949 . . . . 0.0 110.473 -175.874 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.27 -35.21 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.392 -169.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -156.35 -173.25 4.41 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 109.413 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -17.96 64.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -171.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.9 p -128.71 6.21 5.59 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.435 1.494 . . . . 0.0 111.122 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -142.7 142.27 31.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.421 1.088 . . . . 0.0 110.097 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -137.78 162.32 34.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -117.31 121.0 39.94 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -97.98 144.17 11.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -133.33 144.97 49.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.925 1.69 . . . . 0.0 107.592 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -148.31 173.07 13.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.029 1.332 . . . . 0.0 108.385 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -90.03 144.42 31.32 Favored Pre-proline 0 C--O 1.234 0.289 0 O-C-N 121.761 -0.587 . . . . 0.0 109.845 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.93 112.14 3.03 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.402 2.735 . . . . 0.0 109.104 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.419 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 23.5 m -83.22 159.17 62.75 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 150.65 18.93 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.536 2.824 . . . . 0.0 112.077 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -35.77 72.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.909 1.284 . . . . 0.0 109.763 175.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -60.02 -25.85 65.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 117.171 -1.395 . . . . 0.0 114.234 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 76.0 p -93.11 -20.77 20.18 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 120.743 1.61 . . . . 0.0 111.673 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.8 mt -63.23 -40.2 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 166.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 56.61 -3.24 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.616 2.767 . . . . 0.0 115.188 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 -166.56 12.73 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 125.466 1.507 . . . . 0.0 109.394 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -87.68 107.86 18.83 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.391 -0.476 . . . . 0.0 109.919 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -48.81 130.48 17.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.016 1.327 . . . . 0.0 107.956 172.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -84.73 -62.16 1.61 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.19 -165.15 30.34 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.34 160.57 14.19 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -134.95 99.44 4.29 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.601 -0.687 . . . . 0.0 109.2 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.7 mt -77.89 119.01 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.573 1.549 . . . . 0.0 107.019 170.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -91.74 149.64 21.51 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 39.8 p90 -154.24 164.82 37.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.521 1.51 . . . . 0.0 111.546 170.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -148.65 159.19 44.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.854 1.262 . . . . 0.0 111.197 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.64 138.32 54.92 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m -118.87 140.71 49.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -146.05 94.61 2.5 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -13.65 17.95 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.711 2.005 . . . . 0.0 114.31 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.43 -179.21 1.27 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.807 2.043 . . . . 0.0 112.498 -170.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -51.66 127.71 21.29 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.169 1.388 . . . . 0.0 110.466 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -77.49 70.55 3.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.279 1.032 . . . . 0.0 111.418 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -126.48 179.19 5.43 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.355 1.862 . . . . 0.0 108.818 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 23.59 76.75 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.471 3.108 . . . . 0.0 113.823 175.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -158.77 128.65 5.78 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.616 1.166 . . . . 0.0 108.039 -173.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.59 96.81 6.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.574 1.079 . . . . 0.0 108.765 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.3 m170 47.81 -155.14 0.07 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.257 1.423 . . . . 0.0 110.195 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.4 mt -128.71 124.66 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -78.11 122.67 25.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 167.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -102.18 105.34 16.01 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 170.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 2.3 mttp -88.03 172.36 9.6 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 127.383 2.273 . . . . 0.0 109.188 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.0 mm -141.79 161.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.46 1.904 . . . . 0.0 107.199 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.94 108.88 2.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.736 1.214 . . . . 0.0 110.024 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -81.92 135.43 35.4 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.273 1.429 . . . . 0.0 111.257 -163.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -137.11 97.54 3.52 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.52 173.19 11.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.777 0.831 . . . . 0.0 110.865 175.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.81 175.43 46.33 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 121.964 0.758 . . . . 0.0 111.685 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.5 p -83.52 27.02 0.63 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.796 1.638 . . . . 0.0 112.748 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.38 164.95 3.93 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.932 1.349 . . . . 0.0 112.295 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.6 p -127.55 -0.94 6.19 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.762 2.025 . . . . 0.0 110.768 -174.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -152.14 163.45 39.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.06 1.344 . . . . 0.0 108.465 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.66 172.8 34.99 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 127.568 2.509 . . . . 0.0 107.92 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 77.5 mtp -115.09 159.01 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.583 1.191 . . . . 0.0 109.972 -172.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.44 77.27 35.36 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 108.877 168.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -86.07 149.06 9.38 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.503 2.802 . . . . 0.0 110.892 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.46 26.74 9.05 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.737 0.684 . . . . 0.0 112.043 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -109.59 171.08 7.66 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 126.258 1.823 . . . . 0.0 108.02 -173.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -115.25 144.77 32.87 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.896 0.878 . . . . 0.0 110.311 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -70.39 169.21 20.25 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.719 2.946 . . . . 0.0 113.059 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 35.88 51.12 0.71 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.819 2.448 . . . . 0.0 111.048 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 m -129.91 -179.69 5.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 108.528 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -130.14 143.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -136.35 168.2 19.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -126.12 142.6 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 153.85 49.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.452 1.501 . . . . 0.0 109.977 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.25 129.92 21.52 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.625 1.17 . . . . 0.0 109.281 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.49 162.17 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -152.55 161.3 42.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -106.57 146.91 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.09 139.68 41.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -134.1 178.87 6.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.324 0.65 . . . . 0.0 110.295 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.28 -40.14 52.36 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.015 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -73.11 -50.92 20.05 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.95 0.875 . . . . 0.0 111.865 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.4 -167.36 40.03 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -163.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -94.79 170.29 9.55 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 111.078 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.44 -154.29 6.96 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 167.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.0 152.67 79.89 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.505 2.137 . . . . 0.0 112.714 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.49 155.68 24.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.597 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.7 p -67.9 175.77 1.59 Allowed Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.371 1.068 . . . . 0.0 109.679 169.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -53.57 143.34 56.94 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 120.643 0.896 . . . . 0.0 109.857 155.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.66 155.56 37.63 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.3 mmt-85 -136.46 165.39 25.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 120.981 -1.075 . . . . 0.0 108.839 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.42 151.74 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.68 126.12 6.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.832 1.653 . . . . 0.0 107.491 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -88.94 146.95 24.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 p -87.65 156.36 53.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 123.392 0.433 . . . . 0.0 110.215 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.7 -80.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.698 2.932 . . . . 0.0 112.576 -166.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -156.29 -28.09 0.1 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.7 171.09 43.62 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 124.491 1.043 . . . . 0.0 111.573 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.48 -178.34 4.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.145 1.778 . . . . 0.0 108.918 174.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -178.2 -98.67 0.11 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.83 92.44 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.702 2.934 . . . . 0.0 111.652 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.3 m -104.44 169.61 8.37 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 162.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.5 t -146.29 161.8 39.5 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 167.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.867 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -143.797 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.873 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 p -138.17 85.14 2.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.487 1.144 . . . . 0.0 111.436 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 m -114.52 146.76 40.33 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.502 1.121 . . . . 0.0 108.894 166.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 -96.47 2.4 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 159.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.66 -52.93 0.44 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.11 2.164 . . . . 0.0 114.681 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 t 56.94 -175.23 0.06 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.562 1.545 . . . . 0.0 113.461 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.36 -99.06 0.21 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 -169.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 46.87 67.68 0.75 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.872 1.669 . . . . 0.0 110.917 173.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -127.25 169.72 13.2 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.011 1.724 . . . . 0.0 108.575 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.19 149.67 5.06 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -108.56 -50.91 2.96 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.978 1.711 . . . . 0.0 108.146 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -141.25 6.56 1.94 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.242 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.0 mt -80.28 157.12 73.45 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 120.242 1.383 . . . . 0.0 111.753 164.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.76 139.59 25.14 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.32 2.013 . . . . 0.0 111.634 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.9 mtm -92.0 -38.13 12.42 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.993 1.317 . . . . 0.0 113.152 -172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.4 m -133.83 174.83 12.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 118.624 0.647 . . . . 0.0 110.382 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -118.26 162.86 27.89 Favored Pre-proline 0 N--CA 1.441 -0.889 0 C-N-CA 128.449 2.7 . . . . 0.0 108.612 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 46.1 Cg_endo -66.18 161.48 40.08 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.837 2.358 . . . . 0.0 111.368 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.64 -147.45 0.41 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.617 2.532 . . . . 0.0 114.3 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.9 91.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.922 1.689 . . . . 0.0 108.79 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.38 155.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.131 1.372 . . . . 0.0 108.725 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -132.43 163.57 28.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.973 1.709 . . . . 0.0 106.939 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.6 144.91 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -123.8 136.16 54.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.511 2.724 . . . . 0.0 108.204 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.5 t -92.94 102.03 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 m -71.45 -58.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.801 1.64 . . . . 0.0 109.507 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -131.76 -173.85 3.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.8 1.24 . . . . 0.0 110.907 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.32 95.14 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.012 -1.055 . . . . 0.0 113.635 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 p -129.23 12.41 6.04 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.614 0.766 . . . . 0.0 111.243 -169.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 tp -121.12 132.73 55.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 169.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -125.49 165.65 18.08 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 168.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -135.42 139.54 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 142.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -136.33 122.62 20.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.555 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -124.83 -178.47 4.17 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.05 1.74 . . . . 0.0 109.796 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.76 135.44 19.54 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.818 1.247 . . . . 0.0 109.332 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 100.48 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.469 2.78 . . . . 0.0 110.134 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.438 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 18.6 m -65.49 162.36 42.92 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.982 -176.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.06 150.02 86.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.126 2.551 . . . . 0.0 110.928 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.77 -25.32 68.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 167.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -57.2 -51.22 70.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.313 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.2 p -66.55 -34.09 77.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.092 0.86 . . . . 0.0 110.384 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.0 mt -66.46 -23.79 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.039 0.936 . . . . 0.0 110.413 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.26 19.1 mtp180 60.12 -13.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 129.324 3.05 . . . . 0.0 116.44 -173.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.53 -94.24 0.1 Allowed Glycine 0 CA--C 1.518 0.222 0 CA-C-N 120.351 1.432 . . . . 0.0 110.902 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -125.41 133.79 52.37 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.517 1.527 . . . . 0.0 109.824 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.1 tp -70.83 118.73 13.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -70.69 -50.89 31.71 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.01 -173.38 42.89 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -112.81 127.27 56.12 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.932 0.893 . . . . 0.0 109.032 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -103.44 118.86 37.72 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mt -92.94 127.48 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -92.06 154.88 18.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 159.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -159.63 164.03 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.147 1.379 . . . . 0.0 111.498 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -148.6 160.34 43.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.265 -0.897 . . . . 0.0 111.312 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -69.19 138.5 54.14 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 107.93 171.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.8 m -133.96 167.89 19.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 47.9 71.7 0.32 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.653 1.181 . . . . 0.0 110.652 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.5 p -63.69 172.77 1.99 Allowed 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.502 0.721 . . . . 0.0 111.706 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t -50.85 149.62 3.36 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 154.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.3 m -68.09 163.94 21.34 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.038 0.535 . . . . 0.0 111.294 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttt 49.51 39.93 17.97 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.116 1.367 . . . . 0.0 111.901 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -102.34 159.75 15.14 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.321 -0.862 . . . . 0.0 110.938 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -146.57 151.15 36.84 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.661 1.985 . . . . 0.0 107.703 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -145.27 -177.88 5.78 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 162.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 -61.01 1.52 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -93.11 179.78 5.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.569 0.622 . . . . 0.0 109.598 168.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -128.94 130.23 68.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 125.025 1.33 . . . . 0.0 107.522 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' A' ' 69' ' ' GLU . 16.1 pt-20 -69.96 60.7 0.18 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.509 2.724 . . . . 0.0 110.599 167.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -56.81 99.17 0.03 OUTLIER 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.877 1.671 . . . . 0.0 108.34 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -83.62 165.6 18.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.312 2.645 . . . . 0.0 108.997 -171.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.24 153.73 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mt -135.04 152.51 51.77 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.663 2.385 . . . . 0.0 108.699 166.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.8 m -126.66 104.02 7.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.049 1.34 . . . . 0.0 109.048 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -104.17 98.29 8.12 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -74.17 169.43 17.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.17 -179.33 53.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 124.386 0.993 . . . . 0.0 111.205 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -81.31 -1.71 46.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -170.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.415 ' HE3' ' CE1' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -57.2 149.06 20.63 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.499 0.666 . . . . 0.0 112.427 -168.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -108.45 2.31 22.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 111.914 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.415 ' CE1' ' HE3' ' A' ' 79' ' ' LYS . 7.1 p80 -140.19 164.38 30.23 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.5 -0.75 . . . . 0.0 109.758 167.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.16 161.41 33.94 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -173.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 43.3 mtp -117.94 152.61 35.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.703 1.251 . . . . 0.0 111.732 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -109.97 84.98 3.8 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 127.63 2.372 . . . . 0.0 106.961 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -84.58 160.79 12.56 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.41 2.74 . . . . 0.0 110.754 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.86 8.94 81.84 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.469 -0.628 . . . . 0.0 112.844 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -80.03 -179.0 6.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.652 1.581 . . . . 0.0 108.996 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -123.03 150.82 60.28 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 122.999 0.52 . . . . 0.0 110.383 171.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.55 172.24 9.51 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.827 2.351 . . . . 0.0 111.683 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.3 t80 45.58 36.4 2.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.821 2.848 . . . . 0.0 113.258 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.9 m -133.34 164.51 26.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.029 1.732 . . . . 0.0 110.108 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -100.4 152.38 20.42 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -139.37 152.17 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.7 m -127.14 134.65 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 153.5 38.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.082 1.753 . . . . 0.0 110.761 -170.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 124.25 6.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.549 1.14 . . . . 0.0 110.435 -162.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.52 131.41 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 108.518 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -125.13 131.72 53.21 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.611 -1.306 . . . . 0.0 109.812 171.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.57 153.7 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.97 147.04 28.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -133.87 -174.91 3.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.692 1.197 . . . . 0.0 109.181 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.05 -3.56 6.42 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.667 -1.629 . . . . 0.0 115.114 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -117.33 -30.99 5.42 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 120.315 2.057 . . . . 0.0 111.553 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.73 -173.53 44.52 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 119.409 1.004 . . . . 0.0 113.971 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -86.64 144.22 27.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.373 1.069 . . . . 0.0 109.796 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -89.2 -168.77 43.95 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.141 0.877 . . . . 0.0 111.96 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -63.86 152.4 80.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.057 2.505 . . . . 0.0 111.064 169.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.23 139.45 42.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.602 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . 8.6 t -63.41 171.04 2.37 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.114 1.366 . . . . 0.0 108.644 158.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.39 155.7 36.69 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.151 2.567 . . . . 0.0 110.193 -169.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.12 110.04 9.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.6 171.05 14.48 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 170.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.82 161.8 26.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.56 0.744 . . . . 0.0 110.549 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.82 161.17 42.9 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.88 1.672 . . . . 0.0 109.081 167.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -128.55 128.77 44.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.759 2.023 . . . . 0.0 107.523 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.5 p -87.22 160.5 48.59 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.111 0.564 . . . . 0.0 110.503 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.13 172.04 15.39 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.991 3.127 . . . . 0.0 109.039 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.08 -31.49 67.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -167.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.27 -159.01 18.91 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 124.272 0.939 . . . . 0.0 111.371 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 p -156.89 101.41 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 161.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.84 102.07 2.2 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.197 -1.335 . . . . 0.0 110.551 -171.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.86 -50.94 0.32 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.566 2.177 . . . . 0.0 110.86 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.11 174.67 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.985 1.314 . . . . 0.0 112.067 -163.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.0 m -153.89 -56.1 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 127.243 2.217 . . . . 0.0 105.214 170.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.233 0 N-CA-C 104.677 -3.369 . . . . 0.0 104.677 140.049 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.933 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.12 176.73 0.04 OUTLIER 'General case' 0 C--O 1.239 0.515 0 C-N-CA 130.049 3.34 . . . . 0.0 107.431 174.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m 72.35 148.74 0.09 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 127.376 2.271 . . . . 0.0 110.379 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.32 -160.99 30.57 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -155.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m 68.72 163.32 0.22 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.13 1.772 . . . . 0.0 110.227 -153.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 m 167.63 -170.45 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 128.8 2.84 . . . . 0.0 109.197 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.15 173.22 13.44 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -161.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 131.81 -173.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 1 C-N-CA 133.221 4.608 . . . . 0.0 102.907 -164.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 p -149.36 173.0 14.0 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.629 -1.294 . . . . 0.0 109.708 169.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.93 54.03 40.9 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.24 97.59 3.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.115 1.766 . . . . 0.0 106.992 -174.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -76.36 -47.99 21.49 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.452 -168.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt 44.75 133.51 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 1 C-N-CA 133.505 4.722 . . . . 0.0 119.561 167.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.39 155.35 55.62 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.211 1.94 . . . . 0.0 111.595 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.7 mtp -111.9 -33.96 6.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -160.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.47 178.57 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.003 0.82 . . . . 0.0 110.587 -165.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.04 145.93 41.03 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 127.663 2.385 . . . . 0.0 109.838 -173.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -72.2 125.88 11.23 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.187 1.925 . . . . 0.0 109.149 174.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.11 -172.09 43.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 123.972 0.796 . . . . 0.0 111.667 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.9 t30 40.31 58.49 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.563 2.345 . . . . 0.0 110.681 172.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.69 142.98 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.35 100.42 2.88 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.563 -0.711 . . . . 0.0 109.924 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.25 134.87 47.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -171.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -124.28 135.26 53.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.833 1.653 . . . . 0.0 109.89 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.2 102.34 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 118.837 0.744 . . . . 0.0 109.764 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.56 -56.76 11.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.768 2.027 . . . . 0.0 111.121 -177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -126.32 173.78 9.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.447 1.499 . . . . 0.0 107.531 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -30.14 69.51 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.066 -1.021 . . . . 0.0 112.635 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -120.7 10.42 11.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.531 1.132 . . . . 0.0 113.078 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -133.36 117.23 17.04 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.863 1.665 . . . . 0.0 109.597 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.57 166.06 11.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.35 148.04 36.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.754 2.422 . . . . 0.0 107.956 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.76 114.94 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -92.78 157.59 16.34 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.394 1.059 . . . . 0.0 109.249 166.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -149.76 177.43 9.8 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.168 2.187 . . . . 0.0 109.601 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -104.5 133.86 19.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.388 0.675 . . . . 0.0 110.785 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 107.96 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 125.185 3.923 . . . . 0.0 110.664 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 m -57.51 155.47 19.99 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 119.259 -0.401 . . . . 0.0 110.396 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -59.35 131.55 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.917 2.411 . . . . 0.0 108.245 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.09 -32.88 62.34 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.124 0.875 . . . . 0.0 112.138 -173.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -49.59 -41.8 42.86 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.69 1.196 . . . . 0.0 111.911 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.9 p -66.22 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.861 0.865 . . . . 0.0 112.777 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.74 -34.0 65.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.125 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 42.57 57.89 3.31 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 111.706 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.08 -168.64 28.86 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -77.36 128.23 33.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.427 ' CD1' ' H ' ' A' ' 78' ' ' SER . 2.6 tt -60.98 108.49 0.88 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.995 1.318 . . . . 0.0 107.491 172.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.431 HE21 ' HA ' ' A' ' 48' ' ' GLN . 2.7 mm-40 -85.2 -21.25 29.22 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.522 -0.736 . . . . 0.0 112.04 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.32 -168.89 30.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.679 1.133 . . . . 0.0 110.945 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -124.16 118.27 26.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -96.05 130.92 42.94 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.35 119.76 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -91.16 145.36 24.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -156.67 166.0 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 120.202 1.364 . . . . 0.0 110.692 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -148.41 153.48 38.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.774 0.829 . . . . 0.0 111.217 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -68.73 128.35 36.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.0 m -109.0 128.59 55.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -128.66 115.81 18.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -171.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.6 t -63.64 137.19 58.0 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.6 m 67.09 111.15 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.18 1.392 . . . . 0.0 109.331 -151.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -151.64 68.06 0.89 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.322 1.849 . . . . 0.0 106.379 164.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -64.53 142.94 58.25 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.61 80.66 2.0 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -164.06 117.93 1.46 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.906 1.682 . . . . 0.0 107.567 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 55.11 55.52 7.53 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.279 1.832 . . . . 0.0 111.282 168.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -139.66 126.81 21.13 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.962 1.305 . . . . 0.0 110.718 -165.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 104.59 9.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.119 1.768 . . . . 0.0 112.094 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 86.8 mt -68.18 165.81 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.919 1.687 . . . . 0.0 109.666 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -129.62 94.79 3.83 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.25 1.42 . . . . 0.0 109.57 -171.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -92.68 116.42 29.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.943 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -98.48 179.82 4.58 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.16 0.984 . . . . 0.0 108.781 167.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.4 mm -135.13 163.08 37.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.67 155.46 46.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.752 1.621 . . . . 0.0 108.355 167.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -116.55 120.74 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.108 1.363 . . . . 0.0 107.613 -165.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -130.32 150.1 51.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -76.38 -175.49 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.908 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.7 53.83 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 122.628 1.127 . . . . 0.0 112.125 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.427 ' H ' ' CD1' ' A' ' 47' ' ' LEU . 94.6 p 59.57 -23.42 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.768 3.627 . . . . 0.0 118.786 173.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 150.23 12.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.844 0.83 . . . . 0.0 109.237 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 p -110.9 14.25 22.1 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.139 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.47 162.21 40.79 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.949 0.9 . . . . 0.0 112.385 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.56 -174.67 26.6 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 128.246 2.831 . . . . 0.0 108.169 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 mtp -131.98 166.55 21.43 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.512 1.156 . . . . 0.0 110.017 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -122.5 85.36 48.26 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 125.272 1.429 . . . . 0.0 107.29 168.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.39 146.16 6.12 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.283 3.322 . . . . 0.0 111.46 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.51 18.71 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.628 0.632 . . . . 0.0 113.148 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.44 177.63 6.07 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.869 0.868 . . . . 0.0 109.081 -165.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.52 147.94 43.05 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 125.08 1.352 . . . . 0.0 108.32 171.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -74.06 164.48 34.3 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.501 2.134 . . . . 0.0 112.292 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.4 t80 61.2 22.81 13.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.678 1.991 . . . . 0.0 112.794 170.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -120.22 162.5 19.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.084 1.354 . . . . 0.0 111.414 167.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.08 150.7 23.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.182 2.193 . . . . 0.0 107.145 168.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -137.24 156.26 48.51 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.24 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.3 m -125.89 135.46 51.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.36 154.37 47.84 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.918 1.687 . . . . 0.0 109.358 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -138.62 157.26 46.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.89 152.82 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -147.95 145.27 28.52 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.01 147.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.07 146.84 26.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -132.95 -178.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.729 0.812 . . . . 0.0 110.886 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.51 50.4 2.1 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.792 1.187 . . . . 0.0 111.919 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -157.98 -52.79 0.07 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.146 2.178 . . . . 0.0 107.629 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.13 -172.05 36.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.538 0.608 . . . . 0.0 113.294 -171.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -97.44 161.59 13.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.249 1.02 . . . . 0.0 112.767 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.39 -170.58 14.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.855 1.216 . . . . 0.0 113.493 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.55 141.31 45.73 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 124.159 3.239 . . . . 0.0 111.365 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.85 41.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.387 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.4 p -60.54 169.99 1.57 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 164.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -54.32 145.81 53.99 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 108.646 -1.328 . . . . 0.0 108.646 156.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.33 104.55 10.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -80.93 168.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.247 1.819 . . . . 0.0 108.889 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.18 161.24 28.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 122.1 -0.375 . . . . 0.0 110.307 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -159.02 129.36 5.86 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 110.975 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -86.06 139.43 31.15 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 p -94.26 145.28 29.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 -77.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.269 2.646 . . . . 0.0 112.489 -159.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -159.7 -28.98 0.06 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.666 -0.646 . . . . 0.0 111.195 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.54 107.38 1.04 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 125.435 1.493 . . . . 0.0 109.481 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -146.37 102.34 3.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 170.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.35 116.36 8.76 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 169.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -62.63 162.21 25.5 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 CA-C-N 120.366 2.083 . . . . 0.0 109.958 171.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.2 t -146.33 102.01 3.55 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.209 -0.932 . . . . 0.0 109.03 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 m -134.98 177.84 7.49 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.021 0.928 . . . . 0.0 109.3 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 CA-C-O 117.891 -1.505 . . . . 0.0 110.064 179.288 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.183 0 CA-C-O 117.522 -1.71 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m 65.04 90.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.027 1.331 . . . . 0.0 111.275 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.4 m -151.41 168.16 25.71 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.351 -0.843 . . . . 0.0 109.224 -177.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.51 176.53 34.67 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -87.08 95.14 9.84 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.5 t -133.3 150.75 51.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 159.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 122.48 -60.09 0.58 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -173.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.0 m80 52.29 -161.92 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.794 1.238 . . . . 0.0 112.204 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 t -149.47 -171.06 3.8 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.168 1.387 . . . . 0.0 109.107 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.06 72.02 1.23 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 125.536 1.541 . . . . 0.0 109.382 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -110.05 -10.29 14.7 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.88 -26.1 34.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.635 161.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.1 148.76 83.92 Favored Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 123.552 0.741 . . . . 0.0 111.743 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.45 170.09 16.35 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.939 3.093 . . . . 0.0 112.594 -175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.8 mtm -132.78 -31.38 1.33 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -161.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -139.48 147.17 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 121.145 1.793 . . . . 0.0 109.818 174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.04 169.12 15.48 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.921 1.289 . . . . 0.0 109.91 174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.79 162.32 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.095 1.863 . . . . 0.0 111.81 -168.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.25 166.81 52.9 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -31.41 104.51 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.517 2.327 . . . . 0.0 114.273 -160.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.81 142.98 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -122.3 160.14 25.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.681 1.992 . . . . 0.0 106.985 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.03 145.73 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -123.43 128.32 49.66 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.217 1.807 . . . . 0.0 108.444 172.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.5 103.1 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 170.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.32 -48.3 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.409 0.683 . . . . 0.0 109.734 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -143.12 -178.24 5.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.176 1.39 . . . . 0.0 108.013 -174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -38.87 92.37 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.893 -1.129 . . . . 0.0 111.959 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 p -112.8 6.06 17.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.262 1.425 . . . . 0.0 112.098 -171.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.48 137.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.959 1.703 . . . . 0.0 108.691 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.91 161.29 36.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -119.88 128.59 53.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.39 2.276 . . . . 0.0 106.396 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.28 141.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -147.6 159.68 43.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.029 1.286 . . . . 0.0 109.473 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.55 142.66 89.2 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.3 113.08 2.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.242 2.628 . . . . 0.0 109.049 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' CG2' ' HD2' ' A' ' 39' ' ' PRO . 4.9 p -71.94 149.19 92.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.036 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.482 ' HD2' ' CG2' ' A' ' 38' ' ' VAL . 37.2 Cg_endo -70.7 137.66 33.19 Favored 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.567 4.178 . . . . 0.0 108.841 -170.164 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.17 -28.7 59.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.688 0.677 . . . . 0.0 112.043 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -57.72 -42.42 83.76 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.522 173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 86.2 p -68.39 -28.65 67.28 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.01 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.9 -40.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 C-N-CA 124.247 1.019 . . . . 0.0 108.455 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 65.12 -70.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.499 1.92 . . . . 0.0 112.294 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.61 -169.82 1.5 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.705 2.098 . . . . 0.0 111.802 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -80.82 138.72 36.24 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.735 0.814 . . . . 0.0 109.847 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.05 127.58 32.23 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.319 1.048 . . . . 0.0 108.764 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -98.75 -23.52 15.39 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.727 0.811 . . . . 0.0 111.985 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.8 -155.73 21.75 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -128.53 156.28 43.53 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.621 1.168 . . . . 0.0 107.99 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.59 109.72 12.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mt -85.42 141.78 14.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -118.41 117.68 29.69 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.96 1.704 . . . . 0.0 108.932 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.48 ' CD2' HD12 ' A' ' 84' ' ' LEU . 26.5 p90 -133.43 160.63 36.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.429 1.013 . . . . 0.0 112.444 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -149.38 161.0 42.95 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.398 1.479 . . . . 0.0 110.7 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -68.79 137.19 53.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.296 1.838 . . . . 0.0 108.755 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m -127.18 129.98 48.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -162.75 100.85 1.02 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -169.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 m -63.37 110.05 1.8 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.59 129.37 14.22 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 165.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -64.74 104.3 0.81 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 tptt -138.74 101.31 4.29 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -69.87 0.43 Allowed 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.175 0.59 . . . . 0.0 112.052 -168.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -71.68 112.0 7.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.464 -168.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 66.95 111.34 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.999 2.119 . . . . 0.0 112.384 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.3 ttp-105 -145.19 100.7 3.51 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.708 1.203 . . . . 0.0 108.621 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -128.76 176.74 7.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.049 0.939 . . . . 0.0 109.89 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.11 128.73 36.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -83.05 109.79 17.43 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 163.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -87.12 111.88 21.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 166.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -87.4 167.22 14.22 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.506 1.922 . . . . 0.0 109.884 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.26 141.02 43.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 124.85 1.26 . . . . 0.0 107.849 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.435 ' CD2' HD23 ' A' ' 84' ' ' LEU . 11.9 tp -130.58 150.02 51.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.74 2.416 . . . . 0.0 106.879 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.64 137.46 45.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.107 0.963 . . . . 0.0 108.957 -170.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -142.43 93.07 2.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.374 1.07 . . . . 0.0 109.814 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -77.55 171.1 15.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.255 0.55 . . . . 0.0 110.329 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.43 70.38 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.863 -0.523 . . . . 0.0 113.366 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.7 t 58.95 20.47 8.2 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 113.332 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' HZ3' ' CE1' ' A' ' 81' ' ' HIS . 1.1 mmmt -56.53 134.05 53.89 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -89.66 -1.98 58.17 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.853 1.346 . . . . 0.0 112.069 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.43 ' CE1' ' HZ3' ' A' ' 79' ' ' LYS . 3.4 p80 -147.53 144.17 28.33 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.54 162.05 32.63 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -171.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 27.0 mtp -117.44 148.66 41.59 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.45 -0.441 . . . . 0.0 111.346 -162.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.48 HD12 ' CD2' ' A' ' 54' ' ' TYR . 3.6 mm? -105.38 90.62 4.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 128.122 2.569 . . . . 0.0 107.417 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -93.2 162.37 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.712 2.275 . . . . 0.0 112.734 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.28 33.34 86.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.98 163.08 16.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.296 1.038 . . . . 0.0 108.314 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -103.49 134.1 19.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -76.98 169.39 21.73 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.445 2.096 . . . . 0.0 111.652 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.7 t80 54.7 43.15 30.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.173 2.189 . . . . 0.0 111.937 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -149.51 162.61 39.8 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 120.727 -1.233 . . . . 0.0 111.112 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -93.6 156.14 16.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -143.87 159.7 42.08 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.0 m -120.64 130.09 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.6 163.73 22.8 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.125 1.37 . . . . 0.0 109.971 168.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.5 169.08 20.31 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.937 1.295 . . . . 0.0 109.043 165.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.9 t -114.59 132.18 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 m -87.36 153.56 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.99 142.49 31.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.549 1.539 . . . . 0.0 106.868 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -144.53 -175.44 4.65 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.326 0.584 . . . . 0.0 111.125 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.43 -1.06 2.98 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.872 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -124.09 -36.26 2.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 120.56 2.18 . . . . 0.0 111.323 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.57 -150.55 10.98 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 121.697 0.609 . . . . 0.0 112.208 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.74 159.01 22.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.726 1.61 . . . . 0.0 107.91 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -102.94 -162.24 25.74 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.874 0.75 . . . . 0.0 113.574 171.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.76 162.38 25.32 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 159.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.56 166.02 11.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.482 172.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.8 p -65.99 179.36 0.47 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.419 1.088 . . . . 0.0 109.544 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.75 168.71 6.6 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.356 1.163 . . . . 0.0 109.561 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 137.72 58.23 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.087 -1.008 . . . . 0.0 108.858 160.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -115.3 158.24 22.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 161.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.54 161.27 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 166.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -91.86 128.85 37.85 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.07 0.948 . . . . 0.0 108.748 171.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -78.21 163.78 60.3 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.979 -0.534 . . . . 0.0 109.6 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.67 -114.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.686 2.924 . . . . 0.0 110.192 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.79 -31.9 3.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.387 1.449 . . . . 0.0 112.975 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.17 -172.28 22.23 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -164.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.9 t -176.32 -75.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 162.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 165.18 147.92 5.3 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.9 101.06 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.75 2.967 . . . . 0.0 109.864 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.8 t -147.7 148.42 30.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.944 1.698 . . . . 0.0 107.354 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.2 m -157.79 88.74 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 163.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 163.694 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.758 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -124.97 160.54 28.69 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.428 1.091 . . . . 0.0 109.483 -171.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -60.63 163.81 5.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.92 1.288 . . . . 0.0 110.102 166.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.85 171.2 37.73 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.3 m -139.39 118.81 12.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.028 0.931 . . . . 0.0 109.067 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.8 m -146.32 -176.3 5.11 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.354 2.262 . . . . 0.0 107.149 165.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.13 179.85 18.3 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -171.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -161.54 156.72 23.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.23 1.012 . . . . 0.0 108.911 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 t -135.94 -39.31 0.7 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.872 0.469 . . . . 0.0 110.013 161.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.79 -71.8 2.67 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.08 -90.85 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.494 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -168.09 -51.16 0.02 OUTLIER 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.168 1.349 . . . . 0.0 113.319 164.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.5 mt 46.11 158.39 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 130.894 3.678 . . . . 0.0 116.67 -163.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.45 167.41 16.9 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.348 2.699 . . . . 0.0 111.361 171.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.9 mtm -123.2 -35.24 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.44 1.496 . . . . 0.0 113.507 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.3 m -137.69 -176.88 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.342 0.973 . . . . 0.0 110.368 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.41 171.41 7.63 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 127.503 2.321 . . . . 0.0 109.685 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -63.97 141.54 77.82 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.97 1.113 . . . . 0.0 110.475 164.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.73 -177.49 31.91 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -23.9 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 129.942 3.297 . . . . 0.0 114.038 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.58 145.36 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -120.62 157.91 28.51 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 126.213 1.805 . . . . 0.0 106.859 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 141.84 21.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 173.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -124.29 136.75 54.35 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.383 1.473 . . . . 0.0 108.579 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 80.8 t -95.8 105.13 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.277 1.037 . . . . 0.0 108.726 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -80.11 -48.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.491 -173.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -130.91 -178.14 4.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.8 -29.78 64.81 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.626 -1.296 . . . . 0.0 112.922 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.6 p -123.88 14.24 9.25 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 111.096 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -124.89 137.04 54.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 106.628 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.5 155.55 48.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.01 150.36 38.74 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.088 1.355 . . . . 0.0 107.771 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.6 t -129.27 135.11 62.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.18 123.59 32.47 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -129.63 157.93 40.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 110.63 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.86 139.28 95.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.185 0.994 . . . . 0.0 111.369 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.38 109.07 2.84 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.549 2.833 . . . . 0.0 111.084 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.464 ' CG1' ' HD2' ' A' ' 39' ' ' PRO 0.32 48.9 t -79.61 159.17 72.41 Favored Pre-proline 0 N--CA 1.409 -2.492 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -169.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.464 ' HD2' ' CG1' ' A' ' 38' ' ' VAL . 4.7 Cg_exo -59.6 147.2 92.81 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.232 3.955 . . . . 0.0 111.124 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -66.83 -35.41 79.98 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.618 -0.676 . . . . 0.0 109.267 160.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -49.47 -36.69 23.52 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.201 0.6 . . . . 0.0 111.687 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.3 p -91.0 -13.67 32.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 85.4 mt -68.12 -38.52 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 120.44 1.473 . . . . 0.0 108.634 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 47.7 56.4 7.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 110.659 -173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.36 -179.21 32.4 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -73.05 144.45 47.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.24 122.69 25.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 170.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -75.41 -24.27 57.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.978 1.711 . . . . 0.0 111.009 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.95 -177.74 32.04 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 125.836 1.684 . . . . 0.0 109.338 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -99.76 129.18 45.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -113.2 102.5 10.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.499 1.519 . . . . 0.0 107.837 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.6 mt -78.0 121.53 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.69 151.05 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 162.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -157.32 164.78 37.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.205 1.402 . . . . 0.0 111.043 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -149.22 158.65 44.35 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.255 1.022 . . . . 0.0 111.667 168.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -68.71 134.1 49.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.2 m -120.56 148.5 43.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -173.73 164.64 4.39 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.705 1.602 . . . . 0.0 110.165 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.5 m -74.27 -86.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.567 1.147 . . . . 0.0 109.105 151.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.5 m -156.35 169.09 25.38 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.761 1.224 . . . . 0.0 110.725 -160.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.2 t -146.33 -80.96 0.15 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 165.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -153.1 42.85 0.61 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.245 1.018 . . . . 0.0 110.425 175.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.06 149.46 23.12 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.525 -1.36 . . . . 0.0 111.04 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -160.99 67.12 0.31 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.49 1.116 . . . . 0.0 110.578 168.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 -153.04 70.67 0.88 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 120.903 -1.123 . . . . 0.0 111.583 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -163.22 173.73 13.0 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.832 1.253 . . . . 0.0 109.308 164.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -82.91 158.43 22.64 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 118.572 0.624 . . . . 0.0 110.675 169.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.09 123.33 29.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 167.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -75.22 126.63 31.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.472 1.909 . . . . 0.0 108.851 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -109.66 113.08 25.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.601 1.56 . . . . 0.0 110.0 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -92.71 164.4 13.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.875 1.67 . . . . 0.0 111.312 -171.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.52 153.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.037 1.735 . . . . 0.0 106.575 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 tp -131.14 163.16 28.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.277 2.631 . . . . 0.0 107.196 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.4 m -138.25 120.58 15.9 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -132.08 102.67 5.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 107.603 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -84.63 163.75 19.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.483 1.113 . . . . 0.0 108.943 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.26 171.35 25.31 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.5 p -78.6 27.41 0.21 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.85 1.26 . . . . 0.0 113.875 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -52.16 145.32 10.78 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.598 1.159 . . . . 0.0 110.73 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -112.75 10.85 19.3 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.135 1.374 . . . . 0.0 111.956 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -148.67 156.53 42.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.31 1.044 . . . . 0.0 109.787 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.19 117.89 0.61 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.592 0.615 . . . . 0.0 112.033 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 9.7 mtp -76.02 153.0 36.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.886 0.875 . . . . 0.0 112.833 -171.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.71 88.22 1.75 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 128.119 2.568 . . . . 0.0 108.163 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.75 158.99 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.11 2.54 . . . . 0.0 112.073 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.21 18.18 79.48 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.509 -0.744 . . . . 0.0 113.366 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.5 -176.83 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.407 1.883 . . . . 0.0 110.224 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -102.54 147.56 34.2 Favored Pre-proline 0 C--O 1.242 0.689 0 CA-C-N 118.746 0.703 . . . . 0.0 111.229 168.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -73.51 176.8 8.8 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.807 3.005 . . . . 0.0 113.139 171.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 31.2 t80 48.52 29.32 2.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.977 2.511 . . . . 0.0 115.225 170.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.1 m -128.75 -175.44 3.54 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.151 1.38 . . . . 0.0 111.183 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -122.46 152.37 40.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.964 1.306 . . . . 0.0 107.772 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -144.55 158.2 43.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.53 1.132 . . . . 0.0 108.964 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 m -122.75 141.56 51.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.89 149.23 33.86 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.75 2.02 . . . . 0.0 110.181 173.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -137.22 128.17 27.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.038 1.735 . . . . 0.0 108.949 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -89.34 144.21 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -151.96 154.06 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.913 -1.742 . . . . 0.0 108.699 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.59 146.78 5.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.1 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -135.47 -178.31 5.06 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.252 1.021 . . . . 0.0 109.446 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.96 -36.27 89.72 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 121.91 -0.494 . . . . 0.0 112.94 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -75.2 -46.39 34.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.737 0.768 . . . . 0.0 110.427 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.99 -134.44 2.52 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.668 0.667 . . . . 0.0 111.86 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -136.14 165.43 25.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.343 2.257 . . . . 0.0 108.869 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -153.98 8.32 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.37 0.985 . . . . 0.0 112.004 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.29 137.14 50.27 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.865 1.71 . . . . 0.0 109.318 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 162.8 28.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.782 0.801 . . . . 0.0 109.384 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 99.1 p -71.3 171.84 7.95 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.261 -0.9 . . . . 0.0 110.179 168.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -64.18 136.92 54.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.716 1.611 . . . . 0.0 110.379 168.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.5 106.09 0.88 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.226 1.811 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.42 167.25 22.05 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.986 1.314 . . . . 0.0 110.417 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.92 166.36 29.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.114 1.365 . . . . 0.0 108.899 173.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.32 158.76 38.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.784 0.834 . . . . 0.0 109.64 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -112.52 152.98 28.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 126.003 1.721 . . . . 0.0 108.195 171.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 153.68 39.21 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 119.257 0.935 . . . . 0.0 110.887 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.57 -75.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.588 2.859 . . . . 0.0 113.126 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -158.2 -35.23 0.07 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.208 1.403 . . . . 0.0 112.828 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.9 74.27 0.8 Allowed Glycine 0 N--CA 1.452 -0.264 0 O-C-N 121.149 -0.969 . . . . 0.0 110.903 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.4 p 51.23 80.54 0.08 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.651 1.98 . . . . 0.0 111.238 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.38 172.28 22.21 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 162.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -79.41 63.5 8.73 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 125.074 3.849 . . . . 0.0 111.689 -165.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.8 t -63.38 150.73 42.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.344 0.657 . . . . 0.0 110.103 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -143.37 172.12 13.2 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.399 1.88 . . . . 0.0 106.609 174.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 CA-C-O 116.595 -2.225 . . . . 0.0 110.427 -174.7 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.897 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m 46.77 -153.53 0.06 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.388 1.075 . . . . 0.0 109.867 -162.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 t -104.44 178.04 4.67 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.686 1.13 . . . . 0.0 109.401 175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.12 72.52 0.06 OUTLIER Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.066 0.841 . . . . 0.0 111.176 172.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 p 177.56 157.85 0.38 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.738 2.415 . . . . 0.0 108.454 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 m -168.54 67.24 0.07 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.147 1.379 . . . . 0.0 110.393 166.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.24 154.68 30.87 Favored Glycine 0 N--CA 1.471 0.974 0 O-C-N 120.521 -1.362 . . . . 0.0 113.643 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -154.47 149.09 26.39 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.736 1.214 . . . . 0.0 111.788 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 m -84.47 -176.88 6.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.805 2.042 . . . . 0.0 111.808 162.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.24 91.02 1.81 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 167.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.37 -9.11 7.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.726 1.211 . . . . 0.0 112.459 170.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.57 -11.86 12.96 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.507 1.123 . . . . 0.0 109.903 175.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 mt -74.71 153.85 87.28 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 120.214 1.37 . . . . 0.0 109.627 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.06 164.69 24.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.585 1.524 . . . . 0.0 110.354 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.1 mtm -107.77 -35.07 6.78 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.093 0.957 . . . . 0.0 112.023 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.6 m -131.06 160.71 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.318 0.963 . . . . 0.0 111.484 -163.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.57 68.69 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 126.488 1.915 . . . . 0.0 107.807 161.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.61 164.42 11.38 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 109.556 -0.979 . . . . 0.0 109.556 161.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.55 -165.36 2.74 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.445 1.498 . . . . 0.0 113.731 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -54.48 115.94 2.39 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.28 154.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.25 154.5 40.1 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.901 2.08 . . . . 0.0 106.411 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.71 138.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.486 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -124.09 118.9 27.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.312 2.245 . . . . 0.0 105.457 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.7 t -64.8 134.76 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.89 -52.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -141.52 -175.6 4.43 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.241 1.416 . . . . 0.0 109.12 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -33.09 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.366 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.6 p -133.59 36.8 3.33 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.369 1.068 . . . . 0.0 109.519 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -151.81 137.08 17.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.125 0.97 . . . . 0.0 109.701 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.39 138.37 24.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.46 125.24 50.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -99.12 145.35 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.486 ' CD2' HD22 ' A' ' 24' ' ' ASN . 39.3 m-70 -127.8 147.76 50.43 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.278 0.631 . . . . 0.0 109.506 170.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -135.73 -175.08 3.84 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.433 1.493 . . . . 0.0 108.369 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -114.08 136.85 22.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.44 112.44 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.347 2.698 . . . . 0.0 111.704 -172.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -70.52 143.02 89.67 Favored Pre-proline 0 N--CA 1.41 -2.432 0 C-N-CA 124.756 1.222 . . . . 0.0 110.205 -171.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 38' ' ' VAL . 2.5 Cg_endo -62.19 133.44 43.78 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 125.812 4.341 . . . . 0.0 111.864 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.42 -36.3 73.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -52.19 -36.57 52.25 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 p -94.99 -13.97 24.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.41 -34.67 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.477 1.035 . . . . 0.0 109.703 164.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 60.36 6.87 1.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.839 1.656 . . . . 0.0 115.083 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.15 -166.73 23.53 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.398 0.999 . . . . 0.0 110.625 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.27 118.97 13.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.41 HD21 ' H ' ' A' ' 49' ' ' GLY . 2.0 tm? -59.83 122.8 15.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.833 1.253 . . . . 0.0 107.79 167.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.32 -32.88 22.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.756 0.822 . . . . 0.0 111.198 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.41 ' H ' HD21 ' A' ' 47' ' ' LEU . . . 156.32 -178.56 32.75 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -116.56 112.6 21.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.68 109.44 19.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.16 122.74 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -91.97 153.02 19.74 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.462 ' CE1' HD13 ' A' ' 73' ' ' LEU . 33.8 p90 -160.61 159.71 30.81 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.28 1.832 . . . . 0.0 109.482 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -148.99 153.21 37.6 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.695 0.798 . . . . 0.0 110.735 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -68.58 118.6 11.81 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.3 m -89.38 143.9 26.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -124.57 -90.92 0.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.1 t -152.71 156.2 38.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.639 1.576 . . . . 0.0 107.373 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.77 2.58 5.43 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -160.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 t -126.06 112.32 15.73 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 120.086 1.312 . . . . 0.0 108.988 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mttm 37.94 78.31 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 128.736 2.814 . . . . 0.0 112.595 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -129.67 133.92 47.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.99 120.39 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.75 148.77 24.42 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -57.98 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.906 0.776 . . . . 0.0 111.206 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -152.88 165.36 35.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.7 1.6 . . . . 0.0 108.128 -172.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.9 mt -91.55 122.19 42.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.4 127.61 33.09 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 165.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -131.79 156.38 46.09 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.32 1.048 . . . . 0.0 108.984 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -141.06 171.07 14.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.644 0.735 . . . . 0.0 111.76 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.63 148.25 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 106.69 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD13 ' CE1' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -130.3 147.47 52.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.717 2.007 . . . . 0.0 107.722 172.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.4 m -120.29 91.51 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 108.757 -164.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -94.09 76.85 4.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.03 144.74 55.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.319 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.93 167.33 40.15 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.349 0.976 . . . . 0.0 112.528 -175.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -79.57 16.92 0.96 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.324 2.25 . . . . 0.0 115.276 -167.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.07 163.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.794 1.637 . . . . 0.0 113.178 174.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -125.29 9.49 7.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.71 163.8 36.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.412 1.085 . . . . 0.0 108.954 173.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.63 165.66 36.34 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 46.1 mtp -111.91 150.56 30.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.134 0.974 . . . . 0.0 109.457 -168.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.46 79.85 7.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -86.75 162.37 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 110.247 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.18 74.4 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.935 0.779 . . . . 0.0 113.341 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -93.7 171.22 9.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.667 1.587 . . . . 0.0 108.723 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.2 156.74 35.5 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 124.359 1.064 . . . . 0.0 110.12 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -82.7 177.25 7.04 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 124.481 3.454 . . . . 0.0 112.957 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.9 t80 38.24 57.32 1.66 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.724 2.81 . . . . 0.0 111.85 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.5 m -149.98 157.79 43.51 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.378 1.871 . . . . 0.0 109.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -90.62 150.72 21.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -134.93 154.83 51.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.886 1.274 . . . . 0.0 108.162 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.2 m -125.93 138.88 53.8 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 172.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.47 162.85 35.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.388 2.275 . . . . 0.0 109.697 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -134.45 -176.08 4.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.74 139.52 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.561 1.944 . . . . 0.0 106.394 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -140.89 128.82 21.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.683 1.193 . . . . 0.0 107.798 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 m -74.65 153.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.6 t -138.03 150.03 24.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 171.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -138.95 -168.9 2.52 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 109.123 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.88 4.5 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.456 -1.191 . . . . 0.0 116.036 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.02 -47.89 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.182 1.991 . . . . 0.0 111.358 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.3 -166.66 34.46 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 120.689 1.586 . . . . 0.0 113.427 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -95.58 167.85 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.884 1.273 . . . . 0.0 110.259 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -128.6 -157.32 9.26 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.617 1.579 . . . . 0.0 112.582 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.06 150.48 82.51 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.917 2.411 . . . . 0.0 110.222 177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.43 164.6 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.089 0.947 . . . . 0.0 112.131 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 p -69.19 177.22 1.25 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.247 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.98 146.87 15.91 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.73 1.62 . . . . 0.0 110.087 158.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.78 100.5 6.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 168.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.9 mmt-85 -76.57 162.98 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.872 -0.518 . . . . 0.0 110.267 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.78 157.37 38.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.333 0.653 . . . . 0.0 110.046 174.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -150.49 146.74 26.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.382 1.073 . . . . 0.0 109.245 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -109.75 145.11 37.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.355 1.062 . . . . 0.0 108.4 169.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.72 169.2 19.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.775 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -68.23 -75.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.451 2.101 . . . . 0.0 109.266 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -172.45 -39.14 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.212 1.405 . . . . 0.0 110.592 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.88 147.11 8.56 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.718 1.628 . . . . 0.0 112.258 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 42.7 23.31 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.524 3.13 . . . . 0.0 118.743 175.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.94 162.51 28.79 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.911 -1.118 . . . . 0.0 110.326 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.97 167.33 26.98 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.735 2.957 . . . . 0.0 112.162 -170.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.8 m -143.0 111.4 6.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 163.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.17 148.63 16.97 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 164.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.647 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 -172.886 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.3 169.15 12.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.522 1.482 . . . . 0.0 113.261 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mtm -132.91 -40.53 0.94 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.986 0.914 . . . . 0.0 113.413 -165.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.587 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.6 m -135.32 168.66 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.01 166.1 12.56 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 126.754 2.021 . . . . 0.0 109.374 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 32.5 Cg_endo -70.98 141.6 40.66 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.332 1.355 . . . . 0.0 114.44 -166.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.63 178.56 23.86 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.506 1.526 . . . . 0.0 111.726 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 23.65 66.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.877 3.271 . . . . 0.0 114.477 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 112' ' ' ARG . 18.3 t -76.27 132.53 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.46 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -148.23 166.48 27.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.442 1.497 . . . . 0.0 109.44 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.51 141.61 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 120.78 -1.2 . . . . 0.0 108.62 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.0 119.25 29.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.224 2.61 . . . . 0.0 109.225 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.72 130.21 35.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 119.196 0.907 . . . . 0.0 108.851 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.32 -64.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 126.139 1.776 . . . . 0.0 107.993 -171.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -115.88 179.16 4.06 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.589 1.156 . . . . 0.0 108.065 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -18.3 61.52 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.224 -0.922 . . . . 0.0 112.768 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -126.35 0.27 7.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.323 1.849 . . . . 0.0 112.687 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -139.16 128.1 23.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.695 1.598 . . . . 0.0 108.207 -170.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.94 172.57 8.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.65 117.29 13.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 152.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -132.47 148.81 52.41 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.549 1.54 . . . . 0.0 109.138 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -160.28 164.89 32.27 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.662 1.585 . . . . 0.0 109.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -87.83 145.24 36.31 Favored Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 120.942 -1.099 . . . . 0.0 112.034 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.31 102.58 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.854 3.036 . . . . 0.0 111.095 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 4.6 m -64.26 158.88 62.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 10.7 Cg_endo -72.77 144.86 39.93 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.317 3.345 . . . . 0.0 110.229 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.3 mp -56.08 -30.72 62.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.243 0.474 . . . . 0.0 111.143 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -56.75 -28.49 61.27 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.587 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.6 p -89.58 -29.81 18.62 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 111.459 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.625 HD13 ' HB2' ' A' ' 47' ' ' LEU . 81.9 mt -67.83 -38.44 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.331 1.053 . . . . 0.0 109.071 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 50.01 80.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.639 1.575 . . . . 0.0 110.606 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.61 -102.76 0.83 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -138.22 103.58 4.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.6 -166.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.625 ' HB2' HD13 ' A' ' 43' ' ' ILE . 37.0 tp -54.88 119.62 5.65 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 127.006 2.123 . . . . 0.0 109.393 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -86.72 -48.7 8.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.078 0.951 . . . . 0.0 108.941 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.26 173.0 45.98 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -99.93 136.13 40.31 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 161.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -105.7 152.09 23.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.9 mt -126.4 126.2 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.45 141.28 28.7 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -153.02 159.95 42.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.543 1.137 . . . . 0.0 110.962 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -148.46 158.27 44.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.357 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -68.94 127.32 32.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.641 1.576 . . . . 0.0 106.87 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.93 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttt . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.25 149.38 28.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.94 144.7 50.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 128.665 2.786 . . . . 0.0 107.533 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.5 m -130.52 117.14 19.16 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -128.67 85.74 2.37 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.278 1.031 . . . . 0.0 109.011 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -67.54 147.09 53.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.053 0.541 . . . . 0.0 110.245 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.61 167.55 26.24 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 122.705 1.17 . . . . 0.0 111.409 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -87.55 44.37 1.18 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -151.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 167.02 3.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.396 0.617 . . . . 0.0 111.304 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 p -124.53 -1.97 7.99 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.701 1.6 . . . . 0.0 111.355 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -148.61 160.7 42.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.172 1.389 . . . . 0.0 107.39 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.02 134.24 3.26 Favored Glycine 0 N--CA 1.454 -0.162 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.6 mtp -81.67 153.47 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.038 0.419 . . . . 0.0 111.338 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 87' ' ' LEU . 1.5 mm? -106.92 91.08 5.9 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 167.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.87 154.92 2.27 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.953 3.102 . . . . 0.0 111.92 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.19 37.08 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.468 HD21 HD12 ' A' ' 84' ' ' LEU . 3.4 mm? -105.02 -166.41 1.23 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.402 3.081 . . . . 0.0 107.329 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -121.97 146.79 47.19 Favored Pre-proline 0 N--CA 1.45 -0.466 0 O-C-N 120.918 -1.114 . . . . 0.0 111.323 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 167.63 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.265 3.31 . . . . 0.0 111.963 163.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.262 0.3 OUTLIER 40.12 42.1 1.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.841 2.456 . . . . 0.0 111.525 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -133.62 153.12 51.91 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.557 -1.34 . . . . 0.0 108.44 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -94.14 146.53 23.92 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.11 153.99 51.82 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.8 m -126.64 143.71 51.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.08 163.12 39.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.354 1.861 . . . . 0.0 109.714 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -152.76 151.72 30.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 110.216 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.59 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.913 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -137.37 138.5 39.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.096 1.359 . . . . 0.0 108.326 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.12 152.41 3.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 64.0 t -137.36 134.94 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -128.3 -174.95 3.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.433 1.093 . . . . 0.0 109.713 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.72 -7.33 41.05 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.339 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.93 -38.93 5.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.95 1.7 . . . . 0.0 110.541 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.04 -173.27 45.13 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 110.638 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 166.78 22.81 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.34 -0.506 . . . . 0.0 110.814 164.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 -158.42 10.38 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 160.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.75 158.06 44.29 Favored 'Trans proline' 0 C--O 1.237 0.428 0 CA-C-N 119.886 1.843 . . . . 0.0 112.586 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.4 143.35 26.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.639 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.23 175.18 2.96 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 126.064 1.746 . . . . 0.0 111.185 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.35 137.48 65.61 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.731 1.621 . . . . 0.0 109.353 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.73 153.92 27.0 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.271 1.034 . . . . 0.0 110.729 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 21' ' ' VAL . 74.4 mmt-85 -134.5 170.54 15.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 107.687 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.6 m -135.27 157.01 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.786 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -153.72 143.03 21.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -112.4 137.69 50.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 170.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -92.16 151.21 41.49 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.16 -73.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.846 3.031 . . . . 0.0 113.265 -159.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -154.0 -41.31 0.09 Allowed 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.562 0 CA-C-O 119.287 -0.729 . . . . 0.0 111.701 -167.874 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 119.131 -0.462 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.9 -175.78 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.295 2.663 . . . . 0.0 112.807 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 42.5 mtm -126.51 -59.37 1.3 Allowed 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 110.467 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 42' ' ' SER . 35.1 m -122.21 148.93 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.605 0.717 . . . . 0.0 111.635 -168.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.75 168.4 18.47 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.003 2.121 . . . . 0.0 109.912 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 2.0 Cg_endo -61.01 155.82 48.04 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.345 1.363 . . . . 0.0 113.308 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.34 -175.49 30.24 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.115 1.34 . . . . 0.0 111.088 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -36.09 103.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 127.476 2.311 . . . . 0.0 113.757 -163.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.56 139.73 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.27 156.44 45.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -146.46 118.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 119.214 0.915 . . . . 0.0 109.285 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -96.7 121.41 38.52 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.465 1.106 . . . . 0.0 109.202 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.0 t -86.5 108.62 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.603 ' HB ' HD12 ' A' ' 30' ' ' LEU . 40.2 t -71.1 -56.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.765 0.826 . . . . 0.0 108.885 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.19 -174.3 3.29 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.13 0.972 . . . . 0.0 109.674 -163.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -27.84 67.76 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.623 -0.673 . . . . 0.0 112.136 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.4 p -129.39 7.55 5.38 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.46 1.104 . . . . 0.0 111.795 -166.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.649 HD11 ' CE ' ' A' ' 83' ' ' MET . 3.3 tm? -138.54 139.45 38.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.17 1.788 . . . . 0.0 108.352 -174.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -141.03 173.42 11.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.938 167.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 151.22 51.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.635 1.974 . . . . 0.0 108.877 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 t -126.97 134.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -119.47 128.98 54.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -142.99 -179.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.529 1.132 . . . . 0.0 110.279 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.1 144.58 29.69 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.899 0.879 . . . . 0.0 111.704 -172.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.53 96.47 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.409 2.739 . . . . 0.0 111.192 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 32.4 m -64.03 157.04 71.62 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.052 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 58.7 Cg_endo -77.31 146.01 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.308 2.672 . . . . 0.0 109.358 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.06 -30.75 71.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.759 -0.588 . . . . 0.0 111.798 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -59.3 -34.55 72.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.402 -0.808 . . . . 0.0 111.614 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.77 ' HB2' HG22 ' A' ' 16' ' ' VAL . 60.6 p -64.39 -42.99 95.84 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.494 1.043 . . . . 0.0 110.062 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.7 mt -64.25 -31.52 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.086 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 54.72 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.643 2.377 . . . . 0.0 115.232 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.13 -155.57 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.315 1.912 . . . . 0.0 109.591 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -103.94 109.73 21.6 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.82 1.248 . . . . 0.0 110.874 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -46.29 110.45 0.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 127.092 2.157 . . . . 0.0 109.678 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.421 ' H ' ' HA ' ' A' ' 101' ' ' ASN . 56.2 mm-40 -86.01 -12.91 49.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.627 0.727 . . . . 0.0 111.544 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.15 28.43 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -101.47 155.76 17.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 164.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -122.1 144.6 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.48 120.17 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.86 150.85 20.84 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 163.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.592 ' CE1' HD12 ' A' ' 73' ' ' LEU . 21.2 p90 -158.67 160.23 36.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.695 1.598 . . . . 0.0 109.726 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -149.37 157.44 43.32 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.687 0.795 . . . . 0.0 109.789 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -68.12 125.45 26.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.098 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.8 tttp . . . . . 0 N--CA 1.441 -0.893 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.72 143.15 37.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.592 HD12 ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -129.93 153.44 48.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 107.176 167.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -133.28 127.9 34.64 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 72.8 m-85 -138.11 88.93 2.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.77 0.828 . . . . 0.0 109.386 -172.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -71.36 151.37 44.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.273 1.029 . . . . 0.0 110.286 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.62 164.0 29.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.133 1.349 . . . . 0.0 112.199 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -79.74 58.15 2.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.748 1.619 . . . . 0.0 110.428 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.04 171.08 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.556 1.143 . . . . 0.0 109.924 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 7.23 2.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.973 1.709 . . . . 0.0 111.932 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -144.4 159.57 42.5 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.574 0.75 . . . . 0.0 109.362 167.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.45 148.46 12.06 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.352 1.453 . . . . 0.0 111.266 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.649 ' CE ' HD11 ' A' ' 30' ' ' LEU . 21.4 mtp -77.96 169.51 18.17 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -169.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -127.78 96.32 32.68 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 126.835 2.054 . . . . 0.0 105.851 163.105 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -99.49 161.53 0.57 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.267 2.644 . . . . 0.0 111.702 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.36 35.5 56.33 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.331 -0.856 . . . . 0.0 111.784 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -86.45 161.65 18.52 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.59 130.03 24.12 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.12 166.5 18.65 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.381 2.721 . . . . 0.0 112.232 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 8.9 t80 42.95 52.76 5.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.206 . . . . 0.0 113.346 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -152.08 -178.84 7.02 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.55 1.14 . . . . 0.0 110.879 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 162.59 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.394 1.478 . . . . 0.0 108.651 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -136.03 165.58 25.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.669 1.188 . . . . 0.0 108.721 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 m -125.6 146.46 49.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 157.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -139.72 164.09 30.87 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.466 1.906 . . . . 0.0 108.848 167.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -148.54 144.94 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.824 -0.547 . . . . 0.0 109.903 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.01 152.4 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -149.64 143.21 25.38 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.6 146.58 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.1 t -135.29 142.7 39.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 126.156 1.783 . . . . 0.0 107.215 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 48' ' ' GLN . 16.1 p30 -144.65 -174.29 4.29 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.525 1.13 . . . . 0.0 111.156 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.08 -10.05 31.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.057 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -117.27 -22.95 8.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.929 1.365 . . . . 0.0 112.322 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.0 -153.23 23.87 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -127.13 159.8 33.13 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.745 0.783 . . . . 0.0 110.35 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.84 -165.85 27.08 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.139 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.57 166.37 24.19 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.303 1.335 . . . . 0.0 109.92 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.01 150.07 23.28 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.088 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -75.15 165.36 54.46 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -55.58 123.65 14.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.918 2.412 . . . . 0.0 110.809 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.32 143.21 53.47 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.156 1.782 . . . . 0.0 107.896 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -122.23 163.61 19.31 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.31 166.58 22.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 23' ' ' VAL . 37.5 p90 -158.67 159.49 35.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -117.53 143.45 46.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.77 1.228 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.2 p -98.75 143.4 26.28 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -66.09 167.17 18.71 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.846 2.364 . . . . 0.0 108.969 172.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 18.3 tt0 -61.87 -23.69 66.45 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -163.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -172.107 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 CA--C 1.553 1.067 0 N-CA-C 119.999 3.333 . . . . 0.0 119.999 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.94 161.17 40.71 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.171 2.58 . . . . 0.0 111.878 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 mtm -125.76 -26.59 3.47 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -169.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 42' ' ' SER . 29.3 m -140.6 169.22 15.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.494 1.117 . . . . 0.0 110.862 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.29 163.0 17.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.34 2.256 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.58 156.58 60.11 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.828 1.685 . . . . 0.0 113.393 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 166.86 54.92 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -21.3 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 129.073 2.949 . . . . 0.0 115.356 -162.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.67 130.35 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -118.82 161.14 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.68 138.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -123.79 125.29 44.44 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.421 0.689 . . . . 0.0 110.369 169.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 115' ' ' ASN . 59.3 t -70.39 101.28 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 166.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.0 -56.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.878 2.071 . . . . 0.0 109.759 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -132.34 172.35 12.56 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.187 1.395 . . . . 0.0 107.392 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -64.16 0.93 0.81 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.6 p -133.62 -1.25 3.12 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.301 1.84 . . . . 0.0 112.371 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -149.07 119.81 7.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.396 1.078 . . . . 0.0 109.594 -159.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.31 130.72 48.24 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.577 0.626 . . . . 0.0 109.893 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.24 146.03 39.3 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.69 139.91 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 164.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -120.68 151.79 39.06 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.58 1.552 . . . . 0.0 108.035 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -153.0 155.79 37.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.849 0.46 . . . . 0.0 110.819 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.35 136.72 45.88 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.07 129.59 15.39 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.342 2.695 . . . . 0.0 110.388 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.21 151.86 95.8 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.659 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -85.31 159.82 11.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.938 3.092 . . . . 0.0 110.809 -173.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -60.03 -34.37 73.29 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.031 0.532 . . . . 0.0 111.663 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -66.93 -23.01 65.93 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.825 ' HB2' HG22 ' A' ' 16' ' ' VAL . 41.1 p -76.46 -41.08 48.6 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 120.077 1.308 . . . . 0.0 109.49 170.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.22 -32.7 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.237 1.415 . . . . 0.0 110.146 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 50.22 60.82 3.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.471 1.508 . . . . 0.0 110.142 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.09 -147.87 19.41 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.91 122.83 46.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.381 1.472 . . . . 0.0 110.711 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.38 111.44 0.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.75 2.02 . . . . 0.0 109.802 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -77.5 -13.95 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.694 0.797 . . . . 0.0 112.053 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.16 -164.47 27.94 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.12 148.98 31.51 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 107.91 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -125.9 140.98 52.2 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.2 mt -128.85 122.12 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -91.45 148.16 22.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.1 p90 -158.33 164.54 36.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 111.124 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -149.26 162.23 40.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -68.61 136.09 52.48 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.934 2.093 . . . . 0.0 108.38 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m . . . . . 0 C--N 1.322 -0.6 0 C-N-CA 125.788 1.635 . . . . 0.0 106.881 -175.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 18.4 mttm . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.9 mm -122.84 159.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' CD1' HD13 ' A' ' 84' ' ' LEU . 1.2 mt -130.8 141.29 50.34 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 127.16 2.184 . . . . 0.0 107.233 165.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.7 m -112.9 122.21 46.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.781 1.232 . . . . 0.0 107.809 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 62.5 m-85 -128.64 80.22 1.95 Allowed 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.108 0.963 . . . . 0.0 109.168 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.28 155.68 27.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.86 157.7 33.89 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.583 1.563 . . . . 0.0 111.585 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -79.5 34.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.841 1.257 . . . . 0.0 113.937 -169.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 160.81 14.92 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.538 -1.351 . . . . 0.0 111.865 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.3 p -119.82 7.01 10.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.831 2.053 . . . . 0.0 111.089 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.9 170.67 18.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.009 1.323 . . . . 0.0 109.379 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.16 158.63 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 mtp -97.34 157.9 15.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.897 1.348 . . . . 0.0 112.282 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.51 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.2 mm? -108.06 80.93 1.14 Allowed Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 129.853 3.261 . . . . 0.0 106.236 169.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -86.22 153.09 9.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.648 2.899 . . . . 0.0 110.417 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 23.38 56.74 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.741 1.162 . . . . 0.0 112.316 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 84' ' ' LEU . 3.0 mm? -94.5 166.44 12.05 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 172.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 150.7 55.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.553 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 10.9 Cg_endo -70.29 -178.77 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.911 2.407 . . . . 0.0 111.87 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 53.41 36.87 24.17 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.636 1.175 . . . . 0.0 111.333 164.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 m -146.07 155.68 42.94 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.58 1.552 . . . . 0.0 109.477 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -100.63 153.81 19.11 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -143.2 156.24 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.839 0.856 . . . . 0.0 109.426 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.9 m -125.94 139.01 53.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.07 160.59 39.91 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 110.283 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.21 145.29 24.56 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.497 -0.752 . . . . 0.0 110.816 165.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.87 151.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.931 2.092 . . . . 0.0 107.873 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.28 139.69 18.63 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.39 134.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.366 1.067 . . . . 0.0 110.12 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.45 146.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -133.29 -178.86 5.17 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.287 1.435 . . . . 0.0 109.514 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.43 53.0 2.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.198 0.904 . . . . 0.0 111.267 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -162.78 -31.79 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.383 1.873 . . . . 0.0 109.983 172.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.95 -167.68 35.45 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.158 0.866 . . . . 0.0 113.468 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.28 169.09 12.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.044 2.937 . . . . 0.0 110.213 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.45 -155.26 6.57 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 128.32 2.867 . . . . 0.0 110.047 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 137.33 39.64 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.132 2.555 . . . . 0.0 111.991 -175.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.97 158.55 35.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.535 0.734 . . . . 0.0 110.195 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.6 p -63.21 174.22 0.96 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.939 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -50.72 140.44 37.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 153.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -61.18 106.0 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 161.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -85.96 166.2 16.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.76 157.72 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -152.04 136.78 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.469 ' O ' HG21 ' A' ' 25' ' ' VAL . 3.0 p-10 -86.7 159.69 19.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 161.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.9 p -111.2 162.44 20.83 Favored Pre-proline 0 C--O 1.243 0.727 0 C-N-CA 123.975 0.91 . . . . 0.0 108.862 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.44 166.22 30.43 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.193 1.928 . . . . 0.0 109.044 168.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.33 -21.26 66.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.069 0.948 . . . . 0.0 112.46 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.509 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 176.152 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 C--O 1.234 0.257 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.94 166.77 28.84 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 120.991 1.127 . . . . 0.0 110.158 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.3 mtm -117.86 -44.93 2.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.269 -169.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 42' ' ' SER 0.252 33.5 m -129.96 -175.3 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.749 1.158 . . . . 0.0 111.726 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.67 152.6 69.4 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 128.268 2.627 . . . . 0.0 108.862 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.53 137.75 23.3 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.917 1.745 . . . . 0.0 109.253 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.94 -170.81 28.68 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.1 t30 30.43 56.25 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.464 1.905 . . . . 0.0 112.557 -170.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.44 121.68 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -133.36 155.06 50.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.26 -1.336 . . . . 0.0 107.87 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.446 HG11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -146.46 146.0 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.81 129.92 51.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.42 150.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.213 161.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 t -117.03 -78.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -103.08 -179.83 4.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.408 1.083 . . . . 0.0 108.706 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -17.71 63.14 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.457 -1.402 . . . . 0.0 113.47 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.8 p -133.83 10.15 3.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.889 1.276 . . . . 0.0 112.598 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -130.95 132.35 45.01 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.943 1.697 . . . . 0.0 107.548 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.73 169.2 14.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.651 0.781 . . . . 0.0 109.012 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -126.3 135.75 51.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.493 1.517 . . . . 0.0 107.334 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.22 148.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.57 154.65 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.623 1.969 . . . . 0.0 108.664 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -158.09 171.35 20.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.281 0.632 . . . . 0.0 111.386 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.59 137.52 38.74 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.818 1.647 . . . . 0.0 111.317 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.17 112.78 3.63 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.727 2.951 . . . . 0.0 111.077 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.43 158.66 64.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 122.077 -0.389 . . . . 0.0 110.568 170.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.64 160.63 14.45 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.557 2.838 . . . . 0.0 112.288 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -25.39 67.78 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.404 -0.81 . . . . 0.0 112.871 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -60.69 -49.49 77.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.568 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.707 ' HB2' HG22 ' A' ' 16' ' ' VAL . 51.4 p -66.67 -23.66 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.818 1.19 . . . . 0.0 111.503 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 47' ' ' LEU . 90.5 mt -67.57 -32.88 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.539 172.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 47.09 30.06 1.25 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.412 1.485 . . . . 0.0 113.624 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.6 -148.82 12.35 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.569 -1.332 . . . . 0.0 113.648 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -100.52 112.1 24.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.673 1.589 . . . . 0.0 107.84 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 100' ' ' VAL . 3.1 tm? -65.65 121.74 15.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.466 1.906 . . . . 0.0 109.068 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -80.88 -38.44 28.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.81 -178.21 41.23 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 121.379 -0.826 . . . . 0.0 111.945 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -99.44 124.51 44.65 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -76.79 155.63 32.95 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 160.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.16 124.71 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 156.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.543 ' HA ' HD13 ' A' ' 72' ' ' ILE . 9.0 m-85 -91.22 147.52 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 163.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.598 ' CE1' HD12 ' A' ' 73' ' ' LEU . 33.8 p90 -157.37 163.0 39.07 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.467 1.507 . . . . 0.0 110.265 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -149.08 157.16 43.17 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.762 0.791 . . . . 0.0 111.76 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -67.95 125.66 27.02 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.624 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 53' ' ' TYR . 35.4 mm -132.25 155.02 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.448 0.699 . . . . 0.0 109.685 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD12 ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -135.51 157.5 46.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.957 2.503 . . . . 0.0 108.816 170.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -131.02 116.37 17.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.773 1.229 . . . . 0.0 109.633 -170.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.16 97.6 5.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.922 1.289 . . . . 0.0 107.807 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.92 172.03 12.48 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.236 0.541 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.24 15.1 70.06 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.58 26.19 15.88 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 171.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.5 167.52 0.49 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.049 1.74 . . . . 0.0 112.701 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.6 p -102.92 5.12 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 112.399 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.79 168.07 21.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.225 0.61 . . . . 0.0 110.792 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.13 33.24 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.759 2.123 . . . . 0.0 108.626 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.4 mtp -131.85 167.91 18.77 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.891 1.345 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.0 mm? -123.11 76.42 51.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.914 1.686 . . . . 0.0 107.27 172.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -82.38 151.86 15.58 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.92 2.413 . . . . 0.0 110.88 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.89 18.64 46.57 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.428 0.537 . . . . 0.0 112.043 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 93' ' ' TYR . 3.8 mm? -91.84 -169.55 2.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.972 1.309 . . . . 0.0 110.387 -171.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -125.52 149.33 64.5 Favored Pre-proline 0 CA--C 1.54 0.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.347 178.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 1.1 Cg_endo -77.69 173.97 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.423 2.749 . . . . 0.0 112.851 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.1 t80 44.26 53.23 6.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.194 1.798 . . . . 0.0 111.868 172.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m -155.85 146.64 22.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 120.963 -1.086 . . . . 0.0 110.686 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -78.77 151.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.13 0.972 . . . . 0.0 108.876 171.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CE2' HD12 ' A' ' 87' ' ' LEU . 56.4 m-85 -143.7 154.93 43.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.632 1.573 . . . . 0.0 108.113 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.5 m -117.13 147.83 42.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 171.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.446 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -150.6 158.75 44.52 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.66 1.984 . . . . 0.0 110.141 171.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.75 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.3 155.83 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 107.622 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -152.4 142.12 21.92 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 119.832 -1.793 . . . . 0.0 108.686 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 m -81.51 148.21 5.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.488 ' O ' HD22 ' A' ' 47' ' ' LEU . 85.4 t -136.44 136.57 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -136.24 -171.12 2.81 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.378 0.671 . . . . 0.0 110.22 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.67 -15.98 14.64 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.213 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -111.58 -46.99 3.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.117 1.958 . . . . 0.0 111.191 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.04 -170.17 34.12 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.363 0.983 . . . . 0.0 112.406 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -108.16 145.56 33.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 109.467 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.92 -165.23 31.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.906 1.241 . . . . 0.0 114.014 -168.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.71 133.58 49.03 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.252 1.968 . . . . 0.0 108.879 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.29 157.46 16.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.722 0.773 . . . . 0.0 109.977 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 p -67.79 165.46 31.1 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 156.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -63.47 152.91 77.86 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.356 1.37 . . . . 0.0 109.642 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.48 96.91 4.83 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.294 2.238 . . . . 0.0 105.94 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -76.69 168.46 20.04 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.1 1.36 . . . . 0.0 109.562 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.27 164.8 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.201 0.6 . . . . 0.0 111.306 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -160.14 156.47 26.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.942 2.097 . . . . 0.0 108.085 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -122.13 141.37 51.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.324 1.05 . . . . 0.0 109.758 165.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.409 ' HB ' ' HA ' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -74.2 154.25 88.34 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 123.619 0.574 . . . . 0.0 110.792 173.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.41 -73.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.802 3.001 . . . . 0.0 111.403 -168.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.68 -39.77 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.264 0 CA-C-N 118.817 0.735 . . . . 0.0 111.456 -166.929 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 mt . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -66.93 157.31 62.17 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.484 2.123 . . . . 0.0 112.152 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 mtm -112.0 -28.16 8.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -168.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.2 m -143.49 175.98 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.746 1.618 . . . . 0.0 108.052 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -120.06 167.45 12.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.204 2.202 . . . . 0.0 108.776 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HD3' HG23 ' A' ' 99' ' ' VAL . 18.7 Cg_endo -68.27 113.85 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.436 2.091 . . . . 0.0 111.882 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.14 157.07 12.83 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 41.46 62.01 1.65 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.622 1.569 . . . . 0.0 110.326 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -55.46 146.58 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 157.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -140.85 161.32 38.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -147.3 146.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 O-C-N 119.725 -1.859 . . . . 0.0 109.057 169.306 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -123.98 151.28 43.84 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.099 2.56 . . . . 0.0 107.732 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.71 145.02 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 30' ' ' LEU . 99.5 t -111.73 -57.78 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -171.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -125.45 -173.35 2.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.031 1.333 . . . . 0.0 107.593 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.441 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -68.0 -31.89 71.9 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.863 -1.148 . . . . 0.0 112.377 175.102 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.8 p -122.5 13.13 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 111.008 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.748 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.0 tm? -134.66 139.27 45.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.516 1.926 . . . . 0.0 107.804 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -144.05 170.14 16.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.34 117.36 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.67 145.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.77 159.2 27.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 108.054 173.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -161.51 162.07 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.493 1.042 . . . . 0.0 110.635 169.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -85.3 135.13 39.35 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.63 116.76 4.55 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.069 3.179 . . . . 0.0 111.559 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 34.7 m -72.78 158.02 87.89 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.957 -0.465 . . . . 0.0 112.218 -175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 60.5 Cg_endo -83.44 149.81 13.15 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.951 3.101 . . . . 0.0 111.384 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.6 mp -59.09 -26.63 64.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.873 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -60.33 -52.11 66.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 111.189 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.764 ' HB2' HG22 ' A' ' 16' ' ' VAL . 13.5 p -73.91 -23.25 59.53 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 47' ' ' LEU . 84.7 mt -66.05 -26.71 38.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 118.276 -0.868 . . . . 0.0 109.938 167.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? 72.77 -49.74 0.7 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.335 2.654 . . . . 0.0 113.956 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.19 -99.36 1.31 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.639 1.114 . . . . 0.0 112.007 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -137.84 105.34 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.384 1.874 . . . . 0.0 109.227 -169.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.2 tp -59.27 131.46 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -95.65 -24.01 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.101 1.36 . . . . 0.0 110.847 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.71 -153.99 25.56 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -127.83 123.45 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.855 1.662 . . . . 0.0 106.564 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.61 106.0 17.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mt -78.73 118.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -92.49 143.2 26.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.589 ' CE1' HD12 ' A' ' 73' ' ' LEU . 35.8 p90 -154.79 170.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.864 1.211 . . . . 0.0 111.849 172.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -149.66 164.59 34.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.589 1.155 . . . . 0.0 110.44 165.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -68.61 137.62 54.39 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.09 1.356 . . . . 0.0 108.024 164.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 83.0 m . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 172.413 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.407 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 6.9 mmtt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 122.056 0.931 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -132.91 150.36 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.405 2.282 . . . . 0.0 106.895 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.589 HD12 ' CE1' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -145.18 100.64 3.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.535 1.934 . . . . 0.0 107.864 177.095 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 m -71.62 109.29 5.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 59.1 m-85 -108.69 94.42 5.04 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.73 164.88 11.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.829 168.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.56 153.55 28.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -83.39 37.59 0.57 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.128 1.371 . . . . 0.0 111.154 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 170.76 3.53 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.887 2.075 . . . . 0.0 112.19 171.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -133.96 2.45 3.38 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 126.045 1.738 . . . . 0.0 110.614 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -158.32 142.08 15.44 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.111 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.92 138.85 8.03 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -172.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.748 ' HE2' HD11 ' A' ' 30' ' ' LEU . 39.8 mtp -77.23 163.03 26.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.002 0.921 . . . . 0.0 110.887 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.2 mm? -126.5 82.82 65.79 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.133 1.373 . . . . 0.0 107.546 168.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -90.75 154.06 4.14 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.823 2.349 . . . . 0.0 111.795 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.41 51.44 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.457 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.82 -177.7 4.61 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.351 1.46 . . . . 0.0 108.478 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.51 139.68 36.23 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.823 0.849 . . . . 0.0 108.974 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.62 178.4 7.16 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.966 3.111 . . . . 0.0 112.886 -172.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.7 t80 50.89 23.17 1.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.868 2.867 . . . . 0.0 113.514 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.9 m -123.06 157.06 33.62 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.49 1.516 . . . . 0.0 110.351 -172.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -96.83 151.78 19.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -142.07 156.37 45.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.325 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.9 m -126.03 136.12 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -135.69 166.68 22.69 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.743 1.617 . . . . 0.0 109.895 170.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.67 153.08 34.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.838 2.055 . . . . 0.0 106.578 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -121.07 137.54 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.807 1.243 . . . . 0.0 108.465 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.1 ttm105 -135.17 131.36 36.67 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.44 1.496 . . . . 0.0 108.421 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.512 HG23 ' HD3' ' A' ' 18' ' ' PRO 0.25 0.8 OUTLIER -70.99 140.19 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 127.933 2.493 . . . . 0.0 108.013 176.464 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.07 138.58 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -136.99 -175.6 4.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.758 0.823 . . . . 0.0 111.001 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.71 69.77 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.804 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -82.53 -40.25 21.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.973 1.309 . . . . 0.0 110.835 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.36 -165.96 34.05 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 121.943 0.746 . . . . 0.0 111.983 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.44 157.29 20.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.062 0.945 . . . . 0.0 112.534 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.91 -157.99 10.29 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.113 1.339 . . . . 0.0 111.039 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.86 166.57 22.12 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.013 1.809 . . . . 0.0 111.684 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.29 154.05 19.11 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.246 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 5.6 m -70.19 -174.85 0.26 Allowed Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.733 1.613 . . . . 0.0 110.871 173.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 109' ' ' SER . 29.7 Cg_endo -68.35 161.4 44.93 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 CA-C-N 122.307 1.86 . . . . 0.0 109.532 167.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.69 162.09 24.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.258 1.027 . . . . 0.0 109.066 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -132.39 162.36 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.739 1.216 . . . . 0.0 108.271 166.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 159.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.87 147.07 29.36 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.71 144.48 42.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.11 160.73 29.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 110.317 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.76 168.66 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 N-CA-C 108.879 -1.239 . . . . 0.0 108.879 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -61.62 -29.43 70.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.679 0.791 . . . . 0.0 112.116 -174.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 28' ' ' SER . . . . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 125.709 1.624 . . . . 0.0 115.511 163.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.42 -174.33 1.95 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.773 1.649 . . . . 0.0 111.386 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.5 mtm -133.62 -47.03 0.81 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.337 1.455 . . . . 0.0 113.218 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 42' ' ' SER . 14.7 m -131.94 -178.42 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 118.858 0.754 . . . . 0.0 110.196 -169.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.45 164.17 19.25 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 126.487 1.915 . . . . 0.0 109.597 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.21 144.6 75.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.459 1.44 . . . . 0.0 112.482 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.61 170.28 4.93 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.997 1.284 . . . . 0.0 111.468 166.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -49.23 142.44 7.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -147.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.79 121.11 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.157 1.783 . . . . 0.0 106.976 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -122.71 88.29 2.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.715 1.606 . . . . 0.0 111.312 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG13 ' HE ' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -87.45 143.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 157.16 35.47 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.78 2.032 . . . . 0.0 110.089 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.39 103.49 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.65 -54.08 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.656 1.182 . . . . 0.0 109.312 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -138.33 -179.88 6.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.699 1.2 . . . . 0.0 107.864 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -23.46 56.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.269 1.028 . . . . 0.0 111.25 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -122.17 -2.06 9.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.105 2.162 . . . . 0.0 112.694 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 tp -144.01 130.0 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.308 1.443 . . . . 0.0 109.619 -170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.28 117.45 8.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.172 0.896 . . . . 0.0 111.041 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.17 154.7 41.62 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.549 1.14 . . . . 0.0 110.305 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.95 103.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.809 2.043 . . . . 0.0 106.121 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -92.08 154.2 18.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.108 0.413 . . . . 0.0 110.082 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -151.02 177.63 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 110.124 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.86 142.27 25.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.71 122.93 10.4 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.284 2.656 . . . . 0.0 109.65 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.1 164.57 55.75 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 118.887 0.767 . . . . 0.0 110.45 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -64.61 138.93 61.45 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.221 1.947 . . . . 0.0 109.15 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -31.1 41.01 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.822 0.283 . . . . 0.0 111.228 166.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -50.27 -46.99 55.51 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.182 1.393 . . . . 0.0 110.881 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.811 ' HB2' HG22 ' A' ' 16' ' ' VAL . 61.6 p -71.49 -29.48 64.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.46 -20.21 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.672 0.789 . . . . 0.0 109.486 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 45.33 57.06 5.1 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.038 2.135 . . . . 0.0 110.419 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.16 -102.55 0.33 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.444 -1.198 . . . . 0.0 111.427 173.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -138.18 119.66 14.9 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.316 1.047 . . . . 0.0 110.217 -164.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.46 124.71 23.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.451 1.5 . . . . 0.0 109.119 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -92.74 -14.38 28.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.888 0.475 . . . . 0.0 112.098 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 176.37 22.87 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 126.604 2.049 . . . . 0.0 108.25 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.75 151.64 21.01 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -127.9 109.19 11.35 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.904 -1.123 . . . . 0.0 108.939 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.05 133.6 30.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -104.5 147.77 27.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 152.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.81 158.93 40.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.694 1.198 . . . . 0.0 111.268 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.1 p90 -148.71 161.91 40.8 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.947 0.899 . . . . 0.0 110.253 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -68.38 136.26 53.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.2 m . . . . . 0 C--N 1.323 -0.57 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.523 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.4 tttt . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.15 155.7 41.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 84' ' ' LEU . 3.8 mt -133.12 165.93 23.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.206 1.402 . . . . 0.0 108.864 170.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.5 m -138.54 105.29 5.36 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.593 -0.692 . . . . 0.0 109.679 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -116.77 93.0 4.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -72.86 166.86 22.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.549 0.69 . . . . 0.0 109.76 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.89 173.25 47.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 p -73.8 11.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.003 2.121 . . . . 0.0 114.769 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -64.43 156.12 30.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.438 1.095 . . . . 0.0 109.856 -167.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.6 p -118.08 8.99 12.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.208 1.403 . . . . 0.0 111.307 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -150.12 158.87 44.61 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.627 0.771 . . . . 0.0 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.72 143.6 6.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.953 0.787 . . . . 0.0 111.409 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.8 mtp -97.46 153.11 18.33 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.892 -0.769 . . . . 0.0 112.551 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD13 HD11 ' A' ' 73' ' ' LEU . 3.0 mm? -100.32 87.13 0.72 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.52 2.328 . . . . 0.0 109.143 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.42 162.42 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.252 2.634 . . . . 0.0 111.163 171.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.58 21.04 79.32 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.716 -0.615 . . . . 0.0 112.603 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.97 172.64 9.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.829 1.252 . . . . 0.0 107.803 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.53 161.26 49.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 124.769 1.228 . . . . 0.0 108.848 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -89.77 160.84 5.14 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 125.091 3.861 . . . . 0.0 115.086 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 65.1 44.82 3.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.496 3.518 . . . . 0.0 117.613 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.58 -169.39 2.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.992 2.117 . . . . 0.0 109.97 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -110.45 163.83 13.3 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 158.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.44 152.89 46.03 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.516 -0.74 . . . . 0.0 109.883 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.8 m -126.0 139.43 53.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -145.3 162.88 36.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.995 2.118 . . . . 0.0 107.18 172.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -137.35 -176.26 4.34 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.126 0.971 . . . . 0.0 108.937 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.25 160.15 41.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -154.31 154.21 32.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 106.193 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.48 145.39 8.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.0 t -129.22 139.42 51.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -133.33 -177.97 4.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.833 0.853 . . . . 0.0 109.787 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.54 7.49 3.75 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.098 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -122.05 -57.17 1.8 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.861 1.331 . . . . 0.0 110.327 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.73 -156.79 8.52 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -170.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 163.02 29.56 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.313 1.045 . . . . 0.0 110.917 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.32 -158.11 10.76 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.453 1.025 . . . . 0.0 111.978 -166.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.23 158.66 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.569 2.179 . . . . 0.0 111.807 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.58 156.51 25.14 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.941 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.9 p -64.82 -178.17 0.25 Allowed Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.183 166.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -48.33 132.69 24.42 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.591 -1.349 . . . . 0.0 108.591 145.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.22 157.6 19.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 155.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.507 ' HE ' HG13 ' A' ' 23' ' ' VAL . 3.2 mmm180 -126.21 168.55 13.92 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 123.824 0.85 . . . . 0.0 108.961 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -115.57 155.43 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.505 171.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -144.19 142.78 30.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 160.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -114.77 148.28 38.6 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.269 1.427 . . . . 0.0 107.437 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -111.79 162.61 20.42 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 110.421 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.62 170.54 18.35 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.248 1.966 . . . . 0.0 110.177 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.62 -31.32 67.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.902 1.281 . . . . 0.0 111.389 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.662 0 C-N-CA 126.225 1.869 . . . . 0.0 112.128 176.946 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.72 161.7 44.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.724 2.283 . . . . 0.0 111.329 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.7 mtm -108.45 -41.39 4.86 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.539 1.136 . . . . 0.0 112.797 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 42' ' ' SER . 4.7 m -132.25 152.56 36.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.535 0.683 . . . . 0.0 109.432 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.96 168.43 21.9 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 108.339 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 1.6 Cg_endo -60.68 155.63 47.32 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 119.362 0.808 . . . . 0.0 110.635 165.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.25 -155.78 0.76 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.761 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -45.71 128.77 8.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.52 1.128 . . . . 0.0 111.28 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.4 t -105.08 145.43 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -120.96 150.73 40.66 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.48 119.5 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 174.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 130.05 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG11 ' HD3' ' A' ' 117' ' ' PRO . 66.2 t -76.8 118.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -85.63 -52.57 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.501 1.52 . . . . 0.0 107.606 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -136.33 177.73 7.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.337 1.455 . . . . 0.0 109.611 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -38.21 54.4 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.072 1.349 . . . . 0.0 112.608 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -113.61 5.95 16.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.402 1.081 . . . . 0.0 111.692 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 tp -137.39 125.2 22.52 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.712 -168.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.91 157.48 27.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 160.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -98.73 150.81 21.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 163.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 HD23 ' A' ' 84' ' ' LEU . 16.5 t -130.5 139.72 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.542 1.537 . . . . 0.0 107.54 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -128.81 135.4 49.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.348 2.259 . . . . 0.0 105.234 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -140.85 -170.87 3.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.13 0.972 . . . . 0.0 108.967 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -119.77 135.32 24.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.523 1.129 . . . . 0.0 110.321 -167.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.38 96.41 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.509 2.806 . . . . 0.0 110.606 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 19.7 m -63.78 156.08 74.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.392 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.03 149.74 32.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.558 2.172 . . . . 0.0 109.961 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.53 -39.05 72.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.39 1.076 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -58.64 -30.28 67.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.612 ' HB2' HG22 ' A' ' 16' ' ' VAL . 54.1 p -71.68 -37.89 70.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.806 0.73 . . . . 0.0 110.315 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.0 mt -63.34 -27.53 43.24 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.638 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 56.1 13.91 1.32 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.754 1.622 . . . . 0.0 113.393 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.75 -177.85 48.57 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -162.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 111.54 19.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.768 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 tp -44.89 132.01 6.9 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.038 2.135 . . . . 0.0 110.383 168.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -117.48 -12.08 10.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.027 1.331 . . . . 0.0 112.54 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.58 -171.05 30.45 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.529 1.538 . . . . 0.0 110.482 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -114.8 159.65 20.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.984 0.514 . . . . 0.0 109.808 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -127.31 147.42 50.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.842 1.257 . . . . 0.0 108.072 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.0 mt -120.17 124.53 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 162.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -97.22 145.78 25.73 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 160.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.428 ' CD1' HD11 ' A' ' 84' ' ' LEU . 34.0 p90 -155.91 161.25 40.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 109.556 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -149.1 157.32 43.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.399 0.68 . . . . 0.0 109.893 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 93' ' ' TYR . 12.0 tptm -68.8 140.21 55.27 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -175.342 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.4 tttt . . . . . 0 N--CA 1.438 -1.054 0 CA-C-O 119.89 -0.1 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.62 158.33 43.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 122.563 1.173 . . . . 0.0 110.374 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.552 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -141.83 130.99 23.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.319 2.248 . . . . 0.0 108.017 166.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -86.7 145.58 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.309 1.444 . . . . 0.0 108.181 171.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 55.3 m-85 -139.95 161.15 38.28 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.285 1.034 . . . . 0.0 110.344 167.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -77.57 171.27 15.18 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.668 1.223 . . . . 0.0 112.148 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 151.66 36.18 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.812 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 t 62.91 -6.38 0.17 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.167 2.187 . . . . 0.0 115.736 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -67.25 146.35 54.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 120.527 -1.358 . . . . 0.0 107.444 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 p -110.23 7.77 23.34 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.249 1.419 . . . . 0.0 112.255 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.12 167.33 25.3 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.403 0.547 . . . . 0.0 112.037 168.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.61 -172.16 33.57 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 128.652 3.025 . . . . 0.0 107.396 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.9 mtp -129.84 169.29 15.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.968 1.384 . . . . 0.0 111.689 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.552 HD13 ' CD1' ' A' ' 73' ' ' LEU . 4.0 mm? -119.01 84.54 26.75 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 164.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -88.8 157.62 6.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.832 3.021 . . . . 0.0 111.326 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.67 14.33 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.284 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 84' ' ' LEU . 2.8 mm? -73.8 -179.35 3.61 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.573 1.549 . . . . 0.0 108.95 174.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.16 147.91 37.95 Favored Pre-proline 0 C--O 1.237 0.405 0 CA-C-N 118.528 0.604 . . . . 0.0 111.624 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -70.17 173.28 11.58 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.312 2.674 . . . . 0.0 113.022 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.413 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 26.6 t80 48.55 36.97 8.27 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.025 2.13 . . . . 0.0 113.35 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -137.42 142.4 41.66 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 120.661 -1.274 . . . . 0.0 111.807 -169.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -79.47 146.65 32.62 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 161.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.417 ' CZ ' ' HD2' ' A' ' 56' ' ' LYS . 56.3 m-85 -139.0 148.58 43.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 167.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.1 m -115.07 154.14 29.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.68 163.8 38.33 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.96 1.704 . . . . 0.0 109.519 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -140.66 157.64 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.286 1.034 . . . . 0.0 108.936 164.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.72 143.76 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.66 147.33 42.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.31 148.68 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.7 137.92 51.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.463 1.505 . . . . 0.0 107.154 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -141.77 178.18 7.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.282 1.033 . . . . 0.0 109.292 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.22 -1.93 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.296 0.95 . . . . 0.0 114.667 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -123.18 -26.01 4.4 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.299 1.44 . . . . 0.0 110.997 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.46 -159.27 31.87 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-O 121.691 0.606 . . . . 0.0 111.853 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -132.72 124.89 29.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -160.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.39 -160.93 13.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 -165.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.04 171.37 11.39 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 118.997 1.398 . . . . 0.0 109.312 163.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.31 165.45 12.68 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 85.9 p -67.86 -178.04 0.36 Allowed Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 125.525 1.53 . . . . 0.0 111.034 -164.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 22.5 Cg_endo -50.94 134.11 41.59 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 N-CA-C 108.485 -1.39 . . . . 0.0 108.485 149.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.44 141.32 56.56 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.05 169.18 9.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -135.25 150.23 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -156.93 141.04 16.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.156 0.982 . . . . 0.0 108.529 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -120.37 128.4 53.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.536 1.534 . . . . 0.0 109.043 175.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -82.43 158.86 65.6 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 123.946 0.898 . . . . 0.0 110.039 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HD3' HG11 ' A' ' 25' ' ' VAL . 31.3 Cg_endo -67.68 -89.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.938 3.092 . . . . 0.0 112.383 -167.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 28.3 tt0 -151.0 -31.14 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.217 1.371 . . . . 0.0 112.631 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 C-N-CA 125.279 1.419 . . . . 0.0 112.649 -179.555 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -61.37 140.75 89.71 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.752 2.301 . . . . 0.0 113.638 -171.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.5 mtm -79.78 -43.54 22.31 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 125.128 1.371 . . . . 0.0 112.57 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.66 HG22 ' CB ' ' A' ' 42' ' ' SER . 9.5 m -138.08 165.93 24.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.23 0.538 . . . . 0.0 111.279 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -95.22 172.19 5.68 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 109.84 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 27.9 Cg_endo -65.25 169.52 12.16 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.468 2.112 . . . . 0.0 113.223 174.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.31 172.47 55.22 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.922 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -51.04 107.59 0.19 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 113.501 -157.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.21 152.08 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.862 2.065 . . . . 0.0 109.259 -172.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -141.86 156.53 45.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.139 1.776 . . . . 0.0 107.16 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 143.42 20.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 120.893 -1.129 . . . . 0.0 110.373 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -123.69 128.57 49.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.514 2.326 . . . . 0.0 108.835 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -82.26 122.31 36.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 30' ' ' LEU . 50.4 t -81.53 -50.52 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -153.29 -172.48 4.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.302 0.572 . . . . 0.0 110.182 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -35.55 66.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.785 0.834 . . . . 0.0 112.191 -171.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.5 p -127.74 18.59 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.706 1.202 . . . . 0.0 111.204 -168.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.583 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.3 tm? -145.81 140.22 26.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.623 1.569 . . . . 0.0 110.94 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -140.19 167.62 21.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.948 1.299 . . . . 0.0 108.237 169.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 145.68 50.92 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.003 1.721 . . . . 0.0 109.993 174.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.451 HG21 HD23 ' A' ' 84' ' ' LEU . 23.4 t -130.56 133.35 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -166.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.24 149.36 43.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.486 ' CZ3' HD11 ' A' ' 52' ' ' ILE . 34.3 p90 -147.98 154.29 40.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.84 142.13 28.8 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 123.76 11.38 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.283 2.655 . . . . 0.0 110.551 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 ' H ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -51.22 163.31 0.55 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 124.309 1.043 . . . . 0.0 110.73 160.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.76 -134.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 1 C-N-CA 126.738 4.959 . . . . 0.0 107.627 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.67 -31.64 1.76 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 117.476 -1.25 . . . . 0.0 111.446 161.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -49.9 -45.16 50.58 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.166 1.348 . . . . 0.0 112.399 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.66 ' CB ' HG22 ' A' ' 16' ' ' VAL . 86.5 p -75.3 -27.45 59.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.394 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.5 mt -64.04 -29.09 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.015 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 68.29 -26.13 0.13 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.431 2.692 . . . . 0.0 114.291 170.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.79 -164.76 11.7 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 128.473 2.94 . . . . 0.0 107.916 166.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -76.7 149.88 36.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.18 129.89 38.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.165 1.386 . . . . 0.0 107.891 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -98.4 -28.89 13.43 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.584 0.353 . . . . 0.0 111.015 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.52 179.75 38.81 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 121.402 -0.811 . . . . 0.0 111.278 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -122.34 149.92 43.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -122.63 125.83 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.486 HD11 ' CZ3' ' A' ' 35' ' ' TRP . 16.7 mt -94.58 123.52 46.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -92.32 146.23 23.86 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 164.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.98 168.37 27.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.203 1.001 . . . . 0.0 112.356 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -148.91 156.98 43.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.166 1.386 . . . . 0.0 109.911 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -73.64 137.69 44.33 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.467 1.507 . . . . 0.0 108.351 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 124.202 1.001 . . . . 0.0 109.347 -171.497 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 122.349 1.071 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.48 149.85 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 106.223 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.437 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 1.1 mt -139.22 137.08 35.66 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.258 -170.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.0 m -98.76 132.36 44.19 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.767 0.827 . . . . 0.0 109.77 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.437 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 63.7 m-85 -143.87 68.13 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.805 2.042 . . . . 0.0 108.036 170.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -66.08 133.91 51.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.954 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.76 176.47 25.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.665 1.602 . . . . 0.0 112.599 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.9 p -74.88 0.43 15.64 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HE2' ' CE1' ' A' ' 81' ' ' HIS . 2.2 mmmp? -45.9 146.72 1.14 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.035 1.289 . . . . 0.0 112.159 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 p -99.6 -2.95 34.34 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.425 1.89 . . . . 0.0 111.136 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.416 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 15.1 p80 -149.9 166.88 28.26 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.741 -0.599 . . . . 0.0 110.885 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.29 158.72 24.44 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.453 1.025 . . . . 0.0 112.228 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.583 ' HE2' HD11 ' A' ' 30' ' ' LEU . 55.2 mtp -88.18 160.32 17.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.911 0.884 . . . . 0.0 112.187 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.614 HD12 HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -117.35 89.33 31.13 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.641 1.576 . . . . 0.0 107.534 166.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -93.18 156.59 2.6 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.063 3.175 . . . . 0.0 111.421 168.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.73 29.15 19.45 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.887 0.756 . . . . 0.0 111.611 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.614 HD21 HD12 ' A' ' 84' ' ' LEU . 2.9 mm? -101.4 175.82 5.45 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.375 1.87 . . . . 0.0 107.932 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -133.22 150.36 75.12 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 124.851 1.26 . . . . 0.0 110.19 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -71.08 166.3 29.61 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.944 2.43 . . . . 0.0 112.277 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.1 t80 51.48 34.1 11.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.616 2.366 . . . . 0.0 113.461 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.4 m -132.53 148.45 52.38 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.491 1.117 . . . . 0.0 110.578 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.65 151.97 23.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -137.29 149.32 47.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.115 1.366 . . . . 0.0 108.289 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 m -126.03 134.78 51.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 163.25 37.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.823 2.049 . . . . 0.0 108.486 -171.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.94 169.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.05 1.34 . . . . 0.0 108.762 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.42 149.55 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.747 1.219 . . . . 0.0 108.113 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -140.13 147.31 40.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.481 1.512 . . . . 0.0 108.0 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -87.87 154.06 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.096 0.862 . . . . 0.0 109.363 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.4 t -132.12 139.1 51.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -138.63 -170.94 2.95 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.15 0.58 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.2 -8.25 17.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.535 1.065 . . . . 0.0 115.433 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -113.11 -57.41 2.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.15 1.475 . . . . 0.0 109.397 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.37 -163.61 25.64 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.302 0.956 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -87.28 160.65 18.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.74 -157.27 10.09 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 165.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -62.52 156.95 49.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 CA-C-N 119.607 1.703 . . . . 0.0 111.342 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.41 155.23 17.49 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.963 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -66.04 166.89 13.78 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.402 1.481 . . . . 0.0 108.603 168.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.18 162.7 28.77 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.73 1.62 . . . . 0.0 109.671 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -61.53 138.15 58.27 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 122.185 0.993 . . . . 0.0 110.064 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 173.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 159.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.86 156.56 42.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.7 145.36 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 158.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -123.64 146.81 47.92 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 p -90.64 157.43 44.1 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 124.232 1.013 . . . . 0.0 109.598 -167.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.07 164.98 31.75 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.417 2.078 . . . . 0.0 109.003 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.6 -27.57 62.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.556 1.142 . . . . 0.0 112.466 -173.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.41 0 C-N-CA 125.572 1.558 . . . . 0.0 112.012 155.637 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.475 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 86.2 Cg_endo -73.8 172.81 15.09 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.627 2.218 . . . . 0.0 111.137 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.3 mtm -121.34 -30.79 4.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.286 1.435 . . . . 0.0 113.551 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 42' ' ' SER . 34.3 m -140.97 163.12 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 111.371 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.01 169.17 18.6 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.856 2.062 . . . . 0.0 109.029 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 7.6 Cg_endo -70.19 160.36 49.87 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.255 1.304 . . . . 0.0 110.474 165.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.47 -154.15 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.429 1.49 . . . . 0.0 114.46 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -47.41 131.59 13.55 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.528 1.131 . . . . 0.0 110.303 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.73 147.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -131.86 158.42 41.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.15 150.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.82 128.96 50.28 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.16 143.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 159.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 30' ' ' LEU . 92.9 t -111.03 -53.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -132.27 -171.11 2.56 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.992 1.317 . . . . 0.0 108.687 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -64.3 -37.14 86.44 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.056 -1.027 . . . . 0.0 112.517 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.0 p -123.34 11.63 9.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.947 1.299 . . . . 0.0 110.078 -166.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.701 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.3 tm? -134.69 137.77 43.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.58 1.952 . . . . 0.0 109.0 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -139.73 165.51 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.33 118.71 18.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.97 147.88 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 107.313 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -131.0 133.35 45.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -118.39 -158.81 0.73 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.961 2.104 . . . . 0.0 108.247 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.08 137.56 30.97 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 126.492 1.917 . . . . 0.0 109.909 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.68 101.16 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.505 2.804 . . . . 0.0 109.405 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 28.8 m -67.1 158.48 81.18 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 41.0 Cg_endo -71.63 147.86 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.765 2.31 . . . . 0.0 109.128 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -54.18 -22.74 12.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.257 0.623 . . . . 0.0 110.736 171.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -61.68 -47.35 85.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.046 1.738 . . . . 0.0 114.557 174.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.726 ' HB2' HG22 ' A' ' 16' ' ' VAL . 7.9 p -71.37 -31.8 67.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.72 1.6 . . . . 0.0 109.732 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 47' ' ' LEU . 27.1 mt -68.54 -26.02 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.846 0.859 . . . . 0.0 109.736 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 66.13 3.7 2.79 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.168 2.587 . . . . 0.0 113.823 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.67 -161.41 31.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -172.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -70.98 114.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.537 0.669 . . . . 0.0 109.735 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.3 tm? -55.13 120.35 6.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 163.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -85.38 -31.4 22.95 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.85 168.55 28.2 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -99.6 112.5 24.71 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -81.0 142.87 32.97 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.1 mt -112.06 143.45 21.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.447 ' CE2' ' CD1' ' A' ' 72' ' ' ILE . 43.3 m-85 -112.45 140.56 47.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 166.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -153.63 162.15 41.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.122 1.328 . . . . 0.0 110.232 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -148.57 157.78 43.69 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.539 -0.725 . . . . 0.0 109.233 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -69.09 140.59 54.82 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.599 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.6 mttt . . . . . 0 N--CA 1.442 -0.849 0 CA-C-O 123.001 1.382 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 53' ' ' TYR . 3.4 mm -138.92 152.42 24.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.354 -2.203 . . . . 0.0 105.091 -162.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.498 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -148.69 160.47 43.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.259 169.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.1 m -133.58 97.35 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -161.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 73' ' ' LEU . 58.3 m-85 -105.53 112.1 25.06 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.29 166.92 16.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.903 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.51 172.91 4.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.7 m -85.5 41.61 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.469 -1.018 . . . . 0.0 111.387 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE3' ' CE1' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -63.26 155.93 27.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.698 -1.251 . . . . 0.0 110.183 162.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -109.13 -3.78 17.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.605 1.962 . . . . 0.0 112.288 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.489 ' CE1' ' HE3' ' A' ' 79' ' ' LYS . 14.7 p80 -146.22 164.53 32.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.03 158.86 30.62 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.701 ' HE2' HD11 ' A' ' 30' ' ' LEU . 39.4 mtp -90.96 162.61 14.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.871 0.843 . . . . 0.0 111.117 -168.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 84' ' ' LEU . 1.1 mm? -120.82 89.98 46.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 160.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.1 148.95 1.26 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.394 3.396 . . . . 0.0 112.037 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.43 51.11 8.73 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.47 179.71 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.606 2.362 . . . . 0.0 107.773 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.0 142.37 26.12 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 124.466 1.107 . . . . 0.0 110.485 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.29 166.4 25.43 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.425 2.083 . . . . 0.0 110.84 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER 37.25 46.26 0.57 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 129.894 3.278 . . . . 0.0 113.869 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.1 m -119.72 -176.12 3.1 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.332 1.453 . . . . 0.0 109.122 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.07 157.21 19.57 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 148.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -137.61 154.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.1 m -124.24 141.8 51.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 155.23 44.26 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 127.235 2.214 . . . . 0.0 108.813 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.36 169.28 17.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.069 1.348 . . . . 0.0 107.734 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.25 152.71 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -146.53 131.17 17.86 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.9 1.28 . . . . 0.0 107.77 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.85 150.95 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.7 t -146.74 135.82 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.369 1.468 . . . . 0.0 107.069 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.65 178.85 6.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 107.716 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.8 57.28 3.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.345 0.974 . . . . 0.0 112.014 -172.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -160.71 -41.86 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.481 1.913 . . . . 0.0 109.327 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.74 -168.9 42.03 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.69 166.28 11.19 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 110.075 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.475 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -108.84 -174.48 21.48 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 124.367 0.984 . . . . 0.0 113.284 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.33 153.45 74.31 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.748 1.632 . . . . 0.0 110.444 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.44 165.39 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.688 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 54.0 p -110.78 -171.69 0.22 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.106 0.962 . . . . 0.0 112.112 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 48.5 Cg_endo -64.84 139.46 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.01 89.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 112' ' ' ARG . 0.7 OUTLIER -65.57 159.94 23.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 O-C-N 121.952 -0.467 . . . . 0.0 110.425 173.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 t -128.8 167.22 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.47 156.96 36.19 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.85 2.06 . . . . 0.0 108.156 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.75 147.99 44.58 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 125.218 1.407 . . . . 0.0 110.009 170.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -105.21 166.25 11.74 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.377 1.071 . . . . 0.0 111.478 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.92 167.42 16.35 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.856 3.704 . . . . 0.0 111.791 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 38.7 mt-10 -56.49 -33.08 65.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.028 1.331 . . . . 0.0 111.327 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 28' ' ' SER . . . . . . . . 0 N--CA 1.442 -0.921 0 C-N-CA 126.326 1.917 . . . . 0.0 109.341 160.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 84.4 Cg_endo -72.56 152.02 53.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.649 2.899 . . . . 0.0 111.652 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 68.8 mtm -109.04 -38.98 5.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 117.652 -1.166 . . . . 0.0 113.854 -164.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.831 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.7 m -133.87 147.84 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.459 1.481 . . . . 0.0 113.102 -170.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.63 157.25 67.46 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 127.167 2.187 . . . . 0.0 109.991 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.49 162.96 38.58 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.348 2.032 . . . . 0.0 112.196 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.87 -149.04 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.26 2.362 . . . . 0.0 115.053 -175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -66.94 78.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.339 1.455 . . . . 0.0 113.033 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.1 t -53.67 139.98 10.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.73 158.28 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.562 1.545 . . . . 0.0 107.082 171.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.419 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -146.36 123.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.027 0.831 . . . . 0.0 108.942 168.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.83 102.33 7.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 127.998 2.519 . . . . 0.0 109.39 -169.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.28 0.8 OUTLIER -73.87 116.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-O 121.558 0.694 . . . . 0.0 110.313 -171.991 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 30' ' ' LEU . 45.8 t -69.66 -49.59 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -173.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -139.33 -163.85 1.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 108.971 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -29.94 56.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.654 -1.279 . . . . 0.0 113.151 177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 p -124.96 11.79 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.954 1.301 . . . . 0.0 110.764 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.73 HD11 ' HE2' ' A' ' 83' ' ' MET . 1.9 tm? -143.56 136.31 27.41 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.222 1.409 . . . . 0.0 107.862 -171.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -140.08 165.87 26.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.42 121.62 26.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.27 141.75 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -126.96 150.7 49.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.975 0.51 . . . . 0.0 110.3 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -151.26 178.9 8.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.84 142.66 25.05 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.48 -0.762 . . . . 0.0 109.003 172.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.46 111.53 3.13 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 123.039 2.493 . . . . 0.0 107.636 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.59 156.34 86.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -78.51 143.88 19.6 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 122.348 2.032 . . . . 0.0 108.449 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.0 mm? -59.23 -27.62 65.93 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.655 0.382 . . . . 0.0 110.814 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -60.01 -38.55 82.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.831 ' HB2' HG22 ' A' ' 16' ' ' VAL . 86.2 p -67.4 -41.81 84.31 Favored 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 119.027 0.83 . . . . 0.0 110.344 172.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 40' ' ' LEU . 32.3 mt -67.74 -23.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.644 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 56.17 11.31 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.383 1.873 . . . . 0.0 114.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.52 179.01 41.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.436 1.969 . . . . 0.0 108.256 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -73.94 122.9 23.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 43' ' ' ILE . 9.4 tp -57.45 112.55 1.45 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 108.525 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.17 -43.74 77.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.057 0.943 . . . . 0.0 109.472 168.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -177.2 45.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CE2' HD21 ' A' ' 47' ' ' LEU . 92.5 m-85 -105.87 112.51 25.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.453 1.901 . . . . 0.0 105.989 169.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -83.51 153.24 24.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.41 117.26 50.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -91.57 116.55 28.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -135.58 164.01 28.81 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.187 0.903 . . . . 0.0 110.912 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.71 163.51 37.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.202 1.001 . . . . 0.0 110.5 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.32 135.48 50.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.958 1.303 . . . . 0.0 108.177 168.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.927 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 122.343 1.068 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 mp -133.16 139.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 126.828 2.051 . . . . 0.0 105.864 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.704 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 1.1 mt -120.86 153.04 37.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.651 2.38 . . . . 0.0 107.692 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.1 m -134.26 97.92 3.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 110.062 -168.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.704 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 42.6 m-85 -110.13 92.35 4.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 123.945 0.898 . . . . 0.0 108.933 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.2 163.25 27.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.5 177.19 12.86 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.261 0.923 . . . . 0.0 113.023 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 p -76.53 25.3 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.04 2.536 . . . . 0.0 114.241 -169.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -58.2 160.36 5.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.049 1.34 . . . . 0.0 111.322 176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.5 p -128.91 -2.02 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.105 0.962 . . . . 0.0 111.987 -172.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -146.51 163.72 34.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.99 151.86 23.03 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.73 ' HE2' HD11 ' A' ' 30' ' ' LEU . 38.7 mtp -76.9 163.82 26.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -119.58 93.13 47.09 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 157.293 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -93.29 161.02 2.5 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.745 2.296 . . . . 0.0 111.137 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.75 31.82 59.93 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD11 HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -84.69 171.72 12.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.693 1.997 . . . . 0.0 106.923 166.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.64 153.25 45.9 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 123.788 0.835 . . . . 0.0 110.067 163.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.66 169.51 17.28 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.683 2.255 . . . . 0.0 112.63 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.9 t80 47.49 51.04 14.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.146 1.778 . . . . 0.0 111.191 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -153.8 -178.74 7.25 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.812 -1.18 . . . . 0.0 109.683 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -110.0 158.99 17.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -145.5 151.43 38.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.5 m -123.33 142.76 50.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 170.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 162.67 34.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.333 1.853 . . . . 0.0 109.568 174.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.57 144.23 31.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.647 1.579 . . . . 0.0 106.826 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.99 132.56 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -129.93 134.14 47.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.046 1.294 . . . . 0.0 110.824 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.31 152.29 5.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.3 142.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -132.92 -162.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.59 1.156 . . . . 0.0 109.813 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.93 65.74 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -50.62 69.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.861 0.865 . . . . 0.0 110.763 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.42 -168.84 41.88 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 120.003 1.274 . . . . 0.0 112.945 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.56 154.36 27.52 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.746 1.218 . . . . 0.0 110.983 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.471 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -108.28 -172.91 21.65 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 0.0 112.074 166.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.44 156.32 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.139 1.893 . . . . 0.0 110.493 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.82 152.72 21.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.112 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -63.8 -171.79 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.812 1.645 . . . . 0.0 111.459 170.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.95 154.58 16.99 Favored 'Trans proline' 0 C--N 1.352 0.729 0 CA-C-N 120.663 1.272 . . . . 0.0 110.242 163.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.74 85.3 7.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 166.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -67.09 155.93 37.43 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.73 154.22 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 23' ' ' VAL . 53.5 p90 -151.79 152.25 32.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -102.29 160.37 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 169.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p -107.94 146.28 33.15 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.88 -89.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.791 2.994 . . . . 0.0 113.257 -162.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -142.4 -34.97 0.44 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.381 0.991 . . . . 0.0 112.392 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 C-N-CA 125.787 1.66 . . . . 0.0 110.819 -168.099 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.06 160.39 47.59 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.61 2.207 . . . . 0.0 112.805 -171.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.3 mtm -114.7 -39.02 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -170.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG22 ' CB ' ' A' ' 42' ' ' SER . 30.8 m -140.8 155.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.247 0.931 . . . . 0.0 109.521 -178.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 172.02 10.98 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 127.081 2.152 . . . . 0.0 111.108 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HD3' HG13 ' A' ' 99' ' ' VAL . 5.7 Cg_exo -56.6 161.49 9.77 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 120.651 0.9 . . . . 0.0 111.119 167.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.62 -170.51 5.04 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 165.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 151.83 17.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.28 1.038 . . . . 0.0 112.078 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.39 151.69 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.805 1.242 . . . . 0.0 108.009 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.47 158.44 38.34 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.56 1.944 . . . . 0.0 106.575 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.32 115.6 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 170.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -98.8 129.33 45.2 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.079 0.862 . . . . 0.0 109.019 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -79.58 109.99 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 30' ' ' LEU . 3.8 m -78.88 -59.66 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 127.047 2.139 . . . . 0.0 109.0 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -124.58 -176.02 3.42 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.254 1.422 . . . . 0.0 109.914 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -59.87 -58.4 8.72 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.108 -0.995 . . . . 0.0 110.065 161.31 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 p -89.72 2.08 55.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.91 1.684 . . . . 0.0 113.841 -165.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 26' ' ' VAL . 23.9 tp -135.55 140.96 45.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.009 1.724 . . . . 0.0 107.66 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.43 153.83 45.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -95.25 139.07 32.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.78 139.85 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 169.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.9 146.99 50.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.0 p90 -139.4 166.87 23.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.151 1.38 . . . . 0.0 108.437 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.06 147.59 88.38 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.78 141.36 84.72 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.374 1.382 . . . . 0.0 108.615 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 35.3 m -85.64 159.47 55.3 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.218 159.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.88 148.02 81.58 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.702 2.935 . . . . 0.0 109.444 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 40' ' ' LEU 0.276 0.0 OUTLIER -51.17 -27.93 9.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 168.483 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -63.87 -32.97 74.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 117.109 -1.424 . . . . 0.0 112.486 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.486 ' CB ' HG22 ' A' ' 16' ' ' VAL . 77.9 p -74.72 -36.69 62.69 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.373 1.442 . . . . 0.0 109.956 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.518 HD13 ' HB2' ' A' ' 47' ' ' LEU . 21.2 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 108.514 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 80.27 -61.4 0.27 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 129.273 3.029 . . . . 0.0 110.556 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.77 -160.44 17.14 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 126.129 1.823 . . . . 0.0 111.082 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -72.79 121.99 20.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.399 1.08 . . . . 0.0 109.248 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.518 ' HB2' HD13 ' A' ' 43' ' ' ILE . 1.5 tm? -59.94 119.5 7.87 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.743 0.817 . . . . 0.0 109.77 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -78.6 -36.57 44.07 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.09 -175.26 33.15 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -114.09 166.51 11.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -130.27 150.82 51.34 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.411 1.484 . . . . 0.0 107.531 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.2 mt -124.91 124.38 67.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -91.56 138.61 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 165.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.9 p90 -146.78 167.35 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 120.981 1.718 . . . . 0.0 111.366 168.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -149.04 158.03 43.86 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.87 0.868 . . . . 0.0 110.891 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.29 138.15 41.65 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.466 1.106 . . . . 0.0 108.772 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.417 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 11.1 mmtt . . . . . 0 CA--C 1.519 -0.227 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 mm -127.31 159.22 37.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.423 1.489 . . . . 0.0 107.368 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.449 ' CD1' HD13 ' A' ' 84' ' ' LEU . 2.6 mt -136.19 159.17 42.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.174 1.789 . . . . 0.0 108.204 167.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -123.77 141.55 51.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.251 1.82 . . . . 0.0 107.155 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -145.67 104.84 3.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -77.43 175.44 9.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.777 -1.202 . . . . 0.0 109.867 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.28 160.62 5.02 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.651 1.139 . . . . 0.0 113.173 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.5 m -77.32 21.25 0.26 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.196 1.398 . . . . 0.0 113.458 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -48.49 154.59 0.62 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.277 1.031 . . . . 0.0 110.895 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 p -119.43 9.29 11.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.171 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 167.13 24.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.072 0.949 . . . . 0.0 109.062 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.17 -171.1 26.71 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 127.455 2.455 . . . . 0.0 107.505 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -138.28 159.72 41.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 117.963 0.882 . . . . 0.0 110.844 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.9 mm? -112.85 81.6 4.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 127.019 2.127 . . . . 0.0 107.394 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -84.4 155.94 12.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.836 2.357 . . . . 0.0 111.059 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.87 16.47 67.72 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.404 -0.665 . . . . 0.0 112.961 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 93' ' ' TYR . 3.8 mm? -91.7 173.68 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.858 1.263 . . . . 0.0 110.527 -175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.42 144.69 32.84 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.472 -175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.93 176.38 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.976 2.451 . . . . 0.0 113.191 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 38.75 46.49 1.04 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 130.939 3.696 . . . . 0.0 113.933 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 64.1 m -135.09 174.13 10.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.101 1.76 . . . . 0.0 110.67 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -120.84 152.23 38.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.631 1.972 . . . . 0.0 107.106 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.408 ' CE1' HD12 ' A' ' 87' ' ' LEU . 97.2 m-85 -144.33 161.43 38.99 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.056 1.342 . . . . 0.0 111.019 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.4 m -124.15 141.48 52.02 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 161.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.81 153.2 42.99 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.025 1.73 . . . . 0.0 110.137 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.18 129.79 20.23 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -170.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.5 t -89.43 147.32 5.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -145.74 124.08 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.331 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.447 HG13 ' HD3' ' A' ' 18' ' ' PRO . 4.4 m -69.5 152.55 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.414 1.007 . . . . 0.0 109.676 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.13 151.92 25.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.727 1.611 . . . . 0.0 108.352 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -144.68 -171.14 3.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.972 1.309 . . . . 0.0 109.015 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.01 -15.26 78.52 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.996 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -23.77 14.56 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.581 1.552 . . . . 0.0 111.919 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.47 -154.41 25.5 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.858 0.754 . . . . 0.0 111.305 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 173.93 10.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.392 1.477 . . . . 0.0 110.008 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.79 -155.44 6.87 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.693 1.139 . . . . 0.0 112.761 -166.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.57 160.79 41.41 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.689 2.259 . . . . 0.0 110.595 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.99 162.21 13.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.194 1.798 . . . . 0.0 111.462 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 54.1 p -67.58 -176.72 0.28 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.6 0.76 . . . . 0.0 110.335 172.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 19.8 Cg_endo -54.28 129.84 36.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 N-CA-C 108.968 -1.204 . . . . 0.0 108.968 153.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.93 132.49 53.18 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 163.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -115.75 163.46 15.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.443 1.097 . . . . 0.0 109.239 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.49 158.77 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -150.47 151.97 33.52 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.31 141.74 44.45 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.365 1.466 . . . . 0.0 108.008 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.3 p -92.46 157.36 40.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.101 -0.375 . . . . 0.0 111.342 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 75.5 Cg_endo -75.11 171.0 19.17 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.133 2.555 . . . . 0.0 108.178 173.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.97 -35.41 78.4 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 114.863 -162.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.33 0 C-N-CA 125.277 1.418 . . . . 0.0 110.293 174.747 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.47 ' C ' HD21 ' A' ' 101' ' ' ASN . 29.7 mt . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.15 177.29 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.179 1.253 . . . . 0.0 110.0 166.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.1 mtm -134.05 -27.37 1.44 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 42' ' ' SER . 28.5 m -138.59 178.52 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 120.193 1.361 . . . . 0.0 110.101 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.89 162.67 19.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 128.41 2.684 . . . . 0.0 107.626 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.35 151.07 81.87 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 120.863 1.042 . . . . 0.0 109.686 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.31 -94.62 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 125.137 1.351 . . . . 0.0 112.535 -163.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 162.03 13.41 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.5 t -128.97 148.76 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -142.99 152.7 42.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.828 2.051 . . . . 0.0 106.252 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.45 139.13 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 119.975 1.261 . . . . 0.0 110.387 171.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -116.5 145.69 43.13 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 127.398 2.279 . . . . 0.0 107.944 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.62 110.25 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.24 -59.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.642 0.777 . . . . 0.0 108.928 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.277 20.1 p30 -121.12 -105.52 0.38 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.627 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.37 -51.95 1.96 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.695 1.998 . . . . 0.0 109.696 174.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.9 p -101.12 4.32 42.03 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.192 1.397 . . . . 0.0 111.519 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -124.65 122.97 39.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.042 1.737 . . . . 0.0 109.02 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.41 163.38 17.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 109.552 165.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -125.54 115.57 20.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 129.123 2.969 . . . . 0.0 105.994 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.1 t -92.73 145.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.14 146.39 49.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -148.1 155.56 41.59 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -74.0 140.03 76.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.92 155.49 54.73 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.884 2.389 . . . . 0.0 109.374 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG21 HG11 ' A' ' 99' ' ' VAL . 16.2 m -102.31 157.54 33.5 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 166.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -76.16 153.35 36.35 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 122.753 2.302 . . . . 0.0 109.443 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 43' ' ' ILE . 5.3 mp -61.8 -27.4 68.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.064 0.945 . . . . 0.0 111.174 176.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -44.83 -58.78 2.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.574 1.15 . . . . 0.0 110.906 163.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.616 ' HB2' HG22 ' A' ' 16' ' ' VAL . 81.1 p -61.85 -26.31 68.06 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -171.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 40' ' ' LEU . 24.6 mt -87.76 -17.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.159 1.384 . . . . 0.0 109.996 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 55.45 1.95 0.06 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.38 2.272 . . . . 0.0 115.33 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.87 -155.3 21.6 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 127.817 2.627 . . . . 0.0 107.261 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -74.09 132.81 42.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.267 1.533 . . . . 0.0 111.998 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' HD13 ' A' ' 43' ' ' ILE . 8.6 tt -69.32 125.28 26.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -81.07 -60.35 2.32 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.03 -178.79 39.12 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-O 121.955 0.753 . . . . 0.0 113.663 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -107.83 117.89 35.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.878 . . . . 0.0 106.589 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 92.09 4.92 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.74 123.02 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -92.19 145.62 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 164.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.43 163.71 39.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.777 1.231 . . . . 0.0 110.906 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -148.98 159.68 43.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.989 0.916 . . . . 0.0 110.538 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -68.83 132.22 46.42 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 166.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.8 m . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.638 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 tttp . . . . . 0 C--O 1.237 0.402 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -140.96 111.13 3.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.04 166.78 22.85 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.328 1.451 . . . . 0.0 110.165 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.4 m -126.06 125.75 43.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -135.91 116.45 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -79.24 164.44 24.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.323 0.965 . . . . 0.0 109.008 165.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.12 172.43 3.4 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.533 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -87.48 39.68 0.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.799 -0.701 . . . . 0.0 112.279 -153.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -59.88 167.22 2.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.314 1.446 . . . . 0.0 111.567 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -130.04 8.75 5.22 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.899 1.679 . . . . 0.0 110.626 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -156.35 160.47 39.71 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.418 1.887 . . . . 0.0 106.882 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.71 40.4 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 32.1 mtp -132.53 156.25 47.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 118.728 1.264 . . . . 0.0 110.953 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.57 82.4 4.79 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 126.363 1.865 . . . . 0.0 106.349 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -85.23 154.38 10.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.29 1.993 . . . . 0.0 110.848 165.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 16.8 46.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.344 0.973 . . . . 0.0 112.252 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.402 HD12 ' CE2' ' A' ' 93' ' ' TYR . 4.2 mm? -88.59 -171.56 3.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.097 0.949 . . . . 0.0 109.895 -173.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.46 141.57 41.9 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 128.279 2.632 . . . . 0.0 105.92 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -73.54 -173.91 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.004 3.136 . . . . 0.0 112.097 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 50.69 43.36 27.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.686 2.395 . . . . 0.0 113.032 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.8 m -157.54 163.48 38.34 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.97 0.908 . . . . 0.0 112.107 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -88.5 155.09 19.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.177 1.391 . . . . 0.0 107.678 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.402 ' CE2' HD12 ' A' ' 87' ' ' LEU . 82.8 m-85 -144.68 146.95 32.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.826 1.65 . . . . 0.0 108.766 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 19.7 m -126.75 122.69 35.56 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.618 0.767 . . . . 0.0 109.025 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 158.07 39.22 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.209 1.804 . . . . 0.0 109.453 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.57 164.01 33.0 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.885 1.274 . . . . 0.0 109.555 171.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 t -125.71 142.89 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.807 1.643 . . . . 0.0 106.873 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -149.7 132.32 15.84 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 38' ' ' VAL . 1.3 m -82.2 144.64 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.5 t -135.25 139.87 46.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.245 1.818 . . . . 0.0 106.315 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.47 HD21 ' C ' ' A' ' 13' ' ' LEU . 36.4 p-10 -149.21 -172.47 4.13 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.887 0.875 . . . . 0.0 112.246 -168.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.46 12.19 0.14 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.893 2.187 . . . . 0.0 116.86 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -141.94 -35.59 0.44 Allowed 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.061 1.93 . . . . 0.0 112.102 168.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.31 -154.66 9.61 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 119.165 0.893 . . . . 0.0 112.126 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.92 165.54 17.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.362 1.465 . . . . 0.0 109.976 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.29 -173.43 15.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 125.203 1.383 . . . . 0.0 112.71 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.49 135.86 51.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.363 2.709 . . . . 0.0 109.21 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.75 151.35 34.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.918 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -58.9 172.59 0.52 Allowed Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 124.683 1.193 . . . . 0.0 109.451 169.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -56.1 139.44 85.37 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 152.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.74 160.18 23.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.099 170.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -129.99 168.9 15.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.21 162.87 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.331 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -144.32 143.6 31.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -86.19 166.74 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 p -123.73 159.9 53.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 124.071 0.948 . . . . 0.0 109.737 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.49 161.37 43.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -58.65 -23.11 58.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.609 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 CA-C-O 118.281 -1.288 . . . . 0.0 114.537 163.975 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.83 172.61 12.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.887 2.392 . . . . 0.0 111.815 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.6 mtm -124.78 -19.03 5.42 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.7 m -144.02 179.37 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 120.392 1.451 . . . . 0.0 111.275 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 107' ' ' PRO . . . -114.56 158.79 39.21 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 129.045 2.938 . . . . 0.0 108.708 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -69.06 144.67 58.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.252 1.968 . . . . 0.0 111.094 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.42 -179.14 52.27 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.414 1.959 . . . . 0.0 113.169 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 t30 2.05 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.539 3.536 . . . . 0.0 114.671 -171.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.95 132.02 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -126.17 153.96 43.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.506 1.923 . . . . 0.0 107.971 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.55 129.68 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.266 1.027 . . . . 0.0 108.743 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -125.21 135.66 52.79 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 125.337 1.455 . . . . 0.0 112.302 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.367 1.0 OUTLIER -84.73 128.85 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 123.113 1.435 . . . . 0.0 111.753 174.486 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.73 -40.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 128.18 2.592 . . . . 0.0 109.529 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 77.5 m-20 -138.24 -179.91 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.714 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.46 88.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.668 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.8 p -114.63 4.77 15.2 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.137 1.375 . . . . 0.0 112.759 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 17.3 tp -132.27 137.31 47.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.293 1.837 . . . . 0.0 108.328 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -131.51 170.34 14.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.921 1.288 . . . . 0.0 109.372 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -128.88 139.88 51.94 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.6 t -114.54 143.57 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -129.17 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.769 1.628 . . . . 0.0 107.265 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -150.14 151.65 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.786 1.234 . . . . 0.0 108.363 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -69.39 146.18 96.23 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.674 -0.641 . . . . 0.0 110.485 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.76 131.08 29.86 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 108.449 162.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 m -76.11 160.03 79.11 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.57 144.66 67.46 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.526 2.151 . . . . 0.0 109.275 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -26.2 68.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.529 -0.732 . . . . 0.0 111.027 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -55.93 -32.6 63.94 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 118.297 -0.858 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.691 ' HB2' HG22 ' A' ' 16' ' ' VAL . 87.4 p -72.32 -32.29 66.42 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 119.273 0.942 . . . . 0.0 111.642 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mt -75.77 -30.63 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.206 1.002 . . . . 0.0 109.994 -164.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 45.84 34.79 2.0 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.027 2.131 . . . . 0.0 112.81 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.77 -133.25 1.82 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -171.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.91 121.06 22.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.8 tp -52.01 118.08 3.21 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -79.88 -51.83 8.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.57 -170.22 40.34 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -106.09 157.6 17.42 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 163.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -123.91 144.5 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 169.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.5 mt -118.46 126.57 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -92.07 144.94 24.92 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 160.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 35.7 p90 -155.44 159.3 39.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.0 0.92 . . . . 0.0 110.987 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.77 155.51 40.25 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -68.52 130.53 43.12 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.711 1.604 . . . . 0.0 107.636 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.0 m . . . . . 0 C--N 1.325 -0.484 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.219 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt . . . . . 0 CA--C 1.51 -0.563 0 CA-C-O 121.562 0.696 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.24 149.43 33.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -138.55 145.52 40.77 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.593 1.957 . . . . 0.0 107.668 -173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 m -129.87 119.04 22.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.206 1.002 . . . . 0.0 108.694 -163.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -128.87 88.22 2.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.891 1.277 . . . . 0.0 108.401 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -69.3 173.51 5.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.852 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 -178.01 18.66 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.891 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -85.79 11.33 11.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -161.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -56.77 149.35 18.32 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 125.033 1.333 . . . . 0.0 112.307 -166.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -112.66 9.51 19.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.669 1.187 . . . . 0.0 111.312 175.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.92 160.61 43.46 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.059 1.343 . . . . 0.0 109.356 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.67 143.13 8.97 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.7 mtp -86.26 146.98 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.258 0.529 . . . . 0.0 109.818 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.532 HD12 HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -106.8 94.53 10.6 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 126.687 1.995 . . . . 0.0 105.963 174.212 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -92.12 167.21 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.7 2.933 . . . . 0.0 112.175 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.96 19.96 74.12 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.681 -0.637 . . . . 0.0 112.79 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 84' ' ' LEU . 3.9 mm? -85.23 168.67 14.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.651 0.781 . . . . 0.0 109.069 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.87 131.64 22.03 Favored Pre-proline 0 N--CA 1.432 -1.327 0 C-N-CA 126.092 1.757 . . . . 0.0 107.348 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -74.52 162.92 37.16 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.963 1.775 . . . . 0.0 111.529 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.6 t80 50.63 40.5 24.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.127 1.371 . . . . 0.0 112.134 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -136.14 158.82 43.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.269 1.427 . . . . 0.0 110.686 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -94.45 153.73 17.79 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -148.21 154.21 39.79 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.922 1.289 . . . . 0.0 110.017 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.9 m -126.21 149.78 48.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.867 1.667 . . . . 0.0 107.521 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.0 158.48 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.596 2.358 . . . . 0.0 110.488 171.391 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.05 145.13 29.57 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.683 1.193 . . . . 0.0 110.648 168.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.61 151.06 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.249 1.82 . . . . 0.0 108.496 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -144.76 133.5 22.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -73.94 151.41 7.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.91 136.37 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -134.69 -173.51 3.31 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.729 2.012 . . . . 0.0 107.031 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.85 13.44 13.4 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.033 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -123.07 -54.69 1.81 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.67 1.588 . . . . 0.0 110.037 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.09 48.94 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.039 0.836 . . . . 0.0 111.942 -173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -83.66 154.76 23.52 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.593 0.711 . . . . 0.0 110.702 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -100.82 -171.08 28.86 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.877 1.227 . . . . 0.0 112.349 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 40.3 Cg_endo -65.18 137.99 54.33 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.945 1.764 . . . . 0.0 108.751 170.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.63 161.19 29.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 60.3 p -62.97 178.53 0.35 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.487 1.115 . . . . 0.0 108.943 172.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 94.4 Cg_endo -61.49 155.52 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 107.346 -1.828 . . . . 0.0 107.346 157.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.27 151.79 46.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.688 1.232 . . . . 0.0 108.926 162.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -124.74 161.82 25.58 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.2 150.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.474 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.79 165.26 30.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -135.66 144.03 45.8 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.013 2.125 . . . . 0.0 107.289 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.8 p -110.59 153.32 43.62 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.085 0.554 . . . . 0.0 110.548 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.4 -68.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.757 2.304 . . . . 0.0 113.131 -152.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -163.41 -41.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.32 1.448 . . . . 0.0 109.848 168.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.728 0 C-N-CA 126.073 1.797 . . . . 0.0 113.673 175.26 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 118.342 -0.837 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.81 158.75 23.29 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.641 2.227 . . . . 0.0 112.632 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtm -121.5 -31.59 4.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.321 1.049 . . . . 0.0 113.545 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 42' ' ' SER . 31.0 m -140.96 158.05 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.825 0.739 . . . . 0.0 111.666 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.8 159.99 31.19 Favored Pre-proline 0 N--CA 1.444 -0.754 0 C-N-CA 130.021 3.329 . . . . 0.0 111.928 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.35 141.59 35.66 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.34 2.026 . . . . 0.0 111.403 -175.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.05 166.73 51.98 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.546 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.0 t30 49.35 54.55 10.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.619 1.567 . . . . 0.0 112.737 154.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.67 128.8 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.784 1.234 . . . . 0.0 109.296 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 116.13 9.04 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.235 1.814 . . . . 0.0 110.476 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -107.99 138.05 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.163 0.985 . . . . 0.0 108.937 -175.193 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -124.12 124.93 43.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.126 2.171 . . . . 0.0 110.36 -175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.59 102.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.69 ' HB ' HD12 ' A' ' 30' ' ' LEU . 73.9 t -72.65 -48.98 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -138.25 -179.03 5.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 122.271 1.034 . . . . 0.0 109.03 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -35.49 80.62 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.258 -0.901 . . . . 0.0 111.686 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -119.34 17.56 13.02 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.309 1.044 . . . . 0.0 111.363 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.82 HD11 ' CE ' ' A' ' 83' ' ' MET . 3.1 tm? -139.32 137.99 36.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.501 1.92 . . . . 0.0 108.628 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.529 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -136.02 150.62 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -108.4 143.72 36.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.788 2.035 . . . . 0.0 107.046 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.04 119.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -108.34 152.96 23.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -154.12 163.52 39.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.942 0.897 . . . . 0.0 109.594 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -80.3 140.93 52.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.12 140.89 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.712 2.275 . . . . 0.0 108.49 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.11 156.59 79.25 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 164.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.29 147.01 17.98 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.611 2.874 . . . . 0.0 109.841 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.64 -29.06 64.27 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -50.58 -50.31 54.13 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.343 0.519 . . . . 0.0 110.939 168.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.736 ' HB2' HG22 ' A' ' 16' ' ' VAL . 71.8 p -59.74 -37.98 80.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.417 0.553 . . . . 0.0 112.259 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.508 HD13 ' HB2' ' A' ' 47' ' ' LEU . 15.4 mt -70.42 -23.41 24.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.799 -169.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.54 -14.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.572 2.349 . . . . 0.0 115.82 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.03 -163.74 12.34 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.72 3.057 . . . . 0.0 108.55 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -77.96 117.6 19.45 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.803 0.841 . . . . 0.0 111.695 -174.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.508 ' HB2' HD13 ' A' ' 43' ' ' ILE . 36.2 tp -57.3 133.48 55.15 Favored 'General case' 0 CA--C 1.523 -0.07 0 C-N-CA 125.698 1.599 . . . . 0.0 109.987 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -103.72 -23.41 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.201 1.4 . . . . 0.0 110.455 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.82 -164.75 30.45 Favored Glycine 0 C--O 1.239 0.437 0 O-C-N 120.95 -1.094 . . . . 0.0 112.013 167.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.39 141.14 46.47 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.557 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -121.83 97.09 5.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.4 mt -77.95 120.63 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -91.67 141.55 28.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 164.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.557 ' CD2' HD11 ' A' ' 84' ' ' LEU . 41.4 p90 -151.25 166.08 32.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.751 0.82 . . . . 0.0 110.566 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -149.46 159.14 44.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -68.95 136.6 52.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 m . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.131 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt . . . . . 0 C--O 1.24 0.566 0 CA-C-O 120.435 0.159 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.74 149.67 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 128.275 2.63 . . . . 0.0 104.622 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -133.02 161.09 35.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.122 1.769 . . . . 0.0 109.123 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -131.18 121.77 25.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.798 1.181 . . . . 0.0 111.85 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -136.99 115.26 11.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 163.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -80.98 162.51 23.82 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.325 0.583 . . . . 0.0 110.227 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.65 -173.32 21.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.152 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.06 13.98 0.47 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.552 1.941 . . . . 0.0 115.106 -168.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -51.73 147.85 6.2 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.673 1.189 . . . . 0.0 112.036 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.9 p -109.4 5.37 23.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 111.983 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.13 159.43 43.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.883 0.873 . . . . 0.0 109.966 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.15 170.07 30.83 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 126.697 2.094 . . . . 0.0 108.139 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.82 ' CE ' HD11 ' A' ' 30' ' ' LEU . 59.9 mtp -138.37 143.94 40.06 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.282 1.041 . . . . 0.0 110.892 -166.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 54' ' ' TYR . 4.0 mm? -110.33 84.95 4.12 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 127.507 2.323 . . . . 0.0 108.665 -173.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.63 156.75 3.54 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.413 2.742 . . . . 0.0 112.741 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.94 40.76 98.6 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.929 0.776 . . . . 0.0 111.406 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.487 HD12 ' CE2' ' A' ' 93' ' ' TYR . 4.0 mm? -96.1 165.88 12.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.754 1.621 . . . . 0.0 108.536 173.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.77 144.6 30.58 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.56 172.27 12.74 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.305 2.67 . . . . 0.0 111.962 165.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.25 0.3 OUTLIER 45.41 34.75 1.65 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.371 2.668 . . . . 0.0 114.063 172.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.19 -175.81 2.93 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.245 2.218 . . . . 0.0 109.554 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -124.64 154.28 40.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CE2' HD12 ' A' ' 87' ' ' LEU . 81.8 m-85 -145.65 158.71 43.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.854 0.461 . . . . 0.0 109.945 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.3 m -126.45 140.84 52.16 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.47 154.27 47.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.934 2.094 . . . . 0.0 108.991 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.22 166.28 25.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.572 1.549 . . . . 0.0 107.933 166.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.2 147.39 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -139.07 121.31 15.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 111.527 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.43 136.54 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.176 1.39 . . . . 0.0 107.263 172.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.83 143.99 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -131.89 -173.78 3.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.805 2.042 . . . . 0.0 107.601 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.11 92.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.575 0.625 . . . . 0.0 112.052 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -36.13 80.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.89 0.845 . . . . 0.0 111.663 176.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.37 -143.24 10.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 119.358 0.981 . . . . 0.0 111.074 -174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -120.59 173.79 6.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.391 1.076 . . . . 0.0 112.354 -165.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.74 -162.36 9.09 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.293 1.425 . . . . 0.0 111.422 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.97 145.18 84.95 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.832 3.021 . . . . 0.0 111.668 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.99 157.64 34.63 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.387 1.075 . . . . 0.0 110.566 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.3 p -61.06 174.96 0.49 Allowed Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.127 162.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -51.35 148.4 19.4 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.498 0.798 . . . . 0.0 110.812 154.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.59 144.64 52.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 164.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -130.07 171.21 13.06 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.215 1.806 . . . . 0.0 108.514 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.49 164.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.982 1.313 . . . . 0.0 108.816 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 23' ' ' VAL . 41.4 p90 -153.47 148.25 26.41 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.336 1.854 . . . . 0.0 107.219 159.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -86.77 168.12 13.8 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 158.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.0 p -117.53 162.36 28.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 163.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.2 -83.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.272 1.982 . . . . 0.0 113.576 -155.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -142.54 -53.46 0.41 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.304 1.042 . . . . 0.0 109.649 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.357 0 C-N-CA 123.412 0.53 . . . . 0.0 112.372 -179.813 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 118.772 -0.632 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -67.32 170.63 13.03 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.746 2.298 . . . . 0.0 114.272 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.5 mtm -122.35 -39.93 2.53 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 127.06 2.144 . . . . 0.0 111.041 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.757 HG22 ' HB2' ' A' ' 42' ' ' SER . 23.6 m -136.51 150.42 27.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 119.133 0.879 . . . . 0.0 111.755 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.96 168.53 22.3 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 128.426 2.69 . . . . 0.0 110.248 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.47 166.64 16.89 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 121.691 1.594 . . . . 0.0 114.048 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.49 -163.04 1.4 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.625 2.059 . . . . 0.0 112.788 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -58.08 106.33 0.36 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.628 1.171 . . . . 0.0 109.198 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.81 141.6 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.209 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -124.12 152.06 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.94 132.75 14.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -124.05 128.91 50.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 125.016 1.326 . . . . 0.0 110.022 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.297 0.7 OUTLIER -88.46 115.89 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.093 0.949 . . . . 0.0 110.473 -175.874 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.63 ' HB ' HD12 ' A' ' 30' ' ' LEU . 93.5 t -79.27 -35.21 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.392 -169.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -156.35 -173.25 4.41 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 109.413 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -17.96 64.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -171.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.9 p -128.71 6.21 5.59 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.435 1.494 . . . . 0.0 111.122 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.723 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.2 tm? -142.7 142.27 31.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.421 1.088 . . . . 0.0 110.097 -169.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -137.78 162.32 34.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -117.31 121.0 39.94 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -97.98 144.17 11.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -133.33 144.97 49.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.925 1.69 . . . . 0.0 107.592 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -148.31 173.07 13.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.029 1.332 . . . . 0.0 108.385 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -90.03 144.42 31.32 Favored Pre-proline 0 C--O 1.234 0.289 0 O-C-N 121.761 -0.587 . . . . 0.0 109.845 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.93 112.14 3.03 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.402 2.735 . . . . 0.0 109.104 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.22 159.17 62.75 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 150.65 18.93 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.536 2.824 . . . . 0.0 112.077 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.565 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -58.39 -35.77 72.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.909 1.284 . . . . 0.0 109.763 175.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -60.02 -25.85 65.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 117.171 -1.395 . . . . 0.0 114.234 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.757 ' HB2' HG22 ' A' ' 16' ' ' VAL . 76.0 p -93.11 -20.77 20.18 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 120.743 1.61 . . . . 0.0 111.673 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 40' ' ' LEU . 62.8 mt -63.23 -40.2 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 166.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 56.61 -3.24 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.616 2.767 . . . . 0.0 115.188 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 -166.56 12.73 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 125.466 1.507 . . . . 0.0 109.394 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -87.68 107.86 18.83 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.391 -0.476 . . . . 0.0 109.919 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' A' ' 43' ' ' ILE . 14.1 tp -48.81 130.48 17.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.016 1.327 . . . . 0.0 107.956 172.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -84.73 -62.16 1.61 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 76' ' ' GLN . . . -174.19 -165.15 30.34 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.34 160.57 14.19 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -134.95 99.44 4.29 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.601 -0.687 . . . . 0.0 109.2 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.7 mt -77.89 119.01 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.573 1.549 . . . . 0.0 107.019 170.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -91.74 149.64 21.51 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 39.8 p90 -154.24 164.82 37.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.521 1.51 . . . . 0.0 111.546 170.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -148.65 159.19 44.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.854 1.262 . . . . 0.0 111.197 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.64 138.32 54.92 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.816 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 2.3 mttp . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.0 mm -141.79 161.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.46 1.904 . . . . 0.0 107.199 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.504 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -154.94 108.88 2.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.736 1.214 . . . . 0.0 110.024 177.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -81.92 135.43 35.4 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.273 1.429 . . . . 0.0 111.257 -163.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -137.11 97.54 3.52 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.42 ' HA ' ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -76.52 173.19 11.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.777 0.831 . . . . 0.0 110.865 175.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.81 175.43 46.33 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 121.964 0.758 . . . . 0.0 111.685 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.5 p -83.52 27.02 0.63 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.796 1.638 . . . . 0.0 112.748 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -60.38 164.95 3.93 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.932 1.349 . . . . 0.0 112.295 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.444 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 15.6 p -127.55 -0.94 6.19 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.762 2.025 . . . . 0.0 110.768 -174.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -152.14 163.45 39.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.06 1.344 . . . . 0.0 108.465 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.66 172.8 34.99 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 127.568 2.509 . . . . 0.0 107.92 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.723 ' HE2' HD11 ' A' ' 30' ' ' LEU . 77.5 mtp -115.09 159.01 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.583 1.191 . . . . 0.0 109.972 -172.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.7 mm? -121.44 77.27 35.36 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 108.877 168.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -86.07 149.06 9.38 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.503 2.802 . . . . 0.0 110.892 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.46 26.74 9.05 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.737 0.684 . . . . 0.0 112.043 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.434 HD21 HD12 ' A' ' 84' ' ' LEU . 2.3 mm? -109.59 171.08 7.66 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 126.258 1.823 . . . . 0.0 108.02 -173.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -115.25 144.77 32.87 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.896 0.878 . . . . 0.0 110.311 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -70.39 169.21 20.25 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.719 2.946 . . . . 0.0 113.059 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 35.88 51.12 0.71 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.819 2.448 . . . . 0.0 111.048 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 m -129.91 -179.69 5.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 108.528 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -130.14 143.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -136.35 168.2 19.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -126.12 142.6 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 153.85 49.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.452 1.501 . . . . 0.0 109.977 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.25 129.92 21.52 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.625 1.17 . . . . 0.0 109.281 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.49 162.17 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -152.55 161.3 42.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -106.57 146.91 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.09 139.68 41.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -134.1 178.87 6.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.324 0.65 . . . . 0.0 110.295 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.28 -40.14 52.36 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.015 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -73.11 -50.92 20.05 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.95 0.875 . . . . 0.0 111.865 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.4 -167.36 40.03 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -163.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -94.79 170.29 9.55 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 111.078 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.44 -154.29 6.96 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 167.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.0 152.67 79.89 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.505 2.137 . . . . 0.0 112.714 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.49 155.68 24.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.597 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.7 p -67.9 175.77 1.59 Allowed Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.371 1.068 . . . . 0.0 109.679 169.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -53.57 143.34 56.94 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 120.643 0.896 . . . . 0.0 109.857 155.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.66 155.56 37.63 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.3 mmt-85 -136.46 165.39 25.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 120.981 -1.075 . . . . 0.0 108.839 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.42 151.74 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.68 126.12 6.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.832 1.653 . . . . 0.0 107.491 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -88.94 146.95 24.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 p -87.65 156.36 53.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 123.392 0.433 . . . . 0.0 110.215 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.42 ' HD3' ' CG2' ' A' ' 25' ' ' VAL . 17.9 Cg_endo -63.7 -80.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.698 2.932 . . . . 0.0 112.576 -166.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -156.29 -28.09 0.1 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.217 0 C-N-CA 124.491 1.043 . . . . 0.0 111.573 -176.48 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.0 mt . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 119.036 -0.506 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.76 139.59 25.14 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.32 2.013 . . . . 0.0 111.634 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.9 mtm -92.0 -38.13 12.42 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.993 1.317 . . . . 0.0 113.152 -172.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.65 HG22 ' HB2' ' A' ' 42' ' ' SER . 24.4 m -133.83 174.83 12.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 118.624 0.647 . . . . 0.0 110.382 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 107' ' ' PRO . . . -118.26 162.86 27.89 Favored Pre-proline 0 N--CA 1.441 -0.889 0 C-N-CA 128.449 2.7 . . . . 0.0 108.612 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 46.1 Cg_endo -66.18 161.48 40.08 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.837 2.358 . . . . 0.0 111.368 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.64 -147.45 0.41 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.617 2.532 . . . . 0.0 114.3 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.9 91.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.922 1.689 . . . . 0.0 108.79 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.38 155.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.131 1.372 . . . . 0.0 108.725 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -132.43 163.57 28.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.973 1.709 . . . . 0.0 106.939 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.6 144.91 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -123.8 136.16 54.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.511 2.724 . . . . 0.0 108.204 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' HD3' ' A' ' 117' ' ' PRO . 71.5 t -92.94 102.03 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 m -71.45 -58.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.801 1.64 . . . . 0.0 109.507 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -131.76 -173.85 3.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.8 1.24 . . . . 0.0 110.907 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.32 95.14 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.012 -1.055 . . . . 0.0 113.635 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 p -129.23 12.41 6.04 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.614 0.766 . . . . 0.0 111.243 -169.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 tp -121.12 132.73 55.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 169.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . . . -125.49 165.65 18.08 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 168.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -135.42 139.54 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 142.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -136.33 122.62 20.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.555 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -124.83 -178.47 4.17 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.05 1.74 . . . . 0.0 109.796 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.76 135.44 19.54 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.818 1.247 . . . . 0.0 109.332 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 100.48 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.469 2.78 . . . . 0.0 110.134 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.6 m -65.49 162.36 42.92 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.982 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.06 150.02 86.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.126 2.551 . . . . 0.0 110.928 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.77 -25.32 68.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 167.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -57.2 -51.22 70.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.313 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.65 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.2 p -66.55 -34.09 77.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.092 0.86 . . . . 0.0 110.384 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.0 mt -66.46 -23.79 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.039 0.936 . . . . 0.0 110.413 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.26 19.1 mtp180 60.12 -13.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 129.324 3.05 . . . . 0.0 116.44 -173.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.53 -94.24 0.1 Allowed Glycine 0 CA--C 1.518 0.222 0 CA-C-N 120.351 1.432 . . . . 0.0 110.902 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -125.41 133.79 52.37 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.517 1.527 . . . . 0.0 109.824 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.1 tp -70.83 118.73 13.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -70.69 -50.89 31.71 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.01 -173.38 42.89 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -112.81 127.27 56.12 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.932 0.893 . . . . 0.0 109.032 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -103.44 118.86 37.72 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mt -92.94 127.48 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -92.06 154.88 18.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 159.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -159.63 164.03 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.147 1.379 . . . . 0.0 111.498 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -148.6 160.34 43.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.265 -0.897 . . . . 0.0 111.312 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -69.19 138.5 54.14 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 107.93 171.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.8 m . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 177.937 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tttt . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.24 153.73 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.473 ' CD1' HD13 ' A' ' 84' ' ' LEU . 2.1 mt -135.04 152.51 51.77 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.663 2.385 . . . . 0.0 108.699 166.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.8 m -126.66 104.02 7.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.049 1.34 . . . . 0.0 109.048 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -104.17 98.29 8.12 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -74.17 169.43 17.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.17 -179.33 53.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 124.386 0.993 . . . . 0.0 111.205 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -81.31 -1.71 46.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -170.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 149.06 20.63 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.499 0.666 . . . . 0.0 112.427 -168.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -108.45 2.31 22.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 111.914 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.19 164.38 30.23 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.5 -0.75 . . . . 0.0 109.758 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.16 161.41 33.94 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -173.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 43.3 mtp -117.94 152.61 35.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.703 1.251 . . . . 0.0 111.732 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . 3.2 mm? -109.97 84.98 3.8 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 127.63 2.372 . . . . 0.0 106.961 -178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -84.58 160.79 12.56 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.41 2.74 . . . . 0.0 110.754 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.86 8.94 81.84 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.469 -0.628 . . . . 0.0 112.844 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 84' ' ' LEU . 2.4 mm? -80.03 -179.0 6.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.652 1.581 . . . . 0.0 108.996 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -123.03 150.82 60.28 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 122.999 0.52 . . . . 0.0 110.383 171.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.55 172.24 9.51 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.827 2.351 . . . . 0.0 111.683 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.3 t80 45.58 36.4 2.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.821 2.848 . . . . 0.0 113.258 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.9 m -133.34 164.51 26.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.029 1.732 . . . . 0.0 110.108 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -100.4 152.38 20.42 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -139.37 152.17 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.7 m -127.14 134.65 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 153.5 38.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.082 1.753 . . . . 0.0 110.761 -170.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 124.25 6.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.549 1.14 . . . . 0.0 110.435 -162.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.52 131.41 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 108.518 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -125.13 131.72 53.21 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.611 -1.306 . . . . 0.0 109.812 171.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.57 153.7 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.97 147.04 28.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -133.87 -174.91 3.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.692 1.197 . . . . 0.0 109.181 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.05 -3.56 6.42 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.667 -1.629 . . . . 0.0 115.114 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -117.33 -30.99 5.42 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 120.315 2.057 . . . . 0.0 111.553 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.73 -173.53 44.52 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 119.409 1.004 . . . . 0.0 113.971 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -86.64 144.22 27.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.373 1.069 . . . . 0.0 109.796 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -89.2 -168.77 43.95 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.141 0.877 . . . . 0.0 111.96 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 44.4 Cg_endo -63.86 152.4 80.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.057 2.505 . . . . 0.0 111.064 169.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.23 139.45 42.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.602 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . 8.6 t -63.41 171.04 2.37 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.114 1.366 . . . . 0.0 108.644 158.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.39 155.7 36.69 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.151 2.567 . . . . 0.0 110.193 -169.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.12 110.04 9.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.6 171.05 14.48 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 170.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.82 161.8 26.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.56 0.744 . . . . 0.0 110.549 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.82 161.17 42.9 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.88 1.672 . . . . 0.0 109.081 167.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -128.55 128.77 44.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.759 2.023 . . . . 0.0 107.523 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.5 p -87.22 160.5 48.59 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.111 0.564 . . . . 0.0 110.503 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.418 ' HD3' HG11 ' A' ' 25' ' ' VAL . 68.7 Cg_endo -79.13 172.04 15.39 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.991 3.127 . . . . 0.0 109.039 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.08 -31.49 67.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -167.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.26 0 C-N-CA 124.272 0.939 . . . . 0.0 111.371 178.562 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.39 155.35 55.62 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.211 1.94 . . . . 0.0 111.595 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.7 mtp -111.9 -33.96 6.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -160.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.654 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.2 m -140.47 178.57 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.003 0.82 . . . . 0.0 110.587 -165.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.04 145.93 41.03 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 127.663 2.385 . . . . 0.0 109.838 -173.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -72.2 125.88 11.23 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.187 1.925 . . . . 0.0 109.149 174.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.11 -172.09 43.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 123.972 0.796 . . . . 0.0 111.667 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 40.31 58.49 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.563 2.345 . . . . 0.0 110.681 172.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.69 142.98 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.35 100.42 2.88 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.563 -0.711 . . . . 0.0 109.924 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.25 134.87 47.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -171.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -124.28 135.26 53.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.833 1.653 . . . . 0.0 109.89 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.2 102.34 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 118.837 0.744 . . . . 0.0 109.764 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.56 -56.76 11.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.768 2.027 . . . . 0.0 111.121 -177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -126.32 173.78 9.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.447 1.499 . . . . 0.0 107.531 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -30.14 69.51 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.066 -1.021 . . . . 0.0 112.635 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -120.7 10.42 11.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.531 1.132 . . . . 0.0 113.078 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -133.36 117.23 17.04 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.863 1.665 . . . . 0.0 109.597 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.57 166.06 11.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.35 148.04 36.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.754 2.422 . . . . 0.0 107.956 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 44.5 t -127.76 114.94 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -92.78 157.59 16.34 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.394 1.059 . . . . 0.0 109.249 166.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -149.76 177.43 9.8 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.168 2.187 . . . . 0.0 109.601 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -104.5 133.86 19.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.388 0.675 . . . . 0.0 110.785 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 107.96 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 125.185 3.923 . . . . 0.0 110.664 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 m -57.51 155.47 19.99 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 119.259 -0.401 . . . . 0.0 110.396 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -59.35 131.55 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.917 2.411 . . . . 0.0 108.245 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.09 -32.88 62.34 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.124 0.875 . . . . 0.0 112.138 -173.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -49.59 -41.8 42.86 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.69 1.196 . . . . 0.0 111.911 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.654 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.9 p -66.22 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.861 0.865 . . . . 0.0 112.777 -174.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.74 -34.0 65.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.125 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 42.57 57.89 3.31 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 111.706 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.08 -168.64 28.86 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -77.36 128.23 33.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 49' ' ' GLY . 2.6 tt -60.98 108.49 0.88 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.995 1.318 . . . . 0.0 107.491 172.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -85.2 -21.25 29.22 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.522 -0.736 . . . . 0.0 112.04 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.404 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 150.32 -168.89 30.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.679 1.133 . . . . 0.0 110.945 170.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -124.16 118.27 26.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -96.05 130.92 42.94 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.35 119.76 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -91.16 145.36 24.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 50.9 p90 -156.67 166.0 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 120.202 1.364 . . . . 0.0 110.692 173.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -148.41 153.48 38.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.774 0.829 . . . . 0.0 111.217 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -68.73 128.35 36.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 C--N 1.326 -0.418 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.23 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 C--O 1.233 0.223 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.4 mm -135.13 163.08 37.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.485 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -140.67 155.46 46.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.752 1.621 . . . . 0.0 108.355 167.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -116.55 120.74 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.108 1.363 . . . . 0.0 107.613 -165.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -130.32 150.1 51.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -76.38 -175.49 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.908 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.7 53.83 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 122.628 1.127 . . . . 0.0 112.125 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.6 p 59.57 -23.42 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.768 3.627 . . . . 0.0 118.786 173.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 150.23 12.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.844 0.83 . . . . 0.0 109.237 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 p -110.9 14.25 22.1 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.139 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -155.47 162.21 40.79 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.949 0.9 . . . . 0.0 112.385 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.56 -174.67 26.6 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 128.246 2.831 . . . . 0.0 108.169 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 mtp -131.98 166.55 21.43 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.512 1.156 . . . . 0.0 110.017 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.485 HD13 ' CD1' ' A' ' 73' ' ' LEU . 1.8 mm? -122.5 85.36 48.26 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 125.272 1.429 . . . . 0.0 107.29 168.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.39 146.16 6.12 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.283 3.322 . . . . 0.0 111.46 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.51 18.71 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.628 0.632 . . . . 0.0 113.148 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD12 ' A' ' 84' ' ' LEU . 3.1 mm? -92.44 177.63 6.07 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.869 0.868 . . . . 0.0 109.081 -165.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.52 147.94 43.05 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 125.08 1.352 . . . . 0.0 108.32 171.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -74.06 164.48 34.3 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.501 2.134 . . . . 0.0 112.292 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.4 t80 61.2 22.81 13.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.678 1.991 . . . . 0.0 112.794 170.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -120.22 162.5 19.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.084 1.354 . . . . 0.0 111.414 167.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.08 150.7 23.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.182 2.193 . . . . 0.0 107.145 168.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -137.24 156.26 48.51 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.24 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.3 m -125.89 135.46 51.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -139.36 154.37 47.84 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.918 1.687 . . . . 0.0 109.358 178.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -138.62 157.26 46.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.89 152.82 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -147.95 145.27 28.52 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.01 147.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.07 146.84 26.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -132.95 -178.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.729 0.812 . . . . 0.0 110.886 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.51 50.4 2.1 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.792 1.187 . . . . 0.0 111.919 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -157.98 -52.79 0.07 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.146 2.178 . . . . 0.0 107.629 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.13 -172.05 36.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.538 0.608 . . . . 0.0 113.294 -171.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -97.44 161.59 13.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.249 1.02 . . . . 0.0 112.767 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.39 -170.58 14.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.855 1.216 . . . . 0.0 113.493 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.55 141.31 45.73 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 124.159 3.239 . . . . 0.0 111.365 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.85 41.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.387 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.4 p -60.54 169.99 1.57 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 164.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -54.32 145.81 53.99 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 108.646 -1.328 . . . . 0.0 108.646 156.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.33 104.55 10.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -80.93 168.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.247 1.819 . . . . 0.0 108.889 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.18 161.24 28.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 122.1 -0.375 . . . . 0.0 110.307 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -159.02 129.36 5.86 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 110.975 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -86.06 139.43 31.15 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 p -94.26 145.28 29.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 -77.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.269 2.646 . . . . 0.0 112.489 -159.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -159.7 -28.98 0.06 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.666 -0.646 . . . . 0.0 111.195 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.324 0 C-N-CA 125.435 1.493 . . . . 0.0 109.481 -178.71 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt . . . . . 0 C--O 1.237 0.421 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 56.8 Cg_endo -80.45 170.09 16.35 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.939 3.093 . . . . 0.0 112.594 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.8 mtm -132.78 -31.38 1.33 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -161.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG22 ' CB ' ' A' ' 42' ' ' SER . 26.1 m -139.48 147.17 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 121.145 1.793 . . . . 0.0 109.818 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.607 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -87.04 169.12 15.48 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.921 1.289 . . . . 0.0 109.91 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.607 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 37.2 Cg_endo -74.79 162.32 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.095 1.863 . . . . 0.0 111.81 -168.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.25 166.81 52.9 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -31.41 104.51 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.517 2.327 . . . . 0.0 114.273 -160.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.81 142.98 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -122.3 160.14 25.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.681 1.992 . . . . 0.0 106.985 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.602 HG21 ' CD2' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -147.03 145.73 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.009 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -123.43 128.32 49.66 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.217 1.807 . . . . 0.0 108.444 172.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.5 103.1 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 170.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.575 ' HB ' HD12 ' A' ' 30' ' ' LEU . 57.4 t -67.32 -48.3 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.409 0.683 . . . . 0.0 109.734 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -143.12 -178.24 5.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.176 1.39 . . . . 0.0 108.013 -174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -38.87 92.37 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.893 -1.129 . . . . 0.0 111.959 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 p -112.8 6.06 17.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.262 1.425 . . . . 0.0 112.098 -171.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.686 HD11 ' CE ' ' A' ' 83' ' ' MET . 2.5 tm? -134.48 137.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.959 1.703 . . . . 0.0 108.691 -177.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.423 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -135.91 161.29 36.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -119.88 128.59 53.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.39 2.276 . . . . 0.0 106.396 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.28 141.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -147.6 159.68 43.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.029 1.286 . . . . 0.0 109.473 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.55 142.66 89.2 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.3 113.08 2.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.242 2.628 . . . . 0.0 109.049 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.628 HG22 ' HD2' ' A' ' 39' ' ' PRO . 4.9 p -71.94 149.19 92.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.036 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' HG22 ' A' ' 38' ' ' VAL . 37.2 Cg_endo -70.7 137.66 33.19 Favored 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.567 4.178 . . . . 0.0 108.841 -170.164 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.17 -28.7 59.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.688 0.677 . . . . 0.0 112.043 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -57.72 -42.42 83.76 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.522 173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.482 ' CB ' HG22 ' A' ' 16' ' ' VAL . 86.2 p -68.39 -28.65 67.28 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.01 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.9 -40.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 C-N-CA 124.247 1.019 . . . . 0.0 108.455 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 65.12 -70.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.499 1.92 . . . . 0.0 112.294 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.61 -169.82 1.5 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.705 2.098 . . . . 0.0 111.802 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -80.82 138.72 36.24 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.735 0.814 . . . . 0.0 109.847 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.451 HD22 ' H ' ' A' ' 49' ' ' GLY . 2.2 tm? -61.05 127.58 32.23 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.319 1.048 . . . . 0.0 108.764 174.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -98.75 -23.52 15.39 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.727 0.811 . . . . 0.0 111.985 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.451 ' H ' HD22 ' A' ' 47' ' ' LEU . . . 132.8 -155.73 21.75 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -169.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -128.53 156.28 43.53 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.621 1.168 . . . . 0.0 107.99 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.59 109.72 12.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mt -85.42 141.78 14.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -118.41 117.68 29.69 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.96 1.704 . . . . 0.0 108.932 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.515 ' CD2' HD11 ' A' ' 84' ' ' LEU . 26.5 p90 -133.43 160.63 36.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.429 1.013 . . . . 0.0 112.444 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -149.38 161.0 42.95 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.398 1.479 . . . . 0.0 110.7 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -68.79 137.19 53.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.296 1.838 . . . . 0.0 108.755 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.9 tttt . . . . . 0 N--CA 1.444 -0.728 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.26 141.02 43.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 124.85 1.26 . . . . 0.0 107.849 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.9 tp -130.58 150.02 51.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.74 2.416 . . . . 0.0 106.879 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.64 137.46 45.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.107 0.963 . . . . 0.0 108.957 -170.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -142.43 93.07 2.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.374 1.07 . . . . 0.0 109.814 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -77.55 171.1 15.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.255 0.55 . . . . 0.0 110.329 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.43 70.38 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.863 -0.523 . . . . 0.0 113.366 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.7 t 58.95 20.47 8.2 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 113.332 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -56.53 134.05 53.89 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -89.66 -1.98 58.17 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.853 1.346 . . . . 0.0 112.069 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -147.53 144.17 28.33 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.54 162.05 32.63 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -171.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.686 ' CE ' HD11 ' A' ' 30' ' ' LEU . 27.0 mtp -117.44 148.66 41.59 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.45 -0.441 . . . . 0.0 111.346 -162.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.515 HD11 ' CD2' ' A' ' 54' ' ' TYR . 3.6 mm? -105.38 90.62 4.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 128.122 2.569 . . . . 0.0 107.417 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -93.2 162.37 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.712 2.275 . . . . 0.0 112.734 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.28 33.34 86.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.98 163.08 16.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.296 1.038 . . . . 0.0 108.314 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -103.49 134.1 19.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -76.98 169.39 21.73 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.445 2.096 . . . . 0.0 111.652 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.7 t80 54.7 43.15 30.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.173 2.189 . . . . 0.0 111.937 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -149.51 162.61 39.8 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 120.727 -1.233 . . . . 0.0 111.112 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -93.6 156.14 16.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -143.87 159.7 42.08 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.0 m -120.64 130.09 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.6 163.73 22.8 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.125 1.37 . . . . 0.0 109.971 168.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.5 169.08 20.31 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.937 1.295 . . . . 0.0 109.043 165.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.9 t -114.59 132.18 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 m -87.36 153.56 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.99 142.49 31.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.549 1.539 . . . . 0.0 106.868 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -144.53 -175.44 4.65 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.326 0.584 . . . . 0.0 111.125 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.43 -1.06 2.98 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.872 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -124.09 -36.26 2.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 120.56 2.18 . . . . 0.0 111.323 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.57 -150.55 10.98 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 121.697 0.609 . . . . 0.0 112.208 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.74 159.01 22.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.726 1.61 . . . . 0.0 107.91 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.451 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -102.94 -162.24 25.74 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.874 0.75 . . . . 0.0 113.574 171.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.76 162.38 25.32 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 159.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.56 166.02 11.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.482 172.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.8 p -65.99 179.36 0.47 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.419 1.088 . . . . 0.0 109.544 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.75 168.71 6.6 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.356 1.163 . . . . 0.0 109.561 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 137.72 58.23 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.087 -1.008 . . . . 0.0 108.858 160.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -115.3 158.24 22.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 161.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.54 161.27 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.602 ' CD2' HG21 ' A' ' 23' ' ' VAL . 45.7 p90 -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 166.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -91.86 128.85 37.85 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.07 0.948 . . . . 0.0 108.748 171.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -78.21 163.78 60.3 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.979 -0.534 . . . . 0.0 109.6 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.67 -114.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.686 2.924 . . . . 0.0 110.192 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.79 -31.9 3.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.387 1.449 . . . . 0.0 112.975 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.489 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -164.218 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.45 167.41 16.9 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.348 2.699 . . . . 0.0 111.361 171.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.9 mtm -123.2 -35.24 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.44 1.496 . . . . 0.0 113.507 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.69 HG22 ' CB ' ' A' ' 42' ' ' SER . 15.3 m -137.69 -176.88 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.342 0.973 . . . . 0.0 110.368 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -125.41 171.41 7.63 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 127.503 2.321 . . . . 0.0 109.685 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 6.6 Cg_endo -63.97 141.54 77.82 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.97 1.113 . . . . 0.0 110.475 164.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.73 -177.49 31.91 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -23.9 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 129.942 3.297 . . . . 0.0 114.038 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.58 145.36 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -120.62 157.91 28.51 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 126.213 1.805 . . . . 0.0 106.859 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 141.84 21.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 173.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -124.29 136.75 54.35 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.383 1.473 . . . . 0.0 108.579 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 115' ' ' ASN . 80.8 t -95.8 105.13 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.277 1.037 . . . . 0.0 108.726 177.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.719 ' HB ' HD12 ' A' ' 30' ' ' LEU . 85.6 t -80.11 -48.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.491 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -130.91 -178.14 4.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.8 -29.78 64.81 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.626 -1.296 . . . . 0.0 112.922 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.6 p -123.88 14.24 9.25 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 111.096 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.719 HD12 ' HB ' ' A' ' 26' ' ' VAL . 3.3 tm? -124.89 137.04 54.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 106.628 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -138.5 155.55 48.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 167.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.01 150.36 38.74 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.088 1.355 . . . . 0.0 107.771 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 42.6 t -129.27 135.11 62.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.18 123.59 32.47 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -129.63 157.93 40.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 110.63 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.86 139.28 95.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.185 0.994 . . . . 0.0 111.369 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.38 109.07 2.84 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.549 2.833 . . . . 0.0 111.084 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HA ' ' HD3' ' A' ' 39' ' ' PRO 0.32 48.9 t -79.61 159.17 72.41 Favored Pre-proline 0 N--CA 1.409 -2.492 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -169.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' VAL . 4.7 Cg_exo -59.6 147.2 92.81 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.232 3.955 . . . . 0.0 111.124 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 43' ' ' ILE . 2.5 mm? -66.83 -35.41 79.98 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.618 -0.676 . . . . 0.0 109.267 160.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -49.47 -36.69 23.52 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.201 0.6 . . . . 0.0 111.687 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.69 ' CB ' HG22 ' A' ' 16' ' ' VAL . 9.3 p -91.0 -13.67 32.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.676 HD13 ' HB2' ' A' ' 47' ' ' LEU . 85.4 mt -68.12 -38.52 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 120.44 1.473 . . . . 0.0 108.634 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 47.7 56.4 7.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 110.659 -173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.36 -179.21 32.4 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -73.05 144.45 47.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.676 ' HB2' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -77.24 122.69 25.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -75.41 -24.27 57.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.978 1.711 . . . . 0.0 111.009 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.95 -177.74 32.04 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 125.836 1.684 . . . . 0.0 109.338 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -99.76 129.18 45.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -113.2 102.5 10.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.499 1.519 . . . . 0.0 107.837 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.6 mt -78.0 121.53 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.69 151.05 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 162.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -157.32 164.78 37.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.205 1.402 . . . . 0.0 111.043 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -149.22 158.65 44.35 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.255 1.022 . . . . 0.0 111.667 168.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -68.71 134.1 49.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.2 m . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.009 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 tttt . . . . . 0 N--CA 1.444 -0.735 0 CA-C-O 120.495 0.188 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.52 153.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.037 1.735 . . . . 0.0 106.575 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 tp -131.14 163.16 28.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.277 2.631 . . . . 0.0 107.196 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.4 m -138.25 120.58 15.9 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -132.08 102.67 5.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 107.603 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -84.63 163.75 19.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.483 1.113 . . . . 0.0 108.943 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.26 171.35 25.31 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.5 p -78.6 27.41 0.21 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.85 1.26 . . . . 0.0 113.875 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -52.16 145.32 10.78 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.598 1.159 . . . . 0.0 110.73 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -112.75 10.85 19.3 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.135 1.374 . . . . 0.0 111.956 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 1.5 p80 -148.67 156.53 42.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.31 1.044 . . . . 0.0 109.787 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.19 117.89 0.61 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.592 0.615 . . . . 0.0 112.033 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.697 ' HE2' HD11 ' A' ' 30' ' ' LEU . 9.7 mtp -76.02 153.0 36.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.886 0.875 . . . . 0.0 112.833 -171.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.71 88.22 1.75 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 128.119 2.568 . . . . 0.0 108.163 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.75 158.99 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.11 2.54 . . . . 0.0 112.073 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.21 18.18 79.48 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.509 -0.744 . . . . 0.0 113.366 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.5 -176.83 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.407 1.883 . . . . 0.0 110.224 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 15.2 mt-10 -102.54 147.56 34.2 Favored Pre-proline 0 C--O 1.242 0.689 0 CA-C-N 118.746 0.703 . . . . 0.0 111.229 168.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 8.8 Cg_endo -73.51 176.8 8.8 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.807 3.005 . . . . 0.0 113.139 171.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 31.2 t80 48.52 29.32 2.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.977 2.511 . . . . 0.0 115.225 170.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.1 m -128.75 -175.44 3.54 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.151 1.38 . . . . 0.0 111.183 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -122.46 152.37 40.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.964 1.306 . . . . 0.0 107.772 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -144.55 158.2 43.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.53 1.132 . . . . 0.0 108.964 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 m -122.75 141.56 51.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.89 149.23 33.86 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.75 2.02 . . . . 0.0 110.181 173.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -137.22 128.17 27.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.038 1.735 . . . . 0.0 108.949 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -89.34 144.21 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -151.96 154.06 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.913 -1.742 . . . . 0.0 108.699 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.59 146.78 5.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.1 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -135.47 -178.31 5.06 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.252 1.021 . . . . 0.0 109.446 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.96 -36.27 89.72 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 121.91 -0.494 . . . . 0.0 112.94 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -75.2 -46.39 34.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.737 0.768 . . . . 0.0 110.427 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.99 -134.44 2.52 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.668 0.667 . . . . 0.0 111.86 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -136.14 165.43 25.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.343 2.257 . . . . 0.0 108.869 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -153.98 8.32 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.37 0.985 . . . . 0.0 112.004 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 56.9 Cg_endo -65.29 137.14 50.27 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.865 1.71 . . . . 0.0 109.318 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 162.8 28.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.782 0.801 . . . . 0.0 109.384 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 99.1 p -71.3 171.84 7.95 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.261 -0.9 . . . . 0.0 110.179 168.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 40.4 Cg_endo -64.18 136.92 54.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.716 1.611 . . . . 0.0 110.379 168.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.5 106.09 0.88 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.226 1.811 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.42 167.25 22.05 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.986 1.314 . . . . 0.0 110.417 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.92 166.36 29.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.114 1.365 . . . . 0.0 108.899 173.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.32 158.76 38.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.784 0.834 . . . . 0.0 109.64 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.468 ' O ' HG21 ' A' ' 25' ' ' VAL . 7.5 p30 -112.52 152.98 28.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 126.003 1.721 . . . . 0.0 108.195 171.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 153.68 39.21 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 119.257 0.935 . . . . 0.0 110.887 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.57 -75.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.588 2.859 . . . . 0.0 113.126 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -158.2 -35.23 0.07 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.208 1.403 . . . . 0.0 112.828 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 O-C-N 121.149 -0.969 . . . . 0.0 110.903 -177.069 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.06 164.69 24.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.585 1.524 . . . . 0.0 110.354 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.1 mtm -107.77 -35.07 6.78 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.093 0.957 . . . . 0.0 112.023 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.6 m -131.06 160.71 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.318 0.963 . . . . 0.0 111.484 -163.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.57 68.69 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 126.488 1.915 . . . . 0.0 107.807 161.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.61 164.42 11.38 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 109.556 -0.979 . . . . 0.0 109.556 161.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.55 -165.36 2.74 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.445 1.498 . . . . 0.0 113.731 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -54.48 115.94 2.39 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.28 154.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.25 154.5 40.1 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.901 2.08 . . . . 0.0 106.411 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -146.71 138.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.09 118.9 27.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.312 2.245 . . . . 0.0 105.457 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 117' ' ' PRO . 64.7 t -64.8 134.76 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.89 -52.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -141.52 -175.6 4.43 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.241 1.416 . . . . 0.0 109.12 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -33.09 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.366 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.6 p -133.59 36.8 3.33 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.369 1.068 . . . . 0.0 109.519 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.503 HD11 ' HE2' ' A' ' 83' ' ' MET . 1.4 tm? -151.81 137.08 17.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.125 0.97 . . . . 0.0 109.701 171.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.39 138.37 24.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.46 125.24 50.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -99.12 145.35 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -127.8 147.76 50.43 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.278 0.631 . . . . 0.0 109.506 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -135.73 -175.08 3.84 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.433 1.493 . . . . 0.0 108.369 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -114.08 136.85 22.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.44 112.44 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.347 2.698 . . . . 0.0 111.704 -172.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.624 HG12 ' HD2' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -70.52 143.02 89.67 Favored Pre-proline 0 N--CA 1.41 -2.432 0 C-N-CA 124.756 1.222 . . . . 0.0 110.205 -171.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.624 ' HD2' HG12 ' A' ' 38' ' ' VAL . 2.5 Cg_endo -62.19 133.44 43.78 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 125.812 4.341 . . . . 0.0 111.864 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -58.42 -36.3 73.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 175.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -52.19 -36.57 52.25 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.407 ' HB2' HG22 ' A' ' 16' ' ' VAL . 6.2 p -94.99 -13.97 24.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 47' ' ' LEU . 64.9 mt -68.41 -34.67 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.477 1.035 . . . . 0.0 109.703 164.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 60.36 6.87 1.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.839 1.656 . . . . 0.0 115.083 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.15 -166.73 23.53 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.398 0.999 . . . . 0.0 110.625 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.27 118.97 13.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.0 tm? -59.83 122.8 15.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.833 1.253 . . . . 0.0 107.79 167.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.32 -32.88 22.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.756 0.822 . . . . 0.0 111.198 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 76' ' ' GLN . . . 156.32 -178.56 32.75 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -116.56 112.6 21.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.68 109.44 19.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.16 122.74 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -91.97 153.02 19.74 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.481 ' CE1' HD12 ' A' ' 73' ' ' LEU . 33.8 p90 -160.61 159.71 30.81 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.28 1.832 . . . . 0.0 109.482 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -148.99 153.21 37.6 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.695 0.798 . . . . 0.0 110.735 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -68.58 118.6 11.81 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.643 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 18.8 mmtt . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 121.644 0.735 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.63 148.25 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 106.69 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.527 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -130.3 147.47 52.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.717 2.007 . . . . 0.0 107.722 172.633 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.4 m -120.29 91.51 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 108.757 -164.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 66.4 m-85 -94.09 76.85 4.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.409 ' HA ' ' HA3' ' A' ' 49' ' ' GLY . 4.0 pt20 -67.03 144.74 55.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.319 176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.93 167.33 40.15 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.349 0.976 . . . . 0.0 112.528 -175.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -79.57 16.92 0.96 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.324 2.25 . . . . 0.0 115.276 -167.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.07 163.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.794 1.637 . . . . 0.0 113.178 174.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -125.29 9.49 7.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.71 163.8 36.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.412 1.085 . . . . 0.0 108.954 173.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.63 165.66 36.34 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.503 ' HE2' HD11 ' A' ' 30' ' ' LEU . 46.1 mtp -111.91 150.56 30.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.134 0.974 . . . . 0.0 109.457 -168.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.9 mm? -115.46 79.85 7.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -86.75 162.37 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 110.247 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.18 74.4 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.935 0.779 . . . . 0.0 113.341 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.461 HD21 HD12 ' A' ' 84' ' ' LEU . 1.3 mm? -93.7 171.22 9.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.667 1.587 . . . . 0.0 108.723 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.2 156.74 35.5 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 124.359 1.064 . . . . 0.0 110.12 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -82.7 177.25 7.04 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 124.481 3.454 . . . . 0.0 112.957 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.9 t80 38.24 57.32 1.66 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.724 2.81 . . . . 0.0 111.85 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.5 m -149.98 157.79 43.51 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.378 1.871 . . . . 0.0 109.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -90.62 150.72 21.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' CE1' HD12 ' A' ' 87' ' ' LEU . 38.5 m-85 -134.93 154.83 51.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.886 1.274 . . . . 0.0 108.162 175.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.2 m -125.93 138.88 53.8 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 172.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -144.47 162.85 35.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.388 2.275 . . . . 0.0 109.697 177.135 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -134.45 -176.08 4.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.74 139.52 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.561 1.944 . . . . 0.0 106.394 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -140.89 128.82 21.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.683 1.193 . . . . 0.0 107.798 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 m -74.65 153.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.6 t -138.03 150.03 24.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 171.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -138.95 -168.9 2.52 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 109.123 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.88 4.5 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.456 -1.191 . . . . 0.0 116.036 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.02 -47.89 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.182 1.991 . . . . 0.0 111.358 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.3 -166.66 34.46 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 120.689 1.586 . . . . 0.0 113.427 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -95.58 167.85 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.884 1.273 . . . . 0.0 110.259 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -128.6 -157.32 9.26 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.617 1.579 . . . . 0.0 112.582 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.06 150.48 82.51 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.917 2.411 . . . . 0.0 110.222 177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.43 164.6 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.089 0.947 . . . . 0.0 112.131 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 p -69.19 177.22 1.25 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.247 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.98 146.87 15.91 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.73 1.62 . . . . 0.0 110.087 158.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.78 100.5 6.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 168.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.9 mmt-85 -76.57 162.98 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.872 -0.518 . . . . 0.0 110.267 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.78 157.37 38.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.333 0.653 . . . . 0.0 110.046 174.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -150.49 146.74 26.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.382 1.073 . . . . 0.0 109.245 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -109.75 145.11 37.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.355 1.062 . . . . 0.0 108.4 169.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.72 169.2 19.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.775 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' HG11 ' A' ' 25' ' ' VAL . 12.9 Cg_endo -68.23 -75.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.451 2.101 . . . . 0.0 109.266 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -172.45 -39.14 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.212 1.405 . . . . 0.0 110.592 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 C-N-CA 125.718 1.628 . . . . 0.0 112.258 -177.533 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.653 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 t -153.65 -71.48 0.14 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.154 0.982 . . . . 0.0 109.003 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 p 48.37 96.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.622 1.969 . . . . 0.0 111.492 -157.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.2 -154.99 8.09 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.6 m 60.42 176.68 0.1 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.437 1.495 . . . . 0.0 111.765 -166.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 t 62.14 137.18 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.359 1.864 . . . . 0.0 109.482 -155.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.96 -173.79 13.21 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.56 168.71 26.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.32 1.06 . . . . 0.0 109.234 167.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -150.45 151.15 32.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 166.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.44 -161.08 53.5 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -150.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . 0.253 5.6 mt-10 73.96 77.82 0.12 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 129.028 2.931 . . . . 0.0 112.284 173.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -60.14 -52.72 64.13 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.834 2.853 . . . . 0.0 112.201 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 mt 38.19 144.65 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.102 1 C-N-CA 134.986 5.314 . . . . 0.0 119.497 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.3 169.15 12.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.522 1.482 . . . . 0.0 113.261 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mtm -132.91 -40.53 0.94 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.986 0.914 . . . . 0.0 113.413 -165.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.587 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.6 m -135.32 168.66 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.01 166.1 12.56 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 126.754 2.021 . . . . 0.0 109.374 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 32.5 Cg_endo -70.98 141.6 40.66 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.332 1.355 . . . . 0.0 114.44 -166.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.63 178.56 23.86 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.506 1.526 . . . . 0.0 111.726 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 23.65 66.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.877 3.271 . . . . 0.0 114.477 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 112' ' ' ARG . 18.3 t -76.27 132.53 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.46 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -148.23 166.48 27.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.442 1.497 . . . . 0.0 109.44 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.51 141.61 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 120.78 -1.2 . . . . 0.0 108.62 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.0 119.25 29.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.224 2.61 . . . . 0.0 109.225 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.72 130.21 35.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 119.196 0.907 . . . . 0.0 108.851 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.32 -64.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 126.139 1.776 . . . . 0.0 107.993 -171.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -115.88 179.16 4.06 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.589 1.156 . . . . 0.0 108.065 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -18.3 61.52 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.224 -0.922 . . . . 0.0 112.768 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -126.35 0.27 7.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.323 1.849 . . . . 0.0 112.687 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -139.16 128.1 23.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.695 1.598 . . . . 0.0 108.207 -170.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.94 172.57 8.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.65 117.29 13.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 152.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -132.47 148.81 52.41 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.549 1.54 . . . . 0.0 109.138 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -160.28 164.89 32.27 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.662 1.585 . . . . 0.0 109.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -87.83 145.24 36.31 Favored Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 120.942 -1.099 . . . . 0.0 112.034 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.31 102.58 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.854 3.036 . . . . 0.0 111.095 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 4.6 m -64.26 158.88 62.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 10.7 Cg_endo -72.77 144.86 39.93 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.317 3.345 . . . . 0.0 110.229 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.3 mp -56.08 -30.72 62.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.243 0.474 . . . . 0.0 111.143 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -56.75 -28.49 61.27 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.587 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.6 p -89.58 -29.81 18.62 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 111.459 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.625 HD13 ' HB2' ' A' ' 47' ' ' LEU . 81.9 mt -67.83 -38.44 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.331 1.053 . . . . 0.0 109.071 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 50.01 80.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.639 1.575 . . . . 0.0 110.606 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.61 -102.76 0.83 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -138.22 103.58 4.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.6 -166.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.625 ' HB2' HD13 ' A' ' 43' ' ' ILE . 37.0 tp -54.88 119.62 5.65 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 127.006 2.123 . . . . 0.0 109.393 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -86.72 -48.7 8.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.078 0.951 . . . . 0.0 108.941 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.26 173.0 45.98 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -99.93 136.13 40.31 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 161.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -105.7 152.09 23.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.9 mt -126.4 126.2 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.45 141.28 28.7 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -153.02 159.95 42.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.543 1.137 . . . . 0.0 110.962 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -148.46 158.27 44.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.357 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -68.94 127.32 32.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.641 1.576 . . . . 0.0 106.87 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.2 m -110.26 165.73 11.53 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 60.5 15.63 5.75 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 t -102.44 -49.06 3.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.598 1.544 . . . . 0.0 109.416 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 t 53.05 78.94 0.13 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.661 1.984 . . . . 0.0 112.16 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.0 t -18.33 -60.48 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 130.193 3.397 . . . . 0.0 116.222 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.6 tttp 67.83 125.26 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.385 1.874 . . . . 0.0 113.556 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.69 -89.26 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.264 1.825 . . . . 0.0 113.096 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -62.6 107.71 1.0 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.23 1.412 . . . . 0.0 110.865 -166.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 46.32 45.37 13.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.685 1.594 . . . . 0.0 112.372 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -49.58 106.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.712 1.205 . . . . 0.0 111.274 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -153.05 -176.83 5.94 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.679 1.192 . . . . 0.0 108.759 164.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.1 mt -116.37 132.04 67.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.92 109.67 13.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -108.2 96.07 6.11 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -88.05 164.39 15.78 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.252 2.221 . . . . 0.0 109.854 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.25 149.38 28.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.94 144.7 50.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 128.665 2.786 . . . . 0.0 107.533 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.5 m -130.52 117.14 19.16 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -128.67 85.74 2.37 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.278 1.031 . . . . 0.0 109.011 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -67.54 147.09 53.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.053 0.541 . . . . 0.0 110.245 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.61 167.55 26.24 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 122.705 1.17 . . . . 0.0 111.409 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -87.55 44.37 1.18 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -151.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 167.02 3.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.396 0.617 . . . . 0.0 111.304 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 p -124.53 -1.97 7.99 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.701 1.6 . . . . 0.0 111.355 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -148.61 160.7 42.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.172 1.389 . . . . 0.0 107.39 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.02 134.24 3.26 Favored Glycine 0 N--CA 1.454 -0.162 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.6 mtp -81.67 153.47 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.038 0.419 . . . . 0.0 111.338 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 87' ' ' LEU . 1.5 mm? -106.92 91.08 5.9 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 167.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.87 154.92 2.27 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.953 3.102 . . . . 0.0 111.92 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.19 37.08 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.468 HD21 HD12 ' A' ' 84' ' ' LEU . 3.4 mm? -105.02 -166.41 1.23 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.402 3.081 . . . . 0.0 107.329 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -121.97 146.79 47.19 Favored Pre-proline 0 N--CA 1.45 -0.466 0 O-C-N 120.918 -1.114 . . . . 0.0 111.323 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 167.63 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.265 3.31 . . . . 0.0 111.963 163.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.262 0.3 OUTLIER 40.12 42.1 1.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.841 2.456 . . . . 0.0 111.525 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -133.62 153.12 51.91 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.557 -1.34 . . . . 0.0 108.44 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -94.14 146.53 23.92 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.11 153.99 51.82 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.8 m -126.64 143.71 51.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.08 163.12 39.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.354 1.861 . . . . 0.0 109.714 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -152.76 151.72 30.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 110.216 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.59 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.913 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -137.37 138.5 39.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.096 1.359 . . . . 0.0 108.326 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.12 152.41 3.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 64.0 t -137.36 134.94 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -128.3 -174.95 3.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.433 1.093 . . . . 0.0 109.713 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.72 -7.33 41.05 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.339 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.93 -38.93 5.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.95 1.7 . . . . 0.0 110.541 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.04 -173.27 45.13 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 110.638 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 166.78 22.81 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.34 -0.506 . . . . 0.0 110.814 164.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 -158.42 10.38 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 160.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.75 158.06 44.29 Favored 'Trans proline' 0 C--O 1.237 0.428 0 CA-C-N 119.886 1.843 . . . . 0.0 112.586 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.4 143.35 26.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.639 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.23 175.18 2.96 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 126.064 1.746 . . . . 0.0 111.185 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.35 137.48 65.61 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.731 1.621 . . . . 0.0 109.353 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.73 153.92 27.0 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.271 1.034 . . . . 0.0 110.729 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 21' ' ' VAL . 74.4 mmt-85 -134.5 170.54 15.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 107.687 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.6 m -135.27 157.01 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.786 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -153.72 143.03 21.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -112.4 137.69 50.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 170.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -92.16 151.21 41.49 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.16 -73.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.846 3.031 . . . . 0.0 113.265 -159.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -154.0 -41.31 0.09 Allowed 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 151.84 -175.87 30.43 Favored Glycine 0 N--CA 1.464 0.562 0 CA-C-O 119.287 -0.729 . . . . 0.0 111.701 -167.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.1 p 172.71 135.28 0.03 OUTLIER 'General case' 0 C--O 1.236 0.351 0 C-N-CA 128.599 2.76 . . . . 0.0 107.636 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.08 176.58 14.45 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.49 46.29 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.872 3.714 . . . . 0.0 111.506 -175.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.99 156.01 22.28 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.04 -1.037 . . . . 0.0 109.479 169.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.8 m -151.94 -50.26 0.11 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.319 -0.863 . . . . 0.0 110.753 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.307 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 178.369 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.679 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.7 m -149.79 162.7 39.76 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.929 2.092 . . . . 0.0 106.913 170.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -155.24 97.72 1.93 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.45 162.25 19.56 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -172.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 t -143.81 -40.4 0.29 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.549 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.2 m 59.21 -177.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.302 1.441 . . . . 0.0 111.505 -171.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.84 113.83 1.93 Allowed Glycine 0 C--N 1.339 0.737 0 O-C-N 121.138 -0.976 . . . . 0.0 112.481 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -133.04 135.43 45.38 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.767 1.227 . . . . 0.0 108.956 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t 62.6 171.86 0.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.019 1.728 . . . . 0.0 111.068 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.31 99.19 1.62 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -83.45 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 161.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.98 4.0 34.07 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 121.446 -0.784 . . . . 0.0 112.342 -165.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.1 153.59 80.65 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 124.959 1.304 . . . . 0.0 110.779 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.9 -175.78 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.295 2.663 . . . . 0.0 112.807 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 42.5 mtm -126.51 -59.37 1.3 Allowed 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 110.467 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 42' ' ' SER . 35.1 m -122.21 148.93 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.605 0.717 . . . . 0.0 111.635 -168.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.75 168.4 18.47 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.003 2.121 . . . . 0.0 109.912 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 2.0 Cg_endo -61.01 155.82 48.04 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.345 1.363 . . . . 0.0 113.308 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.34 -175.49 30.24 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.115 1.34 . . . . 0.0 111.088 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -36.09 103.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 127.476 2.311 . . . . 0.0 113.757 -163.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.56 139.73 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.27 156.44 45.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -146.46 118.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 119.214 0.915 . . . . 0.0 109.285 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -96.7 121.41 38.52 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.465 1.106 . . . . 0.0 109.202 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.0 t -86.5 108.62 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.603 ' HB ' HD12 ' A' ' 30' ' ' LEU . 40.2 t -71.1 -56.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.765 0.826 . . . . 0.0 108.885 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.19 -174.3 3.29 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.13 0.972 . . . . 0.0 109.674 -163.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -27.84 67.76 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.623 -0.673 . . . . 0.0 112.136 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.4 p -129.39 7.55 5.38 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.46 1.104 . . . . 0.0 111.795 -166.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.649 HD11 ' CE ' ' A' ' 83' ' ' MET . 3.3 tm? -138.54 139.45 38.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.17 1.788 . . . . 0.0 108.352 -174.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -141.03 173.42 11.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.938 167.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 151.22 51.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.635 1.974 . . . . 0.0 108.877 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 t -126.97 134.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -119.47 128.98 54.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -142.99 -179.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.529 1.132 . . . . 0.0 110.279 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.1 144.58 29.69 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.899 0.879 . . . . 0.0 111.704 -172.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.53 96.47 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.409 2.739 . . . . 0.0 111.192 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 32.4 m -64.03 157.04 71.62 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.052 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 58.7 Cg_endo -77.31 146.01 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.308 2.672 . . . . 0.0 109.358 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.06 -30.75 71.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.759 -0.588 . . . . 0.0 111.798 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -59.3 -34.55 72.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.402 -0.808 . . . . 0.0 111.614 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.77 ' HB2' HG22 ' A' ' 16' ' ' VAL . 60.6 p -64.39 -42.99 95.84 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.494 1.043 . . . . 0.0 110.062 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.7 mt -64.25 -31.52 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.086 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 54.72 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.643 2.377 . . . . 0.0 115.232 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.13 -155.57 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.315 1.912 . . . . 0.0 109.591 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -103.94 109.73 21.6 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.82 1.248 . . . . 0.0 110.874 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -46.29 110.45 0.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 127.092 2.157 . . . . 0.0 109.678 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.421 ' H ' ' HA ' ' A' ' 101' ' ' ASN . 56.2 mm-40 -86.01 -12.91 49.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.627 0.727 . . . . 0.0 111.544 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.15 28.43 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -101.47 155.76 17.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 164.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -122.1 144.6 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.48 120.17 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.86 150.85 20.84 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 163.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.592 ' CE1' HD12 ' A' ' 73' ' ' LEU . 21.2 p90 -158.67 160.23 36.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.695 1.598 . . . . 0.0 109.726 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -149.37 157.44 43.32 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.687 0.795 . . . . 0.0 109.789 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -68.12 125.45 26.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.8 m -103.26 125.47 49.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -157.81 120.27 3.8 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -169.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.4 m -68.47 108.88 3.45 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.187 0.995 . . . . 0.0 110.175 -168.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 p -91.92 117.96 30.3 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.011 1.324 . . . . 0.0 110.257 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 t -63.4 153.71 34.35 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.057 -1.027 . . . . 0.0 108.47 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -48.97 97.79 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 128.894 2.878 . . . . 0.0 112.595 -168.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 -134.44 120.13 19.4 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.75 1.22 . . . . 0.0 108.627 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -65.13 159.17 24.01 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 57.67 74.0 0.44 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 126.552 1.941 . . . . 0.0 111.826 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.39 132.78 23.38 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.391 1.876 . . . . 0.0 106.471 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -125.34 111.0 14.67 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.979 1.263 . . . . 0.0 107.634 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.18 133.11 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.681 1.192 . . . . 0.0 108.068 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -88.72 91.3 8.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -69.5 135.58 50.31 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.981 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -117.68 158.02 25.42 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 126.513 1.925 . . . . 0.0 109.626 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.72 143.15 37.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.592 HD12 ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -129.93 153.44 48.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 107.176 167.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -133.28 127.9 34.64 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 72.8 m-85 -138.11 88.93 2.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.77 0.828 . . . . 0.0 109.386 -172.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -71.36 151.37 44.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.273 1.029 . . . . 0.0 110.286 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.62 164.0 29.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.133 1.349 . . . . 0.0 112.199 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -79.74 58.15 2.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.748 1.619 . . . . 0.0 110.428 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.04 171.08 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.556 1.143 . . . . 0.0 109.924 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 7.23 2.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.973 1.709 . . . . 0.0 111.932 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -144.4 159.57 42.5 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.574 0.75 . . . . 0.0 109.362 167.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.45 148.46 12.06 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.352 1.453 . . . . 0.0 111.266 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.649 ' CE ' HD11 ' A' ' 30' ' ' LEU . 21.4 mtp -77.96 169.51 18.17 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -169.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -127.78 96.32 32.68 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 126.835 2.054 . . . . 0.0 105.851 163.105 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -99.49 161.53 0.57 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.267 2.644 . . . . 0.0 111.702 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.36 35.5 56.33 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.331 -0.856 . . . . 0.0 111.784 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -86.45 161.65 18.52 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.59 130.03 24.12 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.12 166.5 18.65 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.381 2.721 . . . . 0.0 112.232 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 8.9 t80 42.95 52.76 5.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.206 . . . . 0.0 113.346 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -152.08 -178.84 7.02 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.55 1.14 . . . . 0.0 110.879 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 162.59 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.394 1.478 . . . . 0.0 108.651 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -136.03 165.58 25.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.669 1.188 . . . . 0.0 108.721 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 m -125.6 146.46 49.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 157.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -139.72 164.09 30.87 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.466 1.906 . . . . 0.0 108.848 167.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -148.54 144.94 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.824 -0.547 . . . . 0.0 109.903 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.01 152.4 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -149.64 143.21 25.38 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.6 146.58 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.1 t -135.29 142.7 39.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 126.156 1.783 . . . . 0.0 107.215 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 48' ' ' GLN . 16.1 p30 -144.65 -174.29 4.29 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.525 1.13 . . . . 0.0 111.156 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.08 -10.05 31.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.057 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -117.27 -22.95 8.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.929 1.365 . . . . 0.0 112.322 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.0 -153.23 23.87 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -127.13 159.8 33.13 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.745 0.783 . . . . 0.0 110.35 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.84 -165.85 27.08 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.139 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.57 166.37 24.19 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.303 1.335 . . . . 0.0 109.92 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.01 150.07 23.28 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.088 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -75.15 165.36 54.46 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -55.58 123.65 14.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.918 2.412 . . . . 0.0 110.809 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.32 143.21 53.47 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.156 1.782 . . . . 0.0 107.896 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -122.23 163.61 19.31 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.31 166.58 22.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 23' ' ' VAL . 37.5 p90 -158.67 159.49 35.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -117.53 143.45 46.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.77 1.228 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.2 p -98.75 143.4 26.28 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -66.09 167.17 18.71 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.846 2.364 . . . . 0.0 108.969 172.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 18.3 tt0 -61.87 -23.69 66.45 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -163.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.81 66.91 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 m -61.36 107.15 0.72 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -176.74 21.89 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 123.575 0.607 . . . . 0.0 111.879 -156.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -63.97 -44.66 12.24 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.223 1.949 . . . . 0.0 110.432 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.8 m 50.58 60.05 4.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.687 1.995 . . . . 0.0 112.338 164.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.8 m 125.63 47.2 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 131.538 3.935 . . . . 0.0 111.609 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.524 0 C-N-CA 124.713 1.149 . . . . 0.0 111.186 173.421 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 CA-C-O 118.977 -0.902 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -117.01 173.3 6.73 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.899 1.279 . . . . 0.0 109.425 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 t -164.27 -175.03 3.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.127 1.371 . . . . 0.0 107.882 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.53 179.65 51.44 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.157 1.361 . . . . 0.0 112.78 171.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 m 127.16 157.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 1 C-N-CA 134.323 5.049 . . . . 0.0 108.621 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.4 t -165.6 170.36 14.32 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.792 1.637 . . . . 0.0 109.784 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.51 116.76 0.38 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.584 1.564 . . . . 0.0 110.647 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -156.32 157.39 35.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.976 1.711 . . . . 0.0 107.759 158.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.1 t -168.94 -40.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.925 2.09 . . . . 0.0 109.008 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.07 -92.91 0.1 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 51.03 67.25 0.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.994 1.718 . . . . 0.0 111.478 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.9 -40.18 72.65 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 113.163 -1.835 . . . . 0.0 112.915 -164.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt 33.9 141.18 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.067 1 C-N-CA 133.55 4.74 . . . . 0.0 119.999 168.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.94 161.17 40.71 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.171 2.58 . . . . 0.0 111.878 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 mtm -125.76 -26.59 3.47 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -169.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 42' ' ' SER . 29.3 m -140.6 169.22 15.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.494 1.117 . . . . 0.0 110.862 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.29 163.0 17.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.34 2.256 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.58 156.58 60.11 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.828 1.685 . . . . 0.0 113.393 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 166.86 54.92 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -21.3 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 129.073 2.949 . . . . 0.0 115.356 -162.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.67 130.35 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -118.82 161.14 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.68 138.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -123.79 125.29 44.44 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.421 0.689 . . . . 0.0 110.369 169.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 115' ' ' ASN . 59.3 t -70.39 101.28 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 166.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.0 -56.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.878 2.071 . . . . 0.0 109.759 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -132.34 172.35 12.56 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.187 1.395 . . . . 0.0 107.392 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -64.16 0.93 0.81 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.6 p -133.62 -1.25 3.12 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.301 1.84 . . . . 0.0 112.371 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -149.07 119.81 7.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.396 1.078 . . . . 0.0 109.594 -159.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.31 130.72 48.24 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.577 0.626 . . . . 0.0 109.893 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.24 146.03 39.3 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.69 139.91 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 164.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -120.68 151.79 39.06 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.58 1.552 . . . . 0.0 108.035 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -153.0 155.79 37.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.849 0.46 . . . . 0.0 110.819 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.35 136.72 45.88 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.07 129.59 15.39 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.342 2.695 . . . . 0.0 110.388 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.21 151.86 95.8 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.659 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -85.31 159.82 11.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.938 3.092 . . . . 0.0 110.809 -173.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -60.03 -34.37 73.29 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.031 0.532 . . . . 0.0 111.663 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -66.93 -23.01 65.93 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.825 ' HB2' HG22 ' A' ' 16' ' ' VAL . 41.1 p -76.46 -41.08 48.6 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 120.077 1.308 . . . . 0.0 109.49 170.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.22 -32.7 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.237 1.415 . . . . 0.0 110.146 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 50.22 60.82 3.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.471 1.508 . . . . 0.0 110.142 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.09 -147.87 19.41 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.91 122.83 46.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.381 1.472 . . . . 0.0 110.711 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.38 111.44 0.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.75 2.02 . . . . 0.0 109.802 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -77.5 -13.95 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.694 0.797 . . . . 0.0 112.053 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.16 -164.47 27.94 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.12 148.98 31.51 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 107.91 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -125.9 140.98 52.2 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.2 mt -128.85 122.12 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -91.45 148.16 22.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.1 p90 -158.33 164.54 36.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 111.124 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -149.26 162.23 40.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -68.61 136.09 52.48 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.934 2.093 . . . . 0.0 108.38 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m -126.95 144.12 51.09 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.788 1.635 . . . . 0.0 106.881 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 51.92 76.76 0.16 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.067 1.747 . . . . 0.0 112.573 -171.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.8 t -133.96 -75.41 0.48 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.682 1.193 . . . . 0.0 109.516 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.6 t -51.93 148.24 6.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.868 1.667 . . . . 0.0 112.646 -171.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 t -52.82 146.15 11.14 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.692 1.597 . . . . 0.0 111.176 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -45.89 114.71 0.82 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.647 1.579 . . . . 0.0 109.972 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 38.4 67.64 0.39 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.629 1.572 . . . . 0.0 113.635 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.14 80.32 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.611 -0.681 . . . . 0.0 112.502 -175.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.0 mtt85 67.61 177.76 0.24 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 127.045 2.138 . . . . 0.0 110.433 -167.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -151.01 57.38 0.91 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.303 -0.873 . . . . 0.0 110.889 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -81.76 123.47 28.79 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.256 1.023 . . . . 0.0 108.615 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.2 mt -135.0 123.95 41.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -77.27 157.96 30.5 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 163.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -128.1 93.55 3.7 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 165.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 18.4 mttm -67.99 153.12 44.4 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.9 mm -122.84 159.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' CD1' HD13 ' A' ' 84' ' ' LEU . 1.2 mt -130.8 141.29 50.34 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 127.16 2.184 . . . . 0.0 107.233 165.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.7 m -112.9 122.21 46.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.781 1.232 . . . . 0.0 107.809 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 62.5 m-85 -128.64 80.22 1.95 Allowed 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.108 0.963 . . . . 0.0 109.168 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.28 155.68 27.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.86 157.7 33.89 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.583 1.563 . . . . 0.0 111.585 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -79.5 34.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.841 1.257 . . . . 0.0 113.937 -169.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 160.81 14.92 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.538 -1.351 . . . . 0.0 111.865 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.3 p -119.82 7.01 10.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.831 2.053 . . . . 0.0 111.089 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.9 170.67 18.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.009 1.323 . . . . 0.0 109.379 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.16 158.63 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 mtp -97.34 157.9 15.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.897 1.348 . . . . 0.0 112.282 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.51 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.2 mm? -108.06 80.93 1.14 Allowed Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 129.853 3.261 . . . . 0.0 106.236 169.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -86.22 153.09 9.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.648 2.899 . . . . 0.0 110.417 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 23.38 56.74 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.741 1.162 . . . . 0.0 112.316 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 84' ' ' LEU . 3.0 mm? -94.5 166.44 12.05 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 172.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 150.7 55.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.553 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 10.9 Cg_endo -70.29 -178.77 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.911 2.407 . . . . 0.0 111.87 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 53.41 36.87 24.17 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.636 1.175 . . . . 0.0 111.333 164.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 m -146.07 155.68 42.94 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.58 1.552 . . . . 0.0 109.477 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -100.63 153.81 19.11 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -143.2 156.24 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.839 0.856 . . . . 0.0 109.426 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.9 m -125.94 139.01 53.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.07 160.59 39.91 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 110.283 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.21 145.29 24.56 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.497 -0.752 . . . . 0.0 110.816 165.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.87 151.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.931 2.092 . . . . 0.0 107.873 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.28 139.69 18.63 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.39 134.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.366 1.067 . . . . 0.0 110.12 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.45 146.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -133.29 -178.86 5.17 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.287 1.435 . . . . 0.0 109.514 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.43 53.0 2.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.198 0.904 . . . . 0.0 111.267 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -162.78 -31.79 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.383 1.873 . . . . 0.0 109.983 172.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.95 -167.68 35.45 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.158 0.866 . . . . 0.0 113.468 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.28 169.09 12.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.044 2.937 . . . . 0.0 110.213 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.45 -155.26 6.57 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 128.32 2.867 . . . . 0.0 110.047 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 137.33 39.64 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.132 2.555 . . . . 0.0 111.991 -175.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.97 158.55 35.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.535 0.734 . . . . 0.0 110.195 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.6 p -63.21 174.22 0.96 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.939 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -50.72 140.44 37.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 153.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -61.18 106.0 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 161.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -85.96 166.2 16.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.76 157.72 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -152.04 136.78 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.469 ' O ' HG21 ' A' ' 25' ' ' VAL . 3.0 p-10 -86.7 159.69 19.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 161.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.9 p -111.2 162.44 20.83 Favored Pre-proline 0 C--O 1.243 0.727 0 C-N-CA 123.975 0.91 . . . . 0.0 108.862 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.44 166.22 30.43 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.193 1.928 . . . . 0.0 109.044 168.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.33 -21.26 66.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.069 0.948 . . . . 0.0 112.46 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.99 -126.57 7.87 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.7 m -118.04 152.27 35.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.432 1.093 . . . . 0.0 108.995 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -172.57 172.01 44.68 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.86 151.8 46.09 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.519 2.146 . . . . 0.0 111.333 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.6 t -150.75 169.44 21.63 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.788 2.035 . . . . 0.0 106.086 162.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.1 t -89.93 175.64 7.12 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 154.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.263 1.92 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 143.345 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.554 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 m -66.05 122.87 18.37 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 166.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 p -82.76 76.5 9.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.924 0.89 . . . . 0.0 108.704 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.11 161.54 32.63 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -148.51 45.19 1.04 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.959 1.304 . . . . 0.0 109.997 -169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -139.45 108.06 5.9 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 45.71 -140.04 5.7 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.838 1.208 . . . . 0.0 111.532 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -133.1 -70.53 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.766 1.626 . . . . 0.0 107.384 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -163.45 -176.79 4.91 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 127.595 2.358 . . . . 0.0 106.579 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.98 113.13 3.59 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 168.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -110.43 -47.47 3.27 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.572 1.149 . . . . 0.0 108.899 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -135.31 -11.28 2.17 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.613 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.99 153.14 94.83 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-N 120.748 1.613 . . . . 0.0 110.127 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.94 166.77 28.84 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 120.991 1.127 . . . . 0.0 110.158 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.3 mtm -117.86 -44.93 2.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.269 -169.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 42' ' ' SER 0.252 33.5 m -129.96 -175.3 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.749 1.158 . . . . 0.0 111.726 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.67 152.6 69.4 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 128.268 2.627 . . . . 0.0 108.862 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.53 137.75 23.3 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.917 1.745 . . . . 0.0 109.253 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.94 -170.81 28.68 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.1 t30 30.43 56.25 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.464 1.905 . . . . 0.0 112.557 -170.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.44 121.68 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -133.36 155.06 50.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.26 -1.336 . . . . 0.0 107.87 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.446 HG11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -146.46 146.0 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.81 129.92 51.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.42 150.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.213 161.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 t -117.03 -78.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -103.08 -179.83 4.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.408 1.083 . . . . 0.0 108.706 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -17.71 63.14 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.457 -1.402 . . . . 0.0 113.47 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.8 p -133.83 10.15 3.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.889 1.276 . . . . 0.0 112.598 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -130.95 132.35 45.01 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.943 1.697 . . . . 0.0 107.548 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.73 169.2 14.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.651 0.781 . . . . 0.0 109.012 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -126.3 135.75 51.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.493 1.517 . . . . 0.0 107.334 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.22 148.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.57 154.65 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.623 1.969 . . . . 0.0 108.664 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -158.09 171.35 20.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.281 0.632 . . . . 0.0 111.386 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.59 137.52 38.74 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.818 1.647 . . . . 0.0 111.317 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.17 112.78 3.63 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.727 2.951 . . . . 0.0 111.077 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.43 158.66 64.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 122.077 -0.389 . . . . 0.0 110.568 170.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.64 160.63 14.45 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.557 2.838 . . . . 0.0 112.288 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -25.39 67.78 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.404 -0.81 . . . . 0.0 112.871 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -60.69 -49.49 77.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.568 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.707 ' HB2' HG22 ' A' ' 16' ' ' VAL . 51.4 p -66.67 -23.66 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.818 1.19 . . . . 0.0 111.503 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 47' ' ' LEU . 90.5 mt -67.57 -32.88 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.539 172.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 47.09 30.06 1.25 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.412 1.485 . . . . 0.0 113.624 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.6 -148.82 12.35 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.569 -1.332 . . . . 0.0 113.648 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -100.52 112.1 24.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.673 1.589 . . . . 0.0 107.84 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 100' ' ' VAL . 3.1 tm? -65.65 121.74 15.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.466 1.906 . . . . 0.0 109.068 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -80.88 -38.44 28.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.81 -178.21 41.23 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 121.379 -0.826 . . . . 0.0 111.945 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -99.44 124.51 44.65 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -76.79 155.63 32.95 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 160.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.16 124.71 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 156.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.543 ' HA ' HD13 ' A' ' 72' ' ' ILE . 9.0 m-85 -91.22 147.52 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 163.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.598 ' CE1' HD12 ' A' ' 73' ' ' LEU . 33.8 p90 -157.37 163.0 39.07 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.467 1.507 . . . . 0.0 110.265 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -149.08 157.16 43.17 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.762 0.791 . . . . 0.0 111.76 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -67.95 125.66 27.02 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m -107.06 165.75 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -141.37 172.69 12.34 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 170.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 m -65.18 115.03 5.1 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.122 -0.986 . . . . 0.0 108.605 169.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t 53.0 53.12 12.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.725 1.21 . . . . 0.0 114.056 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t -63.39 110.73 2.02 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 pmtp? -96.79 -170.24 2.02 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.746 1.618 . . . . 0.0 109.745 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ptt-85 -121.15 82.31 1.91 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.012 1.325 . . . . 0.0 111.215 -158.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -156.5 94.36 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.039 1.736 . . . . 0.0 107.74 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.86 175.16 0.28 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 127.338 2.255 . . . . 0.0 111.463 -176.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 53.13 -179.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.094 2.157 . . . . 0.0 111.876 -162.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -146.68 142.49 27.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.143 1.777 . . . . 0.0 106.291 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.51 116.56 17.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -71.08 105.34 3.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.609 2.364 . . . . 0.0 107.418 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -84.88 86.58 7.35 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -72.26 162.43 29.47 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.589 1.955 . . . . 0.0 109.257 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 53' ' ' TYR . 35.4 mm -132.25 155.02 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.448 0.699 . . . . 0.0 109.685 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD12 ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -135.51 157.5 46.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.957 2.503 . . . . 0.0 108.816 170.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -131.02 116.37 17.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.773 1.229 . . . . 0.0 109.633 -170.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.16 97.6 5.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.922 1.289 . . . . 0.0 107.807 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.92 172.03 12.48 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.236 0.541 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.24 15.1 70.06 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.58 26.19 15.88 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 171.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.5 167.52 0.49 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.049 1.74 . . . . 0.0 112.701 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.6 p -102.92 5.12 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 112.399 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.79 168.07 21.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.225 0.61 . . . . 0.0 110.792 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.13 33.24 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.759 2.123 . . . . 0.0 108.626 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.4 mtp -131.85 167.91 18.77 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.891 1.345 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.0 mm? -123.11 76.42 51.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.914 1.686 . . . . 0.0 107.27 172.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -82.38 151.86 15.58 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.92 2.413 . . . . 0.0 110.88 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.89 18.64 46.57 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.428 0.537 . . . . 0.0 112.043 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 93' ' ' TYR . 3.8 mm? -91.84 -169.55 2.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.972 1.309 . . . . 0.0 110.387 -171.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -125.52 149.33 64.5 Favored Pre-proline 0 CA--C 1.54 0.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.347 178.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 1.1 Cg_endo -77.69 173.97 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.423 2.749 . . . . 0.0 112.851 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.1 t80 44.26 53.23 6.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.194 1.798 . . . . 0.0 111.868 172.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m -155.85 146.64 22.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 120.963 -1.086 . . . . 0.0 110.686 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -78.77 151.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.13 0.972 . . . . 0.0 108.876 171.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CE2' HD12 ' A' ' 87' ' ' LEU . 56.4 m-85 -143.7 154.93 43.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.632 1.573 . . . . 0.0 108.113 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.5 m -117.13 147.83 42.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 171.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.446 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -150.6 158.75 44.52 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.66 1.984 . . . . 0.0 110.141 171.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.75 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.3 155.83 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 107.622 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -152.4 142.12 21.92 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 119.832 -1.793 . . . . 0.0 108.686 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 m -81.51 148.21 5.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.488 ' O ' HD22 ' A' ' 47' ' ' LEU . 85.4 t -136.44 136.57 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -136.24 -171.12 2.81 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.378 0.671 . . . . 0.0 110.22 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.67 -15.98 14.64 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.213 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -111.58 -46.99 3.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.117 1.958 . . . . 0.0 111.191 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.04 -170.17 34.12 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.363 0.983 . . . . 0.0 112.406 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -108.16 145.56 33.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 109.467 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.92 -165.23 31.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.906 1.241 . . . . 0.0 114.014 -168.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.71 133.58 49.03 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.252 1.968 . . . . 0.0 108.879 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.29 157.46 16.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.722 0.773 . . . . 0.0 109.977 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 p -67.79 165.46 31.1 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 156.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -63.47 152.91 77.86 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.356 1.37 . . . . 0.0 109.642 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.48 96.91 4.83 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.294 2.238 . . . . 0.0 105.94 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -76.69 168.46 20.04 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.1 1.36 . . . . 0.0 109.562 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.27 164.8 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.201 0.6 . . . . 0.0 111.306 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -160.14 156.47 26.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.942 2.097 . . . . 0.0 108.085 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -122.13 141.37 51.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.324 1.05 . . . . 0.0 109.758 165.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.409 ' HB ' ' HA ' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -74.2 154.25 88.34 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 123.619 0.574 . . . . 0.0 110.792 173.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.41 -73.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.802 3.001 . . . . 0.0 111.403 -168.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.68 -39.77 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.86 -156.52 26.96 Favored Glycine 0 N--CA 1.46 0.264 0 CA-C-N 118.817 0.735 . . . . 0.0 111.456 -166.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.0 m -134.55 92.28 2.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -115.28 167.34 12.33 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.312 0.958 . . . . 0.0 111.543 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.76 133.59 18.81 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.737 2.291 . . . . 0.0 108.704 168.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.6 t -63.15 -21.17 66.02 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 122.069 -0.395 . . . . 0.0 110.508 168.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.5 t 71.51 -2.91 2.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.38 2.272 . . . . 0.0 114.69 168.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.433 0 N-CA-C 105.778 -2.929 . . . . 0.0 105.778 146.168 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 CA-C-O 119.172 -0.793 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 p -169.53 46.55 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.522 1.529 . . . . 0.0 110.099 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -142.9 169.49 17.47 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 121.369 -0.832 . . . . 0.0 110.525 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.1 55.68 0.09 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.423 1.487 . . . . 0.0 111.006 -175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.4 m -109.81 151.57 26.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 169.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 p -81.53 -69.35 0.62 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.91 172.32 43.81 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.449 1.024 . . . . 0.0 111.274 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.99 -62.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.378 1.071 . . . . 0.0 109.749 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 t -162.99 -177.9 5.75 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.261 1.424 . . . . 0.0 108.298 -162.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.9 98.11 0.72 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -63.84 -55.84 19.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.525 0.73 . . . . 0.0 110.198 167.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -14.85 2.65 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.445 -0.788 . . . . 0.0 111.909 -171.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 mt -69.49 150.82 96.89 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 119.601 1.092 . . . . 0.0 110.857 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -66.93 157.31 62.17 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.484 2.123 . . . . 0.0 112.152 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 mtm -112.0 -28.16 8.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -168.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.2 m -143.49 175.98 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.746 1.618 . . . . 0.0 108.052 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -120.06 167.45 12.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.204 2.202 . . . . 0.0 108.776 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HD3' HG23 ' A' ' 99' ' ' VAL . 18.7 Cg_endo -68.27 113.85 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.436 2.091 . . . . 0.0 111.882 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.14 157.07 12.83 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 41.46 62.01 1.65 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.622 1.569 . . . . 0.0 110.326 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -55.46 146.58 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 157.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -140.85 161.32 38.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -147.3 146.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 O-C-N 119.725 -1.859 . . . . 0.0 109.057 169.306 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -123.98 151.28 43.84 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.099 2.56 . . . . 0.0 107.732 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.71 145.02 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 30' ' ' LEU . 99.5 t -111.73 -57.78 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -171.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -125.45 -173.35 2.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.031 1.333 . . . . 0.0 107.593 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.441 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -68.0 -31.89 71.9 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.863 -1.148 . . . . 0.0 112.377 175.102 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.8 p -122.5 13.13 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 111.008 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.748 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.0 tm? -134.66 139.27 45.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.516 1.926 . . . . 0.0 107.804 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -144.05 170.14 16.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.34 117.36 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.67 145.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.77 159.2 27.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 108.054 173.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -161.51 162.07 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.493 1.042 . . . . 0.0 110.635 169.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -85.3 135.13 39.35 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.63 116.76 4.55 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.069 3.179 . . . . 0.0 111.559 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 34.7 m -72.78 158.02 87.89 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.957 -0.465 . . . . 0.0 112.218 -175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 60.5 Cg_endo -83.44 149.81 13.15 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.951 3.101 . . . . 0.0 111.384 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.6 mp -59.09 -26.63 64.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.873 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -60.33 -52.11 66.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 111.189 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.764 ' HB2' HG22 ' A' ' 16' ' ' VAL . 13.5 p -73.91 -23.25 59.53 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 47' ' ' LEU . 84.7 mt -66.05 -26.71 38.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 118.276 -0.868 . . . . 0.0 109.938 167.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? 72.77 -49.74 0.7 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.335 2.654 . . . . 0.0 113.956 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.19 -99.36 1.31 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.639 1.114 . . . . 0.0 112.007 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -137.84 105.34 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.384 1.874 . . . . 0.0 109.227 -169.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.2 tp -59.27 131.46 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -95.65 -24.01 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.101 1.36 . . . . 0.0 110.847 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.71 -153.99 25.56 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -127.83 123.45 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.855 1.662 . . . . 0.0 106.564 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.61 106.0 17.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mt -78.73 118.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -92.49 143.2 26.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.589 ' CE1' HD12 ' A' ' 73' ' ' LEU . 35.8 p90 -154.79 170.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.864 1.211 . . . . 0.0 111.849 172.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -149.66 164.59 34.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.589 1.155 . . . . 0.0 110.44 165.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -68.61 137.62 54.39 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.09 1.356 . . . . 0.0 108.024 164.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 83.0 m -114.02 140.52 48.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 52.59 73.91 0.32 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.329 1.452 . . . . 0.0 112.458 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t -57.71 136.92 56.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.949 1.3 . . . . 0.0 110.008 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t -82.09 -14.31 55.99 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -163.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -114.04 145.13 42.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.231 1.378 . . . . 0.0 109.945 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -58.64 -48.05 82.33 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 125.911 1.684 . . . . 0.0 110.544 -167.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -66.77 96.52 0.41 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 157.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -83.34 175.02 10.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 146.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -84.16 173.9 10.67 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.877 -1.14 . . . . 0.0 108.409 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -77.94 -71.83 0.4 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.699 -1.25 . . . . 0.0 108.821 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.61 133.72 56.38 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.8 mt -71.43 147.05 11.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.08 54.19 0.39 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.981 2.513 . . . . 0.0 111.83 169.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -51.68 135.77 28.33 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.299 1.44 . . . . 0.0 109.12 161.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.407 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 6.9 mmtt -139.84 169.31 17.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.332 1.053 . . . . 0.0 111.329 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -132.91 150.36 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.405 2.282 . . . . 0.0 106.895 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.589 HD12 ' CE1' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -145.18 100.64 3.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.535 1.934 . . . . 0.0 107.864 177.095 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 m -71.62 109.29 5.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 59.1 m-85 -108.69 94.42 5.04 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.73 164.88 11.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.829 168.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.56 153.55 28.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -83.39 37.59 0.57 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.128 1.371 . . . . 0.0 111.154 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 170.76 3.53 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.887 2.075 . . . . 0.0 112.19 171.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -133.96 2.45 3.38 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 126.045 1.738 . . . . 0.0 110.614 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -158.32 142.08 15.44 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.111 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.92 138.85 8.03 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -172.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.748 ' HE2' HD11 ' A' ' 30' ' ' LEU . 39.8 mtp -77.23 163.03 26.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.002 0.921 . . . . 0.0 110.887 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.2 mm? -126.5 82.82 65.79 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.133 1.373 . . . . 0.0 107.546 168.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -90.75 154.06 4.14 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.823 2.349 . . . . 0.0 111.795 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.41 51.44 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.457 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.82 -177.7 4.61 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.351 1.46 . . . . 0.0 108.478 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.51 139.68 36.23 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.823 0.849 . . . . 0.0 108.974 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.62 178.4 7.16 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.966 3.111 . . . . 0.0 112.886 -172.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.7 t80 50.89 23.17 1.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.868 2.867 . . . . 0.0 113.514 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.9 m -123.06 157.06 33.62 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.49 1.516 . . . . 0.0 110.351 -172.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -96.83 151.78 19.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -142.07 156.37 45.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.325 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.9 m -126.03 136.12 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -135.69 166.68 22.69 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.743 1.617 . . . . 0.0 109.895 170.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.67 153.08 34.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.838 2.055 . . . . 0.0 106.578 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -121.07 137.54 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.807 1.243 . . . . 0.0 108.465 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.1 ttm105 -135.17 131.36 36.67 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.44 1.496 . . . . 0.0 108.421 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.512 HG23 ' HD3' ' A' ' 18' ' ' PRO 0.25 0.8 OUTLIER -70.99 140.19 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 127.933 2.493 . . . . 0.0 108.013 176.464 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.07 138.58 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -136.99 -175.6 4.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.758 0.823 . . . . 0.0 111.001 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.71 69.77 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.804 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -82.53 -40.25 21.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.973 1.309 . . . . 0.0 110.835 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.36 -165.96 34.05 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 121.943 0.746 . . . . 0.0 111.983 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.44 157.29 20.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.062 0.945 . . . . 0.0 112.534 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.91 -157.99 10.29 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.113 1.339 . . . . 0.0 111.039 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.86 166.57 22.12 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.013 1.809 . . . . 0.0 111.684 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.29 154.05 19.11 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.246 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 5.6 m -70.19 -174.85 0.26 Allowed Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.733 1.613 . . . . 0.0 110.871 173.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 109' ' ' SER . 29.7 Cg_endo -68.35 161.4 44.93 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 CA-C-N 122.307 1.86 . . . . 0.0 109.532 167.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.69 162.09 24.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.258 1.027 . . . . 0.0 109.066 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -132.39 162.36 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.739 1.216 . . . . 0.0 108.271 166.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 159.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.87 147.07 29.36 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.71 144.48 42.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.11 160.73 29.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 110.317 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.76 168.66 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 N-CA-C 108.879 -1.239 . . . . 0.0 108.879 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -61.62 -29.43 70.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.679 0.791 . . . . 0.0 112.116 -174.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 28' ' ' SER . . . 87.68 37.71 7.88 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 125.709 1.624 . . . . 0.0 115.511 163.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -58.02 148.96 24.43 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 117.783 0.791 . . . . 0.0 109.94 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.53 110.06 3.61 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 169.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.01 121.19 8.34 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.547 2.174 . . . . 0.0 110.412 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -102.62 146.3 28.37 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.877 1.271 . . . . 0.0 107.712 165.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.1 m -74.22 169.02 18.44 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 161.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.596 0 N-CA-C 106.229 -2.749 . . . . 0.0 106.229 151.97 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.0 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p -166.6 -178.95 4.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -170.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 t -139.11 177.18 8.08 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 161.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.69 110.81 2.33 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -165.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 t -155.69 -57.12 0.09 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.99 -164.9 0.25 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.788 0.835 . . . . 0.0 109.376 -168.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.33 160.93 16.75 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -168.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -147.61 121.89 9.6 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -71.7 175.74 5.43 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.687 1.232 . . . . 0.0 109.039 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.7 159.82 15.23 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.999 -2.441 . . . . 0.0 106.999 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -65.88 -62.94 1.22 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.029 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.0 -52.18 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.989 0.806 . . . . 0.0 111.11 162.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.3 mt 49.93 161.35 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 130.168 3.387 . . . . 0.0 115.74 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.42 -174.33 1.95 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.773 1.649 . . . . 0.0 111.386 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.5 mtm -133.62 -47.03 0.81 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.337 1.455 . . . . 0.0 113.218 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 42' ' ' SER . 14.7 m -131.94 -178.42 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 118.858 0.754 . . . . 0.0 110.196 -169.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.45 164.17 19.25 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 126.487 1.915 . . . . 0.0 109.597 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.21 144.6 75.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.459 1.44 . . . . 0.0 112.482 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.61 170.28 4.93 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.997 1.284 . . . . 0.0 111.468 166.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -49.23 142.44 7.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -147.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.79 121.11 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.157 1.783 . . . . 0.0 106.976 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -122.71 88.29 2.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.715 1.606 . . . . 0.0 111.312 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG13 ' HE ' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -87.45 143.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 157.16 35.47 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.78 2.032 . . . . 0.0 110.089 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.39 103.49 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.65 -54.08 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.656 1.182 . . . . 0.0 109.312 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -138.33 -179.88 6.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.699 1.2 . . . . 0.0 107.864 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -23.46 56.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.269 1.028 . . . . 0.0 111.25 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -122.17 -2.06 9.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.105 2.162 . . . . 0.0 112.694 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 tp -144.01 130.0 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.308 1.443 . . . . 0.0 109.619 -170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.28 117.45 8.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.172 0.896 . . . . 0.0 111.041 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.17 154.7 41.62 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.549 1.14 . . . . 0.0 110.305 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.95 103.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.809 2.043 . . . . 0.0 106.121 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -92.08 154.2 18.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.108 0.413 . . . . 0.0 110.082 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -151.02 177.63 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 110.124 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.86 142.27 25.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.71 122.93 10.4 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.284 2.656 . . . . 0.0 109.65 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.1 164.57 55.75 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 118.887 0.767 . . . . 0.0 110.45 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -64.61 138.93 61.45 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.221 1.947 . . . . 0.0 109.15 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -31.1 41.01 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.822 0.283 . . . . 0.0 111.228 166.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -50.27 -46.99 55.51 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.182 1.393 . . . . 0.0 110.881 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.811 ' HB2' HG22 ' A' ' 16' ' ' VAL . 61.6 p -71.49 -29.48 64.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.46 -20.21 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.672 0.789 . . . . 0.0 109.486 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 45.33 57.06 5.1 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.038 2.135 . . . . 0.0 110.419 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.16 -102.55 0.33 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.444 -1.198 . . . . 0.0 111.427 173.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -138.18 119.66 14.9 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.316 1.047 . . . . 0.0 110.217 -164.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.46 124.71 23.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.451 1.5 . . . . 0.0 109.119 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -92.74 -14.38 28.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.888 0.475 . . . . 0.0 112.098 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 176.37 22.87 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 126.604 2.049 . . . . 0.0 108.25 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.75 151.64 21.01 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -127.9 109.19 11.35 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.904 -1.123 . . . . 0.0 108.939 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.05 133.6 30.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -104.5 147.77 27.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 152.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.81 158.93 40.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.694 1.198 . . . . 0.0 111.268 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.1 p90 -148.71 161.91 40.8 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.947 0.899 . . . . 0.0 110.253 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -68.38 136.26 53.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.2 m -117.39 155.63 29.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 59.38 173.76 0.08 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.474 1.109 . . . . 0.0 112.002 -164.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.1 m -165.78 97.47 0.65 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.898 1.279 . . . . 0.0 109.913 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.2 m -67.57 84.32 0.18 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.234 1.014 . . . . 0.0 111.266 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 t 65.72 141.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.364 2.666 . . . . 0.0 111.608 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 75.46 1.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.223 -0.923 . . . . 0.0 112.517 -159.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -68.81 106.09 2.56 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.51 -0.744 . . . . 0.0 110.475 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 41.86 76.88 0.07 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 129.044 2.938 . . . . 0.0 114.504 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -79.0 152.04 31.19 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 121.437 -0.789 . . . . 0.0 111.805 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -85.92 -100.49 0.07 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.96 0.904 . . . . 0.0 109.181 164.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -122.47 170.07 10.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.969 1.708 . . . . 0.0 108.001 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.5 mt -78.4 130.91 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -69.09 126.95 31.41 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 167.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -105.49 102.98 12.42 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -78.53 161.02 27.33 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.889 2.076 . . . . 0.0 109.389 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.15 155.7 41.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 84' ' ' LEU . 3.8 mt -133.12 165.93 23.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.206 1.402 . . . . 0.0 108.864 170.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.5 m -138.54 105.29 5.36 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.593 -0.692 . . . . 0.0 109.679 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -116.77 93.0 4.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -72.86 166.86 22.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.549 0.69 . . . . 0.0 109.76 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.89 173.25 47.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 p -73.8 11.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.003 2.121 . . . . 0.0 114.769 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -64.43 156.12 30.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.438 1.095 . . . . 0.0 109.856 -167.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.6 p -118.08 8.99 12.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.208 1.403 . . . . 0.0 111.307 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -150.12 158.87 44.61 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.627 0.771 . . . . 0.0 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.72 143.6 6.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.953 0.787 . . . . 0.0 111.409 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.8 mtp -97.46 153.11 18.33 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.892 -0.769 . . . . 0.0 112.551 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD13 HD11 ' A' ' 73' ' ' LEU . 3.0 mm? -100.32 87.13 0.72 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.52 2.328 . . . . 0.0 109.143 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.42 162.42 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.252 2.634 . . . . 0.0 111.163 171.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.58 21.04 79.32 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.716 -0.615 . . . . 0.0 112.603 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.97 172.64 9.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.829 1.252 . . . . 0.0 107.803 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.53 161.26 49.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 124.769 1.228 . . . . 0.0 108.848 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -89.77 160.84 5.14 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 125.091 3.861 . . . . 0.0 115.086 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 65.1 44.82 3.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.496 3.518 . . . . 0.0 117.613 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.58 -169.39 2.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.992 2.117 . . . . 0.0 109.97 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -110.45 163.83 13.3 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 158.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.44 152.89 46.03 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.516 -0.74 . . . . 0.0 109.883 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.8 m -126.0 139.43 53.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -145.3 162.88 36.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.995 2.118 . . . . 0.0 107.18 172.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -137.35 -176.26 4.34 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.126 0.971 . . . . 0.0 108.937 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.25 160.15 41.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -154.31 154.21 32.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 106.193 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.48 145.39 8.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.0 t -129.22 139.42 51.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -133.33 -177.97 4.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.833 0.853 . . . . 0.0 109.787 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.54 7.49 3.75 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.098 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -122.05 -57.17 1.8 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.861 1.331 . . . . 0.0 110.327 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.73 -156.79 8.52 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -170.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 163.02 29.56 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.313 1.045 . . . . 0.0 110.917 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.32 -158.11 10.76 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.453 1.025 . . . . 0.0 111.978 -166.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.23 158.66 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.569 2.179 . . . . 0.0 111.807 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.58 156.51 25.14 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.941 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.9 p -64.82 -178.17 0.25 Allowed Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.183 166.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -48.33 132.69 24.42 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.591 -1.349 . . . . 0.0 108.591 145.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.22 157.6 19.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 155.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.507 ' HE ' HG13 ' A' ' 23' ' ' VAL . 3.2 mmm180 -126.21 168.55 13.92 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 123.824 0.85 . . . . 0.0 108.961 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -115.57 155.43 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.505 171.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -144.19 142.78 30.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 160.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -114.77 148.28 38.6 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.269 1.427 . . . . 0.0 107.437 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -111.79 162.61 20.42 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 110.421 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.62 170.54 18.35 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.248 1.966 . . . . 0.0 110.177 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.62 -31.32 67.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.902 1.281 . . . . 0.0 111.389 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 65.63 97.38 0.02 OUTLIER Glycine 0 C--N 1.338 0.662 0 C-N-CA 126.225 1.869 . . . . 0.0 112.128 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.3 m 55.13 39.08 31.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 117.754 0.777 . . . . 0.0 111.596 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.29 125.32 38.72 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.047 -1.418 . . . . 0.0 109.759 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.99 168.12 24.08 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 CA-C-N 119.848 1.824 . . . . 0.0 109.308 169.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -154.53 -173.14 4.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.1 m -149.91 170.68 18.25 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.988 1.315 . . . . 0.0 108.548 171.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.821 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 -177.958 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.586 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 77.41 145.55 0.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.341 2.257 . . . . 0.0 109.951 -169.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.0 p -165.64 -172.96 2.57 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.161 1.384 . . . . 0.0 109.096 167.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.19 -81.77 1.51 Allowed Glycine 0 CA--C 1.522 0.499 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.887 160.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t -154.17 -101.81 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 t -60.82 136.48 58.09 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.66 1.118 . . . . 0.0 110.945 -174.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.0 33.99 1.03 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.38 1.466 . . . . 0.0 110.584 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -158.71 76.72 0.74 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -165.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.7 p -144.83 90.78 2.09 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.847 -0.533 . . . . 0.0 110.258 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.77 7.85 0.02 OUTLIER Glycine 0 CA--C 1.523 0.556 0 CA-C-O 117.149 -1.917 . . . . 0.0 117.229 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -34.91 -57.03 0.56 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.438 1.895 . . . . 0.0 114.391 -159.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.31 -0.08 13.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.447 1.099 . . . . 0.0 111.59 -173.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 mt -63.85 140.99 97.95 Favored Pre-proline 0 N--CA 1.472 0.634 0 O-C-N 120.668 -1.27 . . . . 0.0 112.937 -166.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.72 161.7 44.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.724 2.283 . . . . 0.0 111.329 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.7 mtm -108.45 -41.39 4.86 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.539 1.136 . . . . 0.0 112.797 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 42' ' ' SER . 4.7 m -132.25 152.56 36.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.535 0.683 . . . . 0.0 109.432 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.96 168.43 21.9 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 108.339 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 1.6 Cg_endo -60.68 155.63 47.32 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 119.362 0.808 . . . . 0.0 110.635 165.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.25 -155.78 0.76 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.761 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -45.71 128.77 8.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.52 1.128 . . . . 0.0 111.28 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.4 t -105.08 145.43 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -120.96 150.73 40.66 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.48 119.5 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 174.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 130.05 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG11 ' HD3' ' A' ' 117' ' ' PRO . 66.2 t -76.8 118.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -85.63 -52.57 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.501 1.52 . . . . 0.0 107.606 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -136.33 177.73 7.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.337 1.455 . . . . 0.0 109.611 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -38.21 54.4 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.072 1.349 . . . . 0.0 112.608 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -113.61 5.95 16.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.402 1.081 . . . . 0.0 111.692 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 tp -137.39 125.2 22.52 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.712 -168.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.91 157.48 27.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 160.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -98.73 150.81 21.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 163.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 HD23 ' A' ' 84' ' ' LEU . 16.5 t -130.5 139.72 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.542 1.537 . . . . 0.0 107.54 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -128.81 135.4 49.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.348 2.259 . . . . 0.0 105.234 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -140.85 -170.87 3.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.13 0.972 . . . . 0.0 108.967 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -119.77 135.32 24.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.523 1.129 . . . . 0.0 110.321 -167.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.38 96.41 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.509 2.806 . . . . 0.0 110.606 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 19.7 m -63.78 156.08 74.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.392 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.03 149.74 32.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.558 2.172 . . . . 0.0 109.961 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.53 -39.05 72.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.39 1.076 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -58.64 -30.28 67.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.612 ' HB2' HG22 ' A' ' 16' ' ' VAL . 54.1 p -71.68 -37.89 70.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.806 0.73 . . . . 0.0 110.315 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.0 mt -63.34 -27.53 43.24 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.638 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 56.1 13.91 1.32 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.754 1.622 . . . . 0.0 113.393 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.75 -177.85 48.57 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -162.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 111.54 19.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.768 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 tp -44.89 132.01 6.9 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.038 2.135 . . . . 0.0 110.383 168.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -117.48 -12.08 10.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.027 1.331 . . . . 0.0 112.54 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.58 -171.05 30.45 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.529 1.538 . . . . 0.0 110.482 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -114.8 159.65 20.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.984 0.514 . . . . 0.0 109.808 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -127.31 147.42 50.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.842 1.257 . . . . 0.0 108.072 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.0 mt -120.17 124.53 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 162.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -97.22 145.78 25.73 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 160.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.428 ' CD1' HD11 ' A' ' 84' ' ' LEU . 34.0 p90 -155.91 161.25 40.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 109.556 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -149.1 157.32 43.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.399 0.68 . . . . 0.0 109.893 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 93' ' ' TYR . 12.0 tptm -68.8 140.21 55.27 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.8 m -130.85 131.31 44.51 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.06 -10.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.2 m 60.84 -60.1 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.161 1.785 . . . . 0.0 113.517 -160.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.87 47.66 6.94 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 127.787 2.435 . . . . 0.0 112.844 -175.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -55.48 131.17 45.39 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -167.57 166.57 14.05 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.696 1.998 . . . . 0.0 106.242 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -61.08 -28.08 68.82 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.571 1.532 . . . . 0.0 113.512 -171.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -134.34 162.36 32.4 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.329 0.968 . . . . 0.0 110.217 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.7 ttt85 98.35 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 130.435 3.494 . . . . 0.0 108.641 164.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -134.49 86.58 2.28 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.736 1.615 . . . . 0.0 107.931 -173.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -150.58 120.57 7.16 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.62 1.568 . . . . 0.0 107.704 171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.0 mt -98.79 124.76 52.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 171.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -81.7 116.24 21.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.389 1.076 . . . . 0.0 108.911 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -98.55 142.65 29.88 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.177 0.991 . . . . 0.0 109.154 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -137.44 165.95 25.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 127.705 2.402 . . . . 0.0 110.94 -164.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.62 158.33 43.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 122.563 1.173 . . . . 0.0 110.374 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.552 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -141.83 130.99 23.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.319 2.248 . . . . 0.0 108.017 166.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -86.7 145.58 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.309 1.444 . . . . 0.0 108.181 171.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 55.3 m-85 -139.95 161.15 38.28 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.285 1.034 . . . . 0.0 110.344 167.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -77.57 171.27 15.18 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.668 1.223 . . . . 0.0 112.148 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 151.66 36.18 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.812 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 t 62.91 -6.38 0.17 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.167 2.187 . . . . 0.0 115.736 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -67.25 146.35 54.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 120.527 -1.358 . . . . 0.0 107.444 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 p -110.23 7.77 23.34 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.249 1.419 . . . . 0.0 112.255 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.12 167.33 25.3 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.403 0.547 . . . . 0.0 112.037 168.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.61 -172.16 33.57 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 128.652 3.025 . . . . 0.0 107.396 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.9 mtp -129.84 169.29 15.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.968 1.384 . . . . 0.0 111.689 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.552 HD13 ' CD1' ' A' ' 73' ' ' LEU . 4.0 mm? -119.01 84.54 26.75 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 164.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -88.8 157.62 6.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.832 3.021 . . . . 0.0 111.326 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.67 14.33 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.284 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 84' ' ' LEU . 2.8 mm? -73.8 -179.35 3.61 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.573 1.549 . . . . 0.0 108.95 174.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.16 147.91 37.95 Favored Pre-proline 0 C--O 1.237 0.405 0 CA-C-N 118.528 0.604 . . . . 0.0 111.624 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -70.17 173.28 11.58 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.312 2.674 . . . . 0.0 113.022 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.413 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 26.6 t80 48.55 36.97 8.27 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.025 2.13 . . . . 0.0 113.35 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -137.42 142.4 41.66 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 120.661 -1.274 . . . . 0.0 111.807 -169.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -79.47 146.65 32.62 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 161.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.417 ' CZ ' ' HD2' ' A' ' 56' ' ' LYS . 56.3 m-85 -139.0 148.58 43.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 167.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.1 m -115.07 154.14 29.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.68 163.8 38.33 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.96 1.704 . . . . 0.0 109.519 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -140.66 157.64 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.286 1.034 . . . . 0.0 108.936 164.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.72 143.76 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.66 147.33 42.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.31 148.68 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.7 137.92 51.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.463 1.505 . . . . 0.0 107.154 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -141.77 178.18 7.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.282 1.033 . . . . 0.0 109.292 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.22 -1.93 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.296 0.95 . . . . 0.0 114.667 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -123.18 -26.01 4.4 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.299 1.44 . . . . 0.0 110.997 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.46 -159.27 31.87 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-O 121.691 0.606 . . . . 0.0 111.853 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -132.72 124.89 29.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -160.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.39 -160.93 13.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 -165.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.04 171.37 11.39 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 118.997 1.398 . . . . 0.0 109.312 163.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.31 165.45 12.68 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 85.9 p -67.86 -178.04 0.36 Allowed Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 125.525 1.53 . . . . 0.0 111.034 -164.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 22.5 Cg_endo -50.94 134.11 41.59 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 N-CA-C 108.485 -1.39 . . . . 0.0 108.485 149.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.44 141.32 56.56 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.05 169.18 9.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -135.25 150.23 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -156.93 141.04 16.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.156 0.982 . . . . 0.0 108.529 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -120.37 128.4 53.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.536 1.534 . . . . 0.0 109.043 175.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -82.43 158.86 65.6 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 123.946 0.898 . . . . 0.0 110.039 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HD3' HG11 ' A' ' 25' ' ' VAL . 31.3 Cg_endo -67.68 -89.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.938 3.092 . . . . 0.0 112.383 -167.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 28.3 tt0 -151.0 -31.14 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.217 1.371 . . . . 0.0 112.631 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.91 -161.18 25.55 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.279 1.419 . . . . 0.0 112.649 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.08 73.79 0.37 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.396 2.278 . . . . 0.0 112.051 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -167.68 158.44 31.29 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 161.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.41 -43.56 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.428 2.752 . . . . 0.0 111.745 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.8 t -144.56 -98.43 0.1 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 t -65.6 -39.0 91.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.46 1.027 . . . . 0.0 109.367 165.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 103.117 -3.993 . . . . 0.0 103.117 -139.235 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.173 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -73.99 90.86 1.99 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 163.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -162.88 162.03 26.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.217 1.007 . . . . 0.0 109.057 -167.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.43 158.2 28.51 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 165.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -174.67 -62.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.2 m -68.43 172.06 6.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.028 1.331 . . . . 0.0 109.96 164.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.69 -42.98 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.55 162.24 29.2 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.596 0.698 . . . . 0.0 109.208 165.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 t -146.77 158.01 43.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.458 1.503 . . . . 0.0 107.381 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.81 -67.49 0.55 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 126.107 1.813 . . . . 0.0 108.772 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 50.11 61.23 3.3 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 126.251 1.82 . . . . 0.0 112.852 170.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.15 -23.18 67.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.274 -167.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.28 134.34 89.18 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 121.246 1.839 . . . . 0.0 110.263 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -61.37 140.75 89.71 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.752 2.301 . . . . 0.0 113.638 -171.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.5 mtm -79.78 -43.54 22.31 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 125.128 1.371 . . . . 0.0 112.57 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.66 HG22 ' CB ' ' A' ' 42' ' ' SER . 9.5 m -138.08 165.93 24.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.23 0.538 . . . . 0.0 111.279 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -95.22 172.19 5.68 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 109.84 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 27.9 Cg_endo -65.25 169.52 12.16 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.468 2.112 . . . . 0.0 113.223 174.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.31 172.47 55.22 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.922 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -51.04 107.59 0.19 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 113.501 -157.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.21 152.08 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.862 2.065 . . . . 0.0 109.259 -172.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -141.86 156.53 45.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.139 1.776 . . . . 0.0 107.16 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 143.42 20.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 120.893 -1.129 . . . . 0.0 110.373 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -123.69 128.57 49.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.514 2.326 . . . . 0.0 108.835 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -82.26 122.31 36.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 30' ' ' LEU . 50.4 t -81.53 -50.52 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -153.29 -172.48 4.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.302 0.572 . . . . 0.0 110.182 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -35.55 66.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.785 0.834 . . . . 0.0 112.191 -171.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.5 p -127.74 18.59 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.706 1.202 . . . . 0.0 111.204 -168.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.583 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.3 tm? -145.81 140.22 26.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.623 1.569 . . . . 0.0 110.94 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -140.19 167.62 21.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.948 1.299 . . . . 0.0 108.237 169.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 145.68 50.92 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.003 1.721 . . . . 0.0 109.993 174.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.451 HG21 HD23 ' A' ' 84' ' ' LEU . 23.4 t -130.56 133.35 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -166.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.24 149.36 43.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.486 ' CZ3' HD11 ' A' ' 52' ' ' ILE . 34.3 p90 -147.98 154.29 40.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.84 142.13 28.8 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 123.76 11.38 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.283 2.655 . . . . 0.0 110.551 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 ' H ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -51.22 163.31 0.55 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 124.309 1.043 . . . . 0.0 110.73 160.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.76 -134.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 1 C-N-CA 126.738 4.959 . . . . 0.0 107.627 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.67 -31.64 1.76 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 117.476 -1.25 . . . . 0.0 111.446 161.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -49.9 -45.16 50.58 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.166 1.348 . . . . 0.0 112.399 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.66 ' CB ' HG22 ' A' ' 16' ' ' VAL . 86.5 p -75.3 -27.45 59.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.394 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.5 mt -64.04 -29.09 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.015 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 68.29 -26.13 0.13 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.431 2.692 . . . . 0.0 114.291 170.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.79 -164.76 11.7 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 128.473 2.94 . . . . 0.0 107.916 166.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -76.7 149.88 36.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.18 129.89 38.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.165 1.386 . . . . 0.0 107.891 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -98.4 -28.89 13.43 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.584 0.353 . . . . 0.0 111.015 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.52 179.75 38.81 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 121.402 -0.811 . . . . 0.0 111.278 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -122.34 149.92 43.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -122.63 125.83 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.486 HD11 ' CZ3' ' A' ' 35' ' ' TRP . 16.7 mt -94.58 123.52 46.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -92.32 146.23 23.86 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 164.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.98 168.37 27.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.203 1.001 . . . . 0.0 112.356 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -148.91 156.98 43.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.166 1.386 . . . . 0.0 109.911 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -73.64 137.69 44.33 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.467 1.507 . . . . 0.0 108.351 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.1 m -130.61 148.17 52.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.202 1.001 . . . . 0.0 109.347 -171.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -146.37 -28.52 0.41 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 31.22 69.6 0.1 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.874 2.47 . . . . 0.0 114.028 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 m -119.55 -179.05 3.76 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 159.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.0 m -114.45 90.04 3.24 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.153 0.581 . . . . 0.0 109.56 -168.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -63.04 157.85 21.0 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.843 -0.536 . . . . 0.0 110.329 172.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ttt-85 -86.51 -37.97 17.7 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -148.09 92.68 2.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.606 1.162 . . . . 0.0 108.486 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -160.03 136.31 8.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.181 0.9 . . . . 0.0 109.815 165.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.37 81.63 1.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.395 1.078 . . . . 0.0 108.272 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -157.96 101.7 1.79 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.678 0.791 . . . . 0.0 109.332 171.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.16 122.2 41.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 166.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -78.91 139.3 38.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 165.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -120.31 125.35 47.85 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -97.67 163.71 12.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.714 1.605 . . . . 0.0 108.733 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.48 149.85 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 106.223 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.437 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 1.1 mt -139.22 137.08 35.66 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.258 -170.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.0 m -98.76 132.36 44.19 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.767 0.827 . . . . 0.0 109.77 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.437 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 63.7 m-85 -143.87 68.13 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.805 2.042 . . . . 0.0 108.036 170.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -66.08 133.91 51.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.954 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.76 176.47 25.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.665 1.602 . . . . 0.0 112.599 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.9 p -74.88 0.43 15.64 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HE2' ' CE1' ' A' ' 81' ' ' HIS . 2.2 mmmp? -45.9 146.72 1.14 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.035 1.289 . . . . 0.0 112.159 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 p -99.6 -2.95 34.34 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.425 1.89 . . . . 0.0 111.136 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.416 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 15.1 p80 -149.9 166.88 28.26 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.741 -0.599 . . . . 0.0 110.885 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.29 158.72 24.44 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.453 1.025 . . . . 0.0 112.228 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.583 ' HE2' HD11 ' A' ' 30' ' ' LEU . 55.2 mtp -88.18 160.32 17.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.911 0.884 . . . . 0.0 112.187 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.614 HD12 HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -117.35 89.33 31.13 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.641 1.576 . . . . 0.0 107.534 166.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -93.18 156.59 2.6 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.063 3.175 . . . . 0.0 111.421 168.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.73 29.15 19.45 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.887 0.756 . . . . 0.0 111.611 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.614 HD21 HD12 ' A' ' 84' ' ' LEU . 2.9 mm? -101.4 175.82 5.45 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.375 1.87 . . . . 0.0 107.932 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -133.22 150.36 75.12 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 124.851 1.26 . . . . 0.0 110.19 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -71.08 166.3 29.61 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.944 2.43 . . . . 0.0 112.277 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.1 t80 51.48 34.1 11.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.616 2.366 . . . . 0.0 113.461 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.4 m -132.53 148.45 52.38 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.491 1.117 . . . . 0.0 110.578 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -85.65 151.97 23.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -137.29 149.32 47.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.115 1.366 . . . . 0.0 108.289 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 m -126.03 134.78 51.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 163.25 37.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.823 2.049 . . . . 0.0 108.486 -171.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.94 169.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.05 1.34 . . . . 0.0 108.762 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.42 149.55 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.747 1.219 . . . . 0.0 108.113 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -140.13 147.31 40.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.481 1.512 . . . . 0.0 108.0 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -87.87 154.06 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.096 0.862 . . . . 0.0 109.363 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.4 t -132.12 139.1 51.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -138.63 -170.94 2.95 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.15 0.58 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.2 -8.25 17.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.535 1.065 . . . . 0.0 115.433 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -113.11 -57.41 2.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.15 1.475 . . . . 0.0 109.397 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.37 -163.61 25.64 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.302 0.956 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -87.28 160.65 18.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.74 -157.27 10.09 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 165.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -62.52 156.95 49.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 CA-C-N 119.607 1.703 . . . . 0.0 111.342 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.41 155.23 17.49 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.963 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -66.04 166.89 13.78 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.402 1.481 . . . . 0.0 108.603 168.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.18 162.7 28.77 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.73 1.62 . . . . 0.0 109.671 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -61.53 138.15 58.27 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 122.185 0.993 . . . . 0.0 110.064 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 173.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 159.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.86 156.56 42.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.7 145.36 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 158.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -123.64 146.81 47.92 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 p -90.64 157.43 44.1 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 124.232 1.013 . . . . 0.0 109.598 -167.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.07 164.98 31.75 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.417 2.078 . . . . 0.0 109.003 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.6 -27.57 62.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.556 1.142 . . . . 0.0 112.466 -173.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.63 -96.52 0.59 Allowed Glycine 0 C--O 1.239 0.41 0 C-N-CA 125.572 1.558 . . . . 0.0 112.012 155.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 t -152.01 165.96 33.05 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 175.64 -113.53 0.45 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 105.317 -3.113 . . . . 0.0 105.317 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.65 142.54 77.64 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.14 1.893 . . . . 0.0 110.726 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 p -141.61 148.49 39.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 161.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.4 m -72.61 173.51 8.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 167.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 C-N-CA 128.175 2.798 . . . . 0.0 106.461 168.757 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.546 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.22 123.55 42.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.021 1.328 . . . . 0.0 109.925 -164.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 m -136.61 73.64 1.46 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.19 1.396 . . . . 0.0 110.008 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.0 -178.49 27.66 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.293 1.425 . . . . 0.0 110.076 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m -114.11 161.91 17.16 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.596 1.158 . . . . 0.0 109.573 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 m -120.28 174.55 6.45 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.66 136.15 2.83 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -148.72 148.44 30.02 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -167.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -139.64 151.39 45.93 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.942 1.297 . . . . 0.0 109.215 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.18 175.38 50.97 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.059 1.314 . . . . 0.0 112.268 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -125.8 -53.09 1.55 Allowed 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 125.187 1.395 . . . . 0.0 109.09 172.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -76.97 -5.09 47.26 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.218 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 mt -71.68 151.69 93.52 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 126.09 1.756 . . . . 0.0 110.782 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.475 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 86.2 Cg_endo -73.8 172.81 15.09 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.627 2.218 . . . . 0.0 111.137 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.3 mtm -121.34 -30.79 4.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.286 1.435 . . . . 0.0 113.551 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 42' ' ' SER . 34.3 m -140.97 163.12 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 111.371 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.01 169.17 18.6 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.856 2.062 . . . . 0.0 109.029 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 7.6 Cg_endo -70.19 160.36 49.87 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.255 1.304 . . . . 0.0 110.474 165.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.47 -154.15 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.429 1.49 . . . . 0.0 114.46 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -47.41 131.59 13.55 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.528 1.131 . . . . 0.0 110.303 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.73 147.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -131.86 158.42 41.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.15 150.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.82 128.96 50.28 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.16 143.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 159.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 30' ' ' LEU . 92.9 t -111.03 -53.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -132.27 -171.11 2.56 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.992 1.317 . . . . 0.0 108.687 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -64.3 -37.14 86.44 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.056 -1.027 . . . . 0.0 112.517 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.0 p -123.34 11.63 9.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.947 1.299 . . . . 0.0 110.078 -166.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.701 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.3 tm? -134.69 137.77 43.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.58 1.952 . . . . 0.0 109.0 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -139.73 165.51 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.33 118.71 18.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.97 147.88 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 107.313 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -131.0 133.35 45.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -118.39 -158.81 0.73 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.961 2.104 . . . . 0.0 108.247 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.08 137.56 30.97 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 126.492 1.917 . . . . 0.0 109.909 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.68 101.16 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.505 2.804 . . . . 0.0 109.405 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 28.8 m -67.1 158.48 81.18 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 41.0 Cg_endo -71.63 147.86 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.765 2.31 . . . . 0.0 109.128 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -54.18 -22.74 12.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.257 0.623 . . . . 0.0 110.736 171.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -61.68 -47.35 85.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.046 1.738 . . . . 0.0 114.557 174.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.726 ' HB2' HG22 ' A' ' 16' ' ' VAL . 7.9 p -71.37 -31.8 67.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.72 1.6 . . . . 0.0 109.732 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 47' ' ' LEU . 27.1 mt -68.54 -26.02 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.846 0.859 . . . . 0.0 109.736 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 66.13 3.7 2.79 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.168 2.587 . . . . 0.0 113.823 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.67 -161.41 31.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -172.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -70.98 114.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.537 0.669 . . . . 0.0 109.735 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.3 tm? -55.13 120.35 6.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 163.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -85.38 -31.4 22.95 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.85 168.55 28.2 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -99.6 112.5 24.71 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -81.0 142.87 32.97 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.1 mt -112.06 143.45 21.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.447 ' CE2' ' CD1' ' A' ' 72' ' ' ILE . 43.3 m-85 -112.45 140.56 47.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 166.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -153.63 162.15 41.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.122 1.328 . . . . 0.0 110.232 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -148.57 157.78 43.69 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.539 -0.725 . . . . 0.0 109.233 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -69.09 140.59 54.82 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.01 150.58 29.08 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 171.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -91.91 158.76 16.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 166.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.4 p -98.15 -88.67 0.31 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -84.42 -52.91 5.81 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.201 0.6 . . . . 0.0 112.411 -170.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -69.57 116.23 9.73 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -89.7 118.18 29.11 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.499 1.119 . . . . 0.0 108.778 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 160.61 19.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 165.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -141.44 156.37 45.78 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 164.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 30.58 68.02 0.11 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.986 2.514 . . . . 0.0 113.825 -173.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -132.52 150.87 52.08 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 159.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -70.19 177.16 3.41 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 159.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.5 mt -124.54 129.25 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.55 124.17 23.58 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -119.75 92.46 3.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -69.81 167.37 17.37 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 127.134 2.174 . . . . 0.0 110.101 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 53' ' ' TYR . 3.4 mm -138.92 152.42 24.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.354 -2.203 . . . . 0.0 105.091 -162.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.498 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -148.69 160.47 43.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.259 169.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.1 m -133.58 97.35 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -161.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 73' ' ' LEU . 58.3 m-85 -105.53 112.1 25.06 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.29 166.92 16.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.903 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.51 172.91 4.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.7 m -85.5 41.61 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.469 -1.018 . . . . 0.0 111.387 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE3' ' CE1' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -63.26 155.93 27.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.698 -1.251 . . . . 0.0 110.183 162.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -109.13 -3.78 17.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.605 1.962 . . . . 0.0 112.288 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.489 ' CE1' ' HE3' ' A' ' 79' ' ' LYS . 14.7 p80 -146.22 164.53 32.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.03 158.86 30.62 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.701 ' HE2' HD11 ' A' ' 30' ' ' LEU . 39.4 mtp -90.96 162.61 14.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.871 0.843 . . . . 0.0 111.117 -168.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 84' ' ' LEU . 1.1 mm? -120.82 89.98 46.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 160.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.1 148.95 1.26 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.394 3.396 . . . . 0.0 112.037 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.43 51.11 8.73 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.47 179.71 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.606 2.362 . . . . 0.0 107.773 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.0 142.37 26.12 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 124.466 1.107 . . . . 0.0 110.485 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.29 166.4 25.43 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.425 2.083 . . . . 0.0 110.84 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER 37.25 46.26 0.57 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 129.894 3.278 . . . . 0.0 113.869 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.1 m -119.72 -176.12 3.1 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.332 1.453 . . . . 0.0 109.122 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.07 157.21 19.57 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 148.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -137.61 154.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.1 m -124.24 141.8 51.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 155.23 44.26 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 127.235 2.214 . . . . 0.0 108.813 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.36 169.28 17.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.069 1.348 . . . . 0.0 107.734 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.25 152.71 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -146.53 131.17 17.86 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.9 1.28 . . . . 0.0 107.77 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.85 150.95 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.7 t -146.74 135.82 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.369 1.468 . . . . 0.0 107.069 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.65 178.85 6.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 107.716 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.8 57.28 3.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.345 0.974 . . . . 0.0 112.014 -172.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -160.71 -41.86 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.481 1.913 . . . . 0.0 109.327 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.74 -168.9 42.03 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.69 166.28 11.19 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 110.075 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.475 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -108.84 -174.48 21.48 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 124.367 0.984 . . . . 0.0 113.284 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.33 153.45 74.31 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.748 1.632 . . . . 0.0 110.444 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.44 165.39 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.688 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 54.0 p -110.78 -171.69 0.22 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.106 0.962 . . . . 0.0 112.112 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 48.5 Cg_endo -64.84 139.46 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.01 89.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 112' ' ' ARG . 0.7 OUTLIER -65.57 159.94 23.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 O-C-N 121.952 -0.467 . . . . 0.0 110.425 173.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 t -128.8 167.22 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.47 156.96 36.19 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.85 2.06 . . . . 0.0 108.156 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.75 147.99 44.58 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 125.218 1.407 . . . . 0.0 110.009 170.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -105.21 166.25 11.74 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.377 1.071 . . . . 0.0 111.478 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.92 167.42 16.35 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.856 3.704 . . . . 0.0 111.791 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 38.7 mt-10 -56.49 -33.08 65.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.028 1.331 . . . . 0.0 111.327 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 28' ' ' SER . . . 127.66 -75.66 0.41 Allowed Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 126.326 1.917 . . . . 0.0 109.341 160.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.8 m -152.56 135.09 15.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.025 2.13 . . . . 0.0 105.481 166.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.87 116.84 8.3 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 117.535 -1.703 . . . . 0.0 109.119 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -72.93 169.82 21.23 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.575 2.183 . . . . 0.0 111.149 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 p -66.59 166.47 12.7 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.571 0.7 . . . . 0.0 109.849 162.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.9 m -154.36 173.73 15.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.035 1.734 . . . . 0.0 107.159 171.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.394 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 -179.792 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.801 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m 36.13 84.97 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 129.474 3.11 . . . . 0.0 113.943 162.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m -70.37 158.38 36.07 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.389 0.614 . . . . 0.0 110.998 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.56 147.72 6.35 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 106.558 -2.617 . . . . 0.0 106.558 -170.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.2 m -78.47 159.1 28.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 163.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.87 167.47 21.68 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.618 1.167 . . . . 0.0 108.81 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.9 -161.79 29.75 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.8 m170 66.77 67.72 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.559 2.344 . . . . 0.0 111.312 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -130.77 128.6 41.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.825 0.85 . . . . 0.0 111.958 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.2 -167.11 11.22 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 127.826 2.631 . . . . 0.0 109.548 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -87.78 -69.79 0.67 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.065 0.946 . . . . 0.0 112.043 -173.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -97.72 -19.08 18.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.828 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.0 mt -66.78 143.81 98.26 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 119.915 1.234 . . . . 0.0 112.002 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 84.4 Cg_endo -72.56 152.02 53.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.649 2.899 . . . . 0.0 111.652 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 68.8 mtm -109.04 -38.98 5.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 117.652 -1.166 . . . . 0.0 113.854 -164.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.831 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.7 m -133.87 147.84 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.459 1.481 . . . . 0.0 113.102 -170.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.63 157.25 67.46 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 127.167 2.187 . . . . 0.0 109.991 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.49 162.96 38.58 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.348 2.032 . . . . 0.0 112.196 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.87 -149.04 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.26 2.362 . . . . 0.0 115.053 -175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -66.94 78.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.339 1.455 . . . . 0.0 113.033 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.1 t -53.67 139.98 10.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.73 158.28 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.562 1.545 . . . . 0.0 107.082 171.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.419 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -146.36 123.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.027 0.831 . . . . 0.0 108.942 168.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.83 102.33 7.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 127.998 2.519 . . . . 0.0 109.39 -169.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.28 0.8 OUTLIER -73.87 116.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-O 121.558 0.694 . . . . 0.0 110.313 -171.991 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 30' ' ' LEU . 45.8 t -69.66 -49.59 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -173.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -139.33 -163.85 1.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 108.971 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -29.94 56.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.654 -1.279 . . . . 0.0 113.151 177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 p -124.96 11.79 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.954 1.301 . . . . 0.0 110.764 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.73 HD11 ' HE2' ' A' ' 83' ' ' MET . 1.9 tm? -143.56 136.31 27.41 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.222 1.409 . . . . 0.0 107.862 -171.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -140.08 165.87 26.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.42 121.62 26.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.27 141.75 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -126.96 150.7 49.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.975 0.51 . . . . 0.0 110.3 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -151.26 178.9 8.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.84 142.66 25.05 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.48 -0.762 . . . . 0.0 109.003 172.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.46 111.53 3.13 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 123.039 2.493 . . . . 0.0 107.636 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.59 156.34 86.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -78.51 143.88 19.6 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 122.348 2.032 . . . . 0.0 108.449 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.0 mm? -59.23 -27.62 65.93 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.655 0.382 . . . . 0.0 110.814 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -60.01 -38.55 82.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.831 ' HB2' HG22 ' A' ' 16' ' ' VAL . 86.2 p -67.4 -41.81 84.31 Favored 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 119.027 0.83 . . . . 0.0 110.344 172.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 40' ' ' LEU . 32.3 mt -67.74 -23.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.644 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 56.17 11.31 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.383 1.873 . . . . 0.0 114.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.52 179.01 41.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.436 1.969 . . . . 0.0 108.256 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -73.94 122.9 23.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 43' ' ' ILE . 9.4 tp -57.45 112.55 1.45 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 108.525 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.17 -43.74 77.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.057 0.943 . . . . 0.0 109.472 168.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -177.2 45.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CE2' HD21 ' A' ' 47' ' ' LEU . 92.5 m-85 -105.87 112.51 25.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.453 1.901 . . . . 0.0 105.989 169.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -83.51 153.24 24.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.41 117.26 50.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -91.57 116.55 28.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -135.58 164.01 28.81 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.187 0.903 . . . . 0.0 110.912 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.71 163.51 37.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.202 1.001 . . . . 0.0 110.5 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.32 135.48 50.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.958 1.303 . . . . 0.0 108.177 168.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 m -126.34 140.05 52.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -166.22 168.44 15.23 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.351 1.06 . . . . 0.0 108.792 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.1 t -135.89 106.64 6.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -145.26 37.56 1.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.274 1.43 . . . . 0.0 110.322 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 p -62.69 63.73 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 130.017 3.327 . . . . 0.0 113.919 -172.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.03 13.59 0.6 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.174 1.79 . . . . 0.0 111.001 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.45 175.54 8.14 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.786 1.235 . . . . 0.0 108.939 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -61.22 162.01 8.11 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -46.88 130.84 12.08 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.593 1.157 . . . . 0.0 111.064 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -105.72 -177.03 3.25 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.448 1.499 . . . . 0.0 107.506 162.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -112.62 157.39 21.28 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 152.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.6 mt -88.91 123.01 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.99 126.13 28.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 167.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -116.21 160.0 21.03 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.409 1.084 . . . . 0.0 110.031 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -142.51 166.4 24.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 122.343 1.068 . . . . 0.0 112.313 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 mp -133.16 139.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 126.828 2.051 . . . . 0.0 105.864 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.704 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 1.1 mt -120.86 153.04 37.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.651 2.38 . . . . 0.0 107.692 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.1 m -134.26 97.92 3.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 110.062 -168.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.704 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 42.6 m-85 -110.13 92.35 4.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 123.945 0.898 . . . . 0.0 108.933 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.2 163.25 27.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.5 177.19 12.86 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.261 0.923 . . . . 0.0 113.023 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 p -76.53 25.3 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.04 2.536 . . . . 0.0 114.241 -169.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -58.2 160.36 5.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.049 1.34 . . . . 0.0 111.322 176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.5 p -128.91 -2.02 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.105 0.962 . . . . 0.0 111.987 -172.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -146.51 163.72 34.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.99 151.86 23.03 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.73 ' HE2' HD11 ' A' ' 30' ' ' LEU . 38.7 mtp -76.9 163.82 26.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -119.58 93.13 47.09 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 157.293 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -93.29 161.02 2.5 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.745 2.296 . . . . 0.0 111.137 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.75 31.82 59.93 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD11 HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -84.69 171.72 12.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.693 1.997 . . . . 0.0 106.923 166.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.64 153.25 45.9 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 123.788 0.835 . . . . 0.0 110.067 163.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.66 169.51 17.28 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.683 2.255 . . . . 0.0 112.63 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.9 t80 47.49 51.04 14.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.146 1.778 . . . . 0.0 111.191 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -153.8 -178.74 7.25 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.812 -1.18 . . . . 0.0 109.683 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -110.0 158.99 17.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -145.5 151.43 38.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.5 m -123.33 142.76 50.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 170.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 162.67 34.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.333 1.853 . . . . 0.0 109.568 174.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.57 144.23 31.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.647 1.579 . . . . 0.0 106.826 170.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.99 132.56 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -129.93 134.14 47.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.046 1.294 . . . . 0.0 110.824 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.31 152.29 5.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.3 142.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -132.92 -162.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.59 1.156 . . . . 0.0 109.813 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.93 65.74 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -50.62 69.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.861 0.865 . . . . 0.0 110.763 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.42 -168.84 41.88 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 120.003 1.274 . . . . 0.0 112.945 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.56 154.36 27.52 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.746 1.218 . . . . 0.0 110.983 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.471 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -108.28 -172.91 21.65 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 0.0 112.074 166.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.44 156.32 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.139 1.893 . . . . 0.0 110.493 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.82 152.72 21.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.112 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -63.8 -171.79 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.812 1.645 . . . . 0.0 111.459 170.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.95 154.58 16.99 Favored 'Trans proline' 0 C--N 1.352 0.729 0 CA-C-N 120.663 1.272 . . . . 0.0 110.242 163.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -82.74 85.3 7.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 166.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -67.09 155.93 37.43 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.73 154.22 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 23' ' ' VAL . 53.5 p90 -151.79 152.25 32.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -102.29 160.37 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 169.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p -107.94 146.28 33.15 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.88 -89.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.791 2.994 . . . . 0.0 113.257 -162.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -142.4 -34.97 0.44 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.381 0.991 . . . . 0.0 112.392 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 66.6 144.51 0.06 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.787 1.66 . . . . 0.0 110.819 -168.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.34 -163.27 0.1 Allowed 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.214 -1.168 . . . . 0.0 110.251 -162.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 94.91 160.03 33.75 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -157.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.39 114.71 4.11 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.413 2.075 . . . . 0.0 110.763 -166.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 m -62.29 -43.45 98.79 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 166.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.9 m -138.89 161.02 38.32 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.466 1.506 . . . . 0.0 107.485 166.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.617 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 171.062 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.71 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 133.63 169.09 0.0 OUTLIER 'General case' 0 C--O 1.233 0.222 1 C-N-CA 131.975 4.11 . . . . 0.0 108.201 167.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m 45.52 -153.8 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.3 1.04 . . . . 0.0 110.461 -168.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.76 88.85 0.07 OUTLIER Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.907 1.231 . . . . 0.0 111.814 170.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 p -73.46 151.16 41.18 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.474 1.137 . . . . 0.0 111.805 176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.81 137.27 52.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.302 1.841 . . . . 0.0 109.928 -167.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.89 170.0 31.92 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.678 0.656 . . . . 0.0 111.53 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.15 133.85 3.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.167 0.987 . . . . 0.0 110.255 177.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 p -151.54 159.78 43.97 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.614 -0.679 . . . . 0.0 110.146 163.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.37 121.82 0.58 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.06 -66.8 0.48 Allowed 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 168.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -122.45 -8.31 8.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.723 0.809 . . . . 0.0 112.361 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.3 mt -69.71 143.71 92.81 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 123.951 0.901 . . . . 0.0 110.299 167.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.06 160.39 47.59 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.61 2.207 . . . . 0.0 112.805 -171.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.3 mtm -114.7 -39.02 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -170.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG22 ' CB ' ' A' ' 42' ' ' SER . 30.8 m -140.8 155.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.247 0.931 . . . . 0.0 109.521 -178.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 172.02 10.98 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 127.081 2.152 . . . . 0.0 111.108 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HD3' HG13 ' A' ' 99' ' ' VAL . 5.7 Cg_exo -56.6 161.49 9.77 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 120.651 0.9 . . . . 0.0 111.119 167.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.62 -170.51 5.04 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 165.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 151.83 17.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.28 1.038 . . . . 0.0 112.078 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.39 151.69 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.805 1.242 . . . . 0.0 108.009 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.47 158.44 38.34 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.56 1.944 . . . . 0.0 106.575 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.32 115.6 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 170.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -98.8 129.33 45.2 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.079 0.862 . . . . 0.0 109.019 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -79.58 109.99 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 30' ' ' LEU . 3.8 m -78.88 -59.66 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 127.047 2.139 . . . . 0.0 109.0 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -124.58 -176.02 3.42 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.254 1.422 . . . . 0.0 109.914 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -59.87 -58.4 8.72 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.108 -0.995 . . . . 0.0 110.065 161.31 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 p -89.72 2.08 55.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.91 1.684 . . . . 0.0 113.841 -165.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 26' ' ' VAL . 23.9 tp -135.55 140.96 45.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.009 1.724 . . . . 0.0 107.66 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.43 153.83 45.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -95.25 139.07 32.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.78 139.85 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 169.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.9 146.99 50.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.0 p90 -139.4 166.87 23.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.151 1.38 . . . . 0.0 108.437 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.06 147.59 88.38 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.78 141.36 84.72 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.374 1.382 . . . . 0.0 108.615 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 35.3 m -85.64 159.47 55.3 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.218 159.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.88 148.02 81.58 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.702 2.935 . . . . 0.0 109.444 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 40' ' ' LEU 0.276 0.0 OUTLIER -51.17 -27.93 9.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 168.483 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -63.87 -32.97 74.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 117.109 -1.424 . . . . 0.0 112.486 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.486 ' CB ' HG22 ' A' ' 16' ' ' VAL . 77.9 p -74.72 -36.69 62.69 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.373 1.442 . . . . 0.0 109.956 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.518 HD13 ' HB2' ' A' ' 47' ' ' LEU . 21.2 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 108.514 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 80.27 -61.4 0.27 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 129.273 3.029 . . . . 0.0 110.556 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.77 -160.44 17.14 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 126.129 1.823 . . . . 0.0 111.082 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -72.79 121.99 20.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.399 1.08 . . . . 0.0 109.248 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' HB2' HD13 ' A' ' 43' ' ' ILE . 1.5 tm? -59.94 119.5 7.87 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.743 0.817 . . . . 0.0 109.77 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -78.6 -36.57 44.07 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.09 -175.26 33.15 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -114.09 166.51 11.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -130.27 150.82 51.34 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.411 1.484 . . . . 0.0 107.531 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.2 mt -124.91 124.38 67.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -91.56 138.61 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 165.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.9 p90 -146.78 167.35 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 120.981 1.718 . . . . 0.0 111.366 168.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -149.04 158.03 43.86 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.87 0.868 . . . . 0.0 110.891 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.29 138.15 41.65 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.466 1.106 . . . . 0.0 108.772 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -108.14 167.86 9.71 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -126.31 96.58 4.75 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.062 1.745 . . . . 0.0 106.781 175.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.0 t -55.49 -58.17 8.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.464 0.706 . . . . 0.0 110.169 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 t -132.05 103.58 6.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.384 0.993 . . . . 0.0 108.535 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 t -142.17 109.18 5.48 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 125.464 1.506 . . . . 0.0 107.707 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -62.14 -25.2 67.61 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.351 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -79.45 136.41 36.92 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -63.37 153.93 33.54 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -76.62 122.0 24.02 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -172.38 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 158.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -45.2 124.27 4.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.696 0.68 . . . . 0.0 111.108 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.6 mt -69.53 126.48 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -169.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -72.8 87.87 1.3 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.704 2.002 . . . . 0.0 107.783 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -90.13 126.1 35.67 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.517 1.527 . . . . 0.0 107.761 174.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 11.1 mmtt -114.27 168.1 10.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 118.833 0.742 . . . . 0.0 109.456 171.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 mm -127.31 159.22 37.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.423 1.489 . . . . 0.0 107.368 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.449 ' CD1' HD13 ' A' ' 84' ' ' LEU . 2.6 mt -136.19 159.17 42.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.174 1.789 . . . . 0.0 108.204 167.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -123.77 141.55 51.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.251 1.82 . . . . 0.0 107.155 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -145.67 104.84 3.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -77.43 175.44 9.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.777 -1.202 . . . . 0.0 109.867 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.28 160.62 5.02 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.651 1.139 . . . . 0.0 113.173 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.5 m -77.32 21.25 0.26 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.196 1.398 . . . . 0.0 113.458 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -48.49 154.59 0.62 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.277 1.031 . . . . 0.0 110.895 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 p -119.43 9.29 11.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.171 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 167.13 24.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.072 0.949 . . . . 0.0 109.062 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.17 -171.1 26.71 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 127.455 2.455 . . . . 0.0 107.505 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -138.28 159.72 41.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 117.963 0.882 . . . . 0.0 110.844 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.9 mm? -112.85 81.6 4.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 127.019 2.127 . . . . 0.0 107.394 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -84.4 155.94 12.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.836 2.357 . . . . 0.0 111.059 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.87 16.47 67.72 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.404 -0.665 . . . . 0.0 112.961 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 93' ' ' TYR . 3.8 mm? -91.7 173.68 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.858 1.263 . . . . 0.0 110.527 -175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.42 144.69 32.84 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.472 -175.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.93 176.38 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.976 2.451 . . . . 0.0 113.191 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 38.75 46.49 1.04 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 130.939 3.696 . . . . 0.0 113.933 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 64.1 m -135.09 174.13 10.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.101 1.76 . . . . 0.0 110.67 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -120.84 152.23 38.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.631 1.972 . . . . 0.0 107.106 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.408 ' CE1' HD12 ' A' ' 87' ' ' LEU . 97.2 m-85 -144.33 161.43 38.99 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.056 1.342 . . . . 0.0 111.019 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.4 m -124.15 141.48 52.02 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 161.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.81 153.2 42.99 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.025 1.73 . . . . 0.0 110.137 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.18 129.79 20.23 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -170.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.5 t -89.43 147.32 5.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -145.74 124.08 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.331 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.447 HG13 ' HD3' ' A' ' 18' ' ' PRO . 4.4 m -69.5 152.55 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.414 1.007 . . . . 0.0 109.676 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.13 151.92 25.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.727 1.611 . . . . 0.0 108.352 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -144.68 -171.14 3.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.972 1.309 . . . . 0.0 109.015 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.01 -15.26 78.52 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.996 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -23.77 14.56 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.581 1.552 . . . . 0.0 111.919 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.47 -154.41 25.5 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.858 0.754 . . . . 0.0 111.305 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 173.93 10.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.392 1.477 . . . . 0.0 110.008 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.79 -155.44 6.87 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.693 1.139 . . . . 0.0 112.761 -166.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.57 160.79 41.41 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.689 2.259 . . . . 0.0 110.595 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.99 162.21 13.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.194 1.798 . . . . 0.0 111.462 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 54.1 p -67.58 -176.72 0.28 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.6 0.76 . . . . 0.0 110.335 172.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 19.8 Cg_endo -54.28 129.84 36.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 N-CA-C 108.968 -1.204 . . . . 0.0 108.968 153.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.93 132.49 53.18 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 163.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -115.75 163.46 15.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.443 1.097 . . . . 0.0 109.239 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.49 158.77 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -150.47 151.97 33.52 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.31 141.74 44.45 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.365 1.466 . . . . 0.0 108.008 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.3 p -92.46 157.36 40.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.101 -0.375 . . . . 0.0 111.342 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 75.5 Cg_endo -75.11 171.0 19.17 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.133 2.555 . . . . 0.0 108.178 173.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.97 -35.41 78.4 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 114.863 -162.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 122.91 -109.84 1.44 Allowed Glycine 0 N--CA 1.461 0.33 0 C-N-CA 125.277 1.418 . . . . 0.0 110.293 174.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 t -138.71 138.4 37.67 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 164.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.55 176.32 52.46 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.13 97.53 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.383 2.722 . . . . 0.0 110.515 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.8 m -142.41 165.11 28.31 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.741 2.016 . . . . 0.0 107.241 165.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 t -142.51 167.46 22.03 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 160.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.757 0 N-CA-C 104.3 -3.52 . . . . 0.0 104.3 -140.414 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.89 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 m -132.8 176.93 8.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.275 1.03 . . . . 0.0 108.579 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 t -150.97 -178.42 6.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.662 1.985 . . . . 0.0 107.289 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.81 174.85 29.18 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.079 1.323 . . . . 0.0 110.247 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.0 m -156.39 170.61 21.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.719 1.608 . . . . 0.0 108.55 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -160.83 -163.48 1.06 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.367 1.867 . . . . 0.0 107.859 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.76 174.91 30.13 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.598 1.571 . . . . 0.0 109.302 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.519 ' CG ' ' H ' ' A' ' 9' ' ' SER . 14.5 t-80 -146.92 -166.9 2.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.657 0.783 . . . . 0.0 109.452 171.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.519 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 11.8 p -112.69 103.06 11.09 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.107 1.363 . . . . 0.0 110.991 -165.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.09 -104.89 0.47 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 32.66 60.54 0.39 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 127.887 2.475 . . . . 0.0 112.073 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -55.87 -50.8 69.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.898 -169.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.47 ' C ' HD21 ' A' ' 101' ' ' ASN . 29.7 mt 50.1 173.89 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 128.72 2.808 . . . . 0.0 113.12 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.15 177.29 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.179 1.253 . . . . 0.0 110.0 166.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.1 mtm -134.05 -27.37 1.44 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 42' ' ' SER . 28.5 m -138.59 178.52 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 120.193 1.361 . . . . 0.0 110.101 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.89 162.67 19.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 128.41 2.684 . . . . 0.0 107.626 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.35 151.07 81.87 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 120.863 1.042 . . . . 0.0 109.686 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.31 -94.62 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 125.137 1.351 . . . . 0.0 112.535 -163.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 162.03 13.41 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.5 t -128.97 148.76 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -142.99 152.7 42.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.828 2.051 . . . . 0.0 106.252 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.45 139.13 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 119.975 1.261 . . . . 0.0 110.387 171.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -116.5 145.69 43.13 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 127.398 2.279 . . . . 0.0 107.944 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.62 110.25 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.24 -59.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.642 0.777 . . . . 0.0 108.928 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.277 20.1 p30 -121.12 -105.52 0.38 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.627 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.37 -51.95 1.96 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.695 1.998 . . . . 0.0 109.696 174.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.9 p -101.12 4.32 42.03 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.192 1.397 . . . . 0.0 111.519 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -124.65 122.97 39.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.042 1.737 . . . . 0.0 109.02 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.41 163.38 17.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 109.552 165.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -125.54 115.57 20.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 129.123 2.969 . . . . 0.0 105.994 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.1 t -92.73 145.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.14 146.39 49.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -148.1 155.56 41.59 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -74.0 140.03 76.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.92 155.49 54.73 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.884 2.389 . . . . 0.0 109.374 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG21 HG11 ' A' ' 99' ' ' VAL . 16.2 m -102.31 157.54 33.5 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 166.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -76.16 153.35 36.35 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 122.753 2.302 . . . . 0.0 109.443 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 43' ' ' ILE . 5.3 mp -61.8 -27.4 68.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.064 0.945 . . . . 0.0 111.174 176.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -44.83 -58.78 2.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.574 1.15 . . . . 0.0 110.906 163.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.616 ' HB2' HG22 ' A' ' 16' ' ' VAL . 81.1 p -61.85 -26.31 68.06 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -171.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 40' ' ' LEU . 24.6 mt -87.76 -17.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.159 1.384 . . . . 0.0 109.996 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 55.45 1.95 0.06 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.38 2.272 . . . . 0.0 115.33 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.87 -155.3 21.6 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 127.817 2.627 . . . . 0.0 107.261 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -74.09 132.81 42.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.267 1.533 . . . . 0.0 111.998 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' HD13 ' A' ' 43' ' ' ILE . 8.6 tt -69.32 125.28 26.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -81.07 -60.35 2.32 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.03 -178.79 39.12 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-O 121.955 0.753 . . . . 0.0 113.663 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -107.83 117.89 35.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.878 . . . . 0.0 106.589 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 92.09 4.92 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.74 123.02 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -92.19 145.62 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 164.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.43 163.71 39.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.777 1.231 . . . . 0.0 110.906 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -148.98 159.68 43.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.989 0.916 . . . . 0.0 110.538 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -68.83 132.22 46.42 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 166.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.8 m -107.47 159.32 16.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 43.68 71.62 0.23 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.051 1.741 . . . . 0.0 112.516 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.0 103.45 4.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.39 145.73 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.712 2.005 . . . . 0.0 112.633 -174.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.7 m -93.67 78.63 4.27 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.002 1.321 . . . . 0.0 109.279 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -139.79 148.21 41.87 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -145.25 129.1 17.33 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -172.8 -169.3 0.56 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.79 2.036 . . . . 0.0 107.046 168.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -61.98 165.79 5.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.122 0.874 . . . . 0.0 110.275 166.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? 45.55 60.58 3.02 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.254 1.422 . . . . 0.0 110.147 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -127.1 148.05 50.16 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.028 1.331 . . . . 0.0 109.086 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.4 mt 62.19 145.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 128.4 2.68 . . . . 0.0 109.702 -168.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -105.69 130.73 53.65 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -118.44 93.77 4.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.971 0.908 . . . . 0.0 109.017 -164.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -84.27 157.88 21.41 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.104 1.761 . . . . 0.0 110.103 -169.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -140.96 111.13 3.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.04 166.78 22.85 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.328 1.451 . . . . 0.0 110.165 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.4 m -126.06 125.75 43.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -135.91 116.45 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -79.24 164.44 24.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.323 0.965 . . . . 0.0 109.008 165.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.12 172.43 3.4 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.533 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -87.48 39.68 0.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.799 -0.701 . . . . 0.0 112.279 -153.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -59.88 167.22 2.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.314 1.446 . . . . 0.0 111.567 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -130.04 8.75 5.22 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.899 1.679 . . . . 0.0 110.626 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -156.35 160.47 39.71 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.418 1.887 . . . . 0.0 106.882 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.71 40.4 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 32.1 mtp -132.53 156.25 47.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 118.728 1.264 . . . . 0.0 110.953 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.57 82.4 4.79 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 126.363 1.865 . . . . 0.0 106.349 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -85.23 154.38 10.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.29 1.993 . . . . 0.0 110.848 165.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 16.8 46.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.344 0.973 . . . . 0.0 112.252 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.402 HD12 ' CE2' ' A' ' 93' ' ' TYR . 4.2 mm? -88.59 -171.56 3.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.097 0.949 . . . . 0.0 109.895 -173.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.46 141.57 41.9 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 128.279 2.632 . . . . 0.0 105.92 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -73.54 -173.91 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.004 3.136 . . . . 0.0 112.097 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 50.69 43.36 27.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.686 2.395 . . . . 0.0 113.032 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.8 m -157.54 163.48 38.34 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.97 0.908 . . . . 0.0 112.107 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -88.5 155.09 19.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.177 1.391 . . . . 0.0 107.678 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.402 ' CE2' HD12 ' A' ' 87' ' ' LEU . 82.8 m-85 -144.68 146.95 32.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.826 1.65 . . . . 0.0 108.766 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 19.7 m -126.75 122.69 35.56 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.618 0.767 . . . . 0.0 109.025 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 158.07 39.22 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.209 1.804 . . . . 0.0 109.453 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.57 164.01 33.0 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.885 1.274 . . . . 0.0 109.555 171.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 t -125.71 142.89 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.807 1.643 . . . . 0.0 106.873 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -149.7 132.32 15.84 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 38' ' ' VAL . 1.3 m -82.2 144.64 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.5 t -135.25 139.87 46.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.245 1.818 . . . . 0.0 106.315 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.47 HD21 ' C ' ' A' ' 13' ' ' LEU . 36.4 p-10 -149.21 -172.47 4.13 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.887 0.875 . . . . 0.0 112.246 -168.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.46 12.19 0.14 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.893 2.187 . . . . 0.0 116.86 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -141.94 -35.59 0.44 Allowed 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.061 1.93 . . . . 0.0 112.102 168.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.31 -154.66 9.61 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 119.165 0.893 . . . . 0.0 112.126 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.92 165.54 17.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.362 1.465 . . . . 0.0 109.976 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.29 -173.43 15.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 125.203 1.383 . . . . 0.0 112.71 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.49 135.86 51.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.363 2.709 . . . . 0.0 109.21 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.75 151.35 34.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.918 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -58.9 172.59 0.52 Allowed Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 124.683 1.193 . . . . 0.0 109.451 169.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -56.1 139.44 85.37 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 152.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.74 160.18 23.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.099 170.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -129.99 168.9 15.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.21 162.87 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.331 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -144.32 143.6 31.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -86.19 166.74 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 p -123.73 159.9 53.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 124.071 0.948 . . . . 0.0 109.737 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.49 161.37 43.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -58.65 -23.11 58.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.609 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.23 6.36 89.4 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.281 -1.288 . . . . 0.0 114.537 163.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.04 158.95 33.77 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.108 1.454 . . . . 0.0 110.778 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.71 155.41 48.27 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.08 87.06 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.876 2.384 . . . . 0.0 106.98 167.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.3 m -147.73 30.79 0.89 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.266 -0.896 . . . . 0.0 110.988 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.8 m -148.04 148.29 30.53 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 165.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.803 0 N-CA-C 106.531 -2.628 . . . . 0.0 106.531 -166.268 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.68 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t -141.65 150.23 41.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 166.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 m -146.36 164.54 32.09 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.453 1.501 . . . . 0.0 107.976 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.62 147.35 17.1 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 m -160.97 152.46 19.25 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.846 2.059 . . . . 0.0 107.489 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -157.16 -176.17 5.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.56 -152.63 24.0 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -173.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -64.17 162.91 13.57 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -59.66 -64.1 1.07 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.48 148.46 0.3 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -170.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -147.82 92.35 2.05 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 121.212 -1.169 . . . . 0.0 107.85 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -148.14 -34.59 0.22 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.436 1.094 . . . . 0.0 109.945 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.9 152.48 68.9 Favored Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.546 1.938 . . . . 0.0 112.29 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.83 172.61 12.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.887 2.392 . . . . 0.0 111.815 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.6 mtm -124.78 -19.03 5.42 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.7 m -144.02 179.37 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 120.392 1.451 . . . . 0.0 111.275 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 107' ' ' PRO . . . -114.56 158.79 39.21 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 129.045 2.938 . . . . 0.0 108.708 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -69.06 144.67 58.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.252 1.968 . . . . 0.0 111.094 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.42 -179.14 52.27 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.414 1.959 . . . . 0.0 113.169 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 t30 2.05 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.539 3.536 . . . . 0.0 114.671 -171.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.95 132.02 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -126.17 153.96 43.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.506 1.923 . . . . 0.0 107.971 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.55 129.68 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.266 1.027 . . . . 0.0 108.743 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -125.21 135.66 52.79 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 125.337 1.455 . . . . 0.0 112.302 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.367 1.0 OUTLIER -84.73 128.85 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 123.113 1.435 . . . . 0.0 111.753 174.486 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.73 -40.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 128.18 2.592 . . . . 0.0 109.529 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 77.5 m-20 -138.24 -179.91 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.714 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.46 88.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.668 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.8 p -114.63 4.77 15.2 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.137 1.375 . . . . 0.0 112.759 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 17.3 tp -132.27 137.31 47.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.293 1.837 . . . . 0.0 108.328 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -131.51 170.34 14.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.921 1.288 . . . . 0.0 109.372 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -128.88 139.88 51.94 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.6 t -114.54 143.57 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -129.17 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.769 1.628 . . . . 0.0 107.265 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -150.14 151.65 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.786 1.234 . . . . 0.0 108.363 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -69.39 146.18 96.23 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.674 -0.641 . . . . 0.0 110.485 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.76 131.08 29.86 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 108.449 162.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 m -76.11 160.03 79.11 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.57 144.66 67.46 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.526 2.151 . . . . 0.0 109.275 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -26.2 68.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.529 -0.732 . . . . 0.0 111.027 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -55.93 -32.6 63.94 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 118.297 -0.858 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.691 ' HB2' HG22 ' A' ' 16' ' ' VAL . 87.4 p -72.32 -32.29 66.42 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 119.273 0.942 . . . . 0.0 111.642 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mt -75.77 -30.63 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.206 1.002 . . . . 0.0 109.994 -164.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 45.84 34.79 2.0 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.027 2.131 . . . . 0.0 112.81 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.77 -133.25 1.82 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -171.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.91 121.06 22.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.8 tp -52.01 118.08 3.21 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -79.88 -51.83 8.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.57 -170.22 40.34 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -106.09 157.6 17.42 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 163.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -123.91 144.5 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 169.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.5 mt -118.46 126.57 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -92.07 144.94 24.92 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 160.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 35.7 p90 -155.44 159.3 39.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.0 0.92 . . . . 0.0 110.987 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.77 155.51 40.25 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -68.52 130.53 43.12 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.711 1.604 . . . . 0.0 107.636 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.0 m -115.52 120.8 40.67 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -134.97 -33.19 0.93 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -170.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.6 m 54.44 -168.46 0.07 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.039 0.936 . . . . 0.0 110.844 -168.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.3 t -160.1 152.15 20.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 163.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -76.01 39.73 0.19 Allowed 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.936 165.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.2 tttm 37.27 62.89 0.79 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.115 1.766 . . . . 0.0 109.329 -161.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -11.92 8.09 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.94 0.896 . . . . 0.0 112.217 -168.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 146.52 88.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 1 C-N-CA 131.872 4.069 . . . . 0.0 108.286 162.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.3 138.13 20.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 168.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -134.89 169.68 17.02 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.156 1.783 . . . . 0.0 106.682 149.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.3 m80 67.66 138.6 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.765 2.826 . . . . 0.0 114.279 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 76.0 mt -133.3 126.99 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -76.84 118.81 19.81 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -112.71 140.44 47.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.694 1.198 . . . . 0.0 109.273 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -136.23 166.08 24.26 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 125.684 1.594 . . . . 0.0 109.807 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.24 149.43 33.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -138.55 145.52 40.77 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.593 1.957 . . . . 0.0 107.668 -173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 m -129.87 119.04 22.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.206 1.002 . . . . 0.0 108.694 -163.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -128.87 88.22 2.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.891 1.277 . . . . 0.0 108.401 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -69.3 173.51 5.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.852 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 -178.01 18.66 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.891 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -85.79 11.33 11.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -161.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -56.77 149.35 18.32 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 125.033 1.333 . . . . 0.0 112.307 -166.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -112.66 9.51 19.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.669 1.187 . . . . 0.0 111.312 175.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.92 160.61 43.46 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.059 1.343 . . . . 0.0 109.356 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.67 143.13 8.97 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.7 mtp -86.26 146.98 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.258 0.529 . . . . 0.0 109.818 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.532 HD12 HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -106.8 94.53 10.6 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 126.687 1.995 . . . . 0.0 105.963 174.212 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -92.12 167.21 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.7 2.933 . . . . 0.0 112.175 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.96 19.96 74.12 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.681 -0.637 . . . . 0.0 112.79 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 84' ' ' LEU . 3.9 mm? -85.23 168.67 14.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.651 0.781 . . . . 0.0 109.069 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.87 131.64 22.03 Favored Pre-proline 0 N--CA 1.432 -1.327 0 C-N-CA 126.092 1.757 . . . . 0.0 107.348 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -74.52 162.92 37.16 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.963 1.775 . . . . 0.0 111.529 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.6 t80 50.63 40.5 24.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.127 1.371 . . . . 0.0 112.134 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -136.14 158.82 43.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.269 1.427 . . . . 0.0 110.686 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -94.45 153.73 17.79 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -148.21 154.21 39.79 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.922 1.289 . . . . 0.0 110.017 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.9 m -126.21 149.78 48.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.867 1.667 . . . . 0.0 107.521 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.0 158.48 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.596 2.358 . . . . 0.0 110.488 171.391 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.05 145.13 29.57 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.683 1.193 . . . . 0.0 110.648 168.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.61 151.06 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.249 1.82 . . . . 0.0 108.496 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -144.76 133.5 22.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -73.94 151.41 7.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.91 136.37 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -134.69 -173.51 3.31 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.729 2.012 . . . . 0.0 107.031 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.85 13.44 13.4 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.033 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -123.07 -54.69 1.81 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.67 1.588 . . . . 0.0 110.037 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.09 48.94 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.039 0.836 . . . . 0.0 111.942 -173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -83.66 154.76 23.52 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.593 0.711 . . . . 0.0 110.702 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -100.82 -171.08 28.86 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.877 1.227 . . . . 0.0 112.349 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 40.3 Cg_endo -65.18 137.99 54.33 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.945 1.764 . . . . 0.0 108.751 170.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.63 161.19 29.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 60.3 p -62.97 178.53 0.35 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.487 1.115 . . . . 0.0 108.943 172.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 94.4 Cg_endo -61.49 155.52 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 107.346 -1.828 . . . . 0.0 107.346 157.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.27 151.79 46.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.688 1.232 . . . . 0.0 108.926 162.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -124.74 161.82 25.58 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.2 150.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.474 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.79 165.26 30.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -135.66 144.03 45.8 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.013 2.125 . . . . 0.0 107.289 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.8 p -110.59 153.32 43.62 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.085 0.554 . . . . 0.0 110.548 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.4 -68.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.757 2.304 . . . . 0.0 113.131 -152.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -163.41 -41.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.32 1.448 . . . . 0.0 109.848 168.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.31 59.19 3.4 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 126.073 1.797 . . . . 0.0 113.673 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -3.92 34.89 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.559 1.18 . . . . 0.0 113.921 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.89 -169.39 52.72 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.6 165.57 7.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.156 1.904 . . . . 0.0 111.91 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -141.73 -153.98 0.49 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.7 t -52.31 -45.21 65.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.012 0.925 . . . . 0.0 111.921 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.653 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 177.177 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.468 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -168.27 66.28 0.07 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.573 1.186 . . . . 0.0 108.277 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -157.54 70.01 0.58 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.69 28.05 1.18 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-O 118.447 -1.196 . . . . 0.0 113.135 -169.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.3 m -140.93 156.58 46.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.037 1.419 . . . . 0.0 111.374 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -151.68 -46.29 0.11 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.831 1.652 . . . . 0.0 108.125 166.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.44 170.78 15.33 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 -165.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.42 106.63 1.73 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 167.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t -158.87 165.23 34.66 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.602 1.161 . . . . 0.0 109.756 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.64 132.04 7.54 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 125.693 1.616 . . . . 0.0 112.967 164.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -93.99 -31.81 14.1 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.856 1.262 . . . . 0.0 110.607 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.77 -24.39 1.33 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.317 -167.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.8 mt -66.08 149.5 97.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.315 1.416 . . . . 0.0 112.108 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.81 158.75 23.29 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.641 2.227 . . . . 0.0 112.632 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtm -121.5 -31.59 4.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.321 1.049 . . . . 0.0 113.545 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 42' ' ' SER . 31.0 m -140.96 158.05 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.825 0.739 . . . . 0.0 111.666 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.8 159.99 31.19 Favored Pre-proline 0 N--CA 1.444 -0.754 0 C-N-CA 130.021 3.329 . . . . 0.0 111.928 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.35 141.59 35.66 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.34 2.026 . . . . 0.0 111.403 -175.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.05 166.73 51.98 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.546 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.0 t30 49.35 54.55 10.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.619 1.567 . . . . 0.0 112.737 154.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.67 128.8 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.784 1.234 . . . . 0.0 109.296 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 116.13 9.04 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.235 1.814 . . . . 0.0 110.476 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -107.99 138.05 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.163 0.985 . . . . 0.0 108.937 -175.193 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -124.12 124.93 43.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.126 2.171 . . . . 0.0 110.36 -175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.59 102.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.69 ' HB ' HD12 ' A' ' 30' ' ' LEU . 73.9 t -72.65 -48.98 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -138.25 -179.03 5.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 122.271 1.034 . . . . 0.0 109.03 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -35.49 80.62 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.258 -0.901 . . . . 0.0 111.686 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -119.34 17.56 13.02 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.309 1.044 . . . . 0.0 111.363 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.82 HD11 ' CE ' ' A' ' 83' ' ' MET . 3.1 tm? -139.32 137.99 36.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.501 1.92 . . . . 0.0 108.628 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.529 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -136.02 150.62 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -108.4 143.72 36.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.788 2.035 . . . . 0.0 107.046 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.04 119.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -108.34 152.96 23.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -154.12 163.52 39.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.942 0.897 . . . . 0.0 109.594 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -80.3 140.93 52.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.12 140.89 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.712 2.275 . . . . 0.0 108.49 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.11 156.59 79.25 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 164.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.29 147.01 17.98 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.611 2.874 . . . . 0.0 109.841 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.64 -29.06 64.27 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -50.58 -50.31 54.13 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.343 0.519 . . . . 0.0 110.939 168.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.736 ' HB2' HG22 ' A' ' 16' ' ' VAL . 71.8 p -59.74 -37.98 80.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.417 0.553 . . . . 0.0 112.259 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.508 HD13 ' HB2' ' A' ' 47' ' ' LEU . 15.4 mt -70.42 -23.41 24.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.799 -169.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.54 -14.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.572 2.349 . . . . 0.0 115.82 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.03 -163.74 12.34 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.72 3.057 . . . . 0.0 108.55 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -77.96 117.6 19.45 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.803 0.841 . . . . 0.0 111.695 -174.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.508 ' HB2' HD13 ' A' ' 43' ' ' ILE . 36.2 tp -57.3 133.48 55.15 Favored 'General case' 0 CA--C 1.523 -0.07 0 C-N-CA 125.698 1.599 . . . . 0.0 109.987 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -103.72 -23.41 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.201 1.4 . . . . 0.0 110.455 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.82 -164.75 30.45 Favored Glycine 0 C--O 1.239 0.437 0 O-C-N 120.95 -1.094 . . . . 0.0 112.013 167.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.39 141.14 46.47 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.557 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -121.83 97.09 5.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.4 mt -77.95 120.63 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -91.67 141.55 28.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 164.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.557 ' CD2' HD11 ' A' ' 84' ' ' LEU . 41.4 p90 -151.25 166.08 32.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.751 0.82 . . . . 0.0 110.566 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -149.46 159.14 44.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -68.95 136.6 52.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 m -124.06 141.99 51.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -146.48 6.35 0.96 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.814 0.846 . . . . 0.0 111.019 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.8 m -146.14 152.48 39.33 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.242 1.817 . . . . 0.0 108.315 166.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -138.45 4.45 2.4 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.358 1.063 . . . . 0.0 110.882 164.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.49 93.94 3.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.467 1.507 . . . . 0.0 108.088 -174.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.5 mttt 93.64 121.79 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 131.252 3.821 . . . . 0.0 111.213 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -75.62 80.38 2.61 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.626 1.571 . . . . 0.0 109.354 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -74.47 178.02 5.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -73.1 147.08 45.27 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 157.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.89 164.71 11.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.941 0.896 . . . . 0.0 110.119 150.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -68.7 146.63 52.8 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 160.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.5 mt -133.81 124.98 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -76.43 103.01 6.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 166.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -95.69 162.08 13.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.227 1.411 . . . . 0.0 110.91 174.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -148.72 171.94 15.4 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.508 1.523 . . . . 0.0 110.792 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.74 149.67 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 128.275 2.63 . . . . 0.0 104.622 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -133.02 161.09 35.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.122 1.769 . . . . 0.0 109.123 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -131.18 121.77 25.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.798 1.181 . . . . 0.0 111.85 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -136.99 115.26 11.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 163.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -80.98 162.51 23.82 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.325 0.583 . . . . 0.0 110.227 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.65 -173.32 21.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.152 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.06 13.98 0.47 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.552 1.941 . . . . 0.0 115.106 -168.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -51.73 147.85 6.2 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.673 1.189 . . . . 0.0 112.036 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.9 p -109.4 5.37 23.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 111.983 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.13 159.43 43.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.883 0.873 . . . . 0.0 109.966 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.15 170.07 30.83 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 126.697 2.094 . . . . 0.0 108.139 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.82 ' CE ' HD11 ' A' ' 30' ' ' LEU . 59.9 mtp -138.37 143.94 40.06 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.282 1.041 . . . . 0.0 110.892 -166.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 54' ' ' TYR . 4.0 mm? -110.33 84.95 4.12 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 127.507 2.323 . . . . 0.0 108.665 -173.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.63 156.75 3.54 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.413 2.742 . . . . 0.0 112.741 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.94 40.76 98.6 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.929 0.776 . . . . 0.0 111.406 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.487 HD12 ' CE2' ' A' ' 93' ' ' TYR . 4.0 mm? -96.1 165.88 12.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.754 1.621 . . . . 0.0 108.536 173.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.77 144.6 30.58 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.56 172.27 12.74 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.305 2.67 . . . . 0.0 111.962 165.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.25 0.3 OUTLIER 45.41 34.75 1.65 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.371 2.668 . . . . 0.0 114.063 172.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.19 -175.81 2.93 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.245 2.218 . . . . 0.0 109.554 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -124.64 154.28 40.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CE2' HD12 ' A' ' 87' ' ' LEU . 81.8 m-85 -145.65 158.71 43.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.854 0.461 . . . . 0.0 109.945 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.3 m -126.45 140.84 52.16 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.47 154.27 47.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.934 2.094 . . . . 0.0 108.991 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.22 166.28 25.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.572 1.549 . . . . 0.0 107.933 166.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.2 147.39 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -139.07 121.31 15.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 111.527 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.43 136.54 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.176 1.39 . . . . 0.0 107.263 172.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.83 143.99 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -131.89 -173.78 3.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.805 2.042 . . . . 0.0 107.601 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.11 92.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.575 0.625 . . . . 0.0 112.052 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -36.13 80.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.89 0.845 . . . . 0.0 111.663 176.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.37 -143.24 10.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 119.358 0.981 . . . . 0.0 111.074 -174.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -120.59 173.79 6.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.391 1.076 . . . . 0.0 112.354 -165.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.74 -162.36 9.09 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.293 1.425 . . . . 0.0 111.422 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.97 145.18 84.95 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.832 3.021 . . . . 0.0 111.668 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.99 157.64 34.63 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.387 1.075 . . . . 0.0 110.566 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.3 p -61.06 174.96 0.49 Allowed Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.127 162.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -51.35 148.4 19.4 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.498 0.798 . . . . 0.0 110.812 154.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.59 144.64 52.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 164.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -130.07 171.21 13.06 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.215 1.806 . . . . 0.0 108.514 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.49 164.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.982 1.313 . . . . 0.0 108.816 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 23' ' ' VAL . 41.4 p90 -153.47 148.25 26.41 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.336 1.854 . . . . 0.0 107.219 159.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -86.77 168.12 13.8 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 158.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.0 p -117.53 162.36 28.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 163.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.2 -83.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.272 1.982 . . . . 0.0 113.576 -155.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -142.54 -53.46 0.41 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.304 1.042 . . . . 0.0 109.649 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 144.69 -157.47 27.27 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 123.412 0.53 . . . . 0.0 112.372 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 m -150.33 178.21 9.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.655 2.782 . . . . 0.0 105.804 166.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 150.62 -108.49 0.39 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-O 117.84 -1.534 . . . . 0.0 110.243 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 87.61 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.355 2.703 . . . . 0.0 110.601 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.1 t -157.69 -175.17 5.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.129 1.772 . . . . 0.0 108.084 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.0 m -149.37 171.06 17.16 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 126.176 1.79 . . . . 0.0 108.582 163.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 CA-C-O 116.459 -2.3 . . . . 0.0 108.231 163.721 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.496 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.5 p -82.73 -168.74 2.16 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.838 2.055 . . . . 0.0 109.28 165.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p -150.07 173.41 13.9 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.051 -1.031 . . . . 0.0 109.035 147.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.09 98.37 0.3 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -71.19 10.78 0.52 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.386 1.474 . . . . 0.0 113.363 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -56.06 -73.86 0.05 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.272 1.429 . . . . 0.0 108.676 166.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.91 140.12 6.06 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -167.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -129.93 -173.51 3.05 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.199 1.4 . . . . 0.0 107.297 166.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.9 p -139.54 -173.92 3.74 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 166.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.01 122.04 0.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -138.35 -17.2 1.17 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.976 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.36 -17.31 0.2 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.279 0.945 . . . . 0.0 111.833 168.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt -76.95 150.02 80.73 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 119.304 0.956 . . . . 0.0 110.587 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -67.32 170.63 13.03 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.746 2.298 . . . . 0.0 114.272 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.5 mtm -122.35 -39.93 2.53 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 127.06 2.144 . . . . 0.0 111.041 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.757 HG22 ' HB2' ' A' ' 42' ' ' SER . 23.6 m -136.51 150.42 27.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 119.133 0.879 . . . . 0.0 111.755 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.96 168.53 22.3 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 128.426 2.69 . . . . 0.0 110.248 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.47 166.64 16.89 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 121.691 1.594 . . . . 0.0 114.048 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.49 -163.04 1.4 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.625 2.059 . . . . 0.0 112.788 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -58.08 106.33 0.36 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.628 1.171 . . . . 0.0 109.198 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.81 141.6 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.209 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -124.12 152.06 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.94 132.75 14.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -124.05 128.91 50.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 125.016 1.326 . . . . 0.0 110.022 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.297 0.7 OUTLIER -88.46 115.89 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.093 0.949 . . . . 0.0 110.473 -175.874 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.63 ' HB ' HD12 ' A' ' 30' ' ' LEU . 93.5 t -79.27 -35.21 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.392 -169.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -156.35 -173.25 4.41 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 109.413 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -17.96 64.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -171.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.9 p -128.71 6.21 5.59 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.435 1.494 . . . . 0.0 111.122 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.723 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.2 tm? -142.7 142.27 31.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.421 1.088 . . . . 0.0 110.097 -169.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -137.78 162.32 34.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -117.31 121.0 39.94 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -97.98 144.17 11.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -133.33 144.97 49.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.925 1.69 . . . . 0.0 107.592 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -148.31 173.07 13.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.029 1.332 . . . . 0.0 108.385 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -90.03 144.42 31.32 Favored Pre-proline 0 C--O 1.234 0.289 0 O-C-N 121.761 -0.587 . . . . 0.0 109.845 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.93 112.14 3.03 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.402 2.735 . . . . 0.0 109.104 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.22 159.17 62.75 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 150.65 18.93 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.536 2.824 . . . . 0.0 112.077 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.565 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -58.39 -35.77 72.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.909 1.284 . . . . 0.0 109.763 175.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -60.02 -25.85 65.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 117.171 -1.395 . . . . 0.0 114.234 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.757 ' HB2' HG22 ' A' ' 16' ' ' VAL . 76.0 p -93.11 -20.77 20.18 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 120.743 1.61 . . . . 0.0 111.673 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 40' ' ' LEU . 62.8 mt -63.23 -40.2 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 166.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 56.61 -3.24 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.616 2.767 . . . . 0.0 115.188 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 -166.56 12.73 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 125.466 1.507 . . . . 0.0 109.394 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -87.68 107.86 18.83 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.391 -0.476 . . . . 0.0 109.919 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' A' ' 43' ' ' ILE . 14.1 tp -48.81 130.48 17.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.016 1.327 . . . . 0.0 107.956 172.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -84.73 -62.16 1.61 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 76' ' ' GLN . . . -174.19 -165.15 30.34 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.34 160.57 14.19 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -134.95 99.44 4.29 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.601 -0.687 . . . . 0.0 109.2 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.7 mt -77.89 119.01 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.573 1.549 . . . . 0.0 107.019 170.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -91.74 149.64 21.51 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 39.8 p90 -154.24 164.82 37.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.521 1.51 . . . . 0.0 111.546 170.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -148.65 159.19 44.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.854 1.262 . . . . 0.0 111.197 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.64 138.32 54.92 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m -118.87 140.71 49.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -146.05 94.61 2.5 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -13.65 17.95 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.711 2.005 . . . . 0.0 114.31 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.43 -179.21 1.27 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.807 2.043 . . . . 0.0 112.498 -170.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -51.66 127.71 21.29 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.169 1.388 . . . . 0.0 110.466 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -77.49 70.55 3.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.279 1.032 . . . . 0.0 111.418 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -126.48 179.19 5.43 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.355 1.862 . . . . 0.0 108.818 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 23.59 76.75 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.471 3.108 . . . . 0.0 113.823 175.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -158.77 128.65 5.78 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.616 1.166 . . . . 0.0 108.039 -173.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.59 96.81 6.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.574 1.079 . . . . 0.0 108.765 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.3 m170 47.81 -155.14 0.07 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.257 1.423 . . . . 0.0 110.195 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.4 mt -128.71 124.66 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -78.11 122.67 25.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 167.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -102.18 105.34 16.01 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 170.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 2.3 mttp -88.03 172.36 9.6 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 127.383 2.273 . . . . 0.0 109.188 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.0 mm -141.79 161.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.46 1.904 . . . . 0.0 107.199 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.504 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -154.94 108.88 2.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.736 1.214 . . . . 0.0 110.024 177.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -81.92 135.43 35.4 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.273 1.429 . . . . 0.0 111.257 -163.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -137.11 97.54 3.52 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.42 ' HA ' ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -76.52 173.19 11.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.777 0.831 . . . . 0.0 110.865 175.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.81 175.43 46.33 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 121.964 0.758 . . . . 0.0 111.685 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.5 p -83.52 27.02 0.63 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.796 1.638 . . . . 0.0 112.748 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -60.38 164.95 3.93 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.932 1.349 . . . . 0.0 112.295 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.444 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 15.6 p -127.55 -0.94 6.19 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.762 2.025 . . . . 0.0 110.768 -174.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -152.14 163.45 39.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.06 1.344 . . . . 0.0 108.465 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.66 172.8 34.99 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 127.568 2.509 . . . . 0.0 107.92 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.723 ' HE2' HD11 ' A' ' 30' ' ' LEU . 77.5 mtp -115.09 159.01 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.583 1.191 . . . . 0.0 109.972 -172.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.7 mm? -121.44 77.27 35.36 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 108.877 168.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -86.07 149.06 9.38 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.503 2.802 . . . . 0.0 110.892 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.46 26.74 9.05 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.737 0.684 . . . . 0.0 112.043 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.434 HD21 HD12 ' A' ' 84' ' ' LEU . 2.3 mm? -109.59 171.08 7.66 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 126.258 1.823 . . . . 0.0 108.02 -173.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -115.25 144.77 32.87 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.896 0.878 . . . . 0.0 110.311 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -70.39 169.21 20.25 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.719 2.946 . . . . 0.0 113.059 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 35.88 51.12 0.71 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.819 2.448 . . . . 0.0 111.048 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 m -129.91 -179.69 5.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 108.528 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -130.14 143.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -136.35 168.2 19.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -126.12 142.6 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 153.85 49.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.452 1.501 . . . . 0.0 109.977 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.25 129.92 21.52 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.625 1.17 . . . . 0.0 109.281 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.49 162.17 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -152.55 161.3 42.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -106.57 146.91 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.09 139.68 41.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -134.1 178.87 6.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.324 0.65 . . . . 0.0 110.295 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.28 -40.14 52.36 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.015 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -73.11 -50.92 20.05 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.95 0.875 . . . . 0.0 111.865 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.4 -167.36 40.03 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -163.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -94.79 170.29 9.55 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 111.078 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.44 -154.29 6.96 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 167.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.0 152.67 79.89 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.505 2.137 . . . . 0.0 112.714 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.49 155.68 24.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.597 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.7 p -67.9 175.77 1.59 Allowed Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.371 1.068 . . . . 0.0 109.679 169.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -53.57 143.34 56.94 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 120.643 0.896 . . . . 0.0 109.857 155.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.66 155.56 37.63 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.3 mmt-85 -136.46 165.39 25.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 120.981 -1.075 . . . . 0.0 108.839 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.42 151.74 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.68 126.12 6.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.832 1.653 . . . . 0.0 107.491 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -88.94 146.95 24.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 p -87.65 156.36 53.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 123.392 0.433 . . . . 0.0 110.215 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.42 ' HD3' ' CG2' ' A' ' 25' ' ' VAL . 17.9 Cg_endo -63.7 -80.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.698 2.932 . . . . 0.0 112.576 -166.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -156.29 -28.09 0.1 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.7 171.09 43.62 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 124.491 1.043 . . . . 0.0 111.573 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.48 -178.34 4.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.145 1.778 . . . . 0.0 108.918 174.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -178.2 -98.67 0.11 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.83 92.44 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.702 2.934 . . . . 0.0 111.652 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.3 m -104.44 169.61 8.37 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 162.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.5 t -146.29 161.8 39.5 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 167.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.867 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -143.797 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.873 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 p -138.17 85.14 2.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.487 1.144 . . . . 0.0 111.436 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 m -114.52 146.76 40.33 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.502 1.121 . . . . 0.0 108.894 166.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 -96.47 2.4 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 159.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.66 -52.93 0.44 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.11 2.164 . . . . 0.0 114.681 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 t 56.94 -175.23 0.06 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.562 1.545 . . . . 0.0 113.461 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.36 -99.06 0.21 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 -169.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 46.87 67.68 0.75 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.872 1.669 . . . . 0.0 110.917 173.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -127.25 169.72 13.2 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.011 1.724 . . . . 0.0 108.575 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.19 149.67 5.06 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -108.56 -50.91 2.96 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.978 1.711 . . . . 0.0 108.146 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -141.25 6.56 1.94 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.242 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.0 mt -80.28 157.12 73.45 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 120.242 1.383 . . . . 0.0 111.753 164.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.76 139.59 25.14 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.32 2.013 . . . . 0.0 111.634 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.9 mtm -92.0 -38.13 12.42 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.993 1.317 . . . . 0.0 113.152 -172.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.65 HG22 ' HB2' ' A' ' 42' ' ' SER . 24.4 m -133.83 174.83 12.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 118.624 0.647 . . . . 0.0 110.382 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 107' ' ' PRO . . . -118.26 162.86 27.89 Favored Pre-proline 0 N--CA 1.441 -0.889 0 C-N-CA 128.449 2.7 . . . . 0.0 108.612 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 46.1 Cg_endo -66.18 161.48 40.08 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.837 2.358 . . . . 0.0 111.368 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.64 -147.45 0.41 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.617 2.532 . . . . 0.0 114.3 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.9 91.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.922 1.689 . . . . 0.0 108.79 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.38 155.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.131 1.372 . . . . 0.0 108.725 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -132.43 163.57 28.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.973 1.709 . . . . 0.0 106.939 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.6 144.91 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -123.8 136.16 54.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.511 2.724 . . . . 0.0 108.204 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' HD3' ' A' ' 117' ' ' PRO . 71.5 t -92.94 102.03 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 m -71.45 -58.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.801 1.64 . . . . 0.0 109.507 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -131.76 -173.85 3.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.8 1.24 . . . . 0.0 110.907 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.32 95.14 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.012 -1.055 . . . . 0.0 113.635 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 p -129.23 12.41 6.04 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.614 0.766 . . . . 0.0 111.243 -169.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 tp -121.12 132.73 55.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 169.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . . . -125.49 165.65 18.08 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 168.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -135.42 139.54 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 142.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -136.33 122.62 20.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.555 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -124.83 -178.47 4.17 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.05 1.74 . . . . 0.0 109.796 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.76 135.44 19.54 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.818 1.247 . . . . 0.0 109.332 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 100.48 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.469 2.78 . . . . 0.0 110.134 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.6 m -65.49 162.36 42.92 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.982 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.06 150.02 86.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.126 2.551 . . . . 0.0 110.928 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.77 -25.32 68.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 167.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -57.2 -51.22 70.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.313 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.65 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.2 p -66.55 -34.09 77.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.092 0.86 . . . . 0.0 110.384 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.0 mt -66.46 -23.79 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.039 0.936 . . . . 0.0 110.413 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.26 19.1 mtp180 60.12 -13.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 129.324 3.05 . . . . 0.0 116.44 -173.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.53 -94.24 0.1 Allowed Glycine 0 CA--C 1.518 0.222 0 CA-C-N 120.351 1.432 . . . . 0.0 110.902 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -125.41 133.79 52.37 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.517 1.527 . . . . 0.0 109.824 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.1 tp -70.83 118.73 13.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -70.69 -50.89 31.71 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.01 -173.38 42.89 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -112.81 127.27 56.12 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.932 0.893 . . . . 0.0 109.032 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -103.44 118.86 37.72 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mt -92.94 127.48 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -92.06 154.88 18.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 159.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -159.63 164.03 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.147 1.379 . . . . 0.0 111.498 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -148.6 160.34 43.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.265 -0.897 . . . . 0.0 111.312 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -69.19 138.5 54.14 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 107.93 171.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.8 m -133.96 167.89 19.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 47.9 71.7 0.32 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.653 1.181 . . . . 0.0 110.652 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.5 p -63.69 172.77 1.99 Allowed 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.502 0.721 . . . . 0.0 111.706 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t -50.85 149.62 3.36 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 154.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.3 m -68.09 163.94 21.34 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.038 0.535 . . . . 0.0 111.294 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttt 49.51 39.93 17.97 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.116 1.367 . . . . 0.0 111.901 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -102.34 159.75 15.14 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.321 -0.862 . . . . 0.0 110.938 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -146.57 151.15 36.84 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.661 1.985 . . . . 0.0 107.703 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -145.27 -177.88 5.78 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 162.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 -61.01 1.52 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -93.11 179.78 5.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.569 0.622 . . . . 0.0 109.598 168.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -128.94 130.23 68.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 125.025 1.33 . . . . 0.0 107.522 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -69.96 60.7 0.18 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.509 2.724 . . . . 0.0 110.599 167.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -56.81 99.17 0.03 OUTLIER 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.877 1.671 . . . . 0.0 108.34 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -83.62 165.6 18.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.312 2.645 . . . . 0.0 108.997 -171.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.24 153.73 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.473 ' CD1' HD13 ' A' ' 84' ' ' LEU . 2.1 mt -135.04 152.51 51.77 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.663 2.385 . . . . 0.0 108.699 166.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.8 m -126.66 104.02 7.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.049 1.34 . . . . 0.0 109.048 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -104.17 98.29 8.12 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -74.17 169.43 17.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.17 -179.33 53.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 124.386 0.993 . . . . 0.0 111.205 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -81.31 -1.71 46.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -170.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 149.06 20.63 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.499 0.666 . . . . 0.0 112.427 -168.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -108.45 2.31 22.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 111.914 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.19 164.38 30.23 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.5 -0.75 . . . . 0.0 109.758 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.16 161.41 33.94 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -173.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 43.3 mtp -117.94 152.61 35.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.703 1.251 . . . . 0.0 111.732 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . 3.2 mm? -109.97 84.98 3.8 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 127.63 2.372 . . . . 0.0 106.961 -178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -84.58 160.79 12.56 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.41 2.74 . . . . 0.0 110.754 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.86 8.94 81.84 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.469 -0.628 . . . . 0.0 112.844 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 84' ' ' LEU . 2.4 mm? -80.03 -179.0 6.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.652 1.581 . . . . 0.0 108.996 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -123.03 150.82 60.28 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 122.999 0.52 . . . . 0.0 110.383 171.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.55 172.24 9.51 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.827 2.351 . . . . 0.0 111.683 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.3 t80 45.58 36.4 2.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.821 2.848 . . . . 0.0 113.258 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.9 m -133.34 164.51 26.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.029 1.732 . . . . 0.0 110.108 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -100.4 152.38 20.42 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -139.37 152.17 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.7 m -127.14 134.65 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 153.5 38.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.082 1.753 . . . . 0.0 110.761 -170.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 124.25 6.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.549 1.14 . . . . 0.0 110.435 -162.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.52 131.41 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 108.518 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -125.13 131.72 53.21 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.611 -1.306 . . . . 0.0 109.812 171.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.57 153.7 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.97 147.04 28.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -133.87 -174.91 3.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.692 1.197 . . . . 0.0 109.181 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.05 -3.56 6.42 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.667 -1.629 . . . . 0.0 115.114 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -117.33 -30.99 5.42 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 120.315 2.057 . . . . 0.0 111.553 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.73 -173.53 44.52 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 119.409 1.004 . . . . 0.0 113.971 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -86.64 144.22 27.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.373 1.069 . . . . 0.0 109.796 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -89.2 -168.77 43.95 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.141 0.877 . . . . 0.0 111.96 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 44.4 Cg_endo -63.86 152.4 80.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.057 2.505 . . . . 0.0 111.064 169.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.23 139.45 42.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.602 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . 8.6 t -63.41 171.04 2.37 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.114 1.366 . . . . 0.0 108.644 158.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.39 155.7 36.69 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.151 2.567 . . . . 0.0 110.193 -169.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.12 110.04 9.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.6 171.05 14.48 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 170.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.82 161.8 26.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.56 0.744 . . . . 0.0 110.549 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.82 161.17 42.9 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.88 1.672 . . . . 0.0 109.081 167.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -128.55 128.77 44.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.759 2.023 . . . . 0.0 107.523 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.5 p -87.22 160.5 48.59 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.111 0.564 . . . . 0.0 110.503 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.418 ' HD3' HG11 ' A' ' 25' ' ' VAL . 68.7 Cg_endo -79.13 172.04 15.39 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.991 3.127 . . . . 0.0 109.039 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.08 -31.49 67.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -167.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.27 -159.01 18.91 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 124.272 0.939 . . . . 0.0 111.371 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 p -156.89 101.41 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 161.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.84 102.07 2.2 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.197 -1.335 . . . . 0.0 110.551 -171.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.86 -50.94 0.32 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.566 2.177 . . . . 0.0 110.86 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.11 174.67 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.985 1.314 . . . . 0.0 112.067 -163.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.0 m -153.89 -56.1 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 127.243 2.217 . . . . 0.0 105.214 170.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.233 0 N-CA-C 104.677 -3.369 . . . . 0.0 104.677 140.049 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.933 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.12 176.73 0.04 OUTLIER 'General case' 0 C--O 1.239 0.515 0 C-N-CA 130.049 3.34 . . . . 0.0 107.431 174.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m 72.35 148.74 0.09 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 127.376 2.271 . . . . 0.0 110.379 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.32 -160.99 30.57 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -155.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m 68.72 163.32 0.22 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.13 1.772 . . . . 0.0 110.227 -153.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 m 167.63 -170.45 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 128.8 2.84 . . . . 0.0 109.197 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.15 173.22 13.44 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -161.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 131.81 -173.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 1 C-N-CA 133.221 4.608 . . . . 0.0 102.907 -164.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 p -149.36 173.0 14.0 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.629 -1.294 . . . . 0.0 109.708 169.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.93 54.03 40.9 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.24 97.59 3.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.115 1.766 . . . . 0.0 106.992 -174.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -76.36 -47.99 21.49 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.452 -168.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt 44.75 133.51 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 1 C-N-CA 133.505 4.722 . . . . 0.0 119.561 167.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.39 155.35 55.62 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.211 1.94 . . . . 0.0 111.595 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.7 mtp -111.9 -33.96 6.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -160.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.654 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.2 m -140.47 178.57 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.003 0.82 . . . . 0.0 110.587 -165.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.04 145.93 41.03 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 127.663 2.385 . . . . 0.0 109.838 -173.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -72.2 125.88 11.23 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.187 1.925 . . . . 0.0 109.149 174.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.11 -172.09 43.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 123.972 0.796 . . . . 0.0 111.667 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 40.31 58.49 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.563 2.345 . . . . 0.0 110.681 172.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.69 142.98 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.35 100.42 2.88 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.563 -0.711 . . . . 0.0 109.924 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.25 134.87 47.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -171.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -124.28 135.26 53.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.833 1.653 . . . . 0.0 109.89 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.2 102.34 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 118.837 0.744 . . . . 0.0 109.764 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.56 -56.76 11.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.768 2.027 . . . . 0.0 111.121 -177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -126.32 173.78 9.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.447 1.499 . . . . 0.0 107.531 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -30.14 69.51 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.066 -1.021 . . . . 0.0 112.635 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -120.7 10.42 11.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.531 1.132 . . . . 0.0 113.078 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -133.36 117.23 17.04 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.863 1.665 . . . . 0.0 109.597 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.57 166.06 11.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.35 148.04 36.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.754 2.422 . . . . 0.0 107.956 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 44.5 t -127.76 114.94 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -92.78 157.59 16.34 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.394 1.059 . . . . 0.0 109.249 166.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -149.76 177.43 9.8 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.168 2.187 . . . . 0.0 109.601 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -104.5 133.86 19.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.388 0.675 . . . . 0.0 110.785 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 107.96 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 125.185 3.923 . . . . 0.0 110.664 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 m -57.51 155.47 19.99 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 119.259 -0.401 . . . . 0.0 110.396 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -59.35 131.55 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.917 2.411 . . . . 0.0 108.245 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.09 -32.88 62.34 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.124 0.875 . . . . 0.0 112.138 -173.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -49.59 -41.8 42.86 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.69 1.196 . . . . 0.0 111.911 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.654 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.9 p -66.22 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.861 0.865 . . . . 0.0 112.777 -174.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.74 -34.0 65.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.125 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 42.57 57.89 3.31 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 111.706 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.08 -168.64 28.86 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -77.36 128.23 33.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 49' ' ' GLY . 2.6 tt -60.98 108.49 0.88 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.995 1.318 . . . . 0.0 107.491 172.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -85.2 -21.25 29.22 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.522 -0.736 . . . . 0.0 112.04 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.404 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 150.32 -168.89 30.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.679 1.133 . . . . 0.0 110.945 170.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -124.16 118.27 26.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -96.05 130.92 42.94 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.35 119.76 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -91.16 145.36 24.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 50.9 p90 -156.67 166.0 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 120.202 1.364 . . . . 0.0 110.692 173.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -148.41 153.48 38.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.774 0.829 . . . . 0.0 111.217 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -68.73 128.35 36.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.0 m -109.0 128.59 55.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -128.66 115.81 18.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -171.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.6 t -63.64 137.19 58.0 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.6 m 67.09 111.15 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.18 1.392 . . . . 0.0 109.331 -151.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -151.64 68.06 0.89 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.322 1.849 . . . . 0.0 106.379 164.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -64.53 142.94 58.25 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.61 80.66 2.0 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -164.06 117.93 1.46 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.906 1.682 . . . . 0.0 107.567 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 55.11 55.52 7.53 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.279 1.832 . . . . 0.0 111.282 168.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -139.66 126.81 21.13 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.962 1.305 . . . . 0.0 110.718 -165.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.62 104.59 9.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.119 1.768 . . . . 0.0 112.094 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 86.8 mt -68.18 165.81 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.919 1.687 . . . . 0.0 109.666 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -129.62 94.79 3.83 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.25 1.42 . . . . 0.0 109.57 -171.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -92.68 116.42 29.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.943 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -98.48 179.82 4.58 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.16 0.984 . . . . 0.0 108.781 167.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.4 mm -135.13 163.08 37.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -140.67 155.46 46.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.752 1.621 . . . . 0.0 108.355 167.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -116.55 120.74 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.108 1.363 . . . . 0.0 107.613 -165.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -130.32 150.1 51.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -76.38 -175.49 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.908 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.7 53.83 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 122.628 1.127 . . . . 0.0 112.125 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.6 p 59.57 -23.42 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.768 3.627 . . . . 0.0 118.786 173.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 150.23 12.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.844 0.83 . . . . 0.0 109.237 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 p -110.9 14.25 22.1 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.139 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -155.47 162.21 40.79 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.949 0.9 . . . . 0.0 112.385 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.56 -174.67 26.6 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 128.246 2.831 . . . . 0.0 108.169 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 mtp -131.98 166.55 21.43 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.512 1.156 . . . . 0.0 110.017 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.485 HD13 ' CD1' ' A' ' 73' ' ' LEU . 1.8 mm? -122.5 85.36 48.26 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 125.272 1.429 . . . . 0.0 107.29 168.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.39 146.16 6.12 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.283 3.322 . . . . 0.0 111.46 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.51 18.71 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.628 0.632 . . . . 0.0 113.148 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD12 ' A' ' 84' ' ' LEU . 3.1 mm? -92.44 177.63 6.07 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.869 0.868 . . . . 0.0 109.081 -165.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.52 147.94 43.05 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 125.08 1.352 . . . . 0.0 108.32 171.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -74.06 164.48 34.3 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.501 2.134 . . . . 0.0 112.292 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.4 t80 61.2 22.81 13.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.678 1.991 . . . . 0.0 112.794 170.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -120.22 162.5 19.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.084 1.354 . . . . 0.0 111.414 167.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.08 150.7 23.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.182 2.193 . . . . 0.0 107.145 168.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -137.24 156.26 48.51 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.24 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.3 m -125.89 135.46 51.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -139.36 154.37 47.84 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.918 1.687 . . . . 0.0 109.358 178.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -138.62 157.26 46.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.89 152.82 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -147.95 145.27 28.52 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.01 147.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.07 146.84 26.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -132.95 -178.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.729 0.812 . . . . 0.0 110.886 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.51 50.4 2.1 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.792 1.187 . . . . 0.0 111.919 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -157.98 -52.79 0.07 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.146 2.178 . . . . 0.0 107.629 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.13 -172.05 36.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.538 0.608 . . . . 0.0 113.294 -171.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -97.44 161.59 13.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.249 1.02 . . . . 0.0 112.767 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.39 -170.58 14.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.855 1.216 . . . . 0.0 113.493 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.55 141.31 45.73 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 124.159 3.239 . . . . 0.0 111.365 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.85 41.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.387 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.4 p -60.54 169.99 1.57 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 164.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -54.32 145.81 53.99 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 108.646 -1.328 . . . . 0.0 108.646 156.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.33 104.55 10.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -80.93 168.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.247 1.819 . . . . 0.0 108.889 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.18 161.24 28.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 122.1 -0.375 . . . . 0.0 110.307 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -159.02 129.36 5.86 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 110.975 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -86.06 139.43 31.15 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 p -94.26 145.28 29.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 -77.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.269 2.646 . . . . 0.0 112.489 -159.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -159.7 -28.98 0.06 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.666 -0.646 . . . . 0.0 111.195 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.54 107.38 1.04 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 125.435 1.493 . . . . 0.0 109.481 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -146.37 102.34 3.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 170.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.35 116.36 8.76 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 169.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -62.63 162.21 25.5 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 CA-C-N 120.366 2.083 . . . . 0.0 109.958 171.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.2 t -146.33 102.01 3.55 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.209 -0.932 . . . . 0.0 109.03 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 m -134.98 177.84 7.49 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.021 0.928 . . . . 0.0 109.3 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 CA-C-O 117.891 -1.505 . . . . 0.0 110.064 179.288 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.183 0 CA-C-O 117.522 -1.71 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m 65.04 90.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.027 1.331 . . . . 0.0 111.275 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.4 m -151.41 168.16 25.71 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.351 -0.843 . . . . 0.0 109.224 -177.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.51 176.53 34.67 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -87.08 95.14 9.84 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.5 t -133.3 150.75 51.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 159.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 122.48 -60.09 0.58 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.0 m80 52.29 -161.92 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.794 1.238 . . . . 0.0 112.204 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 t -149.47 -171.06 3.8 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.168 1.387 . . . . 0.0 109.107 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.06 72.02 1.23 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 125.536 1.541 . . . . 0.0 109.382 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -110.05 -10.29 14.7 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.88 -26.1 34.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.635 161.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.1 148.76 83.92 Favored Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 123.552 0.741 . . . . 0.0 111.743 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 56.8 Cg_endo -80.45 170.09 16.35 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.939 3.093 . . . . 0.0 112.594 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.8 mtm -132.78 -31.38 1.33 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -161.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG22 ' CB ' ' A' ' 42' ' ' SER . 26.1 m -139.48 147.17 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 121.145 1.793 . . . . 0.0 109.818 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.607 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -87.04 169.12 15.48 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.921 1.289 . . . . 0.0 109.91 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.607 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 37.2 Cg_endo -74.79 162.32 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.095 1.863 . . . . 0.0 111.81 -168.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.25 166.81 52.9 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -31.41 104.51 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.517 2.327 . . . . 0.0 114.273 -160.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.81 142.98 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -122.3 160.14 25.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.681 1.992 . . . . 0.0 106.985 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.602 HG21 ' CD2' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -147.03 145.73 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.009 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -123.43 128.32 49.66 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.217 1.807 . . . . 0.0 108.444 172.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.5 103.1 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 170.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.575 ' HB ' HD12 ' A' ' 30' ' ' LEU . 57.4 t -67.32 -48.3 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.409 0.683 . . . . 0.0 109.734 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -143.12 -178.24 5.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.176 1.39 . . . . 0.0 108.013 -174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -38.87 92.37 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.893 -1.129 . . . . 0.0 111.959 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 p -112.8 6.06 17.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.262 1.425 . . . . 0.0 112.098 -171.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.686 HD11 ' CE ' ' A' ' 83' ' ' MET . 2.5 tm? -134.48 137.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.959 1.703 . . . . 0.0 108.691 -177.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.423 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -135.91 161.29 36.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -119.88 128.59 53.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.39 2.276 . . . . 0.0 106.396 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.28 141.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -147.6 159.68 43.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.029 1.286 . . . . 0.0 109.473 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.55 142.66 89.2 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.3 113.08 2.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.242 2.628 . . . . 0.0 109.049 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.628 HG22 ' HD2' ' A' ' 39' ' ' PRO . 4.9 p -71.94 149.19 92.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.036 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' HG22 ' A' ' 38' ' ' VAL . 37.2 Cg_endo -70.7 137.66 33.19 Favored 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.567 4.178 . . . . 0.0 108.841 -170.164 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.17 -28.7 59.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.688 0.677 . . . . 0.0 112.043 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -57.72 -42.42 83.76 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.522 173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.482 ' CB ' HG22 ' A' ' 16' ' ' VAL . 86.2 p -68.39 -28.65 67.28 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.01 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.9 -40.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 C-N-CA 124.247 1.019 . . . . 0.0 108.455 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 65.12 -70.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.499 1.92 . . . . 0.0 112.294 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.61 -169.82 1.5 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.705 2.098 . . . . 0.0 111.802 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -80.82 138.72 36.24 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.735 0.814 . . . . 0.0 109.847 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.451 HD22 ' H ' ' A' ' 49' ' ' GLY . 2.2 tm? -61.05 127.58 32.23 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.319 1.048 . . . . 0.0 108.764 174.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -98.75 -23.52 15.39 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.727 0.811 . . . . 0.0 111.985 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.451 ' H ' HD22 ' A' ' 47' ' ' LEU . . . 132.8 -155.73 21.75 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -169.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -128.53 156.28 43.53 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.621 1.168 . . . . 0.0 107.99 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.59 109.72 12.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mt -85.42 141.78 14.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -118.41 117.68 29.69 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.96 1.704 . . . . 0.0 108.932 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.515 ' CD2' HD11 ' A' ' 84' ' ' LEU . 26.5 p90 -133.43 160.63 36.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.429 1.013 . . . . 0.0 112.444 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -149.38 161.0 42.95 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.398 1.479 . . . . 0.0 110.7 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -68.79 137.19 53.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.296 1.838 . . . . 0.0 108.755 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m -127.18 129.98 48.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -162.75 100.85 1.02 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -169.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 m -63.37 110.05 1.8 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.59 129.37 14.22 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 165.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -64.74 104.3 0.81 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 tptt -138.74 101.31 4.29 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -69.87 0.43 Allowed 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.175 0.59 . . . . 0.0 112.052 -168.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -71.68 112.0 7.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.464 -168.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 66.95 111.34 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.999 2.119 . . . . 0.0 112.384 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.3 ttp-105 -145.19 100.7 3.51 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.708 1.203 . . . . 0.0 108.621 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -128.76 176.74 7.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.049 0.939 . . . . 0.0 109.89 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.11 128.73 36.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -83.05 109.79 17.43 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 163.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -87.12 111.88 21.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 166.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -87.4 167.22 14.22 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.506 1.922 . . . . 0.0 109.884 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.26 141.02 43.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 124.85 1.26 . . . . 0.0 107.849 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.9 tp -130.58 150.02 51.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.74 2.416 . . . . 0.0 106.879 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.64 137.46 45.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.107 0.963 . . . . 0.0 108.957 -170.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -142.43 93.07 2.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.374 1.07 . . . . 0.0 109.814 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -77.55 171.1 15.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.255 0.55 . . . . 0.0 110.329 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.43 70.38 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.863 -0.523 . . . . 0.0 113.366 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.7 t 58.95 20.47 8.2 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 113.332 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -56.53 134.05 53.89 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -89.66 -1.98 58.17 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.853 1.346 . . . . 0.0 112.069 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -147.53 144.17 28.33 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.54 162.05 32.63 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -171.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.686 ' CE ' HD11 ' A' ' 30' ' ' LEU . 27.0 mtp -117.44 148.66 41.59 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.45 -0.441 . . . . 0.0 111.346 -162.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.515 HD11 ' CD2' ' A' ' 54' ' ' TYR . 3.6 mm? -105.38 90.62 4.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 128.122 2.569 . . . . 0.0 107.417 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -93.2 162.37 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.712 2.275 . . . . 0.0 112.734 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.28 33.34 86.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.98 163.08 16.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.296 1.038 . . . . 0.0 108.314 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -103.49 134.1 19.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -76.98 169.39 21.73 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.445 2.096 . . . . 0.0 111.652 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.7 t80 54.7 43.15 30.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.173 2.189 . . . . 0.0 111.937 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -149.51 162.61 39.8 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 120.727 -1.233 . . . . 0.0 111.112 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -93.6 156.14 16.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -143.87 159.7 42.08 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.0 m -120.64 130.09 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.6 163.73 22.8 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.125 1.37 . . . . 0.0 109.971 168.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.5 169.08 20.31 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.937 1.295 . . . . 0.0 109.043 165.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.9 t -114.59 132.18 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 m -87.36 153.56 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.99 142.49 31.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.549 1.539 . . . . 0.0 106.868 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -144.53 -175.44 4.65 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.326 0.584 . . . . 0.0 111.125 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.43 -1.06 2.98 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.872 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -124.09 -36.26 2.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 120.56 2.18 . . . . 0.0 111.323 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.57 -150.55 10.98 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 121.697 0.609 . . . . 0.0 112.208 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.74 159.01 22.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.726 1.61 . . . . 0.0 107.91 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.451 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -102.94 -162.24 25.74 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.874 0.75 . . . . 0.0 113.574 171.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.76 162.38 25.32 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 159.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.56 166.02 11.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.482 172.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.8 p -65.99 179.36 0.47 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.419 1.088 . . . . 0.0 109.544 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.75 168.71 6.6 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.356 1.163 . . . . 0.0 109.561 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 137.72 58.23 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.087 -1.008 . . . . 0.0 108.858 160.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -115.3 158.24 22.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 161.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.54 161.27 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.602 ' CD2' HG21 ' A' ' 23' ' ' VAL . 45.7 p90 -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 166.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -91.86 128.85 37.85 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.07 0.948 . . . . 0.0 108.748 171.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -78.21 163.78 60.3 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.979 -0.534 . . . . 0.0 109.6 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.67 -114.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.686 2.924 . . . . 0.0 110.192 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.79 -31.9 3.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.387 1.449 . . . . 0.0 112.975 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.17 -172.28 22.23 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -164.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.9 t -176.32 -75.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 162.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 165.18 147.92 5.3 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.9 101.06 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.75 2.967 . . . . 0.0 109.864 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.8 t -147.7 148.42 30.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.944 1.698 . . . . 0.0 107.354 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.2 m -157.79 88.74 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 163.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 163.694 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.758 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -124.97 160.54 28.69 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.428 1.091 . . . . 0.0 109.483 -171.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -60.63 163.81 5.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.92 1.288 . . . . 0.0 110.102 166.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.85 171.2 37.73 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.3 m -139.39 118.81 12.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.028 0.931 . . . . 0.0 109.067 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.8 m -146.32 -176.3 5.11 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.354 2.262 . . . . 0.0 107.149 165.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.13 179.85 18.3 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -171.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -161.54 156.72 23.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.23 1.012 . . . . 0.0 108.911 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 t -135.94 -39.31 0.7 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.872 0.469 . . . . 0.0 110.013 161.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.79 -71.8 2.67 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.08 -90.85 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.494 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -168.09 -51.16 0.02 OUTLIER 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.168 1.349 . . . . 0.0 113.319 164.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.5 mt 46.11 158.39 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 130.894 3.678 . . . . 0.0 116.67 -163.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.45 167.41 16.9 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.348 2.699 . . . . 0.0 111.361 171.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.9 mtm -123.2 -35.24 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.44 1.496 . . . . 0.0 113.507 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.69 HG22 ' CB ' ' A' ' 42' ' ' SER . 15.3 m -137.69 -176.88 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.342 0.973 . . . . 0.0 110.368 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -125.41 171.41 7.63 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 127.503 2.321 . . . . 0.0 109.685 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 6.6 Cg_endo -63.97 141.54 77.82 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.97 1.113 . . . . 0.0 110.475 164.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.73 -177.49 31.91 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -23.9 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 129.942 3.297 . . . . 0.0 114.038 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.58 145.36 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -120.62 157.91 28.51 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 126.213 1.805 . . . . 0.0 106.859 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 141.84 21.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 173.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -124.29 136.75 54.35 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.383 1.473 . . . . 0.0 108.579 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 115' ' ' ASN . 80.8 t -95.8 105.13 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.277 1.037 . . . . 0.0 108.726 177.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.719 ' HB ' HD12 ' A' ' 30' ' ' LEU . 85.6 t -80.11 -48.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.491 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -130.91 -178.14 4.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.8 -29.78 64.81 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.626 -1.296 . . . . 0.0 112.922 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.6 p -123.88 14.24 9.25 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 111.096 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.719 HD12 ' HB ' ' A' ' 26' ' ' VAL . 3.3 tm? -124.89 137.04 54.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 106.628 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.55 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -138.5 155.55 48.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 167.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.01 150.36 38.74 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.088 1.355 . . . . 0.0 107.771 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 42.6 t -129.27 135.11 62.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.18 123.59 32.47 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -129.63 157.93 40.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 110.63 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.86 139.28 95.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.185 0.994 . . . . 0.0 111.369 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.38 109.07 2.84 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.549 2.833 . . . . 0.0 111.084 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HA ' ' HD3' ' A' ' 39' ' ' PRO 0.32 48.9 t -79.61 159.17 72.41 Favored Pre-proline 0 N--CA 1.409 -2.492 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -169.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' VAL . 4.7 Cg_exo -59.6 147.2 92.81 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.232 3.955 . . . . 0.0 111.124 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 43' ' ' ILE . 2.5 mm? -66.83 -35.41 79.98 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.618 -0.676 . . . . 0.0 109.267 160.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -49.47 -36.69 23.52 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.201 0.6 . . . . 0.0 111.687 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.69 ' CB ' HG22 ' A' ' 16' ' ' VAL . 9.3 p -91.0 -13.67 32.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.676 HD13 ' HB2' ' A' ' 47' ' ' LEU . 85.4 mt -68.12 -38.52 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 120.44 1.473 . . . . 0.0 108.634 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 47.7 56.4 7.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 110.659 -173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.36 -179.21 32.4 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -73.05 144.45 47.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.676 ' HB2' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -77.24 122.69 25.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -75.41 -24.27 57.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.978 1.711 . . . . 0.0 111.009 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.95 -177.74 32.04 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 125.836 1.684 . . . . 0.0 109.338 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -99.76 129.18 45.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -113.2 102.5 10.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.499 1.519 . . . . 0.0 107.837 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.6 mt -78.0 121.53 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.69 151.05 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 162.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -157.32 164.78 37.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.205 1.402 . . . . 0.0 111.043 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -149.22 158.65 44.35 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.255 1.022 . . . . 0.0 111.667 168.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -68.71 134.1 49.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.2 m -120.56 148.5 43.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -173.73 164.64 4.39 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.705 1.602 . . . . 0.0 110.165 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.5 m -74.27 -86.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.567 1.147 . . . . 0.0 109.105 151.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.5 m -156.35 169.09 25.38 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.761 1.224 . . . . 0.0 110.725 -160.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.2 t -146.33 -80.96 0.15 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 165.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -153.1 42.85 0.61 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.245 1.018 . . . . 0.0 110.425 175.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.06 149.46 23.12 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.525 -1.36 . . . . 0.0 111.04 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -160.99 67.12 0.31 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.49 1.116 . . . . 0.0 110.578 168.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 -153.04 70.67 0.88 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 120.903 -1.123 . . . . 0.0 111.583 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -163.22 173.73 13.0 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.832 1.253 . . . . 0.0 109.308 164.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -82.91 158.43 22.64 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 118.572 0.624 . . . . 0.0 110.675 169.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.09 123.33 29.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 167.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -75.22 126.63 31.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.472 1.909 . . . . 0.0 108.851 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -109.66 113.08 25.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.601 1.56 . . . . 0.0 110.0 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -92.71 164.4 13.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.875 1.67 . . . . 0.0 111.312 -171.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.52 153.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.037 1.735 . . . . 0.0 106.575 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 tp -131.14 163.16 28.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.277 2.631 . . . . 0.0 107.196 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.4 m -138.25 120.58 15.9 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -132.08 102.67 5.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 107.603 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -84.63 163.75 19.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.483 1.113 . . . . 0.0 108.943 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.26 171.35 25.31 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.5 p -78.6 27.41 0.21 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.85 1.26 . . . . 0.0 113.875 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -52.16 145.32 10.78 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.598 1.159 . . . . 0.0 110.73 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -112.75 10.85 19.3 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.135 1.374 . . . . 0.0 111.956 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 1.5 p80 -148.67 156.53 42.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.31 1.044 . . . . 0.0 109.787 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.19 117.89 0.61 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.592 0.615 . . . . 0.0 112.033 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.697 ' HE2' HD11 ' A' ' 30' ' ' LEU . 9.7 mtp -76.02 153.0 36.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.886 0.875 . . . . 0.0 112.833 -171.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.71 88.22 1.75 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 128.119 2.568 . . . . 0.0 108.163 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.75 158.99 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.11 2.54 . . . . 0.0 112.073 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.21 18.18 79.48 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.509 -0.744 . . . . 0.0 113.366 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.5 -176.83 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.407 1.883 . . . . 0.0 110.224 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 15.2 mt-10 -102.54 147.56 34.2 Favored Pre-proline 0 C--O 1.242 0.689 0 CA-C-N 118.746 0.703 . . . . 0.0 111.229 168.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 8.8 Cg_endo -73.51 176.8 8.8 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.807 3.005 . . . . 0.0 113.139 171.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 31.2 t80 48.52 29.32 2.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.977 2.511 . . . . 0.0 115.225 170.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.1 m -128.75 -175.44 3.54 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.151 1.38 . . . . 0.0 111.183 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -122.46 152.37 40.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.964 1.306 . . . . 0.0 107.772 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -144.55 158.2 43.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.53 1.132 . . . . 0.0 108.964 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 m -122.75 141.56 51.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.89 149.23 33.86 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.75 2.02 . . . . 0.0 110.181 173.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -137.22 128.17 27.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.038 1.735 . . . . 0.0 108.949 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -89.34 144.21 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -151.96 154.06 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.913 -1.742 . . . . 0.0 108.699 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.59 146.78 5.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.1 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -135.47 -178.31 5.06 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.252 1.021 . . . . 0.0 109.446 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.96 -36.27 89.72 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 121.91 -0.494 . . . . 0.0 112.94 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -75.2 -46.39 34.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.737 0.768 . . . . 0.0 110.427 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.99 -134.44 2.52 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.668 0.667 . . . . 0.0 111.86 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -136.14 165.43 25.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.343 2.257 . . . . 0.0 108.869 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -153.98 8.32 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.37 0.985 . . . . 0.0 112.004 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 56.9 Cg_endo -65.29 137.14 50.27 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.865 1.71 . . . . 0.0 109.318 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 162.8 28.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.782 0.801 . . . . 0.0 109.384 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 99.1 p -71.3 171.84 7.95 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.261 -0.9 . . . . 0.0 110.179 168.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 40.4 Cg_endo -64.18 136.92 54.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.716 1.611 . . . . 0.0 110.379 168.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.5 106.09 0.88 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.226 1.811 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.42 167.25 22.05 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.986 1.314 . . . . 0.0 110.417 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.92 166.36 29.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.114 1.365 . . . . 0.0 108.899 173.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.32 158.76 38.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.784 0.834 . . . . 0.0 109.64 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.468 ' O ' HG21 ' A' ' 25' ' ' VAL . 7.5 p30 -112.52 152.98 28.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 126.003 1.721 . . . . 0.0 108.195 171.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 153.68 39.21 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 119.257 0.935 . . . . 0.0 110.887 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.57 -75.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.588 2.859 . . . . 0.0 113.126 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -158.2 -35.23 0.07 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.208 1.403 . . . . 0.0 112.828 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.9 74.27 0.8 Allowed Glycine 0 N--CA 1.452 -0.264 0 O-C-N 121.149 -0.969 . . . . 0.0 110.903 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.4 p 51.23 80.54 0.08 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.651 1.98 . . . . 0.0 111.238 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.38 172.28 22.21 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 162.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -79.41 63.5 8.73 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 125.074 3.849 . . . . 0.0 111.689 -165.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.8 t -63.38 150.73 42.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.344 0.657 . . . . 0.0 110.103 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -143.37 172.12 13.2 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.399 1.88 . . . . 0.0 106.609 174.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 CA-C-O 116.595 -2.225 . . . . 0.0 110.427 -174.7 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.897 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m 46.77 -153.53 0.06 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.388 1.075 . . . . 0.0 109.867 -162.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 t -104.44 178.04 4.67 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.686 1.13 . . . . 0.0 109.401 175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.12 72.52 0.06 OUTLIER Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.066 0.841 . . . . 0.0 111.176 172.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 p 177.56 157.85 0.38 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.738 2.415 . . . . 0.0 108.454 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 m -168.54 67.24 0.07 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.147 1.379 . . . . 0.0 110.393 166.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.24 154.68 30.87 Favored Glycine 0 N--CA 1.471 0.974 0 O-C-N 120.521 -1.362 . . . . 0.0 113.643 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -154.47 149.09 26.39 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.736 1.214 . . . . 0.0 111.788 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 m -84.47 -176.88 6.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.805 2.042 . . . . 0.0 111.808 162.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.24 91.02 1.81 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 167.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.37 -9.11 7.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.726 1.211 . . . . 0.0 112.459 170.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.57 -11.86 12.96 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.507 1.123 . . . . 0.0 109.903 175.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 mt -74.71 153.85 87.28 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 120.214 1.37 . . . . 0.0 109.627 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.06 164.69 24.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.585 1.524 . . . . 0.0 110.354 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.1 mtm -107.77 -35.07 6.78 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.093 0.957 . . . . 0.0 112.023 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.6 m -131.06 160.71 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.318 0.963 . . . . 0.0 111.484 -163.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.57 68.69 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 126.488 1.915 . . . . 0.0 107.807 161.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.61 164.42 11.38 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 109.556 -0.979 . . . . 0.0 109.556 161.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.55 -165.36 2.74 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.445 1.498 . . . . 0.0 113.731 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -54.48 115.94 2.39 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.28 154.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.25 154.5 40.1 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.901 2.08 . . . . 0.0 106.411 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -146.71 138.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -124.09 118.9 27.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.312 2.245 . . . . 0.0 105.457 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 117' ' ' PRO . 64.7 t -64.8 134.76 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.89 -52.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -141.52 -175.6 4.43 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.241 1.416 . . . . 0.0 109.12 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -33.09 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.366 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.6 p -133.59 36.8 3.33 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.369 1.068 . . . . 0.0 109.519 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.503 HD11 ' HE2' ' A' ' 83' ' ' MET . 1.4 tm? -151.81 137.08 17.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.125 0.97 . . . . 0.0 109.701 171.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.39 138.37 24.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -105.46 125.24 50.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -99.12 145.35 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -127.8 147.76 50.43 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.278 0.631 . . . . 0.0 109.506 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -135.73 -175.08 3.84 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.433 1.493 . . . . 0.0 108.369 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -114.08 136.85 22.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.44 112.44 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.347 2.698 . . . . 0.0 111.704 -172.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.624 HG12 ' HD2' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -70.52 143.02 89.67 Favored Pre-proline 0 N--CA 1.41 -2.432 0 C-N-CA 124.756 1.222 . . . . 0.0 110.205 -171.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.624 ' HD2' HG12 ' A' ' 38' ' ' VAL . 2.5 Cg_endo -62.19 133.44 43.78 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 125.812 4.341 . . . . 0.0 111.864 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -58.42 -36.3 73.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 175.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -52.19 -36.57 52.25 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.407 ' HB2' HG22 ' A' ' 16' ' ' VAL . 6.2 p -94.99 -13.97 24.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 47' ' ' LEU . 64.9 mt -68.41 -34.67 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.477 1.035 . . . . 0.0 109.703 164.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 60.36 6.87 1.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.839 1.656 . . . . 0.0 115.083 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.15 -166.73 23.53 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.398 0.999 . . . . 0.0 110.625 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.27 118.97 13.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.0 tm? -59.83 122.8 15.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.833 1.253 . . . . 0.0 107.79 167.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.32 -32.88 22.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.756 0.822 . . . . 0.0 111.198 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 76' ' ' GLN . . . 156.32 -178.56 32.75 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -116.56 112.6 21.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.68 109.44 19.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.16 122.74 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -91.97 153.02 19.74 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.481 ' CE1' HD12 ' A' ' 73' ' ' LEU . 33.8 p90 -160.61 159.71 30.81 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.28 1.832 . . . . 0.0 109.482 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -148.99 153.21 37.6 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.695 0.798 . . . . 0.0 110.735 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -68.58 118.6 11.81 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.3 m -89.38 143.9 26.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -124.57 -90.92 0.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.1 t -152.71 156.2 38.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.639 1.576 . . . . 0.0 107.373 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.77 2.58 5.43 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -160.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 t -126.06 112.32 15.73 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 120.086 1.312 . . . . 0.0 108.988 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mttm 37.94 78.31 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 128.736 2.814 . . . . 0.0 112.595 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -129.67 133.92 47.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.99 120.39 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.75 148.77 24.42 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -57.98 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.906 0.776 . . . . 0.0 111.206 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -152.88 165.36 35.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.7 1.6 . . . . 0.0 108.128 -172.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.9 mt -91.55 122.19 42.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.4 127.61 33.09 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 165.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -131.79 156.38 46.09 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.32 1.048 . . . . 0.0 108.984 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 18.8 mmtt -141.06 171.07 14.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.644 0.735 . . . . 0.0 111.76 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.63 148.25 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 106.69 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.527 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -130.3 147.47 52.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.717 2.007 . . . . 0.0 107.722 172.633 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.4 m -120.29 91.51 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 108.757 -164.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 66.4 m-85 -94.09 76.85 4.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.409 ' HA ' ' HA3' ' A' ' 49' ' ' GLY . 4.0 pt20 -67.03 144.74 55.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.319 176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.93 167.33 40.15 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.349 0.976 . . . . 0.0 112.528 -175.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -79.57 16.92 0.96 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.324 2.25 . . . . 0.0 115.276 -167.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.07 163.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.794 1.637 . . . . 0.0 113.178 174.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -125.29 9.49 7.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.71 163.8 36.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.412 1.085 . . . . 0.0 108.954 173.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.63 165.66 36.34 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.503 ' HE2' HD11 ' A' ' 30' ' ' LEU . 46.1 mtp -111.91 150.56 30.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.134 0.974 . . . . 0.0 109.457 -168.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.9 mm? -115.46 79.85 7.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -86.75 162.37 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 110.247 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.18 74.4 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.935 0.779 . . . . 0.0 113.341 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.461 HD21 HD12 ' A' ' 84' ' ' LEU . 1.3 mm? -93.7 171.22 9.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.667 1.587 . . . . 0.0 108.723 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.2 156.74 35.5 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 124.359 1.064 . . . . 0.0 110.12 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -82.7 177.25 7.04 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 124.481 3.454 . . . . 0.0 112.957 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.9 t80 38.24 57.32 1.66 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.724 2.81 . . . . 0.0 111.85 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.5 m -149.98 157.79 43.51 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.378 1.871 . . . . 0.0 109.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -90.62 150.72 21.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' CE1' HD12 ' A' ' 87' ' ' LEU . 38.5 m-85 -134.93 154.83 51.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.886 1.274 . . . . 0.0 108.162 175.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.2 m -125.93 138.88 53.8 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 172.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -144.47 162.85 35.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.388 2.275 . . . . 0.0 109.697 177.135 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -134.45 -176.08 4.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.74 139.52 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.561 1.944 . . . . 0.0 106.394 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -140.89 128.82 21.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.683 1.193 . . . . 0.0 107.798 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 m -74.65 153.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.6 t -138.03 150.03 24.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 171.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -138.95 -168.9 2.52 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 109.123 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.88 4.5 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.456 -1.191 . . . . 0.0 116.036 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.02 -47.89 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.182 1.991 . . . . 0.0 111.358 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.3 -166.66 34.46 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 120.689 1.586 . . . . 0.0 113.427 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -95.58 167.85 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.884 1.273 . . . . 0.0 110.259 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -128.6 -157.32 9.26 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.617 1.579 . . . . 0.0 112.582 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.06 150.48 82.51 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.917 2.411 . . . . 0.0 110.222 177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.43 164.6 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.089 0.947 . . . . 0.0 112.131 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 p -69.19 177.22 1.25 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.247 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.98 146.87 15.91 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.73 1.62 . . . . 0.0 110.087 158.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.78 100.5 6.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 168.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.9 mmt-85 -76.57 162.98 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.872 -0.518 . . . . 0.0 110.267 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.78 157.37 38.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.333 0.653 . . . . 0.0 110.046 174.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -150.49 146.74 26.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.382 1.073 . . . . 0.0 109.245 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -109.75 145.11 37.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.355 1.062 . . . . 0.0 108.4 169.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.72 169.2 19.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.775 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' HG11 ' A' ' 25' ' ' VAL . 12.9 Cg_endo -68.23 -75.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.451 2.101 . . . . 0.0 109.266 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -172.45 -39.14 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.212 1.405 . . . . 0.0 110.592 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.88 147.11 8.56 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.718 1.628 . . . . 0.0 112.258 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 42.7 23.31 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.524 3.13 . . . . 0.0 118.743 175.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.94 162.51 28.79 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.911 -1.118 . . . . 0.0 110.326 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.97 167.33 26.98 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.735 2.957 . . . . 0.0 112.162 -170.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.8 m -143.0 111.4 6.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 163.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.17 148.63 16.97 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 164.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.647 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 -172.886 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.3 169.15 12.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.522 1.482 . . . . 0.0 113.261 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mtm -132.91 -40.53 0.94 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.986 0.914 . . . . 0.0 113.413 -165.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.587 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.6 m -135.32 168.66 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.01 166.1 12.56 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 126.754 2.021 . . . . 0.0 109.374 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 32.5 Cg_endo -70.98 141.6 40.66 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.332 1.355 . . . . 0.0 114.44 -166.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.63 178.56 23.86 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.506 1.526 . . . . 0.0 111.726 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 23.65 66.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.877 3.271 . . . . 0.0 114.477 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 112' ' ' ARG . 18.3 t -76.27 132.53 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.46 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -148.23 166.48 27.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.442 1.497 . . . . 0.0 109.44 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.51 141.61 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 120.78 -1.2 . . . . 0.0 108.62 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.0 119.25 29.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.224 2.61 . . . . 0.0 109.225 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.72 130.21 35.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 119.196 0.907 . . . . 0.0 108.851 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.32 -64.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 126.139 1.776 . . . . 0.0 107.993 -171.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -115.88 179.16 4.06 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.589 1.156 . . . . 0.0 108.065 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -18.3 61.52 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.224 -0.922 . . . . 0.0 112.768 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -126.35 0.27 7.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.323 1.849 . . . . 0.0 112.687 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -139.16 128.1 23.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.695 1.598 . . . . 0.0 108.207 -170.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.94 172.57 8.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.65 117.29 13.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 152.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -132.47 148.81 52.41 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.549 1.54 . . . . 0.0 109.138 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -160.28 164.89 32.27 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.662 1.585 . . . . 0.0 109.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -87.83 145.24 36.31 Favored Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 120.942 -1.099 . . . . 0.0 112.034 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.31 102.58 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.854 3.036 . . . . 0.0 111.095 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 4.6 m -64.26 158.88 62.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 10.7 Cg_endo -72.77 144.86 39.93 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.317 3.345 . . . . 0.0 110.229 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.3 mp -56.08 -30.72 62.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.243 0.474 . . . . 0.0 111.143 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -56.75 -28.49 61.27 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.587 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.6 p -89.58 -29.81 18.62 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 111.459 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.625 HD13 ' HB2' ' A' ' 47' ' ' LEU . 81.9 mt -67.83 -38.44 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.331 1.053 . . . . 0.0 109.071 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 50.01 80.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.639 1.575 . . . . 0.0 110.606 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.61 -102.76 0.83 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -138.22 103.58 4.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.6 -166.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.625 ' HB2' HD13 ' A' ' 43' ' ' ILE . 37.0 tp -54.88 119.62 5.65 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 127.006 2.123 . . . . 0.0 109.393 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -86.72 -48.7 8.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.078 0.951 . . . . 0.0 108.941 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.26 173.0 45.98 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -99.93 136.13 40.31 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 161.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -105.7 152.09 23.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.9 mt -126.4 126.2 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.45 141.28 28.7 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -153.02 159.95 42.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.543 1.137 . . . . 0.0 110.962 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -148.46 158.27 44.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.357 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -68.94 127.32 32.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.641 1.576 . . . . 0.0 106.87 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.2 m . . . . . 0 C--N 1.32 -0.7 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttt . . . . . 0 N--CA 1.438 -1.032 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.25 149.38 28.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.94 144.7 50.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 128.665 2.786 . . . . 0.0 107.533 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.5 m -130.52 117.14 19.16 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -128.67 85.74 2.37 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.278 1.031 . . . . 0.0 109.011 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -67.54 147.09 53.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.053 0.541 . . . . 0.0 110.245 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.61 167.55 26.24 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 122.705 1.17 . . . . 0.0 111.409 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -87.55 44.37 1.18 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -151.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 167.02 3.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.396 0.617 . . . . 0.0 111.304 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 p -124.53 -1.97 7.99 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.701 1.6 . . . . 0.0 111.355 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -148.61 160.7 42.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.172 1.389 . . . . 0.0 107.39 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.02 134.24 3.26 Favored Glycine 0 N--CA 1.454 -0.162 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.6 mtp -81.67 153.47 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.038 0.419 . . . . 0.0 111.338 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 87' ' ' LEU . 1.5 mm? -106.92 91.08 5.9 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 167.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.87 154.92 2.27 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.953 3.102 . . . . 0.0 111.92 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.19 37.08 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.468 HD21 HD12 ' A' ' 84' ' ' LEU . 3.4 mm? -105.02 -166.41 1.23 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.402 3.081 . . . . 0.0 107.329 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -121.97 146.79 47.19 Favored Pre-proline 0 N--CA 1.45 -0.466 0 O-C-N 120.918 -1.114 . . . . 0.0 111.323 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 167.63 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.265 3.31 . . . . 0.0 111.963 163.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.262 0.3 OUTLIER 40.12 42.1 1.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.841 2.456 . . . . 0.0 111.525 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -133.62 153.12 51.91 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.557 -1.34 . . . . 0.0 108.44 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -94.14 146.53 23.92 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.11 153.99 51.82 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.8 m -126.64 143.71 51.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.08 163.12 39.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.354 1.861 . . . . 0.0 109.714 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -152.76 151.72 30.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 110.216 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.59 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.913 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -137.37 138.5 39.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.096 1.359 . . . . 0.0 108.326 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.12 152.41 3.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 64.0 t -137.36 134.94 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -128.3 -174.95 3.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.433 1.093 . . . . 0.0 109.713 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.72 -7.33 41.05 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.339 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.93 -38.93 5.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.95 1.7 . . . . 0.0 110.541 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.04 -173.27 45.13 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 110.638 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 166.78 22.81 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.34 -0.506 . . . . 0.0 110.814 164.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 -158.42 10.38 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 160.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.75 158.06 44.29 Favored 'Trans proline' 0 C--O 1.237 0.428 0 CA-C-N 119.886 1.843 . . . . 0.0 112.586 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.4 143.35 26.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.639 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.23 175.18 2.96 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 126.064 1.746 . . . . 0.0 111.185 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.35 137.48 65.61 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.731 1.621 . . . . 0.0 109.353 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.73 153.92 27.0 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.271 1.034 . . . . 0.0 110.729 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 21' ' ' VAL . 74.4 mmt-85 -134.5 170.54 15.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 107.687 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.6 m -135.27 157.01 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.786 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -153.72 143.03 21.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -112.4 137.69 50.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 170.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -92.16 151.21 41.49 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.16 -73.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.846 3.031 . . . . 0.0 113.265 -159.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -154.0 -41.31 0.09 Allowed 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.562 0 CA-C-O 119.287 -0.729 . . . . 0.0 111.701 -167.874 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 119.131 -0.462 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.9 -175.78 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.295 2.663 . . . . 0.0 112.807 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 42.5 mtm -126.51 -59.37 1.3 Allowed 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 110.467 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 42' ' ' SER . 35.1 m -122.21 148.93 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.605 0.717 . . . . 0.0 111.635 -168.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.75 168.4 18.47 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.003 2.121 . . . . 0.0 109.912 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 2.0 Cg_endo -61.01 155.82 48.04 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.345 1.363 . . . . 0.0 113.308 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.34 -175.49 30.24 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.115 1.34 . . . . 0.0 111.088 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -36.09 103.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 127.476 2.311 . . . . 0.0 113.757 -163.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.56 139.73 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.27 156.44 45.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -146.46 118.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 119.214 0.915 . . . . 0.0 109.285 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -96.7 121.41 38.52 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.465 1.106 . . . . 0.0 109.202 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.0 t -86.5 108.62 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.603 ' HB ' HD12 ' A' ' 30' ' ' LEU . 40.2 t -71.1 -56.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.765 0.826 . . . . 0.0 108.885 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.19 -174.3 3.29 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.13 0.972 . . . . 0.0 109.674 -163.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -27.84 67.76 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.623 -0.673 . . . . 0.0 112.136 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.4 p -129.39 7.55 5.38 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.46 1.104 . . . . 0.0 111.795 -166.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.649 HD11 ' CE ' ' A' ' 83' ' ' MET . 3.3 tm? -138.54 139.45 38.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.17 1.788 . . . . 0.0 108.352 -174.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -141.03 173.42 11.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.938 167.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 151.22 51.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.635 1.974 . . . . 0.0 108.877 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 t -126.97 134.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -119.47 128.98 54.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -142.99 -179.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.529 1.132 . . . . 0.0 110.279 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.1 144.58 29.69 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.899 0.879 . . . . 0.0 111.704 -172.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.53 96.47 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.409 2.739 . . . . 0.0 111.192 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 32.4 m -64.03 157.04 71.62 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.052 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 58.7 Cg_endo -77.31 146.01 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.308 2.672 . . . . 0.0 109.358 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.06 -30.75 71.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.759 -0.588 . . . . 0.0 111.798 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -59.3 -34.55 72.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.402 -0.808 . . . . 0.0 111.614 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.77 ' HB2' HG22 ' A' ' 16' ' ' VAL . 60.6 p -64.39 -42.99 95.84 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.494 1.043 . . . . 0.0 110.062 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.7 mt -64.25 -31.52 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.086 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 54.72 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.643 2.377 . . . . 0.0 115.232 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.13 -155.57 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.315 1.912 . . . . 0.0 109.591 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -103.94 109.73 21.6 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.82 1.248 . . . . 0.0 110.874 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -46.29 110.45 0.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 127.092 2.157 . . . . 0.0 109.678 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.421 ' H ' ' HA ' ' A' ' 101' ' ' ASN . 56.2 mm-40 -86.01 -12.91 49.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.627 0.727 . . . . 0.0 111.544 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.15 28.43 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -101.47 155.76 17.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 164.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -122.1 144.6 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.48 120.17 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.86 150.85 20.84 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 163.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.592 ' CE1' HD12 ' A' ' 73' ' ' LEU . 21.2 p90 -158.67 160.23 36.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.695 1.598 . . . . 0.0 109.726 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -149.37 157.44 43.32 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.687 0.795 . . . . 0.0 109.789 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -68.12 125.45 26.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.098 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.8 tttp . . . . . 0 N--CA 1.441 -0.893 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.72 143.15 37.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.592 HD12 ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -129.93 153.44 48.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 107.176 167.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -133.28 127.9 34.64 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 72.8 m-85 -138.11 88.93 2.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.77 0.828 . . . . 0.0 109.386 -172.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -71.36 151.37 44.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.273 1.029 . . . . 0.0 110.286 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.62 164.0 29.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.133 1.349 . . . . 0.0 112.199 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -79.74 58.15 2.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.748 1.619 . . . . 0.0 110.428 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.04 171.08 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.556 1.143 . . . . 0.0 109.924 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 7.23 2.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.973 1.709 . . . . 0.0 111.932 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -144.4 159.57 42.5 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.574 0.75 . . . . 0.0 109.362 167.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.45 148.46 12.06 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.352 1.453 . . . . 0.0 111.266 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.649 ' CE ' HD11 ' A' ' 30' ' ' LEU . 21.4 mtp -77.96 169.51 18.17 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -169.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -127.78 96.32 32.68 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 126.835 2.054 . . . . 0.0 105.851 163.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -99.49 161.53 0.57 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.267 2.644 . . . . 0.0 111.702 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.36 35.5 56.33 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.331 -0.856 . . . . 0.0 111.784 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -86.45 161.65 18.52 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.59 130.03 24.12 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.12 166.5 18.65 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.381 2.721 . . . . 0.0 112.232 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 8.9 t80 42.95 52.76 5.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.206 . . . . 0.0 113.346 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -152.08 -178.84 7.02 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.55 1.14 . . . . 0.0 110.879 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 162.59 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.394 1.478 . . . . 0.0 108.651 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -136.03 165.58 25.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.669 1.188 . . . . 0.0 108.721 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 m -125.6 146.46 49.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 157.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -139.72 164.09 30.87 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.466 1.906 . . . . 0.0 108.848 167.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -148.54 144.94 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.824 -0.547 . . . . 0.0 109.903 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.01 152.4 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -149.64 143.21 25.38 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.6 146.58 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.1 t -135.29 142.7 39.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 126.156 1.783 . . . . 0.0 107.215 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 48' ' ' GLN . 16.1 p30 -144.65 -174.29 4.29 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.525 1.13 . . . . 0.0 111.156 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.08 -10.05 31.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.057 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -117.27 -22.95 8.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.929 1.365 . . . . 0.0 112.322 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.0 -153.23 23.87 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -127.13 159.8 33.13 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.745 0.783 . . . . 0.0 110.35 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.84 -165.85 27.08 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.139 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.57 166.37 24.19 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.303 1.335 . . . . 0.0 109.92 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.01 150.07 23.28 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.088 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -75.15 165.36 54.46 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -55.58 123.65 14.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.918 2.412 . . . . 0.0 110.809 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.32 143.21 53.47 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.156 1.782 . . . . 0.0 107.896 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -122.23 163.61 19.31 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.31 166.58 22.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 23' ' ' VAL . 37.5 p90 -158.67 159.49 35.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -117.53 143.45 46.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.77 1.228 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.2 p -98.75 143.4 26.28 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -66.09 167.17 18.71 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.846 2.364 . . . . 0.0 108.969 172.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 18.3 tt0 -61.87 -23.69 66.45 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -163.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -172.107 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 CA--C 1.553 1.067 0 N-CA-C 119.999 3.333 . . . . 0.0 119.999 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.94 161.17 40.71 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.171 2.58 . . . . 0.0 111.878 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 mtm -125.76 -26.59 3.47 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -169.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 42' ' ' SER . 29.3 m -140.6 169.22 15.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.494 1.117 . . . . 0.0 110.862 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.29 163.0 17.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.34 2.256 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.58 156.58 60.11 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.828 1.685 . . . . 0.0 113.393 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 166.86 54.92 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -21.3 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 129.073 2.949 . . . . 0.0 115.356 -162.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.67 130.35 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -118.82 161.14 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.68 138.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -123.79 125.29 44.44 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.421 0.689 . . . . 0.0 110.369 169.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 115' ' ' ASN . 59.3 t -70.39 101.28 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 166.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.0 -56.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.878 2.071 . . . . 0.0 109.759 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -132.34 172.35 12.56 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.187 1.395 . . . . 0.0 107.392 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -64.16 0.93 0.81 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.6 p -133.62 -1.25 3.12 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.301 1.84 . . . . 0.0 112.371 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -149.07 119.81 7.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.396 1.078 . . . . 0.0 109.594 -159.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.31 130.72 48.24 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.577 0.626 . . . . 0.0 109.893 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.24 146.03 39.3 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.69 139.91 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 164.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -120.68 151.79 39.06 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.58 1.552 . . . . 0.0 108.035 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -153.0 155.79 37.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.849 0.46 . . . . 0.0 110.819 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.35 136.72 45.88 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.07 129.59 15.39 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.342 2.695 . . . . 0.0 110.388 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.21 151.86 95.8 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.659 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -85.31 159.82 11.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.938 3.092 . . . . 0.0 110.809 -173.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -60.03 -34.37 73.29 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.031 0.532 . . . . 0.0 111.663 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -66.93 -23.01 65.93 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.825 ' HB2' HG22 ' A' ' 16' ' ' VAL . 41.1 p -76.46 -41.08 48.6 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 120.077 1.308 . . . . 0.0 109.49 170.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.22 -32.7 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.237 1.415 . . . . 0.0 110.146 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 50.22 60.82 3.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.471 1.508 . . . . 0.0 110.142 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.09 -147.87 19.41 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.91 122.83 46.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.381 1.472 . . . . 0.0 110.711 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.38 111.44 0.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.75 2.02 . . . . 0.0 109.802 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.5 -13.95 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.694 0.797 . . . . 0.0 112.053 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.16 -164.47 27.94 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.12 148.98 31.51 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 107.91 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -125.9 140.98 52.2 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.2 mt -128.85 122.12 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -91.45 148.16 22.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.1 p90 -158.33 164.54 36.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 111.124 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -149.26 162.23 40.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -68.61 136.09 52.48 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.934 2.093 . . . . 0.0 108.38 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m . . . . . 0 C--N 1.322 -0.6 0 C-N-CA 125.788 1.635 . . . . 0.0 106.881 -175.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 18.4 mttm . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.9 mm -122.84 159.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' CD1' HD13 ' A' ' 84' ' ' LEU . 1.2 mt -130.8 141.29 50.34 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 127.16 2.184 . . . . 0.0 107.233 165.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.7 m -112.9 122.21 46.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.781 1.232 . . . . 0.0 107.809 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 62.5 m-85 -128.64 80.22 1.95 Allowed 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.108 0.963 . . . . 0.0 109.168 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.28 155.68 27.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.86 157.7 33.89 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.583 1.563 . . . . 0.0 111.585 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -79.5 34.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.841 1.257 . . . . 0.0 113.937 -169.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 160.81 14.92 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.538 -1.351 . . . . 0.0 111.865 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.3 p -119.82 7.01 10.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.831 2.053 . . . . 0.0 111.089 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.9 170.67 18.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.009 1.323 . . . . 0.0 109.379 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.16 158.63 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 mtp -97.34 157.9 15.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.897 1.348 . . . . 0.0 112.282 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.51 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.2 mm? -108.06 80.93 1.14 Allowed Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 129.853 3.261 . . . . 0.0 106.236 169.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -86.22 153.09 9.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.648 2.899 . . . . 0.0 110.417 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 23.38 56.74 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.741 1.162 . . . . 0.0 112.316 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 84' ' ' LEU . 3.0 mm? -94.5 166.44 12.05 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 172.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 150.7 55.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.553 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 10.9 Cg_endo -70.29 -178.77 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.911 2.407 . . . . 0.0 111.87 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 53.41 36.87 24.17 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.636 1.175 . . . . 0.0 111.333 164.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 m -146.07 155.68 42.94 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.58 1.552 . . . . 0.0 109.477 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -100.63 153.81 19.11 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -143.2 156.24 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.839 0.856 . . . . 0.0 109.426 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.9 m -125.94 139.01 53.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.07 160.59 39.91 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 110.283 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.21 145.29 24.56 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.497 -0.752 . . . . 0.0 110.816 165.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.87 151.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.931 2.092 . . . . 0.0 107.873 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.28 139.69 18.63 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.39 134.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.366 1.067 . . . . 0.0 110.12 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.45 146.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -133.29 -178.86 5.17 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.287 1.435 . . . . 0.0 109.514 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.43 53.0 2.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.198 0.904 . . . . 0.0 111.267 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -162.78 -31.79 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.383 1.873 . . . . 0.0 109.983 172.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.95 -167.68 35.45 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.158 0.866 . . . . 0.0 113.468 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.28 169.09 12.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.044 2.937 . . . . 0.0 110.213 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.45 -155.26 6.57 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 128.32 2.867 . . . . 0.0 110.047 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 137.33 39.64 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.132 2.555 . . . . 0.0 111.991 -175.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.97 158.55 35.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.535 0.734 . . . . 0.0 110.195 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.6 p -63.21 174.22 0.96 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.939 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -50.72 140.44 37.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 153.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -61.18 106.0 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 161.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -85.96 166.2 16.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.76 157.72 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -152.04 136.78 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.469 ' O ' HG21 ' A' ' 25' ' ' VAL . 3.0 p-10 -86.7 159.69 19.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 161.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.9 p -111.2 162.44 20.83 Favored Pre-proline 0 C--O 1.243 0.727 0 C-N-CA 123.975 0.91 . . . . 0.0 108.862 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.44 166.22 30.43 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.193 1.928 . . . . 0.0 109.044 168.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.33 -21.26 66.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.069 0.948 . . . . 0.0 112.46 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.509 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 176.152 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 C--O 1.234 0.257 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.94 166.77 28.84 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 120.991 1.127 . . . . 0.0 110.158 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.3 mtm -117.86 -44.93 2.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.269 -169.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 42' ' ' SER 0.252 33.5 m -129.96 -175.3 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.749 1.158 . . . . 0.0 111.726 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.67 152.6 69.4 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 128.268 2.627 . . . . 0.0 108.862 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.53 137.75 23.3 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.917 1.745 . . . . 0.0 109.253 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.94 -170.81 28.68 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.1 t30 30.43 56.25 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.464 1.905 . . . . 0.0 112.557 -170.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.44 121.68 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -133.36 155.06 50.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.26 -1.336 . . . . 0.0 107.87 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.446 HG11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -146.46 146.0 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.81 129.92 51.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.42 150.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.213 161.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 t -117.03 -78.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -103.08 -179.83 4.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.408 1.083 . . . . 0.0 108.706 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -17.71 63.14 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.457 -1.402 . . . . 0.0 113.47 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.8 p -133.83 10.15 3.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.889 1.276 . . . . 0.0 112.598 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -130.95 132.35 45.01 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.943 1.697 . . . . 0.0 107.548 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.73 169.2 14.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.651 0.781 . . . . 0.0 109.012 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -126.3 135.75 51.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.493 1.517 . . . . 0.0 107.334 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.22 148.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.57 154.65 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.623 1.969 . . . . 0.0 108.664 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -158.09 171.35 20.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.281 0.632 . . . . 0.0 111.386 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.59 137.52 38.74 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.818 1.647 . . . . 0.0 111.317 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.17 112.78 3.63 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.727 2.951 . . . . 0.0 111.077 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.43 158.66 64.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 122.077 -0.389 . . . . 0.0 110.568 170.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.64 160.63 14.45 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.557 2.838 . . . . 0.0 112.288 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -25.39 67.78 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.404 -0.81 . . . . 0.0 112.871 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -60.69 -49.49 77.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.568 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.707 ' HB2' HG22 ' A' ' 16' ' ' VAL . 51.4 p -66.67 -23.66 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.818 1.19 . . . . 0.0 111.503 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 47' ' ' LEU . 90.5 mt -67.57 -32.88 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.539 172.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 47.09 30.06 1.25 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.412 1.485 . . . . 0.0 113.624 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.6 -148.82 12.35 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.569 -1.332 . . . . 0.0 113.648 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -100.52 112.1 24.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.673 1.589 . . . . 0.0 107.84 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 100' ' ' VAL . 3.1 tm? -65.65 121.74 15.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.466 1.906 . . . . 0.0 109.068 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -80.88 -38.44 28.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.81 -178.21 41.23 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 121.379 -0.826 . . . . 0.0 111.945 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -99.44 124.51 44.65 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -76.79 155.63 32.95 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 160.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.16 124.71 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 156.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.543 ' HA ' HD13 ' A' ' 72' ' ' ILE . 9.0 m-85 -91.22 147.52 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 163.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.598 ' CE1' HD12 ' A' ' 73' ' ' LEU . 33.8 p90 -157.37 163.0 39.07 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.467 1.507 . . . . 0.0 110.265 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -149.08 157.16 43.17 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.762 0.791 . . . . 0.0 111.76 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -67.95 125.66 27.02 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.624 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 53' ' ' TYR . 35.4 mm -132.25 155.02 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.448 0.699 . . . . 0.0 109.685 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD12 ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -135.51 157.5 46.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.957 2.503 . . . . 0.0 108.816 170.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -131.02 116.37 17.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.773 1.229 . . . . 0.0 109.633 -170.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.16 97.6 5.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.922 1.289 . . . . 0.0 107.807 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.92 172.03 12.48 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.236 0.541 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.24 15.1 70.06 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.58 26.19 15.88 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 171.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.5 167.52 0.49 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.049 1.74 . . . . 0.0 112.701 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.6 p -102.92 5.12 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 112.399 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.79 168.07 21.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.225 0.61 . . . . 0.0 110.792 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.13 33.24 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.759 2.123 . . . . 0.0 108.626 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.4 mtp -131.85 167.91 18.77 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.891 1.345 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.0 mm? -123.11 76.42 51.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.914 1.686 . . . . 0.0 107.27 172.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -82.38 151.86 15.58 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.92 2.413 . . . . 0.0 110.88 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.89 18.64 46.57 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.428 0.537 . . . . 0.0 112.043 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 93' ' ' TYR . 3.8 mm? -91.84 -169.55 2.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.972 1.309 . . . . 0.0 110.387 -171.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -125.52 149.33 64.5 Favored Pre-proline 0 CA--C 1.54 0.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.347 178.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 1.1 Cg_endo -77.69 173.97 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.423 2.749 . . . . 0.0 112.851 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.1 t80 44.26 53.23 6.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.194 1.798 . . . . 0.0 111.868 172.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m -155.85 146.64 22.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 120.963 -1.086 . . . . 0.0 110.686 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -78.77 151.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.13 0.972 . . . . 0.0 108.876 171.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CE2' HD12 ' A' ' 87' ' ' LEU . 56.4 m-85 -143.7 154.93 43.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.632 1.573 . . . . 0.0 108.113 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.5 m -117.13 147.83 42.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 171.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.446 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -150.6 158.75 44.52 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.66 1.984 . . . . 0.0 110.141 171.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.75 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.3 155.83 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 107.622 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -152.4 142.12 21.92 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 119.832 -1.793 . . . . 0.0 108.686 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 m -81.51 148.21 5.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.488 ' O ' HD22 ' A' ' 47' ' ' LEU . 85.4 t -136.44 136.57 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -136.24 -171.12 2.81 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.378 0.671 . . . . 0.0 110.22 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.67 -15.98 14.64 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.213 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -111.58 -46.99 3.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.117 1.958 . . . . 0.0 111.191 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.04 -170.17 34.12 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.363 0.983 . . . . 0.0 112.406 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -108.16 145.56 33.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 109.467 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.92 -165.23 31.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.906 1.241 . . . . 0.0 114.014 -168.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.71 133.58 49.03 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.252 1.968 . . . . 0.0 108.879 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.29 157.46 16.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.722 0.773 . . . . 0.0 109.977 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 p -67.79 165.46 31.1 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 156.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -63.47 152.91 77.86 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.356 1.37 . . . . 0.0 109.642 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.48 96.91 4.83 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.294 2.238 . . . . 0.0 105.94 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -76.69 168.46 20.04 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.1 1.36 . . . . 0.0 109.562 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.27 164.8 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.201 0.6 . . . . 0.0 111.306 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -160.14 156.47 26.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.942 2.097 . . . . 0.0 108.085 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -122.13 141.37 51.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.324 1.05 . . . . 0.0 109.758 165.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.409 ' HB ' ' HA ' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -74.2 154.25 88.34 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 123.619 0.574 . . . . 0.0 110.792 173.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.41 -73.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.802 3.001 . . . . 0.0 111.403 -168.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.68 -39.77 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.264 0 CA-C-N 118.817 0.735 . . . . 0.0 111.456 -166.929 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 mt . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -66.93 157.31 62.17 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.484 2.123 . . . . 0.0 112.152 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 mtm -112.0 -28.16 8.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -168.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.2 m -143.49 175.98 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.746 1.618 . . . . 0.0 108.052 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -120.06 167.45 12.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.204 2.202 . . . . 0.0 108.776 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HD3' HG23 ' A' ' 99' ' ' VAL . 18.7 Cg_endo -68.27 113.85 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.436 2.091 . . . . 0.0 111.882 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.14 157.07 12.83 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 41.46 62.01 1.65 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.622 1.569 . . . . 0.0 110.326 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -55.46 146.58 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 157.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -140.85 161.32 38.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -147.3 146.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 O-C-N 119.725 -1.859 . . . . 0.0 109.057 169.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -123.98 151.28 43.84 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.099 2.56 . . . . 0.0 107.732 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.71 145.02 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 30' ' ' LEU . 99.5 t -111.73 -57.78 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -171.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.45 -173.35 2.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.031 1.333 . . . . 0.0 107.593 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.441 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -68.0 -31.89 71.9 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.863 -1.148 . . . . 0.0 112.377 175.102 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.8 p -122.5 13.13 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 111.008 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.748 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.0 tm? -134.66 139.27 45.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.516 1.926 . . . . 0.0 107.804 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -144.05 170.14 16.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.34 117.36 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.67 145.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.77 159.2 27.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 108.054 173.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -161.51 162.07 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.493 1.042 . . . . 0.0 110.635 169.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -85.3 135.13 39.35 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.63 116.76 4.55 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.069 3.179 . . . . 0.0 111.559 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 34.7 m -72.78 158.02 87.89 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.957 -0.465 . . . . 0.0 112.218 -175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 60.5 Cg_endo -83.44 149.81 13.15 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.951 3.101 . . . . 0.0 111.384 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.6 mp -59.09 -26.63 64.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.873 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -60.33 -52.11 66.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 111.189 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.764 ' HB2' HG22 ' A' ' 16' ' ' VAL . 13.5 p -73.91 -23.25 59.53 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 47' ' ' LEU . 84.7 mt -66.05 -26.71 38.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 118.276 -0.868 . . . . 0.0 109.938 167.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? 72.77 -49.74 0.7 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.335 2.654 . . . . 0.0 113.956 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.19 -99.36 1.31 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.639 1.114 . . . . 0.0 112.007 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -137.84 105.34 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.384 1.874 . . . . 0.0 109.227 -169.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.2 tp -59.27 131.46 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -95.65 -24.01 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.101 1.36 . . . . 0.0 110.847 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.71 -153.99 25.56 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -127.83 123.45 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.855 1.662 . . . . 0.0 106.564 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.61 106.0 17.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mt -78.73 118.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -92.49 143.2 26.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.589 ' CE1' HD12 ' A' ' 73' ' ' LEU . 35.8 p90 -154.79 170.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.864 1.211 . . . . 0.0 111.849 172.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -149.66 164.59 34.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.589 1.155 . . . . 0.0 110.44 165.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -68.61 137.62 54.39 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.09 1.356 . . . . 0.0 108.024 164.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 83.0 m . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 172.413 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.407 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 6.9 mmtt . . . . . 0 N--CA 1.449 -0.503 0 CA-C-O 122.056 0.931 . . . . 0.0 111.329 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -132.91 150.36 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.405 2.282 . . . . 0.0 106.895 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.589 HD12 ' CE1' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -145.18 100.64 3.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.535 1.934 . . . . 0.0 107.864 177.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 m -71.62 109.29 5.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 59.1 m-85 -108.69 94.42 5.04 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.73 164.88 11.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.829 168.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.56 153.55 28.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -83.39 37.59 0.57 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.128 1.371 . . . . 0.0 111.154 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 170.76 3.53 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.887 2.075 . . . . 0.0 112.19 171.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -133.96 2.45 3.38 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 126.045 1.738 . . . . 0.0 110.614 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -158.32 142.08 15.44 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.111 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.92 138.85 8.03 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -172.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.748 ' HE2' HD11 ' A' ' 30' ' ' LEU . 39.8 mtp -77.23 163.03 26.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.002 0.921 . . . . 0.0 110.887 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.2 mm? -126.5 82.82 65.79 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.133 1.373 . . . . 0.0 107.546 168.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -90.75 154.06 4.14 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.823 2.349 . . . . 0.0 111.795 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.41 51.44 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.457 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.82 -177.7 4.61 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.351 1.46 . . . . 0.0 108.478 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.51 139.68 36.23 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.823 0.849 . . . . 0.0 108.974 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.62 178.4 7.16 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.966 3.111 . . . . 0.0 112.886 -172.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.7 t80 50.89 23.17 1.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.868 2.867 . . . . 0.0 113.514 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.9 m -123.06 157.06 33.62 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.49 1.516 . . . . 0.0 110.351 -172.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -96.83 151.78 19.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -142.07 156.37 45.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.325 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.9 m -126.03 136.12 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -135.69 166.68 22.69 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.743 1.617 . . . . 0.0 109.895 170.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.67 153.08 34.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.838 2.055 . . . . 0.0 106.578 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -121.07 137.54 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.807 1.243 . . . . 0.0 108.465 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.1 ttm105 -135.17 131.36 36.67 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.44 1.496 . . . . 0.0 108.421 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.512 HG23 ' HD3' ' A' ' 18' ' ' PRO 0.25 0.8 OUTLIER -70.99 140.19 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 127.933 2.493 . . . . 0.0 108.013 176.464 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.07 138.58 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -136.99 -175.6 4.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.758 0.823 . . . . 0.0 111.001 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.71 69.77 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.804 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -82.53 -40.25 21.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.973 1.309 . . . . 0.0 110.835 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.36 -165.96 34.05 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 121.943 0.746 . . . . 0.0 111.983 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.44 157.29 20.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.062 0.945 . . . . 0.0 112.534 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.91 -157.99 10.29 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.113 1.339 . . . . 0.0 111.039 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.86 166.57 22.12 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.013 1.809 . . . . 0.0 111.684 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.29 154.05 19.11 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.246 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 5.6 m -70.19 -174.85 0.26 Allowed Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.733 1.613 . . . . 0.0 110.871 173.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 109' ' ' SER . 29.7 Cg_endo -68.35 161.4 44.93 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 CA-C-N 122.307 1.86 . . . . 0.0 109.532 167.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.69 162.09 24.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.258 1.027 . . . . 0.0 109.066 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -132.39 162.36 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.739 1.216 . . . . 0.0 108.271 166.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 159.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.87 147.07 29.36 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.71 144.48 42.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.11 160.73 29.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 110.317 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.76 168.66 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 N-CA-C 108.879 -1.239 . . . . 0.0 108.879 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -61.62 -29.43 70.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.679 0.791 . . . . 0.0 112.116 -174.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 28' ' ' SER . . . . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 125.709 1.624 . . . . 0.0 115.511 163.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.42 -174.33 1.95 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.773 1.649 . . . . 0.0 111.386 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.5 mtm -133.62 -47.03 0.81 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.337 1.455 . . . . 0.0 113.218 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 42' ' ' SER . 14.7 m -131.94 -178.42 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 118.858 0.754 . . . . 0.0 110.196 -169.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.45 164.17 19.25 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 126.487 1.915 . . . . 0.0 109.597 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.21 144.6 75.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.459 1.44 . . . . 0.0 112.482 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.61 170.28 4.93 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.997 1.284 . . . . 0.0 111.468 166.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -49.23 142.44 7.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -147.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.79 121.11 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.157 1.783 . . . . 0.0 106.976 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -122.71 88.29 2.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.715 1.606 . . . . 0.0 111.312 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.507 HG13 ' HE ' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -87.45 143.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 157.16 35.47 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.78 2.032 . . . . 0.0 110.089 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.39 103.49 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.65 -54.08 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.656 1.182 . . . . 0.0 109.312 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -138.33 -179.88 6.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.699 1.2 . . . . 0.0 107.864 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -23.46 56.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.269 1.028 . . . . 0.0 111.25 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -122.17 -2.06 9.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.105 2.162 . . . . 0.0 112.694 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 tp -144.01 130.0 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.308 1.443 . . . . 0.0 109.619 -170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.28 117.45 8.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.172 0.896 . . . . 0.0 111.041 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.17 154.7 41.62 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.549 1.14 . . . . 0.0 110.305 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.95 103.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.809 2.043 . . . . 0.0 106.121 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -92.08 154.2 18.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.108 0.413 . . . . 0.0 110.082 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -151.02 177.63 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 110.124 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.86 142.27 25.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.71 122.93 10.4 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.284 2.656 . . . . 0.0 109.65 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.1 164.57 55.75 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 118.887 0.767 . . . . 0.0 110.45 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -64.61 138.93 61.45 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.221 1.947 . . . . 0.0 109.15 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -31.1 41.01 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.822 0.283 . . . . 0.0 111.228 166.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -50.27 -46.99 55.51 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.182 1.393 . . . . 0.0 110.881 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.811 ' HB2' HG22 ' A' ' 16' ' ' VAL . 61.6 p -71.49 -29.48 64.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.46 -20.21 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.672 0.789 . . . . 0.0 109.486 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 45.33 57.06 5.1 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.038 2.135 . . . . 0.0 110.419 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.16 -102.55 0.33 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.444 -1.198 . . . . 0.0 111.427 173.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -138.18 119.66 14.9 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.316 1.047 . . . . 0.0 110.217 -164.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.46 124.71 23.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.451 1.5 . . . . 0.0 109.119 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -92.74 -14.38 28.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.888 0.475 . . . . 0.0 112.098 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 176.37 22.87 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 126.604 2.049 . . . . 0.0 108.25 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.75 151.64 21.01 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -127.9 109.19 11.35 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.904 -1.123 . . . . 0.0 108.939 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.05 133.6 30.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -104.5 147.77 27.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 152.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.81 158.93 40.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.694 1.198 . . . . 0.0 111.268 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.1 p90 -148.71 161.91 40.8 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.947 0.899 . . . . 0.0 110.253 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -68.38 136.26 53.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.2 m . . . . . 0 C--N 1.323 -0.57 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.523 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.4 tttt . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.15 155.7 41.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 84' ' ' LEU . 3.8 mt -133.12 165.93 23.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.206 1.402 . . . . 0.0 108.864 170.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.5 m -138.54 105.29 5.36 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.593 -0.692 . . . . 0.0 109.679 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -116.77 93.0 4.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -72.86 166.86 22.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.549 0.69 . . . . 0.0 109.76 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.89 173.25 47.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 p -73.8 11.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.003 2.121 . . . . 0.0 114.769 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -64.43 156.12 30.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.438 1.095 . . . . 0.0 109.856 -167.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.6 p -118.08 8.99 12.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.208 1.403 . . . . 0.0 111.307 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -150.12 158.87 44.61 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.627 0.771 . . . . 0.0 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.72 143.6 6.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.953 0.787 . . . . 0.0 111.409 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.8 mtp -97.46 153.11 18.33 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.892 -0.769 . . . . 0.0 112.551 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD13 HD11 ' A' ' 73' ' ' LEU . 3.0 mm? -100.32 87.13 0.72 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.52 2.328 . . . . 0.0 109.143 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.42 162.42 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.252 2.634 . . . . 0.0 111.163 171.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.58 21.04 79.32 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.716 -0.615 . . . . 0.0 112.603 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.97 172.64 9.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.829 1.252 . . . . 0.0 107.803 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.53 161.26 49.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 124.769 1.228 . . . . 0.0 108.848 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -89.77 160.84 5.14 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 125.091 3.861 . . . . 0.0 115.086 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 65.1 44.82 3.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.496 3.518 . . . . 0.0 117.613 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.58 -169.39 2.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.992 2.117 . . . . 0.0 109.97 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -110.45 163.83 13.3 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 158.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.44 152.89 46.03 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.516 -0.74 . . . . 0.0 109.883 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.8 m -126.0 139.43 53.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -145.3 162.88 36.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.995 2.118 . . . . 0.0 107.18 172.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -137.35 -176.26 4.34 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.126 0.971 . . . . 0.0 108.937 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.25 160.15 41.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -154.31 154.21 32.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 106.193 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.48 145.39 8.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.0 t -129.22 139.42 51.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -133.33 -177.97 4.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.833 0.853 . . . . 0.0 109.787 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.54 7.49 3.75 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.098 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -122.05 -57.17 1.8 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.861 1.331 . . . . 0.0 110.327 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.73 -156.79 8.52 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -170.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 163.02 29.56 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.313 1.045 . . . . 0.0 110.917 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.32 -158.11 10.76 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.453 1.025 . . . . 0.0 111.978 -166.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.23 158.66 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.569 2.179 . . . . 0.0 111.807 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.58 156.51 25.14 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.941 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.9 p -64.82 -178.17 0.25 Allowed Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.183 166.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -48.33 132.69 24.42 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.591 -1.349 . . . . 0.0 108.591 145.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.22 157.6 19.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 155.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.507 ' HE ' HG13 ' A' ' 23' ' ' VAL . 3.2 mmm180 -126.21 168.55 13.92 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 123.824 0.85 . . . . 0.0 108.961 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -115.57 155.43 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.505 171.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -144.19 142.78 30.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 160.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -114.77 148.28 38.6 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.269 1.427 . . . . 0.0 107.437 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -111.79 162.61 20.42 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 110.421 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.62 170.54 18.35 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.248 1.966 . . . . 0.0 110.177 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.62 -31.32 67.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.902 1.281 . . . . 0.0 111.389 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.662 0 C-N-CA 126.225 1.869 . . . . 0.0 112.128 176.946 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.72 161.7 44.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.724 2.283 . . . . 0.0 111.329 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.7 mtm -108.45 -41.39 4.86 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.539 1.136 . . . . 0.0 112.797 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 42' ' ' SER . 4.7 m -132.25 152.56 36.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.535 0.683 . . . . 0.0 109.432 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.96 168.43 21.9 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 108.339 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 1.6 Cg_endo -60.68 155.63 47.32 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 119.362 0.808 . . . . 0.0 110.635 165.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.25 -155.78 0.76 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.761 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -45.71 128.77 8.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.52 1.128 . . . . 0.0 111.28 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.4 t -105.08 145.43 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -120.96 150.73 40.66 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.48 119.5 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 174.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.28 130.05 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG11 ' HD3' ' A' ' 117' ' ' PRO . 66.2 t -76.8 118.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -85.63 -52.57 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.501 1.52 . . . . 0.0 107.606 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -136.33 177.73 7.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.337 1.455 . . . . 0.0 109.611 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -38.21 54.4 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.072 1.349 . . . . 0.0 112.608 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -113.61 5.95 16.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.402 1.081 . . . . 0.0 111.692 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 tp -137.39 125.2 22.52 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.712 -168.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.91 157.48 27.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 160.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -98.73 150.81 21.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 163.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 HD23 ' A' ' 84' ' ' LEU . 16.5 t -130.5 139.72 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.542 1.537 . . . . 0.0 107.54 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.81 135.4 49.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.348 2.259 . . . . 0.0 105.234 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -140.85 -170.87 3.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.13 0.972 . . . . 0.0 108.967 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -119.77 135.32 24.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.523 1.129 . . . . 0.0 110.321 -167.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.38 96.41 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.509 2.806 . . . . 0.0 110.606 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 19.7 m -63.78 156.08 74.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.392 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.03 149.74 32.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.558 2.172 . . . . 0.0 109.961 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.53 -39.05 72.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.39 1.076 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -58.64 -30.28 67.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.612 ' HB2' HG22 ' A' ' 16' ' ' VAL . 54.1 p -71.68 -37.89 70.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.806 0.73 . . . . 0.0 110.315 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.0 mt -63.34 -27.53 43.24 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.638 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 56.1 13.91 1.32 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.754 1.622 . . . . 0.0 113.393 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.75 -177.85 48.57 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -162.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 111.54 19.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.768 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 tp -44.89 132.01 6.9 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.038 2.135 . . . . 0.0 110.383 168.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -117.48 -12.08 10.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.027 1.331 . . . . 0.0 112.54 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.58 -171.05 30.45 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.529 1.538 . . . . 0.0 110.482 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -114.8 159.65 20.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.984 0.514 . . . . 0.0 109.808 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -127.31 147.42 50.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.842 1.257 . . . . 0.0 108.072 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.0 mt -120.17 124.53 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 162.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -97.22 145.78 25.73 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 160.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.428 ' CD1' HD11 ' A' ' 84' ' ' LEU . 34.0 p90 -155.91 161.25 40.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 109.556 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -149.1 157.32 43.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.399 0.68 . . . . 0.0 109.893 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 93' ' ' TYR . 12.0 tptm -68.8 140.21 55.27 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -175.342 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.4 tttt . . . . . 0 N--CA 1.438 -1.054 0 CA-C-O 119.89 -0.1 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.62 158.33 43.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 122.563 1.173 . . . . 0.0 110.374 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.552 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -141.83 130.99 23.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.319 2.248 . . . . 0.0 108.017 166.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -86.7 145.58 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.309 1.444 . . . . 0.0 108.181 171.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 55.3 m-85 -139.95 161.15 38.28 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.285 1.034 . . . . 0.0 110.344 167.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -77.57 171.27 15.18 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.668 1.223 . . . . 0.0 112.148 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 151.66 36.18 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.812 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 t 62.91 -6.38 0.17 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.167 2.187 . . . . 0.0 115.736 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -67.25 146.35 54.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 120.527 -1.358 . . . . 0.0 107.444 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 p -110.23 7.77 23.34 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.249 1.419 . . . . 0.0 112.255 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.12 167.33 25.3 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.403 0.547 . . . . 0.0 112.037 168.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.61 -172.16 33.57 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 128.652 3.025 . . . . 0.0 107.396 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.9 mtp -129.84 169.29 15.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.968 1.384 . . . . 0.0 111.689 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.552 HD13 ' CD1' ' A' ' 73' ' ' LEU . 4.0 mm? -119.01 84.54 26.75 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 164.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -88.8 157.62 6.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.832 3.021 . . . . 0.0 111.326 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.67 14.33 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.284 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 84' ' ' LEU . 2.8 mm? -73.8 -179.35 3.61 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.573 1.549 . . . . 0.0 108.95 174.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.16 147.91 37.95 Favored Pre-proline 0 C--O 1.237 0.405 0 CA-C-N 118.528 0.604 . . . . 0.0 111.624 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -70.17 173.28 11.58 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.312 2.674 . . . . 0.0 113.022 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.413 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 26.6 t80 48.55 36.97 8.27 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.025 2.13 . . . . 0.0 113.35 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -137.42 142.4 41.66 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 120.661 -1.274 . . . . 0.0 111.807 -169.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -79.47 146.65 32.62 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 161.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.417 ' CZ ' ' HD2' ' A' ' 56' ' ' LYS . 56.3 m-85 -139.0 148.58 43.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 167.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.1 m -115.07 154.14 29.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.68 163.8 38.33 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.96 1.704 . . . . 0.0 109.519 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -140.66 157.64 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.286 1.034 . . . . 0.0 108.936 164.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.72 143.76 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.66 147.33 42.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.31 148.68 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.7 137.92 51.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.463 1.505 . . . . 0.0 107.154 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -141.77 178.18 7.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.282 1.033 . . . . 0.0 109.292 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.22 -1.93 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.296 0.95 . . . . 0.0 114.667 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -123.18 -26.01 4.4 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.299 1.44 . . . . 0.0 110.997 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.46 -159.27 31.87 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-O 121.691 0.606 . . . . 0.0 111.853 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -132.72 124.89 29.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -160.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.39 -160.93 13.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 -165.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.04 171.37 11.39 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 118.997 1.398 . . . . 0.0 109.312 163.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.31 165.45 12.68 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 85.9 p -67.86 -178.04 0.36 Allowed Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 125.525 1.53 . . . . 0.0 111.034 -164.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 22.5 Cg_endo -50.94 134.11 41.59 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 N-CA-C 108.485 -1.39 . . . . 0.0 108.485 149.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.44 141.32 56.56 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.05 169.18 9.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -135.25 150.23 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -156.93 141.04 16.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.156 0.982 . . . . 0.0 108.529 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -120.37 128.4 53.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.536 1.534 . . . . 0.0 109.043 175.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -82.43 158.86 65.6 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 123.946 0.898 . . . . 0.0 110.039 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HD3' HG11 ' A' ' 25' ' ' VAL . 31.3 Cg_endo -67.68 -89.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.938 3.092 . . . . 0.0 112.383 -167.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 28.3 tt0 -151.0 -31.14 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.217 1.371 . . . . 0.0 112.631 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 C-N-CA 125.279 1.419 . . . . 0.0 112.649 -179.555 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 118.412 -0.804 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -61.37 140.75 89.71 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.752 2.301 . . . . 0.0 113.638 -171.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.5 mtm -79.78 -43.54 22.31 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 125.128 1.371 . . . . 0.0 112.57 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.66 HG22 ' CB ' ' A' ' 42' ' ' SER . 9.5 m -138.08 165.93 24.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.23 0.538 . . . . 0.0 111.279 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -95.22 172.19 5.68 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 109.84 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 27.9 Cg_endo -65.25 169.52 12.16 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.468 2.112 . . . . 0.0 113.223 174.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.31 172.47 55.22 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.922 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -51.04 107.59 0.19 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 113.501 -157.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.21 152.08 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.862 2.065 . . . . 0.0 109.259 -172.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -141.86 156.53 45.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.139 1.776 . . . . 0.0 107.16 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 143.42 20.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 120.893 -1.129 . . . . 0.0 110.373 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -123.69 128.57 49.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.514 2.326 . . . . 0.0 108.835 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -82.26 122.31 36.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 30' ' ' LEU . 50.4 t -81.53 -50.52 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -153.29 -172.48 4.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.302 0.572 . . . . 0.0 110.182 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -35.55 66.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.785 0.834 . . . . 0.0 112.191 -171.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.5 p -127.74 18.59 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.706 1.202 . . . . 0.0 111.204 -168.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.583 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.3 tm? -145.81 140.22 26.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.623 1.569 . . . . 0.0 110.94 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -140.19 167.62 21.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.948 1.299 . . . . 0.0 108.237 169.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 145.68 50.92 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.003 1.721 . . . . 0.0 109.993 174.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.451 HG21 HD23 ' A' ' 84' ' ' LEU . 23.4 t -130.56 133.35 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -166.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -122.24 149.36 43.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.486 ' CZ3' HD11 ' A' ' 52' ' ' ILE . 34.3 p90 -147.98 154.29 40.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.84 142.13 28.8 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 123.76 11.38 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.283 2.655 . . . . 0.0 110.551 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 ' H ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -51.22 163.31 0.55 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 124.309 1.043 . . . . 0.0 110.73 160.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.76 -134.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 1 C-N-CA 126.738 4.959 . . . . 0.0 107.627 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.67 -31.64 1.76 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 117.476 -1.25 . . . . 0.0 111.446 161.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -49.9 -45.16 50.58 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.166 1.348 . . . . 0.0 112.399 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.66 ' CB ' HG22 ' A' ' 16' ' ' VAL . 86.5 p -75.3 -27.45 59.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.394 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.5 mt -64.04 -29.09 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.015 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 68.29 -26.13 0.13 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.431 2.692 . . . . 0.0 114.291 170.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.79 -164.76 11.7 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 128.473 2.94 . . . . 0.0 107.916 166.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -76.7 149.88 36.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.18 129.89 38.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.165 1.386 . . . . 0.0 107.891 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -98.4 -28.89 13.43 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.584 0.353 . . . . 0.0 111.015 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.52 179.75 38.81 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 121.402 -0.811 . . . . 0.0 111.278 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -122.34 149.92 43.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -122.63 125.83 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.486 HD11 ' CZ3' ' A' ' 35' ' ' TRP . 16.7 mt -94.58 123.52 46.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -92.32 146.23 23.86 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 164.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.98 168.37 27.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.203 1.001 . . . . 0.0 112.356 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -148.91 156.98 43.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.166 1.386 . . . . 0.0 109.911 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -73.64 137.69 44.33 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.467 1.507 . . . . 0.0 108.351 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.1 m . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 124.202 1.001 . . . . 0.0 109.347 -171.497 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 122.349 1.071 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.48 149.85 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 106.223 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.437 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 1.1 mt -139.22 137.08 35.66 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.258 -170.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.0 m -98.76 132.36 44.19 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.767 0.827 . . . . 0.0 109.77 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.437 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 63.7 m-85 -143.87 68.13 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.805 2.042 . . . . 0.0 108.036 170.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -66.08 133.91 51.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.954 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.76 176.47 25.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.665 1.602 . . . . 0.0 112.599 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.9 p -74.88 0.43 15.64 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HE2' ' CE1' ' A' ' 81' ' ' HIS . 2.2 mmmp? -45.9 146.72 1.14 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.035 1.289 . . . . 0.0 112.159 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 p -99.6 -2.95 34.34 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.425 1.89 . . . . 0.0 111.136 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.416 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 15.1 p80 -149.9 166.88 28.26 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.741 -0.599 . . . . 0.0 110.885 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.29 158.72 24.44 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.453 1.025 . . . . 0.0 112.228 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.583 ' HE2' HD11 ' A' ' 30' ' ' LEU . 55.2 mtp -88.18 160.32 17.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.911 0.884 . . . . 0.0 112.187 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.614 HD12 HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -117.35 89.33 31.13 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.641 1.576 . . . . 0.0 107.534 166.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -93.18 156.59 2.6 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.063 3.175 . . . . 0.0 111.421 168.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.73 29.15 19.45 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.887 0.756 . . . . 0.0 111.611 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.614 HD21 HD12 ' A' ' 84' ' ' LEU . 2.9 mm? -101.4 175.82 5.45 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.375 1.87 . . . . 0.0 107.932 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -133.22 150.36 75.12 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 124.851 1.26 . . . . 0.0 110.19 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -71.08 166.3 29.61 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.944 2.43 . . . . 0.0 112.277 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.1 t80 51.48 34.1 11.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.616 2.366 . . . . 0.0 113.461 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.4 m -132.53 148.45 52.38 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.491 1.117 . . . . 0.0 110.578 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.65 151.97 23.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -137.29 149.32 47.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.115 1.366 . . . . 0.0 108.289 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 m -126.03 134.78 51.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 163.25 37.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.823 2.049 . . . . 0.0 108.486 -171.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.94 169.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.05 1.34 . . . . 0.0 108.762 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.42 149.55 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.747 1.219 . . . . 0.0 108.113 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -140.13 147.31 40.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.481 1.512 . . . . 0.0 108.0 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -87.87 154.06 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.096 0.862 . . . . 0.0 109.363 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.4 t -132.12 139.1 51.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -138.63 -170.94 2.95 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.15 0.58 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.2 -8.25 17.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.535 1.065 . . . . 0.0 115.433 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -113.11 -57.41 2.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.15 1.475 . . . . 0.0 109.397 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.37 -163.61 25.64 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.302 0.956 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -87.28 160.65 18.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.74 -157.27 10.09 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 165.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -62.52 156.95 49.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 CA-C-N 119.607 1.703 . . . . 0.0 111.342 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.41 155.23 17.49 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.963 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -66.04 166.89 13.78 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.402 1.481 . . . . 0.0 108.603 168.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.18 162.7 28.77 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.73 1.62 . . . . 0.0 109.671 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -61.53 138.15 58.27 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 122.185 0.993 . . . . 0.0 110.064 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 173.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 159.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.86 156.56 42.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.7 145.36 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 158.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -123.64 146.81 47.92 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 p -90.64 157.43 44.1 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 124.232 1.013 . . . . 0.0 109.598 -167.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.07 164.98 31.75 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.417 2.078 . . . . 0.0 109.003 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.6 -27.57 62.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.556 1.142 . . . . 0.0 112.466 -173.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.41 0 C-N-CA 125.572 1.558 . . . . 0.0 112.012 155.637 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 119.378 -0.344 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.475 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 86.2 Cg_endo -73.8 172.81 15.09 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.627 2.218 . . . . 0.0 111.137 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.3 mtm -121.34 -30.79 4.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.286 1.435 . . . . 0.0 113.551 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 42' ' ' SER . 34.3 m -140.97 163.12 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 111.371 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.01 169.17 18.6 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.856 2.062 . . . . 0.0 109.029 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 7.6 Cg_endo -70.19 160.36 49.87 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.255 1.304 . . . . 0.0 110.474 165.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.47 -154.15 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.429 1.49 . . . . 0.0 114.46 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -47.41 131.59 13.55 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.528 1.131 . . . . 0.0 110.303 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.73 147.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -131.86 158.42 41.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.15 150.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.82 128.96 50.28 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.16 143.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 159.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 30' ' ' LEU . 92.9 t -111.03 -53.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -132.27 -171.11 2.56 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.992 1.317 . . . . 0.0 108.687 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -64.3 -37.14 86.44 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.056 -1.027 . . . . 0.0 112.517 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.0 p -123.34 11.63 9.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.947 1.299 . . . . 0.0 110.078 -166.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.701 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.3 tm? -134.69 137.77 43.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.58 1.952 . . . . 0.0 109.0 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -139.73 165.51 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.33 118.71 18.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.97 147.88 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 107.313 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -131.0 133.35 45.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -118.39 -158.81 0.73 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.961 2.104 . . . . 0.0 108.247 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.08 137.56 30.97 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 126.492 1.917 . . . . 0.0 109.909 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.68 101.16 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.505 2.804 . . . . 0.0 109.405 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 28.8 m -67.1 158.48 81.18 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 41.0 Cg_endo -71.63 147.86 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.765 2.31 . . . . 0.0 109.128 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -54.18 -22.74 12.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.257 0.623 . . . . 0.0 110.736 171.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -61.68 -47.35 85.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.046 1.738 . . . . 0.0 114.557 174.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.726 ' HB2' HG22 ' A' ' 16' ' ' VAL . 7.9 p -71.37 -31.8 67.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.72 1.6 . . . . 0.0 109.732 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 47' ' ' LEU . 27.1 mt -68.54 -26.02 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.846 0.859 . . . . 0.0 109.736 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 66.13 3.7 2.79 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.168 2.587 . . . . 0.0 113.823 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.67 -161.41 31.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -172.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -70.98 114.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.537 0.669 . . . . 0.0 109.735 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.3 tm? -55.13 120.35 6.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 163.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -85.38 -31.4 22.95 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.85 168.55 28.2 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -99.6 112.5 24.71 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -81.0 142.87 32.97 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.1 mt -112.06 143.45 21.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.447 ' CE2' ' CD1' ' A' ' 72' ' ' ILE . 43.3 m-85 -112.45 140.56 47.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 166.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -153.63 162.15 41.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.122 1.328 . . . . 0.0 110.232 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -148.57 157.78 43.69 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.539 -0.725 . . . . 0.0 109.233 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -69.09 140.59 54.82 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.599 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 171.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.6 mttt . . . . . 0 N--CA 1.442 -0.849 0 CA-C-O 123.001 1.382 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 53' ' ' TYR . 3.4 mm -138.92 152.42 24.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.354 -2.203 . . . . 0.0 105.091 -162.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.498 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -148.69 160.47 43.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.259 169.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.1 m -133.58 97.35 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -161.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 73' ' ' LEU . 58.3 m-85 -105.53 112.1 25.06 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.29 166.92 16.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.903 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.51 172.91 4.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.7 m -85.5 41.61 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.469 -1.018 . . . . 0.0 111.387 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE3' ' CE1' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -63.26 155.93 27.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.698 -1.251 . . . . 0.0 110.183 162.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -109.13 -3.78 17.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.605 1.962 . . . . 0.0 112.288 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.489 ' CE1' ' HE3' ' A' ' 79' ' ' LYS . 14.7 p80 -146.22 164.53 32.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.03 158.86 30.62 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.701 ' HE2' HD11 ' A' ' 30' ' ' LEU . 39.4 mtp -90.96 162.61 14.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.871 0.843 . . . . 0.0 111.117 -168.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 84' ' ' LEU . 1.1 mm? -120.82 89.98 46.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 160.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.1 148.95 1.26 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.394 3.396 . . . . 0.0 112.037 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.43 51.11 8.73 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.47 179.71 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.606 2.362 . . . . 0.0 107.773 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.0 142.37 26.12 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 124.466 1.107 . . . . 0.0 110.485 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.29 166.4 25.43 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.425 2.083 . . . . 0.0 110.84 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER 37.25 46.26 0.57 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 129.894 3.278 . . . . 0.0 113.869 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.1 m -119.72 -176.12 3.1 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.332 1.453 . . . . 0.0 109.122 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.07 157.21 19.57 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 148.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -137.61 154.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.1 m -124.24 141.8 51.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 155.23 44.26 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 127.235 2.214 . . . . 0.0 108.813 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.36 169.28 17.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.069 1.348 . . . . 0.0 107.734 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.25 152.71 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -146.53 131.17 17.86 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.9 1.28 . . . . 0.0 107.77 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.85 150.95 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.7 t -146.74 135.82 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.369 1.468 . . . . 0.0 107.069 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.65 178.85 6.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 107.716 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.8 57.28 3.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.345 0.974 . . . . 0.0 112.014 -172.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -160.71 -41.86 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.481 1.913 . . . . 0.0 109.327 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.74 -168.9 42.03 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.69 166.28 11.19 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 110.075 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.475 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -108.84 -174.48 21.48 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 124.367 0.984 . . . . 0.0 113.284 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.33 153.45 74.31 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.748 1.632 . . . . 0.0 110.444 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.44 165.39 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.688 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 54.0 p -110.78 -171.69 0.22 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.106 0.962 . . . . 0.0 112.112 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 48.5 Cg_endo -64.84 139.46 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.01 89.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 112' ' ' ARG . 0.7 OUTLIER -65.57 159.94 23.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 O-C-N 121.952 -0.467 . . . . 0.0 110.425 173.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 t -128.8 167.22 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.47 156.96 36.19 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.85 2.06 . . . . 0.0 108.156 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.75 147.99 44.58 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 125.218 1.407 . . . . 0.0 110.009 170.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -105.21 166.25 11.74 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.377 1.071 . . . . 0.0 111.478 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.92 167.42 16.35 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.856 3.704 . . . . 0.0 111.791 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 38.7 mt-10 -56.49 -33.08 65.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.028 1.331 . . . . 0.0 111.327 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 28' ' ' SER . . . . . . . . 0 N--CA 1.442 -0.921 0 C-N-CA 126.326 1.917 . . . . 0.0 109.341 160.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 84.4 Cg_endo -72.56 152.02 53.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.649 2.899 . . . . 0.0 111.652 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 68.8 mtm -109.04 -38.98 5.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 117.652 -1.166 . . . . 0.0 113.854 -164.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.831 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.7 m -133.87 147.84 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.459 1.481 . . . . 0.0 113.102 -170.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.63 157.25 67.46 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 127.167 2.187 . . . . 0.0 109.991 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.49 162.96 38.58 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.348 2.032 . . . . 0.0 112.196 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.87 -149.04 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.26 2.362 . . . . 0.0 115.053 -175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -66.94 78.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.339 1.455 . . . . 0.0 113.033 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.1 t -53.67 139.98 10.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.73 158.28 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.562 1.545 . . . . 0.0 107.082 171.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.419 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -146.36 123.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.027 0.831 . . . . 0.0 108.942 168.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.83 102.33 7.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 127.998 2.519 . . . . 0.0 109.39 -169.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.28 0.8 OUTLIER -73.87 116.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-O 121.558 0.694 . . . . 0.0 110.313 -171.991 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 30' ' ' LEU . 45.8 t -69.66 -49.59 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -173.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -139.33 -163.85 1.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 108.971 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -29.94 56.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.654 -1.279 . . . . 0.0 113.151 177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 p -124.96 11.79 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.954 1.301 . . . . 0.0 110.764 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.73 HD11 ' HE2' ' A' ' 83' ' ' MET . 1.9 tm? -143.56 136.31 27.41 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.222 1.409 . . . . 0.0 107.862 -171.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -140.08 165.87 26.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.42 121.62 26.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.27 141.75 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -126.96 150.7 49.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.975 0.51 . . . . 0.0 110.3 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -151.26 178.9 8.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.84 142.66 25.05 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.48 -0.762 . . . . 0.0 109.003 172.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.46 111.53 3.13 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 123.039 2.493 . . . . 0.0 107.636 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.59 156.34 86.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -78.51 143.88 19.6 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 122.348 2.032 . . . . 0.0 108.449 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.0 mm? -59.23 -27.62 65.93 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.655 0.382 . . . . 0.0 110.814 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -60.01 -38.55 82.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.831 ' HB2' HG22 ' A' ' 16' ' ' VAL . 86.2 p -67.4 -41.81 84.31 Favored 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 119.027 0.83 . . . . 0.0 110.344 172.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 40' ' ' LEU . 32.3 mt -67.74 -23.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.644 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 56.17 11.31 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.383 1.873 . . . . 0.0 114.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.52 179.01 41.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.436 1.969 . . . . 0.0 108.256 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -73.94 122.9 23.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 43' ' ' ILE . 9.4 tp -57.45 112.55 1.45 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 108.525 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.17 -43.74 77.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.057 0.943 . . . . 0.0 109.472 168.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -177.2 45.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CE2' HD21 ' A' ' 47' ' ' LEU . 92.5 m-85 -105.87 112.51 25.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.453 1.901 . . . . 0.0 105.989 169.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -83.51 153.24 24.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.41 117.26 50.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -91.57 116.55 28.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -135.58 164.01 28.81 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.187 0.903 . . . . 0.0 110.912 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.71 163.51 37.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.202 1.001 . . . . 0.0 110.5 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.32 135.48 50.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.958 1.303 . . . . 0.0 108.177 168.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 122.343 1.068 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 mp -133.16 139.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 126.828 2.051 . . . . 0.0 105.864 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.704 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 1.1 mt -120.86 153.04 37.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.651 2.38 . . . . 0.0 107.692 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.1 m -134.26 97.92 3.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 110.062 -168.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.704 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 42.6 m-85 -110.13 92.35 4.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 123.945 0.898 . . . . 0.0 108.933 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.2 163.25 27.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.5 177.19 12.86 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.261 0.923 . . . . 0.0 113.023 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 p -76.53 25.3 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.04 2.536 . . . . 0.0 114.241 -169.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -58.2 160.36 5.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.049 1.34 . . . . 0.0 111.322 176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.5 p -128.91 -2.02 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.105 0.962 . . . . 0.0 111.987 -172.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -146.51 163.72 34.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.99 151.86 23.03 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.73 ' HE2' HD11 ' A' ' 30' ' ' LEU . 38.7 mtp -76.9 163.82 26.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -119.58 93.13 47.09 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 157.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -93.29 161.02 2.5 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.745 2.296 . . . . 0.0 111.137 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.75 31.82 59.93 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD11 HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -84.69 171.72 12.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.693 1.997 . . . . 0.0 106.923 166.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.64 153.25 45.9 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 123.788 0.835 . . . . 0.0 110.067 163.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.66 169.51 17.28 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.683 2.255 . . . . 0.0 112.63 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.9 t80 47.49 51.04 14.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.146 1.778 . . . . 0.0 111.191 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -153.8 -178.74 7.25 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.812 -1.18 . . . . 0.0 109.683 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -110.0 158.99 17.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -145.5 151.43 38.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.5 m -123.33 142.76 50.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 170.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 162.67 34.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.333 1.853 . . . . 0.0 109.568 174.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.57 144.23 31.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.647 1.579 . . . . 0.0 106.826 170.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.99 132.56 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -129.93 134.14 47.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.046 1.294 . . . . 0.0 110.824 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.31 152.29 5.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.3 142.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -132.92 -162.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.59 1.156 . . . . 0.0 109.813 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.93 65.74 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -50.62 69.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.861 0.865 . . . . 0.0 110.763 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.42 -168.84 41.88 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 120.003 1.274 . . . . 0.0 112.945 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.56 154.36 27.52 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.746 1.218 . . . . 0.0 110.983 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.471 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -108.28 -172.91 21.65 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 0.0 112.074 166.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.44 156.32 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.139 1.893 . . . . 0.0 110.493 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.82 152.72 21.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.112 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -63.8 -171.79 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.812 1.645 . . . . 0.0 111.459 170.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.95 154.58 16.99 Favored 'Trans proline' 0 C--N 1.352 0.729 0 CA-C-N 120.663 1.272 . . . . 0.0 110.242 163.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.445 ' HA ' HD22 ' A' ' 96' ' ' ASN . 2.7 m-20 -82.74 85.3 7.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 166.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -67.09 155.93 37.43 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.73 154.22 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 23' ' ' VAL . 53.5 p90 -151.79 152.25 32.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -102.29 160.37 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 169.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p -107.94 146.28 33.15 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.88 -89.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.791 2.994 . . . . 0.0 113.257 -162.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -142.4 -34.97 0.44 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.381 0.991 . . . . 0.0 112.392 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.125 0 C-N-CA 125.787 1.66 . . . . 0.0 110.819 -168.099 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 119.139 -0.458 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.06 160.39 47.59 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.61 2.207 . . . . 0.0 112.805 -171.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.3 mtm -114.7 -39.02 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -170.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG22 ' CB ' ' A' ' 42' ' ' SER . 30.8 m -140.8 155.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.247 0.931 . . . . 0.0 109.521 -178.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 172.02 10.98 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 127.081 2.152 . . . . 0.0 111.108 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HD3' HG13 ' A' ' 99' ' ' VAL . 5.7 Cg_exo -56.6 161.49 9.77 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 120.651 0.9 . . . . 0.0 111.119 167.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.62 -170.51 5.04 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 165.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 151.83 17.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.28 1.038 . . . . 0.0 112.078 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.39 151.69 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.805 1.242 . . . . 0.0 108.009 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.47 158.44 38.34 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.56 1.944 . . . . 0.0 106.575 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.32 115.6 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 170.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -98.8 129.33 45.2 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.079 0.862 . . . . 0.0 109.019 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -79.58 109.99 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 30' ' ' LEU . 3.8 m -78.88 -59.66 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 127.047 2.139 . . . . 0.0 109.0 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -124.58 -176.02 3.42 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.254 1.422 . . . . 0.0 109.914 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -59.87 -58.4 8.72 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.108 -0.995 . . . . 0.0 110.065 161.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 p -89.72 2.08 55.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.91 1.684 . . . . 0.0 113.841 -165.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 26' ' ' VAL . 23.9 tp -135.55 140.96 45.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.009 1.724 . . . . 0.0 107.66 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.43 153.83 45.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -95.25 139.07 32.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.78 139.85 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 169.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.9 146.99 50.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.0 p90 -139.4 166.87 23.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.151 1.38 . . . . 0.0 108.437 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.06 147.59 88.38 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.78 141.36 84.72 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.374 1.382 . . . . 0.0 108.615 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 35.3 m -85.64 159.47 55.3 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.218 159.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.88 148.02 81.58 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.702 2.935 . . . . 0.0 109.444 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' C ' HD22 ' A' ' 40' ' ' LEU 0.276 0.0 OUTLIER -51.17 -27.93 9.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 168.483 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -63.87 -32.97 74.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 117.109 -1.424 . . . . 0.0 112.486 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.486 ' CB ' HG22 ' A' ' 16' ' ' VAL . 77.9 p -74.72 -36.69 62.69 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.373 1.442 . . . . 0.0 109.956 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.518 HD13 ' HB2' ' A' ' 47' ' ' LEU . 21.2 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 108.514 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 80.27 -61.4 0.27 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 129.273 3.029 . . . . 0.0 110.556 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.77 -160.44 17.14 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 126.129 1.823 . . . . 0.0 111.082 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -72.79 121.99 20.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.399 1.08 . . . . 0.0 109.248 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.518 ' HB2' HD13 ' A' ' 43' ' ' ILE . 1.5 tm? -59.94 119.5 7.87 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.743 0.817 . . . . 0.0 109.77 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -78.6 -36.57 44.07 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.09 -175.26 33.15 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -114.09 166.51 11.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -130.27 150.82 51.34 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.411 1.484 . . . . 0.0 107.531 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.2 mt -124.91 124.38 67.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -91.56 138.61 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 165.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.9 p90 -146.78 167.35 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 120.981 1.718 . . . . 0.0 111.366 168.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -149.04 158.03 43.86 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.87 0.868 . . . . 0.0 110.891 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.29 138.15 41.65 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.466 1.106 . . . . 0.0 108.772 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.417 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 11.1 mmtt . . . . . 0 CA--C 1.519 -0.227 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 mm -127.31 159.22 37.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.423 1.489 . . . . 0.0 107.368 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.449 ' CD1' HD13 ' A' ' 84' ' ' LEU . 2.6 mt -136.19 159.17 42.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.174 1.789 . . . . 0.0 108.204 167.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -123.77 141.55 51.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.251 1.82 . . . . 0.0 107.155 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -145.67 104.84 3.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -77.43 175.44 9.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.777 -1.202 . . . . 0.0 109.867 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.28 160.62 5.02 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.651 1.139 . . . . 0.0 113.173 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.5 m -77.32 21.25 0.26 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.196 1.398 . . . . 0.0 113.458 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -48.49 154.59 0.62 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.277 1.031 . . . . 0.0 110.895 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 p -119.43 9.29 11.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.171 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 167.13 24.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.072 0.949 . . . . 0.0 109.062 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.17 -171.1 26.71 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 127.455 2.455 . . . . 0.0 107.505 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -138.28 159.72 41.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 117.963 0.882 . . . . 0.0 110.844 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.9 mm? -112.85 81.6 4.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 127.019 2.127 . . . . 0.0 107.394 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -84.4 155.94 12.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.836 2.357 . . . . 0.0 111.059 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.87 16.47 67.72 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.404 -0.665 . . . . 0.0 112.961 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 93' ' ' TYR . 3.8 mm? -91.7 173.68 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.858 1.263 . . . . 0.0 110.527 -175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.42 144.69 32.84 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.472 -175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.93 176.38 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.976 2.451 . . . . 0.0 113.191 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 38.75 46.49 1.04 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 130.939 3.696 . . . . 0.0 113.933 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 64.1 m -135.09 174.13 10.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.101 1.76 . . . . 0.0 110.67 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -120.84 152.23 38.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.631 1.972 . . . . 0.0 107.106 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.408 ' CE1' HD12 ' A' ' 87' ' ' LEU . 97.2 m-85 -144.33 161.43 38.99 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.056 1.342 . . . . 0.0 111.019 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.4 m -124.15 141.48 52.02 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 161.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.81 153.2 42.99 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.025 1.73 . . . . 0.0 110.137 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.18 129.79 20.23 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -170.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.5 t -89.43 147.32 5.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -145.74 124.08 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.331 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.447 HG13 ' HD3' ' A' ' 18' ' ' PRO . 4.4 m -69.5 152.55 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.414 1.007 . . . . 0.0 109.676 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.13 151.92 25.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.727 1.611 . . . . 0.0 108.352 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -144.68 -171.14 3.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.972 1.309 . . . . 0.0 109.015 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.01 -15.26 78.52 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.996 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -23.77 14.56 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.581 1.552 . . . . 0.0 111.919 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.47 -154.41 25.5 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.858 0.754 . . . . 0.0 111.305 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 173.93 10.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.392 1.477 . . . . 0.0 110.008 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.79 -155.44 6.87 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.693 1.139 . . . . 0.0 112.761 -166.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.57 160.79 41.41 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.689 2.259 . . . . 0.0 110.595 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.99 162.21 13.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.194 1.798 . . . . 0.0 111.462 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 54.1 p -67.58 -176.72 0.28 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.6 0.76 . . . . 0.0 110.335 172.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 19.8 Cg_endo -54.28 129.84 36.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 N-CA-C 108.968 -1.204 . . . . 0.0 108.968 153.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.93 132.49 53.18 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 163.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -115.75 163.46 15.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.443 1.097 . . . . 0.0 109.239 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.49 158.77 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -150.47 151.97 33.52 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.31 141.74 44.45 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.365 1.466 . . . . 0.0 108.008 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.3 p -92.46 157.36 40.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.101 -0.375 . . . . 0.0 111.342 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 75.5 Cg_endo -75.11 171.0 19.17 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.133 2.555 . . . . 0.0 108.178 173.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.97 -35.41 78.4 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 114.863 -162.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.33 0 C-N-CA 125.277 1.418 . . . . 0.0 110.293 174.747 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.47 ' C ' HD21 ' A' ' 101' ' ' ASN . 29.7 mt . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.15 177.29 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.179 1.253 . . . . 0.0 110.0 166.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.1 mtm -134.05 -27.37 1.44 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 42' ' ' SER . 28.5 m -138.59 178.52 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 120.193 1.361 . . . . 0.0 110.101 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.89 162.67 19.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 128.41 2.684 . . . . 0.0 107.626 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.35 151.07 81.87 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 120.863 1.042 . . . . 0.0 109.686 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.31 -94.62 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 125.137 1.351 . . . . 0.0 112.535 -163.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 162.03 13.41 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.5 t -128.97 148.76 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -142.99 152.7 42.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.828 2.051 . . . . 0.0 106.252 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.45 139.13 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 119.975 1.261 . . . . 0.0 110.387 171.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -116.5 145.69 43.13 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 127.398 2.279 . . . . 0.0 107.944 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.62 110.25 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.24 -59.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.642 0.777 . . . . 0.0 108.928 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.277 20.1 p30 -121.12 -105.52 0.38 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.627 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.37 -51.95 1.96 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.695 1.998 . . . . 0.0 109.696 174.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.9 p -101.12 4.32 42.03 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.192 1.397 . . . . 0.0 111.519 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -124.65 122.97 39.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.042 1.737 . . . . 0.0 109.02 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.41 163.38 17.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 109.552 165.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -125.54 115.57 20.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 129.123 2.969 . . . . 0.0 105.994 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.1 t -92.73 145.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.14 146.39 49.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -148.1 155.56 41.59 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -74.0 140.03 76.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.92 155.49 54.73 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.884 2.389 . . . . 0.0 109.374 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.453 HG21 HG11 ' A' ' 99' ' ' VAL . 16.2 m -102.31 157.54 33.5 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 166.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -76.16 153.35 36.35 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 122.753 2.302 . . . . 0.0 109.443 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 43' ' ' ILE . 5.3 mp -61.8 -27.4 68.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.064 0.945 . . . . 0.0 111.174 176.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -44.83 -58.78 2.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.574 1.15 . . . . 0.0 110.906 163.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.616 ' HB2' HG22 ' A' ' 16' ' ' VAL . 81.1 p -61.85 -26.31 68.06 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -171.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 40' ' ' LEU . 24.6 mt -87.76 -17.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.159 1.384 . . . . 0.0 109.996 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 55.45 1.95 0.06 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.38 2.272 . . . . 0.0 115.33 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.87 -155.3 21.6 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 127.817 2.627 . . . . 0.0 107.261 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -74.09 132.81 42.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.267 1.533 . . . . 0.0 111.998 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' HD13 ' A' ' 43' ' ' ILE . 8.6 tt -69.32 125.28 26.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -81.07 -60.35 2.32 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.03 -178.79 39.12 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-O 121.955 0.753 . . . . 0.0 113.663 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -107.83 117.89 35.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.878 . . . . 0.0 106.589 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 92.09 4.92 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.74 123.02 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -92.19 145.62 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 164.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.43 163.71 39.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.777 1.231 . . . . 0.0 110.906 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -148.98 159.68 43.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.989 0.916 . . . . 0.0 110.538 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -68.83 132.22 46.42 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 166.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.8 m . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.638 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 tttp . . . . . 0 C--O 1.237 0.402 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -140.96 111.13 3.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.04 166.78 22.85 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.328 1.451 . . . . 0.0 110.165 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.4 m -126.06 125.75 43.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -135.91 116.45 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -79.24 164.44 24.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.323 0.965 . . . . 0.0 109.008 165.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.12 172.43 3.4 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.533 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -87.48 39.68 0.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.799 -0.701 . . . . 0.0 112.279 -153.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -59.88 167.22 2.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.314 1.446 . . . . 0.0 111.567 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -130.04 8.75 5.22 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.899 1.679 . . . . 0.0 110.626 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -156.35 160.47 39.71 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.418 1.887 . . . . 0.0 106.882 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.71 40.4 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 32.1 mtp -132.53 156.25 47.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 118.728 1.264 . . . . 0.0 110.953 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.57 82.4 4.79 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 126.363 1.865 . . . . 0.0 106.349 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -85.23 154.38 10.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.29 1.993 . . . . 0.0 110.848 165.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 16.8 46.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.344 0.973 . . . . 0.0 112.252 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.402 HD12 ' CE2' ' A' ' 93' ' ' TYR . 4.2 mm? -88.59 -171.56 3.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.097 0.949 . . . . 0.0 109.895 -173.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.46 141.57 41.9 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 128.279 2.632 . . . . 0.0 105.92 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -73.54 -173.91 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.004 3.136 . . . . 0.0 112.097 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 50.69 43.36 27.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.686 2.395 . . . . 0.0 113.032 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.8 m -157.54 163.48 38.34 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.97 0.908 . . . . 0.0 112.107 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -88.5 155.09 19.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.177 1.391 . . . . 0.0 107.678 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.402 ' CE2' HD12 ' A' ' 87' ' ' LEU . 82.8 m-85 -144.68 146.95 32.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.826 1.65 . . . . 0.0 108.766 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 19.7 m -126.75 122.69 35.56 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.618 0.767 . . . . 0.0 109.025 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 158.07 39.22 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.209 1.804 . . . . 0.0 109.453 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.57 164.01 33.0 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.885 1.274 . . . . 0.0 109.555 171.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 t -125.71 142.89 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.807 1.643 . . . . 0.0 106.873 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -149.7 132.32 15.84 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 38' ' ' VAL . 1.3 m -82.2 144.64 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.5 t -135.25 139.87 46.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.245 1.818 . . . . 0.0 106.315 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.47 HD21 ' C ' ' A' ' 13' ' ' LEU . 36.4 p-10 -149.21 -172.47 4.13 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.887 0.875 . . . . 0.0 112.246 -168.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.46 12.19 0.14 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.893 2.187 . . . . 0.0 116.86 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -141.94 -35.59 0.44 Allowed 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.061 1.93 . . . . 0.0 112.102 168.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.31 -154.66 9.61 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 119.165 0.893 . . . . 0.0 112.126 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.92 165.54 17.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.362 1.465 . . . . 0.0 109.976 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.29 -173.43 15.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 125.203 1.383 . . . . 0.0 112.71 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.49 135.86 51.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.363 2.709 . . . . 0.0 109.21 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.75 151.35 34.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.918 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -58.9 172.59 0.52 Allowed Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 124.683 1.193 . . . . 0.0 109.451 169.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -56.1 139.44 85.37 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 152.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.74 160.18 23.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.099 170.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -129.99 168.9 15.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.21 162.87 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.331 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -144.32 143.6 31.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -86.19 166.74 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 p -123.73 159.9 53.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 124.071 0.948 . . . . 0.0 109.737 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.49 161.37 43.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -58.65 -23.11 58.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.609 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 CA-C-O 118.281 -1.288 . . . . 0.0 114.537 163.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.83 172.61 12.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.887 2.392 . . . . 0.0 111.815 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.6 mtm -124.78 -19.03 5.42 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.7 m -144.02 179.37 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 120.392 1.451 . . . . 0.0 111.275 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 107' ' ' PRO . . . -114.56 158.79 39.21 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 129.045 2.938 . . . . 0.0 108.708 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -69.06 144.67 58.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.252 1.968 . . . . 0.0 111.094 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.42 -179.14 52.27 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.414 1.959 . . . . 0.0 113.169 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 t30 2.05 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.539 3.536 . . . . 0.0 114.671 -171.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.95 132.02 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -126.17 153.96 43.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.506 1.923 . . . . 0.0 107.971 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.55 129.68 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.266 1.027 . . . . 0.0 108.743 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -125.21 135.66 52.79 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 125.337 1.455 . . . . 0.0 112.302 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.367 1.0 OUTLIER -84.73 128.85 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 123.113 1.435 . . . . 0.0 111.753 174.486 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.73 -40.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 128.18 2.592 . . . . 0.0 109.529 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 77.5 m-20 -138.24 -179.91 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.714 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.46 88.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.668 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.8 p -114.63 4.77 15.2 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.137 1.375 . . . . 0.0 112.759 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 17.3 tp -132.27 137.31 47.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.293 1.837 . . . . 0.0 108.328 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -131.51 170.34 14.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.921 1.288 . . . . 0.0 109.372 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -128.88 139.88 51.94 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.6 t -114.54 143.57 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -129.17 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.769 1.628 . . . . 0.0 107.265 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -150.14 151.65 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.786 1.234 . . . . 0.0 108.363 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -69.39 146.18 96.23 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.674 -0.641 . . . . 0.0 110.485 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.76 131.08 29.86 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 108.449 162.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 m -76.11 160.03 79.11 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.57 144.66 67.46 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.526 2.151 . . . . 0.0 109.275 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -26.2 68.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.529 -0.732 . . . . 0.0 111.027 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -55.93 -32.6 63.94 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 118.297 -0.858 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.691 ' HB2' HG22 ' A' ' 16' ' ' VAL . 87.4 p -72.32 -32.29 66.42 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 119.273 0.942 . . . . 0.0 111.642 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mt -75.77 -30.63 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.206 1.002 . . . . 0.0 109.994 -164.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 45.84 34.79 2.0 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.027 2.131 . . . . 0.0 112.81 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.77 -133.25 1.82 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -171.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.91 121.06 22.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.8 tp -52.01 118.08 3.21 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -79.88 -51.83 8.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.57 -170.22 40.34 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -106.09 157.6 17.42 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 163.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -123.91 144.5 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 169.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.5 mt -118.46 126.57 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -92.07 144.94 24.92 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 160.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 35.7 p90 -155.44 159.3 39.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.0 0.92 . . . . 0.0 110.987 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.77 155.51 40.25 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -68.52 130.53 43.12 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.711 1.604 . . . . 0.0 107.636 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.0 m . . . . . 0 C--N 1.325 -0.484 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.219 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt . . . . . 0 CA--C 1.51 -0.563 0 CA-C-O 121.562 0.696 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.24 149.43 33.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -138.55 145.52 40.77 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.593 1.957 . . . . 0.0 107.668 -173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 m -129.87 119.04 22.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.206 1.002 . . . . 0.0 108.694 -163.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -128.87 88.22 2.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.891 1.277 . . . . 0.0 108.401 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -69.3 173.51 5.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.852 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 -178.01 18.66 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.891 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -85.79 11.33 11.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -161.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -56.77 149.35 18.32 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 125.033 1.333 . . . . 0.0 112.307 -166.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -112.66 9.51 19.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.669 1.187 . . . . 0.0 111.312 175.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.92 160.61 43.46 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.059 1.343 . . . . 0.0 109.356 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.67 143.13 8.97 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.7 mtp -86.26 146.98 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.258 0.529 . . . . 0.0 109.818 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.532 HD12 HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -106.8 94.53 10.6 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 126.687 1.995 . . . . 0.0 105.963 174.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -92.12 167.21 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.7 2.933 . . . . 0.0 112.175 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.96 19.96 74.12 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.681 -0.637 . . . . 0.0 112.79 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 84' ' ' LEU . 3.9 mm? -85.23 168.67 14.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.651 0.781 . . . . 0.0 109.069 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.87 131.64 22.03 Favored Pre-proline 0 N--CA 1.432 -1.327 0 C-N-CA 126.092 1.757 . . . . 0.0 107.348 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -74.52 162.92 37.16 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.963 1.775 . . . . 0.0 111.529 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.6 t80 50.63 40.5 24.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.127 1.371 . . . . 0.0 112.134 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -136.14 158.82 43.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.269 1.427 . . . . 0.0 110.686 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -94.45 153.73 17.79 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -148.21 154.21 39.79 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.922 1.289 . . . . 0.0 110.017 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.9 m -126.21 149.78 48.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.867 1.667 . . . . 0.0 107.521 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.0 158.48 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.596 2.358 . . . . 0.0 110.488 171.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.05 145.13 29.57 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.683 1.193 . . . . 0.0 110.648 168.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.61 151.06 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.249 1.82 . . . . 0.0 108.496 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -144.76 133.5 22.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -73.94 151.41 7.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.91 136.37 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -134.69 -173.51 3.31 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.729 2.012 . . . . 0.0 107.031 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.85 13.44 13.4 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.033 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -123.07 -54.69 1.81 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.67 1.588 . . . . 0.0 110.037 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.09 48.94 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.039 0.836 . . . . 0.0 111.942 -173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -83.66 154.76 23.52 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.593 0.711 . . . . 0.0 110.702 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -100.82 -171.08 28.86 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.877 1.227 . . . . 0.0 112.349 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 40.3 Cg_endo -65.18 137.99 54.33 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.945 1.764 . . . . 0.0 108.751 170.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.63 161.19 29.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 60.3 p -62.97 178.53 0.35 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.487 1.115 . . . . 0.0 108.943 172.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 94.4 Cg_endo -61.49 155.52 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 107.346 -1.828 . . . . 0.0 107.346 157.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.27 151.79 46.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.688 1.232 . . . . 0.0 108.926 162.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -124.74 161.82 25.58 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.2 150.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.474 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.79 165.26 30.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -135.66 144.03 45.8 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.013 2.125 . . . . 0.0 107.289 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.8 p -110.59 153.32 43.62 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.085 0.554 . . . . 0.0 110.548 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.4 -68.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.757 2.304 . . . . 0.0 113.131 -152.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -163.41 -41.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.32 1.448 . . . . 0.0 109.848 168.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.728 0 C-N-CA 126.073 1.797 . . . . 0.0 113.673 175.26 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 118.342 -0.837 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.81 158.75 23.29 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.641 2.227 . . . . 0.0 112.632 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtm -121.5 -31.59 4.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.321 1.049 . . . . 0.0 113.545 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 42' ' ' SER . 31.0 m -140.96 158.05 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.825 0.739 . . . . 0.0 111.666 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.8 159.99 31.19 Favored Pre-proline 0 N--CA 1.444 -0.754 0 C-N-CA 130.021 3.329 . . . . 0.0 111.928 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.35 141.59 35.66 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.34 2.026 . . . . 0.0 111.403 -175.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.05 166.73 51.98 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.546 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.0 t30 49.35 54.55 10.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.619 1.567 . . . . 0.0 112.737 154.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.67 128.8 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.784 1.234 . . . . 0.0 109.296 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 116.13 9.04 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.235 1.814 . . . . 0.0 110.476 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -107.99 138.05 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.163 0.985 . . . . 0.0 108.937 -175.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -124.12 124.93 43.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.126 2.171 . . . . 0.0 110.36 -175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.59 102.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.69 ' HB ' HD12 ' A' ' 30' ' ' LEU . 73.9 t -72.65 -48.98 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -138.25 -179.03 5.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 122.271 1.034 . . . . 0.0 109.03 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -35.49 80.62 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.258 -0.901 . . . . 0.0 111.686 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -119.34 17.56 13.02 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.309 1.044 . . . . 0.0 111.363 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.82 HD11 ' CE ' ' A' ' 83' ' ' MET . 3.1 tm? -139.32 137.99 36.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.501 1.92 . . . . 0.0 108.628 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.529 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -136.02 150.62 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -108.4 143.72 36.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.788 2.035 . . . . 0.0 107.046 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.04 119.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -108.34 152.96 23.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -154.12 163.52 39.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.942 0.897 . . . . 0.0 109.594 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -80.3 140.93 52.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.12 140.89 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.712 2.275 . . . . 0.0 108.49 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.11 156.59 79.25 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 164.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.29 147.01 17.98 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.611 2.874 . . . . 0.0 109.841 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.64 -29.06 64.27 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -50.58 -50.31 54.13 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.343 0.519 . . . . 0.0 110.939 168.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.736 ' HB2' HG22 ' A' ' 16' ' ' VAL . 71.8 p -59.74 -37.98 80.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.417 0.553 . . . . 0.0 112.259 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.508 HD13 ' HB2' ' A' ' 47' ' ' LEU . 15.4 mt -70.42 -23.41 24.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.799 -169.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.54 -14.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.572 2.349 . . . . 0.0 115.82 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.03 -163.74 12.34 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.72 3.057 . . . . 0.0 108.55 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -77.96 117.6 19.45 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.803 0.841 . . . . 0.0 111.695 -174.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.508 ' HB2' HD13 ' A' ' 43' ' ' ILE . 36.2 tp -57.3 133.48 55.15 Favored 'General case' 0 CA--C 1.523 -0.07 0 C-N-CA 125.698 1.599 . . . . 0.0 109.987 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -103.72 -23.41 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.201 1.4 . . . . 0.0 110.455 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.82 -164.75 30.45 Favored Glycine 0 C--O 1.239 0.437 0 O-C-N 120.95 -1.094 . . . . 0.0 112.013 167.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.39 141.14 46.47 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.557 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -121.83 97.09 5.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.4 mt -77.95 120.63 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -91.67 141.55 28.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 164.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.557 ' CD2' HD11 ' A' ' 84' ' ' LEU . 41.4 p90 -151.25 166.08 32.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.751 0.82 . . . . 0.0 110.566 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -149.46 159.14 44.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -68.95 136.6 52.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 m . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.131 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt . . . . . 0 C--O 1.24 0.566 0 CA-C-O 120.435 0.159 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.74 149.67 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 128.275 2.63 . . . . 0.0 104.622 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -133.02 161.09 35.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.122 1.769 . . . . 0.0 109.123 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -131.18 121.77 25.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.798 1.181 . . . . 0.0 111.85 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -136.99 115.26 11.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 163.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -80.98 162.51 23.82 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.325 0.583 . . . . 0.0 110.227 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.65 -173.32 21.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.152 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.06 13.98 0.47 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.552 1.941 . . . . 0.0 115.106 -168.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -51.73 147.85 6.2 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.673 1.189 . . . . 0.0 112.036 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.9 p -109.4 5.37 23.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 111.983 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.13 159.43 43.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.883 0.873 . . . . 0.0 109.966 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.15 170.07 30.83 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 126.697 2.094 . . . . 0.0 108.139 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.82 ' CE ' HD11 ' A' ' 30' ' ' LEU . 59.9 mtp -138.37 143.94 40.06 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.282 1.041 . . . . 0.0 110.892 -166.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 54' ' ' TYR . 4.0 mm? -110.33 84.95 4.12 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 127.507 2.323 . . . . 0.0 108.665 -173.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.63 156.75 3.54 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.413 2.742 . . . . 0.0 112.741 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.94 40.76 98.6 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.929 0.776 . . . . 0.0 111.406 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.487 HD12 ' CE2' ' A' ' 93' ' ' TYR . 4.0 mm? -96.1 165.88 12.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.754 1.621 . . . . 0.0 108.536 173.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.77 144.6 30.58 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.56 172.27 12.74 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.305 2.67 . . . . 0.0 111.962 165.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.25 0.3 OUTLIER 45.41 34.75 1.65 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.371 2.668 . . . . 0.0 114.063 172.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.19 -175.81 2.93 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.245 2.218 . . . . 0.0 109.554 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -124.64 154.28 40.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CE2' HD12 ' A' ' 87' ' ' LEU . 81.8 m-85 -145.65 158.71 43.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.854 0.461 . . . . 0.0 109.945 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.3 m -126.45 140.84 52.16 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.47 154.27 47.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.934 2.094 . . . . 0.0 108.991 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.22 166.28 25.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.572 1.549 . . . . 0.0 107.933 166.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.2 147.39 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -139.07 121.31 15.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 111.527 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.43 136.54 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.176 1.39 . . . . 0.0 107.263 172.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.83 143.99 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -131.89 -173.78 3.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.805 2.042 . . . . 0.0 107.601 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.11 92.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.575 0.625 . . . . 0.0 112.052 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -36.13 80.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.89 0.845 . . . . 0.0 111.663 176.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.37 -143.24 10.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 119.358 0.981 . . . . 0.0 111.074 -174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -120.59 173.79 6.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.391 1.076 . . . . 0.0 112.354 -165.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.74 -162.36 9.09 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.293 1.425 . . . . 0.0 111.422 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.97 145.18 84.95 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.832 3.021 . . . . 0.0 111.668 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.99 157.64 34.63 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.387 1.075 . . . . 0.0 110.566 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.3 p -61.06 174.96 0.49 Allowed Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.127 162.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -51.35 148.4 19.4 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.498 0.798 . . . . 0.0 110.812 154.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.59 144.64 52.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 164.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -130.07 171.21 13.06 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.215 1.806 . . . . 0.0 108.514 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.49 164.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.982 1.313 . . . . 0.0 108.816 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 23' ' ' VAL . 41.4 p90 -153.47 148.25 26.41 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.336 1.854 . . . . 0.0 107.219 159.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -86.77 168.12 13.8 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 158.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.0 p -117.53 162.36 28.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 163.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.2 -83.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.272 1.982 . . . . 0.0 113.576 -155.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -142.54 -53.46 0.41 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.304 1.042 . . . . 0.0 109.649 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.357 0 C-N-CA 123.412 0.53 . . . . 0.0 112.372 -179.813 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 118.772 -0.632 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -67.32 170.63 13.03 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.746 2.298 . . . . 0.0 114.272 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.5 mtm -122.35 -39.93 2.53 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 127.06 2.144 . . . . 0.0 111.041 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.757 HG22 ' HB2' ' A' ' 42' ' ' SER . 23.6 m -136.51 150.42 27.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 119.133 0.879 . . . . 0.0 111.755 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.96 168.53 22.3 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 128.426 2.69 . . . . 0.0 110.248 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.47 166.64 16.89 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 121.691 1.594 . . . . 0.0 114.048 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.49 -163.04 1.4 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.625 2.059 . . . . 0.0 112.788 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -58.08 106.33 0.36 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.628 1.171 . . . . 0.0 109.198 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.81 141.6 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.209 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -124.12 152.06 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.94 132.75 14.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -124.05 128.91 50.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 125.016 1.326 . . . . 0.0 110.022 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.297 0.7 OUTLIER -88.46 115.89 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.093 0.949 . . . . 0.0 110.473 -175.874 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.63 ' HB ' HD12 ' A' ' 30' ' ' LEU . 93.5 t -79.27 -35.21 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.392 -169.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -156.35 -173.25 4.41 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 109.413 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -17.96 64.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -171.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.9 p -128.71 6.21 5.59 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.435 1.494 . . . . 0.0 111.122 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.723 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.2 tm? -142.7 142.27 31.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.421 1.088 . . . . 0.0 110.097 -169.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -137.78 162.32 34.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -117.31 121.0 39.94 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -97.98 144.17 11.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -133.33 144.97 49.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.925 1.69 . . . . 0.0 107.592 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -148.31 173.07 13.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.029 1.332 . . . . 0.0 108.385 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -90.03 144.42 31.32 Favored Pre-proline 0 C--O 1.234 0.289 0 O-C-N 121.761 -0.587 . . . . 0.0 109.845 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.93 112.14 3.03 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.402 2.735 . . . . 0.0 109.104 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.22 159.17 62.75 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 150.65 18.93 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.536 2.824 . . . . 0.0 112.077 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.565 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -58.39 -35.77 72.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.909 1.284 . . . . 0.0 109.763 175.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -60.02 -25.85 65.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 117.171 -1.395 . . . . 0.0 114.234 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.757 ' HB2' HG22 ' A' ' 16' ' ' VAL . 76.0 p -93.11 -20.77 20.18 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 120.743 1.61 . . . . 0.0 111.673 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 40' ' ' LEU . 62.8 mt -63.23 -40.2 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 166.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 56.61 -3.24 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.616 2.767 . . . . 0.0 115.188 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 -166.56 12.73 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 125.466 1.507 . . . . 0.0 109.394 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -87.68 107.86 18.83 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.391 -0.476 . . . . 0.0 109.919 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' A' ' 43' ' ' ILE . 14.1 tp -48.81 130.48 17.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.016 1.327 . . . . 0.0 107.956 172.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -84.73 -62.16 1.61 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 76' ' ' GLN . . . -174.19 -165.15 30.34 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.34 160.57 14.19 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -134.95 99.44 4.29 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.601 -0.687 . . . . 0.0 109.2 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.7 mt -77.89 119.01 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.573 1.549 . . . . 0.0 107.019 170.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -91.74 149.64 21.51 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 39.8 p90 -154.24 164.82 37.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.521 1.51 . . . . 0.0 111.546 170.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -148.65 159.19 44.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.854 1.262 . . . . 0.0 111.197 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.64 138.32 54.92 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m . . . . . 0 C--N 1.325 -0.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.816 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 2.3 mttp . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.0 mm -141.79 161.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.46 1.904 . . . . 0.0 107.199 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.504 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -154.94 108.88 2.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.736 1.214 . . . . 0.0 110.024 177.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -81.92 135.43 35.4 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.273 1.429 . . . . 0.0 111.257 -163.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -137.11 97.54 3.52 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.42 ' HA ' ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -76.52 173.19 11.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.777 0.831 . . . . 0.0 110.865 175.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.81 175.43 46.33 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 121.964 0.758 . . . . 0.0 111.685 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.5 p -83.52 27.02 0.63 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.796 1.638 . . . . 0.0 112.748 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -60.38 164.95 3.93 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.932 1.349 . . . . 0.0 112.295 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.444 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 15.6 p -127.55 -0.94 6.19 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.762 2.025 . . . . 0.0 110.768 -174.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -152.14 163.45 39.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.06 1.344 . . . . 0.0 108.465 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.66 172.8 34.99 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 127.568 2.509 . . . . 0.0 107.92 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.723 ' HE2' HD11 ' A' ' 30' ' ' LEU . 77.5 mtp -115.09 159.01 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.583 1.191 . . . . 0.0 109.972 -172.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.7 mm? -121.44 77.27 35.36 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 108.877 168.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -86.07 149.06 9.38 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.503 2.802 . . . . 0.0 110.892 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.46 26.74 9.05 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.737 0.684 . . . . 0.0 112.043 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.434 HD21 HD12 ' A' ' 84' ' ' LEU . 2.3 mm? -109.59 171.08 7.66 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 126.258 1.823 . . . . 0.0 108.02 -173.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -115.25 144.77 32.87 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.896 0.878 . . . . 0.0 110.311 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -70.39 169.21 20.25 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.719 2.946 . . . . 0.0 113.059 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 35.88 51.12 0.71 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.819 2.448 . . . . 0.0 111.048 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 m -129.91 -179.69 5.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 108.528 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -130.14 143.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -136.35 168.2 19.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -126.12 142.6 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 153.85 49.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.452 1.501 . . . . 0.0 109.977 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.25 129.92 21.52 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.625 1.17 . . . . 0.0 109.281 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.49 162.17 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -152.55 161.3 42.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -106.57 146.91 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.09 139.68 41.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -134.1 178.87 6.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.324 0.65 . . . . 0.0 110.295 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.28 -40.14 52.36 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.015 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -73.11 -50.92 20.05 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.95 0.875 . . . . 0.0 111.865 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.4 -167.36 40.03 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -163.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -94.79 170.29 9.55 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 111.078 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.44 -154.29 6.96 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 167.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.0 152.67 79.89 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.505 2.137 . . . . 0.0 112.714 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.49 155.68 24.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.597 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.7 p -67.9 175.77 1.59 Allowed Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.371 1.068 . . . . 0.0 109.679 169.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -53.57 143.34 56.94 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 120.643 0.896 . . . . 0.0 109.857 155.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.66 155.56 37.63 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.3 mmt-85 -136.46 165.39 25.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 120.981 -1.075 . . . . 0.0 108.839 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.42 151.74 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.68 126.12 6.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.832 1.653 . . . . 0.0 107.491 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -88.94 146.95 24.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 p -87.65 156.36 53.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 123.392 0.433 . . . . 0.0 110.215 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.42 ' HD3' ' CG2' ' A' ' 25' ' ' VAL . 17.9 Cg_endo -63.7 -80.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.698 2.932 . . . . 0.0 112.576 -166.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -156.29 -28.09 0.1 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.217 0 C-N-CA 124.491 1.043 . . . . 0.0 111.573 -176.48 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.0 mt . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 119.036 -0.506 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.76 139.59 25.14 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.32 2.013 . . . . 0.0 111.634 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.9 mtm -92.0 -38.13 12.42 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.993 1.317 . . . . 0.0 113.152 -172.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.65 HG22 ' HB2' ' A' ' 42' ' ' SER . 24.4 m -133.83 174.83 12.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 118.624 0.647 . . . . 0.0 110.382 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 107' ' ' PRO . . . -118.26 162.86 27.89 Favored Pre-proline 0 N--CA 1.441 -0.889 0 C-N-CA 128.449 2.7 . . . . 0.0 108.612 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 46.1 Cg_endo -66.18 161.48 40.08 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.837 2.358 . . . . 0.0 111.368 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.64 -147.45 0.41 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.617 2.532 . . . . 0.0 114.3 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.9 91.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.922 1.689 . . . . 0.0 108.79 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.38 155.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.131 1.372 . . . . 0.0 108.725 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -132.43 163.57 28.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.973 1.709 . . . . 0.0 106.939 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.6 144.91 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -123.8 136.16 54.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.511 2.724 . . . . 0.0 108.204 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' HD3' ' A' ' 117' ' ' PRO . 71.5 t -92.94 102.03 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 m -71.45 -58.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.801 1.64 . . . . 0.0 109.507 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -131.76 -173.85 3.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.8 1.24 . . . . 0.0 110.907 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.32 95.14 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.012 -1.055 . . . . 0.0 113.635 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 p -129.23 12.41 6.04 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.614 0.766 . . . . 0.0 111.243 -169.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 tp -121.12 132.73 55.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 169.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . . . -125.49 165.65 18.08 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 168.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -135.42 139.54 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 142.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -136.33 122.62 20.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.555 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -124.83 -178.47 4.17 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.05 1.74 . . . . 0.0 109.796 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.76 135.44 19.54 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.818 1.247 . . . . 0.0 109.332 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 100.48 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.469 2.78 . . . . 0.0 110.134 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.6 m -65.49 162.36 42.92 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.982 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.06 150.02 86.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.126 2.551 . . . . 0.0 110.928 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.77 -25.32 68.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 167.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -57.2 -51.22 70.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.313 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.65 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.2 p -66.55 -34.09 77.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.092 0.86 . . . . 0.0 110.384 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.0 mt -66.46 -23.79 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.039 0.936 . . . . 0.0 110.413 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.26 19.1 mtp180 60.12 -13.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 129.324 3.05 . . . . 0.0 116.44 -173.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.53 -94.24 0.1 Allowed Glycine 0 CA--C 1.518 0.222 0 CA-C-N 120.351 1.432 . . . . 0.0 110.902 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -125.41 133.79 52.37 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.517 1.527 . . . . 0.0 109.824 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.1 tp -70.83 118.73 13.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -70.69 -50.89 31.71 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.01 -173.38 42.89 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -112.81 127.27 56.12 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.932 0.893 . . . . 0.0 109.032 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -103.44 118.86 37.72 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mt -92.94 127.48 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -92.06 154.88 18.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 159.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -159.63 164.03 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.147 1.379 . . . . 0.0 111.498 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -148.6 160.34 43.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.265 -0.897 . . . . 0.0 111.312 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -69.19 138.5 54.14 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 107.93 171.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.8 m . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 177.937 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tttt . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.24 153.73 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.473 ' CD1' HD13 ' A' ' 84' ' ' LEU . 2.1 mt -135.04 152.51 51.77 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.663 2.385 . . . . 0.0 108.699 166.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.8 m -126.66 104.02 7.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.049 1.34 . . . . 0.0 109.048 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -104.17 98.29 8.12 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -74.17 169.43 17.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.17 -179.33 53.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 124.386 0.993 . . . . 0.0 111.205 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -81.31 -1.71 46.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -170.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 149.06 20.63 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.499 0.666 . . . . 0.0 112.427 -168.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -108.45 2.31 22.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 111.914 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.19 164.38 30.23 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.5 -0.75 . . . . 0.0 109.758 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.16 161.41 33.94 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -173.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 43.3 mtp -117.94 152.61 35.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.703 1.251 . . . . 0.0 111.732 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . 3.2 mm? -109.97 84.98 3.8 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 127.63 2.372 . . . . 0.0 106.961 -178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -84.58 160.79 12.56 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.41 2.74 . . . . 0.0 110.754 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.86 8.94 81.84 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.469 -0.628 . . . . 0.0 112.844 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 84' ' ' LEU . 2.4 mm? -80.03 -179.0 6.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.652 1.581 . . . . 0.0 108.996 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -123.03 150.82 60.28 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 122.999 0.52 . . . . 0.0 110.383 171.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.55 172.24 9.51 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.827 2.351 . . . . 0.0 111.683 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.3 t80 45.58 36.4 2.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.821 2.848 . . . . 0.0 113.258 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.9 m -133.34 164.51 26.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.029 1.732 . . . . 0.0 110.108 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -100.4 152.38 20.42 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -139.37 152.17 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.7 m -127.14 134.65 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 153.5 38.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.082 1.753 . . . . 0.0 110.761 -170.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 124.25 6.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.549 1.14 . . . . 0.0 110.435 -162.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.52 131.41 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 108.518 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -125.13 131.72 53.21 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.611 -1.306 . . . . 0.0 109.812 171.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.57 153.7 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.97 147.04 28.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -133.87 -174.91 3.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.692 1.197 . . . . 0.0 109.181 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.05 -3.56 6.42 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.667 -1.629 . . . . 0.0 115.114 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -117.33 -30.99 5.42 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 120.315 2.057 . . . . 0.0 111.553 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.73 -173.53 44.52 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 119.409 1.004 . . . . 0.0 113.971 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -86.64 144.22 27.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.373 1.069 . . . . 0.0 109.796 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -89.2 -168.77 43.95 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.141 0.877 . . . . 0.0 111.96 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 44.4 Cg_endo -63.86 152.4 80.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.057 2.505 . . . . 0.0 111.064 169.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.23 139.45 42.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.602 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . 8.6 t -63.41 171.04 2.37 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.114 1.366 . . . . 0.0 108.644 158.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.39 155.7 36.69 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.151 2.567 . . . . 0.0 110.193 -169.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.12 110.04 9.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.6 171.05 14.48 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 170.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.82 161.8 26.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.56 0.744 . . . . 0.0 110.549 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.82 161.17 42.9 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.88 1.672 . . . . 0.0 109.081 167.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -128.55 128.77 44.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.759 2.023 . . . . 0.0 107.523 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.5 p -87.22 160.5 48.59 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.111 0.564 . . . . 0.0 110.503 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.418 ' HD3' HG11 ' A' ' 25' ' ' VAL . 68.7 Cg_endo -79.13 172.04 15.39 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.991 3.127 . . . . 0.0 109.039 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.08 -31.49 67.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -167.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.26 0 C-N-CA 124.272 0.939 . . . . 0.0 111.371 178.562 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 119.561 3.171 . . . . 0.0 119.561 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.39 155.35 55.62 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.211 1.94 . . . . 0.0 111.595 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.7 mtp -111.9 -33.96 6.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -160.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.654 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.2 m -140.47 178.57 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.003 0.82 . . . . 0.0 110.587 -165.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.04 145.93 41.03 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 127.663 2.385 . . . . 0.0 109.838 -173.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -72.2 125.88 11.23 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.187 1.925 . . . . 0.0 109.149 174.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.11 -172.09 43.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 123.972 0.796 . . . . 0.0 111.667 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.9 t30 40.31 58.49 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.563 2.345 . . . . 0.0 110.681 172.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.69 142.98 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.35 100.42 2.88 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.563 -0.711 . . . . 0.0 109.924 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.25 134.87 47.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -171.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -124.28 135.26 53.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.833 1.653 . . . . 0.0 109.89 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.2 102.34 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 118.837 0.744 . . . . 0.0 109.764 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.56 -56.76 11.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.768 2.027 . . . . 0.0 111.121 -177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -126.32 173.78 9.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.447 1.499 . . . . 0.0 107.531 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -30.14 69.51 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.066 -1.021 . . . . 0.0 112.635 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -120.7 10.42 11.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.531 1.132 . . . . 0.0 113.078 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -133.36 117.23 17.04 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.863 1.665 . . . . 0.0 109.597 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.57 166.06 11.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.35 148.04 36.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.754 2.422 . . . . 0.0 107.956 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 44.5 t -127.76 114.94 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -92.78 157.59 16.34 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.394 1.059 . . . . 0.0 109.249 166.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -149.76 177.43 9.8 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.168 2.187 . . . . 0.0 109.601 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -104.5 133.86 19.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.388 0.675 . . . . 0.0 110.785 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 107.96 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 125.185 3.923 . . . . 0.0 110.664 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 m -57.51 155.47 19.99 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 119.259 -0.401 . . . . 0.0 110.396 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -59.35 131.55 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.917 2.411 . . . . 0.0 108.245 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.09 -32.88 62.34 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.124 0.875 . . . . 0.0 112.138 -173.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -49.59 -41.8 42.86 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.69 1.196 . . . . 0.0 111.911 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.654 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.9 p -66.22 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.861 0.865 . . . . 0.0 112.777 -174.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.74 -34.0 65.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.125 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 42.57 57.89 3.31 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 111.706 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.08 -168.64 28.86 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -77.36 128.23 33.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 49' ' ' GLY . 2.6 tt -60.98 108.49 0.88 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.995 1.318 . . . . 0.0 107.491 172.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' A' ' 48' ' ' GLN . 2.7 mm-40 -85.2 -21.25 29.22 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.522 -0.736 . . . . 0.0 112.04 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.404 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 150.32 -168.89 30.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.679 1.133 . . . . 0.0 110.945 170.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -124.16 118.27 26.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -96.05 130.92 42.94 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.35 119.76 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -91.16 145.36 24.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 50.9 p90 -156.67 166.0 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 120.202 1.364 . . . . 0.0 110.692 173.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -148.41 153.48 38.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.774 0.829 . . . . 0.0 111.217 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -68.73 128.35 36.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 C--N 1.326 -0.418 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.23 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.6 mttt . . . . . 0 C--O 1.233 0.223 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.4 mm -135.13 163.08 37.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.485 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -140.67 155.46 46.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.752 1.621 . . . . 0.0 108.355 167.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -116.55 120.74 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.108 1.363 . . . . 0.0 107.613 -165.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -130.32 150.1 51.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -76.38 -175.49 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.908 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.7 53.83 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 122.628 1.127 . . . . 0.0 112.125 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.6 p 59.57 -23.42 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.768 3.627 . . . . 0.0 118.786 173.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 150.23 12.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.844 0.83 . . . . 0.0 109.237 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 p -110.9 14.25 22.1 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.139 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -155.47 162.21 40.79 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.949 0.9 . . . . 0.0 112.385 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.56 -174.67 26.6 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 128.246 2.831 . . . . 0.0 108.169 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 mtp -131.98 166.55 21.43 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.512 1.156 . . . . 0.0 110.017 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.485 HD13 ' CD1' ' A' ' 73' ' ' LEU . 1.8 mm? -122.5 85.36 48.26 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 125.272 1.429 . . . . 0.0 107.29 168.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.39 146.16 6.12 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.283 3.322 . . . . 0.0 111.46 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.51 18.71 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.628 0.632 . . . . 0.0 113.148 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD12 ' A' ' 84' ' ' LEU . 3.1 mm? -92.44 177.63 6.07 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.869 0.868 . . . . 0.0 109.081 -165.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.52 147.94 43.05 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 125.08 1.352 . . . . 0.0 108.32 171.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -74.06 164.48 34.3 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.501 2.134 . . . . 0.0 112.292 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.4 t80 61.2 22.81 13.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.678 1.991 . . . . 0.0 112.794 170.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -120.22 162.5 19.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.084 1.354 . . . . 0.0 111.414 167.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.08 150.7 23.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.182 2.193 . . . . 0.0 107.145 168.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -137.24 156.26 48.51 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.24 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.3 m -125.89 135.46 51.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -139.36 154.37 47.84 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.918 1.687 . . . . 0.0 109.358 178.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -138.62 157.26 46.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.89 152.82 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -147.95 145.27 28.52 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.01 147.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.07 146.84 26.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -132.95 -178.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.729 0.812 . . . . 0.0 110.886 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.51 50.4 2.1 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.792 1.187 . . . . 0.0 111.919 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -157.98 -52.79 0.07 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.146 2.178 . . . . 0.0 107.629 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.13 -172.05 36.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.538 0.608 . . . . 0.0 113.294 -171.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -97.44 161.59 13.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.249 1.02 . . . . 0.0 112.767 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.39 -170.58 14.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.855 1.216 . . . . 0.0 113.493 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.55 141.31 45.73 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 124.159 3.239 . . . . 0.0 111.365 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.85 41.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.387 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.4 p -60.54 169.99 1.57 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 164.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -54.32 145.81 53.99 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 108.646 -1.328 . . . . 0.0 108.646 156.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.33 104.55 10.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -80.93 168.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.247 1.819 . . . . 0.0 108.889 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.18 161.24 28.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 122.1 -0.375 . . . . 0.0 110.307 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -159.02 129.36 5.86 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 110.975 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -86.06 139.43 31.15 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 p -94.26 145.28 29.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 -77.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.269 2.646 . . . . 0.0 112.489 -159.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -159.7 -28.98 0.06 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.666 -0.646 . . . . 0.0 111.195 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.324 0 C-N-CA 125.435 1.493 . . . . 0.0 109.481 -178.71 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt . . . . . 0 C--O 1.237 0.421 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 56.8 Cg_endo -80.45 170.09 16.35 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.939 3.093 . . . . 0.0 112.594 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.8 mtm -132.78 -31.38 1.33 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -161.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG22 ' CB ' ' A' ' 42' ' ' SER . 26.1 m -139.48 147.17 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 121.145 1.793 . . . . 0.0 109.818 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.607 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -87.04 169.12 15.48 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.921 1.289 . . . . 0.0 109.91 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.607 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 37.2 Cg_endo -74.79 162.32 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.095 1.863 . . . . 0.0 111.81 -168.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.25 166.81 52.9 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -31.41 104.51 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.517 2.327 . . . . 0.0 114.273 -160.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.81 142.98 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -122.3 160.14 25.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.681 1.992 . . . . 0.0 106.985 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.602 HG21 ' CD2' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -147.03 145.73 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.009 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -123.43 128.32 49.66 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.217 1.807 . . . . 0.0 108.444 172.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.5 103.1 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 170.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.575 ' HB ' HD12 ' A' ' 30' ' ' LEU . 57.4 t -67.32 -48.3 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.409 0.683 . . . . 0.0 109.734 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -143.12 -178.24 5.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.176 1.39 . . . . 0.0 108.013 -174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -38.87 92.37 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.893 -1.129 . . . . 0.0 111.959 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 p -112.8 6.06 17.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.262 1.425 . . . . 0.0 112.098 -171.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.686 HD11 ' CE ' ' A' ' 83' ' ' MET . 2.5 tm? -134.48 137.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.959 1.703 . . . . 0.0 108.691 -177.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.423 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -135.91 161.29 36.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -119.88 128.59 53.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.39 2.276 . . . . 0.0 106.396 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.28 141.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -147.6 159.68 43.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.029 1.286 . . . . 0.0 109.473 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.55 142.66 89.2 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.3 113.08 2.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.242 2.628 . . . . 0.0 109.049 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.628 HG22 ' HD2' ' A' ' 39' ' ' PRO . 4.9 p -71.94 149.19 92.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.036 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' HG22 ' A' ' 38' ' ' VAL . 37.2 Cg_endo -70.7 137.66 33.19 Favored 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.567 4.178 . . . . 0.0 108.841 -170.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.17 -28.7 59.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.688 0.677 . . . . 0.0 112.043 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -57.72 -42.42 83.76 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.522 173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.482 ' CB ' HG22 ' A' ' 16' ' ' VAL . 86.2 p -68.39 -28.65 67.28 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.01 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.9 -40.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 C-N-CA 124.247 1.019 . . . . 0.0 108.455 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 65.12 -70.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.499 1.92 . . . . 0.0 112.294 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.61 -169.82 1.5 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.705 2.098 . . . . 0.0 111.802 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -80.82 138.72 36.24 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.735 0.814 . . . . 0.0 109.847 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.451 HD22 ' H ' ' A' ' 49' ' ' GLY . 2.2 tm? -61.05 127.58 32.23 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.319 1.048 . . . . 0.0 108.764 174.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -98.75 -23.52 15.39 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.727 0.811 . . . . 0.0 111.985 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.451 ' H ' HD22 ' A' ' 47' ' ' LEU . . . 132.8 -155.73 21.75 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -169.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -128.53 156.28 43.53 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.621 1.168 . . . . 0.0 107.99 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.59 109.72 12.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mt -85.42 141.78 14.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -118.41 117.68 29.69 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.96 1.704 . . . . 0.0 108.932 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.515 ' CD2' HD11 ' A' ' 84' ' ' LEU . 26.5 p90 -133.43 160.63 36.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.429 1.013 . . . . 0.0 112.444 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -149.38 161.0 42.95 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.398 1.479 . . . . 0.0 110.7 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -68.79 137.19 53.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.296 1.838 . . . . 0.0 108.755 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.966 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.9 tttt . . . . . 0 N--CA 1.444 -0.728 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.26 141.02 43.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 124.85 1.26 . . . . 0.0 107.849 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.9 tp -130.58 150.02 51.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.74 2.416 . . . . 0.0 106.879 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.64 137.46 45.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.107 0.963 . . . . 0.0 108.957 -170.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -142.43 93.07 2.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.374 1.07 . . . . 0.0 109.814 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -77.55 171.1 15.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.255 0.55 . . . . 0.0 110.329 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.43 70.38 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.863 -0.523 . . . . 0.0 113.366 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.7 t 58.95 20.47 8.2 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 113.332 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -56.53 134.05 53.89 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -89.66 -1.98 58.17 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.853 1.346 . . . . 0.0 112.069 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -147.53 144.17 28.33 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.54 162.05 32.63 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -171.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.686 ' CE ' HD11 ' A' ' 30' ' ' LEU . 27.0 mtp -117.44 148.66 41.59 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.45 -0.441 . . . . 0.0 111.346 -162.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.515 HD11 ' CD2' ' A' ' 54' ' ' TYR . 3.6 mm? -105.38 90.62 4.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 128.122 2.569 . . . . 0.0 107.417 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -93.2 162.37 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.712 2.275 . . . . 0.0 112.734 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.28 33.34 86.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.98 163.08 16.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.296 1.038 . . . . 0.0 108.314 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -103.49 134.1 19.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -76.98 169.39 21.73 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.445 2.096 . . . . 0.0 111.652 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.7 t80 54.7 43.15 30.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.173 2.189 . . . . 0.0 111.937 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -149.51 162.61 39.8 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 120.727 -1.233 . . . . 0.0 111.112 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -93.6 156.14 16.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -143.87 159.7 42.08 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.0 m -120.64 130.09 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.6 163.73 22.8 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.125 1.37 . . . . 0.0 109.971 168.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.5 169.08 20.31 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.937 1.295 . . . . 0.0 109.043 165.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.9 t -114.59 132.18 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 m -87.36 153.56 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.99 142.49 31.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.549 1.539 . . . . 0.0 106.868 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -144.53 -175.44 4.65 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.326 0.584 . . . . 0.0 111.125 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.43 -1.06 2.98 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.872 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -124.09 -36.26 2.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 120.56 2.18 . . . . 0.0 111.323 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.57 -150.55 10.98 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 121.697 0.609 . . . . 0.0 112.208 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.74 159.01 22.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.726 1.61 . . . . 0.0 107.91 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.451 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -102.94 -162.24 25.74 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.874 0.75 . . . . 0.0 113.574 171.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.76 162.38 25.32 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 159.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.56 166.02 11.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.482 172.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.8 p -65.99 179.36 0.47 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.419 1.088 . . . . 0.0 109.544 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.75 168.71 6.6 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.356 1.163 . . . . 0.0 109.561 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 137.72 58.23 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.087 -1.008 . . . . 0.0 108.858 160.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -115.3 158.24 22.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 161.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.54 161.27 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.602 ' CD2' HG21 ' A' ' 23' ' ' VAL . 45.7 p90 -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 166.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -91.86 128.85 37.85 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.07 0.948 . . . . 0.0 108.748 171.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -78.21 163.78 60.3 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.979 -0.534 . . . . 0.0 109.6 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.67 -114.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.686 2.924 . . . . 0.0 110.192 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.79 -31.9 3.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.387 1.449 . . . . 0.0 112.975 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.489 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -164.218 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.45 167.41 16.9 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.348 2.699 . . . . 0.0 111.361 171.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.9 mtm -123.2 -35.24 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.44 1.496 . . . . 0.0 113.507 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.69 HG22 ' CB ' ' A' ' 42' ' ' SER . 15.3 m -137.69 -176.88 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.342 0.973 . . . . 0.0 110.368 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -125.41 171.41 7.63 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 127.503 2.321 . . . . 0.0 109.685 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 6.6 Cg_endo -63.97 141.54 77.82 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.97 1.113 . . . . 0.0 110.475 164.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.73 -177.49 31.91 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -23.9 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 129.942 3.297 . . . . 0.0 114.038 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.58 145.36 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -120.62 157.91 28.51 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 126.213 1.805 . . . . 0.0 106.859 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 141.84 21.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 173.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -124.29 136.75 54.35 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.383 1.473 . . . . 0.0 108.579 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 115' ' ' ASN . 80.8 t -95.8 105.13 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.277 1.037 . . . . 0.0 108.726 177.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.719 ' HB ' HD12 ' A' ' 30' ' ' LEU . 85.6 t -80.11 -48.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.491 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -130.91 -178.14 4.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.8 -29.78 64.81 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.626 -1.296 . . . . 0.0 112.922 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.6 p -123.88 14.24 9.25 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 111.096 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.719 HD12 ' HB ' ' A' ' 26' ' ' VAL . 3.3 tm? -124.89 137.04 54.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 106.628 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -138.5 155.55 48.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 167.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.01 150.36 38.74 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.088 1.355 . . . . 0.0 107.771 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 42.6 t -129.27 135.11 62.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.18 123.59 32.47 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -129.63 157.93 40.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 110.63 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.86 139.28 95.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.185 0.994 . . . . 0.0 111.369 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.38 109.07 2.84 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.549 2.833 . . . . 0.0 111.084 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HA ' ' HD3' ' A' ' 39' ' ' PRO 0.32 48.9 t -79.61 159.17 72.41 Favored Pre-proline 0 N--CA 1.409 -2.492 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -169.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' VAL . 4.7 Cg_exo -59.6 147.2 92.81 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.232 3.955 . . . . 0.0 111.124 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 43' ' ' ILE . 2.5 mm? -66.83 -35.41 79.98 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.618 -0.676 . . . . 0.0 109.267 160.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -49.47 -36.69 23.52 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.201 0.6 . . . . 0.0 111.687 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.69 ' CB ' HG22 ' A' ' 16' ' ' VAL . 9.3 p -91.0 -13.67 32.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.676 HD13 ' HB2' ' A' ' 47' ' ' LEU . 85.4 mt -68.12 -38.52 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 120.44 1.473 . . . . 0.0 108.634 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 47.7 56.4 7.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 110.659 -173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.36 -179.21 32.4 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -73.05 144.45 47.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.676 ' HB2' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -77.24 122.69 25.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -75.41 -24.27 57.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.978 1.711 . . . . 0.0 111.009 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.95 -177.74 32.04 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 125.836 1.684 . . . . 0.0 109.338 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -99.76 129.18 45.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -113.2 102.5 10.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.499 1.519 . . . . 0.0 107.837 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.6 mt -78.0 121.53 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.69 151.05 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 162.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -157.32 164.78 37.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.205 1.402 . . . . 0.0 111.043 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -149.22 158.65 44.35 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.255 1.022 . . . . 0.0 111.667 168.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -68.71 134.1 49.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.2 m . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.009 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 tttt . . . . . 0 N--CA 1.444 -0.735 0 CA-C-O 120.495 0.188 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.52 153.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.037 1.735 . . . . 0.0 106.575 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 tp -131.14 163.16 28.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.277 2.631 . . . . 0.0 107.196 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.4 m -138.25 120.58 15.9 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -132.08 102.67 5.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 107.603 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -84.63 163.75 19.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.483 1.113 . . . . 0.0 108.943 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.26 171.35 25.31 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.5 p -78.6 27.41 0.21 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.85 1.26 . . . . 0.0 113.875 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -52.16 145.32 10.78 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.598 1.159 . . . . 0.0 110.73 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -112.75 10.85 19.3 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.135 1.374 . . . . 0.0 111.956 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 1.5 p80 -148.67 156.53 42.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.31 1.044 . . . . 0.0 109.787 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.19 117.89 0.61 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.592 0.615 . . . . 0.0 112.033 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.697 ' HE2' HD11 ' A' ' 30' ' ' LEU . 9.7 mtp -76.02 153.0 36.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.886 0.875 . . . . 0.0 112.833 -171.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.71 88.22 1.75 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 128.119 2.568 . . . . 0.0 108.163 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.75 158.99 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.11 2.54 . . . . 0.0 112.073 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.21 18.18 79.48 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.509 -0.744 . . . . 0.0 113.366 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.5 -176.83 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.407 1.883 . . . . 0.0 110.224 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 15.2 mt-10 -102.54 147.56 34.2 Favored Pre-proline 0 C--O 1.242 0.689 0 CA-C-N 118.746 0.703 . . . . 0.0 111.229 168.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 8.8 Cg_endo -73.51 176.8 8.8 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.807 3.005 . . . . 0.0 113.139 171.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 31.2 t80 48.52 29.32 2.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.977 2.511 . . . . 0.0 115.225 170.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.1 m -128.75 -175.44 3.54 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.151 1.38 . . . . 0.0 111.183 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -122.46 152.37 40.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.964 1.306 . . . . 0.0 107.772 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -144.55 158.2 43.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.53 1.132 . . . . 0.0 108.964 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 m -122.75 141.56 51.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.89 149.23 33.86 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.75 2.02 . . . . 0.0 110.181 173.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -137.22 128.17 27.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.038 1.735 . . . . 0.0 108.949 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -89.34 144.21 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -151.96 154.06 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.913 -1.742 . . . . 0.0 108.699 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.59 146.78 5.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.1 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -135.47 -178.31 5.06 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.252 1.021 . . . . 0.0 109.446 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.96 -36.27 89.72 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 121.91 -0.494 . . . . 0.0 112.94 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -75.2 -46.39 34.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.737 0.768 . . . . 0.0 110.427 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.99 -134.44 2.52 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.668 0.667 . . . . 0.0 111.86 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -136.14 165.43 25.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.343 2.257 . . . . 0.0 108.869 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -153.98 8.32 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.37 0.985 . . . . 0.0 112.004 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 56.9 Cg_endo -65.29 137.14 50.27 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.865 1.71 . . . . 0.0 109.318 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 162.8 28.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.782 0.801 . . . . 0.0 109.384 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 99.1 p -71.3 171.84 7.95 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.261 -0.9 . . . . 0.0 110.179 168.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 40.4 Cg_endo -64.18 136.92 54.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.716 1.611 . . . . 0.0 110.379 168.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.5 106.09 0.88 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.226 1.811 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.42 167.25 22.05 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.986 1.314 . . . . 0.0 110.417 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.92 166.36 29.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.114 1.365 . . . . 0.0 108.899 173.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.32 158.76 38.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.784 0.834 . . . . 0.0 109.64 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.468 ' O ' HG21 ' A' ' 25' ' ' VAL . 7.5 p30 -112.52 152.98 28.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 126.003 1.721 . . . . 0.0 108.195 171.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 153.68 39.21 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 119.257 0.935 . . . . 0.0 110.887 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.57 -75.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.588 2.859 . . . . 0.0 113.126 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -158.2 -35.23 0.07 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.208 1.403 . . . . 0.0 112.828 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 O-C-N 121.149 -0.969 . . . . 0.0 110.903 -177.069 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.06 164.69 24.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.585 1.524 . . . . 0.0 110.354 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.1 mtm -107.77 -35.07 6.78 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.093 0.957 . . . . 0.0 112.023 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.6 m -131.06 160.71 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.318 0.963 . . . . 0.0 111.484 -163.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.57 68.69 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 126.488 1.915 . . . . 0.0 107.807 161.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.61 164.42 11.38 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 109.556 -0.979 . . . . 0.0 109.556 161.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.55 -165.36 2.74 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.445 1.498 . . . . 0.0 113.731 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -54.48 115.94 2.39 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.28 154.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.25 154.5 40.1 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.901 2.08 . . . . 0.0 106.411 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -146.71 138.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.539 HD21 ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -124.09 118.9 27.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.312 2.245 . . . . 0.0 105.457 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 117' ' ' PRO . 64.7 t -64.8 134.76 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.89 -52.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -141.52 -175.6 4.43 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.241 1.416 . . . . 0.0 109.12 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -33.09 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.366 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.6 p -133.59 36.8 3.33 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.369 1.068 . . . . 0.0 109.519 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.503 HD11 ' HE2' ' A' ' 83' ' ' MET . 1.4 tm? -151.81 137.08 17.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.125 0.97 . . . . 0.0 109.701 171.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.39 138.37 24.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.427 ' HB3' HD22 ' A' ' 24' ' ' ASN . 1.1 tp10 -105.46 125.24 50.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -99.12 145.35 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.539 ' CD2' HD21 ' A' ' 24' ' ' ASN . 39.3 m-70 -127.8 147.76 50.43 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.278 0.631 . . . . 0.0 109.506 170.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -135.73 -175.08 3.84 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.433 1.493 . . . . 0.0 108.369 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -114.08 136.85 22.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.44 112.44 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.347 2.698 . . . . 0.0 111.704 -172.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.624 HG12 ' HD2' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -70.52 143.02 89.67 Favored Pre-proline 0 N--CA 1.41 -2.432 0 C-N-CA 124.756 1.222 . . . . 0.0 110.205 -171.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.624 ' HD2' HG12 ' A' ' 38' ' ' VAL . 2.5 Cg_endo -62.19 133.44 43.78 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 125.812 4.341 . . . . 0.0 111.864 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -58.42 -36.3 73.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 175.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -52.19 -36.57 52.25 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.407 ' HB2' HG22 ' A' ' 16' ' ' VAL . 6.2 p -94.99 -13.97 24.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 47' ' ' LEU . 64.9 mt -68.41 -34.67 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.477 1.035 . . . . 0.0 109.703 164.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 60.36 6.87 1.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.839 1.656 . . . . 0.0 115.083 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.15 -166.73 23.53 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.398 0.999 . . . . 0.0 110.625 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.27 118.97 13.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.0 tm? -59.83 122.8 15.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.833 1.253 . . . . 0.0 107.79 167.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.32 -32.88 22.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.756 0.822 . . . . 0.0 111.198 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 76' ' ' GLN . . . 156.32 -178.56 32.75 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -116.56 112.6 21.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.68 109.44 19.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.16 122.74 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -91.97 153.02 19.74 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.481 ' CE1' HD12 ' A' ' 73' ' ' LEU . 33.8 p90 -160.61 159.71 30.81 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.28 1.832 . . . . 0.0 109.482 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -148.99 153.21 37.6 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.695 0.798 . . . . 0.0 110.735 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -68.58 118.6 11.81 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.643 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 18.8 mmtt . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 121.644 0.735 . . . . 0.0 111.76 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.63 148.25 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 106.69 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.527 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -130.3 147.47 52.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.717 2.007 . . . . 0.0 107.722 172.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.4 m -120.29 91.51 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 108.757 -164.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 66.4 m-85 -94.09 76.85 4.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.409 ' HA ' ' HA3' ' A' ' 49' ' ' GLY . 4.0 pt20 -67.03 144.74 55.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.319 176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.93 167.33 40.15 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.349 0.976 . . . . 0.0 112.528 -175.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -79.57 16.92 0.96 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.324 2.25 . . . . 0.0 115.276 -167.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.07 163.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.794 1.637 . . . . 0.0 113.178 174.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -125.29 9.49 7.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.71 163.8 36.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.412 1.085 . . . . 0.0 108.954 173.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.63 165.66 36.34 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.503 ' HE2' HD11 ' A' ' 30' ' ' LEU . 46.1 mtp -111.91 150.56 30.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.134 0.974 . . . . 0.0 109.457 -168.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.9 mm? -115.46 79.85 7.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -86.75 162.37 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 110.247 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.18 74.4 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.935 0.779 . . . . 0.0 113.341 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.461 HD21 HD12 ' A' ' 84' ' ' LEU . 1.3 mm? -93.7 171.22 9.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.667 1.587 . . . . 0.0 108.723 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.2 156.74 35.5 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 124.359 1.064 . . . . 0.0 110.12 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -82.7 177.25 7.04 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 124.481 3.454 . . . . 0.0 112.957 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.9 t80 38.24 57.32 1.66 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.724 2.81 . . . . 0.0 111.85 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.5 m -149.98 157.79 43.51 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.378 1.871 . . . . 0.0 109.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -90.62 150.72 21.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' CE1' HD12 ' A' ' 87' ' ' LEU . 38.5 m-85 -134.93 154.83 51.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.886 1.274 . . . . 0.0 108.162 175.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.2 m -125.93 138.88 53.8 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 172.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -144.47 162.85 35.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.388 2.275 . . . . 0.0 109.697 177.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -134.45 -176.08 4.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.74 139.52 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.561 1.944 . . . . 0.0 106.394 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -140.89 128.82 21.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.683 1.193 . . . . 0.0 107.798 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 m -74.65 153.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.6 t -138.03 150.03 24.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 171.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -138.95 -168.9 2.52 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 109.123 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.88 4.5 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.456 -1.191 . . . . 0.0 116.036 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.02 -47.89 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.182 1.991 . . . . 0.0 111.358 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.3 -166.66 34.46 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 120.689 1.586 . . . . 0.0 113.427 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -95.58 167.85 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.884 1.273 . . . . 0.0 110.259 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -128.6 -157.32 9.26 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.617 1.579 . . . . 0.0 112.582 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.06 150.48 82.51 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.917 2.411 . . . . 0.0 110.222 177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.43 164.6 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.089 0.947 . . . . 0.0 112.131 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 p -69.19 177.22 1.25 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.247 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.98 146.87 15.91 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.73 1.62 . . . . 0.0 110.087 158.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.78 100.5 6.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 168.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.9 mmt-85 -76.57 162.98 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.872 -0.518 . . . . 0.0 110.267 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.78 157.37 38.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.333 0.653 . . . . 0.0 110.046 174.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -150.49 146.74 26.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.382 1.073 . . . . 0.0 109.245 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -109.75 145.11 37.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.355 1.062 . . . . 0.0 108.4 169.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.72 169.2 19.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.775 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' HG11 ' A' ' 25' ' ' VAL . 12.9 Cg_endo -68.23 -75.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.451 2.101 . . . . 0.0 109.266 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -172.45 -39.14 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.212 1.405 . . . . 0.0 110.592 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 C-N-CA 125.718 1.628 . . . . 0.0 112.258 -177.533 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.653 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 t -153.65 -71.48 0.14 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.154 0.982 . . . . 0.0 109.003 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 p 48.37 96.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.622 1.969 . . . . 0.0 111.492 -157.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.2 -154.99 8.09 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.6 m 60.42 176.68 0.1 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.437 1.495 . . . . 0.0 111.765 -166.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 t 62.14 137.18 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.359 1.864 . . . . 0.0 109.482 -155.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.96 -173.79 13.21 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -157.56 168.71 26.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 118.32 1.06 . . . . 0.0 109.234 167.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -150.45 151.15 32.31 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 166.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.44 -161.08 53.5 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -150.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . 0.253 5.6 mt-10 73.96 77.82 0.12 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 129.028 2.931 . . . . 0.0 112.284 173.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -60.14 -52.72 64.13 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.834 2.853 . . . . 0.0 112.201 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 mt 38.19 144.65 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.102 1 C-N-CA 134.986 5.314 . . . . 0.0 119.497 177.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -65.3 169.15 12.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.522 1.482 . . . . 0.0 113.261 177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.1 mtm -132.91 -40.53 0.94 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.986 0.914 . . . . 0.0 113.413 -165.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.587 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.6 m -135.32 168.66 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.01 166.1 12.56 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 126.754 2.021 . . . . 0.0 109.374 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 32.5 Cg_endo -70.98 141.6 40.66 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.332 1.355 . . . . 0.0 114.44 -166.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.63 178.56 23.86 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.506 1.526 . . . . 0.0 111.726 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 23.65 66.0 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 129.877 3.271 . . . . 0.0 114.477 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.431 HG12 ' HG3' ' A' ' 112' ' ' ARG . 18.3 t -76.27 132.53 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.46 175.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -148.23 166.48 27.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.442 1.497 . . . . 0.0 109.44 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.51 141.61 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 O-C-N 120.78 -1.2 . . . . 0.0 108.62 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.0 119.25 29.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.224 2.61 . . . . 0.0 109.225 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -71.72 130.21 35.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 119.196 0.907 . . . . 0.0 108.851 171.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.32 -64.7 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 126.139 1.776 . . . . 0.0 107.993 -171.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -115.88 179.16 4.06 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.589 1.156 . . . . 0.0 108.065 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.48 -18.3 61.52 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.224 -0.922 . . . . 0.0 112.768 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -126.35 0.27 7.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.323 1.849 . . . . 0.0 112.687 -169.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -139.16 128.1 23.62 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.695 1.598 . . . . 0.0 108.207 -170.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -122.94 172.57 8.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.65 117.29 13.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 152.86 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -132.47 148.81 52.41 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.549 1.54 . . . . 0.0 109.138 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 15.0 p90 -160.28 164.89 32.27 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.662 1.585 . . . . 0.0 109.617 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -87.83 145.24 36.31 Favored Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 120.942 -1.099 . . . . 0.0 112.034 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.31 102.58 1.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.854 3.036 . . . . 0.0 111.095 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 4.6 m -64.26 158.88 62.18 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -171.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 10.7 Cg_endo -72.77 144.86 39.93 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 124.317 3.345 . . . . 0.0 110.229 178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.3 mp -56.08 -30.72 62.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.243 0.474 . . . . 0.0 111.143 169.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -56.75 -28.49 61.27 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.587 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.6 p -89.58 -29.81 18.62 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 119.081 0.855 . . . . 0.0 111.459 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.625 HD13 ' HB2' ' A' ' 47' ' ' LEU . 81.9 mt -67.83 -38.44 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.331 1.053 . . . . 0.0 109.071 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mtp85 50.01 80.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.639 1.575 . . . . 0.0 110.606 -168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.61 -102.76 0.83 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 167.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -138.22 103.58 4.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.837 . . . . 0.0 109.6 -166.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.625 ' HB2' HD13 ' A' ' 43' ' ' ILE . 37.0 tp -54.88 119.62 5.65 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 127.006 2.123 . . . . 0.0 109.393 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -86.72 -48.7 8.04 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.078 0.951 . . . . 0.0 108.941 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.26 173.0 45.98 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -99.93 136.13 40.31 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 161.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -105.7 152.09 23.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 167.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.9 mt -126.4 126.2 68.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 170.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.45 141.28 28.7 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -153.02 159.95 42.94 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.543 1.137 . . . . 0.0 110.962 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.8 p90 -148.46 158.27 44.0 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.594 0.711 . . . . 0.0 110.357 176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -68.94 127.32 32.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.641 1.576 . . . . 0.0 106.87 170.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 46.2 m -110.26 165.73 11.53 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 60.5 15.63 5.75 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 t -102.44 -49.06 3.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.598 1.544 . . . . 0.0 109.416 167.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.0 t 53.05 78.94 0.13 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.661 1.984 . . . . 0.0 112.16 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.0 t -18.33 -60.48 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 130.193 3.397 . . . . 0.0 116.222 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.6 tttp 67.83 125.26 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.385 1.874 . . . . 0.0 113.556 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.69 -89.26 0.02 OUTLIER 'General case' 0 C--O 1.233 0.191 0 C-N-CA 126.264 1.825 . . . . 0.0 113.096 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -62.6 107.71 1.0 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.23 1.412 . . . . 0.0 110.865 -166.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.8 ttt85 46.32 45.37 13.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.685 1.594 . . . . 0.0 112.372 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -49.58 106.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.712 1.205 . . . . 0.0 111.274 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -153.05 -176.83 5.94 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.679 1.192 . . . . 0.0 108.759 164.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.1 mt -116.37 132.04 67.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.92 109.67 13.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -108.2 96.07 6.11 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -88.05 164.39 15.78 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.252 2.221 . . . . 0.0 109.854 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.25 149.38 28.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.94 144.7 50.31 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 128.665 2.786 . . . . 0.0 107.533 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.5 m -130.52 117.14 19.16 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -128.67 85.74 2.37 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.278 1.031 . . . . 0.0 109.011 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -67.54 147.09 53.25 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.053 0.541 . . . . 0.0 110.245 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.61 167.55 26.24 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 122.705 1.17 . . . . 0.0 111.409 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -87.55 44.37 1.18 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.834 1.049 . . . . 0.0 113.834 -151.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 167.02 3.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.396 0.617 . . . . 0.0 111.304 177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.7 p -124.53 -1.97 7.99 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 125.701 1.6 . . . . 0.0 111.355 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -148.61 160.7 42.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.172 1.389 . . . . 0.0 107.39 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.02 134.24 3.26 Favored Glycine 0 N--CA 1.454 -0.162 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.6 mtp -81.67 153.47 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.038 0.419 . . . . 0.0 111.338 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.468 HD12 HD21 ' A' ' 87' ' ' LEU . 1.5 mm? -106.92 91.08 5.9 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 167.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.87 154.92 2.27 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.953 3.102 . . . . 0.0 111.92 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.19 37.08 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.468 HD21 HD12 ' A' ' 84' ' ' LEU . 3.4 mm? -105.02 -166.41 1.23 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.402 3.081 . . . . 0.0 107.329 176.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -121.97 146.79 47.19 Favored Pre-proline 0 N--CA 1.45 -0.466 0 O-C-N 120.918 -1.114 . . . . 0.0 111.323 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.62 167.63 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 124.265 3.31 . . . . 0.0 111.963 163.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.262 0.3 OUTLIER 40.12 42.1 1.08 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.841 2.456 . . . . 0.0 111.525 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.3 m -133.62 153.12 51.91 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.557 -1.34 . . . . 0.0 108.44 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -94.14 146.53 23.92 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 168.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.11 153.99 51.82 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.8 m -126.64 143.71 51.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.08 163.12 39.01 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.354 1.861 . . . . 0.0 109.714 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -152.76 151.72 30.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.169 0.988 . . . . 0.0 110.216 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.59 142.21 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.913 -174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -137.37 138.5 39.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.096 1.359 . . . . 0.0 108.326 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -85.12 152.41 3.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 64.0 t -137.36 134.94 47.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -128.3 -174.95 3.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.433 1.093 . . . . 0.0 109.713 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.72 -7.33 41.05 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.509 -1.162 . . . . 0.0 114.339 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.93 -38.93 5.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.95 1.7 . . . . 0.0 110.541 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.04 -173.27 45.13 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 119.409 1.004 . . . . 0.0 110.638 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 166.78 22.81 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.34 -0.506 . . . . 0.0 110.814 164.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -121.32 -158.42 10.38 Favored Glycine 0 CA--C 1.531 1.061 0 N-CA-C 108.14 -1.984 . . . . 0.0 108.14 160.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.75 158.06 44.29 Favored 'Trans proline' 0 C--O 1.237 0.428 0 CA-C-N 119.886 1.843 . . . . 0.0 112.586 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.4 143.35 26.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.639 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.23 175.18 2.96 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 126.064 1.746 . . . . 0.0 111.185 176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.35 137.48 65.61 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.731 1.621 . . . . 0.0 109.353 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.73 153.92 27.0 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.271 1.034 . . . . 0.0 110.729 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.431 ' HG3' HG12 ' A' ' 21' ' ' VAL . 74.4 mmt-85 -134.5 170.54 15.61 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 107.687 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.6 m -135.27 157.01 39.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.786 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -153.72 143.03 21.52 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -112.4 137.69 50.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 170.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -92.16 151.21 41.49 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.16 -73.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.846 3.031 . . . . 0.0 113.265 -159.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -154.0 -41.31 0.09 Allowed 'General case' 0 C--N 1.339 0.114 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 151.84 -175.87 30.43 Favored Glycine 0 N--CA 1.464 0.562 0 CA-C-O 119.287 -0.729 . . . . 0.0 111.701 -167.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.1 p 172.71 135.28 0.03 OUTLIER 'General case' 0 C--O 1.236 0.351 0 C-N-CA 128.599 2.76 . . . . 0.0 107.636 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 134.08 176.58 14.45 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.49 46.29 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 124.872 3.714 . . . . 0.0 111.506 -175.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.99 156.01 22.28 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.04 -1.037 . . . . 0.0 109.479 169.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 72.8 m -151.94 -50.26 0.11 Allowed 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.319 -0.863 . . . . 0.0 110.753 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.307 0 N-CA-C 108.164 -1.974 . . . . 0.0 108.164 178.369 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.679 0 CA-C-O 118.735 -1.036 . . . . 0.0 112.854 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.7 m -149.79 162.7 39.76 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.929 2.092 . . . . 0.0 106.913 170.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -155.24 97.72 1.93 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.45 162.25 19.56 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -172.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 t -143.81 -40.4 0.29 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.549 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.2 m 59.21 -177.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.302 1.441 . . . . 0.0 111.505 -171.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.84 113.83 1.93 Allowed Glycine 0 C--N 1.339 0.737 0 O-C-N 121.138 -0.976 . . . . 0.0 112.481 172.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -133.04 135.43 45.38 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.767 1.227 . . . . 0.0 108.956 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t 62.6 171.86 0.14 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.019 1.728 . . . . 0.0 111.068 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.31 99.19 1.62 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 -171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -83.45 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 161.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.98 4.0 34.07 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 121.446 -0.784 . . . . 0.0 112.342 -165.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.1 153.59 80.65 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 124.959 1.304 . . . . 0.0 110.779 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.9 -175.78 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.295 2.663 . . . . 0.0 112.807 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 42.5 mtm -126.51 -59.37 1.3 Allowed 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.693 1.597 . . . . 0.0 110.467 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 42' ' ' SER . 35.1 m -122.21 148.93 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 121.605 0.717 . . . . 0.0 111.635 -168.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.75 168.4 18.47 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 127.003 2.121 . . . . 0.0 109.912 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 2.0 Cg_endo -61.01 155.82 48.04 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.345 1.363 . . . . 0.0 113.308 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.34 -175.49 30.24 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.115 1.34 . . . . 0.0 111.088 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -36.09 103.99 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 127.476 2.311 . . . . 0.0 113.757 -163.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.3 t -73.56 139.73 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.27 156.44 45.42 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -146.46 118.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 119.214 0.915 . . . . 0.0 109.285 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -96.7 121.41 38.52 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 124.465 1.106 . . . . 0.0 109.202 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.0 t -86.5 108.62 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.603 ' HB ' HD12 ' A' ' 30' ' ' LEU . 40.2 t -71.1 -56.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.765 0.826 . . . . 0.0 108.885 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -130.19 -174.3 3.29 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 124.13 0.972 . . . . 0.0 109.674 -163.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -27.84 67.76 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.623 -0.673 . . . . 0.0 112.136 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 80.4 p -129.39 7.55 5.38 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.46 1.104 . . . . 0.0 111.795 -166.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.649 HD11 ' CE ' ' A' ' 83' ' ' MET . 3.3 tm? -138.54 139.45 38.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.17 1.788 . . . . 0.0 108.352 -174.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -141.03 173.42 11.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.801 1.64 . . . . 0.0 107.938 167.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.91 151.22 51.85 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 126.635 1.974 . . . . 0.0 108.877 176.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.3 t -126.97 134.83 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -119.47 128.98 54.5 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.0 p90 -142.99 -179.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.529 1.132 . . . . 0.0 110.279 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.1 144.58 29.69 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.899 0.879 . . . . 0.0 111.704 -172.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.53 96.47 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.409 2.739 . . . . 0.0 111.192 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 32.4 m -64.03 157.04 71.62 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.052 -176.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 58.7 Cg_endo -77.31 146.01 24.56 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.308 2.672 . . . . 0.0 109.358 -170.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.06 -30.75 71.84 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.759 -0.588 . . . . 0.0 111.798 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -59.3 -34.55 72.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 118.402 -0.808 . . . . 0.0 111.614 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.77 ' HB2' HG22 ' A' ' 16' ' ' VAL . 60.6 p -64.39 -42.99 95.84 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.494 1.043 . . . . 0.0 110.062 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.7 mt -64.25 -31.52 53.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.086 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 54.72 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.643 2.377 . . . . 0.0 115.232 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.13 -155.57 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.315 1.912 . . . . 0.0 109.591 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -103.94 109.73 21.6 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.82 1.248 . . . . 0.0 110.874 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.3 tp -46.29 110.45 0.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 127.092 2.157 . . . . 0.0 109.678 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.421 ' H ' ' HA ' ' A' ' 101' ' ' ASN . 56.2 mm-40 -86.01 -12.91 49.07 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.627 0.727 . . . . 0.0 111.544 169.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.05 -175.15 28.43 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -101.47 155.76 17.88 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 164.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -122.1 144.6 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.48 120.17 64.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -91.86 150.85 20.84 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 163.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.592 ' CE1' HD12 ' A' ' 73' ' ' LEU . 21.2 p90 -158.67 160.23 36.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.695 1.598 . . . . 0.0 109.726 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -149.37 157.44 43.32 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.687 0.795 . . . . 0.0 109.789 171.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -68.12 125.45 26.41 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.8 m -103.26 125.47 49.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -157.81 120.27 3.8 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -169.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.4 m -68.47 108.88 3.45 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.187 0.995 . . . . 0.0 110.175 -168.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 p -91.92 117.96 30.3 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.011 1.324 . . . . 0.0 110.257 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 t -63.4 153.71 34.35 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 121.057 -1.027 . . . . 0.0 108.47 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -48.97 97.79 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 128.894 2.878 . . . . 0.0 112.595 -168.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 45.5 mtp85 -134.44 120.13 19.4 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.75 1.22 . . . . 0.0 108.627 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -65.13 159.17 24.01 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 57.67 74.0 0.44 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 126.552 1.941 . . . . 0.0 111.826 169.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.39 132.78 23.38 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.391 1.876 . . . . 0.0 106.471 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -125.34 111.0 14.67 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.979 1.263 . . . . 0.0 107.634 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.18 133.11 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.681 1.192 . . . . 0.0 108.068 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -88.72 91.3 8.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -69.5 135.58 50.31 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.981 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -117.68 158.02 25.42 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 126.513 1.925 . . . . 0.0 109.626 -173.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.72 143.15 37.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -170.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.592 HD12 ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -129.93 153.44 48.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.443 2.297 . . . . 0.0 107.176 167.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.2 m -133.28 127.9 34.64 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -168.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 72.8 m-85 -138.11 88.93 2.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.77 0.828 . . . . 0.0 109.386 -172.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -71.36 151.37 44.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.273 1.029 . . . . 0.0 110.286 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.62 164.0 29.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.133 1.349 . . . . 0.0 112.199 175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -79.74 58.15 2.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.748 1.619 . . . . 0.0 110.428 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -85.04 171.08 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.556 1.143 . . . . 0.0 109.924 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 7.23 2.9 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 125.973 1.709 . . . . 0.0 111.932 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -144.4 159.57 42.5 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.574 0.75 . . . . 0.0 109.362 167.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.45 148.46 12.06 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 125.352 1.453 . . . . 0.0 111.266 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.649 ' CE ' HD11 ' A' ' 30' ' ' LEU . 21.4 mtp -77.96 169.51 18.17 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -169.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -127.78 96.32 32.68 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 126.835 2.054 . . . . 0.0 105.851 163.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -99.49 161.53 0.57 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.267 2.644 . . . . 0.0 111.702 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.36 35.5 56.33 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 121.331 -0.856 . . . . 0.0 111.784 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -86.45 161.65 18.52 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.59 130.03 24.12 Favored Pre-proline 0 N--CA 1.447 -0.622 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.12 166.5 18.65 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.381 2.721 . . . . 0.0 112.232 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 8.9 t80 42.95 52.76 5.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.206 . . . . 0.0 113.346 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -152.08 -178.84 7.02 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.55 1.14 . . . . 0.0 110.879 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 162.59 17.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.394 1.478 . . . . 0.0 108.651 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -136.03 165.58 25.34 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.669 1.188 . . . . 0.0 108.721 176.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.2 m -125.6 146.46 49.69 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 157.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -139.72 164.09 30.87 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.466 1.906 . . . . 0.0 108.848 167.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -148.54 144.94 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.824 -0.547 . . . . 0.0 109.903 163.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.01 152.4 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -149.64 143.21 25.38 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 m -89.6 146.58 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.1 t -135.29 142.7 39.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 126.156 1.783 . . . . 0.0 107.215 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 48' ' ' GLN . 16.1 p30 -144.65 -174.29 4.29 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.525 1.13 . . . . 0.0 111.156 -178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.08 -10.05 31.68 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.734 -1.037 . . . . 0.0 114.057 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -117.27 -22.95 8.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.929 1.365 . . . . 0.0 112.322 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.0 -153.23 23.87 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -127.13 159.8 33.13 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.745 0.783 . . . . 0.0 110.35 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.84 -165.85 27.08 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 112.139 -175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.57 166.37 24.19 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.303 1.335 . . . . 0.0 109.92 168.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.01 150.07 23.28 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.088 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 p -75.15 165.36 54.46 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -55.58 123.65 14.33 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.918 2.412 . . . . 0.0 110.809 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.32 143.21 53.47 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.156 1.782 . . . . 0.0 107.896 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 58.2 mmt-85 -122.23 163.61 19.31 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.31 166.58 22.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 23' ' ' VAL . 37.5 p90 -158.67 159.49 35.4 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -117.53 143.45 46.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.77 1.228 . . . . 0.0 109.676 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.2 p -98.75 143.4 26.28 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -66.09 167.17 18.71 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.846 2.364 . . . . 0.0 108.969 172.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 18.3 tt0 -61.87 -23.69 66.45 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -163.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.81 66.91 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 108.269 -1.932 . . . . 0.0 108.269 -172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 3.4 m -61.36 107.15 0.72 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.48 -176.74 21.89 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 123.575 0.607 . . . . 0.0 111.879 -156.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -63.97 -44.66 12.24 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.223 1.949 . . . . 0.0 110.432 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.8 m 50.58 60.05 4.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.687 1.995 . . . . 0.0 112.338 164.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.8 m 125.63 47.2 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 131.538 3.935 . . . . 0.0 111.609 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.524 0 C-N-CA 124.713 1.149 . . . . 0.0 111.186 173.421 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 CA-C-O 118.977 -0.902 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -117.01 173.3 6.73 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.899 1.279 . . . . 0.0 109.425 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 t -164.27 -175.03 3.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.127 1.371 . . . . 0.0 107.882 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.53 179.65 51.44 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.157 1.361 . . . . 0.0 112.78 171.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.0 m 127.16 157.6 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 1 C-N-CA 134.323 5.049 . . . . 0.0 108.621 -178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.4 t -165.6 170.36 14.32 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.792 1.637 . . . . 0.0 109.784 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 164.51 116.76 0.38 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.584 1.564 . . . . 0.0 110.647 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -156.32 157.39 35.63 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.976 1.711 . . . . 0.0 107.759 158.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.1 t -168.94 -40.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.925 2.09 . . . . 0.0 109.008 -178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.07 -92.91 0.1 Allowed Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 51.03 67.25 0.97 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.994 1.718 . . . . 0.0 111.478 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.9 -40.18 72.65 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 113.163 -1.835 . . . . 0.0 112.915 -164.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.8 mt 33.9 141.18 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.067 1 C-N-CA 133.55 4.74 . . . . 0.0 119.999 168.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.94 161.17 40.71 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.171 2.58 . . . . 0.0 111.878 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 mtm -125.76 -26.59 3.47 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -169.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 42' ' ' SER . 29.3 m -140.6 169.22 15.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 124.494 1.117 . . . . 0.0 110.862 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.29 163.0 17.95 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.34 2.256 . . . . 0.0 109.821 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.58 156.58 60.11 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.828 1.685 . . . . 0.0 113.393 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.89 166.86 54.92 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -21.3 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 129.073 2.949 . . . . 0.0 115.356 -162.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.67 130.35 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.2 mtt-85 -118.82 161.14 20.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.68 138.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -123.79 125.29 44.44 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 123.421 0.689 . . . . 0.0 110.369 169.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 115' ' ' ASN . 59.3 t -70.39 101.28 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 166.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -63.0 -56.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 126.878 2.071 . . . . 0.0 109.759 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -132.34 172.35 12.56 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.187 1.395 . . . . 0.0 107.392 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -64.16 0.93 0.81 Allowed 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.6 p -133.62 -1.25 3.12 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.301 1.84 . . . . 0.0 112.371 -178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -149.07 119.81 7.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.396 1.078 . . . . 0.0 109.594 -159.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -128.31 130.72 48.24 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.577 0.626 . . . . 0.0 109.893 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -76.24 146.03 39.3 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.69 139.91 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 164.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -120.68 151.79 39.06 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.58 1.552 . . . . 0.0 108.035 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -153.0 155.79 37.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.849 0.46 . . . . 0.0 110.819 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.35 136.72 45.88 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -72.07 129.59 15.39 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.342 2.695 . . . . 0.0 110.388 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.21 151.86 95.8 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.659 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -85.31 159.82 11.21 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.938 3.092 . . . . 0.0 110.809 -173.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -60.03 -34.37 73.29 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.031 0.532 . . . . 0.0 111.663 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -66.93 -23.01 65.93 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.825 ' HB2' HG22 ' A' ' 16' ' ' VAL . 41.1 p -76.46 -41.08 48.6 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 120.077 1.308 . . . . 0.0 109.49 170.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.22 -32.7 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.237 1.415 . . . . 0.0 110.146 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.8 mtm180 50.22 60.82 3.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.471 1.508 . . . . 0.0 110.142 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.09 -147.87 19.41 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.91 122.83 46.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.381 1.472 . . . . 0.0 110.711 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.38 111.44 0.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.75 2.02 . . . . 0.0 109.802 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.5 -13.95 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.694 0.797 . . . . 0.0 112.053 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 145.16 -164.47 27.94 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -111.12 148.98 31.51 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 107.91 165.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -125.9 140.98 52.2 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.2 mt -128.85 122.12 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -91.45 148.16 22.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 167.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.1 p90 -158.33 164.54 36.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.634 1.574 . . . . 0.0 111.124 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -149.26 162.23 40.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.198 0.999 . . . . 0.0 111.26 169.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -68.61 136.09 52.48 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.934 2.093 . . . . 0.0 108.38 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.5 m -126.95 144.12 51.09 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.788 1.635 . . . . 0.0 106.881 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 51.92 76.76 0.16 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.067 1.747 . . . . 0.0 112.573 -171.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 25.8 t -133.96 -75.41 0.48 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.682 1.193 . . . . 0.0 109.516 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.6 t -51.93 148.24 6.15 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.868 1.667 . . . . 0.0 112.646 -171.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 t -52.82 146.15 11.14 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.692 1.597 . . . . 0.0 111.176 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -45.89 114.71 0.82 Allowed 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.647 1.579 . . . . 0.0 109.972 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 38.4 67.64 0.39 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.629 1.572 . . . . 0.0 113.635 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.14 80.32 1.47 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.611 -0.681 . . . . 0.0 112.502 -175.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 55.0 mtt85 67.61 177.76 0.24 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 127.045 2.138 . . . . 0.0 110.433 -167.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.6 ttp-105 -151.01 57.38 0.91 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.303 -0.873 . . . . 0.0 110.889 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -81.76 123.47 28.79 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.256 1.023 . . . . 0.0 108.615 171.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.2 mt -135.0 123.95 41.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 -177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -77.27 157.96 30.5 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 163.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -128.1 93.55 3.7 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 165.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 18.4 mttm -67.99 153.12 44.4 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.9 mm -122.84 159.39 26.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' CD1' HD13 ' A' ' 84' ' ' LEU . 1.2 mt -130.8 141.29 50.34 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 127.16 2.184 . . . . 0.0 107.233 165.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.7 m -112.9 122.21 46.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.781 1.232 . . . . 0.0 107.809 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 73' ' ' LEU . 62.5 m-85 -128.64 80.22 1.95 Allowed 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.108 0.963 . . . . 0.0 109.168 -177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.28 155.68 27.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.86 157.7 33.89 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.583 1.563 . . . . 0.0 111.585 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -79.5 34.76 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.841 1.257 . . . . 0.0 113.937 -169.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.24 160.81 14.92 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.538 -1.351 . . . . 0.0 111.865 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.3 p -119.82 7.01 10.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.831 2.053 . . . . 0.0 111.089 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.9 170.67 18.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.009 1.323 . . . . 0.0 109.379 170.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.16 158.63 30.72 Favored Glycine 0 CA--C 1.52 0.392 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 mtp -97.34 157.9 15.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.897 1.348 . . . . 0.0 112.282 -176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.51 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.2 mm? -108.06 80.93 1.14 Allowed Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 129.853 3.261 . . . . 0.0 106.236 169.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -86.22 153.09 9.46 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.648 2.899 . . . . 0.0 110.417 170.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.39 23.38 56.74 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 124.741 1.162 . . . . 0.0 112.316 -176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 84' ' ' LEU . 3.0 mm? -94.5 166.44 12.05 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 172.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 150.7 55.48 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.924 -1.034 . . . . 0.0 108.553 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' A' ' 28' ' ' SER . 10.9 Cg_endo -70.29 -178.77 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.911 2.407 . . . . 0.0 111.87 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 53.41 36.87 24.17 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.636 1.175 . . . . 0.0 111.333 164.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 m -146.07 155.68 42.94 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 125.58 1.552 . . . . 0.0 109.477 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -100.63 153.81 19.11 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -143.2 156.24 44.71 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.839 0.856 . . . . 0.0 109.426 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.9 m -125.94 139.01 53.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.07 160.59 39.91 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 110.283 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.21 145.29 24.56 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.497 -0.752 . . . . 0.0 110.816 165.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.87 151.67 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.931 2.092 . . . . 0.0 107.873 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -153.28 139.69 18.63 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.39 134.71 43.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 124.366 1.067 . . . . 0.0 110.12 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.45 146.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -133.29 -178.86 5.17 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.287 1.435 . . . . 0.0 109.514 173.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.43 53.0 2.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.198 0.904 . . . . 0.0 111.267 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -162.78 -31.79 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.383 1.873 . . . . 0.0 109.983 172.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.95 -167.68 35.45 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-O 122.158 0.866 . . . . 0.0 113.468 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.28 169.09 12.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.044 2.937 . . . . 0.0 110.213 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.45 -155.26 6.57 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 128.32 2.867 . . . . 0.0 110.047 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.34 137.33 39.64 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.132 2.555 . . . . 0.0 111.991 -175.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.97 158.55 35.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.535 0.734 . . . . 0.0 110.195 174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.6 p -63.21 174.22 0.96 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.939 167.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -50.72 140.44 37.4 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 153.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -61.18 106.0 0.56 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 161.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -85.96 166.2 16.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.76 157.72 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -152.04 136.78 17.05 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.469 ' O ' HG21 ' A' ' 25' ' ' VAL . 3.0 p-10 -86.7 159.69 19.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 161.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.9 p -111.2 162.44 20.83 Favored Pre-proline 0 C--O 1.243 0.727 0 C-N-CA 123.975 0.91 . . . . 0.0 108.862 169.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.44 166.22 30.43 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.193 1.928 . . . . 0.0 109.044 168.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -63.33 -21.26 66.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.069 0.948 . . . . 0.0 112.46 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 85.99 -126.57 7.87 Favored Glycine 0 C--O 1.24 0.509 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 176.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.7 m -118.04 152.27 35.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.432 1.093 . . . . 0.0 108.995 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -172.57 172.01 44.68 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.86 151.8 46.09 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.519 2.146 . . . . 0.0 111.333 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.6 t -150.75 169.44 21.63 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.788 2.035 . . . . 0.0 106.086 162.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.1 t -89.93 175.64 7.12 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 154.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.263 1.92 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 143.345 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.554 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 m -66.05 122.87 18.37 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 166.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 p -82.76 76.5 9.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.924 0.89 . . . . 0.0 108.704 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.11 161.54 32.63 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -148.51 45.19 1.04 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.959 1.304 . . . . 0.0 109.997 -169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -139.45 108.06 5.9 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 45.71 -140.04 5.7 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.838 1.208 . . . . 0.0 111.532 -175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -133.1 -70.53 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.766 1.626 . . . . 0.0 107.384 166.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.4 t -163.45 -176.79 4.91 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 127.595 2.358 . . . . 0.0 106.579 -172.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.98 113.13 3.59 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 168.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -110.43 -47.47 3.27 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.572 1.149 . . . . 0.0 108.899 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -135.31 -11.28 2.17 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.613 -168.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.9 mt -70.99 153.14 94.83 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-N 120.748 1.613 . . . . 0.0 110.127 175.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.94 166.77 28.84 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 120.991 1.127 . . . . 0.0 110.158 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.3 mtm -117.86 -44.93 2.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.269 -169.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.707 HG22 ' HB2' ' A' ' 42' ' ' SER 0.252 33.5 m -129.96 -175.3 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 119.749 1.158 . . . . 0.0 111.726 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -124.67 152.6 69.4 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 128.268 2.627 . . . . 0.0 108.862 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.53 137.75 23.3 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.917 1.745 . . . . 0.0 109.253 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.94 -170.81 28.68 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.1 t30 30.43 56.25 0.19 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.464 1.905 . . . . 0.0 112.557 -170.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.0 t -71.44 121.68 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -133.36 155.06 50.14 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.26 -1.336 . . . . 0.0 107.87 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.446 HG11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -146.46 146.0 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.81 129.92 51.79 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.7 t -68.42 150.31 10.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.213 161.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.2 t -117.03 -78.17 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -169.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -103.08 -179.83 4.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.408 1.083 . . . . 0.0 108.706 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -17.71 63.14 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.457 -1.402 . . . . 0.0 113.47 177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.8 p -133.83 10.15 3.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.889 1.276 . . . . 0.0 112.598 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.5 tp -130.95 132.35 45.01 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.943 1.697 . . . . 0.0 107.548 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.73 169.2 14.09 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.651 0.781 . . . . 0.0 109.012 167.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -126.3 135.75 51.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.493 1.517 . . . . 0.0 107.334 175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.22 148.03 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -133.57 154.65 50.7 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.623 1.969 . . . . 0.0 108.664 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -158.09 171.35 20.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.281 0.632 . . . . 0.0 111.386 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.59 137.52 38.74 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.818 1.647 . . . . 0.0 111.317 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.17 112.78 3.63 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.727 2.951 . . . . 0.0 111.077 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.43 158.66 64.95 Favored Pre-proline 0 CA--C 1.546 0.825 0 O-C-N 122.077 -0.389 . . . . 0.0 110.568 170.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.64 160.63 14.45 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.557 2.838 . . . . 0.0 112.288 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.22 -25.39 67.78 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.404 -0.81 . . . . 0.0 112.871 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -60.69 -49.49 77.32 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.568 169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.707 ' HB2' HG22 ' A' ' 16' ' ' VAL . 51.4 p -66.67 -23.66 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.818 1.19 . . . . 0.0 111.503 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 47' ' ' LEU . 90.5 mt -67.57 -32.88 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.539 172.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 47.09 30.06 1.25 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.412 1.485 . . . . 0.0 113.624 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.6 -148.82 12.35 Favored Glycine 0 C--N 1.336 0.577 0 O-C-N 120.569 -1.332 . . . . 0.0 113.648 -170.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -100.52 112.1 24.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.673 1.589 . . . . 0.0 107.84 171.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 100' ' ' VAL . 3.1 tm? -65.65 121.74 15.67 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 126.466 1.906 . . . . 0.0 109.068 174.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -80.88 -38.44 28.09 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.778 0.831 . . . . 0.0 109.952 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 166.81 -178.21 41.23 Favored Glycine 0 C--N 1.34 0.758 0 O-C-N 121.379 -0.826 . . . . 0.0 111.945 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -99.44 124.51 44.65 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -76.79 155.63 32.95 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 160.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.16 124.71 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 156.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.543 ' HA ' HD13 ' A' ' 72' ' ' ILE . 9.0 m-85 -91.22 147.52 23.0 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 163.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.598 ' CE1' HD12 ' A' ' 73' ' ' LEU . 33.8 p90 -157.37 163.0 39.07 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.467 1.507 . . . . 0.0 110.265 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -149.08 157.16 43.17 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.762 0.791 . . . . 0.0 111.76 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -67.95 125.66 27.02 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.6 m -107.06 165.75 11.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -141.37 172.69 12.34 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 170.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.5 m -65.18 115.03 5.1 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.122 -0.986 . . . . 0.0 108.605 169.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t 53.0 53.12 12.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.725 1.21 . . . . 0.0 114.056 173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.5 t -63.39 110.73 2.02 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 pmtp? -96.79 -170.24 2.02 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.746 1.618 . . . . 0.0 109.745 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ptt-85 -121.15 82.31 1.91 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.012 1.325 . . . . 0.0 111.215 -158.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -156.5 94.36 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.039 1.736 . . . . 0.0 107.74 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.86 175.16 0.28 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 127.338 2.255 . . . . 0.0 111.463 -176.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 53.13 -179.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.094 2.157 . . . . 0.0 111.876 -162.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -146.68 142.49 27.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.143 1.777 . . . . 0.0 106.291 171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.51 116.56 17.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -71.08 105.34 3.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.609 2.364 . . . . 0.0 107.418 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -84.88 86.58 7.35 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 170.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -72.26 162.43 29.47 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.589 1.955 . . . . 0.0 109.257 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 53' ' ' TYR . 35.4 mm -132.25 155.02 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 123.448 0.699 . . . . 0.0 109.685 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD12 ' CE1' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -135.51 157.5 46.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.957 2.503 . . . . 0.0 108.816 170.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.5 m -131.02 116.37 17.7 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.773 1.229 . . . . 0.0 109.633 -170.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.16 97.6 5.3 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.922 1.289 . . . . 0.0 107.807 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.92 172.03 12.48 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.236 0.541 . . . . 0.0 110.596 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.24 15.1 70.06 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 116.406 1.322 . . . . 0.0 116.406 174.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.58 26.19 15.88 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 171.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -55.5 167.52 0.49 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.049 1.74 . . . . 0.0 112.701 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.6 p -102.92 5.12 38.25 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 112.399 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.79 168.07 21.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.225 0.61 . . . . 0.0 110.792 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.6 -179.13 33.24 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.759 2.123 . . . . 0.0 108.626 175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 21.4 mtp -131.85 167.91 18.77 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 118.891 1.345 . . . . 0.0 110.733 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.0 mm? -123.11 76.42 51.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 125.914 1.686 . . . . 0.0 107.27 172.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -82.38 151.86 15.58 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.92 2.413 . . . . 0.0 110.88 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.89 18.64 46.57 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.428 0.537 . . . . 0.0 112.043 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.435 HD12 ' CE2' ' A' ' 93' ' ' TYR . 3.8 mm? -91.84 -169.55 2.31 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.972 1.309 . . . . 0.0 110.387 -171.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER -125.52 149.33 64.5 Favored Pre-proline 0 CA--C 1.54 0.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.347 178.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 1.1 Cg_endo -77.69 173.97 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.423 2.749 . . . . 0.0 112.851 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.1 t80 44.26 53.23 6.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.194 1.798 . . . . 0.0 111.868 172.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m -155.85 146.64 22.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 120.963 -1.086 . . . . 0.0 110.686 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -78.77 151.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.13 0.972 . . . . 0.0 108.876 171.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CE2' HD12 ' A' ' 87' ' ' LEU . 56.4 m-85 -143.7 154.93 43.99 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.632 1.573 . . . . 0.0 108.113 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.5 m -117.13 147.83 42.09 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 171.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.446 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -150.6 158.75 44.52 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 126.66 1.984 . . . . 0.0 110.141 171.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.75 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.3 155.83 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.573 1.549 . . . . 0.0 107.622 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -152.4 142.12 21.92 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 119.832 -1.793 . . . . 0.0 108.686 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 m -81.51 148.21 5.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.488 ' O ' HD22 ' A' ' 47' ' ' LEU . 85.4 t -136.44 136.57 48.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -136.24 -171.12 2.81 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.378 0.671 . . . . 0.0 110.22 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.67 -15.98 14.64 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 118.404 -1.22 . . . . 0.0 115.213 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -111.58 -46.99 3.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 120.117 1.958 . . . . 0.0 111.191 -175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.04 -170.17 34.12 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 119.363 0.983 . . . . 0.0 112.406 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -108.16 145.56 33.99 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.187 0.995 . . . . 0.0 109.467 176.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.92 -165.23 31.48 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.906 1.241 . . . . 0.0 114.014 -168.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.71 133.58 49.03 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.252 1.968 . . . . 0.0 108.879 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.29 157.46 16.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.722 0.773 . . . . 0.0 109.977 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.4 p -67.79 165.46 31.1 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 156.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -63.47 152.91 77.86 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.356 1.37 . . . . 0.0 109.642 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.48 96.91 4.83 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.294 2.238 . . . . 0.0 105.94 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -76.69 168.46 20.04 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 125.1 1.36 . . . . 0.0 109.562 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.27 164.8 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.201 0.6 . . . . 0.0 111.306 175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -160.14 156.47 26.78 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.942 2.097 . . . . 0.0 108.085 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -122.13 141.37 51.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.324 1.05 . . . . 0.0 109.758 165.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.409 ' HB ' ' HA ' ' A' ' 89' ' ' PRO . 1.0 OUTLIER -74.2 154.25 88.34 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 123.619 0.574 . . . . 0.0 110.792 173.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.41 -73.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.802 3.001 . . . . 0.0 111.403 -168.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.68 -39.77 0.06 Allowed 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 154.86 -156.52 26.96 Favored Glycine 0 N--CA 1.46 0.264 0 CA-C-N 118.817 0.735 . . . . 0.0 111.456 -166.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.0 m -134.55 92.28 2.89 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -115.28 167.34 12.33 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.312 0.958 . . . . 0.0 111.543 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.76 133.59 18.81 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.737 2.291 . . . . 0.0 108.704 168.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.6 t -63.15 -21.17 66.02 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 122.069 -0.395 . . . . 0.0 110.508 168.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.5 t 71.51 -2.91 2.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.38 2.272 . . . . 0.0 114.69 168.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.433 0 N-CA-C 105.778 -2.929 . . . . 0.0 105.778 146.168 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 CA-C-O 119.172 -0.793 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 p -169.53 46.55 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.522 1.529 . . . . 0.0 110.099 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -142.9 169.49 17.47 Favored 'General case' 0 C--O 1.239 0.533 0 O-C-N 121.369 -0.832 . . . . 0.0 110.525 -174.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.1 55.68 0.09 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.423 1.487 . . . . 0.0 111.006 -175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.4 m -109.81 151.57 26.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 169.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 p -81.53 -69.35 0.62 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.91 172.32 43.81 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.449 1.024 . . . . 0.0 111.274 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.99 -62.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 124.378 1.071 . . . . 0.0 109.749 -173.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 t -162.99 -177.9 5.75 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.261 1.424 . . . . 0.0 108.298 -162.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.9 98.11 0.72 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 174.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -63.84 -55.84 19.9 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.525 0.73 . . . . 0.0 110.198 167.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.04 -14.85 2.65 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.445 -0.788 . . . . 0.0 111.909 -171.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.4 mt -69.49 150.82 96.89 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 119.601 1.092 . . . . 0.0 110.857 168.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -66.93 157.31 62.17 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.484 2.123 . . . . 0.0 112.152 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 mtm -112.0 -28.16 8.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -168.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.764 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.2 m -143.49 175.98 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 125.746 1.618 . . . . 0.0 108.052 -174.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -120.06 167.45 12.49 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 127.204 2.202 . . . . 0.0 108.776 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HD3' HG23 ' A' ' 99' ' ' VAL . 18.7 Cg_endo -68.27 113.85 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.436 2.091 . . . . 0.0 111.882 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.14 157.07 12.83 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.5 t30 41.46 62.01 1.65 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.622 1.569 . . . . 0.0 110.326 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.6 t -55.46 146.58 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 157.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -140.85 161.32 38.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG11 HD11 ' A' ' 95' ' ' LEU . 0.2 OUTLIER -147.3 146.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 O-C-N 119.725 -1.859 . . . . 0.0 109.057 169.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -123.98 151.28 43.84 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.099 2.56 . . . . 0.0 107.732 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.71 145.02 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 171.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 30' ' ' LEU . 99.5 t -111.73 -57.78 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -171.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -125.45 -173.35 2.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.031 1.333 . . . . 0.0 107.593 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.441 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -68.0 -31.89 71.9 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.863 -1.148 . . . . 0.0 112.377 175.102 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.8 p -122.5 13.13 10.14 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 111.008 -171.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.748 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.0 tm? -134.66 139.27 45.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.516 1.926 . . . . 0.0 107.804 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -144.05 170.14 16.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 173.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.34 117.36 14.31 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -175.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -88.67 145.68 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -121.77 159.2 27.17 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.6 1.56 . . . . 0.0 108.054 173.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.5 p90 -161.51 162.07 30.2 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.493 1.042 . . . . 0.0 110.635 169.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -85.3 135.13 39.35 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.63 116.76 4.55 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 124.069 3.179 . . . . 0.0 111.559 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 34.7 m -72.78 158.02 87.89 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.957 -0.465 . . . . 0.0 112.218 -175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 60.5 Cg_endo -83.44 149.81 13.15 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.951 3.101 . . . . 0.0 111.384 -176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.6 mp -59.09 -26.63 64.82 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.873 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -60.33 -52.11 66.68 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.52 1.054 . . . . 0.0 111.189 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.764 ' HB2' HG22 ' A' ' 16' ' ' VAL . 13.5 p -73.91 -23.25 59.53 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 47' ' ' LEU . 84.7 mt -66.05 -26.71 38.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 CA-C-O 118.276 -0.868 . . . . 0.0 109.938 167.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? 72.77 -49.74 0.7 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 128.335 2.654 . . . . 0.0 113.956 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -124.19 -99.36 1.31 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 124.639 1.114 . . . . 0.0 112.007 -176.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -137.84 105.34 5.54 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 126.384 1.874 . . . . 0.0 109.227 -169.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.441 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.2 tp -59.27 131.46 51.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -95.65 -24.01 16.76 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.101 1.36 . . . . 0.0 110.847 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 148.71 -153.99 25.56 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 170.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -127.83 123.45 35.18 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.855 1.662 . . . . 0.0 106.564 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -100.61 106.0 17.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.7 mt -78.73 118.57 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -92.49 143.2 26.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.589 ' CE1' HD12 ' A' ' 73' ' ' LEU . 35.8 p90 -154.79 170.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.864 1.211 . . . . 0.0 111.849 172.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -149.66 164.59 34.77 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.589 1.155 . . . . 0.0 110.44 165.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 tptm -68.61 137.62 54.39 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.09 1.356 . . . . 0.0 108.024 164.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 83.0 m -114.02 140.52 48.37 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 172.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 52.59 73.91 0.32 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.329 1.452 . . . . 0.0 112.458 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 t -57.71 136.92 56.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.949 1.3 . . . . 0.0 110.008 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t -82.09 -14.31 55.99 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -163.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 65.5 m -114.04 145.13 42.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 120.231 1.378 . . . . 0.0 109.945 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -58.64 -48.05 82.33 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 125.911 1.684 . . . . 0.0 110.544 -167.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -66.77 96.52 0.41 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 157.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -83.34 175.02 10.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 146.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -84.16 173.9 10.67 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.877 -1.14 . . . . 0.0 108.409 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -77.94 -71.83 0.4 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.699 -1.25 . . . . 0.0 108.821 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.61 133.72 56.38 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.8 mt -71.43 147.05 11.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.08 54.19 0.39 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.981 2.513 . . . . 0.0 111.83 169.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -51.68 135.77 28.33 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.299 1.44 . . . . 0.0 109.12 161.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.407 ' HB3' ' CE1' ' A' ' 54' ' ' TYR . 6.9 mmtt -139.84 169.31 17.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.332 1.053 . . . . 0.0 111.329 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mp -132.91 150.36 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.405 2.282 . . . . 0.0 106.895 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.589 HD12 ' CE1' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -145.18 100.64 3.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.535 1.934 . . . . 0.0 107.864 177.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 m -71.62 109.29 5.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 59.1 m-85 -108.69 94.42 5.04 Favored 'General case' 0 CA--C 1.515 -0.365 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.73 164.88 11.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.829 168.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.56 153.55 28.09 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -83.39 37.59 0.57 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.128 1.371 . . . . 0.0 111.154 -177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.29 170.76 3.53 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.887 2.075 . . . . 0.0 112.19 171.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -133.96 2.45 3.38 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 126.045 1.738 . . . . 0.0 110.614 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -158.32 142.08 15.44 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.111 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.92 138.85 8.03 Favored Glycine 0 CA--C 1.517 0.2 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -172.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.748 ' HE2' HD11 ' A' ' 30' ' ' LEU . 39.8 mtp -77.23 163.03 26.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.002 0.921 . . . . 0.0 110.887 -175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.426 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.2 mm? -126.5 82.82 65.79 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.133 1.373 . . . . 0.0 107.546 168.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -90.75 154.06 4.14 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.823 2.349 . . . . 0.0 111.795 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.68 28.41 51.44 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.457 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.82 -177.7 4.61 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.351 1.46 . . . . 0.0 108.478 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.51 139.68 36.23 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.823 0.849 . . . . 0.0 108.974 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.62 178.4 7.16 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.966 3.111 . . . . 0.0 112.886 -172.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.7 t80 50.89 23.17 1.35 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.868 2.867 . . . . 0.0 113.514 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.9 m -123.06 157.06 33.62 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.49 1.516 . . . . 0.0 110.351 -172.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -96.83 151.78 19.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -142.07 156.37 45.4 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.664 0.786 . . . . 0.0 109.325 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.9 m -126.03 136.12 52.57 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -135.69 166.68 22.69 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.743 1.617 . . . . 0.0 109.895 170.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.67 153.08 34.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.838 2.055 . . . . 0.0 106.578 -174.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -121.07 137.54 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.807 1.243 . . . . 0.0 108.465 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.1 ttm105 -135.17 131.36 36.67 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 125.44 1.496 . . . . 0.0 108.421 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.512 HG23 ' HD3' ' A' ' 18' ' ' PRO 0.25 0.8 OUTLIER -70.99 140.19 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 127.933 2.493 . . . . 0.0 108.013 176.464 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.2 t -136.07 138.58 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -136.99 -175.6 4.09 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.758 0.823 . . . . 0.0 111.001 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.4 -29.71 69.77 Favored Glycine 0 C--N 1.337 0.623 0 CA-C-O 118.714 -1.048 . . . . 0.0 112.804 -171.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -82.53 -40.25 21.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.973 1.309 . . . . 0.0 110.835 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.36 -165.96 34.05 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 121.943 0.746 . . . . 0.0 111.983 -175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.44 157.29 20.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.062 0.945 . . . . 0.0 112.534 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.91 -157.99 10.29 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.113 1.339 . . . . 0.0 111.039 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -66.86 166.57 22.12 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.013 1.809 . . . . 0.0 111.684 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -101.29 154.05 19.11 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 113.017 -1.901 . . . . 0.0 109.246 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.481 ' HB3' ' HD2' ' A' ' 110' ' ' PRO . 5.6 m -70.19 -174.85 0.26 Allowed Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.733 1.613 . . . . 0.0 110.871 173.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 109' ' ' SER . 29.7 Cg_endo -68.35 161.4 44.93 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 CA-C-N 122.307 1.86 . . . . 0.0 109.532 167.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.69 162.09 24.47 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 122.258 1.027 . . . . 0.0 109.066 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -132.39 162.36 31.3 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.739 1.216 . . . . 0.0 108.271 166.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -129.19 159.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 171.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -147.87 147.07 29.36 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 162.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -112.71 144.48 42.16 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.11 160.73 29.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 124.34 1.056 . . . . 0.0 110.317 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.76 168.66 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 N-CA-C 108.879 -1.239 . . . . 0.0 108.879 174.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -61.62 -29.43 70.05 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.679 0.791 . . . . 0.0 112.116 -174.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 28' ' ' SER . . . 87.68 37.71 7.88 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 125.709 1.624 . . . . 0.0 115.511 163.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -58.02 148.96 24.43 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 117.783 0.791 . . . . 0.0 109.94 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.53 110.06 3.61 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 169.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.01 121.19 8.34 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 120.547 2.174 . . . . 0.0 110.412 -177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.8 t -102.62 146.3 28.37 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.877 1.271 . . . . 0.0 107.712 165.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.1 m -74.22 169.02 18.44 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 161.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.596 0 N-CA-C 106.229 -2.749 . . . . 0.0 106.229 151.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.0 0 N-CA-C 108.278 -1.929 . . . . 0.0 108.278 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p -166.6 -178.95 4.62 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -170.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 t -139.11 177.18 8.08 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 161.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.69 110.81 2.33 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.993 -2.043 . . . . 0.0 107.993 -165.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 t -155.69 -57.12 0.09 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.99 -164.9 0.25 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.788 0.835 . . . . 0.0 109.376 -168.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.33 160.93 16.75 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -168.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -147.61 121.89 9.6 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -71.7 175.74 5.43 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.687 1.232 . . . . 0.0 109.039 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.7 159.82 15.23 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.999 -2.441 . . . . 0.0 106.999 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -65.88 -62.94 1.22 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.029 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.0 -52.18 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.989 0.806 . . . . 0.0 111.11 162.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.3 mt 49.93 161.35 0.04 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 130.168 3.387 . . . . 0.0 115.74 -168.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.42 -174.33 1.95 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.773 1.649 . . . . 0.0 111.386 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.5 mtm -133.62 -47.03 0.81 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.337 1.455 . . . . 0.0 113.218 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.811 HG22 ' HB2' ' A' ' 42' ' ' SER . 14.7 m -131.94 -178.42 2.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 118.858 0.754 . . . . 0.0 110.196 -169.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.45 164.17 19.25 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 126.487 1.915 . . . . 0.0 109.597 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.21 144.6 75.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.459 1.44 . . . . 0.0 112.482 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.61 170.28 4.93 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.997 1.284 . . . . 0.0 111.468 166.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -49.23 142.44 7.22 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 -147.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.0 t -95.79 121.11 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.157 1.783 . . . . 0.0 106.976 -170.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -122.71 88.29 2.9 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.715 1.606 . . . . 0.0 111.312 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.507 HG13 ' HE ' ' A' ' 112' ' ' ARG . 0.2 OUTLIER -87.45 143.69 10.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 157.16 35.47 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.78 2.032 . . . . 0.0 110.089 176.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.39 103.49 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -67.65 -54.08 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.656 1.182 . . . . 0.0 109.312 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -138.33 -179.88 6.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.699 1.2 . . . . 0.0 107.864 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -23.46 56.15 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.269 1.028 . . . . 0.0 111.25 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -122.17 -2.06 9.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.105 2.162 . . . . 0.0 112.694 -166.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.3 tp -144.01 130.0 19.5 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.308 1.443 . . . . 0.0 109.619 -170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.28 117.45 8.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.172 0.896 . . . . 0.0 111.041 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.17 154.7 41.62 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.549 1.14 . . . . 0.0 110.305 176.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.95 103.32 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 C-N-CA 126.809 2.043 . . . . 0.0 106.121 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -92.08 154.2 18.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.108 0.413 . . . . 0.0 110.082 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -151.02 177.63 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.201 1.4 . . . . 0.0 110.124 172.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.86 142.27 25.31 Favored Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.645 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.71 122.93 10.4 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 123.284 2.656 . . . . 0.0 109.65 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 m -71.1 164.57 55.75 Favored Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 118.887 0.767 . . . . 0.0 110.45 175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -64.61 138.93 61.45 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.221 1.947 . . . . 0.0 109.15 168.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -31.1 41.01 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 117.822 0.283 . . . . 0.0 111.228 166.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -50.27 -46.99 55.51 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.182 1.393 . . . . 0.0 110.881 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.811 ' HB2' HG22 ' A' ' 16' ' ' VAL . 61.6 p -71.49 -29.48 64.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.46 -20.21 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 123.672 0.789 . . . . 0.0 109.486 177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 45.33 57.06 5.1 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 127.038 2.135 . . . . 0.0 110.419 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.16 -102.55 0.33 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.444 -1.198 . . . . 0.0 111.427 173.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -138.18 119.66 14.9 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.316 1.047 . . . . 0.0 110.217 -164.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.46 124.71 23.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.451 1.5 . . . . 0.0 109.119 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -92.74 -14.38 28.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 122.888 0.475 . . . . 0.0 112.098 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 149.8 176.37 22.87 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 126.604 2.049 . . . . 0.0 108.25 172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -99.75 151.64 21.01 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -127.9 109.19 11.35 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.904 -1.123 . . . . 0.0 108.939 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.05 133.6 30.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -104.5 147.77 27.22 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 152.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -154.81 158.93 40.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.694 1.198 . . . . 0.0 111.268 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.1 p90 -148.71 161.91 40.8 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.947 0.899 . . . . 0.0 110.253 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -68.38 136.26 53.07 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.2 m -117.39 155.63 29.29 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 59.38 173.76 0.08 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.474 1.109 . . . . 0.0 112.002 -164.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.1 m -165.78 97.47 0.65 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.898 1.279 . . . . 0.0 109.913 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.2 m -67.57 84.32 0.18 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.234 1.014 . . . . 0.0 111.266 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 t 65.72 141.48 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.364 2.666 . . . . 0.0 111.608 -173.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.54 75.46 1.51 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.223 -0.923 . . . . 0.0 112.517 -159.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 -68.81 106.09 2.56 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.51 -0.744 . . . . 0.0 110.475 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 41.86 76.88 0.07 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 129.044 2.938 . . . . 0.0 114.504 171.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -79.0 152.04 31.19 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 121.437 -0.789 . . . . 0.0 111.805 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -85.92 -100.49 0.07 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.96 0.904 . . . . 0.0 109.181 164.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -122.47 170.07 10.35 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.969 1.708 . . . . 0.0 108.001 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.5 mt -78.4 130.91 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -69.09 126.95 31.41 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 167.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -105.49 102.98 12.42 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -78.53 161.02 27.33 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.889 2.076 . . . . 0.0 109.389 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.15 155.7 41.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 84' ' ' LEU . 3.8 mt -133.12 165.93 23.62 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.206 1.402 . . . . 0.0 108.864 170.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.5 m -138.54 105.29 5.36 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.593 -0.692 . . . . 0.0 109.679 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -116.77 93.0 4.03 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -72.86 166.86 22.14 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.549 0.69 . . . . 0.0 109.76 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.89 173.25 47.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.6 p -73.8 11.31 0.88 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.003 2.121 . . . . 0.0 114.769 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -64.43 156.12 30.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.438 1.095 . . . . 0.0 109.856 -167.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.6 p -118.08 8.99 12.56 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.208 1.403 . . . . 0.0 111.307 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -150.12 158.87 44.61 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.627 0.771 . . . . 0.0 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.72 143.6 6.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.953 0.787 . . . . 0.0 111.409 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.8 mtp -97.46 153.11 18.33 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.892 -0.769 . . . . 0.0 112.551 -168.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD13 HD11 ' A' ' 73' ' ' LEU . 3.0 mm? -100.32 87.13 0.72 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.52 2.328 . . . . 0.0 109.143 171.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.42 162.42 12.89 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.252 2.634 . . . . 0.0 111.163 171.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.58 21.04 79.32 Favored Glycine 0 CA--C 1.526 0.765 0 O-C-N 121.716 -0.615 . . . . 0.0 112.603 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.97 172.64 9.86 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.829 1.252 . . . . 0.0 107.803 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -124.53 161.26 49.16 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 124.769 1.228 . . . . 0.0 108.848 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -89.77 160.84 5.14 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 125.091 3.861 . . . . 0.0 115.086 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 65.1 44.82 3.23 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.496 3.518 . . . . 0.0 117.613 175.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.58 -169.39 2.14 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.992 2.117 . . . . 0.0 109.97 172.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -110.45 163.83 13.3 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 158.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -140.44 152.89 46.03 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.516 -0.74 . . . . 0.0 109.883 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.8 m -126.0 139.43 53.43 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -145.3 162.88 36.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.995 2.118 . . . . 0.0 107.18 172.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -137.35 -176.26 4.34 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.126 0.971 . . . . 0.0 108.937 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.25 160.15 41.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -154.31 154.21 32.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.545 1.938 . . . . 0.0 106.193 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -95.48 145.39 8.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.0 t -129.22 139.42 51.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -133.33 -177.97 4.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.833 0.853 . . . . 0.0 109.787 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.54 7.49 3.75 Favored Glycine 0 CA--C 1.521 0.459 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.098 -174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -122.05 -57.17 1.8 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.861 1.331 . . . . 0.0 110.327 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.73 -156.79 8.52 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -170.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 163.02 29.56 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.313 1.045 . . . . 0.0 110.917 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.32 -158.11 10.76 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.453 1.025 . . . . 0.0 111.978 -166.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.23 158.66 54.13 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.569 2.179 . . . . 0.0 111.807 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.58 156.51 25.14 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.941 174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.9 p -64.82 -178.17 0.25 Allowed Pre-proline 0 C--O 1.243 0.724 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.183 166.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -48.33 132.69 24.42 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 N-CA-C 108.591 -1.349 . . . . 0.0 108.591 145.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -62.22 157.6 19.03 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 155.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.507 ' HE ' HG13 ' A' ' 23' ' ' VAL . 3.2 mmm180 -126.21 168.55 13.92 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 123.824 0.85 . . . . 0.0 108.961 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -115.57 155.43 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.505 171.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -144.19 142.78 30.74 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 160.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -114.77 148.28 38.6 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.269 1.427 . . . . 0.0 107.437 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -111.79 162.61 20.42 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 124.213 1.005 . . . . 0.0 110.421 -168.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -71.62 170.54 18.35 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.248 1.966 . . . . 0.0 110.177 168.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.62 -31.32 67.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.902 1.281 . . . . 0.0 111.389 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 65.63 97.38 0.02 OUTLIER Glycine 0 C--N 1.338 0.662 0 C-N-CA 126.225 1.869 . . . . 0.0 112.128 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.3 m 55.13 39.08 31.37 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 117.754 0.777 . . . . 0.0 111.596 -176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.29 125.32 38.72 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.047 -1.418 . . . . 0.0 109.759 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.99 168.12 24.08 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 CA-C-N 119.848 1.824 . . . . 0.0 109.308 169.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -154.53 -173.14 4.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.1 m -149.91 170.68 18.25 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.988 1.315 . . . . 0.0 108.548 171.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.821 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 -177.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.586 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 77.41 145.55 0.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.341 2.257 . . . . 0.0 109.951 -169.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.0 p -165.64 -172.96 2.57 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.161 1.384 . . . . 0.0 109.096 167.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.19 -81.77 1.51 Allowed Glycine 0 CA--C 1.522 0.499 0 CA-C-O 119.553 -0.582 . . . . 0.0 112.887 160.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.7 t -154.17 -101.81 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 t -60.82 136.48 58.09 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.66 1.118 . . . . 0.0 110.945 -174.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.0 33.99 1.03 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.38 1.466 . . . . 0.0 110.584 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -158.71 76.72 0.74 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -165.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.7 p -144.83 90.78 2.09 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.847 -0.533 . . . . 0.0 110.258 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.77 7.85 0.02 OUTLIER Glycine 0 CA--C 1.523 0.556 0 CA-C-O 117.149 -1.917 . . . . 0.0 117.229 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -34.91 -57.03 0.56 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.438 1.895 . . . . 0.0 114.391 -159.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.31 -0.08 13.97 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.447 1.099 . . . . 0.0 111.59 -173.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 mt -63.85 140.99 97.95 Favored Pre-proline 0 N--CA 1.472 0.634 0 O-C-N 120.668 -1.27 . . . . 0.0 112.937 -166.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.72 161.7 44.37 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.724 2.283 . . . . 0.0 111.329 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 52.7 mtm -108.45 -41.39 4.86 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 124.539 1.136 . . . . 0.0 112.797 -169.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.612 HG22 ' HB2' ' A' ' 42' ' ' SER . 4.7 m -132.25 152.56 36.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.535 0.683 . . . . 0.0 109.432 -165.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.96 168.43 21.9 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 108.339 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 1.6 Cg_endo -60.68 155.63 47.32 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 CA-C-N 119.362 0.808 . . . . 0.0 110.635 165.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.25 -155.78 0.76 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.761 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -45.71 128.77 8.82 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.52 1.128 . . . . 0.0 111.28 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.4 t -105.08 145.43 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -120.96 150.73 40.66 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 170.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.48 119.5 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 174.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.28 130.05 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG11 ' HD3' ' A' ' 117' ' ' PRO . 66.2 t -76.8 118.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -85.63 -52.57 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 125.501 1.52 . . . . 0.0 107.606 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -136.33 177.73 7.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.337 1.455 . . . . 0.0 109.611 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -38.21 54.4 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.072 1.349 . . . . 0.0 112.608 176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -113.61 5.95 16.76 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.402 1.081 . . . . 0.0 111.692 -173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.2 tp -137.39 125.2 22.52 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 110.712 -168.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.91 157.48 27.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 160.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -98.73 150.81 21.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 163.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 HD23 ' A' ' 84' ' ' LEU . 16.5 t -130.5 139.72 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 125.542 1.537 . . . . 0.0 107.54 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -128.81 135.4 49.09 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.348 2.259 . . . . 0.0 105.234 -172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -140.85 -170.87 3.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.13 0.972 . . . . 0.0 108.967 176.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -119.77 135.32 24.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.523 1.129 . . . . 0.0 110.321 -167.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.38 96.41 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.509 2.806 . . . . 0.0 110.606 -173.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.417 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 19.7 m -63.78 156.08 74.14 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.392 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.03 149.74 32.98 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.558 2.172 . . . . 0.0 109.961 -174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.53 -39.05 72.72 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.39 1.076 . . . . 0.0 109.724 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -58.64 -30.28 67.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.612 ' HB2' HG22 ' A' ' 16' ' ' VAL . 54.1 p -71.68 -37.89 70.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.806 0.73 . . . . 0.0 110.315 174.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.0 mt -63.34 -27.53 43.24 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 CA-C-O 118.1 -0.952 . . . . 0.0 109.638 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 56.1 13.91 1.32 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.754 1.622 . . . . 0.0 113.393 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.75 -177.85 48.57 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -162.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.78 111.54 19.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.768 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 tp -44.89 132.01 6.9 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.038 2.135 . . . . 0.0 110.383 168.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -117.48 -12.08 10.43 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.027 1.331 . . . . 0.0 112.54 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 150.58 -171.05 30.45 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.529 1.538 . . . . 0.0 110.482 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -114.8 159.65 20.36 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.984 0.514 . . . . 0.0 109.808 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -127.31 147.42 50.24 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.842 1.257 . . . . 0.0 108.072 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.0 mt -120.17 124.53 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 162.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -97.22 145.78 25.73 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 160.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.428 ' CD1' HD11 ' A' ' 84' ' ' LEU . 34.0 p90 -155.91 161.25 40.58 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 109.556 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -149.1 157.32 43.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.399 0.68 . . . . 0.0 109.893 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.47 ' HG2' HE22 ' A' ' 58' ' ' GLN . 12.0 tptm -68.8 140.21 55.27 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 92.8 m -130.85 131.31 44.51 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.47 HE22 ' HG2' ' A' ' 56' ' ' LYS . 1.4 pm0 -166.06 -10.33 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.2 m 60.84 -60.1 0.08 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.161 1.785 . . . . 0.0 113.517 -160.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 43.87 47.66 6.94 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 127.787 2.435 . . . . 0.0 112.844 -175.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -55.48 131.17 45.39 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 173.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -167.57 166.57 14.05 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.696 1.998 . . . . 0.0 106.242 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -61.08 -28.08 68.82 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 120.571 1.532 . . . . 0.0 113.512 -171.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -134.34 162.36 32.4 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.329 0.968 . . . . 0.0 110.217 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.7 ttt85 98.35 87.89 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 130.435 3.494 . . . . 0.0 108.641 164.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -134.49 86.58 2.28 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.736 1.615 . . . . 0.0 107.931 -173.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -150.58 120.57 7.16 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.62 1.568 . . . . 0.0 107.704 171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.0 mt -98.79 124.76 52.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 171.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -81.7 116.24 21.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.389 1.076 . . . . 0.0 108.911 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -98.55 142.65 29.88 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.177 0.991 . . . . 0.0 109.154 173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -137.44 165.95 25.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 127.705 2.402 . . . . 0.0 110.94 -164.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -131.62 158.33 43.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-O 122.563 1.173 . . . . 0.0 110.374 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.552 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -141.83 130.99 23.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.319 2.248 . . . . 0.0 108.017 166.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.3 m -86.7 145.58 26.62 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.309 1.444 . . . . 0.0 108.181 171.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 55.3 m-85 -139.95 161.15 38.28 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.285 1.034 . . . . 0.0 110.344 167.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -77.57 171.27 15.18 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 122.668 1.223 . . . . 0.0 112.148 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.68 151.66 36.18 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.812 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 t 62.91 -6.38 0.17 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.167 2.187 . . . . 0.0 115.736 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -67.25 146.35 54.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 120.527 -1.358 . . . . 0.0 107.444 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.9 p -110.23 7.77 23.34 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.249 1.419 . . . . 0.0 112.255 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.12 167.33 25.3 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.403 0.547 . . . . 0.0 112.037 168.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.61 -172.16 33.57 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 128.652 3.025 . . . . 0.0 107.396 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.9 mtp -129.84 169.29 15.36 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.968 1.384 . . . . 0.0 111.689 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.552 HD13 ' CD1' ' A' ' 73' ' ' LEU . 4.0 mm? -119.01 84.54 26.75 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 164.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -88.8 157.62 6.12 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.832 3.021 . . . . 0.0 111.326 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.67 14.33 75.18 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.994 -0.892 . . . . 0.0 113.284 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 84' ' ' LEU . 2.8 mm? -73.8 -179.35 3.61 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.573 1.549 . . . . 0.0 108.95 174.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -112.16 147.91 37.95 Favored Pre-proline 0 C--O 1.237 0.405 0 CA-C-N 118.528 0.604 . . . . 0.0 111.624 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -70.17 173.28 11.58 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 123.312 2.674 . . . . 0.0 113.022 176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.413 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 26.6 t80 48.55 36.97 8.27 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.025 2.13 . . . . 0.0 113.35 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -137.42 142.4 41.66 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 120.661 -1.274 . . . . 0.0 111.807 -169.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -79.47 146.65 32.62 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 161.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.417 ' CZ ' ' HD2' ' A' ' 56' ' ' LYS . 56.3 m-85 -139.0 148.58 43.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 167.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.1 m -115.07 154.14 29.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.68 163.8 38.33 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.96 1.704 . . . . 0.0 109.519 -177.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -140.66 157.64 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.286 1.034 . . . . 0.0 108.936 164.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.72 143.76 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.4 ttt180 -138.66 147.33 42.71 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.31 148.68 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.7 137.92 51.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 C-N-CA 125.463 1.505 . . . . 0.0 107.154 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -141.77 178.18 7.67 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.282 1.033 . . . . 0.0 109.292 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.22 -1.93 12.09 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.296 0.95 . . . . 0.0 114.667 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -123.18 -26.01 4.4 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.299 1.44 . . . . 0.0 110.997 -173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 163.46 -159.27 31.87 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-O 121.691 0.606 . . . . 0.0 111.853 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -132.72 124.89 29.02 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -160.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.39 -160.93 13.29 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.912 -0.475 . . . . 0.0 111.912 -165.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -67.04 171.37 11.39 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 CA-C-N 118.997 1.398 . . . . 0.0 109.312 163.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.31 165.45 12.68 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 85.9 p -67.86 -178.04 0.36 Allowed Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 125.525 1.53 . . . . 0.0 111.034 -164.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 22.5 Cg_endo -50.94 134.11 41.59 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 N-CA-C 108.485 -1.39 . . . . 0.0 108.485 149.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.44 141.32 56.56 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 167.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.05 169.18 9.11 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.9 m -135.25 150.23 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -156.93 141.04 16.37 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.156 0.982 . . . . 0.0 108.529 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -120.37 128.4 53.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.536 1.534 . . . . 0.0 109.043 175.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -82.43 158.86 65.6 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 123.946 0.898 . . . . 0.0 110.039 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.424 ' HD3' HG11 ' A' ' 25' ' ' VAL . 31.3 Cg_endo -67.68 -89.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.938 3.092 . . . . 0.0 112.383 -167.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 28.3 tt0 -151.0 -31.14 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.217 1.371 . . . . 0.0 112.631 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.91 -161.18 25.55 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.279 1.419 . . . . 0.0 112.649 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.08 73.79 0.37 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 127.396 2.278 . . . . 0.0 112.051 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -167.68 158.44 31.29 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 161.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.41 -43.56 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.428 2.752 . . . . 0.0 111.745 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 23.8 t -144.56 -98.43 0.1 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -174.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 t -65.6 -39.0 91.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.46 1.027 . . . . 0.0 109.367 165.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 103.117 -3.993 . . . . 0.0 103.117 -139.235 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.173 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -73.99 90.86 1.99 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 163.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -162.88 162.03 26.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.217 1.007 . . . . 0.0 109.057 -167.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.43 158.2 28.51 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 107.778 -2.129 . . . . 0.0 107.778 165.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -174.67 -62.79 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.2 m -68.43 172.06 6.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.028 1.331 . . . . 0.0 109.96 164.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.69 -42.98 0.08 OUTLIER Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.55 162.24 29.2 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.596 0.698 . . . . 0.0 109.208 165.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 t -146.77 158.01 43.81 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.458 1.503 . . . . 0.0 107.381 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.81 -67.49 0.55 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 126.107 1.813 . . . . 0.0 108.772 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 50.11 61.23 3.3 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 126.251 1.82 . . . . 0.0 112.852 170.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.15 -23.18 67.05 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.274 -167.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.28 134.34 89.18 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 121.246 1.839 . . . . 0.0 110.263 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -61.37 140.75 89.71 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.752 2.301 . . . . 0.0 113.638 -171.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.5 mtm -79.78 -43.54 22.31 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 125.128 1.371 . . . . 0.0 112.57 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.66 HG22 ' CB ' ' A' ' 42' ' ' SER . 9.5 m -138.08 165.93 24.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.23 0.538 . . . . 0.0 111.279 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -95.22 172.19 5.68 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 127.112 2.165 . . . . 0.0 109.84 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 27.9 Cg_endo -65.25 169.52 12.16 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.468 2.112 . . . . 0.0 113.223 174.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.31 172.47 55.22 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 114.493 -1.231 . . . . 0.0 111.922 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -51.04 107.59 0.19 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.448 1.499 . . . . 0.0 113.501 -157.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.21 152.08 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 126.862 2.065 . . . . 0.0 109.259 -172.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -141.86 156.53 45.53 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.139 1.776 . . . . 0.0 107.16 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 143.42 20.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 120.893 -1.129 . . . . 0.0 110.373 171.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -123.69 128.57 49.82 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.514 2.326 . . . . 0.0 108.835 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.8 t -82.26 122.31 36.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.478 ' HB ' HD12 ' A' ' 30' ' ' LEU . 50.4 t -81.53 -50.52 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -153.29 -172.48 4.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.302 0.572 . . . . 0.0 110.182 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.97 -35.55 66.85 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.785 0.834 . . . . 0.0 112.191 -171.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.5 p -127.74 18.59 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.706 1.202 . . . . 0.0 111.204 -168.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.583 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.3 tm? -145.81 140.22 26.95 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.623 1.569 . . . . 0.0 110.94 176.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -140.19 167.62 21.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.948 1.299 . . . . 0.0 108.237 169.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.06 145.68 50.92 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.003 1.721 . . . . 0.0 109.993 174.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.451 HG21 HD23 ' A' ' 84' ' ' LEU . 23.4 t -130.56 133.35 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -166.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.4 m170 -122.24 149.36 43.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.486 ' CZ3' HD11 ' A' ' 52' ' ' ILE . 34.3 p90 -147.98 154.29 40.12 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 172.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.84 142.13 28.8 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.97 123.76 11.38 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.283 2.655 . . . . 0.0 110.551 -171.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG22 ' H ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -51.22 163.31 0.55 Allowed Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 124.309 1.043 . . . . 0.0 110.73 160.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.76 -134.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 1 C-N-CA 126.738 4.959 . . . . 0.0 107.627 177.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.67 -31.64 1.76 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 117.476 -1.25 . . . . 0.0 111.446 161.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -49.9 -45.16 50.58 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 120.166 1.348 . . . . 0.0 112.399 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.66 ' CB ' HG22 ' A' ' 16' ' ' VAL . 86.5 p -75.3 -27.45 59.33 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.394 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.5 mt -64.04 -29.09 46.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 117.659 -1.162 . . . . 0.0 109.015 169.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 68.29 -26.13 0.13 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 128.431 2.692 . . . . 0.0 114.291 170.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.79 -164.76 11.7 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 128.473 2.94 . . . . 0.0 107.916 166.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -76.7 149.88 36.37 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 170.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.18 129.89 38.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.165 1.386 . . . . 0.0 107.891 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 73.2 mm-40 -98.4 -28.89 13.43 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.584 0.353 . . . . 0.0 111.015 172.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.52 179.75 38.81 Favored Glycine 0 N--CA 1.448 -0.536 0 O-C-N 121.402 -0.811 . . . . 0.0 111.278 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -122.34 149.92 43.11 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -122.63 125.83 46.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.486 HD11 ' CZ3' ' A' ' 35' ' ' TRP . 16.7 mt -94.58 123.52 46.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -92.32 146.23 23.86 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 164.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -156.98 168.37 27.7 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.203 1.001 . . . . 0.0 112.356 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -148.91 156.98 43.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.166 1.386 . . . . 0.0 109.911 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -73.64 137.69 44.33 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.467 1.507 . . . . 0.0 108.351 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.1 m -130.61 148.17 52.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.202 1.001 . . . . 0.0 109.347 -171.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -146.37 -28.52 0.41 Allowed 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 31.22 69.6 0.1 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.874 2.47 . . . . 0.0 114.028 -176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 m -119.55 -179.05 3.76 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 159.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.0 m -114.45 90.04 3.24 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.153 0.581 . . . . 0.0 109.56 -168.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -63.04 157.85 21.0 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.843 -0.536 . . . . 0.0 110.329 172.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.0 ttt-85 -86.51 -37.97 17.7 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -148.09 92.68 2.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.606 1.162 . . . . 0.0 108.486 168.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -160.03 136.31 8.81 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.181 0.9 . . . . 0.0 109.815 165.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.37 81.63 1.18 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.395 1.078 . . . . 0.0 108.272 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -157.96 101.7 1.79 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.678 0.791 . . . . 0.0 109.332 171.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.16 122.2 41.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 166.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -78.91 139.3 38.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 165.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -120.31 125.35 47.85 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -97.67 163.71 12.72 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.714 1.605 . . . . 0.0 108.733 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mt -136.48 149.85 27.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 106.223 -174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.437 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 1.1 mt -139.22 137.08 35.66 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.687 1.595 . . . . 0.0 109.258 -170.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.0 m -98.76 132.36 44.19 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.767 0.827 . . . . 0.0 109.77 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.437 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 63.7 m-85 -143.87 68.13 1.28 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.805 2.042 . . . . 0.0 108.036 170.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -66.08 133.91 51.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.978 -1.464 . . . . 0.0 109.954 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.76 176.47 25.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.665 1.602 . . . . 0.0 112.599 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.9 p -74.88 0.43 15.64 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -167.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HE2' ' CE1' ' A' ' 81' ' ' HIS . 2.2 mmmp? -45.9 146.72 1.14 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.035 1.289 . . . . 0.0 112.159 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 p -99.6 -2.95 34.34 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.425 1.89 . . . . 0.0 111.136 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.416 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 15.1 p80 -149.9 166.88 28.26 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.741 -0.599 . . . . 0.0 110.885 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.29 158.72 24.44 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.453 1.025 . . . . 0.0 112.228 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.583 ' HE2' HD11 ' A' ' 30' ' ' LEU . 55.2 mtp -88.18 160.32 17.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.911 0.884 . . . . 0.0 112.187 -170.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.614 HD12 HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -117.35 89.33 31.13 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 125.641 1.576 . . . . 0.0 107.534 166.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -93.18 156.59 2.6 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 124.063 3.175 . . . . 0.0 111.421 168.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.73 29.15 19.45 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.887 0.756 . . . . 0.0 111.611 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.614 HD21 HD12 ' A' ' 84' ' ' LEU . 2.9 mm? -101.4 175.82 5.45 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 126.375 1.87 . . . . 0.0 107.932 -176.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -133.22 150.36 75.12 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 124.851 1.26 . . . . 0.0 110.19 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -71.08 166.3 29.61 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.944 2.43 . . . . 0.0 112.277 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 13.1 t80 51.48 34.1 11.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.616 2.366 . . . . 0.0 113.461 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.4 m -132.53 148.45 52.38 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 124.491 1.117 . . . . 0.0 110.578 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -85.65 151.97 23.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 169.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -137.29 149.32 47.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.115 1.366 . . . . 0.0 108.289 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.0 m -126.03 134.78 51.34 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.57 163.25 37.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.823 2.049 . . . . 0.0 108.486 -171.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.94 169.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.05 1.34 . . . . 0.0 108.762 173.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.42 149.55 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.747 1.219 . . . . 0.0 108.113 173.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -140.13 147.31 40.01 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.481 1.512 . . . . 0.0 108.0 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -87.87 154.06 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 CA-C-N 119.096 0.862 . . . . 0.0 109.363 174.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.4 t -132.12 139.1 51.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -138.63 -170.94 2.95 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.15 0.58 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.2 -8.25 17.12 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.535 1.065 . . . . 0.0 115.433 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -113.11 -57.41 2.29 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.15 1.475 . . . . 0.0 109.397 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.37 -163.61 25.64 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.302 0.956 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -87.28 160.65 18.35 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 169.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.74 -157.27 10.09 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 108.499 -1.841 . . . . 0.0 108.499 165.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -62.52 156.95 49.05 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 CA-C-N 119.607 1.703 . . . . 0.0 111.342 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -93.41 155.23 17.49 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 112.947 -1.933 . . . . 0.0 108.963 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -66.04 166.89 13.78 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.402 1.481 . . . . 0.0 108.603 168.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -64.18 162.7 28.77 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.73 1.62 . . . . 0.0 109.671 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -61.53 138.15 58.27 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 122.185 0.993 . . . . 0.0 110.064 172.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 173.84 6.79 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 159.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.86 156.56 42.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 171.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -154.7 145.36 22.33 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 158.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -123.64 146.81 47.92 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 p -90.64 157.43 44.1 Favored Pre-proline 0 C--N 1.32 -0.705 0 C-N-CA 124.232 1.013 . . . . 0.0 109.598 -167.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.07 164.98 31.75 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.417 2.078 . . . . 0.0 109.003 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -57.6 -27.57 62.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.556 1.142 . . . . 0.0 112.466 -173.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 121.63 -96.52 0.59 Allowed Glycine 0 C--O 1.239 0.41 0 C-N-CA 125.572 1.558 . . . . 0.0 112.012 155.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.6 t -152.01 165.96 33.05 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 175.64 -113.53 0.45 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 105.317 -3.113 . . . . 0.0 105.317 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.65 142.54 77.64 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.14 1.893 . . . . 0.0 110.726 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.0 p -141.61 148.49 39.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 161.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.4 m -72.61 173.51 8.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 167.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 C-N-CA 128.175 2.798 . . . . 0.0 106.461 168.757 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.546 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.22 123.55 42.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.021 1.328 . . . . 0.0 109.925 -164.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 m -136.61 73.64 1.46 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.19 1.396 . . . . 0.0 110.008 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.0 -178.49 27.66 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.293 1.425 . . . . 0.0 110.076 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m -114.11 161.91 17.16 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.596 1.158 . . . . 0.0 109.573 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.7 m -120.28 174.55 6.45 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.66 136.15 2.83 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -148.72 148.44 30.02 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -167.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -139.64 151.39 45.93 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.942 1.297 . . . . 0.0 109.215 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.18 175.38 50.97 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.059 1.314 . . . . 0.0 112.268 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -125.8 -53.09 1.55 Allowed 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 125.187 1.395 . . . . 0.0 109.09 172.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -76.97 -5.09 47.26 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.218 -173.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.9 mt -71.68 151.69 93.52 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 126.09 1.756 . . . . 0.0 110.782 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.475 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 86.2 Cg_endo -73.8 172.81 15.09 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.627 2.218 . . . . 0.0 111.137 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 54.3 mtm -121.34 -30.79 4.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.286 1.435 . . . . 0.0 113.551 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.726 HG22 ' HB2' ' A' ' 42' ' ' SER . 34.3 m -140.97 163.12 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 111.371 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.01 169.17 18.6 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.856 2.062 . . . . 0.0 109.029 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 7.6 Cg_endo -70.19 160.36 49.87 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.255 1.304 . . . . 0.0 110.474 165.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.47 -154.15 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.429 1.49 . . . . 0.0 114.46 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -47.41 131.59 13.55 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.528 1.131 . . . . 0.0 110.303 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.73 147.37 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -131.86 158.42 41.36 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.15 150.22 15.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.82 128.96 50.28 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.16 143.47 15.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 159.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 30' ' ' LEU . 92.9 t -111.03 -53.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -132.27 -171.11 2.56 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.992 1.317 . . . . 0.0 108.687 -174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 0.3 OUTLIER -64.3 -37.14 86.44 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.056 -1.027 . . . . 0.0 112.517 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.0 p -123.34 11.63 9.36 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.947 1.299 . . . . 0.0 110.078 -166.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.701 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.3 tm? -134.69 137.77 43.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.58 1.952 . . . . 0.0 109.0 -178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -139.73 165.51 27.07 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.33 118.71 18.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.97 147.88 4.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 107.313 178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -131.0 133.35 45.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -118.39 -158.81 0.73 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.961 2.104 . . . . 0.0 108.247 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.08 137.56 30.97 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 126.492 1.917 . . . . 0.0 109.909 -175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -76.68 101.16 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.505 2.804 . . . . 0.0 109.405 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 28.8 m -67.1 158.48 81.18 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 175.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 38' ' ' VAL . 41.0 Cg_endo -71.63 147.86 52.14 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.765 2.31 . . . . 0.0 109.128 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -54.18 -22.74 12.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.257 0.623 . . . . 0.0 110.736 171.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.483 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -61.68 -47.35 85.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 126.046 1.738 . . . . 0.0 114.557 174.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.726 ' HB2' HG22 ' A' ' 16' ' ' VAL . 7.9 p -71.37 -31.8 67.74 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.72 1.6 . . . . 0.0 109.732 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 47' ' ' LEU . 27.1 mt -68.54 -26.02 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.846 0.859 . . . . 0.0 109.736 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 66.13 3.7 2.79 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.168 2.587 . . . . 0.0 113.823 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.67 -161.41 31.96 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -172.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -70.98 114.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.537 0.669 . . . . 0.0 109.735 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.3 tm? -55.13 120.35 6.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 163.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -85.38 -31.4 22.95 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.536 0.734 . . . . 0.0 109.291 176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.85 168.55 28.2 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -99.6 112.5 24.71 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -81.0 142.87 32.97 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.1 mt -112.06 143.45 21.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 170.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.447 ' CE2' ' CD1' ' A' ' 72' ' ' ILE . 43.3 m-85 -112.45 140.56 47.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 166.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -153.63 162.15 41.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 120.122 1.328 . . . . 0.0 110.232 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -148.57 157.78 43.69 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.539 -0.725 . . . . 0.0 109.233 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -69.09 140.59 54.82 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.01 150.58 29.08 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 171.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -91.91 158.76 16.11 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 166.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.4 p -98.15 -88.67 0.31 Allowed 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.0 t -84.42 -52.91 5.81 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.201 0.6 . . . . 0.0 112.411 -170.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.0 t -69.57 116.23 9.73 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -89.7 118.18 29.11 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.499 1.119 . . . . 0.0 108.778 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 160.61 19.07 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 165.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -141.44 156.37 45.78 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 164.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 30.58 68.02 0.11 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.986 2.514 . . . . 0.0 113.825 -173.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -132.52 150.87 52.08 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 159.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -70.19 177.16 3.41 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 159.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 53.5 mt -124.54 129.25 73.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.55 124.17 23.58 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -119.75 92.46 3.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -69.81 167.37 17.37 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 127.134 2.174 . . . . 0.0 110.101 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 53' ' ' TYR . 3.4 mm -138.92 152.42 24.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 112.354 -2.203 . . . . 0.0 105.091 -162.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.498 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -148.69 160.47 43.13 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.259 169.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.1 m -133.58 97.35 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -161.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' CZ ' ' CD2' ' A' ' 73' ' ' LEU . 58.3 m-85 -105.53 112.1 25.06 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 169.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.29 166.92 16.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.903 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.51 172.91 4.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.7 m -85.5 41.61 0.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.469 -1.018 . . . . 0.0 111.387 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE3' ' CE1' ' A' ' 81' ' ' HIS . 0.0 OUTLIER -63.26 155.93 27.0 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 120.698 -1.251 . . . . 0.0 110.183 162.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.8 p -109.13 -3.78 17.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 126.605 1.962 . . . . 0.0 112.288 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.489 ' CE1' ' HE3' ' A' ' 79' ' ' LYS . 14.7 p80 -146.22 164.53 32.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.055 0.455 . . . . 0.0 109.98 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.03 158.86 30.62 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.701 ' HE2' HD11 ' A' ' 30' ' ' LEU . 39.4 mtp -90.96 162.61 14.67 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.871 0.843 . . . . 0.0 111.117 -168.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 84' ' ' LEU . 1.1 mm? -120.82 89.98 46.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 160.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -96.1 148.95 1.26 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.394 3.396 . . . . 0.0 112.037 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.43 51.11 8.73 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.47 179.71 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.606 2.362 . . . . 0.0 107.773 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.0 142.37 26.12 Favored Pre-proline 0 C--O 1.239 0.511 0 C-N-CA 124.466 1.107 . . . . 0.0 110.485 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -68.29 166.4 25.43 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.425 2.083 . . . . 0.0 110.84 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER 37.25 46.26 0.57 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 129.894 3.278 . . . . 0.0 113.869 176.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.1 m -119.72 -176.12 3.1 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.332 1.453 . . . . 0.0 109.122 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.07 157.21 19.57 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 148.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -137.61 154.97 49.68 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 163.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.1 m -124.24 141.8 51.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 155.23 44.26 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 127.235 2.214 . . . . 0.0 108.813 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.36 169.28 17.16 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.069 1.348 . . . . 0.0 107.734 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.2 t -121.25 152.71 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -146.53 131.17 17.86 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.9 1.28 . . . . 0.0 107.77 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.85 150.95 5.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.7 t -146.74 135.82 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 125.369 1.468 . . . . 0.0 107.069 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.65 178.85 6.84 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.813 1.245 . . . . 0.0 107.716 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.8 57.28 3.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.345 0.974 . . . . 0.0 112.014 -172.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -160.71 -41.86 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.481 1.913 . . . . 0.0 109.327 173.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 171.74 -168.9 42.03 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -171.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -99.69 166.28 11.19 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.056 0.942 . . . . 0.0 110.075 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.475 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -108.84 -174.48 21.48 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 124.367 0.984 . . . . 0.0 113.284 170.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.33 153.45 74.31 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.748 1.632 . . . . 0.0 110.444 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.44 165.39 16.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.688 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 54.0 p -110.78 -171.69 0.22 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.106 0.962 . . . . 0.0 112.112 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 48.5 Cg_endo -64.84 139.46 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 N-CA-C 108.525 -1.375 . . . . 0.0 108.525 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.01 89.55 0.61 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 112' ' ' ARG . 0.7 OUTLIER -65.57 159.94 23.53 Favored 'General case' 0 CA--C 1.505 -0.755 0 O-C-N 121.952 -0.467 . . . . 0.0 110.425 173.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.1 t -128.8 167.22 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 171.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.47 156.96 36.19 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.85 2.06 . . . . 0.0 108.156 167.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.75 147.99 44.58 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 125.218 1.407 . . . . 0.0 110.009 170.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 p -105.21 166.25 11.74 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.377 1.071 . . . . 0.0 111.478 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -81.92 167.42 16.35 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 124.856 3.704 . . . . 0.0 111.791 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 90' ' ' PHE . 38.7 mt-10 -56.49 -33.08 65.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.028 1.331 . . . . 0.0 111.327 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 28' ' ' SER . . . 127.66 -75.66 0.41 Allowed Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 126.326 1.917 . . . . 0.0 109.341 160.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.8 m -152.56 135.09 15.24 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.025 2.13 . . . . 0.0 105.481 166.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -56.87 116.84 8.3 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 117.535 -1.703 . . . . 0.0 109.119 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -72.93 169.82 21.23 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.575 2.183 . . . . 0.0 111.149 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 p -66.59 166.47 12.7 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.571 0.7 . . . . 0.0 109.849 162.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.9 m -154.36 173.73 15.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.035 1.734 . . . . 0.0 107.159 171.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.394 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 -179.792 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.801 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m 36.13 84.97 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 129.474 3.11 . . . . 0.0 113.943 162.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m -70.37 158.38 36.07 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.389 0.614 . . . . 0.0 110.998 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.56 147.72 6.35 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 106.558 -2.617 . . . . 0.0 106.558 -170.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.2 m -78.47 159.1 28.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 163.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.87 167.47 21.68 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.618 1.167 . . . . 0.0 108.81 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.9 -161.79 29.75 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 -174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.8 m170 66.77 67.72 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.559 2.344 . . . . 0.0 111.312 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.9 m -130.77 128.6 41.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.825 0.85 . . . . 0.0 111.958 -169.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -142.2 -167.11 11.22 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 127.826 2.631 . . . . 0.0 109.548 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -87.78 -69.79 0.67 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.065 0.946 . . . . 0.0 112.043 -173.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -97.72 -19.08 18.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.828 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.0 mt -66.78 143.81 98.26 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 119.915 1.234 . . . . 0.0 112.002 -177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.471 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 84.4 Cg_endo -72.56 152.02 53.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.649 2.899 . . . . 0.0 111.652 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 68.8 mtm -109.04 -38.98 5.42 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 117.652 -1.166 . . . . 0.0 113.854 -164.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.831 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.7 m -133.87 147.84 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 120.459 1.481 . . . . 0.0 113.102 -170.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.63 157.25 67.46 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 127.167 2.187 . . . . 0.0 109.991 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -68.49 162.96 38.58 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 122.348 2.032 . . . . 0.0 112.196 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.87 -149.04 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.26 2.362 . . . . 0.0 115.053 -175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -66.94 78.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.339 1.455 . . . . 0.0 113.033 -171.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.1 t -53.67 139.98 10.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -122.73 158.28 30.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.562 1.545 . . . . 0.0 107.082 171.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.419 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -146.36 123.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 119.027 0.831 . . . . 0.0 108.942 168.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.83 102.33 7.51 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 127.998 2.519 . . . . 0.0 109.39 -169.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.28 0.8 OUTLIER -73.87 116.73 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-O 121.558 0.694 . . . . 0.0 110.313 -171.991 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 30' ' ' LEU . 45.8 t -69.66 -49.59 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -173.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -139.33 -163.85 1.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.236 1.815 . . . . 0.0 108.971 -164.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -29.94 56.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.654 -1.279 . . . . 0.0 113.151 177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.3 p -124.96 11.79 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.954 1.301 . . . . 0.0 110.764 -168.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.73 HD11 ' HE2' ' A' ' 83' ' ' MET . 1.9 tm? -143.56 136.31 27.41 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.222 1.409 . . . . 0.0 107.862 -171.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -140.08 165.87 26.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.42 121.62 26.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.27 141.75 15.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -126.96 150.7 49.26 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.975 0.51 . . . . 0.0 110.3 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.3 p90 -151.26 178.9 8.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.424 . . . . 0.0 109.945 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.84 142.66 25.05 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.48 -0.762 . . . . 0.0 109.003 172.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.46 111.53 3.13 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 123.039 2.493 . . . . 0.0 107.636 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.4 m -66.59 156.34 86.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -78.51 143.88 19.6 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 122.348 2.032 . . . . 0.0 108.449 -172.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.535 ' HA ' HD12 ' A' ' 43' ' ' ILE . 3.0 mm? -59.23 -27.62 65.93 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.655 0.382 . . . . 0.0 110.814 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -60.01 -38.55 82.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 173.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.831 ' HB2' HG22 ' A' ' 16' ' ' VAL . 86.2 p -67.4 -41.81 84.31 Favored 'General case' 0 C--O 1.227 -0.096 0 CA-C-N 119.027 0.83 . . . . 0.0 110.344 172.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 40' ' ' LEU . 32.3 mt -67.74 -23.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.156 -0.926 . . . . 0.0 109.644 -174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 56.17 11.31 0.75 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.383 1.873 . . . . 0.0 114.06 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.52 179.01 41.75 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 126.436 1.969 . . . . 0.0 108.256 -177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -73.94 122.9 23.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.532 ' HB2' HD13 ' A' ' 43' ' ' ILE . 9.4 tp -57.45 112.55 1.45 Allowed 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.57 1.148 . . . . 0.0 108.525 175.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -68.17 -43.74 77.51 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.057 0.943 . . . . 0.0 109.472 168.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.46 -177.2 45.94 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.41 ' CE2' HD21 ' A' ' 47' ' ' LEU . 92.5 m-85 -105.87 112.51 25.6 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.453 1.901 . . . . 0.0 105.989 169.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -83.51 153.24 24.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.41 117.26 50.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -91.57 116.55 28.96 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -135.58 164.01 28.81 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 119.187 0.903 . . . . 0.0 110.912 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.1 p90 -149.71 163.51 37.76 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.202 1.001 . . . . 0.0 110.5 170.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.32 135.48 50.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.958 1.303 . . . . 0.0 108.177 168.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 19.2 m -126.34 140.05 52.81 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -166.22 168.44 15.23 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.351 1.06 . . . . 0.0 108.792 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.1 t -135.89 106.64 6.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.5 m -145.26 37.56 1.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.274 1.43 . . . . 0.0 110.322 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 p -62.69 63.73 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 130.017 3.327 . . . . 0.0 113.919 -172.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.03 13.59 0.6 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.174 1.79 . . . . 0.0 111.001 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.45 175.54 8.14 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.786 1.235 . . . . 0.0 108.939 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -61.22 162.01 8.11 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -46.88 130.84 12.08 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.593 1.157 . . . . 0.0 111.064 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -105.72 -177.03 3.25 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.448 1.499 . . . . 0.0 107.506 162.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -112.62 157.39 21.28 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 152.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 85.6 mt -88.91 123.01 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -66.99 126.13 28.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 167.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -116.21 160.0 21.03 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.409 1.084 . . . . 0.0 110.031 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -142.51 166.4 24.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 122.343 1.068 . . . . 0.0 112.313 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 mp -133.16 139.14 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 126.828 2.051 . . . . 0.0 105.864 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.704 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 1.1 mt -120.86 153.04 37.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 127.651 2.38 . . . . 0.0 107.692 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.1 m -134.26 97.92 3.97 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.4 0.68 . . . . 0.0 110.062 -168.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.704 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 42.6 m-85 -110.13 92.35 4.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 123.945 0.898 . . . . 0.0 108.933 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.2 163.25 27.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 120.962 0.41 . . . . 0.0 110.516 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.5 177.19 12.86 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.261 0.923 . . . . 0.0 113.023 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.7 p -76.53 25.3 0.14 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.04 2.536 . . . . 0.0 114.241 -169.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -58.2 160.36 5.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.049 1.34 . . . . 0.0 111.322 176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.5 p -128.91 -2.02 5.26 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.105 0.962 . . . . 0.0 111.987 -172.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -146.51 163.72 34.83 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.99 151.86 23.03 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.73 ' HE2' HD11 ' A' ' 30' ' ' LEU . 38.7 mtp -76.9 163.82 26.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -119.58 93.13 47.09 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 157.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -93.29 161.02 2.5 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.745 2.296 . . . . 0.0 111.137 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.75 31.82 59.93 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD11 HD12 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -84.69 171.72 12.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.693 1.997 . . . . 0.0 106.923 166.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.64 153.25 45.9 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 123.788 0.835 . . . . 0.0 110.067 163.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -68.66 169.51 17.28 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.683 2.255 . . . . 0.0 112.63 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.9 t80 47.49 51.04 14.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.146 1.778 . . . . 0.0 111.191 170.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.5 m -153.8 -178.74 7.25 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 120.812 -1.18 . . . . 0.0 109.683 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -110.0 158.99 17.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -145.5 151.43 38.17 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.5 m -123.33 142.76 50.62 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 170.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.2 162.67 34.92 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.333 1.853 . . . . 0.0 109.568 174.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.57 144.23 31.2 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.647 1.579 . . . . 0.0 106.826 170.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.99 132.56 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.3 ttm180 -129.93 134.14 47.28 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.046 1.294 . . . . 0.0 110.824 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.31 152.29 5.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.3 t -145.3 142.61 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 p30 -132.92 -162.34 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.59 1.156 . . . . 0.0 109.813 171.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.93 65.74 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.14 -50.62 69.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.861 0.865 . . . . 0.0 110.763 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.42 -168.84 41.88 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 120.003 1.274 . . . . 0.0 112.945 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.56 154.36 27.52 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.746 1.218 . . . . 0.0 110.983 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.471 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -108.28 -172.91 21.65 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 0.0 112.074 166.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.44 156.32 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.139 1.893 . . . . 0.0 110.493 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.82 152.72 21.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.112 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -63.8 -171.79 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.812 1.645 . . . . 0.0 111.459 170.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.95 154.58 16.99 Favored 'Trans proline' 0 C--N 1.352 0.729 0 CA-C-N 120.663 1.272 . . . . 0.0 110.242 163.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.445 ' HA ' HD22 ' A' ' 96' ' ' ASN . 2.7 m-20 -82.74 85.3 7.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 166.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 22.0 mmt-85 -67.09 155.93 37.43 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.73 154.22 37.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 23' ' ' VAL . 53.5 p90 -151.79 152.25 32.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -102.29 160.37 14.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 169.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.6 p -107.94 146.28 33.15 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.88 -89.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.791 2.994 . . . . 0.0 113.257 -162.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -142.4 -34.97 0.44 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.381 0.991 . . . . 0.0 112.392 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 66.6 144.51 0.06 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.787 1.66 . . . . 0.0 110.819 -168.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.34 -163.27 0.1 Allowed 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.214 -1.168 . . . . 0.0 110.251 -162.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 94.91 160.03 33.75 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 108.707 -1.757 . . . . 0.0 108.707 -157.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.39 114.71 4.11 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.413 2.075 . . . . 0.0 110.763 -166.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 m -62.29 -43.45 98.79 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 166.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.9 m -138.89 161.02 38.32 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.466 1.506 . . . . 0.0 107.485 166.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.617 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 171.062 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.71 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 133.63 169.09 0.0 OUTLIER 'General case' 0 C--O 1.233 0.222 1 C-N-CA 131.975 4.11 . . . . 0.0 108.201 167.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m 45.52 -153.8 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.3 1.04 . . . . 0.0 110.461 -168.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 155.76 88.85 0.07 OUTLIER Glycine 0 C--N 1.336 0.559 0 CA-C-N 119.907 1.231 . . . . 0.0 111.814 170.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 p -73.46 151.16 41.18 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.474 1.137 . . . . 0.0 111.805 176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.81 137.27 52.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.302 1.841 . . . . 0.0 109.928 -167.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.89 170.0 31.92 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.678 0.656 . . . . 0.0 111.53 -177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -164.15 133.85 3.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.167 0.987 . . . . 0.0 110.255 177.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 p -151.54 159.78 43.97 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.614 -0.679 . . . . 0.0 110.146 163.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.37 121.82 0.58 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.06 -66.8 0.48 Allowed 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 168.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -122.45 -8.31 8.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.723 0.809 . . . . 0.0 112.361 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 65.3 mt -69.71 143.71 92.81 Favored Pre-proline 0 CA--C 1.533 0.323 0 C-N-CA 123.951 0.901 . . . . 0.0 110.299 167.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.06 160.39 47.59 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.61 2.207 . . . . 0.0 112.805 -171.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.3 mtm -114.7 -39.02 3.83 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -170.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG22 ' CB ' ' A' ' 42' ' ' SER . 30.8 m -140.8 155.79 22.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.247 0.931 . . . . 0.0 109.521 -178.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 172.02 10.98 Favored Pre-proline 0 N--CA 1.445 -0.693 0 C-N-CA 127.081 2.152 . . . . 0.0 111.108 175.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HD3' HG13 ' A' ' 99' ' ' VAL . 5.7 Cg_exo -56.6 161.49 9.77 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 120.651 0.9 . . . . 0.0 111.119 167.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.62 -170.51 5.04 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 165.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -57.96 151.83 17.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 122.28 1.038 . . . . 0.0 112.078 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -113.39 151.69 15.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 124.805 1.242 . . . . 0.0 108.009 -168.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.47 158.44 38.34 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.56 1.944 . . . . 0.0 106.575 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.32 115.6 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 170.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -98.8 129.33 45.2 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 124.079 0.862 . . . . 0.0 109.019 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 91.6 t -79.58 109.99 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 30' ' ' LEU . 3.8 m -78.88 -59.66 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 127.047 2.139 . . . . 0.0 109.0 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -124.58 -176.02 3.42 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.254 1.422 . . . . 0.0 109.914 -175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . 0.5 OUTLIER -59.87 -58.4 8.72 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.108 -0.995 . . . . 0.0 110.065 161.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 p -89.72 2.08 55.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.91 1.684 . . . . 0.0 113.841 -165.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 26' ' ' VAL . 23.9 tp -135.55 140.96 45.1 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.009 1.724 . . . . 0.0 107.66 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.43 153.83 45.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 161.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -95.25 139.07 32.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 164.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -116.78 139.85 41.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 169.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -127.9 146.99 50.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 24.0 p90 -139.4 166.87 23.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.151 1.38 . . . . 0.0 108.437 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -73.06 147.59 88.38 Favored Pre-proline 0 N--CA 1.464 0.27 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 166.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -62.78 141.36 84.72 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.374 1.382 . . . . 0.0 108.615 162.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 18' ' ' PRO . 35.3 m -85.64 159.47 55.3 Favored Pre-proline 0 C--O 1.243 0.719 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.218 159.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.88 148.02 81.58 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.702 2.935 . . . . 0.0 109.444 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' C ' HD22 ' A' ' 40' ' ' LEU 0.276 0.0 OUTLIER -51.17 -27.93 9.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 168.483 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -63.87 -32.97 74.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 117.109 -1.424 . . . . 0.0 112.486 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.486 ' CB ' HG22 ' A' ' 16' ' ' VAL . 77.9 p -74.72 -36.69 62.69 Favored 'General case' 0 C--O 1.227 -0.106 0 CA-C-N 120.373 1.442 . . . . 0.0 109.956 176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.518 HD13 ' HB2' ' A' ' 47' ' ' LEU . 21.2 mt -63.57 -37.24 79.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 108.514 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 80.27 -61.4 0.27 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 129.273 3.029 . . . . 0.0 110.556 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.77 -160.44 17.14 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 126.129 1.823 . . . . 0.0 111.082 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -72.79 121.99 20.81 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.399 1.08 . . . . 0.0 109.248 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' HB2' HD13 ' A' ' 43' ' ' ILE . 1.5 tm? -59.94 119.5 7.87 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.743 0.817 . . . . 0.0 109.77 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -78.6 -36.57 44.07 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 155.09 -175.26 33.15 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -114.09 166.51 11.55 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -130.27 150.82 51.34 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.411 1.484 . . . . 0.0 107.531 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.2 mt -124.91 124.38 67.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 170.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -91.56 138.61 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 165.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 45.9 p90 -146.78 167.35 24.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 120.981 1.718 . . . . 0.0 111.366 168.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -149.04 158.03 43.86 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.87 0.868 . . . . 0.0 110.891 167.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.29 138.15 41.65 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.466 1.106 . . . . 0.0 108.772 169.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.4 m -108.14 167.86 9.71 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -126.31 96.58 4.75 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 126.062 1.745 . . . . 0.0 106.781 175.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.0 t -55.49 -58.17 8.88 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.464 0.706 . . . . 0.0 110.169 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 t -132.05 103.58 6.36 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.384 0.993 . . . . 0.0 108.535 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 t -142.17 109.18 5.48 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 125.464 1.506 . . . . 0.0 107.707 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -62.14 -25.2 67.61 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.351 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.6 mtt85 -79.45 136.41 36.92 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -63.37 153.93 33.54 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -76.62 122.0 24.02 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -172.38 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 158.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -45.2 124.27 4.56 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 118.696 0.68 . . . . 0.0 111.108 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.6 mt -69.53 126.48 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -169.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -72.8 87.87 1.3 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.704 2.002 . . . . 0.0 107.783 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -90.13 126.1 35.67 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.517 1.527 . . . . 0.0 107.761 174.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 11.1 mmtt -114.27 168.1 10.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 118.833 0.742 . . . . 0.0 109.456 171.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 mm -127.31 159.22 37.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.423 1.489 . . . . 0.0 107.368 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.449 ' CD1' HD13 ' A' ' 84' ' ' LEU . 2.6 mt -136.19 159.17 42.55 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.174 1.789 . . . . 0.0 108.204 167.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 m -123.77 141.55 51.92 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.251 1.82 . . . . 0.0 107.155 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -145.67 104.84 3.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -77.43 175.44 9.79 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.777 -1.202 . . . . 0.0 109.867 170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 72.28 160.62 5.02 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.651 1.139 . . . . 0.0 113.173 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.5 m -77.32 21.25 0.26 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.196 1.398 . . . . 0.0 113.458 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -48.49 154.59 0.62 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.277 1.031 . . . . 0.0 110.895 165.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 p -119.43 9.29 11.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.171 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 167.13 24.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.072 0.949 . . . . 0.0 109.062 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.17 -171.1 26.71 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 127.455 2.455 . . . . 0.0 107.505 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.6 mtp -138.28 159.72 41.31 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 117.963 0.882 . . . . 0.0 110.844 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.9 mm? -112.85 81.6 4.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 C-N-CA 127.019 2.127 . . . . 0.0 107.394 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -84.4 155.94 12.48 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.836 2.357 . . . . 0.0 111.059 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.87 16.47 67.72 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 119.404 -0.665 . . . . 0.0 112.961 178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 93' ' ' TYR . 3.8 mm? -91.7 173.68 7.75 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.858 1.263 . . . . 0.0 110.527 -175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -115.42 144.69 32.84 Favored Pre-proline 0 C--O 1.24 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.472 -175.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -70.93 176.38 7.74 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.976 2.451 . . . . 0.0 113.191 174.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 38.75 46.49 1.04 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 130.939 3.696 . . . . 0.0 113.933 176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 64.1 m -135.09 174.13 10.95 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.101 1.76 . . . . 0.0 110.67 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -120.84 152.23 38.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.631 1.972 . . . . 0.0 107.106 172.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.408 ' CE1' HD12 ' A' ' 87' ' ' LEU . 97.2 m-85 -144.33 161.43 38.99 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.056 1.342 . . . . 0.0 111.019 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.4 m -124.15 141.48 52.02 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 161.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.81 153.2 42.99 Favored 'General case' 0 C--N 1.339 0.116 0 C-N-CA 126.025 1.73 . . . . 0.0 110.137 171.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.18 129.79 20.23 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -170.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.5 t -89.43 147.32 5.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -145.74 124.08 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.583 -0.722 . . . . 0.0 110.331 -178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.447 HG13 ' HD3' ' A' ' 18' ' ' PRO . 4.4 m -69.5 152.55 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.414 1.007 . . . . 0.0 109.676 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.13 151.92 25.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 125.727 1.611 . . . . 0.0 108.352 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -144.68 -171.14 3.55 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.972 1.309 . . . . 0.0 109.015 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.01 -15.26 78.52 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.996 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 -23.77 14.56 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.581 1.552 . . . . 0.0 111.919 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.47 -154.41 25.5 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.858 0.754 . . . . 0.0 111.305 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.06 173.93 10.9 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.392 1.477 . . . . 0.0 110.008 179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.79 -155.44 6.87 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.693 1.139 . . . . 0.0 112.761 -166.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.57 160.79 41.41 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.689 2.259 . . . . 0.0 110.595 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.99 162.21 13.82 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.194 1.798 . . . . 0.0 111.462 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 54.1 p -67.58 -176.72 0.28 Allowed Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.6 0.76 . . . . 0.0 110.335 172.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 19.8 Cg_endo -54.28 129.84 36.69 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 N-CA-C 108.968 -1.204 . . . . 0.0 108.968 153.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.93 132.49 53.18 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 163.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -115.75 163.46 15.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.443 1.097 . . . . 0.0 109.239 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.49 158.77 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -150.47 151.97 33.52 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -111.31 141.74 44.45 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.365 1.466 . . . . 0.0 108.008 172.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.3 p -92.46 157.36 40.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 122.101 -0.375 . . . . 0.0 111.342 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 75.5 Cg_endo -75.11 171.0 19.17 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.133 2.555 . . . . 0.0 108.178 173.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -61.97 -35.41 78.4 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 114.863 -162.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 122.91 -109.84 1.44 Allowed Glycine 0 N--CA 1.461 0.33 0 C-N-CA 125.277 1.418 . . . . 0.0 110.293 174.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.2 t -138.71 138.4 37.67 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 164.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.55 176.32 52.46 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.13 97.53 0.35 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.383 2.722 . . . . 0.0 110.515 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.8 m -142.41 165.11 28.31 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.741 2.016 . . . . 0.0 107.241 165.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.3 t -142.51 167.46 22.03 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 160.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.757 0 N-CA-C 104.3 -3.52 . . . . 0.0 104.3 -140.414 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.89 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 m -132.8 176.93 8.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.275 1.03 . . . . 0.0 108.579 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 t -150.97 -178.42 6.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.662 1.985 . . . . 0.0 107.289 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.81 174.85 29.18 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.079 1.323 . . . . 0.0 110.247 175.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.0 m -156.39 170.61 21.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.719 1.608 . . . . 0.0 108.55 176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.7 t -160.83 -163.48 1.06 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.367 1.867 . . . . 0.0 107.859 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.76 174.91 30.13 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 125.598 1.571 . . . . 0.0 109.302 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.519 ' CG ' ' H ' ' A' ' 9' ' ' SER . 14.5 t-80 -146.92 -166.9 2.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.657 0.783 . . . . 0.0 109.452 171.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.519 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 11.8 p -112.69 103.06 11.09 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.107 1.363 . . . . 0.0 110.991 -165.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.09 -104.89 0.47 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 32.66 60.54 0.39 Allowed 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 127.887 2.475 . . . . 0.0 112.073 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -55.87 -50.8 69.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.898 -169.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.47 ' C ' HD21 ' A' ' 101' ' ' ASN . 29.7 mt 50.1 173.89 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 C-N-CA 128.72 2.808 . . . . 0.0 113.12 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.15 177.29 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.179 1.253 . . . . 0.0 110.0 166.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.1 mtm -134.05 -27.37 1.44 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 42' ' ' SER . 28.5 m -138.59 178.52 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 120.193 1.361 . . . . 0.0 110.101 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.89 162.67 19.17 Favored Pre-proline 0 N--CA 1.445 -0.704 0 C-N-CA 128.41 2.684 . . . . 0.0 107.626 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.35 151.07 81.87 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 120.863 1.042 . . . . 0.0 109.686 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.31 -94.62 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 125.137 1.351 . . . . 0.0 112.535 -163.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 162.03 13.41 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 167.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.5 t -128.97 148.76 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 -142.99 152.7 42.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.828 2.051 . . . . 0.0 106.252 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.45 139.13 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 119.975 1.261 . . . . 0.0 110.387 171.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -116.5 145.69 43.13 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 127.398 2.279 . . . . 0.0 107.944 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t -101.62 110.25 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -61.24 -59.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.642 0.777 . . . . 0.0 108.928 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.277 20.1 p30 -121.12 -105.52 0.38 Allowed 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.627 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.37 -51.95 1.96 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.695 1.998 . . . . 0.0 109.696 174.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.9 p -101.12 4.32 42.03 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.192 1.397 . . . . 0.0 111.519 -173.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -124.65 122.97 39.01 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.042 1.737 . . . . 0.0 109.02 169.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.41 163.38 17.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.423 1.089 . . . . 0.0 109.552 165.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -125.54 115.57 20.39 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 129.123 2.969 . . . . 0.0 105.994 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.1 t -92.73 145.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 173.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.14 146.39 49.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -148.1 155.56 41.59 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 121.524 -0.735 . . . . 0.0 109.537 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -74.0 140.03 76.89 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -61.92 155.49 54.73 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.884 2.389 . . . . 0.0 109.374 176.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.453 HG21 HG11 ' A' ' 99' ' ' VAL . 16.2 m -102.31 157.54 33.5 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 166.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -76.16 153.35 36.35 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 122.753 2.302 . . . . 0.0 109.443 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 43' ' ' ILE . 5.3 mp -61.8 -27.4 68.73 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.064 0.945 . . . . 0.0 111.174 176.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -44.83 -58.78 2.89 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.574 1.15 . . . . 0.0 110.906 163.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.616 ' HB2' HG22 ' A' ' 16' ' ' VAL . 81.1 p -61.85 -26.31 68.06 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -171.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 40' ' ' LEU . 24.6 mt -87.76 -17.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.159 1.384 . . . . 0.0 109.996 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 55.45 1.95 0.06 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.38 2.272 . . . . 0.0 115.33 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 173.87 -155.3 21.6 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 127.817 2.627 . . . . 0.0 107.261 -172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -74.09 132.81 42.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 119.267 1.533 . . . . 0.0 111.998 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HB2' HD13 ' A' ' 43' ' ' ILE . 8.6 tt -69.32 125.28 26.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 165.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -81.07 -60.35 2.32 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.03 -178.79 39.12 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-O 121.955 0.753 . . . . 0.0 113.663 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -107.83 117.89 35.3 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.878 . . . . 0.0 106.589 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 92.09 4.92 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.6 mt -77.74 123.02 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -92.19 145.62 24.36 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 164.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.43 163.71 39.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.777 1.231 . . . . 0.0 110.906 170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -148.98 159.68 43.99 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.989 0.916 . . . . 0.0 110.538 169.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -68.83 132.22 46.42 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 166.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.8 m -107.47 159.32 16.5 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 43.68 71.62 0.23 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.051 1.741 . . . . 0.0 112.516 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.0 103.45 4.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -173.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.39 145.73 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.712 2.005 . . . . 0.0 112.633 -174.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.7 m -93.67 78.63 4.27 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.002 1.321 . . . . 0.0 109.279 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -139.79 148.21 41.87 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 66.4 mtt85 -145.25 129.1 17.33 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -172.8 -169.3 0.56 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.79 2.036 . . . . 0.0 107.046 168.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -61.98 165.79 5.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.122 0.874 . . . . 0.0 110.275 166.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? 45.55 60.58 3.02 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.254 1.422 . . . . 0.0 110.147 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -127.1 148.05 50.16 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 125.028 1.331 . . . . 0.0 109.086 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.4 mt 62.19 145.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 128.4 2.68 . . . . 0.0 109.702 -168.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -105.69 130.73 53.65 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -118.44 93.77 4.24 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.971 0.908 . . . . 0.0 109.017 -164.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -84.27 157.88 21.41 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.104 1.761 . . . . 0.0 110.103 -169.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -140.96 111.13 3.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.04 166.78 22.85 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.328 1.451 . . . . 0.0 110.165 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.4 m -126.06 125.75 43.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -135.91 116.45 13.8 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 165.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -79.24 164.44 24.15 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.323 0.965 . . . . 0.0 109.008 165.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.12 172.43 3.4 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 113.734 -1.576 . . . . 0.0 113.533 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -87.48 39.68 0.89 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.799 -0.701 . . . . 0.0 112.279 -153.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -59.88 167.22 2.29 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.314 1.446 . . . . 0.0 111.567 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.2 p -130.04 8.75 5.22 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.899 1.679 . . . . 0.0 110.626 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -156.35 160.47 39.71 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.418 1.887 . . . . 0.0 106.882 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.39 175.71 40.4 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 32.1 mtp -132.53 156.25 47.16 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 118.728 1.264 . . . . 0.0 110.953 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.57 82.4 4.79 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 126.363 1.865 . . . . 0.0 106.349 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -85.23 154.38 10.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.29 1.993 . . . . 0.0 110.848 165.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.05 16.8 46.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.344 0.973 . . . . 0.0 112.252 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.402 HD12 ' CE2' ' A' ' 93' ' ' TYR . 4.2 mm? -88.59 -171.56 3.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.097 0.949 . . . . 0.0 109.895 -173.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.46 141.57 41.9 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 128.279 2.632 . . . . 0.0 105.92 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -73.54 -173.91 1.49 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 124.004 3.136 . . . . 0.0 112.097 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 50.69 43.36 27.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.686 2.395 . . . . 0.0 113.032 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.8 m -157.54 163.48 38.34 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.97 0.908 . . . . 0.0 112.107 174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -88.5 155.09 19.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.177 1.391 . . . . 0.0 107.678 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.402 ' CE2' HD12 ' A' ' 87' ' ' LEU . 82.8 m-85 -144.68 146.95 32.49 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.826 1.65 . . . . 0.0 108.766 -176.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 19.7 m -126.75 122.69 35.56 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.618 0.767 . . . . 0.0 109.025 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.31 158.07 39.22 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.209 1.804 . . . . 0.0 109.453 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -145.57 164.01 33.0 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.885 1.274 . . . . 0.0 109.555 171.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.0 t -125.71 142.89 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 125.807 1.643 . . . . 0.0 106.873 -166.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -149.7 132.32 15.84 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -171.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 38' ' ' VAL . 1.3 m -82.2 144.64 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.5 t -135.25 139.87 46.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.245 1.818 . . . . 0.0 106.315 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.47 HD21 ' C ' ' A' ' 13' ' ' LEU . 36.4 p-10 -149.21 -172.47 4.13 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.887 0.875 . . . . 0.0 112.246 -168.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.46 12.19 0.14 Allowed Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.893 2.187 . . . . 0.0 116.86 -175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -141.94 -35.59 0.44 Allowed 'General case' 0 C--N 1.339 0.138 0 CA-C-N 120.061 1.93 . . . . 0.0 112.102 168.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -170.31 -154.66 9.61 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 119.165 0.893 . . . . 0.0 112.126 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.92 165.54 17.23 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.362 1.465 . . . . 0.0 109.976 176.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -120.29 -173.43 15.04 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 125.203 1.383 . . . . 0.0 112.71 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.49 135.86 51.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.363 2.709 . . . . 0.0 109.21 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.75 151.35 34.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.918 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.7 p -58.9 172.59 0.52 Allowed Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 124.683 1.193 . . . . 0.0 109.451 169.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -56.1 139.44 85.37 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 152.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.74 160.18 23.51 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 122.635 1.207 . . . . 0.0 108.099 170.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 -129.99 168.9 15.98 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.7 m -124.21 162.87 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 CA-C-N 113.254 -1.794 . . . . 0.0 109.331 170.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -144.32 143.6 31.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 163.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -86.19 166.74 15.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 p -123.73 159.9 53.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 124.071 0.948 . . . . 0.0 109.737 171.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.49 161.37 43.71 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 N-CA-C 108.662 -1.322 . . . . 0.0 108.662 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -58.65 -23.11 58.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.652 1.181 . . . . 0.0 112.609 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.23 6.36 89.4 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.281 -1.288 . . . . 0.0 114.537 163.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.04 158.95 33.77 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 119.108 1.454 . . . . 0.0 110.778 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.71 155.41 48.27 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.08 87.06 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.876 2.384 . . . . 0.0 106.98 167.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.3 m -147.73 30.79 0.89 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.266 -0.896 . . . . 0.0 110.988 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.8 m -148.04 148.29 30.53 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 165.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.803 0 N-CA-C 106.531 -2.628 . . . . 0.0 106.531 -166.268 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.68 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t -141.65 150.23 41.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 166.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.2 m -146.36 164.54 32.09 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.453 1.501 . . . . 0.0 107.976 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.62 147.35 17.1 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.8 m -160.97 152.46 19.25 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.846 2.059 . . . . 0.0 107.489 171.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -157.16 -176.17 5.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.56 -152.63 24.0 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 108.654 -1.779 . . . . 0.0 108.654 -173.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -64.17 162.91 13.57 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -59.66 -64.1 1.07 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.48 148.46 0.3 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -170.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -147.82 92.35 2.05 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 121.212 -1.169 . . . . 0.0 107.85 -174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -148.14 -34.59 0.22 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.436 1.094 . . . . 0.0 109.945 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 31.0 mt -81.9 152.48 68.9 Favored Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.546 1.938 . . . . 0.0 112.29 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.83 172.61 12.98 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.887 2.392 . . . . 0.0 111.815 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 46.6 mtm -124.78 -19.03 5.42 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.7 m -144.02 179.37 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 120.392 1.451 . . . . 0.0 111.275 -178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 107' ' ' PRO . . . -114.56 158.79 39.21 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 129.045 2.938 . . . . 0.0 108.708 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -69.06 144.67 58.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.252 1.968 . . . . 0.0 111.094 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.42 -179.14 52.27 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.414 1.959 . . . . 0.0 113.169 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 t30 2.05 82.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 130.539 3.536 . . . . 0.0 114.671 -171.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.6 t -79.95 132.02 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -126.17 153.96 43.89 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.506 1.923 . . . . 0.0 107.971 174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.55 129.68 9.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 124.266 1.027 . . . . 0.0 108.743 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -125.21 135.66 52.79 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 125.337 1.455 . . . . 0.0 112.302 173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.367 1.0 OUTLIER -84.73 128.85 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.634 0 CA-C-O 123.113 1.435 . . . . 0.0 111.753 174.486 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.73 -40.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 128.18 2.592 . . . . 0.0 109.529 -174.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 77.5 m-20 -138.24 -179.91 6.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.066 -1.424 . . . . 0.0 111.714 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -42.46 88.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.668 171.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.8 p -114.63 4.77 15.2 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.137 1.375 . . . . 0.0 112.759 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 17.3 tp -132.27 137.31 47.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.293 1.837 . . . . 0.0 108.328 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -131.51 170.34 14.85 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.921 1.288 . . . . 0.0 109.372 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -128.88 139.88 51.94 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.6 t -114.54 143.57 24.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -129.17 144.13 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.769 1.628 . . . . 0.0 107.265 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.3 p90 -150.14 151.65 33.47 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.786 1.234 . . . . 0.0 108.363 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -69.39 146.18 96.23 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.674 -0.641 . . . . 0.0 110.485 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.76 131.08 29.86 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.605 1.537 . . . . 0.0 108.449 162.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 m -76.11 160.03 79.11 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -67.57 144.66 67.46 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.526 2.151 . . . . 0.0 109.275 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -26.2 68.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.529 -0.732 . . . . 0.0 111.027 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -55.93 -32.6 63.94 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 118.297 -0.858 . . . . 0.0 112.723 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.691 ' HB2' HG22 ' A' ' 16' ' ' VAL . 87.4 p -72.32 -32.29 66.42 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 119.273 0.942 . . . . 0.0 111.642 -175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.6 mt -75.77 -30.63 21.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.206 1.002 . . . . 0.0 109.994 -164.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 45.84 34.79 2.0 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.027 2.131 . . . . 0.0 112.81 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.77 -133.25 1.82 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -171.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -132.91 121.06 22.3 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.8 tp -52.01 118.08 3.21 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 171.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -79.88 -51.83 8.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.57 -170.22 40.34 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -106.09 157.6 17.42 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 163.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -123.91 144.5 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 169.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.5 mt -118.46 126.57 75.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -92.07 144.94 24.92 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 160.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 35.7 p90 -155.44 159.3 39.72 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.0 0.92 . . . . 0.0 110.987 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 41.5 p90 -149.77 155.51 40.25 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -68.52 130.53 43.12 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.711 1.604 . . . . 0.0 107.636 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.0 m -115.52 120.8 40.67 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -134.97 -33.19 0.93 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -170.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.6 m 54.44 -168.46 0.07 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.039 0.936 . . . . 0.0 110.844 -168.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.3 t -160.1 152.15 20.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 163.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.2 t -76.01 39.73 0.19 Allowed 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.936 165.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.2 tttm 37.27 62.89 0.79 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.115 1.766 . . . . 0.0 109.329 -161.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -11.92 8.09 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.94 0.896 . . . . 0.0 112.217 -168.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 146.52 88.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 1 C-N-CA 131.872 4.069 . . . . 0.0 108.286 162.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.3 138.13 20.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 168.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -134.89 169.68 17.02 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.156 1.783 . . . . 0.0 106.682 149.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.3 m80 67.66 138.6 0.03 OUTLIER 'General case' 0 C--O 1.234 0.257 0 C-N-CA 128.765 2.826 . . . . 0.0 114.279 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 76.0 mt -133.3 126.99 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -76.84 118.81 19.81 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.0 mttt -112.71 140.44 47.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.694 1.198 . . . . 0.0 109.273 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -136.23 166.08 24.26 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 125.684 1.594 . . . . 0.0 109.807 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 mp -131.24 149.43 33.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -138.55 145.52 40.77 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.593 1.957 . . . . 0.0 107.668 -173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 m -129.87 119.04 22.66 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 124.206 1.002 . . . . 0.0 108.694 -163.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -128.87 88.22 2.69 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.891 1.277 . . . . 0.0 108.401 176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -69.3 173.51 5.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.852 172.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 67.24 -178.01 18.66 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 121.818 -0.551 . . . . 0.0 111.891 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -85.79 11.33 11.36 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -161.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -56.77 149.35 18.32 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 125.033 1.333 . . . . 0.0 112.307 -166.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -112.66 9.51 19.3 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.669 1.187 . . . . 0.0 111.312 175.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.92 160.61 43.46 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.059 1.343 . . . . 0.0 109.356 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.67 143.13 8.97 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 29.7 mtp -86.26 146.98 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.258 0.529 . . . . 0.0 109.818 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.532 HD12 HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -106.8 94.53 10.6 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 126.687 1.995 . . . . 0.0 105.963 174.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -92.12 167.21 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.7 2.933 . . . . 0.0 112.175 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.96 19.96 74.12 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.681 -0.637 . . . . 0.0 112.79 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 84' ' ' LEU . 3.9 mm? -85.23 168.67 14.54 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.651 0.781 . . . . 0.0 109.069 -176.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.87 131.64 22.03 Favored Pre-proline 0 N--CA 1.432 -1.327 0 C-N-CA 126.092 1.757 . . . . 0.0 107.348 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -74.52 162.92 37.16 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.963 1.775 . . . . 0.0 111.529 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.6 t80 50.63 40.5 24.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.127 1.371 . . . . 0.0 112.134 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.8 m -136.14 158.82 43.5 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.269 1.427 . . . . 0.0 110.686 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -94.45 153.73 17.79 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 170.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -148.21 154.21 39.79 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.922 1.289 . . . . 0.0 110.017 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.9 m -126.21 149.78 48.8 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.867 1.667 . . . . 0.0 107.521 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -151.0 158.48 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.596 2.358 . . . . 0.0 110.488 171.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.05 145.13 29.57 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.683 1.193 . . . . 0.0 110.648 168.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.61 151.06 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 126.249 1.82 . . . . 0.0 108.496 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.1 ttt180 -144.76 133.5 22.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -73.94 151.41 7.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.9 t -137.91 136.37 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -134.69 -173.51 3.31 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.729 2.012 . . . . 0.0 107.031 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -77.85 13.44 13.4 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.228 -1.318 . . . . 0.0 114.033 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -123.07 -54.69 1.81 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.67 1.588 . . . . 0.0 110.037 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.09 48.94 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.039 0.836 . . . . 0.0 111.942 -173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -83.66 154.76 23.52 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.593 0.711 . . . . 0.0 110.702 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -100.82 -171.08 28.86 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.877 1.227 . . . . 0.0 112.349 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 40.3 Cg_endo -65.18 137.99 54.33 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.945 1.764 . . . . 0.0 108.751 170.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.63 161.19 29.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.445 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 60.3 p -62.97 178.53 0.35 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.487 1.115 . . . . 0.0 108.943 172.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 94.4 Cg_endo -61.49 155.52 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 107.346 -1.828 . . . . 0.0 107.346 157.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.27 151.79 46.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 122.688 1.232 . . . . 0.0 108.926 162.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -124.74 161.82 25.58 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 172.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.2 150.08 34.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.474 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.79 165.26 30.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -135.66 144.03 45.8 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.013 2.125 . . . . 0.0 107.289 -173.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.8 p -110.59 153.32 43.62 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.085 0.554 . . . . 0.0 110.548 -172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -69.4 -68.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.757 2.304 . . . . 0.0 113.131 -152.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -163.41 -41.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.32 1.448 . . . . 0.0 109.848 168.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.31 59.19 3.4 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 126.073 1.797 . . . . 0.0 113.673 175.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -3.92 34.89 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.559 1.18 . . . . 0.0 113.921 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.89 -169.39 52.72 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.6 165.57 7.66 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.156 1.904 . . . . 0.0 111.91 175.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.7 t -141.73 -153.98 0.49 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 170.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.7 t -52.31 -45.21 65.47 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.012 0.925 . . . . 0.0 111.921 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.653 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 177.177 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.468 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -168.27 66.28 0.07 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.573 1.186 . . . . 0.0 108.277 -175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -157.54 70.01 0.58 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.69 28.05 1.18 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-O 118.447 -1.196 . . . . 0.0 113.135 -169.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.3 m -140.93 156.58 46.05 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.037 1.419 . . . . 0.0 111.374 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -151.68 -46.29 0.11 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 125.831 1.652 . . . . 0.0 108.125 166.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.44 170.78 15.33 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 -165.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.42 106.63 1.73 Allowed 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 167.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t -158.87 165.23 34.66 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.602 1.161 . . . . 0.0 109.756 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.64 132.04 7.54 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 125.693 1.616 . . . . 0.0 112.967 164.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -93.99 -31.81 14.1 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.856 1.262 . . . . 0.0 110.607 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -135.77 -24.39 1.33 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.317 -167.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.8 mt -66.08 149.5 97.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.315 1.416 . . . . 0.0 112.108 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.81 158.75 23.29 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.641 2.227 . . . . 0.0 112.632 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtm -121.5 -31.59 4.0 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.321 1.049 . . . . 0.0 113.545 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 42' ' ' SER . 31.0 m -140.96 158.05 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 118.825 0.739 . . . . 0.0 111.666 -177.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.8 159.99 31.19 Favored Pre-proline 0 N--CA 1.444 -0.754 0 C-N-CA 130.021 3.329 . . . . 0.0 111.928 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -72.35 141.59 35.66 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.34 2.026 . . . . 0.0 111.403 -175.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.05 166.73 51.98 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.546 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.0 t30 49.35 54.55 10.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.619 1.567 . . . . 0.0 112.737 154.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.4 t -77.67 128.8 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.784 1.234 . . . . 0.0 109.296 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 116.13 9.04 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.235 1.814 . . . . 0.0 110.476 -173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG21 ' CD1' ' A' ' 114' ' ' PHE . 0.2 OUTLIER -107.99 138.05 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.163 0.985 . . . . 0.0 108.937 -175.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -124.12 124.93 43.59 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.126 2.171 . . . . 0.0 110.36 -175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.59 102.41 9.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.69 ' HB ' HD12 ' A' ' 30' ' ' LEU . 73.9 t -72.65 -48.98 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -138.25 -179.03 5.55 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 122.271 1.034 . . . . 0.0 109.03 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -35.49 80.62 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 121.258 -0.901 . . . . 0.0 111.686 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.1 p -119.34 17.56 13.02 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.309 1.044 . . . . 0.0 111.363 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.82 HD11 ' CE ' ' A' ' 83' ' ' MET . 3.1 tm? -139.32 137.99 36.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.501 1.92 . . . . 0.0 108.628 176.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.529 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -136.02 150.62 49.28 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 167.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -108.4 143.72 36.95 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.788 2.035 . . . . 0.0 107.046 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.9 t -125.04 119.16 55.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -108.34 152.96 23.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.3 p90 -154.12 163.52 39.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.942 0.897 . . . . 0.0 109.594 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -80.3 140.93 52.92 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -67.12 140.89 55.49 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.712 2.275 . . . . 0.0 108.49 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.11 156.59 79.25 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 164.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.29 147.01 17.98 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.611 2.874 . . . . 0.0 109.841 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -57.64 -29.06 64.27 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -50.58 -50.31 54.13 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 118.343 0.519 . . . . 0.0 110.939 168.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.736 ' HB2' HG22 ' A' ' 16' ' ' VAL . 71.8 p -59.74 -37.98 80.46 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.417 0.553 . . . . 0.0 112.259 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.508 HD13 ' HB2' ' A' ' 47' ' ' LEU . 15.4 mt -70.42 -23.41 24.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.799 -169.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.54 -14.91 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.572 2.349 . . . . 0.0 115.82 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.03 -163.74 12.34 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.72 3.057 . . . . 0.0 108.55 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -77.96 117.6 19.45 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.803 0.841 . . . . 0.0 111.695 -174.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.508 ' HB2' HD13 ' A' ' 43' ' ' ILE . 36.2 tp -57.3 133.48 55.15 Favored 'General case' 0 CA--C 1.523 -0.07 0 C-N-CA 125.698 1.599 . . . . 0.0 109.987 174.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -103.72 -23.41 13.44 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.201 1.4 . . . . 0.0 110.455 175.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 151.82 -164.75 30.45 Favored Glycine 0 C--O 1.239 0.437 0 O-C-N 120.95 -1.094 . . . . 0.0 112.013 167.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.39 141.14 46.47 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.557 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.2 ttp180 -121.83 97.09 5.33 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.4 mt -77.95 120.63 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -91.67 141.55 28.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 164.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.557 ' CD2' HD11 ' A' ' 84' ' ' LEU . 41.4 p90 -151.25 166.08 32.0 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.751 0.82 . . . . 0.0 110.566 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -149.46 159.14 44.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.232 0.613 . . . . 0.0 111.431 171.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 tptm -68.95 136.6 52.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 m -124.06 141.99 51.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -146.48 6.35 0.96 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.814 0.846 . . . . 0.0 111.019 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.8 m -146.14 152.48 39.33 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.242 1.817 . . . . 0.0 108.315 166.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -138.45 4.45 2.4 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.358 1.063 . . . . 0.0 110.882 164.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.49 93.94 3.23 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.467 1.507 . . . . 0.0 108.088 -174.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.5 mttt 93.64 121.79 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 131.252 3.821 . . . . 0.0 111.213 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -75.62 80.38 2.61 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.626 1.571 . . . . 0.0 109.354 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -74.47 178.02 5.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -73.1 147.08 45.27 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 157.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.89 164.71 11.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.941 0.896 . . . . 0.0 110.119 150.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -68.7 146.63 52.8 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 160.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 55.5 mt -133.81 124.98 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -76.43 103.01 6.22 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 166.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -95.69 162.08 13.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.227 1.411 . . . . 0.0 110.91 174.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -148.72 171.94 15.4 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.508 1.523 . . . . 0.0 110.792 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.8 mp -132.74 149.67 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 128.275 2.63 . . . . 0.0 104.622 166.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -133.02 161.09 35.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.122 1.769 . . . . 0.0 109.123 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.4 m -131.18 121.77 25.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.798 1.181 . . . . 0.0 111.85 -171.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -136.99 115.26 11.71 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 163.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -80.98 162.51 23.82 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.325 0.583 . . . . 0.0 110.227 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.65 -173.32 21.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 114.751 -1.113 . . . . 0.0 114.152 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.06 13.98 0.47 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.552 1.941 . . . . 0.0 115.106 -168.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -51.73 147.85 6.2 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.673 1.189 . . . . 0.0 112.036 176.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.9 p -109.4 5.37 23.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 111.983 -177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.13 159.43 43.31 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.883 0.873 . . . . 0.0 109.966 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.15 170.07 30.83 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 126.697 2.094 . . . . 0.0 108.139 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.82 ' CE ' HD11 ' A' ' 30' ' ' LEU . 59.9 mtp -138.37 143.94 40.06 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 118.282 1.041 . . . . 0.0 110.892 -166.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.557 HD11 ' CD2' ' A' ' 54' ' ' TYR . 4.0 mm? -110.33 84.95 4.12 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 127.507 2.323 . . . . 0.0 108.665 -173.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.63 156.75 3.54 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.413 2.742 . . . . 0.0 112.741 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 63.94 40.76 98.6 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 123.929 0.776 . . . . 0.0 111.406 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.487 HD12 ' CE2' ' A' ' 93' ' ' TYR . 4.0 mm? -96.1 165.88 12.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.754 1.621 . . . . 0.0 108.536 173.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -90.77 144.6 30.58 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.56 172.27 12.74 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.305 2.67 . . . . 0.0 111.962 165.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . 0.25 0.3 OUTLIER 45.41 34.75 1.65 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.371 2.668 . . . . 0.0 114.063 172.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -118.19 -175.81 2.93 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.245 2.218 . . . . 0.0 109.554 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -124.64 154.28 40.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 170.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CE2' HD12 ' A' ' 87' ' ' LEU . 81.8 m-85 -145.65 158.71 43.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.854 0.461 . . . . 0.0 109.945 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.3 m -126.45 140.84 52.16 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 167.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.47 154.27 47.7 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.934 2.094 . . . . 0.0 108.991 175.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.22 166.28 25.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.572 1.549 . . . . 0.0 107.933 166.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.2 147.39 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -139.07 121.31 15.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.879 0.872 . . . . 0.0 111.527 169.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -69.43 136.54 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.176 1.39 . . . . 0.0 107.263 172.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.83 143.99 32.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -131.89 -173.78 3.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.805 2.042 . . . . 0.0 107.601 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.11 92.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 118.575 0.625 . . . . 0.0 112.052 -176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -36.13 80.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.89 0.845 . . . . 0.0 111.663 176.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.37 -143.24 10.43 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 119.358 0.981 . . . . 0.0 111.074 -174.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -120.59 173.79 6.96 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.391 1.076 . . . . 0.0 112.354 -165.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.74 -162.36 9.09 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.293 1.425 . . . . 0.0 111.422 173.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -64.97 145.18 84.95 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.832 3.021 . . . . 0.0 111.668 -176.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.99 157.64 34.63 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.387 1.075 . . . . 0.0 110.566 174.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.3 p -61.06 174.96 0.49 Allowed Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.127 162.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -51.35 148.4 19.4 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.498 0.798 . . . . 0.0 110.812 154.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.59 144.64 52.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 164.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.0 mmt-85 -130.07 171.21 13.06 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.215 1.806 . . . . 0.0 108.514 172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.49 164.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.982 1.313 . . . . 0.0 108.816 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.41 ' CD1' HG21 ' A' ' 23' ' ' VAL . 41.4 p90 -153.47 148.25 26.41 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 126.336 1.854 . . . . 0.0 107.219 159.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -86.77 168.12 13.8 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 158.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 26.0 p -117.53 162.36 28.96 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 163.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.2 -83.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.272 1.982 . . . . 0.0 113.576 -155.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -142.54 -53.46 0.41 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.304 1.042 . . . . 0.0 109.649 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 144.69 -157.47 27.27 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 123.412 0.53 . . . . 0.0 112.372 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 m -150.33 178.21 9.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.655 2.782 . . . . 0.0 105.804 166.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 150.62 -108.49 0.39 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-O 117.84 -1.534 . . . . 0.0 110.243 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.97 87.61 0.85 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.355 2.703 . . . . 0.0 110.601 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.1 t -157.69 -175.17 5.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.129 1.772 . . . . 0.0 108.084 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.0 m -149.37 171.06 17.16 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 126.176 1.79 . . . . 0.0 108.582 163.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 CA-C-O 116.459 -2.3 . . . . 0.0 108.231 163.721 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.496 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.5 p -82.73 -168.74 2.16 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.838 2.055 . . . . 0.0 109.28 165.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.7 p -150.07 173.41 13.9 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.051 -1.031 . . . . 0.0 109.035 147.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.09 98.37 0.3 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -71.19 10.78 0.52 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.386 1.474 . . . . 0.0 113.363 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 67.1 m -56.06 -73.86 0.05 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.272 1.429 . . . . 0.0 108.676 166.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.91 140.12 6.06 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -167.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -129.93 -173.51 3.05 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.199 1.4 . . . . 0.0 107.297 166.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.9 p -139.54 -173.92 3.74 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 166.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.01 122.04 0.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -138.35 -17.2 1.17 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 118.316 -0.85 . . . . 0.0 111.976 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.36 -17.31 0.2 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.279 0.945 . . . . 0.0 111.833 168.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt -76.95 150.02 80.73 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 119.304 0.956 . . . . 0.0 110.587 175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -67.32 170.63 13.03 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.746 2.298 . . . . 0.0 114.272 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 21.5 mtm -122.35 -39.93 2.53 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 127.06 2.144 . . . . 0.0 111.041 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.757 HG22 ' HB2' ' A' ' 42' ' ' SER . 23.6 m -136.51 150.42 27.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 119.133 0.879 . . . . 0.0 111.755 -175.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.96 168.53 22.3 Favored Pre-proline 0 N--CA 1.447 -0.612 0 C-N-CA 128.426 2.69 . . . . 0.0 110.248 173.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -64.47 166.64 16.89 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 121.691 1.594 . . . . 0.0 114.048 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.49 -163.04 1.4 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.625 2.059 . . . . 0.0 112.788 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -58.08 106.33 0.36 Allowed 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.628 1.171 . . . . 0.0 109.198 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.81 141.6 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.209 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -124.12 152.06 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.94 132.75 14.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -124.05 128.91 50.03 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 125.016 1.326 . . . . 0.0 110.022 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 31' ' ' ALA 0.297 0.7 OUTLIER -88.46 115.89 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-O 122.093 0.949 . . . . 0.0 110.473 -175.874 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.63 ' HB ' HD12 ' A' ' 30' ' ' LEU . 93.5 t -79.27 -35.21 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.392 -169.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -156.35 -173.25 4.41 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.806 0.843 . . . . 0.0 109.413 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -17.96 64.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -171.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.9 p -128.71 6.21 5.59 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.435 1.494 . . . . 0.0 111.122 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.723 HD11 ' HE2' ' A' ' 83' ' ' MET . 2.2 tm? -142.7 142.27 31.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.421 1.088 . . . . 0.0 110.097 -169.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . . . -137.78 162.32 34.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 167.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -117.31 121.0 39.94 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 t -97.98 144.17 11.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -133.33 144.97 49.99 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.925 1.69 . . . . 0.0 107.592 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -148.31 173.07 13.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.029 1.332 . . . . 0.0 108.385 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -90.03 144.42 31.32 Favored Pre-proline 0 C--O 1.234 0.289 0 O-C-N 121.761 -0.587 . . . . 0.0 109.845 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.93 112.14 3.03 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.402 2.735 . . . . 0.0 109.104 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 m -83.22 159.17 62.75 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.7 150.65 18.93 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.536 2.824 . . . . 0.0 112.077 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.565 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -58.39 -35.77 72.52 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.909 1.284 . . . . 0.0 109.763 175.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -60.02 -25.85 65.63 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 117.171 -1.395 . . . . 0.0 114.234 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.757 ' HB2' HG22 ' A' ' 16' ' ' VAL . 76.0 p -93.11 -20.77 20.18 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 120.743 1.61 . . . . 0.0 111.673 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 40' ' ' LEU . 62.8 mt -63.23 -40.2 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 166.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 56.61 -3.24 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.616 2.767 . . . . 0.0 115.188 -171.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 -166.56 12.73 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 125.466 1.507 . . . . 0.0 109.394 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -87.68 107.86 18.83 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 122.391 -0.476 . . . . 0.0 109.919 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' A' ' 43' ' ' ILE . 14.1 tp -48.81 130.48 17.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.016 1.327 . . . . 0.0 107.956 172.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -84.73 -62.16 1.61 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 165.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 76' ' ' GLN . . . -174.19 -165.15 30.34 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -99.34 160.57 14.19 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -134.95 99.44 4.29 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.601 -0.687 . . . . 0.0 109.2 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.7 mt -77.89 119.01 25.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 125.573 1.549 . . . . 0.0 107.019 170.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -91.74 149.64 21.51 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 71' ' ' LYS . 39.8 p90 -154.24 164.82 37.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 120.521 1.51 . . . . 0.0 111.546 170.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -148.65 159.19 44.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.854 1.262 . . . . 0.0 111.197 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.64 138.32 54.92 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.6 m -118.87 140.71 49.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -146.05 94.61 2.5 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -13.65 17.95 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.711 2.005 . . . . 0.0 114.31 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.43 -179.21 1.27 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.807 2.043 . . . . 0.0 112.498 -170.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -51.66 127.71 21.29 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.169 1.388 . . . . 0.0 110.466 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -77.49 70.55 3.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.279 1.032 . . . . 0.0 111.418 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -126.48 179.19 5.43 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.355 1.862 . . . . 0.0 108.818 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 23.59 76.75 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 129.471 3.108 . . . . 0.0 113.823 175.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -158.77 128.65 5.78 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.616 1.166 . . . . 0.0 108.039 -173.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.59 96.81 6.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.574 1.079 . . . . 0.0 108.765 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.3 m170 47.81 -155.14 0.07 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 125.257 1.423 . . . . 0.0 110.195 -174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 54.4 mt -128.71 124.66 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -78.11 122.67 25.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 167.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -102.18 105.34 16.01 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 170.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 2.3 mttp -88.03 172.36 9.6 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 127.383 2.273 . . . . 0.0 109.188 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.0 mm -141.79 161.39 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.46 1.904 . . . . 0.0 107.199 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.504 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.3 OUTLIER -154.94 108.88 2.91 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.736 1.214 . . . . 0.0 110.024 177.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.7 m -81.92 135.43 35.4 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.273 1.429 . . . . 0.0 111.257 -163.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -137.11 97.54 3.52 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.42 ' HA ' ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -76.52 173.19 11.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.777 0.831 . . . . 0.0 110.865 175.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.81 175.43 46.33 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-O 121.964 0.758 . . . . 0.0 111.685 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.5 p -83.52 27.02 0.63 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.796 1.638 . . . . 0.0 112.748 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -60.38 164.95 3.93 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.932 1.349 . . . . 0.0 112.295 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.444 ' H ' ' HD3' ' A' ' 79' ' ' LYS . 15.6 p -127.55 -0.94 6.19 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 126.762 2.025 . . . . 0.0 110.768 -174.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -152.14 163.45 39.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.06 1.344 . . . . 0.0 108.465 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.66 172.8 34.99 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 127.568 2.509 . . . . 0.0 107.92 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.723 ' HE2' HD11 ' A' ' 30' ' ' LEU . 77.5 mtp -115.09 159.01 21.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.583 1.191 . . . . 0.0 109.972 -172.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD13 ' CD1' ' A' ' 73' ' ' LEU . 2.7 mm? -121.44 77.27 35.36 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 108.877 168.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -86.07 149.06 9.38 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.503 2.802 . . . . 0.0 110.892 169.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.46 26.74 9.05 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 123.737 0.684 . . . . 0.0 112.043 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.434 HD21 HD12 ' A' ' 84' ' ' LEU . 2.3 mm? -109.59 171.08 7.66 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 126.258 1.823 . . . . 0.0 108.02 -173.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -115.25 144.77 32.87 Favored Pre-proline 0 C--O 1.236 0.386 0 C-N-CA 123.896 0.878 . . . . 0.0 110.311 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -70.39 169.21 20.25 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.719 2.946 . . . . 0.0 113.059 175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.6 t80 35.88 51.12 0.71 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.819 2.448 . . . . 0.0 111.048 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.1 m -129.91 -179.69 5.35 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 108.528 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -130.14 143.93 51.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 173.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -136.35 168.2 19.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.1 m -126.12 142.6 51.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 168.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 153.85 49.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.452 1.501 . . . . 0.0 109.977 169.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -142.25 129.92 21.52 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.625 1.17 . . . . 0.0 109.281 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.49 162.17 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttt85 -152.55 161.3 42.77 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 m -106.57 146.91 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.09 139.68 41.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -134.1 178.87 6.62 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.324 0.65 . . . . 0.0 110.295 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.28 -40.14 52.36 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.015 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -73.11 -50.92 20.05 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 117.95 0.875 . . . . 0.0 111.865 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 173.4 -167.36 40.03 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -163.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -94.79 170.29 9.55 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.399 1.48 . . . . 0.0 111.078 -175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.44 -154.29 6.96 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 167.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.0 152.67 79.89 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.505 2.137 . . . . 0.0 112.714 -173.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.49 155.68 24.46 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.517 -1.674 . . . . 0.0 109.597 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 82.7 p -67.9 175.77 1.59 Allowed Pre-proline 0 C--O 1.236 0.388 0 C-N-CA 124.371 1.068 . . . . 0.0 109.679 169.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -53.57 143.34 56.94 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 120.643 0.896 . . . . 0.0 109.857 155.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.66 155.56 37.63 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 169.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 54.3 mmt-85 -136.46 165.39 25.94 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 120.981 -1.075 . . . . 0.0 108.839 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.42 151.74 34.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -155.68 126.12 6.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.832 1.653 . . . . 0.0 107.491 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -88.94 146.95 24.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 p -87.65 156.36 53.14 Favored Pre-proline 0 CA--C 1.542 0.661 0 O-C-N 123.392 0.433 . . . . 0.0 110.215 171.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.42 ' HD3' ' CG2' ' A' ' 25' ' ' VAL . 17.9 Cg_endo -63.7 -80.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.698 2.932 . . . . 0.0 112.576 -166.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -156.29 -28.09 0.1 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.7 171.09 43.62 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 124.491 1.043 . . . . 0.0 111.573 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.48 -178.34 4.89 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.145 1.778 . . . . 0.0 108.918 174.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -178.2 -98.67 0.11 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -66.83 92.44 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.702 2.934 . . . . 0.0 111.652 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.3 m -104.44 169.61 8.37 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 162.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.5 t -146.29 161.8 39.5 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 167.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.867 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 -143.797 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.873 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 p -138.17 85.14 2.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.487 1.144 . . . . 0.0 111.436 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.2 m -114.52 146.76 40.33 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.502 1.121 . . . . 0.0 108.894 166.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 -96.47 2.4 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 159.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.66 -52.93 0.44 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.11 2.164 . . . . 0.0 114.681 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.2 t 56.94 -175.23 0.06 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.562 1.545 . . . . 0.0 113.461 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.36 -99.06 0.21 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 -169.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 46.87 67.68 0.75 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.872 1.669 . . . . 0.0 110.917 173.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -127.25 169.72 13.2 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 126.011 1.724 . . . . 0.0 108.575 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.19 149.67 5.06 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -108.56 -50.91 2.96 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.978 1.711 . . . . 0.0 108.146 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -141.25 6.56 1.94 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.242 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.0 mt -80.28 157.12 73.45 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-N 120.242 1.383 . . . . 0.0 111.753 164.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -74.76 139.59 25.14 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.32 2.013 . . . . 0.0 111.634 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 51.9 mtm -92.0 -38.13 12.42 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.993 1.317 . . . . 0.0 113.152 -172.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.65 HG22 ' HB2' ' A' ' 42' ' ' SER . 24.4 m -133.83 174.83 12.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 118.624 0.647 . . . . 0.0 110.382 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 107' ' ' PRO . . . -118.26 162.86 27.89 Favored Pre-proline 0 N--CA 1.441 -0.889 0 C-N-CA 128.449 2.7 . . . . 0.0 108.612 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 46.1 Cg_endo -66.18 161.48 40.08 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.837 2.358 . . . . 0.0 111.368 -178.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.64 -147.45 0.41 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 127.617 2.532 . . . . 0.0 114.3 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.9 91.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.922 1.689 . . . . 0.0 108.79 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.38 155.28 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.131 1.372 . . . . 0.0 108.725 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -132.43 163.57 28.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.973 1.709 . . . . 0.0 106.939 170.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.6 144.91 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 174.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -123.8 136.16 54.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.511 2.724 . . . . 0.0 108.204 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.418 HG11 ' HD3' ' A' ' 117' ' ' PRO . 71.5 t -92.94 102.03 13.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 m -71.45 -58.83 4.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 125.801 1.64 . . . . 0.0 109.507 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -131.76 -173.85 3.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.8 1.24 . . . . 0.0 110.907 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -40.32 95.14 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.012 -1.055 . . . . 0.0 113.635 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.1 p -129.23 12.41 6.04 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.614 0.766 . . . . 0.0 111.243 -169.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.7 tp -121.12 132.73 55.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 169.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . . . -125.49 165.65 18.08 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 168.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -135.42 139.54 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.25 142.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -136.33 122.62 20.54 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.555 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p90 -124.83 -178.47 4.17 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.05 1.74 . . . . 0.0 109.796 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.76 135.44 19.54 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.818 1.247 . . . . 0.0 109.332 -172.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 100.48 1.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.469 2.78 . . . . 0.0 110.134 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.6 m -65.49 162.36 42.92 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.982 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.06 150.02 86.3 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.126 2.551 . . . . 0.0 110.928 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.77 -25.32 68.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.191 -0.943 . . . . 0.0 109.622 167.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -57.2 -51.22 70.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.313 173.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.65 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.2 p -66.55 -34.09 77.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.092 0.86 . . . . 0.0 110.384 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 83.0 mt -66.46 -23.79 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.039 0.936 . . . . 0.0 110.413 176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . 0.26 19.1 mtp180 60.12 -13.69 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 129.324 3.05 . . . . 0.0 116.44 -173.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.53 -94.24 0.1 Allowed Glycine 0 CA--C 1.518 0.222 0 CA-C-N 120.351 1.432 . . . . 0.0 110.902 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -125.41 133.79 52.37 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.517 1.527 . . . . 0.0 109.824 -172.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.1 tp -70.83 118.73 13.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -70.69 -50.89 31.71 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.01 -173.38 42.89 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -112.81 127.27 56.12 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.932 0.893 . . . . 0.0 109.032 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -103.44 118.86 37.72 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mt -92.94 127.48 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -92.06 154.88 18.46 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 159.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -159.63 164.03 34.46 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.147 1.379 . . . . 0.0 111.498 171.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -148.6 160.34 43.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.265 -0.897 . . . . 0.0 111.312 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -69.19 138.5 54.14 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.416 1.486 . . . . 0.0 107.93 171.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.8 m -133.96 167.89 19.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 47.9 71.7 0.32 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.653 1.181 . . . . 0.0 110.652 -174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.5 p -63.69 172.77 1.99 Allowed 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.502 0.721 . . . . 0.0 111.706 -177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.7 t -50.85 149.62 3.36 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 154.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.3 m -68.09 163.94 21.34 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.038 0.535 . . . . 0.0 111.294 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 64.7 tttt 49.51 39.93 17.97 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.116 1.367 . . . . 0.0 111.901 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -102.34 159.75 15.14 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 121.321 -0.862 . . . . 0.0 110.938 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -146.57 151.15 36.84 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.661 1.985 . . . . 0.0 107.703 171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -145.27 -177.88 5.78 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 162.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.22 -61.01 1.52 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -93.11 179.78 5.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.569 0.622 . . . . 0.0 109.598 168.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -128.94 130.23 68.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 125.025 1.33 . . . . 0.0 107.522 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -69.96 60.7 0.18 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.509 2.724 . . . . 0.0 110.599 167.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.0 mttt -56.81 99.17 0.03 OUTLIER 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.877 1.671 . . . . 0.0 108.34 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -83.62 165.6 18.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.312 2.645 . . . . 0.0 108.997 -171.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mp -136.24 153.73 31.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -173.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.473 ' CD1' HD13 ' A' ' 84' ' ' LEU . 2.1 mt -135.04 152.51 51.77 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.663 2.385 . . . . 0.0 108.699 166.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.8 m -126.66 104.02 7.87 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.049 1.34 . . . . 0.0 109.048 -171.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -104.17 98.29 8.12 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -74.17 169.43 17.59 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 167.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.17 -179.33 53.38 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 124.386 0.993 . . . . 0.0 111.205 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -81.31 -1.71 46.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -170.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 149.06 20.63 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.499 0.666 . . . . 0.0 112.427 -168.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -108.45 2.31 22.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 111.914 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -140.19 164.38 30.23 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.5 -0.75 . . . . 0.0 109.758 167.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.16 161.41 33.94 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -173.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 43.3 mtp -117.94 152.61 35.11 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 118.703 1.251 . . . . 0.0 111.732 -169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . 3.2 mm? -109.97 84.98 3.8 Favored Pre-proline 0 C--N 1.328 -0.338 0 C-N-CA 127.63 2.372 . . . . 0.0 106.961 -178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -84.58 160.79 12.56 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 123.41 2.74 . . . . 0.0 110.754 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.86 8.94 81.84 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.469 -0.628 . . . . 0.0 112.844 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 84' ' ' LEU . 2.4 mm? -80.03 -179.0 6.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.652 1.581 . . . . 0.0 108.996 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -123.03 150.82 60.28 Favored Pre-proline 0 C--O 1.236 0.371 0 C-N-CA 122.999 0.52 . . . . 0.0 110.383 171.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -66.55 172.24 9.51 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 122.827 2.351 . . . . 0.0 111.683 172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.3 t80 45.58 36.4 2.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.821 2.848 . . . . 0.0 113.258 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.9 m -133.34 164.51 26.94 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.029 1.732 . . . . 0.0 110.108 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -100.4 152.38 20.42 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -139.37 152.17 46.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.7 m -127.14 134.65 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 153.5 38.16 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.082 1.753 . . . . 0.0 110.761 -170.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.26 124.25 6.78 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.549 1.14 . . . . 0.0 110.435 -162.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.52 131.41 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.676 1.19 . . . . 0.0 108.518 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -125.13 131.72 53.21 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.611 -1.306 . . . . 0.0 109.812 171.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.57 153.7 5.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.97 147.04 28.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 173.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -133.87 -174.91 3.67 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.692 1.197 . . . . 0.0 109.181 171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.05 -3.56 6.42 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 117.667 -1.629 . . . . 0.0 115.114 -174.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -117.33 -30.99 5.42 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 120.315 2.057 . . . . 0.0 111.553 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.73 -173.53 44.52 Favored Glycine 0 CA--C 1.52 0.371 0 CA-C-N 119.409 1.004 . . . . 0.0 113.971 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -86.64 144.22 27.26 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.373 1.069 . . . . 0.0 109.796 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -89.2 -168.77 43.95 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 124.141 0.877 . . . . 0.0 111.96 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 44.4 Cg_endo -63.86 152.4 80.86 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.057 2.505 . . . . 0.0 111.064 169.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.23 139.45 42.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.602 175.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 18' ' ' PRO . 8.6 t -63.41 171.04 2.37 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.114 1.366 . . . . 0.0 108.644 158.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.39 155.7 36.69 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.151 2.567 . . . . 0.0 110.193 -169.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.12 110.04 9.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.6 171.05 14.48 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 170.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.4 m -139.82 161.8 26.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 123.56 0.744 . . . . 0.0 110.549 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.82 161.17 42.9 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.88 1.672 . . . . 0.0 109.081 167.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -128.55 128.77 44.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.759 2.023 . . . . 0.0 107.523 175.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.5 p -87.22 160.5 48.59 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 123.111 0.564 . . . . 0.0 110.503 -170.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.418 ' HD3' HG11 ' A' ' 25' ' ' VAL . 68.7 Cg_endo -79.13 172.04 15.39 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.991 3.127 . . . . 0.0 109.039 -176.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -58.08 -31.49 67.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -167.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.27 -159.01 18.91 Favored Glycine 0 C--O 1.228 -0.26 0 C-N-CA 124.272 0.939 . . . . 0.0 111.371 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.8 p -156.89 101.41 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 161.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.84 102.07 2.2 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.197 -1.335 . . . . 0.0 110.551 -171.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.86 -50.94 0.32 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.566 2.177 . . . . 0.0 110.86 172.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.11 174.67 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.985 1.314 . . . . 0.0 112.067 -163.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.0 m -153.89 -56.1 0.11 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 127.243 2.217 . . . . 0.0 105.214 170.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.233 0 N-CA-C 104.677 -3.369 . . . . 0.0 104.677 140.049 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.933 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.12 176.73 0.04 OUTLIER 'General case' 0 C--O 1.239 0.515 0 C-N-CA 130.049 3.34 . . . . 0.0 107.431 174.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m 72.35 148.74 0.09 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 127.376 2.271 . . . . 0.0 110.379 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.32 -160.99 30.57 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -155.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m 68.72 163.32 0.22 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.13 1.772 . . . . 0.0 110.227 -153.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 m 167.63 -170.45 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 128.8 2.84 . . . . 0.0 109.197 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.15 173.22 13.44 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -161.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 131.81 -173.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 1 C-N-CA 133.221 4.608 . . . . 0.0 102.907 -164.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 p -149.36 173.0 14.0 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 120.629 -1.294 . . . . 0.0 109.708 169.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.93 54.03 40.9 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.24 97.59 3.33 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.115 1.766 . . . . 0.0 106.992 -174.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -76.36 -47.99 21.49 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.452 -168.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt 44.75 133.51 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.055 1 C-N-CA 133.505 4.722 . . . . 0.0 119.561 167.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.39 155.35 55.62 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.211 1.94 . . . . 0.0 111.595 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.7 mtp -111.9 -33.96 6.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -160.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.654 HG22 ' HB2' ' A' ' 42' ' ' SER . 16.2 m -140.47 178.57 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 119.003 0.82 . . . . 0.0 110.587 -165.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.04 145.93 41.03 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 127.663 2.385 . . . . 0.0 109.838 -173.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -72.2 125.88 11.23 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.187 1.925 . . . . 0.0 109.149 174.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.11 -172.09 43.35 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 123.972 0.796 . . . . 0.0 111.667 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.9 t30 40.31 58.49 2.25 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.563 2.345 . . . . 0.0 110.681 172.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -74.69 142.98 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.35 100.42 2.88 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.563 -0.711 . . . . 0.0 109.924 -177.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.25 134.87 47.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -171.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -124.28 135.26 53.26 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.833 1.653 . . . . 0.0 109.89 -177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.2 102.34 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 118.837 0.744 . . . . 0.0 109.764 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.56 -56.76 11.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.768 2.027 . . . . 0.0 111.121 -177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -126.32 173.78 9.06 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 125.447 1.499 . . . . 0.0 107.531 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -30.14 69.51 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.066 -1.021 . . . . 0.0 112.635 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -120.7 10.42 11.0 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.531 1.132 . . . . 0.0 113.078 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.6 tp -133.36 117.23 17.04 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.863 1.665 . . . . 0.0 109.597 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.57 166.06 11.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 165.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.35 148.04 36.5 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.754 2.422 . . . . 0.0 107.956 168.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 44.5 t -127.76 114.94 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -92.78 157.59 16.34 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 124.394 1.059 . . . . 0.0 109.249 166.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -149.76 177.43 9.8 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.168 2.187 . . . . 0.0 109.601 168.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -104.5 133.86 19.97 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.388 0.675 . . . . 0.0 110.785 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.35 107.96 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 125.185 3.923 . . . . 0.0 110.664 -175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 m -57.51 155.47 19.99 Favored Pre-proline 0 C--O 1.24 0.59 0 CA-C-O 119.259 -0.401 . . . . 0.0 110.396 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -59.35 131.55 41.49 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.917 2.411 . . . . 0.0 108.245 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.09 -32.88 62.34 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.124 0.875 . . . . 0.0 112.138 -173.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -49.59 -41.8 42.86 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.69 1.196 . . . . 0.0 111.911 173.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.654 ' HB2' HG22 ' A' ' 16' ' ' VAL . 79.9 p -66.22 -18.66 65.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.861 0.865 . . . . 0.0 112.777 -174.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.74 -34.0 65.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.113 0 CA-C-O 118.364 -0.827 . . . . 0.0 109.125 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 42.57 57.89 3.31 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.373 1.069 . . . . 0.0 111.706 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.08 -168.64 28.86 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -77.36 128.23 33.93 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 49' ' ' GLY . 2.6 tt -60.98 108.49 0.88 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.995 1.318 . . . . 0.0 107.491 172.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' A' ' 48' ' ' GLN . 2.7 mm-40 -85.2 -21.25 29.22 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.522 -0.736 . . . . 0.0 112.04 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.404 ' H ' HD23 ' A' ' 47' ' ' LEU . . . 150.32 -168.89 30.29 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 124.679 1.133 . . . . 0.0 110.945 170.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -124.16 118.27 26.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -96.05 130.92 42.94 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.35 119.76 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -91.16 145.36 24.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 166.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 95' ' ' LEU . 50.9 p90 -156.67 166.0 34.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 120.202 1.364 . . . . 0.0 110.692 173.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -148.41 153.48 38.59 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 123.774 0.829 . . . . 0.0 111.217 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -68.73 128.35 36.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 85.0 m -109.0 128.59 55.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -128.66 115.81 18.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -171.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.6 t -63.64 137.19 58.0 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.6 m 67.09 111.15 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.18 1.392 . . . . 0.0 109.331 -151.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -151.64 68.06 0.89 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.322 1.849 . . . . 0.0 106.379 164.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -64.53 142.94 58.25 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.61 80.66 2.0 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -164.06 117.93 1.46 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.906 1.682 . . . . 0.0 107.567 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 55.11 55.52 7.53 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.279 1.832 . . . . 0.0 111.282 168.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -139.66 126.81 21.13 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.962 1.305 . . . . 0.0 110.718 -165.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 104.59 9.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.119 1.768 . . . . 0.0 112.094 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 86.8 mt -68.18 165.81 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.919 1.687 . . . . 0.0 109.666 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -129.62 94.79 3.83 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.25 1.42 . . . . 0.0 109.57 -171.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -92.68 116.42 29.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.943 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -98.48 179.82 4.58 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.16 0.984 . . . . 0.0 108.781 167.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.4 mm -135.13 163.08 37.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -140.67 155.46 46.5 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.752 1.621 . . . . 0.0 108.355 167.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -116.55 120.74 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.108 1.363 . . . . 0.0 107.613 -165.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -130.32 150.1 51.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -76.38 -175.49 3.26 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.908 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.54 168.7 53.83 Favored Glycine 0 N--CA 1.442 -0.957 0 CA-C-O 122.628 1.127 . . . . 0.0 112.125 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.6 p 59.57 -23.42 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.768 3.627 . . . . 0.0 118.786 173.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.48 150.23 12.22 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.844 0.83 . . . . 0.0 109.237 173.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 p -110.9 14.25 22.1 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.139 172.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -155.47 162.21 40.79 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.949 0.9 . . . . 0.0 112.385 179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.56 -174.67 26.6 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 128.246 2.831 . . . . 0.0 108.169 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 23.4 mtp -131.98 166.55 21.43 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.512 1.156 . . . . 0.0 110.017 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.485 HD13 ' CD1' ' A' ' 73' ' ' LEU . 1.8 mm? -122.5 85.36 48.26 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 125.272 1.429 . . . . 0.0 107.29 168.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -88.39 146.16 6.12 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.283 3.322 . . . . 0.0 111.46 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.59 15.51 18.71 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.628 0.632 . . . . 0.0 113.148 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD21 HD12 ' A' ' 84' ' ' LEU . 3.1 mm? -92.44 177.63 6.07 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.869 0.868 . . . . 0.0 109.081 -165.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.52 147.94 43.05 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 125.08 1.352 . . . . 0.0 108.32 171.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -74.06 164.48 34.3 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.501 2.134 . . . . 0.0 112.292 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.4 t80 61.2 22.81 13.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.678 1.991 . . . . 0.0 112.794 170.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -120.22 162.5 19.27 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.084 1.354 . . . . 0.0 111.414 167.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.08 150.7 23.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.182 2.193 . . . . 0.0 107.145 168.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -137.24 156.26 48.51 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.24 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.3 m -125.89 135.46 51.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 175.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -139.36 154.37 47.84 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.918 1.687 . . . . 0.0 109.358 178.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -138.62 157.26 46.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.89 152.82 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -147.95 145.27 28.52 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 m -95.01 147.67 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.07 146.84 26.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -132.95 -178.2 4.85 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.729 0.812 . . . . 0.0 110.886 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.51 50.4 2.1 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.792 1.187 . . . . 0.0 111.919 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -157.98 -52.79 0.07 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.146 2.178 . . . . 0.0 107.629 165.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -171.13 -172.05 36.95 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 118.538 0.608 . . . . 0.0 113.294 -171.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -97.44 161.59 13.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.249 1.02 . . . . 0.0 112.767 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.39 -170.58 14.93 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.855 1.216 . . . . 0.0 113.493 -178.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.55 141.31 45.73 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 124.159 3.239 . . . . 0.0 111.365 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.85 41.13 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.387 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.4 p -60.54 169.99 1.57 Allowed Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 123.175 0.59 . . . . 0.0 109.493 164.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -54.32 145.81 53.99 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 N-CA-C 108.646 -1.328 . . . . 0.0 108.646 156.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.33 104.55 10.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -80.93 168.13 19.08 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.247 1.819 . . . . 0.0 108.889 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 m -139.18 161.24 28.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 O-C-N 122.1 -0.375 . . . . 0.0 110.307 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -159.02 129.36 5.86 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.554 1.542 . . . . 0.0 110.975 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -86.06 139.43 31.15 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 171.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 38.3 p -94.26 145.28 29.45 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.05 -77.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.269 2.646 . . . . 0.0 112.489 -159.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -159.7 -28.98 0.06 Allowed 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.666 -0.646 . . . . 0.0 111.195 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.54 107.38 1.04 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 125.435 1.493 . . . . 0.0 109.481 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.3 t -146.37 102.34 3.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 170.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.35 116.36 8.76 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 169.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -62.63 162.21 25.5 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 CA-C-N 120.366 2.083 . . . . 0.0 109.958 171.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.2 t -146.33 102.01 3.55 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.209 -0.932 . . . . 0.0 109.03 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.4 m -134.98 177.84 7.49 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.021 0.928 . . . . 0.0 109.3 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 CA-C-O 117.891 -1.505 . . . . 0.0 110.064 179.288 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.183 0 CA-C-O 117.522 -1.71 . . . . 0.0 108.879 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 m 65.04 90.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.027 1.331 . . . . 0.0 111.275 175.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.4 m -151.41 168.16 25.71 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.351 -0.843 . . . . 0.0 109.224 -177.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.51 176.53 34.67 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 m -87.08 95.14 9.84 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.5 t -133.3 150.75 51.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 159.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 122.48 -60.09 0.58 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -173.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.0 m80 52.29 -161.92 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.794 1.238 . . . . 0.0 112.204 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.8 t -149.47 -171.06 3.8 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.168 1.387 . . . . 0.0 109.107 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.06 72.02 1.23 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 125.536 1.541 . . . . 0.0 109.382 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -110.05 -10.29 14.7 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.88 -26.1 34.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.635 161.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.1 148.76 83.92 Favored Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 123.552 0.741 . . . . 0.0 111.743 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HG2' ' CA ' ' A' ' 106' ' ' GLY . 56.8 Cg_endo -80.45 170.09 16.35 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.939 3.093 . . . . 0.0 112.594 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.8 mtm -132.78 -31.38 1.33 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -161.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG22 ' CB ' ' A' ' 42' ' ' SER . 26.1 m -139.48 147.17 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 121.145 1.793 . . . . 0.0 109.818 174.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.607 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -87.04 169.12 15.48 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.921 1.289 . . . . 0.0 109.91 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.607 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 37.2 Cg_endo -74.79 162.32 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.095 1.863 . . . . 0.0 111.81 -168.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.25 166.81 52.9 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.095 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -31.41 104.51 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.517 2.327 . . . . 0.0 114.273 -160.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -69.81 142.98 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -122.3 160.14 25.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.681 1.992 . . . . 0.0 106.985 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.602 HG21 ' CD2' ' A' ' 114' ' ' PHE . 0.1 OUTLIER -147.03 145.73 19.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 168.009 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -123.43 128.32 49.66 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.217 1.807 . . . . 0.0 108.444 172.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.0 t -78.5 103.1 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 170.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.575 ' HB ' HD12 ' A' ' 30' ' ' LEU . 57.4 t -67.32 -48.3 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.409 0.683 . . . . 0.0 109.734 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -143.12 -178.24 5.74 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.176 1.39 . . . . 0.0 108.013 -174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.79 -38.87 92.37 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.893 -1.129 . . . . 0.0 111.959 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.4 p -112.8 6.06 17.84 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.262 1.425 . . . . 0.0 112.098 -171.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.686 HD11 ' CE ' ' A' ' 83' ' ' MET . 2.5 tm? -134.48 137.18 43.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.959 1.703 . . . . 0.0 108.691 -177.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.423 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -135.91 161.29 36.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 168.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -119.88 128.59 53.79 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 127.39 2.276 . . . . 0.0 106.396 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.3 t -106.28 141.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 173.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.96 144.09 51.11 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -147.6 159.68 43.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.029 1.286 . . . . 0.0 109.473 177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.55 142.66 89.2 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.3 113.08 2.29 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.242 2.628 . . . . 0.0 109.049 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.628 HG22 ' HD2' ' A' ' 39' ' ' PRO . 4.9 p -71.94 149.19 92.38 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 118.316 -1.354 . . . . 0.0 109.036 -177.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.628 ' HD2' HG22 ' A' ' 38' ' ' VAL . 37.2 Cg_endo -70.7 137.66 33.19 Favored 'Trans proline' 0 N--CA 1.445 -1.352 1 C-N-CA 125.567 4.178 . . . . 0.0 108.841 -170.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mp -56.17 -28.7 59.11 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.688 0.677 . . . . 0.0 112.043 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -57.72 -42.42 83.76 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 119.25 -0.405 . . . . 0.0 111.522 173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.482 ' CB ' HG22 ' A' ' 16' ' ' VAL . 86.2 p -68.39 -28.65 67.28 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.552 -0.737 . . . . 0.0 112.01 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.9 -40.45 85.79 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 C-N-CA 124.247 1.019 . . . . 0.0 108.455 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 65.12 -70.36 0.09 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.499 1.92 . . . . 0.0 112.294 -170.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.61 -169.82 1.5 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.705 2.098 . . . . 0.0 111.802 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -80.82 138.72 36.24 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.735 0.814 . . . . 0.0 109.847 174.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.451 HD22 ' H ' ' A' ' 49' ' ' GLY . 2.2 tm? -61.05 127.58 32.23 Favored 'General case' 0 C--O 1.23 0.068 0 C-N-CA 124.319 1.048 . . . . 0.0 108.764 174.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -98.75 -23.52 15.39 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.727 0.811 . . . . 0.0 111.985 172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.451 ' H ' HD22 ' A' ' 47' ' ' LEU . . . 132.8 -155.73 21.75 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -169.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -128.53 156.28 43.53 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.621 1.168 . . . . 0.0 107.99 176.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -125.59 109.72 12.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.1 mt -85.42 141.78 14.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -118.41 117.68 29.69 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.96 1.704 . . . . 0.0 108.932 175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.515 ' CD2' HD11 ' A' ' 84' ' ' LEU . 26.5 p90 -133.43 160.63 36.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.429 1.013 . . . . 0.0 112.444 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.4 p90 -149.38 161.0 42.95 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.398 1.479 . . . . 0.0 110.7 171.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -68.79 137.19 53.78 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.296 1.838 . . . . 0.0 108.755 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 88.4 m -127.18 129.98 48.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -162.75 100.85 1.02 Allowed 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -169.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.8 m -63.37 110.05 1.8 Allowed 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.59 129.37 14.22 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 165.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -64.74 104.3 0.81 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 15.2 tptt -138.74 101.31 4.29 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -171.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -69.87 0.43 Allowed 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.175 0.59 . . . . 0.0 112.052 -168.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -71.68 112.0 7.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.464 -168.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 66.95 111.34 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.999 2.119 . . . . 0.0 112.384 177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.3 ttp-105 -145.19 100.7 3.51 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.708 1.203 . . . . 0.0 108.621 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -128.76 176.74 7.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.049 0.939 . . . . 0.0 109.89 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.8 mt -138.11 128.73 36.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -83.05 109.79 17.43 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 163.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -87.12 111.88 21.37 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 166.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -87.4 167.22 14.22 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.506 1.922 . . . . 0.0 109.884 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -135.26 141.02 43.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 124.85 1.26 . . . . 0.0 107.849 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.9 tp -130.58 150.02 51.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.74 2.416 . . . . 0.0 106.879 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.64 137.46 45.41 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.107 0.963 . . . . 0.0 108.957 -170.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -142.43 93.07 2.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.374 1.07 . . . . 0.0 109.814 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -77.55 171.1 15.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.255 0.55 . . . . 0.0 110.329 173.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.43 70.38 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 121.863 -0.523 . . . . 0.0 113.366 175.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.7 t 58.95 20.47 8.2 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.547 1.539 . . . . 0.0 113.332 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -56.53 134.05 53.89 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.7 p -89.66 -1.98 58.17 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.853 1.346 . . . . 0.0 112.069 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -147.53 144.17 28.33 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.54 162.05 32.63 Favored Glycine 0 CA--C 1.519 0.314 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -171.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.686 ' CE ' HD11 ' A' ' 30' ' ' LEU . 27.0 mtp -117.44 148.66 41.59 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.45 -0.441 . . . . 0.0 111.346 -162.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.515 HD11 ' CD2' ' A' ' 54' ' ' TYR . 3.6 mm? -105.38 90.62 4.08 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 128.122 2.569 . . . . 0.0 107.417 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -93.2 162.37 2.53 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.712 2.275 . . . . 0.0 112.734 176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.28 33.34 86.48 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.98 163.08 16.5 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.296 1.038 . . . . 0.0 108.314 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -103.49 134.1 19.94 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -76.98 169.39 21.73 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.445 2.096 . . . . 0.0 111.652 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.7 t80 54.7 43.15 30.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.173 2.189 . . . . 0.0 111.937 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -149.51 162.61 39.8 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 120.727 -1.233 . . . . 0.0 111.112 173.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -93.6 156.14 16.89 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -143.87 159.7 42.08 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.0 m -120.64 130.09 53.99 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.6 163.73 22.8 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.125 1.37 . . . . 0.0 109.971 168.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -147.5 169.08 20.31 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.937 1.295 . . . . 0.0 109.043 165.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.9 t -114.59 132.18 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.2 ttt85 -124.93 144.24 50.45 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 m -87.36 153.56 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.99 142.49 31.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.549 1.539 . . . . 0.0 106.868 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -144.53 -175.44 4.65 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.326 0.584 . . . . 0.0 111.125 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.43 -1.06 2.98 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 117.834 -1.537 . . . . 0.0 115.872 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -124.09 -36.26 2.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 120.56 2.18 . . . . 0.0 111.323 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 175.57 -150.55 10.98 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 121.697 0.609 . . . . 0.0 112.208 -174.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.74 159.01 22.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.726 1.61 . . . . 0.0 107.91 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.451 ' CA ' ' HG2' ' A' ' 14' ' ' PRO . . . -102.94 -162.24 25.74 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.874 0.75 . . . . 0.0 113.574 171.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.76 162.38 25.32 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 159.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -99.56 166.02 11.35 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.482 172.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.8 p -65.99 179.36 0.47 Allowed Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.419 1.088 . . . . 0.0 109.544 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.75 168.71 6.6 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 120.356 1.163 . . . . 0.0 109.561 171.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 137.72 58.23 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 121.087 -1.008 . . . . 0.0 108.858 160.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -115.3 158.24 22.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 161.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.9 m -134.54 161.27 40.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.602 ' CD2' HG21 ' A' ' 23' ' ' VAL . 45.7 p90 -150.61 136.51 18.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 166.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -91.86 128.85 37.85 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.07 0.948 . . . . 0.0 108.748 171.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.7 p -78.21 163.78 60.3 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.979 -0.534 . . . . 0.0 109.6 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -73.67 -114.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.686 2.924 . . . . 0.0 110.192 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -123.79 -31.9 3.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.387 1.449 . . . . 0.0 112.975 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.17 -172.28 22.23 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -164.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.9 t -176.32 -75.12 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 103.838 -2.653 . . . . 0.0 103.838 162.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 165.18 147.92 5.3 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -71.9 101.06 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.75 2.967 . . . . 0.0 109.864 -174.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.8 t -147.7 148.42 30.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.944 1.698 . . . . 0.0 107.354 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.2 m -157.79 88.74 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 163.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 163.694 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.758 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -124.97 160.54 28.69 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.428 1.091 . . . . 0.0 109.483 -171.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -60.63 163.81 5.15 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.92 1.288 . . . . 0.0 110.102 166.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.85 171.2 37.73 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.3 m -139.39 118.81 12.89 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.028 0.931 . . . . 0.0 109.067 -174.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.8 m -146.32 -176.3 5.11 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.354 2.262 . . . . 0.0 107.149 165.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.13 179.85 18.3 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -171.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -161.54 156.72 23.78 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.23 1.012 . . . . 0.0 108.911 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 t -135.94 -39.31 0.7 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.872 0.469 . . . . 0.0 110.013 161.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.79 -71.8 2.67 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -78.08 -90.85 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.494 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -168.09 -51.16 0.02 OUTLIER 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.168 1.349 . . . . 0.0 113.319 164.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.5 mt 46.11 158.39 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 130.894 3.678 . . . . 0.0 116.67 -163.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.45 167.41 16.9 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.348 2.699 . . . . 0.0 111.361 171.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 50.9 mtm -123.2 -35.24 3.01 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.44 1.496 . . . . 0.0 113.507 -168.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.69 HG22 ' CB ' ' A' ' 42' ' ' SER . 15.3 m -137.69 -176.88 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.342 0.973 . . . . 0.0 110.368 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB1' ' HD2' ' A' ' 18' ' ' PRO . . . -125.41 171.41 7.63 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 127.503 2.321 . . . . 0.0 109.685 -177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HD2' ' HB1' ' A' ' 17' ' ' ALA . 6.6 Cg_endo -63.97 141.54 77.82 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 120.97 1.113 . . . . 0.0 110.475 164.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.73 -177.49 31.91 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -23.9 87.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 129.942 3.297 . . . . 0.0 114.038 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.58 145.36 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -120.62 157.91 28.51 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 126.213 1.805 . . . . 0.0 106.859 169.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 141.84 21.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 173.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -124.29 136.75 54.35 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.383 1.473 . . . . 0.0 108.579 176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 115' ' ' ASN . 80.8 t -95.8 105.13 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 122.277 1.037 . . . . 0.0 108.726 177.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.719 ' HB ' HD12 ' A' ' 30' ' ' LEU . 85.6 t -80.11 -48.82 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.491 -173.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -130.91 -178.14 4.68 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.8 -29.78 64.81 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.626 -1.296 . . . . 0.0 112.922 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 59.6 p -123.88 14.24 9.25 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 111.096 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.719 HD12 ' HB ' ' A' ' 26' ' ' VAL . 3.3 tm? -124.89 137.04 54.3 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.795 1.638 . . . . 0.0 106.628 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.55 ' N ' HD13 ' A' ' 30' ' ' LEU . . . -138.5 155.55 48.32 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 167.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.01 150.36 38.74 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 125.088 1.355 . . . . 0.0 107.771 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 42.6 t -129.27 135.11 62.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.18 123.59 32.47 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.2 p90 -129.63 157.93 40.73 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 110.63 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.86 139.28 95.61 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.185 0.994 . . . . 0.0 111.369 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.38 109.07 2.84 Favored 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 123.549 2.833 . . . . 0.0 111.084 174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HA ' ' HD3' ' A' ' 39' ' ' PRO 0.32 48.9 t -79.61 159.17 72.41 Favored Pre-proline 0 N--CA 1.409 -2.492 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 -169.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' VAL . 4.7 Cg_exo -59.6 147.2 92.81 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 125.232 3.955 . . . . 0.0 111.124 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 43' ' ' ILE . 2.5 mm? -66.83 -35.41 79.98 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.618 -0.676 . . . . 0.0 109.267 160.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -49.47 -36.69 23.52 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.201 0.6 . . . . 0.0 111.687 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.69 ' CB ' HG22 ' A' ' 16' ' ' VAL . 9.3 p -91.0 -13.67 32.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.676 HD13 ' HB2' ' A' ' 47' ' ' LEU . 85.4 mt -68.12 -38.52 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 120.44 1.473 . . . . 0.0 108.634 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 47.7 56.4 7.18 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.238 1.015 . . . . 0.0 110.659 -173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.36 -179.21 32.4 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -73.05 144.45 47.09 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 158.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.676 ' HB2' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -77.24 122.69 25.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -75.41 -24.27 57.12 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.978 1.711 . . . . 0.0 111.009 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.95 -177.74 32.04 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 125.836 1.684 . . . . 0.0 109.338 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -99.76 129.18 45.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -113.2 102.5 10.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.499 1.519 . . . . 0.0 107.837 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.6 mt -78.0 121.53 30.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 172.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -91.69 151.05 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 162.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -157.32 164.78 37.24 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.205 1.402 . . . . 0.0 111.043 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 47.2 p90 -149.22 158.65 44.35 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.255 1.022 . . . . 0.0 111.667 168.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -68.71 134.1 49.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.2 m -120.56 148.5 43.78 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -173.73 164.64 4.39 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.705 1.602 . . . . 0.0 110.165 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.5 m -74.27 -86.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.567 1.147 . . . . 0.0 109.105 151.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.5 m -156.35 169.09 25.38 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.761 1.224 . . . . 0.0 110.725 -160.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.2 t -146.33 -80.96 0.15 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 165.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -153.1 42.85 0.61 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.245 1.018 . . . . 0.0 110.425 175.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.06 149.46 23.12 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.525 -1.36 . . . . 0.0 111.04 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -160.99 67.12 0.31 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.49 1.116 . . . . 0.0 110.578 168.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.6 ttt-85 -153.04 70.67 0.88 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 120.903 -1.123 . . . . 0.0 111.583 170.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -163.22 173.73 13.0 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.832 1.253 . . . . 0.0 109.308 164.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -82.91 158.43 22.64 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 118.572 0.624 . . . . 0.0 110.675 169.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.0 mt -74.09 123.33 29.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 167.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -75.22 126.63 31.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.472 1.909 . . . . 0.0 108.851 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -109.66 113.08 25.55 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.601 1.56 . . . . 0.0 110.0 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -92.71 164.4 13.4 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.875 1.67 . . . . 0.0 111.312 -171.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -137.52 153.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.037 1.735 . . . . 0.0 106.575 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 tp -131.14 163.16 28.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.277 2.631 . . . . 0.0 107.196 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.4 m -138.25 120.58 15.9 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -132.08 102.67 5.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.977 1.311 . . . . 0.0 107.603 172.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -84.63 163.75 19.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.483 1.113 . . . . 0.0 108.943 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.26 171.35 25.31 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.5 p -78.6 27.41 0.21 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.85 1.26 . . . . 0.0 113.875 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -52.16 145.32 10.78 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.598 1.159 . . . . 0.0 110.73 177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -112.75 10.85 19.3 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.135 1.374 . . . . 0.0 111.956 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 1.5 p80 -148.67 156.53 42.51 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.31 1.044 . . . . 0.0 109.787 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.19 117.89 0.61 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.592 0.615 . . . . 0.0 112.033 -173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.697 ' HE2' HD11 ' A' ' 30' ' ' LEU . 9.7 mtp -76.02 153.0 36.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.886 0.875 . . . . 0.0 112.833 -171.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.71 88.22 1.75 Allowed Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 128.119 2.568 . . . . 0.0 108.163 166.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -92.75 158.99 2.83 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.11 2.54 . . . . 0.0 112.073 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.21 18.18 79.48 Favored Glycine 0 CA--C 1.528 0.883 0 O-C-N 121.509 -0.744 . . . . 0.0 113.366 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.5 -176.83 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.407 1.883 . . . . 0.0 110.224 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . 15.2 mt-10 -102.54 147.56 34.2 Favored Pre-proline 0 C--O 1.242 0.689 0 CA-C-N 118.746 0.703 . . . . 0.0 111.229 168.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 88' ' ' GLU . 8.8 Cg_endo -73.51 176.8 8.8 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.807 3.005 . . . . 0.0 113.139 171.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 31.2 t80 48.52 29.32 2.03 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.977 2.511 . . . . 0.0 115.225 170.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.1 m -128.75 -175.44 3.54 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.151 1.38 . . . . 0.0 111.183 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -122.46 152.37 40.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.964 1.306 . . . . 0.0 107.772 171.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -144.55 158.2 43.87 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.53 1.132 . . . . 0.0 108.964 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 m -122.75 141.56 51.67 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.89 149.23 33.86 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 126.75 2.02 . . . . 0.0 110.181 173.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -137.22 128.17 27.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.038 1.735 . . . . 0.0 108.949 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -89.34 144.21 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -151.96 154.06 35.31 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 119.913 -1.742 . . . . 0.0 108.699 177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.59 146.78 5.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.1 t -130.12 140.21 49.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 105.164 -2.161 . . . . 0.0 105.164 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -135.47 -178.31 5.06 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.252 1.021 . . . . 0.0 109.446 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.96 -36.27 89.72 Favored Glycine 0 CA--C 1.527 0.825 0 O-C-N 121.91 -0.494 . . . . 0.0 112.94 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 tptt -75.2 -46.39 34.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.737 0.768 . . . . 0.0 110.427 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.99 -134.44 2.52 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 118.668 0.667 . . . . 0.0 111.86 -171.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -136.14 165.43 25.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.343 2.257 . . . . 0.0 108.869 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -127.74 -153.98 8.32 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.37 0.985 . . . . 0.0 112.004 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 56.9 Cg_endo -65.29 137.14 50.27 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.865 1.71 . . . . 0.0 109.318 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 162.8 28.61 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.782 0.801 . . . . 0.0 109.384 172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HD2' ' A' ' 110' ' ' PRO . 99.1 p -71.3 171.84 7.95 Favored Pre-proline 0 CA--C 1.546 0.809 0 O-C-N 121.261 -0.9 . . . . 0.0 110.179 168.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 109' ' ' SER . 40.4 Cg_endo -64.18 136.92 54.07 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.716 1.611 . . . . 0.0 110.379 168.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.5 106.09 0.88 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.226 1.811 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.42 167.25 22.05 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.986 1.314 . . . . 0.0 110.417 171.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.92 166.36 29.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.114 1.365 . . . . 0.0 108.899 173.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -156.32 158.76 38.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.784 0.834 . . . . 0.0 109.64 163.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.468 ' O ' HG21 ' A' ' 25' ' ' VAL . 7.5 p30 -112.52 152.98 28.16 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 126.003 1.721 . . . . 0.0 108.195 171.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 153.68 39.21 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 119.257 0.935 . . . . 0.0 110.887 173.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.57 -75.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.588 2.859 . . . . 0.0 113.126 -168.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -158.2 -35.23 0.07 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.208 1.403 . . . . 0.0 112.828 170.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.9 74.27 0.8 Allowed Glycine 0 N--CA 1.452 -0.264 0 O-C-N 121.149 -0.969 . . . . 0.0 110.903 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.4 p 51.23 80.54 0.08 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.651 1.98 . . . . 0.0 111.238 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -135.38 172.28 22.21 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 162.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -79.41 63.5 8.73 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 125.074 3.849 . . . . 0.0 111.689 -165.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.8 t -63.38 150.73 42.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.344 0.657 . . . . 0.0 110.103 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -143.37 172.12 13.2 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.399 1.88 . . . . 0.0 106.609 174.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.204 0 CA-C-O 116.595 -2.225 . . . . 0.0 110.427 -174.7 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.897 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 m 46.77 -153.53 0.06 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.388 1.075 . . . . 0.0 109.867 -162.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 t -104.44 178.04 4.67 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.686 1.13 . . . . 0.0 109.401 175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.12 72.52 0.06 OUTLIER Glycine 0 C--N 1.339 0.732 0 C-N-CA 124.066 0.841 . . . . 0.0 111.176 172.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 p 177.56 157.85 0.38 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.738 2.415 . . . . 0.0 108.454 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 m -168.54 67.24 0.07 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.147 1.379 . . . . 0.0 110.393 166.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.24 154.68 30.87 Favored Glycine 0 N--CA 1.471 0.974 0 O-C-N 120.521 -1.362 . . . . 0.0 113.643 171.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -154.47 149.09 26.39 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.736 1.214 . . . . 0.0 111.788 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 m -84.47 -176.88 6.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.805 2.042 . . . . 0.0 111.808 162.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.24 91.02 1.81 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 167.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.37 -9.11 7.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 124.726 1.211 . . . . 0.0 112.459 170.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.57 -11.86 12.96 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.507 1.123 . . . . 0.0 109.903 175.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 mt -74.71 153.85 87.28 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 120.214 1.37 . . . . 0.0 109.627 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -65.06 164.69 24.13 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.585 1.524 . . . . 0.0 110.354 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.1 mtm -107.77 -35.07 6.78 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.093 0.957 . . . . 0.0 112.023 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 42' ' ' SER . 32.6 m -131.06 160.71 42.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.318 0.963 . . . . 0.0 111.484 -163.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.57 68.69 Favored Pre-proline 0 N--CA 1.439 -0.999 0 C-N-CA 126.488 1.915 . . . . 0.0 107.807 161.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -59.61 164.42 11.38 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 109.556 -0.979 . . . . 0.0 109.556 161.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.55 -165.36 2.74 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 125.445 1.498 . . . . 0.0 113.731 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -54.48 115.94 2.39 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.1 t -81.28 154.0 4.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -124.25 154.5 40.1 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.901 2.08 . . . . 0.0 106.411 170.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -146.71 138.96 19.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 167.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.539 HD21 ' CD2' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -124.09 118.9 27.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.312 2.245 . . . . 0.0 105.457 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 117' ' ' PRO . 64.7 t -64.8 134.76 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 166.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -94.89 -52.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -141.52 -175.6 4.43 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 125.241 1.416 . . . . 0.0 109.12 -170.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -33.09 74.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.366 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.6 p -133.59 36.8 3.33 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.369 1.068 . . . . 0.0 109.519 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.503 HD11 ' HE2' ' A' ' 83' ' ' MET . 1.4 tm? -151.81 137.08 17.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 124.125 0.97 . . . . 0.0 109.701 171.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.39 138.37 24.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.427 ' HB3' HD22 ' A' ' 24' ' ' ASN . 1.1 tp10 -105.46 125.24 50.76 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.4 t -99.12 145.35 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 174.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.539 ' CD2' HD21 ' A' ' 24' ' ' ASN . 39.3 m-70 -127.8 147.76 50.43 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.278 0.631 . . . . 0.0 109.506 170.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.7 p90 -135.73 -175.08 3.84 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.433 1.493 . . . . 0.0 108.369 168.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -114.08 136.85 22.22 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.44 112.44 2.82 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.347 2.698 . . . . 0.0 111.704 -172.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.624 HG12 ' HD2' ' A' ' 39' ' ' PRO . 0.9 OUTLIER -70.52 143.02 89.67 Favored Pre-proline 0 N--CA 1.41 -2.432 0 C-N-CA 124.756 1.222 . . . . 0.0 110.205 -171.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.624 ' HD2' HG12 ' A' ' 38' ' ' VAL . 2.5 Cg_endo -62.19 133.44 43.78 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 125.812 4.341 . . . . 0.0 111.864 179.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -58.42 -36.3 73.4 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 175.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -52.19 -36.57 52.25 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.407 ' HB2' HG22 ' A' ' 16' ' ' VAL . 6.2 p -94.99 -13.97 24.8 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.859 0.864 . . . . 0.0 112.971 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 47' ' ' LEU . 64.9 mt -68.41 -34.67 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.477 1.035 . . . . 0.0 109.703 164.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 60.36 6.87 1.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.839 1.656 . . . . 0.0 115.083 -175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.15 -166.73 23.53 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.398 0.999 . . . . 0.0 110.625 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -70.27 118.97 13.76 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.641 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.0 tm? -59.83 122.8 15.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.833 1.253 . . . . 0.0 107.79 167.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -85.32 -32.88 22.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.756 0.822 . . . . 0.0 111.198 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 76' ' ' GLN . . . 156.32 -178.56 32.75 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.856 -0.897 . . . . 0.0 110.856 -175.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -116.56 112.6 21.57 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -87.68 109.44 19.69 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.9 mt -85.16 122.74 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -91.97 153.02 19.74 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 157.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.481 ' CE1' HD12 ' A' ' 73' ' ' LEU . 33.8 p90 -160.61 159.71 30.81 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.28 1.832 . . . . 0.0 109.482 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -148.99 153.21 37.6 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.695 0.798 . . . . 0.0 110.735 172.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -68.58 118.6 11.81 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.041 -2.207 . . . . 0.0 105.041 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 41.3 m -89.38 143.9 26.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -124.57 -90.92 0.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.1 t -152.71 156.2 38.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.639 1.576 . . . . 0.0 107.373 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.77 2.58 5.43 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -160.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 t -126.06 112.32 15.73 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 120.086 1.312 . . . . 0.0 108.988 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mttm 37.94 78.31 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 128.736 2.814 . . . . 0.0 112.595 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -129.67 133.92 47.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.99 120.39 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.75 148.77 24.42 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 174.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -57.98 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.906 0.776 . . . . 0.0 111.206 172.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -152.88 165.36 35.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.7 1.6 . . . . 0.0 108.128 -172.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 40.9 mt -91.55 122.19 42.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.4 127.61 33.09 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 165.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -131.79 156.38 46.09 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.32 1.048 . . . . 0.0 108.984 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 18.8 mmtt -141.06 171.07 14.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.644 0.735 . . . . 0.0 111.76 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.63 148.25 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.975 1.71 . . . . 0.0 106.69 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.527 ' CD1' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -130.3 147.47 52.02 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.717 2.007 . . . . 0.0 107.722 172.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.4 m -120.29 91.51 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 108.757 -164.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 66.4 m-85 -94.09 76.85 4.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.409 ' HA ' ' HA3' ' A' ' 49' ' ' GLY . 4.0 pt20 -67.03 144.74 55.99 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.319 176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.93 167.33 40.15 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.349 0.976 . . . . 0.0 112.528 -175.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -79.57 16.92 0.96 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.324 2.25 . . . . 0.0 115.276 -167.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.07 163.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.794 1.637 . . . . 0.0 113.178 174.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -125.29 9.49 7.94 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -148.71 163.8 36.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.412 1.085 . . . . 0.0 108.954 173.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.63 165.66 36.34 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.503 ' HE2' HD11 ' A' ' 30' ' ' LEU . 46.1 mtp -111.91 150.56 30.3 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.134 0.974 . . . . 0.0 109.457 -168.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 73' ' ' LEU . 3.9 mm? -115.46 79.85 7.41 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 167.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -86.75 162.37 9.18 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 110.247 165.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.49 15.18 74.4 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.935 0.779 . . . . 0.0 113.341 179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.461 HD21 HD12 ' A' ' 84' ' ' LEU . 1.3 mm? -93.7 171.22 9.02 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.667 1.587 . . . . 0.0 108.723 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.2 156.74 35.5 Favored Pre-proline 0 C--O 1.236 0.373 0 C-N-CA 124.359 1.064 . . . . 0.0 110.12 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -82.7 177.25 7.04 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 124.481 3.454 . . . . 0.0 112.957 168.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 45.9 t80 38.24 57.32 1.66 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.724 2.81 . . . . 0.0 111.85 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.5 m -149.98 157.79 43.51 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.378 1.871 . . . . 0.0 109.124 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -90.62 150.72 21.59 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' CE1' HD12 ' A' ' 87' ' ' LEU . 38.5 m-85 -134.93 154.83 51.55 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.886 1.274 . . . . 0.0 108.162 175.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.2 m -125.93 138.88 53.8 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 172.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 HG11 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -144.47 162.85 35.5 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.388 2.275 . . . . 0.0 109.697 177.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -134.45 -176.08 4.09 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.74 139.52 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.561 1.944 . . . . 0.0 106.394 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -140.89 128.82 21.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.683 1.193 . . . . 0.0 107.798 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 m -74.65 153.41 6.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.6 t -138.03 150.03 24.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 171.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -138.95 -168.9 2.52 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 124.023 0.929 . . . . 0.0 109.123 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.8 -5.88 4.5 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.456 -1.191 . . . . 0.0 116.036 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -119.02 -47.89 2.47 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 120.182 1.991 . . . . 0.0 111.358 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -177.3 -166.66 34.46 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 120.689 1.586 . . . . 0.0 113.427 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -95.58 167.85 11.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.884 1.273 . . . . 0.0 110.259 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -128.6 -157.32 9.26 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.617 1.579 . . . . 0.0 112.582 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.06 150.48 82.51 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.917 2.411 . . . . 0.0 110.222 177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.43 164.6 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.089 0.947 . . . . 0.0 112.131 -175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 p -69.19 177.22 1.25 Allowed Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.247 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.98 146.87 15.91 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.73 1.62 . . . . 0.0 110.087 158.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.78 100.5 6.31 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 168.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.9 mmt-85 -76.57 162.98 27.33 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.872 -0.518 . . . . 0.0 110.267 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.78 157.37 38.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.333 0.653 . . . . 0.0 110.046 174.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -150.49 146.74 26.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.382 1.073 . . . . 0.0 109.245 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -109.75 145.11 37.19 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.355 1.062 . . . . 0.0 108.4 169.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.72 169.2 19.61 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.775 177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' HG11 ' A' ' 25' ' ' VAL . 12.9 Cg_endo -68.23 -75.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.451 2.101 . . . . 0.0 109.266 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -172.45 -39.14 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.212 1.405 . . . . 0.0 110.592 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.88 147.11 8.56 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.718 1.628 . . . . 0.0 112.258 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 42.7 23.31 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.524 3.13 . . . . 0.0 118.743 175.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.94 162.51 28.79 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 120.911 -1.118 . . . . 0.0 110.326 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.97 167.33 26.98 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.735 2.957 . . . . 0.0 112.162 -170.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.8 m -143.0 111.4 6.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 163.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.17 148.63 16.97 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 164.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.647 0 N-CA-C 108.686 -1.765 . . . . 0.0 108.686 -172.886 . . . . . . . . 0 0 . 1 stop_ save_